Systems and Methods for Stable and Heritable Alteration by Precision Editing (SHAPE)

ABSTRACT

Described herein are systems, methods, and compositions for the precise editing of DNA sequence(s) at specific loci to alter expression of target gene products at the pre-transcriptional or post-transcriptional level in a durable fashion, termed Stable and Heritable Alteration by Precision Editing (SHAPE). The SHAPE platform utilizes genetic modifiers (e.g., nucleases, (CRISPR guided) transposases, recombinases, base editors, and prime editors) to install specific sequence motifs at target sequences through precision genome engineering.

CLAIM OF PRIORITY

This application is a U.S. National Phase Application under 35 U.S.C. §371 of International Patent Application No. PCT/US2021/034996, filed onMay 28, 2021, which claims the benefit of U.S. Provisional patentapplication Ser. No. 63/032,486, filed on May 29, 2020. The entirecontents of the foregoing are hereby incorporated by reference.

FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT

This invention was made with Government support under Grant Nos.GM118158, CA211707, CA204954, and HG010717 awarded by the NationalInstitutes of Health. The Government has certain rights in theinvention.

SEQUENCE LISTING

This application contains a Sequence Listing that has been submittedelectronically as an ASCII text file named ‘29539 0527US1 SequenceListing’. The ASCII text file, created on Nov. 21, 2022, is 891kilobytes in size. The material in the ASCII text file is herebyincorporated by reference in its entirety.

TECHNICAL FIELD

Described herein are systems, methods, and compositions for the preciseediting of DNA sequence(s) at specific loci to alter expression oftarget gene products at the pre-transcriptional or post-transcriptionallevel in a durable fashion, termed Stable and Heritable Alteration byPrecision Editing (SHAPE). The SHAPE platform utilizes genetic modifiers(e.g., nucleases, (CRISPR guided) transposases, recombinases, baseeditors, and prime editors) to install specific sequence motifs attarget sequences through precision genome engineering.

BACKGROUND

Precisely controlling gene expression in biosystems has importantapplications in biotechnology and therapeutic settings^(5 6 6, 7).Pre-transcriptional strategies for gene regulation include the use ofartificial transcription factors (ATFs) where a programmable DNA-bindingdomain (e.g., zinc fingers, transcription activator-like effectors,CRISPR-Cas) is coupled with an effector domain (e.g., VP64, p65, KRAB)to alter gene transcription⁶, whereas post-transcriptional strategiesinclude targeted protein degradation (TPD) and RNA interference (RNAi).These gene regulation strategies are transient in nature and requirere-dosing or constitutive expression of the exogenous biomolecules tohave durable and sustained effect(s). There remains a need for durablegene regulation strategies that don't require constitutive presence ofexogenous biomolecules.

SUMMARY

Described herein are genome engineering strategies for the preciseinstallation of sequence motifs at specific loci to alter expression oftarget gene products at the pre-transcriptional or post-transcriptionallevel, termed Stable and Heritable Alteration by Precision Editing(SHAPE). The SHAPE platform includes the identification of 1) functionalsequence motifs with regulatory potential, 2) target regions forsequence modification to take place, and 3) genetic modifiers to use toachieve the precise edit of interest to ultimately induce targeted geneexpression change(s) for a cell type or cell types of interest (Table 1and 2).

Thus, provided herein are methods for identifying a method for alteringexpression of target genes in selected cell types.

Thus, provided herein are methods for identifying a genetic modifier toalter expression of a target gene in a selected cell type. The methodsinclude: providing, optionally from a database, one or more candidateregulatory motif sequences with regulatory potential (as describedherein, e.g., binding sites for transcription factors or other factorsthat affect gene expression and are expressed in the cell, e.g.,endogenous factors) in the selected cell type; selecting a sequence of aputative regulatory region of the target gene, preferably wherein theputative regulatory region is in a promoter, enhancer, insulator,untranslated region (UTR), or intron, optionally in a non-coding regionof the target gene; comparing the sequence of the putative regulatoryregion to the candidate regulatory motif sequences, identifying acandidate regulatory motif sequence that has either little to noidentity at all (e.g., for the insertion strategy) as a potentialinsertion site or that has at least 50% identity and at least onemismatch (i.e., not 100% identity, for the substitution strategy) to a(corresponding) portion of the sequence of the regulatory sequence as apotential substitution site;

determining sequence alterations needed to make the putative regulatoryregion match (e.g., to include or have 100% identity with) the candidateregulatory motif sequence; and

identifying one or more genetic modifiers capable of making the sequencealterations needed to make the putative regulatory region match thecandidate regulatory motif sequence. In some embodiments, identifying agenetic modifier comprises using a computer or an algorithm thatcompares the putative regulatory region and candidate regulatory motifsequences from a database and identifies candidate regulatory motifsequences that differ from the putative regulatory region by at leastone nucleotide and up to 100% as a potential insertion site, or thatdiffer from the putative regulatory region by at least one nucleotideand up to a selected amount, optionally at least 50% identity, as apotential substitution site, determines sequence alterations needed tomake the putative regulatory region match the candidate regulatory motifsequence, compares the sequence alterations to a database ofmodifications that could be made by a set of genetic modifiers, andidentifying one or more genetic modifiers that can alter the putativeregulatory region to match the candidate regulatory motif sequence, tothereby introduce a functional regulatory motif.

In some embodiments, the candidate regulatory sequence motif hasregulatory potential to affect target gene expression at thepre-transcriptional or post-transcriptional level.

In some embodiments, the candidate regulatory sequence motif is atranscription factor binding sequence that can recruit endogenoustranscription factors within a cell type or cell types of interest(e.g., cell type-specific factors), where the sequence motif may or maynot exist in the genome of the selected cell type.

In some embodiments, the candidate regulatory sequence motif altersspacing of endogenous transcription factor binding sites in the putativeregulatory region.

In some embodiments, the candidate regulatory sequence motif is aresponse element that is activated by a receptor-ligand complex throughbinding of an exogenously delivered small molecule, hormone, or drug forinducible target gene activation.

In some embodiments, the candidate regulatory sequence motif eitherstabilizes or de-stabilizes target gene transcripts, where the candidateregulatory sequence motif may or may not exist in the genome of theselected cell type.

In some embodiments, the candidate regulatory sequence motif is ahybridization target for endogenous non-coding RNAs (e.g., miRNAs,siRNAs, lncRNAs), where the sequence motif may or may not exist in thegenome of interest.

In some embodiments, the candidate regulatory sequence motif modifiesthe translation initiation and/or elongation efficiency for target genetranscripts (e.g., Kozak sequence, optimal codon structure), and whereinthe candidate regulatory sequence motif may or may not exist in thegenome of the selected cell type.

In some embodiments, the putative regulatory region has the potential tomodify expression of the target gene at the pre-transcriptional orpost-transcriptional level.

In some embodiments, the putative regulatory region is a non-coding DNAsequence within 1 Mb or more of a target gene of interest, orspatially-proximal as determined by chromosome conformation captureassays.

In some embodiments, the putative regulatory region is a promoter of atarget gene of interest, e.g., a proximal regions e.g., 1000 bp upstreamand 500 bp downstream of the transcription start site (TSS).

In some embodiments, the putative regulatory region comprises putativeenhancer elements of a target gene of interest as defined by histonemarks associated and/or chromatin accessibility features associated withfunctional enhancer elements (e.g., H3K4me1, H3K27ac); putativeinsulator elements of the target gene of interest as defined by histonemarks associated and/or chromatin accessibility features associated withfunctional insulator elements; and/or putative silencer elements of thetarget genes of interest as defined by histone marks associated and/orchromatin accessibility features associated with functional silencerelements.

In some embodiments, the putative regulatory region comprisesuntranslated regions (UTRs) of the target gene transcripts.

In some embodiments, the putative regulatory regions comprise anintronic region of the target gene transcripts.

In some embodiments, the putative regulatory regions comprises a codingsequence of target gene transcripts.

In some embodiments, the identified genetic modifier can introduce aspecific sequence motif or modification at the target genomic region.

In some embodiments, the genetic modifier comprises a CRISPR-Cas domain,a zinc-finger DNA binding domain, or a transcription activator-like(TAL) effector domain.

In some embodiments, the CRISPR-Cas domain is used with a gRNA, whereinthe gRNA comprises a sequence complementary to a sequence of the targetcis-regulatory element of interest.

In some embodiments, the genetic modifier is a programmable nuclease(e.g., zinc finger nucleases, transcription activator-like effectornucleases, Cas9, CasX, Cas12), a base editor (e.g., ABE, CBE), or aprime editor (e.g., SpCas9H840A-MMLV-RT).

In some embodiments, the CRISPR-Cas prime editor further comprises aprime editing gRNA (pegRNA) and nicking sgRNA (ngRNA) wherein the pegRNAand ngRNA comprise a sequence complementary to a sequence of the targetcis-regulatory element of interest.

Also provided herein are methods for altering expression of a targetgene in a selected cell type. The methods include providing, optionallyfrom a database, one or more candidate regulatory motif sequences withregulatory potential in the selected cell type; selecting a sequence ofa putative regulatory region of the target gene, preferably wherein theputative regulatory region is in a promoter, enhancer, insulator,untranslated region (UTR), or intron, optionally in a non-coding regionof the target gene; comparing the sequence of the putative regulatoryregion to the candidate regulatory motif sequences, identifying acandidate regulatory motif sequence that has either no identity at allas a potential insertion site or that has at least 50% identity and atleast one mismatch to a portion of the sequence of the regulatorysequence as a potential substitution site; determining sequencealterations needed to make the putative regulatory region match thecandidate regulatory motif sequence; and identifying one or more geneticmodifiers capable of making the sequence alterations needed to make theputative regulatory region match the candidate regulatory motifsequence, and contacting the cell with the one or more genetic modifiersunder conditions and for a time sufficient for the one or more geneticmodifiers to make the putative regulatory region match the candidateregulatory motif sequence.

In some embodiments, identifying a genetic modifier comprises using acomputer or an algorithm that compares the putative regulatory regionand candidate regulatory motif sequences from a database and identifiescandidate regulatory motif sequences that differ from the putativeregulatory region by at least one nucleotide and up to 100% as apotential insertion site, or that differ from the putative regulatoryregion by at least one nucleotide and up to a selected amount,optionally at least 50% identity, as a potential substitution site,determines sequence alterations needed to make the putative regulatoryregion match the candidate regulatory motif sequence, compares thesequence alterations to a database of modifications that could be madeby a set of genetic modifiers, and identifying one or more geneticmodifiers that can alter the putative regulatory region to match thecandidate regulatory motif sequence, to thereby introduce a functionalregulatory motif.

Also provided herein are methods for altering expression of a targetgene in a selected cell, the method comprising contacting the selectedcell with a genetic modifier identified using a method described herein,under conditions sufficient to increase the target gene expression inthe cell.

Additionally, provided herein are methods for heterotopic activation ofa target gene expression in a selected cell, the method comprisingcontacting the cell with a genetic modifier identified using a methoddescribed herein, under conditions sufficient to increase the targetgene expression in the cell.

In some embodiments, the candidate regulatory sequence motif isintroduced into the putative regulatory region as a single motif or arepetitive sequence with multiple copies of the single motif, optionallywith linker sequences therebetween.

In some embodiments, the genetic modifier introduces multiplex edits(e.g., installation of multiple transcription factor binding sites) inorder to induce more robust modification of a single target geneexpression. For example, a single type of modifier such as a primeeditor or CRISPR Cas domain containing protein can be used, wherein thatmodifier is guided to multiple locations in the genome via multipleguide RNAs to enable multiplex edits.

In some embodiments, the genetic modifier introduces multiplex edits(e.g., installation of multiple transcription factor binding sites) inorder to perform multi-gene expression control.

In some embodiments, the cell is a eukaryotic cell, e.g., a mammaliancell, e.g., a human cell.

Also provided herein are methods for treating or reducing risk of acondition or a disease in a subject, wherein the condition or thedisease is caused, at least in part, by insufficient expression of thetarget gene, the method comprising administering to the subject aneffective amount of a genetic modifier identified using a methoddescribed herein, under conditions sufficient to increase the targetgene expression in the cell, thereby treating or reducing risk of thecondition or the disease in the subject.

In some embodiments, the condition or the disease is caused, at least inpart, by insufficient expression of the target gene on an allele.

In some embodiments, the condition or the disease is related tohaploinsufficiency.

In some embodiments, the condition or the disease is caused, at least inpart, by a dominant-negative gene.

In some embodiments, the condition or the disease is caused, at least inpart, by insufficient expression of a target gene that is under thecontrol of an enhancer, wherein the enhancer controls the expression ofa plurality of genes.

In some embodiments, the method causes an increase in the expression ofthe target gene in the cell or in the cell of the subject by at least1.1 fold as measured by mRNA expression.

Also provided herein are method for treating or reducing risk of acondition or a disease in a subject, wherein the condition or thedisease is caused, at least in part, by overexpression of the targetgene, the method comprising administering to the subject an effectiveamount of a genetic modifier identified using a method as describedherein, under conditions sufficient to increase the target geneexpression in the cell, thereby treating or reducing risk of thecondition or the disease in the subject.

In some embodiments, the method causes a decrease in the expression ofthe target gene in the cell or in the cell of the subject by at least1.1 fold.

In some embodiments, the subject is a mammal, e.g., a human.

In some embodiments, the present methods include:

-   -   Identifying one or more regulatory motif sequences with        regulatory potential in the selected cell type or tissue;    -   Identifying a sequence of a putative regulatory region of the        target gene;    -   Comparing the sequence of the regulatory region to the        regulatory motif sequences, and identifying a candidate motif        sequence that has:

-   (A) For a substitution-based strategy: at least 5% identity and at    least one mismatch (i.e., not 100% identity) to a portion of the    sequence of the regulatory sequence;    -   identifying a genetic modifier (e.g. base or prime editors)        capable of altering the regulatory region to match (have 50-100%        identity with) the candidate motif sequence, sufficient to        create a binding site.

-   (B) For an insertion-based strategy: no homology between the    endogenous target sequence and the intended created motif is needed.    The nucleotides/bases that include the regulatory sequence or motif    will be inserted into a regulatory region of any gene of interest.    Following the identification of the regulatory motif and target    sequence for genome engineering, a genetic modifier (e.g. prime    editors, nuclease for homology directed repair (HDR) strategy,    targeted transposases or recombinases) is identified that is capable    of altering the regulatory region to match (have 100% identity with)    the candidate motif sequence.

-   (C) For an indel-based strategy: DSBs via genetic modifiers (e.g.    SpCas9) and the resulting insertion and deletion (indel) mutations    are often predictable (e.g. +1 insertions, MMEJ patterns) to a    certain degree and can be utilized to introduce new binding sites    (50-100% identity with candidate motifs) for the recruitment of    transcription factors (activators or repressors). Furthermore, indel    mutations can also introduce different spacing between endogenous    transcription factor binding sites, leading to an alternative way to    modulate target gene expression.

The methods can include using an algorithm that compares the targetregulatory regions and regulatory motif sequences identified above andidentifies candidate regulatory motif sequences that differ from thetarget gene regulatory region by up to 100% for the insertion strategyand less than a selected amount, e.g., by 95% for the insertionstrategy, and compares the candidate regulatory motifs to the possiblemodifications that would be made by a set of genetic modifiers (e.g., topredict the modification(s) made by each of a set of genetic modifiers,to identify one or more genetic modifiers that can be used to modify thetarget regulatory region to introduce a functional regulatory motif.

The methods can include CRISPR-guided multiplex gene editing with guideRNAs targeting a nuclease or base/prime editor at two, three, or more,e.g., up to 25, endogenous target sites to introduce multiple regulatorysequences in a given cell type or tissue to modify gene regulation atone or multiple genes in parallel (Campa et al, Nature Methods 2019, Vol16, pp 887-893). In the referenced paper Cas12a is used for geneediting. This enzyme has been shown to work efficiently in the contextof 2^(nd) generation CRISPR tools as well, such as e.g. base editors(Richter et al, Nat Biotechnol (2020).doi.org/10.1038/s41587-020-0453-z).

Also provided herein are methods for identifying a genetic modifier toalter expression of a target gene in a selected cell type, the methodscomprising:

Identifying one or more regulatory motif sequences with regulatorypotential in the selected cell type;Identifying a sequence of a putative regulatory region of the targetgene, preferably wherein the regulatory region is in a promoter,enhancer, insulator, UTR, or intron, optionally in a non-coding regionof the target gene;Comparing the sequence of the regulatory region to the regulatory motifsequences, and identifying a candidate motif sequence that has either nohomology at all in case of the insertion strategy or that has at least50% identity and at least one mismatch (i.e., not 100% identity) to aportion of the sequence of the regulatory sequence in case of thesubstitution strategy; and Identifying a genetic modifier capable ofaltering the regulatory region to match (have 100% identity with) thecandidate motif sequence, preferably wherein the genetic modifier is azinc finger nuclease, CRISPR-Cas9 nuclease, base editor, or prime editoroptionally comprising using an algorithm that compares the targetregulatory regions and regulatory motif sequences and identifiescandidate regulatory motif sequences that differ from the target generegulatory region by up to 1-100% for the insertion strategy and lessthan a selected amount, e.g., by 95% for the substitution strategy andcompares the candidate regulatory motifs to the possible modificationsthat would be made by a set of genetic modifiers, to identify one ormore genetic modifiers that can be used to modify the target regulatoryregion to introduce a functional regulatory motif.

In some embodiments, the identified or discovered sequence motif ormodification has regulatory potential to affect target gene expressionat the pre-transcriptional or post-transcriptional level.

In some embodiments, the identified or discovered sequence motif is atranscription factor binding sequence that can recruit endogenoustranscription factors within a cell type or cell types of interest (celltype-specific), where the sequence motif that may or may not exist inthe genome of interest.

In some embodiments, the identified or discovered sequence modificationalters the spacing of endogenous transcription factor binding sites inthe genome.

In some embodiments, the sequence motif is a response element that isactivated by a receptor-ligand complex through binding of an exogenouslydelivered small molecule, hormone, or drug for inducible target geneactivation.

In some embodiments, the identified or discovered sequence motif ormodification either stabilizes or de-stabilizes target gene transcripts,where the sequence motif that may or may not exist in the genome ofinterest.

In some embodiments, the identified or discovered sequence motif is ahybridization target for endogenous non-coding RNAs (e.g., miRNAs,siRNAs, lncRNAs), where the sequence motif that may or may not exist inthe genome of interest.

In some embodiments, the identified or discovered sequence motifmodifies the translation initiation and/or elongation efficiency fortarget gene transcripts (e.g., Kozak sequence, optimal codon structure),where the sequence motif that may or may not exist in the genome ofinterest.

In some embodiments, the identified or discovered sequence motif ormodification is determined by a combination of gene expression (e.g.,RNA-seq), chromatin accessibility (e.g., ATAC-seq, DNase-seq),DNA-protein interaction (e.g., ChIP-seq), and/or primary DNA sequencedata from a single cell type or set of cell types of interest.

In some embodiments, the identification or discovery of sequence motifscan be performed by integrative analysis of genomics data acrossdifferent cell types, e.g., using a computational strategy whereinregions of interest are uncovered based on their cell type specificactivity for a particular class of functional regions and on genomicdata e.g., chromatin marks (e.g., H3k27ac, H3k27me3), chromatinaccessibility (e.g., DNase-seq or ATAC-seq) or DNA methylation; based onthe recovered regions and a list of known TF motifs, regions aresearched for enriched patterns and their significance evaluated;integrating gene expression data a short list of candidate TF areprovided to account for their endogenous expression across the differentcell types and their expected potency based on genes that are downstreamof the regions uncovered in the second step; and a ranked list of TFsequences is generated based on this integrative approach for each celltype.

In some embodiments, the discovery of the sequence motifs is done by denovo motif discovery analysis within a single cell type or set of celltypes of interest.

In some embodiments, the discovery of sequence motifs is done byanalyzing cis-regulatory DNA sequence composition of top-expressinggenes (e.g., top 1%, 5%, 20%, 50%) ranked by normalized expressionvalues (e.g., RPKM, FPKM, TPM, fold-change) in a single cell type or setof cell types of interest.

In some embodiments, the discovery of the sequence motifs is done byanalyzing cis-regulatory DNA sequence composition of bottom-expressinggenes (e.g., bottom 1%, 5%, 20%, 50%) ranked by normalized expressionvalues (e.g., RPKM, FPKM, TPM, fold-change) in a single cell type or setof cell types of interest.

In some embodiments, the discovery of the sequence motifs is donethrough frequency-based methods including the construction ofposition-weight matrices for a single cell type or set of cell types ofinterest.

In some embodiments, the discovery of the sequence motifs is donethrough neural network architectures to identify sequence motifs thatmay or may not exist in a single cell type or set of cell types ofinterest.

In some embodiments, the discovery of the sequence motifs is donethrough generation of synthetic DNA sequences using language models—agenerative deep learning technique—where the sequence motifs may or maynot exist in a single cell type or set of cell types of interest.

In some embodiments, the discovery of the sequence motifs is donethrough generation of synthetic DNA sequences using deep variationalautoencoders—a generative deep learning model—where the sequence motifsmay or may not exist in a single cell type or set of cell types ofinterest.

In some embodiments, the discovery of the sequence motifs is donethrough generation of synthetic DNA sequences using GenerativeAdversarial Networks (GANs)—a generative deep learning model—where thesequence motifs may or may not exist in a single cell type or set ofcell types of interest.

In some embodiments, the discovery of the sequence motifs is donethrough the identification of transcription factor binding sequencemotifs with dependencies with other sequence motifs (e.g., pairwise,triwise interactions).

In some embodiments, the discovery of the sequence motifs is donethrough the identification of transcription factor binding sequencemotifs that recruit additional transcriptional machinery throughprotein-protein interactions.

In some embodiments, the identified sequence motif is from an onlinedatabase for transcription factor binding motifs (e.g., JASPAR,HOCOMOCO).

In some embodiments, the sequence motif is introduced as a single motifor a repetitive sequence with multiple copies of the single motif thatmay or may not have linker sequences interspaced.

In some embodiments, the sequence motif is introduced as a combinationof different sequence motifs with predicted additive or synergisticeffects on target gene expression at the pre-transcriptional and/orpost-transcriptional level, where the multiple sequence motifs may ormay not have linker sequences interspaced.

In some embodiments, the target genomic region to introduce the sequencemotif or modification is able to or has the potential to modify targetgene expression at the pre-transcriptional or post-transcriptionallevel.

In some embodiments, the target genomic regions are non-coding DNAsequences within 1 Mb or more of the target gene(s) of interest, orspatially-proximal as determined by chromosome conformation captureassays.

In some embodiments, the target genomic regions are promoters of thetarget gene(s) of interest, defined as proximal regions e.g., 1000 bpupstream and 500 bp downstream of the transcription start site (TSS).

In some embodiments, the target genomic regions are putative enhancerelements of the target gene(s) of interest defined by histone marksassociated and/or chromatin accessibility features associated withfunctional enhancer elements (e.g., H3K4me1, H3K27ac).

In some embodiments, the target genomic regions are putative insulatorelements of the target gene(s) of interest defined by histone marksassociated and/or chromatin accessibility features associated withfunctional insulator elements.

In some embodiments, the target genomic regions are putative silencerelements of the target gene(s) of interest defined by histone marksassociated and/or chromatin accessibility features associated withfunctional silencer elements.

In some embodiments, the target genomic regions are untranslated regions(UTRs) of target gene transcripts.

In some embodiments, the target genomic regions are intronic regions oftarget gene transcripts.

In some embodiments, the target genomic regions are coding sequences oftarget gene transcripts.

In some embodiments, the genetic modifier to use is able to introducethe specific sequence motif or modification at the target genomic regionwith sufficient efficiency and precision.

In some embodiments, the genetic modifier comprises a CRISPR-Cas domain,a zinc-finger DNA binding domain, or a transcription activator-like(TAL) effector domain.

In some embodiments, the genetic modifier is a programmable nuclease(e.g., zinc finger nucleases, transcription activator-like effectornucleases, Cas9, CasX, Cas12).

In some embodiments, the CRISPR-Cas domain further comprises a gRNAwherein the gRNA comprises a sequence complementary to a sequence of thetarget cis-regulatory element of interest.

In some embodiments, the genetic modifier is a base editor (e.g., ABE,CBE).

In some embodiments, the genetic modifier is a prime editor (e.g.,SpCas9H840A-MMLV-RT).

In some embodiments, the CRISPR-Cas prime editor further comprises aprime editing gRNA (pegRNA) and nicking sgRNA (ngRNA) wherein the pegRNAand ngRNA comprise a sequence complementary to a sequence of the targetcis-regulatory element of interest.

In some embodiments, the genetic modifier introduces multiplex edits(e.g., installation of multiple transcription factor binding sites) inorder to induce more robust modification of a single target geneexpression.

In some embodiments, the genetic modifier introduces multiplex edits(e.g., installation of multiple transcription factor binding sites) inorder to perform multi-gene expression control.

In some embodiments, the use of unbiased saturation mutagenesisscreening to empirically determine genetic editing modalities (e.g.,programmable nucleases, base editors, prime editors) and target sites(e.g., promoter, enhancers, UTRs) to modify target gene(s) expression.

The present methods can be used for increasing a target gene expressionin a cell, and for heterotopic activation of a target gene expression ina cell, by contacting the cell with a genetic modifier identified usinga method described herein.

In some embodiments, the cell is a eukaryotic cell.

In some embodiments, the cell is a mammalian cell.

In some embodiments, the cell is a human cell.

Also provided are methods for treating or preventing a condition or adisease in a subject, the method comprising administering to the subjectan effective amount of a genetic modifier identified by a methoddescribed herein, e.g., in a pharmaceutical composition, therebytreating or preventing the condition or the disease.

In some embodiments, the condition or the disease is caused, at least inpart, by insufficient expression of the target gene.

In some embodiments, the condition or the disease is caused, at least inpart, by insufficient expression of the target gene on an allele.

In some embodiments, the condition or the disease is related tohaploinsufficiency.

In some embodiments, the condition or the disease is caused, at least inpart, by a dominant-negative gene.

In some embodiments, the administration of the pharmaceuticalcomposition increases expression of the target gene, thereby treatingthe condition or the disease.

In some embodiments, the condition or the disease is caused, at least inpart, by insufficient expression of a target gene that is under thecontrol of an enhancer, wherein the enhancer controls the expression ofa plurality of genes.

In some embodiments, the method causes increase in the expression of thetarget gene in the cell or in the cell of the subject by at least 1.1fold, 2 fold, at least 3 fold, at least 4 fold, at least 5 fold, atleast 6 fold, at least 7 fold, at least 8 fold, at least 9 fold, atleast 10 fold, at least 15 fold, at least 20 fold, at least 25 fold, atleast 30 fold, at least 35 fold, at least 40 fold, at least 45 fold, atleast 50 fold, at least 60 fold, at least 70 fold, at least 80 fold, atleast 90 fold, at least 100 fold, at least 150 fold, at least 200 fold,at least 300 fold, at least 350 fold, at least 400 fold, at least 450fold, at least 500 fold, at least 600 fold, at least 700 fold, at least800 fold, at least 900 fold, at least 1000 fold, at least 1100 fold, atleast 1200 fold, at least 1300 fold, at least 1400 fold, at least 1500fold, at least 1600 fold, at least 1700 fold, at least 1800 fold, atleast 1900 fold, at least 2000 fold, at least 2500 fold, or at least3000 fold, as measured by mRNA expression.

In some embodiments, the method causes a decrease in the expression ofthe target gene in the cell or in the cell of the subject by at least1.1 fold, 2 fold, at least 3 fold, at least 4 fold, at least 5 fold, atleast 6 fold, at least 7 fold, at least 8 fold, at least 9 fold, atleast 10 fold, at least 15 fold, at least 20 fold, at least 25 fold, atleast 30 fold, at least 35 fold, at least 40 fold, at least 45 fold, atleast 50 fold, at least 60 fold, at least 70 fold, at least 80 fold, atleast 90 fold, at least 100 fold, at least 150 fold, at least 200 fold,at least 300 fold, at least 350 fold, at least 400 fold, at least 450fold, at least 500 fold, at least 600 fold, at least 700 fold, at least800 fold, at least 900 fold, at least 1000 fold, at least 1100 fold, atleast 1200 fold, at least 1300 fold, at least 1400 fold, at least 1500fold, at least 1600 fold, at least 1700 fold, at least 1800 fold, atleast 1900 fold, at least 2000 fold, at least 2500 fold, or at least3000 fold, as measured by mRNA expression.

In some embodiments, the methods include providing a cell of theselected cell type and contacting the cell with the genetic modifier toalter the regulatory region to match the candidate motif sequence.

In some embodiments, the methods alter expression of gene products atthe pre-transcriptional (e.g., recruitment of endogenous transcriptionfactors, transcription activation or repression) or post-transcriptionallevel (e.g., sequence motifs that modify transcript stability, sequencemotifs that modify translation initiation and/or elongation efficiency),in the context of a single cell type or set of cell types of interest.

In some embodiments, identifying one or more candidate motif sequenceswith regulatory potential in the selected cell type comprises referringto a database comprising a plurality of regulatory sequence motifs,e.g., endogenous regulatory sequences that are present in the selectedcell type (e.g., in the species of the cell) but not in the target gene,or exogenous regulatory sequences (e.g., not present in the cell, from adifferent species, or artificial regulatory sequences) that bind to afactor present in the cell (e.g., a transcription factor, targetsequence for endogenous non-coding RNAs, a sequence motif in theuntranslated regions (UTR) of a transcript that increases or decreasesthe stability and/or affects the transcription of the RNA molecules,and/or sequence motif that modifies the translation initiation orelongation efficiency of transcripts, in the selected cell type.

In some embodiments, the candidate sequence motif is a transcriptionfactor binding sequence, e.g., a binding sequence that is endogenous(present in the genome, but not in the gene, of the cell of interest),or exogenous (e.g., not present in the cell of interest, e.g., anartificial TF binding site or a TF binding site from another cell typeor species that binds an endogenous TF that is expressed in the cell) ofinterest (Table 3A).

In some embodiments, the candidate sequence motif is a range for spacingbetween endogenous transcription factor binding sites that modifies geneexpression.

In some embodiments, the candidate sequence motif is a known sequencemotif in the untranslated regions (UTR) of transcripts that increases ordecreases the stability and/or affects the transcription of these RNAmolecules in cells, either endogenous or exogenous.

In some embodiments, the candidate sequence motif is a known targetsequence for endogenous non-coding RNAs (e.g., miRNAs, siRNAs, lncRNAs)that affect the target transcript stability.

In some embodiments, the candidate sequence motif is a sequence motifthat is exogenous (not present in the genome of interest), but thatrecruits endogenous non-coding RNAs (e.g., miRNAs, siRNAs, lncRNAs) thataffect the target transcript stability (Table G, H, I, and J).

In some embodiments, the candidate sequence motif is an (endogenous orexogenous) sequence motif that modifies the translation initiation(e.g., Kozak sequence) or elongation (e.g., codon optimization)efficiency of transcripts.

In some embodiments, the candidate sequence motif encodes a 2Aself-cleaving peptide (e.g., T2A, P2A, E2A, F2A).

In some embodiments, the candidate sequence motif encodes an inteinsequence.

In one aspect, the present application includes identifying targetgenomic regions to modify that, upon the introduction of specificsequence motifs within this genomic region, may alter expression of atarget gene or set of target genes at the pre-transcriptional orpost-transcriptional level, in the context of a cell type or set of celltypes of interest.

In some embodiments, the target genomic regions are non-coding DNAsequences within 1 Mb or more of the target gene(s) of interest.

In some embodiments, the target genomic regions are promoters of thetarget gene(s) of interest, defined as proximal regions e.g., 1000 bpupstream and 500 bp downstream of the transcription start site (TSS).

In some embodiments, the target genomic regions are putative enhancerelements of the target gene(s) of interest defined by histone marksand/or chromatin accessibility features associated with functionalenhancer elements (e.g., H3K4me1, H3K27ac)¹⁷.

In some embodiments, the target genomic regions are putative insulatorelements of the target gene(s) of interest defined by histone marksand/or chromatin accessibility features associated with functionalinsulator elements^(17,18).

In some embodiments, the target genomic regions are putative silencerelements of the target gene(s) of interest defined by histone marksand/or chromatin accessibility features associated with functionalsilencer elements¹⁹.

In some embodiments, the target genomic regions are untranslated regions(UTRs) of target gene transcripts.

In some embodiments, the target genomic regions are intronic regions oftarget gene transcripts.

In some embodiments, the target genomic regions are coding sequences oftarget gene transcripts.

In some embodiments, the endogenous regulatory region of a gene (e.g.,the promoter) is targeted to modify or enhance downstream transcriptionof translation machinery. This can be achieved e.g., by installing ormodifying a TATA box (also known as Goldberg-Hogness box) in archae oreukaryotes or a Pribnow box in prokaryotes or by installing enhancedKozak ((gcc)gccRccAUGG (SEQ ID NO: 478)) in eukaryotes, Shine-Dalgarno(AGGAGGU) in prokaryotes, start codon (AUG and CUG in mammalian cells,AUA and AUU in mitochondria, GUG and UUG in E. coli) or stop codon (UGA,UAG, UAA) sequences²⁰.

In some embodiments binding sites of non-coding RNAs (ncRNAs), such asmicroRNAs (miRNAs) or long non-coding RNAs (lncRNAs) are installed ormodified to alter the binding of said ncRNAs to DNA or RNA with theresult of altered gene expression, and/or RNA abundance, and/or proteinexpression.

The methods can include producing a list of candidate sequencemodifications that can be made to add a candidate motif to the targetsequence.

The present methods also include identifying genetic modifiers that canintroduce specific candidate sequence motifs into target genomic regionswith high predicted precision and efficiency that may alter expressionof a target gene or set of genes at the pre-transcriptional orpost-transcriptional level, in the context of a cell type or set of celltypes of interest. Genetic modifiers can include a programmable nuclease(e.g., zinc finger nucleases, transcription activator-like effectornucleases, and CRISPR-Cas systems, e.g., Cas9, CasX, Cas12); baseeditors (e.g. ABEs, CBEs, and CGBEs); and prime editors, inter alia(Table 2).

In some embodiments, algorithms can be used to identify a geneticmodifier, e.g., based on comparing the desired sequence modifications tobe made to the changes that could be made by a number of geneticmodifiers.

In some embodiments, the sequence motif is to be introduced as a singlemotif or a repetitive sequence with multiple copies of the single motifthat may or may not have linker sequences interspaced.

In some embodiments, the sequence motif is to be introduced as acombination of different sequence motifs with predicted additive orsynergistic effects on target gene expression at the pre-transcriptionaland/or post-transcriptional level, where the multiple sequence motifsmay or may not have linker sequences interspaced.

In some embodiments, the methods can include predicting a sequencemodification that would be caused by one genetic modifiers, e.g., usingan algorithm, e.g., a computer-based method.

Unless otherwise defined, all technical and scientific terms used hereinhave the same meaning as commonly understood by one of ordinary skill inthe art to which this invention belongs. Methods and materials aredescribed herein for use in the present invention; other, suitablemethods and materials known in the art can also be used. The materials,methods, and examples are illustrative only and not intended to belimiting. All publications, patent applications, patents, sequences,database entries, and other references mentioned herein are incorporatedby reference in their entirety. In case of conflict, the presentspecification, including definitions, will control.

Other features and advantages of the invention will be apparent from thefollowing detailed description and figures, and from the claims

DESCRIPTION OF DRAWINGS

FIG. 1 . Illustration of the MYOD1 locus and experimental designs forprime editing. Illustration of the human MYOD1 gene, open chromatinfeatures at MYOD1 locus from ATAC-seq from HEK293T cell line, andpegRNAs and nicking sgRNAs locations. Three pegRNAs (Table B) weredesigned upstream of MYOD1, and two nicking sgRNAs (Table C) weredesigned downstream of each pegRNA.

FIG. 2 . Quantification of the desired transcription factor motifinsertion event by prime editing across multiple motif sequences. Onlyperfect insertion events by prime editing were included in thisanalysis. A total of 3 pegRNAs (A, B, and C) and 10 transcription factormotifs (Table D) were tested. The length of insertions were eithersingle copies of the transcription factor binding motif (1×) or twocopies of the single motifs without an intervening linker sequence (2×).Each pegRNA was paired with 3 different nicking sgRNAs (1 upstream, 2downstream) and the editing efficiencies are grouped into each bar.

FIG. 3 . MYOD1 gene expression changes with ELF motif insertion. RNAexpression levels of the endogenous MYOD1 gene in HEK293T in thepresence of PE3, pegRNA that has ELF motif, and nicking sgRNA. For motif#, 1× and 2× indicate that pegRNA has single or double ELF motifs,respectively. Three pegRNAs (A, B, C) and two nicking sgRNAs for eachpegRNA were tested. MYOD1 transcript levels were measured by RT-qPCR,normalized to HPRT1 levels, and values shown are normalized relative toa control sample (labelled Empty) in which pegRNA cassette wasexpressed.

FIG. 4 . MYOD1 gene expression changes with NFY motif insertion. RNAexpression levels of the endogenous MYOD1 gene in HEK293T in thepresence of PE3, pegRNA that has NFY motif, and nicking sgRNA. For motif#, 1× and 2× indicate that pegRNA has single or double NFY motifs,respectively. Three pegRNAs (A, B, C) and two nicking sgRNAs for eachpegRNA were tested. MYOD1 transcript levels were measured by RT-qPCR,normalized to HPRT1 levels, and values shown are normalized relative toa control sample (labelled Empty) in which pegRNA cassette wasexpressed.

FIG. 5 . MYOD1 gene expression changes with GATA motif insertion. RNAexpression levels of the endogenous MYOD1 gene in HEK293T in thepresence of PE3, pegRNA that has GATA1 motif, nicking sgRNA, andexogenous expression of GATA1. For motif #, 1×, 2×, and 3× indicate thatpegRNA has single or double or triple GATA1 motifs, respectively. ThreepegRNAs (A, B, C) and two nicking sgRNAs for each pegRNA were tested.MYOD1 transcript levels were measured by RT-qPCR, normalized to HPRT1levels, and values shown are normalized relative to a control sample(labelled Empty) in which pegRNA cassette was expressed.

FIG. 6 . MYOD1 gene expression changes with SP motif insertion. RNAexpression levels of the endogenous MYOD1 gene in HEK293T in thepresence of PE3, pegRNA that has SP1 motif, and nicking sgRNA. For motif#, 1× indicates that pegRNA has a single SP1 motif. Three pegRNAs (A, B,C) and two nicking sgRNAs for each pegRNA were tested. MYOD1 transcriptlevels were measured by RT-qPCR, normalized to HPRT1 levels, and valuesshown are normalized relative to a control sample (labelled Empty) inwhich pegRNA cassette was expressed.

FIG. 7 . MYOD1 gene expression changes with EWS-FLI1 motif insertion.RNA expression levels of the endogenous MYOD1 gene in HEK293T in thepresence of PE3, pegRNA that has EWS-FLI1 motif, nicking sgRNA, andexogenous EWS-FLI1. For motif #, 3× and 6× indicate that pegRNA hastriple or sextuple of GGAA motifs. Three pegRNAs (A, B, C) and twonicking sgRNAs for each pegRNA were tested. MYOD1 transcript levels weremeasured by RT-qPCR, normalized to HPRT1 levels, and values shown arenormalized relative to a control sample (labelled Empty) in which pegRNAcassette was expressed.

FIGS. 8A-B. Genome-wide analysis of possible CCA>TTG base edits in thehuman genome in gene promoters that could create transcription factorbinding sites. A) Bar plots showing computationally determined number ofgenes (y-axis) that could be targeted by SPACE to install 1-10 (or more)transcription factor (TF) binding sites (x-axis) in proximity of thetranscription start site of the coding genes in the human genome. Siteswere filtered to contain a preferential SPACE editing window (C3-C4-A5with 1 being the most PAM-distal position) and a canonical NGG-PAM. B)Bar plots showing computationally determined number of genes (y-axis)that could be targeted by SPACE to install 1-5 (or more) transcriptionfactor binding sites (x-axis) in proximity of the transcription startsite of coding genes in the human genome for 4 transcription factors.Sites were filtered to contain a preferential SPACE editing window(C3-C4-A5) and a canonical NGG-PAM (Table A).

FIG. 9 . Additional genome-wide analysis to detect possible CCA>TTG baseedits in the human genome in gene promoters that could createtranscription factor binding sites by using the dual-deaminase baseeditor SPACE (BE-SHAPE). Bar plots showing computationally determinednumber of genes (y-axis) that could be targeted by SPACE to install 1-5(or more) transcription factor binding sites (x-axis) in proximity ofthe transcription start site of coding genes in the human genome foradditional 6 transcription factors. Sites were filtered to contain apreferential SPACE editing window (C3-C4-A5) and a canonical NGG-PAM.

FIGS. 10A-C. Base editing with the dual-deaminase base editor SPACEestablishes synthetic transcription factor binding sites at targetpromoters by installing highly complex combinatorial substitutions. A)Allele frequency table from next-generation sequencing (NGS) data showsone allele with SPACE-induced dual base edits (black rectangle; 3.32%frequency) that introduces a binding site for the transcription factorCEBPA in the promoter of the gene RCC1. Four more alleles with editsthat might enhance TF binding but are less congruent to the canonical TFbinding site are depicted in the rectangles with black dashed lines(frequencies of 30.18%, 2.47%, 2.09%, and 2.04% respectively). B) Allelefrequency table from next-generation sequencing (NGS) data shows oneallele with SPACE-induced dual base edits (black rectangle; 10.78%frequency) that introduces a binding site for the transcription factorNFIX in the promoter of the gene RARA. One more allele with edits thatmight enhance TF binding but is less congruent to the canonical TFbinding site is depicted in the rectangle with black dashed lines(frequency of 1.96%). C) Allele frequency table from next-generationsequencing (NGS) data shows one allele with SPACE-induced dual baseedits (black rectangle; 10.15% frequency) that introduces a binding sitefor the transcription factor PBX1 in the promoter of the gene IVD. Onemore allele with edits that might enhance TF binding but is lesscongruent to the canonical TF binding site is depicted in the rectanglewith black dashed lines (frequency of 12.5%).

FIGS. 11A-C. Editing with the base editor SPACE results in geneexpression changes of target genes (BE-SHAPE). A) Allele frequency tablefrom next-generation sequencing (NGS) data shows two alleles withSPACE-induced dual base edits (black rectangles; 13.1% and 3% frequency,respectively) that introduce a binding site for the transcription factorNFIX in the promoter of the gene COMT. B) Allele frequency table fromnext-generation sequencing (NGS) data shows one allele withSPACE-induced dual base edits (black rectangles; 9.8% frequency) thatintroduce a binding site for the transcription factor CEBPA in thepromoter of the gene SAE1.Three more alleles with edits that mightenhance TF binding but are less congruent to the canonical TF bindingsite are depicted in the rectangles with black dashed lines (frequenciesof 18.4%, 13.4%, and 3.0% respectively). C) Fold-change of expression(y-axis) observed in SPACE-edited HEK293T cells for five tested genes(x-axis). For each gene, nCas9 or SPACE (left and right bar) wastargeted to the promoter region (˜500 bp to transcription start site,TSS) in two independent replicates, measured with 3 separate RT-qPCRmeasurements each. Dots represent separate RT-qPCR measurements. Errorbars represent standard deviation (SD).

FIG. 12 . Overview of the SHAPE workflow. The SHAPE strategy is aimed atintroducing genetic edits to modify the gene expression of a target geneor genes at either the pre- or post-transcriptional level. A) Given atarget gene or genes of interest (e.g. haploinsufficiency disease), theSHAPE pipeline identifies B) cell type-specific regulatory motifs (e.g.TF motifs, miRNA targets), C) genetic editors (e.g. nucleases, baseeditors, prime editors) to install these identified regulatory motifswith high precision, and D) regions to perform the precise geneticediting (e.g. promoters, enhancers, insulators, UTRs) to affect targetgene(s) expression. Following the identification of these elements, E)precise genetic editing is performed to F) induce target gene(s)expression changes.

FIG. 13A-B. Stable MYOD1 expression by ELF motif insertion via primeediting but not with dCas9-VPR recruitment in HEK293T. A) Stable ELF(2×)motif insertion at the promoter of MYOD1 over 30 days post-transfectionwith prime editor (PE) and GFP construct. B) A comparison of PE anddCas9-VPR in stable activation of MYOD1 expression over 30 dayspost-transfection. U: unsorted, S: sorted

FIGS. 14A-B. Stable IL2RA expression by ELF motif insertion via primeediting but not with dCas9-VPR recruitment in HEK239T. A) Stable ELF(2×)motif insertion at the promoter of IL2RA over 30 days post-transfectionwith prime editor (PE) and GFP construct. B) A comparison of PE anddCas9-VPR in stable activation of IL2RA expression over 30 dayspost-transfection. U: unsorted, S: sorted

FIGS. 15A-B. Stable EpCAM expression by ELF motif insertion via primeediting but not with dCas9-VPR recruitment in HEK239T. A) Stable ELF(2×)motif insertion at the promoter of EpCAM over 30 days post-transfectionwith prime editor (PE) and GFP construct. B) A comparison of PE anddCas9-VPR in stable activation of EpCAM expression over 30 dayspost-transfection. U: unsorted, S: sorted

FIGS. 16A-B. Stable MYOD1 expression by ELF motif insertion via primeediting but not with dCas9-VPR recruitment in K562. A) Stable ELF(2×)motif insertion at the promoter of MYOD1 over 30 days post-transfectionwith prime editor (PE) and GFP construct. B) Prime editing led stableactivation of MYOD1 expression over 30 days post-transfection. U:unsorted, S: sorted

FIGS. 17A-B. Stable HBB expression by ELF motif insertion via primeediting but not with dCas9-VPR recruitment in K562. A) Stable ELF(2×)motif insertion at the promoter of HBB over 30 days post-transfectionwith prime editor (PE) and GFP construct. B) Prime editing led stableactivation of HBB expression over 30 days post-transfection. U:unsorted, S: sorted.

FIGS. 18A-B. Stable IL2RA expression by ELF motif insertion via primeediting but not with dCas9-VPR recruitment in K562. A) Stable ELF(2×)motif insertion at the promoter of IL2RA over 30 days post-transfectionwith prime editor (PE) and GFP construct. B) Prime editing led stableactivation of IL2RA expression over 30 days post-transfection. U:unsorted, S: sorted

FIGS. 19A-C. Stable HER2 and protein expression by ELF motif insertionvia prime editing but not with dCas9-VPR recruitment in K562. A) StableELF(2×) motif insertion at the promoter of HER2 over 30 dayspost-transfection with PE. B) Prime editing led stable activation ofHER2 expression over 30 days post-transfection. C) A comparison of PEand dCas9-VPR in stable activation of HER2 protein expression. U:unsorted, S: sorted

FIGS. 20A-B. Stable IL2RA mRNA and protein expression by ELF motifinsertion via prime editing but not with dCas9-VPR recruitment in K562.A) Stable ELF(2×) motif insertion at the promoter of IL2RA over 30 dayspost-transfection with PE. B) A comparison of PE and dCas9-VPR in stableactivation of IL2RA protein expression. U: unsorted, S: sorted

FIGS. 21A-C. Stable EpCAM mRNA and protein expression by ELF motifinsertion via prime editing but not with dCas9-VPR recruitment inHEK239T. A) Stable ELF(2×) motif insertion at the promoter of EpCAM over30 days post-transfection with PE. B) A comparison of PE and dCas9-VPRin stable activation of EpCAM expression. C) A comparison of PE anddCas9-VPR in stable activation of EpCAM protein expression. U: unsorted,S: sorted

FIG. 22 . Pooled screening of transcription factor cluster motifinsertions via prime editing for activation and repression of IL2RAexpression in HEK239T. A library of 100 archetype sequences derived fromhierarchal-clustered transcription factor motifs (Table E) and relevantcontrols were inserted via prime editing into the IL2RA promoter toassess each motif's regulatory potential for either activation orrepression of IL2RA expression. A total of 5 negative sequences,generated via a random sequence generator, were included in the screento serve as negative controls (dark grey). A positive control of ELF(2×)motif was also included (black). Following prime editing of theinsertion library, cells were sorted based on IL2RA protein expressionat the cell surface into negative and positive populations.Next-generation DNA sequencing was performed to assess the proportion ofeach insertion sequence within the two populations and read counts wereused to calculate enrichment (log 2 fold-change) for the insertionsequences.

FIG. 23 . Pooled screening of single-base mutagenized ELF motifinsertion via prime editing for tuneable IL2RA expression in HEK293T. Alibrary of single-base mutagenized ELF(2×) motif sequences (Table F)were inserted via prime editing into the IL2RA promoter to assesssingle-base genetic variants of the ELF(2×) motif for the tuning ofIL2RA expression. A total of 5 negative sequences, generated via arandom sequence generator, were included in the screen to serve asnegative controls (dark grey). A positive control of ELF(2×) motif wasalso included (black). Following prime editing of the insertion library,cells were sorted based on IL2RA protein expression at the cell surfaceinto negative and positive populations. Next-generation DNA sequencingwas performed to assess the proportion of each insertion sequence withinthe two populations and read counts were used to calculate enrichment(log 2 fold-change) for the inserted sequences.

DETAILED DESCRIPTION

Precisely controlling gene expression in biosystems has importantapplications in biotechnology and therapeutic settings.Pre-transcriptional strategies for gene regulation include the use ofartificial transcription factors (ATFs), whereas post-transcriptionalstrategies include targeted protein degradation (TPD) and RNAinterference (RNAi). These gene regulation strategies are transient innature and require re-dosing or constitutive expression of the exogenousbiomolecules to have durable effect(s).

The regulation of endogenous gene expression is not a simple process,with dynamic transcriptional changes occurring across biologicalprocesses such as differentiation and disease. The DNA primary sequenceplays a role in this gene regulation control, but how it encodes robustor dynamic gene expression modules is not clear. For example, manysequence motifs exist in the genome, however only a subset of thesesequence motifs are bound by transcription factors. Previously, it wasnot clear that the introduction of a sequence motif into a new contextcan lead to the modification of gene expression.

Installing a single TF motif at an inactive promoter could lead toincreased gene expression. It is well known that a lot of TFs work inconcert to bring co-factors and RNA polymerases for gene expression,which might require complex TF motifs at the target promoters orenhancers.

Here we describe a strategy to introduce sequence motifs intonon-endogenous contexts, where these sequence motifs recruit endogenoustranscription factors that lead to the modification of gene expression.As shown herein, a single TF motif insertion modulates gene expressionat a target gene. A single ELF motif which is ˜12 bp inserted at MYOD1promoter increased ˜20 fold of MYOD1 gene expression in HEK293T. Theseresults suggest we can modulate gene expression by introducing a singleTF motif for endogenously active TF in cell types of interest andtitrate gene expressions by inserting multiple copies of this single TFmotif.

Described herein are strategies for the targeted modification (e.g.,activation or repression) of gene expression in a stable and heritablemanner, which we call Stable and Heritable Alteration by PrecisionEditing (SHAPE). The SHAPE methodology is based on the targeted andprecise introduction of sequence motifs at regions in the genome thatenable changes in target gene expression at either thepre-transcriptional or post-transcriptional level.

The SHAPE platform utilizes genetic modifiers (e.g., nucleases, (CRISPRguided) transposases, recombinases, base editors, and prime editors) toinstall specific sequence motifs at target sequences through precisiongenome engineering. Insertion and deletion (indel) mutations fromprogrammable nucleases (e.g., zinc finger nucleases, transcriptionactivator-like effector nucleases, Cas9, CasX, Cas12), base edits fromcytosine and/or adenine base editors (e.g., CBEs, ABEs), and all typesof prime edits from prime editors (e.g., SpCas9H840A-MMLV-RTPE3) can beutilized to introduce specific sequence motifs at target non-coding DNAsequences (e.g., promoters, enhancers, insulators) or coding (e.g.,exons) to influence the gene expression or untranslated regions (UTRs)of target genes. The newly-introduced edits can take the form ofdifferent regulatory elements, including: transcription factor bindingsites (TFBSs) that recruit endogenous transcription factors to modifytarget gene transcription, sequence modifications that alter the spacingof endogenous TFBSs, sequence elements that modify the stability (e.g.,stabilize, de-stabilize) of target gene transcripts, or sequencecompositions that modify target gene translation initiation and/orelongation. Following the introduction of these genetic edits, targetgene expression can be modified in a stable and heritable fashion. Ifthe newly introduced motif recruits endogenous transcriptional machinery(e.g., transcription factors), stabilizes the RNA of target genes, ordrives expression of novel transcriptional products, the expression oftarget genes can be altered in a stable and heritable fashion.

SHAPE Platform

The SHAPE platform provides a framework, e.g., a computational(computer-implemented) framework, for the identification or generationof 1) functional DNA sequence motifs with regulatory potential, 2)target regions for sequence modification, and 3) genetic modifiers touse to ultimately achieve the precise installation of sequence motifsthat induce targeted gene expression change(s) at thepre-transcriptional or post-transcriptional level. Overall, the SHAPEplatform enables genetically-encoded gene regulation through the preciseinstallation of sequence motifs within endogenous DNA sequence, offeringa differentiated strategy for stable and heritable transcriptionalmodulation at the pre-transcriptional or post-transcriptional level withthe transient expression of genetic modifiers.

An overview of different exemplary strategies of SHAPE for heritabletargeted gene activation is outlined in Table 1, where gene activationstrategies are mapped to the possible edit types. These edit types arethen mapped to potential genetic modifiers that have the ability tointroduce the specific edit in Table 2.

TABLE 1 Overview of SHAPE strategies Gene expression Level ofmodification System regulation Target elements strategy Edit type(s)Mammalian, insect, Pre- Non-coding sequences De novo TFBS Substitutionbacterial, transcriptional (e.g., promoters, creation Insertion plant,yeast enhancers, insulators, Deletion silencer/repressors, Combinationintrons) TFBS sequence Substitution modification(s) TFBS spacingInsertion modification(s) Deletion Combination Post- 5′ and/or 3′Transcript Substitution transcriptional untranslated regionsstabilization/ Insertion (UTRs) destabilization Deletion CombinationCoding sequences Translation Substitution (e.g., translation startinitiation/elongation Insertion sites, codon Deletion structures)Combination

TABLE 2 Edit type breakdown with relevant genetic modifiers Edit type(s)Specific edit type Genetic modifier type Substitution Transition Baseeditors, prime editors Transversion Base editors, prime editors MixedPrime editors Insertion 1-2 bp Nucleases, prime editors >2 bp Primeeditors, nucleases + ssODNs (HDR), nucleases + dsODNs (NHEJ) DeletionMMEJ-driven Nucleases, prime editors Non-MMEJ Dual nucleases, primeeditors Combination Substitution, Prime editors insertion, deletionInversion Inversion Dual nucleases

Generation of novel synthetic DNA sequence motifs that can recruitendogenous transcription factors can be done using a generativetechnique known as language modeling. A language model is typically aprobability distribution over sequence of words that can occur in anatural language e.g., English or French. They are typically trained topredict the next word in a sentence. After training is done, the modelcan be used to generate novel sentences that are semanticallymeaningful. This type of modeling can also be used to generate de novoDNA sequences. The model typically uses a neural network where thelayers consist of Long Short Term Memory (LSTM) units. The neuralnetwork can be trained on a large corpora of DNA sequences, and thenfine-tuned on known DNA sequence motifs in a conditional manner togenerate novel synthetic DNA motifs that are functional in terms ofrecruiting transcription factors.

The modification of endogenous transcription factor sequence compositionby genetic editing is a viable strategy for gene activation. Whiletranscription factors typically bind a core DNA sequence, there can beminor differences in the totality of sequences transcription factorsbind across a genome. In addition to a range of different DNA sequencesa transcription factor is capable of binding, the transcription factormay also exhibit different binding strength for each DNA sequencevariant.′ The identification of the optimal binding sequence oftranscription factors and downstream regulatory potential of thisbinding event can be determined through integration of chromatinaccessibility (e.g., ATAC-seq, DNase-seq), protein-DNA interaction(e.g., ChIP-seq) and gene expression (e.g., RNA-seq) data. Following theidentification of top DNA sequence binding motifs for all transcriptionfactors, the identification of sub-optimal endogenous transcriptionfactor binding motifs in cis-regulatory regions of a target gene can beperformed. The utilization of genetic modifiers to introducesubstitution edits (e.g., base editors, prime editors) can introducemore optimal transcription factor binding sites to promote heritabletarget gene activation.

Identification of Candidate Regulatory Sequence Motifs

The identification or generation of regulatory sequence motifs to beintroduced into the genome can be determined through integrativeanalysis of by gene expression, chromatin accessibility, and/orDNA-protein interactions data, and de novo motif discovery, orgenerative neural network frameworks within a single cell type or set ofcell types of interest. These sequence motifs can take the form ofbinding motifs for the recruitment of endogenous transcription factors,sequence motifs that promote the stabilization of RNA molecules, orsequence motifs that enable the expression of non-coding RNA for targetgene repression.

Exemplary candidate regulatory sequence motifs can include one or moreof a transcription factor binding sequence that has been determinedexperimentally in-vitro (e.g., SELEX)⁸, experimentally in-vivo (e.g.,ChIP-seq, ChIP-qPCR)⁹, or computationally¹⁰ ¹¹ based on experimentaldata; a sequence motif that is not present in the genome of interest,but has been predicted to facilitate transcription factor binding; aknown range for spacing between endogenous transcription factor bindingsites that has been shown to modify gene expression; a predicted rangefor spacing between endogenous transcription factor binding sites thathas been predicted to modify gene expression; a known sequence motif inthe untranslated regions (UTR) of transcripts that increases ordecreases the stability and/or affects the transcription of these RNAmolecules in cells¹²; a sequence motif that is not present in the genomeof interest, but has been predicted to modify the stability and/oraffects the transcription of RNA molecules when placed in 5′ and/or 3′untranslated regions (UTRs); a known target sequence for endogenousnon-coding RNAs (e.g., miRNAs, siRNAs, lncRNAs) that affects the targettranscript stability¹³; a sequence motif that is not present in thegenome of interest, but has been predicted to recruit endogenousnon-coding RNAs (e.g., miRNAs, siRNAs, lncRNAs) that affects the targettranscript stability; a known sequence motif that modifies thetranslation initiation (e.g., Kozak sequence) or elongation (e.g., codonoptimization) efficiency of transcripts¹⁴; a sequence motif that is notpresent in the genome of interest, but has been predicted to modify thetranslation initiation (e.g., Kozak sequence) or elongation (e.g., codonoptimization) efficiency of transcripts; a sequence encoding a 2Aself-cleaving peptide (e.g., T2A, P2A, E2A, F2A); and/or a sequenceencoding an intein sequence.

A number of methods are known in the art for identifying candidatesequence motifs.

In some embodiments, the identification of candidate DNA sequence motifsis performed by integrative analysis of genomics data across differentcell types and with a computational strategy we have recently proposedcalled Haystack¹⁵. First, regions of interest are uncovered based ontheir cell type specific activity for a particular class of functionalregions and on genomic data e.g., chromatin marks (e.g., H3k27ac,H3k27me3), chromatin accessibility (e.g., DNase-seq or ATAC-seq) or DNAmethylation. Second, based on the recovered regions and a list of knownTF motifs, regions are searched for enriched patterns and theirsignificance evaluated. Third, integrating gene expression data a shortlist of candidate TF are provided to account for their endogenousexpression across the different cell types and their expected potencybased on genes that are downstream of the regions uncovered in thesecond step. Finally, a ranked list of TF sequences is also generatedbased on this integrative approach for each cell type.

As previously described (Pinello et al. Bioinformatics 2018) byexploiting chromatin accessibility (or histone marks) and geneexpression variability across cell types key regulatory regions andregulators were extracted that are cell type specific. By theintegration of available data from large consortia (Roadmap Epigenomicand ENCODE projects) and using Haystack (github.com/pinellolab/haystackbio) we have curated a list of regions and transcription factors forseveral human primary cells and cell lines. Importantly, this strategycan be applied to any organism for which a reference genome isavailable.

In some embodiments, the discovery of the sequence motifs is done by denovo motif discovery analysis within a single cell type or set of celltypes of interest.

In some embodiments, the discovery of sequence motifs is done byanalyzing cis-regulatory DNA sequence composition of top-expressinggenes (e.g., top 1%, 5%, 20%, 50%) ranked by normalized expressionvalues (e.g., RPKM, FPKM, TPM, fold-change) in a single cell type or setof cell types of interest.

In some embodiments, the discovery of the sequence motifs is done byanalyzing cis-regulatory DNA sequence composition of bottom-expressinggenes (e.g., bottom 1%, 5%, 20%, 50%) ranked by normalized expressionvalues (e.g., RPKM, FPKM, TPM, fold-change) in a single cell type or setof cell types of interest.

In some embodiments, the discovery of the sequence motifs is donethrough frequency-based methods including the construction ofposition-weight matrices for a single cell type or set of cell types ofinterest.

In some embodiments, the discovery of the sequence motifs is donethrough neural network architectures to identify sequence motifs thatmay or may not exist in a single cell type or set of cell types ofinterest.

In some embodiments, the discovery of the sequence motifs is donethrough generation of synthetic DNA sequences using language models—agenerative deep learning technique—where the sequence motifs may or maynot exist in a single cell type or set of cell types of interest.

In some embodiments, the discovery of the sequence motifs is donethrough generation of synthetic DNA sequences using deep variationalautoencoders—a generative deep learning model—where the sequence motifsmay or may not exist in a single cell type or set of cell types ofinterest.

In some embodiments, the discovery of the sequence motifs is donethrough generation of synthetic DNA sequences using GenerativeAdversarial Networks (GANs)—a generative deep learning model—where thesequence motifs may or may not exist in a single cell type or set ofcell types of interest.

In some embodiments, the discovery of the sequence motifs is donethrough the identification of transcription factor binding sequencemotifs with dependencies with other sequence motifs (e.g., pairwise,triwise interactions)¹⁶.

In some embodiments, the discovery of the sequence motifs is donethrough the identification of transcription factor binding sequencemotifs that recruit additional transcriptional machinery throughprotein-protein interactions.

In addition, a number of regulatory sequence motifs, e.g., transcriptionfactors and transcription factor binding sequence motifs, are known,including those that are cell-type specific and those that are hormoneresponsive. For example, Table 3A provides a list of TFs and their entrynumber in the JASPAR database, which provides their recognitionsequences.

Activating target genes in a cell-type-specific manner can be achievedby recruiting cell-type specific endogenous TFs (many of which are knownin the art) at the promoters, enhancers or both of genes of interest.First, a list of cell-type-specific TFs for the target cell lines can bedetermined based on the expression levels from RNA-seq of native celllines³³. Second, individual or repeats of a cell-type specific TF motifor combination of multiple TF motifs can be introduced at the promoters,enhancers or both of genes of interest in the target cell lines viagenetic modifiers. For controls, cell lines that do not or lowly expresscell-type-specific TFs that express in target cell lines should betested to see if target genes are not expressed even though same genomicmodifications were installed.

A number of databases provide lists of cell-specific transcriptionfactors, including TRANSFAC and TFregulome®; see also D'Alessio, A. C.et al. A Systematic Approach to Identify Candidate Transcription Factorsthat Control Cell Identity. Stem Cell Reports 5, 763-Instead of therecruitment of endogenous transcription factors, SHAPE can also be usedto introduce de novo transcription factor binding sites that act asresponse elements for TFs or TF-like proteins that can be activated(e.g., by expression or reduced degradation) by an exogenous smallmolecule, hormone or drug following the subsequent addition of theexogenous small molecule, hormone, or drug. Upon induction of thisexogenous ligand, the response element would recruit thereceptor-exogenous ligand complexes to the target locus and give rise totarget gene activation. Examples include the use of vitamin D thatinteract with vitamin D receptor (VDR) transcription factor byinstalling VDR response motif at the promoters or enhancers at targetgenes of interest.

Table 3B provides a list of examples of hormone responsive transcriptionfactors and elements.

TABLE 3A Examples of transcription factors from the JASPAR database thatmay be recruited using SHAPE JASPAR ID Transcription factor MA0206.1abd-A MA0165.1 Abd-B MA0265.1 ABF1 MA0570.2 ABF1 MA0266.1 ABF2 MA0941.1ABF2 MA0930.1 ABF3 MA1659.1 ABF4 MA0564.1 ABI3 MA0123.1 abi4 MA0931.1ABI5 MA1244.1 ABR1 MA0267.1 ACE2 MA0207.1 achi MA1277.1 Adof1 MA0268.1ADR1 MA0269.1 AFT1 MA0270.1 AFT2 MA0005.2 AG MA0585.1 AGL1 MA1204.1AGL13 MA0548.2 AGL15 MA1199.1 AGL16 MA1200.1 AGL25 MA1012.1 AGL27MA0001.2 AGL3 MA1201.1 AGL42 MA1202.1 AGL55 MA1205.1 AGL6 MA1203.1 AGL63MA0932.1 AHL12 MA0933.1 AHL20 MA0934.1 AHL25 MA0006.1 Ahr::Arnt MA0959.1AIB MA1235.1 AIL7 MA0208.1 al MA0854.1 Alx1 MA0634.1 ALX3 MA0853.1 Alx4MA1663.1 ANAC050 MA1660.1 ANAC13 MA1375.1 ANL2 MA0571.1 ANT MA0166.1Antp MA0209.1 ap MA0940.1 AP1 MA0556.1 AP3 MA0007.3 Ar MA0210.1 araMA1098.1 ARALYDRAFT_484486 MA1097.1 ARALYDRAFT_493022 MA1095.1ARALYDRAFT_495258 MA1096.1 ARALYDRAFT_496250 MA1054.1 ARALYDRAFT_897773MA1338.1 AREB3 MA0942.1 ARF1 MA1685.1 ARF10 MA1686.1 ARF13 MA1687.1ARF14 MA1688.1 ARF16 MA1689.1 ARF18 MA1206.1 ARF2 MA1690.1 ARF25MA1691.1 ARF27 MA1692.1 ARF29 MA1009.1 ARF3 MA1693.1 ARF34 MA1694.1ARF35 MA1695.1 ARF36 MA1696.1 ARF39 MA1697.1 ARF4 MA0943.1 ARF5 MA1698.1ARF7 MA0944.1 ARF8 MA0271.1 ARG80 MA0272.1 ARG81 MA1463.1 ARGFX MA0151.1Arid3a MA0601.1 Arid3b MA0602.1 Arid5a MA0004.1 Arnt MA0259.1ARNT::HIF1A MA1464.1 ARNT2 MA0603.1 Amtl MA0273.1 ARO80 MA0274.1 ARR1MA0945.1 ARR1 MA0121.1 ARR10 MA0946.1 ARR11 MA0947.1 ARR14 MA0948.1ARR18 MA0949.1 ARR2 MA0874.1 Arx MA1100.2 ASCL1 MA1631.1 ASCL1(var. 2)MA0816.1 Ascl2 MA0275.1 ASG1 MA0276.1 ASH1 MA1661.1 AT-GTL1 MA1259.1AT1G01250 MA1387.1 AT1G13300 MA1160.1 AT1G14580 MA1400.1 At1g19000MA1255.1 AT1G22810 MA1263.1 AT1G36060 MA1222.1 AT1G44830 MA1275.1AT1G47655 MA1186.1 At1g49010 MA1268.1 AT1G69570 MA1288.1 At1g72010MA1353.1 AT1G72740 MA1397.1 At1g74840 MA1250.1 AT1G75490 MA1367.1AT1G76870 MA1366.1 AT1G76880 MA1260.1 AT1G77640 MA1380.1 AT2G20110MA1272.1 AT2G28810 MA1245.2 AT2G33710 MA1193.1 At2g38090 MA1385.1AT2G40260 MA1229.1 AT2G44940 MA1285.1 At2g45680 MA1182.1 At3g09600MA1662.1 AT3G10030 MA1191.1 AT3G10113 MA1194.1 AT3G10580 MA1188.1At3g11280 MA1253.1 AT3G16280 MA1388.1 AT3G24120 MA1270.1 AT3G45610MA1381.1 AT3G46070 MA1276.1 AT3G52440 MA1242.1 AT3G57600 MA1354.1AT4G12670 MA1237.1 AT4G16750 MA1228.1 AT4G18450 MA1232.1 AT4G28140MA1241.1 AT4G32800 MA1281.1 AT5G02460 MA1196.1 At5g05790 MA1399.1At5g08520 MA1226.1 AT5G18450 MA1365.2 AT5G47660 MA1195.1 AT5G56840MA1192.1 At5g58900 MA1189.1 AT5G61620 MA1267.1 AT5G66940 MA1261.1AT5G67000 MA1438.1 atf-7 MA0604.1 Atf1 MA1632.1 ATF2 MA0605.2 ATF3MA0833.2 ATF4 MA1466.1 ATF6 MA834.1 ATF7 MA0950.1 ATHB-12 MA0951.1ATHB-16 MA0110.3 ATHB-5 MA0952.1 ATHB-51 MA0953.1 ATHB-6 MA0573.1 ATHB-9MA1212.1 ATHB13 MA1026.2 ATHB15 MA1211.1 ATHB18 MA1209.1 ATHB20 MA1327.2ATHB23 MA1328.1 ATHB34 MA1406.1 ATHB4 MA1214.1 ATHB40 MA1215.1 ATHB53MA0954.2 ATHB7 MA0461.2 Atoh1 MA1467.1 ATOH1(var. 2) MA1468.1 ATOH7MA0167.1 Awh MA0277.1 AZF1 MA0168.1 B-H1 MA0169.1 B-H2 MA1633.1 BACH1MA0591.1 Bach1::Mafk MA1101.2 BACH 2 MA1470.1 BACH2(var. 2) MA0211.1 bapMA0877.2 BARHL1 MA0635.1 BARHL2 MA0875.1 BARX1 MA1471.1 BARX2 MA0278.1BAS1 MA1634.1 BATF MA0462.2 BATF::JUN MA0835.2 BATF3 MA0212.1 bcdMA0463.2 BCL6 MA0731.1 BCL6B MA0529.2 BEAF-32 MA0956.1 BEE2 MA1332.1BEH2 MA1333.1 BEH3 MA1331.1 BEH4 MA0242.1 Bgb::run MA0960.1 BHLH104MA0961.1 BHLH112 MA0958.1 BHLH13 MA1358.1 bHLH130 MA1361.1 bHLH18MA0957.1 BHLH3 MA1359.1 bHLH31 MA0962.1 BHLH34 MA1363.1 bHLH69 MA1360.1bHLH74 MA1362.1 bHLH77 MA0963.1 BHLH78 MA1357.1 bHLH80 MA0607.1 Bhlha15MA1472.1 BHLHA15(var. 2) MA0818.1 BHLHE22 MA1635.1 BHLHE22(var. 2)MA0817.1 BHLHE23 MA0464.2 BHLHE40 MA0636.1 BHLHE41 MA0964.1 BIM1MA0965.1 BIM2 MA0966.1 BIM3 MA0537.1 blmp-1 MA1404.1 BPC1 MA1403.1 BPC5MA1402.1 BPC6 MA0010.1 br MA0011.1 br(var. 2) MA0012.1 br(var. 3)MA0013.1 br(var. 4) MA0213.1 brk MA0214.1 bsh MA0876.1 BSX MA0443.1 btdMA0215.1 btn MA1407.1 bZIP14 MA1349.1 bZIP16 MA1344.1 bZIP28 MA1340.1bZIP3 MA1350.1 bZIP42 MA1339.1 bZIP43 MA1337.1 bZIP44 MA1345.1 bZIP48MA1342.1 bZIP50 MA1343.1 bZIP52 MA1341.1 bZIP53 MA0967.1 BZIP60 MA0968.2bZIP68 MA0096.1 bZIP910 MA0097.1 bZIP911 MA0550.2 BZR1 MA0549.1 BZR2MA0170.1 C15 MA0216.2 cad MA0279.1 CAD1 MA1197.1 CAMTA1 MA0280.1 CAT8MA0217.1 caup MA0281.1 CBF1 MA1224.1 CBF1 MA1217.1 CBF2 MA1218.1 CBF4MA0972.1 CCA1 MA0579.1 CDC5 MA0973.1 CDF2 MA0974.2 CDF3 MA0878.2 CDX1MA0465.2 CDX2 MA1473.1 CDX4 MA1444.1 cebp-1 MA0102.4 CEBPA MA0466.2CEBPB MA0836.2 CEBPD MA0837.1 CEBPE MA0838.1 CEBPG MA1636.1 CEBPG(var.2) MA0263.1 ceh-10::ttx-3 MA0264.1 ceh-22 MA1445.1 ceh-28 MA1699.1ceh-38 MA0921.1 ceh-48 MA1219.1 CEJ1 MA0637.1 CENPB MA0282.1 CEP3MA0922.1 ces-2 MA0015.1 Cf2 MA0171.1 CG11085 MA0172.1 CG11294 MA0173.1CG11617 MA0176.1 CG15696-RA MA0177.1 CG18599 MA0178.1 CG32105 MA0179.1CG32532 MA0444.1 CG34031 MA0182.1 CG4328-RA MA0184.1 CG9876 MA0283.1CHA4 MA0260.1 che-1 MA0284.1 CIN5 MA1700.1 Clamp MA0819.1 CLOCK MA0969.1CMTA2 MA0970.1 CMTA3 MA0530.1 cnc::maf-S MA1279.1 COG1 MA1432.1 cre-1MA0018.4 CREB1 MA0638.1 CREB3 MA0839.1 CREB3L1 MA0608.1 Creb3l2 MA1474.1CREB3L4 MA1475.1 CREB3L4(var. 2) MA0840.1 Creb5 MA0609.2 CREM MA0975.1CRF2 MA0976.2 CRF4 MA0467.1 Crx MA0285.1 CRZ1 MA0286.1 CST6 MA0218.1 CtMA0139.1 CTCF MA0531.1 CTCF MA1102.2 CTCFL MA0287.1 CUP2 MA0288.1 CUP9MA0754.1 CUX1 MA0755.1 CUX2 MA0445.1 D MA0538.1 daf-12 MA1446.1 daf-16MA1271.1 DAG2 MA0289.1 DAL80 MA0290.1 DAL81 MA0291.1 DAL82 MA0639.1 DBPMA0174.1 Dbx MA0019.1 Ddit3::Cebpa MA0185.1 Deaf1 MA1376.1 DEAR3MA1251.1 DEAR5 MA0186.1 Dfd MA0022.1 dl MA0023.1 dl(var. 2) MA0187.1 DllMA0879.1 Dlx1 MA0885.1 Dlx2 MA0880.1 Dlx3 MA0881.1 Dlx4 MA1476.1 DLX5MA0882.1 DLX6 MA0883.1 Dmbx1 MA1603.1 Dmrt1 MA0610.1 DMRT3 MA1455.1dmrt99B MA1478.1 DMRTA2 MA1479.1 DMRTC2 MA0981.1 DOF1.8 MA0020.1 Dof2MA0982.1 DOF2.4 MA0977.1 DOF2.5 MA0021.1 Dof3 MA1273.1 dof4.2 MA1269.1dof4.5 MA1071.1 DOF5.3 MA0983.1 DOF5.6 MA0984.1 DOF5.7 MA0351.1 DOT6MA1668.1 DPBF3 MA1480.1 DPRX MA0540.1 dpy-27 MA0188.1 Dr MA0985.1 DRE1CMA1243.1 DREB19 MA0971.1 DREB1A MA1669.1 DREB1B MA1670.1 DREB1C MA0978.1DREB1E MA1032.1 DREB1G MA1258.1 DREB2 MA1248.1 DREB26 MA0986.1 DREB2CMA1456.1 Dref MA1481.1 DRGX MA0919.1 dsc-1 MA0611.1 Dux MA0468.1 DUX4MA0884.1 DUXA MA0915.1 dve MA0580.1 DYT1 MA0024.3 E2F1 MA0864.2 E2F2MA0469.3 E2F3 MA0470.2 E2F4 MA0471.2 E2F6 MA0758.1 E2F7 MA0865.1 E2F8MA1414.1 E2FA MA0189.1 E5 MA0154.4 EBF1 MA1604.1 Ebf2 MA1637.1 EBF3MA0292.1 ECM22 MA0293.1 ECM23 MA0534.1 EcR::usp MA0294.1 EDS1 MA0990.1EDT1 MA0541.1 efl-1 MA1167.1 EFM MA0162.4 EGR1 MA0472.2 EGR2 MA0732.1EGR3 MA0733.1 EGR4 MA0598.3 EHF MA0026.1 Eip74EF MA0473.3 ELF1 MA1483.1ELF2 MA0640.2 ELF3 MA0641.1 ELF4 MA0136.2 ELF5 MA0028.2 ELK1 MA0759.1ELK3 MA0076.2 ELK4 MA1701.1 elt-2 MA0542.1 elt-3 MA1439.1 elt-6 MA0128.1EmBP-1 MA0219.1 ems MA0612.2 EMXI MA0886.1 EMX2 MA0220.1 en MA0027.2 EN1MA0642.1 EN2 MA0800.1 EOMES MA0543.1 eor-1 MA1401.1 EPR1 MA0760.1 ERFMA0979.1 ERF008 MA1265.2 ERF015 MA1234.1 ERF017 MA1048.1 ERF018 MA1424.1ERF019 MA1233.2 ERF021 MA1227.2 ERF027 MA1223.1 ERF035 MA1230.1 ERF037MA0995.2 ERF039 MA0996.1 ERF043 MA0997.1 ERF069 MA1247.1 ERF087 MA1049.1ERF094 MA0998.1 ERF096 MA0999.1 ERF098 MA1240.1 ERF10 MA1239.1 ERF104MA1000.2 ERF105 MA1053.1 ERF109 MA1001.2 ERF11 MA1002.1 ERF112 MA1671.1ERF118 MA1004.1 ERF13 MA1231.1 ERF15 MA0567.1 ERF1B MA1262.1 ERF2MA1005.2 ERF3 MA1238.2 ERF38 MA0992.2 ERF4 MA1225.1 ERF5 MA1006.1 ERF6MA0993.1 ERF7 MA0994.1 ERF8 MA1257.1 ERF9 MA0474.2 ERG MA0420.1 ERT1MA1264.1 ESE1 MA1236.1 ESE3 MA0112.3 ESR1 MA0258.2 ESR2 MA0592.3 ESRRAMA0141.3 ESRRB MA0643.1 Esrrg MA0644.1 ESX1 MA0098.3 ETS1 MA1484.1 ETS2MA0916.1 Ets21C MA0761.2 ETV1 MA0762.1 ETV2 MA0763.1 ETV3 MA0764.2 ETV4MA0765.2 ETV5 MA0645.1 ETV6 MA0221.1 eve MA0887.1 EVX1 MA0888.1 EVX2MA0149.1 EWSR1-FLI1 MA0222.1 exd MA0224.1 exex MA0575.1 F3A4.140MA1408.1 FaEOBII MA1382.1 FAR1 MA1485.1 FERD3L MA0156.2 FEV MA0295.1FHL1 MA0557.1 FHY3 MA0820.1 FIGLA MA0446.1 fkh MA0920.1 fkh-2 MA1440.1fkh-9 MA0296.1 FKH1 MA0297.1 FKH2 MA0558.1 FLC MA0475.2 FLI1 MA0476.1FOS MA1448.1 fos-1 MA0099.3 FOS::JUN MA1126.1 FOS::JUN(var. 2) MA1134.1FOS::JUNB MA1141.1 FOS::JUND MA1127.1 FOSB::JUN MA1135.1 FOSB::JUNBMA1136.1 FOSB::JUNB(var. 2) MA0477.2 FOSL1 MA1128.1 FOSL1::JUN MA1129.1FOSLl::JUN(var. 2) MA1137.1 FOSL1::JUNB MA1142.1 FOSL1::JUND MA1143.1FOSLl::JUND(var. 2) MA0478.1 FOSL2 MA1130.1 FOSL2::JUN MA1131.1FOSL2::JUN(var. 2) MA1138.1 FOSL2::JUNB MA1139.1 FOSL2::JUNB(var. 2)MA1144.1 FOSL2::JUND MA1145.1 FOSL2::JUND(var. 2) MA0148.4 FOXA1MA0047.3 FOXA2 MA1683.1 FOXA3 MA0845.1 FOXB1 MA0032.2 FOXC1 MA0846.1FOXC2 MA0031.1 FOXD1 MA0847.2 FOXD2 MA0041.1 Foxd3 MA1487.1 FOXE1MA1606.1 Foxf1 MA0030.1 FOXF2 MA0613.1 FOXG1 MA0479.1 FOXH1 MA0042.2FOXl1 MA0614.1 Foxj2 MA0851.1 Foxj3 MA0852.2 FOXK1 MA1103.2 FOXK2MA0033.2 FOXL1 MA1607.1 Foxl2 MA1684.1 Foxn1 MA1489.1 FOXN3 MA0480.1Foxo1 MA0157.2 FOXO3 MA0848.1 FOXO4 MA0849.1 FOXO6 MA0481.3 FOXP1MA0593.1 FOXP2 MA0850.1 FOXP3 MA0040.1 Foxq1 MA0225.1 ftz MA0565.2 FUS3MA0298.1 FZF1 MA0062.3 GABPA MA0299.1 GAL4 MA0034.1 Gam1 MA0300.1 GAT1MA0301.1 GAT3 MA0302.1 GAT4 MA0035.4 GATA1 MA0140.2 GATA1::TAL1 MA1013.1GATA10 MA1014.1 GATA11 MA1015.1 GATA12 MA1325.1 GATA14 MA1016.1 GATA15MA1323.1 GATA19 MA0036.3 GATA2 MA1324.1 GATA20 MA0037.3 GATA3 MA0482.2GATA4 MA0766.2 GATA5 MA1396.1 GATA6 MA1104.2 GATA6 MA1017.1 GATA8MA1018.1 GATA9 MA1672.1 GBF2 MA1351.1 GBF3 MA1334.1 GBF6 MA0889.1 GBX1MA0890.1 GBX2 MA0646.1 GCM1 MA0767.1 GCM2 MA0917.1 gcm2 MA0303.1 GCN4MA0304.1 GCR1 MA0305.1 GCR2 MA0038.2 GFl1 MA0483.1 Gfi1b MA0306.1 GIS1MA0734.2 GLI2 MA1491.1 GLI3 MA0735.1 GLIS1 MA0736.1 GLIS2 MA0737.1 GLIS3MA0307.1 GLN3 MA1019.1 Glyma19g26560.1 MA0615.1 Gmeb1 MA0862.1 GMEB2MA1457.1 grh MA0647.1 GRHL1 MA1105.2 GRHL2 MA0190.1 Gsc MA0648.1 GSCMA0891.1 GSC2 MA0308.1 GSM1 MA0892.1 GSX1 MA0893.2 GSX2 MA0447.1 gtMA1020.1 GT-1 MA1208.1 GT-2 MA1368.2 GT-4 MA1207.1 GT-A3 MA0309.1 GZF3MA0449.1 h MA0448.1 H2.0 MA0310.1 HAC1 MA0311.1 HAL9 MA0092.1Hand1::Tcf3 MA1638.1 HAND2 MA0312.1 HAP1 MA0313.1 HAP2 MA0314.1 HAP3MA0316.1 HAP5 MA1024.1 HAT1 MA1198.1 HAT2 MA1210.1 HAT22 MA0008.2 HAT5MA0049.1 hb MA1025.1 HBI1 MA0226.1 hbn MA0317.1 HCM1 MA1369.1 HDG1MA1099.2 HES1 MA0616.2 HES2 MA0821.1 HES5 MA1493.1 HES6 MA0822.1 HES7MA0894.1 HESX1 MA0823.1 HEY1 MA0649.1 HEY2 MA0191.1 HGTX MA0183.1 HHEXMA1390.1 HHO2 MA1386.1 HHO3 MA1164.1 HHO5 MA1165.1 HHO6 MA0739.1 Hic1MA0738.1 HIC2 MA1106.1 HIF1A MA0131.2 HINFP MA0450.1 hkb MA0043.3 HLFMA0545.1 hlh-1 MA1449.1 hlh-30 MA0109.1 HLTF MA0895.1 HMBOX1 MA0044.1HMG-1 MA0045.1 HMG-I/Y MA0327.1 HMRAl MA0318.1 HMRA2 MA0192.1 HmxMA0896.1 Hmx1 MA0897.1 Hmx2 MA0898.1 Hmx3 MA0046.2 HNF1A MA0153.2 HNF1BMA0114.4 HNF4A MA1494.1 HNF4A(var. 2) MA0484.2 HNF4G MA1495.1 HOXA1MA0899.1 HOXA10 MA0911.1 Hoxa11 MA0650.2 HOXA13 MA0900.2 HOXA2 MA1496.1HOXA4 MA0158.2 HOXA5 MA1497.1 HOXA6 MA1498.1 HOXA7 MA0594.2 HOXA9MA0901.2 HOXB13 MA0902.2 HOXB2 MA0903.1 HOXB3 MA1499.1 HOXB4 MA0904.2HOXB5 MA1500.1 HOXB6 MA1501.1 HOXB7 MA1502.1 HOXB8 MA1503.1 HOXB9MA0905.1 HOXC10 MA0651.1 HOXC11 MA0906.1 HOXC12 MA0907.1 HOXC13 MA1504.1HOXC4 MA1505.1 HOXC8 MA0485.2 HOXC9 MA1506.1 HOXD10 MA0908.1 HOXD11MA0873.1 HOXD12 MA0909.2 HOXD13 MA0912.2 HOXD3 MA1507.1 HOXD4 MA0910.2HOXD8 MA0913.2 HOXD9 MA1458.1 Hsf MA0319.1 HSF1 MA0486.2 HSF1 MA0770.1HSF2 MA0771.1 HSF4 MA1664.1 HSFA6B MA1665.1 HSFB2A MA1666.1 HSFB2BMA1667.1 HSFC1 MA0227.1 hth MA0551.1 HY5 MA1425.1 HYH MA0120.1 id1MA1373.1 IDD2 MA1371.1 IDD4 MA1370.1 IDD5 MA1374.1 IDD7 MA1508.1 IKZF1MA0320.1 IME1 MA0228.1 ind MA0321.1 INO2 MA0322.1 INO4 MA0155.1 INSM1MA0229.1 inv MA0050.2 IRF1 MA0051.1 IRF2 MA1418.1 IRF3 MA1419.1 IRF4MA1420.1 IRF5 MA1509.1 IRF6 MA0772.1 IRF7 MA0652.1 IRF8 MA0653.1 IRF9MA1608.1 Isl1 MA0914.1 ISL2 MA0654.1 ISX MA0323.1 IXRI MA0655.1 JDP2MA0656.1 JDP2(var. 2) MA1156.1 JKD MA0488.1 JUN MA1132.1 JUN::JUNBMA1133.1 JUN::JUNB(var. 2) MA0489.1 JUN(var. 2) MA0490.2 JUNB MA1140.2JUNB(var. 2) MA0491.2 JUND MA0492.1 JUND(var. 2) MA1027.1 KAN1 MA1383.1KAN2 MA1028.1 KAN4 MA0493.1 KIf1 MA1511.1 KLF10 MA1512.1 KLF11 MA0742.1Klf12 MA0657.1 KLF13 MA0740.1 KLF14 MA1513.1 KLF15 MA0741.1 KLF16MA1514.1 KLF17 MA1515.1 KLF2 MA1516.1 KLF3 MA0039.4 KLF4 MA0599.1 KLF5MA1517.1 KLF6 MA1107.2 KLF9 MA0451.1 kni MA0452.2 Kr MA1398.2 KUA1MA0230.1 lab MA1673.1 LBD18 MA0231.1 Ibe MA0232.1 Ibl MA0618.1 LBX1MA0699.1 LBX2 MA1187.1 LCL1 MA0581.1 LEC2 MA0768.1 LEF1 MA1246.1 LEPMA0324.1 LEU3 MA0590.1 LFY MA1518.1 LHX1 MA0700.2 LHX2 MA0135.1 Lhx3MA0704.1 Lhx4 MA1519.1 LHX5 MA0658.1 LHX6 MA0705.1 Lhx8 MA0701.2 LHX9MA1185.1 LHY1 MA0923.1 lim-4 MA1441.1 lim-7 MA0194.1 Lim1 MA0195.1 Lim3MA0261.1 lin-14 MA1450.1 lin-54 MA0619.1 LIN54 MA0175.1 Ims MA0702.2LMX1A MA0703.2 LMX1B MA0325.1 LYS14 MA1459.1 M1BP MA0262.1 mab-3MA1442.1 mab-5 MA0326.1 MAC1 MA0118.1 Macho-1 MA0535.1 Mad MA1520.1 MAFMA0501.1 MAF::NFE2 MA1521.1 MAFA MA0117.2 Mafb MA0495.3 MAFF MA0659.2MAFG MA0496.3 MAFK MA0328.2 MATALPHA2 MA0058.3 MAX MA0059.1 MAX::MYCMA1522.1 MAZ MA0329.1 MBP1 MA0330.1 MBP1::SWI6 MA0331.1 MCM1 MA0029.1Mecom MA0052.4 MEF2A MA0660.1 MEF2B MA0497.1 MEF2C MA0773.1 MEF2DMA0498.2 MEIS1 MA1639.1 MEIS1(var. 2) MA0774.1 MEIS2 MA1640.1 MEIS2(var.2) MA0775.1 MEIS3 MA0661.1 MEOX1 MA0706.1 MEOX2 MA0332.1 MET28 MA0333.1MET31 MA0334.1 MET32 MA0335.1 MET4 MA0801.1 MGA MA0336.1 MGA1 MA1158.1MGP MA0337.1 MIG1 MA0338.1 MIG2 MA0339.1 MIG3 MA0233.1 mirr MA0620.3MITF MA0621.1 mix-a MA0662.1 MIXL1 MA0663.1 MLX MA0622.1 MIxip MA0664.1MLXIPL MA0053.1 MNB1A MA0825.1 MNT MA0707.1 MNX1 MA0379.1 MOT2 MA0340.1MOT3 MA1523.1 MSANTD3 MA0665.1 MSC MA1524.1 MSGN1 MA1433.1 msn-1MA0341.1 MSN2 MA0342.1 MSN4 MA0666.1 MSX1 MA0708.1 MSX2 MA0709.1 Msx3MA0863.1 MTF1 MA1108.2 MXI1 MA0100.3 MYB MA0054.1 myb.Ph3 MA1179.1 MYB1MA1173.1 MYB101 MA1169.1 MYB105 MA1036.1 MYB111 MA1181.1 MYB113 MA1170.1MYB118 MA1176.1 MYB119 MA1426.1 MYB124 MA0574.1 MYB15 MA1037.1 MYB24MA1292.1 MYB27 MA1038.1 MYB3 MA1391.2 MYB33 MA1178.1 MYB3R1 MA1180.1MYB3R4 MA1172.1 MYB3R5 MA1039.1 MYB4 MA1040.1 MYB46 MA1171.1 MYB52MA1041.1 MYB55 MA1174.1 MYB56 MA1293.1 MYB57 MA1042.1 MYB59 MA1294.1MYB62 MA1177.1 MYB65 MA1393.2 MYB70 MA1394.2 MYB73 MA1395.1 MYB77MA1175.1 MYB81 MA1392.1 MYB98 MA0776.1 MYBL1 MA0777.1 MYBL2 MA0147.3 MYCMA0566.1 MYC2 MA0568.1 MYC3 MA0569.1 MYC4 MA0104.4 MYCN MA1641.1 MYF5MA0667.1 MYF6 MA0499.2 MYOD1 MA0500.2 MYOG MA1168.1 MYR2 MA0056.2 MZF1MA0057.1 MZF1(var. 2) MA1674.1 NAC017 MA0935.1 NAC025 MA1427.1 NAC028MA1675.1 NAC029 MA1045.1 NAC043 MA0937.1 NAC055 MA0938.1 NAC058 MA1676.1NAC062 MA1677.1 NAC078 MA0939.1 NAC080 MA1043.1 NAC083 MA1044.1 NAC92MA0929.1 NCU00019 MA1434.1 NCU02182 MA0343.1 NDT80 MA1109.1 NEUROD1MA0668.1 NEUROD2 MA0623.2 NEUROG1 MA0669.1 NEUROG2 MA1642.1 NEUROG2(var.2) MA0606.1 NFAT5 MA0624.1 NFATC1 MA0152.1 NFATC2 MA0625.1 NFATC3MA1525.1 NFATC4 MA0841.1 NFE2 MA0089.2 NFE2L1 MA0150.2 Nfe2l2 MA0670.1NFIA MA1643.1 NFIB MA0161.2 NFIC MA0119.1 NFIC::TLX1 MA1527.1 NFIC(var.2) MA0025.2 NFIL3 MA0671.1 NFIX MA1528.1 NFIX(var. 2) MA0105.4 NFKB1MA0778.1 NFKB2 MA0060.3 NFYA MA0502.2 NFYB MA1644.1 NFYC MA0048.2 NHLH1MA1529.1 NHLH2 MA0344.1 NHP10 MA0345.1 NHP6A MA0346.1 NHP6B MA1451.1nhr-6 MA1435.1 nit-4 MA0196.1 NK7.1 MA1645.1 NKX2-2 MA0672.1 NKX2-3MA0063.2 NKX2-5 MA0503.1 Nkx2-5(var. 2) MA0673.1 NKX2-8 MA0124.2 Nkx3-1MA0122.3 Nkx3-2 MA0674.1 NKX6-1 MA0675.1 NKX6-2 MA1530.1 NKX6-3 MA0125.1Nobox MA0710.1 NOTO MA0626.1 Npas2 MA1531.1 NR1D1 MA1532.1 NR1D2MA0115.1 NR1H2::RXRA MA0494.1 Nr1h3::Rxra MA1110.1 NR1H4 MA1146.1NR1H4::RXRA MA1533.1 NR1I2 MA1534.1 NR1I3 MA1535.1 NR2C1 MA0504.1 NR2C2MA1536.1 NR2C2(var. 2) MA0676.1 Nr2e1 MA0164.1 Nr2e3 MA0017.2 NR2F1MA1537.1 NR2F1(var. 2) MA1538.1 NR2F1(var. 3) MA1111.1 NR2F2 MA0677.1Nr2f6 MA0728.1 Nr2f6(var. 2) MA1539.1 NR2F6(var. 3) MA0113.3 NR3C1MA0727.1 NR3C2 MA1112.2 NR4A1 MA0160.1 NR4A2 MA1147.1 NR4A2::RXRAMA1540.1 NR5A1 MA0505.1 Nr5a2 MA1541.1 NR6A1 MA0506.1 NRF1 MA0347.1 NRG1MA0842.2 NRL MA0421.1 NSI1 MA1678.1 NTL8 MA1046.1 NTL9 MA0197.2 nubMA1157.1 NUC MA1436.1 nuc-1 MA1417.1 O2 MA0348.1 OAF1 MA1278.1 OBP1MA1274.1 OBP3 MA1280.1 OBP4 MA0234.1 oc MA0454.1 odd MA0198.1 OdsHMA1033.1 OJ1058_F05.8 MA1031.1 OJ1581_H09.2 MA0826.1 OLIG1 MA0678.1OLIG2 MA0827.1 OLIG3 MA0235.1 onecut MA0679.2 ONECUT1 MA0756.1 ONECUT2MA0757.1 ONECUT3 MA0456.1 opa MA0349.1 OPI1 MA0199.1 Optix MA1034.10s05g0497200 MA1050.1 Osl_08196 MA1542.1 OSR1 MA1646.1 OSR2 MA1409.1OsRR22 MA0236.1 otp MA0711.1 OTX1 MA0712.2 OTX2 MA0126.1 ovo MA1544.1OVOL1 MA1545.1 OVOL2 MA1030.1 P0510F09.23 MA0924.1 pal-1 MA0237.2 panMA0779.1 PAX1 MA0067.1 Pax2 MA0780.1 PAX3 MA1546.1 PAX3(var. 2) MA0068.2PAX4 MA0014.3 PAX5 MA0069.1 PAX6 MA0680.1 PAX7 MA0781.1 PAX9 MA0238.1 pbMA0064.1 PBF MA0070.1 PBX1 MA1113.2 PBX2 MA1114.1 PBX3 MA1702.1 Pdp1MA0352.1 PDR1 MA0353.1 PDR3 MA0354.1 PDR8 MA0132.2 PDX1 MA0127.1 PENDMA0546.1 pha-4 MA0355.1 PHD1 MA0457.1 PHDP MA1389.1 PHL1 MA1163.1 PHL11MA1166.1 PHL12 MA1384.1 PHL7 MA1460.1 pho MA0356.1 PHO2 MA0357.1 PHO4MA0713.1 PHOX2A MA0681.2 PHOX2B MA0987.1 PHYPADRAFT_140773 MA0988.1PHYPADRAFT_143875 MA0989.1 PHYPADRAFT_153324 MA1007.1 PHYPADRAFT_173530MA1008.1 PHYPADRAFT_182268 MA1023.1 PHYPADRAFT_28324 MA1022.1PHYPADRAFT_38837 MA1021.1 PHYPADRAFT_48267 MA1010.1 PHYPADRAFT_64121MA1011.1 PHYPADRAFT_72483 MA0559.1 PI MA0552.1 PIF1 MA0560.1 PIF3MA0561.1 PIF4 MA0562.1 PIF5 MA1364.1 PIF7 MA0682.2 PITX1 MA1547.1 PITX2MA0714.1 PITX3 MA0782.2 PKNOX1 MA0783.1 PKNOX2 MA0163.1 PLAG1 MA1615.1Plagl1 MA1548.1 PLAGL2 MA1377.1 PLT1 MA1378.1 PLT3 MA0536.1 pnr MA0955.1PQPTR_0002s00440g MA0784.1 POU1F1 MA0785.1 POU2F1 MA0507.1 POU2F2MA0627.2 POU2F3 MA0786.1 POU3F1 MA0787.1 POU3F2 MA0788.1 POU3F3 MA0789.1POU3F4 MA0790.1 POU4F1 MA0683.1 POU4F2 MA0791.1 POU4F3 MA1115.1 POU5F1MA0142.1 Pou5f1::Sox2 MA0792.1 POU5F1B MA0628.1 POU6F1 MA1549.1POU6F1(var. 2) MA0793.1 POU6F2 MA1148.1 PPARA::RXRA MA1550.1 PPARDMA0066.1 PPARG MA0065.2 Pparg::Rxra MA0200.1 Pph13 MA1703.1 pqm-1MA0239.1 prd MA0508.3 PRDM1 MA1616.1 Prdm15 MA1647.1 PRDM4 MA0715.1PROP1 MA0794.1 PROX1 MA0716.1 PRRX1 MA0075.3 PRRX2 MA1282.1 PTF1MA1618.1 Ptf1a MA1619.1 Ptf1a(var. 2) MA1620.1 Ptf1a(var. 3) MA0201.1Ptx1 MA1252.1 PUCHI MA0358.1 PUT3 MA1416.1 RAMOSA1 MA0359.1 RAP1MA1679.1 RAP2-1 MA0980.2 RAP2-10 MA1051.1 RAP2-3 MA1052.1 RAP2-6MA1216.1 RAP21 MA1249.1 RAP210 MA1266.1 RAP211 MA1256.1 RAP212 MA1221.1RAP26 MA0729.1 RARA MA0159.1 RARA::RXRA MA1149.1 RARA::RXRG MA0730.1RARA(var. 2) MA0857.1 Rarb MA0858.1 Rarb(var. 2) MA1552.1 RARB(var. 3)MA0859.1 Rarg MA0860.1 Rarg(var. 2) MA1553.1 RARG(var. 3) MA0582.1 RAV1MA0583.1 RAV1(var. 2) MA0718.1 RAX MA0717.1 RAX2 MA0576.1 RAX3 MA1116.1RBPJ MA1621.1 Rbpj1 MA0360.1 RDR1 MA0361.1 RDS1 MA0362.1 RDS2 MA0363.1REB1 MA1415.1 REF6 MA0364.1 REI1 MA0101.1 REL MA0107.1 RELA MA1117.1RELB MA0240.1 repo MA0138.2 REST MA0365.1 RFX1 MA0509.2 RFX1 MA0600.2RFX2 MA0798.2 RFX3 MA0799.1 RFX4 MA0510.2 RFX5 MA1554.1 RFX7 MA0366.1RGM1 MA0367.1 RGT1 MA0629.1 Rhox11 MA0719.1 RHOXF1 MA0368.1 RIM101MA0369.1 RLM1 MA0370.1 RME1 MA0241.1 ro MA0071.1 RORA MA0072.1 RORA(var.2) MA1150.1 RORB MA1151.1 RORC MA0371.1 ROX1 MA0372.1 RPH1 MA0373.1 RPN4MA0073.1 RREB1 MA0374.1 RSC3 MA0375.1 RSC30 MA1431.1 rst2 MA0376.1 RTG3MA0002.2 RUNX1 MA0511.2 RUNX2 MA0684.2 RUNX3 MA1184.1 RVE1 MA1190.1 RVE5MA1183.1 RVE6 MA1680.1 RVE7 MA0202.1 Rx MA0512.2 Rxra MA0074.1 RXRA::VDRMA0855.1 RXRB MA1555.1 RXRB(var. 2) MA0856.1 RXRG MA1556.1 RXRG(var. 2)MA0193.1 schlank MA0203.1 Scr MA0743.2 SCRT1 MA0744.2 SCRT2 MA0243.1 sdMA0584.1 1-Sep MA0563.1 3-Sep MA0377.1 SFL1 MA0378.1 SFP1 MA1159.1 SGR5MA0630.1 SHOX MA0720.1 Shox2 MA0380.1 SIP4 MA1118.1 SIX1 MA1119.1 SIX2MA0631.1 Six3 MA0204.1 Six4 MA1405.1 SIZF2 MA0547.1 skn-1 MA0381.1 SKN7MA0382.1 SKO1 MA0244.1 slbo MA0245.1 slou MA0458.1 slp1 MA0925.1 sma-4MA1622.1 Smad2::Smad3 MA0513.1 SMAD2::SMAD3::SMAD4 MA0795.1 SMAD3MA1153.1 Smad4 MA1557.1 SMAD5 MA0383.1 SMP1 MA0553.1 SMZ MA0086.2 snaMA1558.1 SNAI1 MA0745.2 SNAI2 MA1559.1 SNAI3 MA0544.1 snpc-4 MA0384.1SNT2 MA0246.1 so MA0554.1 SOC1 MA1560.1 SOHLH2 MA0385.1 SOK2 MA1379.1SOL1 MA0870.1 Sox1 MA0442.2 SOX10 MA0869.1 Sox11 MA1561.1 SOX12 MA1120.1SOX13 MA1562.1 SOX14 MA1152.1 SOX15 MA0078.1 Sox17 MA1563.1 SOX18MA0143.4 SOX2 MA0866.1 SOX21 MA0514.1 Sox3 MA0867.2 SOX4 MA0087.1 Sox5MA0515.1 Sox6 MA0868.2 SOX8 MA0077.1 SOX9 MA0079.4 SP1 MA0516.2 SP2MA0746.2 SP3 MA0685.1 SP4 MA0747.1 SP8 MA1564.1 SP9 MA0686.1 SPDEFMA0080.5 SPI1 MA0081.2 SPIB MA0687.1 SPIC MA1055.1 SPL1 MA1056.1 SPL11MA1057.1 SPL12 MA1321.1 SPL13 MA0586.2 SPL14 MA1320.1 SPL15 MA0577.2SPL3 MA1058.1 SPL4 MA1059.2 SPL5 MA1060.1 SPL7 MA0578.1 SPL8 MA1322.1SPL9 MA1061.1 SPT MA0386.1 SPT15 MA0387.1 SPT2 MA0388.1 SPT23 MA0111.1Spz1 MA0082.1 squamosa MA0389.1 SRD1 MA0595.1 SREBF1 MA0829.2SREBF1(var. 2) MA0596.1 SREBF2 MA0828.1 SREBF2(var. 2) MA0083.3 SRFMA1681.1 SRM1 MA0084.1 SRY MA0137.3 STAT1 MA0517.1 STAT1::STAT2 MA1623.1Stat2 MA0144.2 STAT3 MA0518.1 Stat4 MA1624.1 Stat5a MA0519.1Stat5a::Stat5b MA1625.1 Stat5b MA0520.1 Stat6 MA0532.1 Stat92E MA0390.1STB3 MA0391.1 STB4 MA0392.1 STB5 MA1410.1 StBRC1 MA0393.1 STE12 MA0394.1STP1 MA0395.1 STP2 MA0396.1 STP3 MA0397.1 STP4 MA1372.1 STZ MA0085.1Su(H) MA0533.1 su(Hw) MA0398.1 SUM1 MA0399.1 SUT1 MA0400.1 SUT2 MA1461.1SV MA0555.1 SVP MA0401.1 SWI4 MA0402.1 SWI5 MA0936.1 T11|18.17 MA0091.1TAL1::TCF3 MA1430.1 TB1 MA0403.1 TBF1 MA0108.2 TBP MA1355.1 TBP3MA0802.1 TBR1 MA0404.1 TBS1 MA0805.1 TBX1 MA0803.1 TBX15 MA1565.1 TBX18MA0804.1 TBX19 MA0688.1 TBX2 MA0689.1 TBX20 MA0690.1 TBX21 MA1566.1 TBX3MA0806.1 TBX4 MA0807.1 TBX5 MA1567.1 TBX6 MA0009.2 TBXT MA0521.1 Tcf12MA1648.1 TCF12(var. 2) MA0832.1 Tcf21 MA1568.1 TCF21(var. 2) MA0522.3TCF3 MA0830.2 TCF4 MA0769.2 TCF7 MA1421.1 TCF7L1 MA0523.1 TCF7L2MA0632.2 TCFL5 MA1284.1 TCP1 MA1283.1 TCP14 MA1062.2 TCP15 MA0587.1TCP16 MA1290.1 TCP17 MA1063.1 TCP19 MA1064.1 TCP2 MA1065.2 TCP20MA1287.1 TCP21 MA1066.1 TCP23 MA1286.1 TCP24 MA1289.1 TCP3 MA1035.1 TCP4MA1067.1 TCP5 MA1291.1 TCP7 MA1428.1 TCP8 MA1162.1 TCX2 MA1682.1 TCX3MA0431.1 TDA9 MA0405.1 TEA1 MA0090.3 TEAD1 MA1121.1 TEAD2 MA0808.1 TEAD3MA0809.2 TEAD4 MA0406.1 TEC1 MA0843.1 TEF MA0003.4 TFAP2A MA0810.1TFAP2A(var. 2) MA0872.1 TFAP2A(var. 3) MA0811.1 TFAP2B MA0812.1TFAP2B(var. 2) MA0813.1 TFAP2B(var. 3) MA0524.2 TFAP2C MA0814.2TFAP2C(var. 2) MA0815.1 TFAP2C(var. 3) MA1569.1 TFAP2E MA0691.1 TFAP4MA1570.1 TFAP4(var. 2) MA0145.3 TFCP2 MA1122.1 TFDP1 MA0831.2 TFE3MA0692.1 TFEB MA0871.2 TFEC MA0588.1 TGA1 MA1346.1 TGA10 MA0129.1 TGA1AMA1068.1 TGA2 MA1336.1 TGA3 MA1335.1 TGA4 MA1047.2 TGA5 MA1069.1 TGA6MA1070.1 TGA7 MA1348.1 TGA9 MA0796.1 TGIF1 MA0797.1 TGIF2 MA1571.1TGIF2LX MA1572.1 TGIF2LY MA0597.1 THAP1 MA1573.1 THAP11 MA0407.1 THI2MA1574.1 THRB MA1575.1 THRB(var. 2) MA1576.1 THRB(var. 3) MA0247.2 tinMA1220.1 TINY MA0459.1 tll MA1577.1 TLX2 MA0350.1 TOD6 MA0408.1 TOS8MA0106.3 TP53 MA0525.2 TP63 MA0861.1 TP73 MA0205.2 Trl MA1352.1 TRP1MA1356.1 TRP2 MA1411.1 TSAR1 MA1412.1 TSAR2 MA1161.1 TSO1 MA0460.1 ttkMA0248.1 tup MA0249.2 twi MA1123.2 TWIST1 MA0633.1 Twist2 MA0409.1 TYE7MA0094.2 Ubx MA0410.1 UGA3 MA1413.1 UIF1 MA0412.1 UME6 MA1443.1 unc-30MA0250.1 unc-4 MA0918.1 unc-62 MA0926.1 unc-86 MA0721.1 UNCX MA1074.1UNE10 MA0251.1 unpg MA0411.1 UPC2 MA0422.1 URC2 MA0093.3 USF1 MA0526.3UMA0256.1 MA0257.1 zen2 MA0928.1 zfh-2 MA1651.1 ZFP42 MA1583.1 ZFP57MA0146.2 Zfx MA1329.2 ZHD1 MA1213.1 ZHD3 MA1326.1 ZHD5 MA1330.1 ZHD6MA0696.1 ZIC1 MA1628.1 Zic1::Zic2 MA1629.1 Zic2 MA0697.1 ZIC3 MA0751.1ZIC4 MA1584.1 ZIC5 MA1704.1 zip-8 MA1585.1 ZKSCAN1 MA1652.1 ZKSCAN5MA0441.1 ZMS1 MA1587.1 ZNF135 MA1588.1 ZNF136 MA1589.1 ZNF140 MA0088.2ZNF143 MA1653.1 ZNF148 MA1654.1 ZNF16 MA1124.1 ZNF24 MA0528.2 ZNF263MA1592.1 ZNF274 MA1630.1 Znf281 MA1154.1 ZNF282 MA1593.1 ZNF317 MA1655.1ZNF341 MA0130.1 ZNF354C MA1594.1 ZNF382 MA1125.1 ZNF384 MA0752.1 ZNF410MA0116.1 Znf423 MA1656.1 ZNF449 MA1596.1 ZNF460 MA1597.1 ZNF528 MA1657.1ZNF652 MA1599.1 ZNF682 1MA1600.1 ZNF684 MA0753.2 ZNF740 MA1601.1 ZNF75DMA1602.1 ZSCAN29 MA1155.1 ZSCAN4 KY48 MA1317.1 WRKY50 MA1305.1 WRKY55MA1089.1 WRKY57 MA1304.1 WRKY59 MA1300.1 WRKY6 MA1090.1 WRKY60 MA1091.1WRKY62 MA1092.1 WRKY63 MA1302.1 WRKY65 MA1313.1 WRKY7 MA1308.1 WRKY70MA1316.1 WRKY71 MA1093.1 WRKY75 MA1094.1 WRKY8 MA1627.1 Wt1 MA0414.1XBP1 MA0844.1 XBP1 MA0415.1 YAP1 MA0416.1 YAP3 MA0417.1 YAP5 MA0418.1YAP6 MA0419.1 YAP7 MA0423.1 YER130C MA0424.1 YER184C MA0425.1 YGR067CMA0426.1 YHPI MA0428.1 YKL222C MA0429.1 YLL054C MA0430.1 YLR278CMA0432.1 YNR063W MA0433.1 YOX1 MA0434.1 YPR013C MA0435.1 YPR015CMA0436.1 YPR022C MA0437.1 YPR196W MA0438.1 YRM1 MA0439.1 YRR1 MA0095.2YYl MA0748.2 YY2 MA0255.1 z MA0440.1 ZAP1 MA0589.1 ZAP1 MA0749.1 ZBED1MA1649.1 ZBTB12 MA1650.1 ZBTB14 MA0698.1 ZBTB18 MA1579.1 ZBTB26 MA1580.1ZBTB32 MA0527.1 ZBTB33 MA1581.1 ZBTB6 MA0750.2 ZBTB7A MA0694.1 ZBTB7BMA0695.1 ZBTB7C MA0103.3 ZEB1 MA0927.1 vab-7 MA0722.1 VAX1 MA0723.1 VAX2MA0693.2 VDR MA0724.1 VENTX MA1578.1 VEZF1 MA1462.1 vfl MA0252.1 visMA0253.1 vnd MA0181.1 Vsx1 MA0725.1 VSX1 MA0180.1 Vsx2 MA0726.1 VSX2MA0254.1 vvl MA1437.1 wc-1 MA1306.1 WRKY11 MA1075.1 WRKY12 MA1314.1WRKY14 MA1076.2 WRKY15 MA1299.1 WRKY17 MA1077.1 WRKY18 MA1078.1 WRKY2MA1295.1 WRKY20 MA1079.1 WRKY21 MA1303.1 WRKY22 MA1080.1 WRKY23 MA1315.1WRKY24 MA1081.1 WRKY25 MA1297.1 WRKY26 MA1318.1 WRKY27 MA1311.2 WRKY28MA1298.1 WRKY29 MA1309.1 WRKY3 MA1083.1 WRKY30 MA1307.1 WRKY31 MA1301.1WRKY33 MA1084.1 WRKY38 MA1085.2 WRKY40 MA1310.1 WRKY42 MA1086.1 WRKY43MA1087.1 WRKY45 MA1296.1 WRKY46 MA1312.1 WRKY47 MA1088.1 WRKY48 MA1317.1WRKY50 MA1305.1 WRKY55 MA1089.1 WRKY57 MA1304.1 WRKY59 MA1300.1 WRKY6MA1090.1 WRKY60 MA1091.1 WRKY62 MA1092.1 WRKY63 MA1302.1 WRKY65 MA1313.1WRKY7 MA1308.1 WRKY70 MA1316.1 WRKY71 MA1093.1 WRKY75 MA1094.1 WRKY8MA1627.1 Wt1 MA0414.1 XBP1 MA0844.1 XBP1 MA0415.1 YAP1 MA0416.1 YAP3MA0417.1 YAP5 MA0418.1 YAP6 MA0419.1 YAP7 MA0423.1 YER130C MA0424.1YER184C MA0425.1 YGR067C MA0426.1 YHP1 MA0428.1 YKL222C MA0429.1 YLL054CMA0430.1 YLR278C MA0432.1 YNR063W MA0433.1 YOX1 MA0434.1 YPR013CMA0435.1 YPR015C MA0436.1 YPR022C MA0437.1 YPR196W MA0438.1 YRM1MA0439.1 YRR1 MA0095.2 YYl MA0748.2 YY2 MA0255.1 z MA0440.1 ZAP1MA0589.1 ZAP1 MA0749.1 ZBED1 MA1649.1 ZBTB12 MA1650.1 ZBTB14 MA0698.1ZBTB18 MA1579.1 ZBTB26 MA1580.1 ZBTB32 MA0527.1 ZBTB33 MA1581.1 ZBTB6MA0750.2 ZBTB7A MA0694.1 ZBTB7B MA0695.1 ZBTB7C MA0103.3 ZEB1 MA0256.1zen MA0257.1 zen2 MA0928.1 zfh-2 MA1651.1 ZFP42 MA1583.1 ZFP57 MA0146.2Zfx MA1329.2 ZHD1 MA1213.1 ZHD3 MA1326.1 ZHD5 MA1330.1 ZHD6 MA0696.1ZIC1 MA1628.1 Zic1::Zic2 MA1629.1 Zic2 MA0697.1 ZIC3 MA0751.1 ZIC4MA1584.1 ZIC5 MA1704.1 zip-8 MA1585.1 ZKSCAN1 MA1652.1 ZKSCAN5 MA0441.1ZMS1 MA1587.1 ZNF135 MA1588.1 ZNF136 MA1589.1 ZNF140 MA0088.2 ZNF143MA1653.1 ZNF148 MA1654.1 ZNF16 MA1124.1 ZNF24 MA0528.2 ZNF263 MA1592.1ZNF274 MA1630.1 Znf281 MA1154.1 ZNF282 MA1593.1 ZNF317 MA1655.1 ZNF341MA0130.1 ZNF354C MA1594.1 ZNF382 MA1125.1 ZNF384 MA0752.1 ZNF410MA0116.1 Znf423 MA1656.1 ZNF449 MA1596.1 ZNF460 MA1597.1 ZNF528 MA1657.1ZNF652 MA1599.1 ZNF682 MA1600.1 ZNF684 MA0753.2 ZNF740 MA1601.1 ZNF75DMA1602.1 ZSCAN29 MA1155.1 ZSCAN4

TABLE 3B Examples of hormone responsive transcription factors andelements ²⁸ Associating Nuclear Receptor Ligand Response ElementRORα,β,γ retinoids RORαRE LXRα,β oxysterols, including 22(R)- LXREhydroxycholesterol, 24(S)- hydroxycholesterol, and 24(S),25-epoxycholesterol FXR Chenodeoxycholic acid and other AGGTCA bile acidsVDR Vitamin D (1,25(OH)2D) VDRE Lithocholic acid ERα,β EstrogenERE-TATA, ERE GR cortisol and other glucocorticoids decoy GRE, GRE, plfG

The modification of endogenous transcription factor spacing by geneticediting is another viable strategy for gene activation. Transcriptionfactor cooperativity³⁰ ³¹ is a well-known phenomenon where multipletranscription factors bound in proximity leads to greater overallbinding stabilization and downstream regulatory effect. First, theanalysis of endogenous transcription factor spacing for optimalregulatory potential can be determined based on primary DNA sequence infunctional cis-regulatory elements or based on studies of transcriptionfactor pair binding data in vitro (e.g., CAP-SELEX)¹⁶. Next, the mappingof endogenous transcription factor binding sites in cis-regulatoryelements of a target gene of interest can be performed to determinesub-optimal endogenous transcription factor binding spacing³². Theutilization of genetic modifiers that can introduce insertion ordeletion edits (e.g., programmable nucleases, prime editors) can then betargeted to modify the endogenous transcription factor binding sitedistances to promote heritable target gene activation.

Selection of Target Genomic Regulatory Regions

The identification and selection of target genomic regulatory regionscan be made based on identification or prediction (e.g., bioinformaticor empirical) of cis-regulatory elements (e.g., promoters, enhancers,insulators, silencers/repressors) that regulate a target gene or set oftarget genes of interest, untranslated regions (UTRs) of target genetranscripts that can modify transcript stability, or regions along thetranscript that can modify translation initiation and/or elongationefficiency of the target gene transcript, or locations in the genomewhere expression of an non-coding RNA could lead to targeted generepression.

In some embodiments, the target genomic regions are non-coding DNAsequences within 1 Mb or more of the target gene(s) of interest.

In some embodiments, the target genomic regions are promoters of thetarget gene(s) of interest, defined as proximal regions e.g., 1000 bpupstream and 500 bp downstream of the transcription start site (TSS).

In some embodiments, the target genomic regions are putative enhancerelements of the target gene(s) of interest defined by histone marksand/or chromatin accessibility features associated with functionalenhancer elements (e.g., H3K4me1, H3K27ac)¹⁷.

In some embodiments, the target genomic regions are putative insulatorelements of the target gene(s) of interest defined by histone marksand/or chromatin accessibility features associated with functionalinsulator elements^(17, 18).

In some embodiments, the target genomic regions are putative silencerelements of the target gene(s) of interest defined by histone marksand/or chromatin accessibility features associated with functionalsilencer elements¹⁹.

In some embodiments, the target genomic regions are untranslated regions(UTRs) of target gene transcripts.

In some embodiments, the target genomic regions are intronic regions oftarget gene transcripts.

In some embodiments, the target genomic regions are coding sequences oftarget gene transcripts.

In some embodiments, the endogenous regulatory region of a gene (e.g.,the promoter) is targeted to modify or enhance downstream transcriptionof translation machinery. This can be achieved e.g., by installing ormodifying a TATA box (also known as Goldberg-Hogness box) in archae oreukaryotes or a Pribnow box in prokaryotes or by installing enhancedKozak ((gcc)gccRccAUGG (SEQ ID NO: 478)) in eukaryotes, Shine-Dalgarno(AGGAGGU) in prokaryotes, start codon (AUG and CUG in mammalian cells,AUA and AUU in mitochondria, GUG and UUG in E. coli) or stop codon (UGA,UAG, UAA) sequences²⁰.

In some embodiments binding sites of non-coding RNAs (ncRNAs), such asmicroRNAs (miRNAs) or long non-coding RNAs (lncRNAs) are installed ormodified to alter the binding of said ncRNAs to DNA or RNA with theresult of altered gene expression, and/or RNA abundance, and/or proteinexpression.

Selection of Genetic Modifiers

The identification of genetic modifiers can be determined based onpredictions (e.g., bioinformatic or empirical) of ability, efficiencyand precision of a given modifier to introduce specific sequence motifsat a target region of interest (Table 1). The methods can includeidentifying genetic modifiers to introduce specific sequence motifs intotarget genomic regions with high predicted precision and efficiency toalter expression of a target gene or set of genes at thepre-transcriptional or post-transcriptional level, in the context of acell type or set of cell types of interest.

In some embodiments, the methods can include using an algorithm thatcompares the target regulatory regions and regulatory motif sequencesidentified above and identifies candidate regulatory motif sequences.and compares the candidate regulatory motifs to the possiblemodifications that would be made by a set of genetic modifiers (e.g., topredict the modification(s) made by each of a set of genetic modifiers,to identify one or more genetic modifiers that can be used to modify thetarget regulatory region to introduce a functional regulatory motif. Insome embodiments, the candidate regulatory motif sequences differ fromthe target gene regulatory region by less than a selected amount, e.g.,by 1-50%, and a Base Editor or prime editor can be selected to make thechanges. In some embodiments, there is no identity between the targetregulatory regions and regulatory motif sequences, and a prime editor isselected for inserting a regulatory motif into the target regulatoryregion.

The identification of a genetic modifier (e.g., programmable nuclease,base editor, prime editor) can be performed through the unbiasedsaturating mutagenesis of regulatory regions (e.g., promoters,enhancers) associated with a target gene. Comprehensive genetic tilingof these regulatory elements and downstream readout of the editingeffects on gene activation can be used to empirically identifycombinations of genetic modifiers and target sites that yield varyinglevels of target gene activation. This strategy can be performed in apooled library format where target gene activation is a selectable orsortable feature, allowing for the high-throughput identification ofcandidates for SHAPE.

In some embodiments, the sequence motif is introduced as a single motifor a repetitive sequence with multiple copies of the single motif thatmay or may not have linker sequences interspaced.

In some embodiments, the sequence motif is introduced as a combinationof different sequence motifs with predicted additive or synergisticeffects on target gene expression at the pre-transcriptional and/orpost-transcriptional level, where the multiple sequence motifs may ormay not have linker sequences interspaced.

In some embodiments, algorithms to predict sequence alleles followingnuclease genome editing events are used to identify a programmablenuclease type (e.g., zinc finger nucleases, transcription activator-likeeffector nucleases, Cas9, CasX, Cas12) and target cleavage indice(s)within a DNA sequence of interest to produce an allele that resembles asequence motif or modification of interest.

In some embodiments, algorithms focused on patterns ofmicrohomology-mediated end joining (MMEJ) and/or non-homologous endjoining (NHEJ) following nuclease-induced DBA double-strand breaks(DSBs) can be used for the prediction of alleles following genomeediting by a programmable nuclease (e.g., zinc finger nucleases,transcription activator-like effector nucleases, Cas9, CasX, Cas12)²¹.

In some embodiments, the use of the predominant +1 insertion allele fromCas9 editing can be used to precisely install sequence motifs ofinterest²².

In some embodiments, algorithms to predict sequence alleles followingbase editing events can be used to identify the base editor type (e.g.,ABEs, CBEs) and base editing window(s) within a DNA sequence of interestto produce an allele that resembles a sequence motif or modification ofinterest^(23,24 25).

In some embodiments, algorithms to predict sequence alleles followingbase editing events can be used to identify the base editor type (e.g.,ABEs, CBEs) and base editing window(s) within a DNA sequence of interestto produce an allele that modifies (e.g., strengthens, weakens) theregulatory potential of an existing sequence motif.

In some embodiments, algorithms to predict sequence alleles followingprime editing events can be used to identify the prime editor type(e.g., SpCas9H840A-MMLV-RT), prime editing guide RNAs (pegRNAs), andnicking sgRNAs (ngRNAs) to install a specific sequence motif ormodification that can affect the expression of the target gene at thepre-transcriptional or post-transcriptional level².

In some embodiments, prime editing can be used to install specificsubstitution edits within an endogenous sequence context to introducespecific sequence motifs of interest. In some embodiments, prime editingcan be used to install specific insertion edits within an endogenoussequence context to introduce specific sequence motifs of interest.

In some embodiments, prime editing can be used to install specificinsertion edits to modify endogenous sequence motifs within untranslatedregions (UTRs) of target gene transcripts or insert sequences thatcontain RNA-stabilizing or de-stabilizing sequence motifs intountranslated regions (UTRs) of target gene transcripts to affect theabundance and/or expression of the target gene products (e.g., RNA,protein).

In some embodiments, prime editing can be used to install specificdeletion edits within an endogenous sequence context to introducespecific sequence motifs of interest.

In some embodiments, prime editing can be used to install specificcombination edits (e.g., substitution, insertion, and/or deletion edits)within an endogenous sequence context to introduce specific sequencemotifs of interest

In some embodiments, the design of pegRNAs and ngRNAs for prime editingwill introduce silent mutations into the protospacer adjacent motif(PAM).

In some embodiments, the design of ngRNAs for prime editing willpreferentially target the genome following the editing event (known asPE3b).

In some embodiments, the introduction of a transcription factor (TF)binding site in promoter or enhancer sequences or any other DNA sequencethat might affect transient or heritable gene activation can be inducedusing a base editor (BE). In this case an endogenous sequence would bealtered by BEs to allow TF binding by increasing homology of theendogenous sequence to a known TF binding site, thereby enabling a SHAPEevent (BE-SHAPE).

In some embodiments, the unbiased saturation mutagenesis across genomicsequences (e.g., promoter, enhancers, untranslated regions) can beperformed to empirically determine the strategy for SHAPE.

In some embodiments, multiplex genetic editing can be utilized to inducemore robust modification of target gene expression at thepre-transcriptional and/or post-transcriptional level.

In some embodiments, multiplex genetic editing can be utilized to modifymultiple target gene expressions in parallel at the pre-transcriptionaland/or post-transcriptional level.

In some embodiments, the installation of sequence motifs that act asresponse elements (Table 3C) can be used to perform induciblemodification of gene expression (e.g., activation, repression)followingthe introduction of an exogenous small molecule, hormone, or drug.

In some embodiments, the installation of cell-type-specific sequencemotifs can be used to achieve cell-type-specific modification of theexpression of a target gene or set of target genes.

In some embodiments, the use of homology directed repair (HDR) throughprogrammable nucleases and a donor DNA (e.g., ssODN, dsODN) can be usedto introduce sequence motifs of interest into a target site²³.

In some embodiments, the use of NHEJ-mediated DNA sequence integrationthrough programmable nucleases and double-stranded oligodeoxynucleotides(dsODN) or circular DNA donors (e.g., plasmids, minicircles) can be usedto introduce sequence motifs of interest into a target site²⁶ ²⁷.

In some embodiments, a DNA sequence alteration described herein can beperformed using CRISPR-guided DNA base editors such as the cytosine baseeditor (CBE) that allows for the introduction of C-to-T and G-to-Amodifications, the adenine base editor (ABE) that allows for theintroduction of A-to-G and T-to-C modifications, the cytosine-to-guaninetransversion base editor (CGBE) that allows for the introduction ofC-to-G and G-to-C modifications, as well as the synchronous programmingof adenine and cytosine editor (SPACE) that allows for the simultaneousintroduction of A-to-G (T-to-C on opposite strand) and C-to-T (G-to-A onopposite strand) modifications within the same editing window at thessDNA bubble generated by RNA-guided fusion proteins.

While CBEs and CGBEs are comprised of a cytidine deaminase (e.g.,pmCDA1, hAPOBEC3A, hAID, hAPOBEC3G or rAPOBEC1) as well as a CRISPR CasRGN or a variant thereof, ABEs contain an adenosine deaminase (e.g., E.coli TadA or variants thereof as momoners or dimers) and a CRISPR Casprotein, and SPACE contains both adenine (e.g., E. coli TadA) andcytosine deaminases (e.g., pmCDA1) as well as CRISPR-Cas proteins (e.g.,S. pyogenes Cas9).

In one aspect, the present invention relates to the use of an ABE orSPACE comprising: an adenosine deaminase, e.g., a wild type and/orengineered adenosine deaminase (e.g., ABEs 0.1, 0.2, 1.1, 1.2, 2.1, 2.2,2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 2.10, 2.11, 2.12, 3.1, 3.2, 3.3, 3.4,3.5, 3.6, 3.7, 3.8, 4.1, 4.2, 4.3, 5.1, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7,5.8, 5.9, 5.10, 5.11, 5.12, 5.13, 5.14, 6.1, 6.2, 6.3, 6.4, 6.5, 6.6,7.1, 7.2, 7.3, 7.4, 7.5, 7.6, 7.7, 7.8, 7.9, 7.10, or ABEmax), E. coliTadA monomer, or variations of homo- or heterodimers thereof, bearingone or more mutations in either or both monomers (e.g., the TadA mutantused in miniABEmax-V82G, miniABEmax-K20A/R21A, miniABEmax-V106W, thatdecrease RNA editing activity while preserving DNA editing activity; acytidine deaminase (e.g., pmCDA1, rat APOBEC1, human APOBEC3A, or humanAID) or variations thereof with reduced RNA off-target editing, one ormultiple uracil-n-clycosalyse inhibitors (UGIs); and a programmable DNAbinding domain (e.g., Cas9-D10A); and optionally further comprising oneor more nuclear localization sequences (e.g., SV40 large T antigen NLS(PKKKRRV, SEQ ID NO: 1), bipartite NLS (KRTADGSEFESPKKKRKV, SEQ ID NO.2), or nucleoplasmin NLS (KRPAATKKAGQAKKKK, SEQ ID NO. 3). Other NLSsare known in the art; see, e.g., Cokol et al., EMBO Rep. 2000 Nov. 15;1(5): 411-415; Freitas and Cunha, Curr Genomics. 2009 December; 10(8):550-557.

In some embodiments, the dual-deaminase BE SPACE would be used and itwould include a heterodimeric combined N-terminal adenosine and cytidinedeaminase fusion (e.g., pmCDA1 or rAPOBEC1 or hA3A or AID fused to TadAmonomers or dimers with a linker) or a heterodimeric combined C-terminaladenosine and cytidine deaminase fusion (e.g., pmCDA1 or rAPOBEC1 orhA3A or AID fused to TadA monomers or dimers with a linker). In both N-and C-terminal positions of these “hybrid fusion deaminase designs” thedeaminases can be fused in either of these two orders: NH2-cytidinedeaminase-linker-adenosine deaminase or NH2-adenosinedeaminase-linker-cytidine deaminase.

In some embodiments, the programmable DNA binding domain is selectedfrom the group consisting of engineered C2H2 zinc-fingers, transcriptionactivator effector-like effectors (TALEs), and Clustered RegularlyInterspaced Short Palindromic Repeats (CRISPR) Cas RNA-guided nucleases(RGNs) and variants thereof (e.g., Tables F L and MG).

In some embodiments, the CRISPR RGN is an ssDNA nickase or iscatalytically inactive, e.g., a Cas9, CasX or Cas12a that has ssDNAnickase activity or is catalytically inactive.

In one aspect, the present invention relates to a base editing systemcomprising: (i) ABE, CBE, CGBE, or SPACE, wherein the programmable DNAbinding domain is a CRISPR Cas RGN or a variant thereof; and (ii) atleast one guide RNA compatible with the base editor that directs thebase editor to a target sequence which is can then be deaminated inorder to generate e.g., a TF binding site or any other modification thatallows for the transcriptional activation of a targeted gene.

In one aspect, the present invention relates to an isolated nucleic acidencoding any of the CBEs, ABEs, CGBEs, and SPACE or other base editingsystems described herein to induce a BE-SHAPE event.

In one aspect, the present invention relates to a vector comprising anisolated nucleic acid described herein.

In one aspect, the present invention relates to an isolated host cell,preferably a mammalian host cell, comprising any of the nucleic acidsdescribed herein.

In some embodiments, the isolated host cell described herein expresses abase editor and a gRNA for DNA modification to induce a BE-SHAPE eventdescribed herein.

In one aspect, the present invention relates to a method of deaminatinga selected adenine and/or cytosine in a nucleic acid, the methodcomprising contacting the nucleic acid with SPACE, a base editingsystem, an isolated nucleic acid, a vector, or an isolated host celldescribed herein.

In one aspect, the present invention relates to a composition comprisinga purified CBE, ABE, SPACE, or CGBE, a base editing system, an isolatednucleic acid, a vector, or an isolated host cell described herein.

In some embodiments, the composition includes one or moreribonucleoprotein (RNP) complexes.

In some embodiments, CBE, ABE, CGBE, or SPACE that are being used forBE-SHAPE comprise one or more uracil-N-glycosylase inhibitors (UGIs). Insome embodiments, the base editors comprise a linker between theadenosine deaminase and the programmable DNA binding domain as well asthe cytidine deaminase and the DNA binding domain, or both in the caseof SPACE. In some embodiments the TadA domain can be monomeric,homodimeric or heterodimeric and contain all combinations of wild type(WT) E. coli TadA, or mutant variants of TadA.

In some embodiments one or two deaminase domains can be located at theC-terminus (e.g., pmCDA1) and N-terminus (TadA) or vice versa or theycan both be located at the C- or N-terminus.

In some embodiments, the programmable DNA binding domain is selectedfrom the group consisting of engineered C2H2 zinc-fingers, transcriptionactivator effector-like effectors (TALEs), and Clustered RegularlyInterspaced Short Palindromic Repeats (CRISPR)-Cas RNA-guided nucleases(RGNs) and variants thereof.

In some embodiments, the CRISPR-Cas RGN is an ssDNA nickase or iscatalytically inactive, e.g., a Cas9 or Cas12a that is catalyticallyinactive or has ssDNA nickase activity (Table 4A).

In some embodiments, the methods include the use of base editing systemscomprising (i) the adenine base editors described herein, wherein theprogrammable DNA binding domain is a CRISPR Cas RGN or a variant thereof(Table 4B); and (ii) at least one guide RNA compatible with the baseeditor that directs the base editor to a target sequence.

In some embodiments, the methods include the use of nucleic acidsencoding ABE, CBE, CGBE or SPACE; vectors comprising the isolatednucleic acids; and isolated host cells, preferably mammalian host cells,comprising the nucleic acids. In some embodiments, the isolated hostcell expresses an adenine base editor.

In some embodiments, the methods include the use of methods fordeaminating a selected adenine in a nucleic acid, the method comprisingcontacting the nucleic acid with an adenine base editor or base editingsystem as described herein.

In some embodiments, the methods include the use of compositionscomprising a purified ABE, CBE, CGBE or SPACE or base editing system asdescribed herein. In some embodiments, the composition comprises one ormore ribonucleoprotein (RNP) complexes.

In some embodiments, the guide RNAs that are used to target BEs forBE-SHAPE can be truncated by reducing spacer length to <20 nucleotides,e.g., to 17-18 nucleotides, which has been shown to enhance specificityof CRISPR-Cas nucleases (Fu & Sander et al, Nature Biotechnology 2014,32(3):279-284) and may also affect base editing windows (Kim et al,Nature Biotechnology 2017, 35(4): 371-376).

In some embodiments, multiplex base editing with CBE, ABE, CGBE, andSPACE can be used to enhance the efficiency of BE-SHAPE. In this aspect,one or more gRNAs can be guiding one or more base editors (e.g., CBE andABE, or ABE and CGBE, or SPACE and CGBE) to one or more genomic targetsites to install multiple TF binding sites (or other sequence changesthat drive transcriptional activation) at once in one cell or apopulation of cells, or a tissue, both in vivo or ex vivo.

In some embodiments, anti-CRISPR tools (Bondy-Denomy et al, Nature 2013,493(7432):429-32 and Nature 2015, 526(7571):136-9; Pawluk et al, Cell2016, 167(7):1829-1838.e9.) can be used to control the efficiency ofCRISPR-based SHAPE platforms by altering the capacity of DNA bindingand/or cleavage of the CRISPR-Cas protein when used as a nuclease orwithin a base or prime editor.

TABLE 4A List of Exemplary Cas9 or Cas12a Orthologs UniProt or GenBankNickase Mutations/Catalytic Ortholog Accession Number residues S.pyogenes Cas9 (SpCas9) Q99ZW2.1 D10A, E762A, H840A, N854A, N863A,D986A¹⁷ S. aureus Cas9 (SaCas9) J7RUA5.1 D10A and N580¹⁸ S. thermophilusCas9 G3ECR1.2 D31A and N891A¹⁹ (St1Cas9) S. pasteurianus Cas9 BAK30384.1D10, H599* (SpaCas9) C. jejuni Cas9 (CjCas9) Q0P897.1 D8A, H559A²⁰ F.novicida Cas9 (FnCas9) A0Q5Y3.1 D11, N995²¹ P. lavamentivorans Cas9A7HP89.1 D8, H601* (PlCas9) C. lari Cas9 (ClCas9) G1UFN3.1 D7, H567*Pasteurella multocida Cas9 Q9CLT2.1 F. novicida Cpf1 (FnCpf1) A0Q7Q2.1D917, E1006, D1255²¹ M. bovoculi Cpf1 (MbCpf1) WP 052585281.1 D986A** A.sp. BV3L6 Cpf1 (AsCpf1) U2UMQ6.1 D908, 993E, Q1226, D1263²³ L. bacteriumN2006 (LbCpf1) A0A182DWE3.1 D832A²⁴ *predicted based on UniRuleannotation on the UniProt database. **Unpublished but deposited ataddgene by Ervin Welker: pTE4565 (Addgene plasmid No 88903)

TABLE 4B List of Exemplary High Fidelity and/or PAM-relaxed RGNOrthologs Published HF/PAM- RGN variants PMID Mutations* S. pyogenesCas9 26628643 K810A/K1003A/R1060A (1.0); (SpCas9) eSpCas9K848A/K1003A/R1060A(1.1) S. pyogenes Cas9 29431739M495V/Y515N/K526E/R661Q; (SpCas9) evoCas9 (M495V/Y515N/K526E/R661S;M495V/Y515N/K526E/R661L) S. pyogenes Cas9 26735016N497A/R661A/Q695A/Q926A (SpCas9) HF1 S. pyogenes Cas9 30082871 R691A(SpCas9) HiFi Cas9 S. pyogenes Cas9 28931002 N692A, M694A, Q695A, H698A(SpCas9) HypaCas9 S. pyogenes Cas9 30082838 F539S, M763I, K890N (SpCas9)Sniper- Cas9 S. pyogenes Cas9 29512652 A262T, R324L, S409I, E480K,E543D, M694I, E1219V (SpCas9) xCas9 S. pyogenes Cas9 30166441 R1335V,L1111R, D1135V, G1218R, (SpCas9) SpCas9- E1219F, A1322R, T1337R NG S.pyogenes Cas9 26098369 D1135V, R1335Q, T1337R; (SpCas9)D1135V/G1218R/R1335E/T1337R VQR/VRER S. aureus Cas9 26524662E782K/N968K/R1015H (SaCas9)-KKH enAsCas12a USSN One or more of: E174R,S170R, S542R, K548R, 15/960,271 K548V, N551R, N552R, K607R, K607H, e.g.,E174R/S542R/K548R, E174R/S542R/K607R, E174R/S542R/K548V/N552R,S170R/S542R/K548R, S170R/E174R, E174R/S542R, S170R/S542R,E174R/S542R/K548R/N551R, E174R/S542R/K607H, S170R/S542R/K607R, orS170R/S542R/K548V/N552R enAsCas12a-HF USSN One or more of: E174R, S542R,K548R, e.g., 15/960,271 E174R/S542R/K548R, E174R/S542R/K607R,E174R/S542R/K548V/N552R, S170R/S542R/K548R, S170R/E174R, E174R/S542R,S170R/S542R, E174R/S542R/K548R/N551R, E174R/S542R/K607H,S170R/S542R/K607R, or S170R/S542R/K548V/N552R, with the addition of oneor more of: N282A, T315A, N515A and K949A enLbCas12a(HF) USSN One ormore of T152R, T152K, D156R, D156K, 15/960,271 Q529K, G532R, G532K,G532Q, K538R, K538V, D541R, Y542R, M592A, K595R, K595H, K595S or K595Q,e.g., D156R/G532R/K538R, D156R/G532R/K595R, D156R/G532R/K538V/Y542R,T152R/G532R/K538R, T152R/D156R, D156R/G532R, T152R/G532R,D156R/G532R/K538R/D541R, D156R/G532R/K595H, T152R/G532R/K595R,T152R/G532R/K538V/Y542R, optionally with the addition of one or more of:N260A, N256A, K514A, D505A, K881A, S286A, K272A, K897A enFnCas12a(HF)USSN One or more of T177A, K180R, K180K, E184R, 15/960,271 E184K, T604K,N607R, N607K, N607Q, K613R, K613V, D616R, N617R, M668A, K671R, K671H,K671S, or K671Q, e.g., E184R/N607R/K613R, E184R/N607R/K671R,E184R/N607R/K613V/N617R, K180R/N607R/K613R, K180R/E184R, E184R/N607R,K180R/N607R, E184R/N607R/K613R/D616R, E184R/N607R/K671H,K180R/N607R/K671R, K180R/N607R/K613V/N617R, optionally with the additionof one or more of: N305A, N301A, K589A, N580A, K962A, S334A, K320A,K978A chimeric Cas9 30718489 S. aureus Cas9 with PAM interaction domainfrom cCas9 SaCas9 orthologues, expands recognition and targetability ofNNVRRN, NNVACT, NNVATG, NNVATT, NNVGCT, NNVGTG, and NNVGTT PAM sequencesStreptococcus doi.org/10.1 Recognizes 5’-NAA-3’ PAM macacae (Smac)101/429654 Cas9 NCTC 11558 Spy-mac Cas9, doi.org/10.1 Recognizes5’-NAA-3’ PAM Smac-py Cas9 101/429654 N. meningitidis 30581144Recognizes N₄CC PAM Nme2Cas9 SpG Cas9 (SEQ-ID 32217751 SpCas9 variantcapable of targeting NGN PAMs 158)D1135L/S1136W/G1218K/E1219Q/R1335Q/T1337R Also as SpG-HF1 in combinationwith N497A/R661A/Q695A/Q926A SpRY Cas9 (SEQ-ID 32217751 SpCas9 variantcapable of targeting NRN>NYN PAMs 157)SpRY(A61R/L1111R/D1135L/S1136W/G1218K/E1219Q/N1317R/A1322R/R1333P/R1335Q/T1337R); also as SpRY-HF1 in combinationwith N497A/R661A/Q695A/Q926A *predicted based on UniRule annotation onthe UniProt database.

SHAPE Applications

Examples of applications of the SHAPE strategy include SHAPE-TF(transcription factor), SHAPE-UTR (untranslated region), SHAPE-RNAi (RNAinterference), and SHAPE-protein (e.g., Kozak sequence, codonoptimization).

SHAPE-TF

In some instances, the SHAPE strategy can alter target gene expressionat the pre-transcriptional level through the targeted introduction oftranscription factor binding motifs (SHAPE-TF) into regions in thegenome. Following the introduction of these transcription factor bindingmotifs (e.g., identified using a method described herein, or from adatabase such as the JASPAR database (e.g., 8th release—Fornes et al,“JASPAR 2020: update of the open-access database of transcription factorbinding profiles”, Nucleic Acids Research Volume 48, Issue D1, 8 Jan.2020, Pages D87—D92.), the recruitment of endogenous transcriptionfactors to the target locus can enable the activation or repression oftarget gene expression through the increase or decrease in genetranscription, respectively. In addition to the introduction ormodification of transcription factor binding sites, SHAPE-TF can alsowork through the modification of spacing between endogenoustranscription factor binding sites to achieve alteration of target geneexpression. To achieve SHAPE-TF, there are several steps that include 1)the identification/discovery of sequence motifs that can activelyrecruit transcription factors or modify endogenous transcription factorspacing, respectively, 2) the identification of target genomicsequence(s) to introduce the sequence motif or modification to affecttarget gene expression, and 3) identification of the genetic modifier touse to install the precise edit.

SHAPE-UTR

In some instances, the SHAPE strategy can alter target gene expressionat the post-transcriptional level through the targeted introduction ofsequence motifs into untranslated regions (SHAPE-UTR) of target genetranscripts to affect transcript stability and downstream proteinexpression. Following the introduction of these sequence motifs intoUTRs, the stabilization or de-stabilization of target gene transcriptscan enable the activation or repression of target gene expressionthrough the increase or decrease in gene translation, respectively. Toachieve SHAPE-UTR, there are several steps that include 1) theidentification or discovery of sequence motifs that can modify atranscript stability when placed at the 5′ and/or 3′ UTRs, 2) theidentification of specific regions within the 5′ and/or 3′ UTRs tointroduce a sequence motif to affect transcript stability, and 3)identification of the genetic modifier to use to install the preciseedit.

SHAPE-RNAi

In some instances, the SHAPE strategy can alter target gene expressionat the post-transcriptional level through the targeted introduction ofsequence motifs (e.g., microRNA binding sites on DNA/RNA, e.g., from themirtarbase database (e.g., miRTarBase Release 8.0—Chou et al,“miRTarBase update 2018: A resource for experimentally validatedmicroRNA-target interactions” Nucleic Acids Research 2018 Jan. 4;46(D1):D296-D302)) that are targeted by endogenous non-coding RNAs(e.g., miRNAs, siRNAs, lncRNAs) to achieve RNA interference(SHAPE-RNAi). Following the introduction of these sequence motifs,endogenous non-coding RNAs may bind the introduced sequence andde-stabilize or inhibit translation of the target transcripts. Toachieve SHAPE-RNAi, there are several steps that include 1) theidentification or discovery of sequence motifs that can be targeted byendogenous non-coding RNA molecules, 2) the identification of specificregions in the target transcript that can promote RNA interference, and3) identification of the genetic modifier to use to install the preciseedit.

SHAPE-Protein

In some instances, the SHAPE strategy can alter target gene expressionat the post-transcriptional level through sequence optimization fortarget gene transcripts (SHAPE-protein) to increase translationefficiency. The introduction of sequence motifs can be performed throughthe de novo introduction of new regulatory elements or optimization ofendogenous regulatory elements that play a role in transcription ortranslation initiation and/or elongation. These sequence motifs can berelated to elements such as the Kozak sequence or optimal codonstructures for the coding regions of target gene transcripts. To achieveSHAPE-protein, there are several steps that include 1) theidentification or discovery of sequence motifs that can modifytranslation initiation and/or elongation efficiency, 2) theidentification of specific regions in genome to introduce a sequencemotif for modification of translation initiation and/or elongation, and3) identification of the genetic modifier to use to install the preciseedit.

Methods of Altering Expression of Disease-Related Target Genes

The present methods can include using SHAPE to alter expression ofdisease related target genes. Thus in some embodiments, the target geneis associated with a disease. Examples of haploinsufficiency diseases(Table 5; from Matharu N, Rattanasopha S, Tamura S, et al. Science.2019; 363(6424)) and diseases caused by non-coding mutations (Table 6)are listed below. Rather than correcting a mutation that leads tohaploinsufficiency, the present methods can be used to rescuehaploinsufficiency with synthetic upregulation of a healthyallele—without reverting the “damaged” allele to WT sequence. Table 6shows disease-related enhancer SNPs that cause other diseases based ondown-regulated or upregulated expression. Again, rather than correctingthe exact SNPs/genetic variants that cause disease, the present methodscan be used to mitigate the effects of those SNPs.

TABLE 5 Examples of genes leading to haploinsufficiency diseasetargetable by SHAPE Gene name Gene ID PMID Transcript ID AAGABENSG00000103591 ENST00000261880 ABCA4 ENSG00000198691 ENST00000370225ABCA7 ENSG00000064687 ENST00000263094 ABCC6 ENSG00000275331ENST00000620078 ABCC9 ENSG00000069431 ENST00000261201 ABCD1ENSG00000101986 ENST00000218104 ACSL4 ENSG00000068366 ENST00000340800ACTB ENSG00000075624 ENST00000331789 ACTC1 ENSG00000159251ENST00000290378 ACTN2 ENSG00000077522 ENST00000366578 ACVRL1ENSG00000139567 ENST00000388922 ADAR ENSG00000160710 ENST00000368474AFF2 ENSG00000155966 ENST00000370460 AFG3L2 ENSG00000141385ENST00000269143 AGRP ENSG00000159723 ENST00000290953 AHSPENSG00000169877 ENST00000302312 AKT3 ENSG00000275199 ENST00000613395ALDH1A2 ENSG00000128918 ENST00000249750 ALX4 ENSG00000052850ENST00000329255 ANK2 ENSG00000145362 ENST00000503423 ANKRD11ENSG00000167522 ENST00000301030 ANOS1 ENSG00000011201 ENST00000262648ANXA7 ENSG00000138279 ENST00000372921 AP1S2 ENSG00000182287ENST00000329235 APC ENSG00000134982 ENST00000257430 AR ENSG00000169083ENST00000374690 ARID2 ENSG00000189079 ENST00000334344 ARSEENSG00000157399 ENST00000381134 ARX ENSG00000004848 ENST00000379044ASXL1 ENSG00000171456 ENST00000375687 ASXL2 ENSG00000143970ENST00000435504 ATM ENSG00000149311 ENST00000278616 ATP1A1ENSG00000163399 ENST00000295598 ATP1A2 ENSG00000018625 ENST00000361216ATP2A2 ENSG00000174437 ENST00000539276 ATP2C1 ENSG00000017260ENST00000359644 ATP7A ENSG00000165240 ENST00000341514 ATP8A2ENSG00000132932 ENST00000381655 ATR ENSG00000175054 ENST00000350721 ATRXENSG00000085224 ENST00000373344 AUTS2 ENSG00000158321 ENST00000342771AVPR2 ENSG00000126895 ENST00000358927 B4GALT7 ENSG00000027847ENST00000029410 BAG1 ENSG00000107262 ENST00000634734 BAG3ENSG00000151929 ENST00000369085 BCL11A ENSG00000119866 ENST00000335712BCL11B ENSG00000127152 ENST00000357195 BCO1 ENSG00000135697ENST00000258168 BCOR ENSG00000183337 ENST00000342274 BECN1ENSG00000126581 ENST00000361523 BLM ENSG00000197299 ENST00000355112 BMP4ENSG00000125378 ENST00000559087 BMPR1A ENSG00000107779 ENST00000372037BMPR2 ENSG00000204217 ENST00000374580 BRAF ENSG00000157764ENST00000288602 BRCA1 ENSG00000012048 ENST00000471181 BRCA2ENSG00000139618 ENST00000380152 BRWD3 ENSG00000165288 ENST00000373275BTK ENSG00000010671 ENST00000308731 BUB1B ENSG00000156970ENST00000287598 BUB3 ENSG00000154473 ENST00000368865 C3 ENSG00000125730ENST00000245907 CACNA1A ENSG00000141837 ENST00000360228 CACNA1CENSG00000151067 ENST00000347598 CACNB2 ENSG00000165995 ENST00000324631CAMTA1 ENSG00000171735 ENST00000303635 CASK ENSG00000147044ENST00000378166 CAV1 ENSG00000105974 ENST00000341049 CAV3ENSG00000182533 ENST00000343849 CBFB ENSG00000067955 ENST00000290858CCNA2 ENSG00000145386 ENST00000618014 CD2AP ENSG00000198087ENST00000359314 CDC73 ENSG00000134371 ENST00000367435 CDH1ENSG00000039068 ENST00000261769 CDKL5 ENSG00000008086 ENST00000379989CDKN1B ENSG00000111276 ENST00000228872 CDKN1C ENSG00000273707ENST00000616138 CDKN2A ENSG00000147889 ENST00000304494 CDKN2BENSG00000147883 ENST00000276925 CDKN2C ENSG00000123080 ENST00000262662CEP152 ENSG00000103995 ENST00000399334 CHD2 ENSG00000173575ENST00000577670 CHD5 ENSG00000116254 ENST00000262450 CHD7ENSG00000171316 ENST00000423902 CHD8 ENSG00000100888 ENST00000430710CHL1 ENSG00000134121 ENST00000256509 CHM ENSG00000188419 ENST00000357749CHRDL1 ENSG00000101938 ENST00000394797 CHRM3 ENSG00000133019ENST00000255380 CHRNB2 ENSG00000160716 ENST00000368476 CICENSG00000079432 ENST00000575354 CLCN5 ENSG00000171365 ENST00000376108CNKSR2 ENSG00000149970 ENST00000425654 CNTN4 ENSG00000144619ENST00000418658 CNTNAP2 ENSG00000278728 ENST00000613345 COCHENSG00000100473 ENST00000396618 COL10A1 ENSG00000123500 ENST00000243222COL11A1 ENSG00000060718 ENST00000370096 COL1A1 ENSG00000108821ENST00000225964 COL1A2 ENSG00000164692 ENST00000297268 COL2A1ENSG00000139219 ENST00000380518 COL3A1 ENSG00000168542 ENST00000304636COL4A1 ENSG00000187498 ENST00000375820 COL5A1 ENSG00000130635ENST00000371817 COL6A1 ENSG00000142156 ENST00000361866 COMTENSG00000093010 ENST00000585066 COPS3 ENSG00000141030 ENST00000268717COPS5 ENSG00000121022 ENST00000357849 CREBBP ENSG00000005339ENST00000262367 CRX ENSG00000105392 ENST00000221996 CRYABENSG00000109846 ENST00000527950 CRYBB2 ENSG00000244752 ENST00000398215CSF1R ENSG00000182578 ENST00000286301 CSF2RA ENSG00000198223ENST00000417535 CSH1 ENSG00000136488 ENST00000316193 CSRP3ENSG00000129170 ENST00000533783 CTCF ENSG00000102974 ENST00000264010CTLA4 ENSG00000163599 ENST00000302823 CTNND2 ENSG00000169862ENST00000304623 CUL4B ENSG00000158290 ENST00000404115 CYBBENSG00000165168 ENST00000378588 CYP11A1 ENSG00000140459 ENST00000268053DCC ENSG00000187323 ENST00000442544 DCX ENSG00000077279 ENST00000356220DDX3X ENSG00000215301 ENST00000629496 DEAF1 ENSG00000282712ENST00000634194 DEPDC5 ENSG00000100150 ENST00000382112 DFFBENSG00000169598 ENST00000378209 DFNA5 ENSG00000105928 ENST00000342947DGCR2 ENSG00000070413 ENST00000263196 DICER1 ENSG00000100697ENST00000526495 DIRC2 ENSG00000138463 ENST00000261038 DKC1ENSG00000130826 ENST00000626756 DLG3 ENSG00000082458 ENST00000374360DLL4 ENSG00000128917 ENST00000249749 DMD ENSG00000198947 ENST00000357033DMPK ENSG00000104936 ENST00000291270 DMRT1 ENSG00000137090ENST00000382276 DMRT2 ENSG00000173253 ENST00000382251 DSC2ENSG00000134755 ENST00000280904 DSG1 ENSG00000134760 ENST00000257192DSG2 ENSG00000046604 ENST00000261590 DSP ENSG00000096696 ENST00000379802DYRK1A ENSG00000157540 ENST00000398960 EBF3 ENSG00000108001ENST00000368648 EBP ENSG00000147155 ENST00000495186 EDA ENSG00000158813ENST00000374553 EDN3 ENSG00000124205 ENST00000337938 EDNRBENSG00000136160 ENST00000334286 EEF1E1 ENSG00000124802 ENST00000379715EFNB1 ENSG00000090776 ENST00000204961 EFTUD2 ENSG00000108883ENST00000426333 EGR1 ENSG00000120738 ENST00000239938 EHHADHENSG00000113790 ENST00000231887 EHMT1 ENSG00000181090 ENST00000629335ELAVL4 ENSG00000162374 ENST00000371819 ELN ENSG00000049540ENST00000252034 ELOVL4 ENSG00000118402 ENST00000369816 EMX2ENSG00000170370 ENST00000553456 ENAM ENSG00000132464 ENST00000396073 ENGENSG00000106991 ENST00000344849 EP300 ENSG00000100393 ENST00000408233ERF ENSG00000105722 ENST00000222329 ERMARD ENSG00000276187ENST00000621205 ETV6 ENSG00000139083 ENST00000396373 EXT1ENSG00000182197 ENST00000378204 EXT2 ENSG00000151348 ENST00000533608EYA1 ENSG00000104313 ENST00000340726 EYA4 ENSG00000112319ENST00000531901 F8 ENSG00000185010 ENST00000360256 F9 ENSG00000101981ENST00000218099 FAM58A ENSG00000262919 ENST00000440428 FANCBENSG00000181544 ENST00000324138 FAS ENSG00000026103 ENST00000355740FBLN1 ENSG00000077942 ENST00000327858 FBN1 ENSG00000166147ENST00000316623 FBN2 ENSG00000138829 ENST00000508053 FBXO38ENSG00000145868 ENST00000340253 FBXW7 ENSG00000109670 ENST00000281708FECH ENSG00000066926 ENST00000262093 FEN1 ENSG00000168496ENST00000305885 FGD1 ENSG00000102302 ENST00000375135 FGF10ENSG00000070193 ENST00000264664 FGF3 ENSG00000186895 ENST00000334134FGF8 ENSG00000107831 ENST00000320185 FGFR1 ENSG00000077782ENST00000447712 FGFR3 ENSG00000068078 ENST00000440486 FIGLAENSG00000183733 ENST00000332372 FKBP6 ENSG00000077800 ENST00000252037FLCN ENSG00000154803 ENST00000285071 FLG ENSG00000143631 ENST00000368799FLI1 ENSG00000151702 ENST00000527786 FLNA ENSG00000196924ENST00000422373 FOXC1 ENSG00000054598 ENST00000380874 FOXC2ENSG00000176692 ENST00000320354 FOXE3 ENSG00000186790 ENST00000335071FOXF1 ENSG00000103241 ENST00000262426 FOXG1 ENSG00000176165ENST00000313071 FOXL2 ENSG00000183770 ENST00000330315 FOXO1ENSG00000150907 ENST00000379561 FOXP1 ENSG00000114861 ENST00000318789FOXP2 ENSG00000128573 ENST00000393491 FRMD7 ENSG00000165694ENST00000298542 FSCN2 ENSG00000186765 ENST00000417245 FSHRENSG00000170820 ENST00000406846 FTL ENSG00000087086 ENST00000331825FTSJ1 ENSG00000068438 ENST00000348411 FUS ENSG00000089280ENST00000254108 FZD4 ENSG00000174804 ENST00000531380 GALR1ENSG00000166573 ENST00000299727 GATA2 ENSG00000179348 ENST00000341105GATA3 ENSG00000107485 ENST00000346208 GATA4 ENSG00000136574ENST00000335135 GATA6 ENSG00000141448 ENST00000269216 GCH1ENSG00000131979 ENST00000491895 GCK ENSG00000106633 ENST00000403799 GCKRENSG00000084734 ENST00000264717 GCNT1 ENSG00000187210 ENST00000442371GDF5 ENSG00000125965 ENST00000374372 GDI1 ENSG00000203879ENST00000447750 GDNF ENSG00000168621 ENST00000515058 GHRLENSG00000157017 ENST00000335542 GJA5 ENSG00000265107 ENST00000621517GJA8 ENSG00000121634 ENST00000369235 GK ENSG00000198814 ENST00000378943GLA ENSG00000102393 ENST00000218516 GLI2 ENSG00000074047 ENST00000452319GLI3 ENSG00000106571 ENST00000395925 GLMN ENSG00000174842ENST00000370360 GNAS ENSG00000087460 ENST00000371102 GPC3ENSG00000147257 ENST00000370818 GREB1L ENSG00000141449 ENST00000424526GRIA3 ENSG00000125675 ENST00000620443 GRIN1 ENSG00000176884ENST00000371553 GRIN2A ENSG00000183454 ENST00000396573 GRIN2BENSG00000273079 ENST00000609686 GRN ENSG00000030582 ENST00000053867GTF2I ENSG00000263001 ENST00000573035 GTF2IRD1 ENSG00000006704ENST00000265755 H2AFX ENSG00000188486 ENST00000530167 HCCSENSG00000004961 ENST00000321143 HCN4 ENSG00000138622 ENST00000261917HDAC4 ENSG00000068024 ENST00000345617 HIC1 ENSG00000177374ENST00000322941 HIRA ENSG00000100084 ENST00000263208 HIVEP2ENSG00000010818 ENST00000367603 HMGA1 ENSG00000137309 ENST00000311487HMGA2 ENSG00000149948 ENST00000403681 HNF1A ENSG00000135100ENST00000257555 HNF1B ENSG00000276194 ENST00000617811 HNF4AENSG00000101076 ENST00000609795 HNRNPK ENSG00000165119 ENST00000384871HNRNPU ENSG00000153187 ENST00000475997 HOXD13 ENSG00000128714ENST00000392539 HPRT1 ENSG00000165704 ENST00000298556 HRGENSG00000113905 ENST00000232003 HUWE1 ENSG00000086758 ENST00000262854ID2 ENSG00000115738 ENST00000234091 IDS ENSG00000010404 ENST00000340855IGF1 ENSG00000017427 ENST00000337514 IGF1R ENSG00000140443ENST00000268035 IGFALS ENSG00000099769 ENST00000215539 IKBKGENSG00000269335 ENST00000594239 IKZF1 ENSG00000185811 ENST00000331340IL1RAPL1 ENSG00000169306 ENST00000378993 IRF3 ENSG00000126456ENST00000377139 IRF6 ENSG00000117595 ENST00000367021 JAG1ENSG00000101384 ENST00000254958 KANSL1 ENSG00000278458 ENST00000627698KAT6B ENSG00000156650 ENST00000287239 KCNAB2 ENSG00000069424ENST00000378097 KCNE1 ENSG00000180509 ENST00000337385 KCNE2ENSG00000159197 ENST00000290310 KCNH2 ENSG00000055118 ENST00000262186KCNJ18 ENSG00000260458 ENST00000567955 KCNJ2 ENSG00000123700ENST00000243457 KCNQ1 ENSG00000282076 ENST00000632153 KCNQ2ENSG00000281151 ENST00000627948 KCNQ4 ENSG00000117013 ENST00000347132KDM5C ENSG00000126012 ENST00000375401 KDM6A ENSG00000147050ENST00000377967 KHDRBS2 ENSG00000112232 ENST00000281156 KIF11ENSG00000138160 ENST00000260731 KIF1B ENSG00000054523 ENST00000263934KLF1 ENSG00000105610 ENST00000264834 KLF6 ENSG00000067082ENST00000497571 KLHL10 ENSG00000161594 ENST00000293303 KMT2AENSG00000118058 ENST00000389506 KMT2B ENSG00000272333 ENST00000420124KMT2D ENSG00000167548 ENST00000301067 KRAS ENSG00000133703ENST00000256078 KRIT1 ENSG00000001631 ENST00000394507 KRT5ENSG00000186081 ENST00000252242 KRT74 ENSG00000170484 ENST00000305620L1CAM ENSG00000198910 ENST00000370060 LAMA4 ENSG00000112769ENST00000522006 LAMP2 ENSG00000005893 ENST00000434600 LDLRENSG00000130164 ENST00000619864 LEMD3 ENSG00000174106 ENST00000308330LETM1 ENSG00000168924 ENST00000302787 LGI1 ENSG00000108231ENST00000371418 LHX4 ENSG00000121454 ENST00000263726 LIG4ENSG00000174405 ENST00000405925 LIMK1 ENSG00000106683 ENST00000336180LMNA ENSG00000160789 ENST00000368300 LMX1B ENSG00000136944ENST00000373474 LRP5 ENSG00000162337 ENST00000294304 LZTR1ENSG00000099949 ENST00000215739 MAD2L1 ENSG00000164109 ENST00000296509MAGEL2 ENSG00000254585 ENST00000532292 MAGT1 ENSG00000102158ENST00000358075 MAOA ENSG00000189221 ENST00000338702 MAP2K1ENSG00000169032 ENST00000307102 MAP2K2 ENSG00000126934 ENST00000262948MAPK10 ENSG00000109339 ENST00000395169 MAPKAPK3 ENSG00000114738ENST00000446044 MAPT ENSG00000277956 ENST00000626571 MBD5ENSG00000204406 ENST00000407073 MC3R ENSG00000124089 ENST00000243911MC4R ENSG00000166603 ENST00000299766 MECP2 ENSG00000169057ENST00000303391 MED13L ENSG00000123066 ENST00000281928 MED15ENSG00000099917 ENST00000292733 MEF2C ENSG00000081189 ENST00000340208MEIS2 ENSG00000134138 ENST00000424352 MEN1 ENSG00000133895ENST00000394376 MFAP5 ENSG00000197614 ENST00000359478 MIB1ENSG00000101752 ENST00000261537 MID1 ENSG00000101871 ENST00000380787MITF ENSG00000187098 ENST00000394351 MLH1 ENSG00000076242ENST00000231790 MLLT3 ENSG00000171843 ENST00000380338 MMEENSG00000196549 ENST00000492661 MNX1 ENSG00000130675 ENST00000469500 MPZENSG00000158887 ENST00000533357 MSH2 ENSG00000095002 ENST00000233146MSH6 ENSG00000116062 ENST00000234420 MSX1 ENSG00000163132ENST00000382723 MSX2 ENSG00000120149 ENST00000239243 MTAPENSG00000099810 ENST00000380172 MTM1 ENSG00000171100 ENST00000370396MUTYH ENSG00000132781 ENST00000372098 MYBPC3 ENSG00000134571ENST00000545968 MYCN ENSG00000134323 ENST00000281043 MYF6ENSG00000111046 ENST00000228641 MYH11 ENSG00000133392 ENST00000300036MYH7 ENSG00000092054 ENST00000355349 MYH9 ENSG00000100345ENST00000216181 MYLK ENSG00000065534 ENST00000360304 MYOCENSG00000034971 ENST00000037502 MYPN ENSG00000138347 ENST00000540630MYT1L ENSG00000186487 ENST00000428368 NBN ENSG00000104320ENST00000265433 NCF1 ENSG00000158517 ENST00000289473 NCSTNENSG00000162736 ENST00000294785 NDP ENSG00000124479 ENST00000378062 NEBLENSG00000078114 ENST00000417816 NEXMIF ENSG00000050030 ENST00000055682NEXN ENSG00000162614 ENST00000334785 NF1 ENSG00000196712 ENST00000356175NF2 ENSG00000186575 ENST00000338641 NFIA ENSG00000162599 ENST00000403491NFIX ENSG00000008441 ENST00000397661 NFKB1 ENSG00000109320ENST00000226574 NFKB2 ENSG00000077150 ENST00000369966 NFKBIAENSG00000100906 ENST00000216797 NFRKB ENSG00000170322 ENST00000446488NHS ENSG00000188158 ENST00000380060 NIPBL ENSG00000164190ENST00000282516 NKX2-1 ENSG00000136352 ENST00000518149 NKX2-5ENSG00000183072 ENST00000329198 NKX3-1 ENSG00000167034 ENST00000380871NLGN4X ENSG00000146938 ENST00000381095 NLRP3 ENSG00000162711ENST00000391828 NODAL ENSG00000156574 ENST00000287139 NOGENSG00000183691 ENST00000332822 NOTCH1 ENSG00000148400 ENST00000277541NPAS3 ENSG00000151322 ENST00000346562 NPM1 ENSG00000181163ENST00000517671 NPRL3 ENSG00000103148 ENST00000620134 NR0B1ENSG00000169297 ENST00000378970 NR2F2 ENSG00000185551 ENST00000410719NR5A1 ENSG00000136931 ENST00000373588 NRXN1 ENSG00000179915ENST00000401669 NSD1 ENSG00000165671 ENST00000439151 NSDHLENSG00000147383 ENST00000370274 NT5E ENSG00000135318 ENST00000257770NUP98 ENSG00000110713 ENST00000324932 NUS1 ENSG00000153989ENST00000368494 NXF5 ENSG00000126952 ENST00000473265 NYX ENSG00000188937ENST00000342595 OCRL ENSG00000122126 ENST00000371113 OFD1ENSG00000046651 ENST00000340096 OPA1 ENSG00000198836 ENST00000361908OPHN1 ENSG00000079482 ENST00000355520 OTC ENSG00000036473ENST00000039007 OTX2 ENSG00000165588 ENST00000555006 P2RX5ENSG00000083454 ENST00000225328 P2RY8 ENSG00000182162 ENST00000381297PAFAH1B1 ENSG00000007168 ENST00000397195 PAK2 ENSG00000180370ENST00000327134 PAK3 ENSG00000077264 ENST00000446737 PARK2ENSG00000185345 ENST00000366898 PAX1 ENSG00000125813 ENST00000398485PAX2 ENSG00000075891 ENST00000355243 PAX3 ENSG00000135903ENST00000392070 PAX5 ENSG00000196092 ENST00000358127 PAX6ENSG00000007372 ENST00000379132 PAX8 ENSG00000125618 ENST00000429538PAX9 ENSG00000198807 ENST00000402703 PCDH19 ENSG00000165194ENST00000255531 PCGF2 ENSG00000278644 ENST00000631566 PDHA1ENSG00000131828 ENST00000545074 PDLIM3 ENSG00000154553 ENST00000284770PGAP1 ENSG00000197121 ENST00000354764 PGK1 ENSG00000102144ENST00000373316 PHB2 ENSG00000215021 ENST00000535923 PHEXENSG00000102174 ENST00000379374 PHF6 ENSG00000156531 ENST00000370803PHF8 ENSG00000172943 ENST00000338154 PHIP ENSG00000146247ENST00000275034 PHOX2B ENSG00000109132 ENST00000226382 PIGAENSG00000165195 ENST00000333590 PIK3R1 ENSG00000145675 ENST00000521381PINK1 ENSG00000158828 ENST00000622012 PITX2 ENSG00000164093ENST00000306732 PITX3 ENSG00000107859 ENST00000370002 PKD1ENSG00000008710 ENST00000612014 PKD2 ENSG00000118762 ENST00000237596PKP2 ENSG00000057294 ENST00000340811 PLIN1 ENSG00000166819ENST00000430628 PLK4 ENSG00000142731 ENST00000270861 PLP1ENSG00000123560 ENST00000612423 PMP22 ENSG00000109099 ENST00000312280PNPLA6 ENSG00000032444 ENST00000221249 POLG2 ENSG00000256525ENST00000539111 POLR1D ENSG00000186184 ENST00000302979 POLR2FENSG00000100142 ENST00000442738 PORCN ENSG00000102312 ENST00000359882POT1 ENSG00000128513 ENST00000357628 PPARA ENSG00000186951ENST00000262735 PPARG ENSG00000132170 ENST00000287820 PQBP1ENSG00000102103 ENST00000376563 PRKAG2 ENSG00000106617 ENST00000287878PRKAR1A ENSG00000108946 ENST00000392711 PRM1 ENSG00000175646ENST00000312511 PRM2 ENSG00000122304 ENST00000241808 PRMT7ENSG00000132600 ENST00000339507 PRODH ENSG00000100033 ENST00000610940PROX1 ENSG00000117707 ENST00000498508 PRPF31 ENSG00000277953ENST00000622636 PRPS1 ENSG00000147224 ENST00000372435 PRRT2ENSG00000167371 ENST00000358758 PSMD12 ENSG00000197170 ENST00000356126PTCH1 ENSG00000185920 ENST00000331920 PTEN ENSG00000171862ENST00000371953 PTHLH ENSG00000087494 ENST00000201015 PTPN11ENSG00000179295 ENST00000351677 PUM1 ENSG00000134644 ENST00000257075QRICH1 ENSG00000198218 ENST00000395443 RAB39B ENSG00000155961ENST00000369454 RAD50 ENSG00000113522 ENST00000378823 RAD51ENSG00000051180 ENST00000267868 RAD51B ENSG00000182185 ENST00000471583RAE1 ENSG00000101146 ENST00000395841 RAI1 ENSG00000108557ENST00000353383 RANGRF ENSG00000108961 ENST00000226105 RASA1ENSG00000145715 ENST00000274376 RASSF1 ENSG00000068028 ENST00000357043RB1 ENSG00000139687 ENST00000267163 RBFOX1 ENSG00000078328ENST00000311745 RBM20 ENSG00000203867 ENST00000369519 RBPJENSG00000168214 ENST00000342295 RELN ENSG00000189056 ENST00000343529 RETENSG00000165731 ENST00000355710 RFC2 ENSG00000049541 ENST00000055077RNF135 ENSG00000181481 ENST00000328381 ROBO1 ENSG00000169855ENST00000495273 ROR2 ENSG00000169071 ENST00000375708 RP2 ENSG00000102218ENST00000218340 RPRM ENSG00000177519 ENST00000325926 RPS17ENSG00000278229 ENST00000617731 RPS19 ENSG00000105372 ENST00000598742RPS20 ENSG00000008988 ENST00000009589 RPS24 ENSG00000138326ENST00000372360 RPS26 ENSG00000197728 ENST00000356464 RPS28ENSG00000233927 ENST00000600659 RPS29 ENSG00000213741 ENST00000245458RPS4X ENSG00000198034 ENST00000316084 RPS6KA3 ENSG00000177189ENST00000379565 RS1 ENSG00000102104 ENST00000379984 RTN2 ENSG00000125744ENST00000344680 RTN4R ENSG00000040608 ENST00000043402 RUNX1ENSG00000159216 ENST00000300305 RUNX2 ENSG00000124813 ENST00000371432RYR1 ENSG00000196218 ENST00000359596 RYR2 ENSG00000198626ENST00000366574 SALL1 ENSG00000103449 ENST00000251020 SALL3ENSG00000277015 ENST00000614883 SALL4 ENSG00000101115 ENST00000217086SATB2 ENSG00000119042 ENST00000457245 SBDS ENSG00000126524ENST00000246868 SCN10A ENSG00000185313 ENST00000449082 SCN1AENSG00000144285 ENST00000375405 SCN2A ENSG00000136531 ENST00000631182SCN5A ENSG00000183873 ENST00000333535 SCN8A ENSG00000196876ENST00000354534 SDHAF2 ENSG00000167985 ENST00000301761 SDHBENSG00000117118 ENST00000375499 SDHC ENSG00000143252 ENST00000367975SDHD ENSG00000204370 ENST00000375549 SEM1 ENSG00000127922ENST00000248566 SEMA3A ENSG00000075213 ENST00000265362 SEMA5AENSG00000112902 ENST00000382496 SETBP1 ENSG00000152217 ENST00000282030SETD5 ENSG00000168137 ENST00000402198 SF1 ENSG00000168066ENST00000227503 SF3B4 ENSG00000143368 ENST00000271628 SGCEENSG00000127990 ENST00000265735 SH2B1 ENSG00000178188 ENST00000337120SH2D1A ENSG00000183918 ENST00000371139 SH3BP2 ENSG00000087266ENST00000452765 SH3TC2 ENSG00000169247 ENST00000515425 SHANK3ENSG00000251322 ENST00000262795 SHH ENSG00000164690 ENST00000297261SHMT1 ENSG00000176974 ENST00000617912 SHOC2 ENSG00000108061ENST00000369452 SHOX ENSG00000185960 ENST00000381578 SI ENSG00000090402ENST00000264382 SIM1 ENSG00000112246 ENST00000369208 SIN3AENSG00000169375 ENST00000360439 SIX3 ENSG00000138083 ENST00000260653SIX6 ENSG00000184302 ENST00000327720 SLC16A12 ENSG00000152779ENST00000371790 SLC16A2 ENSG00000147100 ENST00000587091 SLC2A1ENSG00000117394 ENST00000426263 SLC33A1 ENSG00000169359 ENST00000392845SLC36A2 ENSG00000186335 ENST00000335244 SLC40A1 ENSG00000138449ENST00000261024 SLC4A10 ENSG00000144290 ENST00000415876 SLC52A1ENSG00000132517 ENST00000424747 SLC5A3 ENSG00000198743 ENST00000381151SLC5A7 ENSG00000115665 ENST00000264047 SLC6A8 ENSG00000130821ENST00000253122 SLC9A3R1 ENSG00000109062 ENST00000581999 SLC9A6ENSG00000198689 ENST00000370695 SMAD3 ENSG00000166949 ENST00000327367SMAD4 ENSG00000141646 ENST00000398417 SMAD5 ENSG00000113658ENST00000545620 SMARCA4 ENSG00000127616 ENST00000589677 SMARCB1ENSG00000275837 ENST00000629690 SMARCC1 ENSG00000173473 ENST00000254480SMS ENSG00000102172 ENST00000404933 SNCA ENSG00000145335 ENST00000336904SNURF ENSG00000273173 ENST00000338327 SOCS1 ENSG00000185338ENST00000332029 SON ENSG00000159140 ENST00000436227 SOX10ENSG00000100146 ENST00000360880 SOX11 ENSG00000176887 ENST00000322002SOX18 ENSG00000203883 ENST00000340356 SOX2 ENSG00000181449ENST00000325404 SOX5 ENSG00000134532 ENST00000546136 SOX8ENSG00000005513 ENST00000293894 SOX9 ENSG00000125398 ENST00000245479SPAST ENSG00000021574 ENST00000615843 SPINK1 ENSG00000164266ENST00000296695 SPR ENSG00000116096 ENST00000234454 SPRED1ENSG00000166068 ENST00000299084 SPTBN2 ENSG00000173898 ENST00000533211SRGAP3 ENSG00000196220 ENST00000383836 SRY ENSG00000184895ENST00000383070 ST7 ENSG00000004866 ENST00000622083 STAT5AENSG00000126561 ENST00000345506 STAT5B ENSG00000173757 ENST00000293328STK11 ENSG00000118046 ENST00000326873 STK25 ENSG00000115694ENST00000316586 STS ENSG00000101846 ENST00000217961 STXBP1ENSG00000136854 ENST00000373299 SUMO1 ENSG00000116030 ENST00000392246SUZ12 ENSG00000178691 ENST00000322652 SYN1 ENSG00000008056ENST00000295987 SYNGAP1 ENSG00000227460 ENST00000629380 TAB2ENSG00000055208 ENST00000367456 TBK1 ENSG00000183735 ENST00000331710TBX1 ENSG00000184058 ENST00000332710 TBX20 ENSG00000164532ENST00000408931 TBX22 ENSG00000277800 ENST00000619509 TBX3ENSG00000135111 ENST00000257566 TBX4 ENSG00000121075 ENST00000240335TBX5 ENSG00000089225 ENST00000310346 TCF12 ENSG00000140262ENST00000438423 TCF4 ENSG00000196628 ENST00000356073 TCOF1ENSG00000070814 ENST00000377797 TDGF1 ENSG00000241186 ENST00000296145TERC ENSG00000270141 ENST00000602385 TERT ENSG00000164362ENST00000310581 TFAP2B ENSG00000008196 ENST00000393655 TFRCENSG00000072274 ENST00000360110 TGFB1 ENSG00000105329 ENST00000221930TGFBR1 ENSG00000106799 ENST00000374994 TGFBR2 ENSG00000163513ENST00000295754 TGIF1 ENSG00000177426 ENST00000550958 TIMM8AENSG00000126953 ENST00000372902 TKT ENSG00000163931 ENST00000462138 TLK2ENSG00000146872 ENST00000346027 TLR3 ENSG00000164342 ENST00000296795TM4SF20 ENSG00000168955 ENST00000304568 TMPO ENSG00000120802ENST00000266732 TNNI3 ENSG00000129991 ENST00000344887 TNNT2ENSG00000118194 ENST00000236918 TNXA ENSG00000224140 ENST00000423622TNXB ENSG00000236236 ENST00000550539 TOP3A ENSG00000177302ENST00000542570 TP53 ENSG00000141510 ENST00000269305 TP53BP2ENSG00000143514 ENST00000343537 TP63 ENSG00000073282 ENST00000354600TP73 ENSG00000078900 ENST00000378295 TPM1 ENSG00000140416ENST00000288398 TRAPPC2 ENSG00000196459 ENST00000359680 TRIP12ENSG00000153827 ENST00000283943 TRPM4 ENSG00000130529 ENST00000252826TRPS1 ENSG00000104447 ENST00000395715 TRPV4 ENSG00000111199ENST00000261740 TSC1 ENSG00000165699 ENST00000298552 TSC2ENSG00000103197 ENST00000219476 TSPAN7 ENSG00000156298 ENST00000378482TTN ENSG00000155657 ENST00000589042 TWIST1 ENSG00000122691ENST00000242261 TYRP1 ENSG00000107165 ENST00000388918 UBE2AENSG00000077721 ENST00000371558 UBE3A ENSG00000114062 ENST00000232165UPF3B ENSG00000125351 ENST00000276201 USP7 ENSG00000187555ENST00000344836 USP9X ENSG00000124486 ENST00000324545 VAMP1ENSG00000139190 ENST00000396308 VEGFA ENSG00000112715 ENST00000425836VEGFC ENSG00000150630 ENST00000618562 VHL ENSG00000134086ENST00000256474 WDR26 ENSG00000162923 ENST00000414423 WDR45ENSG00000196998 ENST00000356463 WNT2B ENSG00000134245 ENST00000369684WT1 ENSG00000184937 ENST00000332351 WWOX ENSG00000186153 ENST00000566780XIAP ENSG00000101966 ENST00000434753 XRCC5 ENSG00000079246ENST00000392133 YAP1 ENSG00000137693 ENST00000282441 YWHAEENSG00000274474 ENST00000627231 ZC4H2 ENSG00000126970 ENST00000374839ZDHHC9 ENSG00000188706 ENST00000357166 ZEB2 ENSG00000169554ENST00000627532 ZFPM2 ENSG00000169946 ENST00000407775 ZIC1ENSG00000152977 ENST00000282928 ZIC2 ENSG00000043355 ENST00000376335ZIC3 ENSG00000156925 ENST00000287538 ZIC4 ENSG00000174963ENST00000383075 ZMPSTE24 ENSG00000084073 ENST00000372759 ZNF41ENSG00000147124 ENST00000377065 ZNF462 ENSG00000148143 ENST00000277225ZNF674 ENSG00000251192 ENST00000523374 ZNF711 ENSG00000147180ENST00000373165

TABLE 6 Examples of functional non-coding mutations targetable by SHAPEGene name Chr Start Stop Mutation Consequence A20 chr6 138230039138230039 TT > A Loss of NF-kB binding; Decreasing of enhancer activityA20 chr6 138230040 138230040 TT > A Loss of NF-kB binding;Decreasing of enhancer activity ABCG2 chr4 88924371 88924371 A > GDecreasing of enhancer activity ABCG2 chr4 89073197 89073197 A > CDecreasing of enhancer activity ACSBG1 chr15 78292380 78292380 A > GDecreasing of enhancer activity ACSBG1 chr15 78292544 78292544 G > ADecreasing of enhancer activity ACSBG1 chr15 78292823 78292823 G > CDecreasing of enhancer activity ADAP1 chr7 982031 982031 G > CChange of ATF5 binding ADAP1 chr7 982031 982031 G > CChange of BCL11A binding ADAP1 chr7 982031 982031 G > CChange of SPI1 binding ADAP1 chr7 982031 982031 G > CChange of ZNF227 binding ADAP1 chr7 982031 982031 G > CChange of ZNF263 binding ADAP1 chr7 982031 982031 G > CChange of ZNF281 binding ADAP1 chr7 982159 982159 G > TChange of ELF2 binding ADAP1 chr7 982159 982159 G > TChange of HOXC5 binding ADAP1 chr7 982159 982159 G > TChange of MAZ binding ADAP1 chr7 982159 982159 G > TChange of SPI1 binding ADAP1 chr7 982159 982159 G > TChange of TAF1 binding ADAP1 chr7 982159 982159 G > TChange of ZNF263 binding ADAP1 chr7 982159 982159 G > TChange of ZNF281 binding ADAP1 chr7 982159 982159 G > TChange of ZNF658B binding ADAP1 chr7 982233 982233 G > AChange of ATF5 binding ADAP1 chr7 982233 982233 G > AChange of BCL11A binding ADAP1 chr7 982233 982233 G > AChange of HOXC5 binding ADAP1 chr7 982233 982233 G > AChange of SPI1 binding ADAP1 chr7 982233 982233 G > AChange of ZNF227 binding ADAP1 chr7 982233 982233 G > AChange of ZNF263 binding ADAP1 chr7 982233 982233 G > AChange of ZNF658B binding ADAP1 chr7 982258 982258 G > CChange of ELF2 binding ADAP1 chr7 982258 982258 G > CChange of HOXC5 binding ADAP1 chr7 982258 982258 G > CChange of MAZ binding ADAP1 chr7 982258 982258 G > CChange of SPI1 binding ADAP1 chr7 982258 982258 G > CChange of TAF1 binding ADAP1 chr7 982258 982258 G > CChange of ZNF263 binding ADAP1 chr7 982258 982258 G > CChange of ZNF281 binding ADAP1 chr7 982258 982258 G > CChange of ZNF658B binding ADAP1 chr7 982269 982269 G > AChange of ELF2 binding ADAP1 chr7 982269 982269 G > AChange of HOXC5 binding ADAP1 chr7 982269 982269 G > AChange of MAZ binding ADAP1 chr7 982269 982269 G > AChange of SPI1 binding ADAP1 chr7 982269 982269 G > AChange of TAF1 binding ADAP1 chr7 982269 982269 G > AChange of ZNF263 binding ADAP1 chr7 982269 982269 G > AChange of ZNF658B binding ADAP1 chr7 982401 982401 A > GChange of HOXC5 binding ADAP1 chr7 982401 982401 A > GChange of MAZ binding ADAP1 chr7 982401 982401 A > GChange of SPI1 binding ADAP1 chr7 982401 982401 A > GChange of TAF1 binding ADAP1 chr7 982401 982401 A > GChange of ZNF263 binding ADAP1 chr7 982401 982401 A > GChange of ZNF658B binding ADAP1 chr7 982407 982407 A > GChange of HOXC5 binding ADAP1 chr7 982407 982407 A > GChange of MAZ binding ADAP1 chr7 982407 982407 A > GChange of SPI1 binding ADAP1 chr7 982407 982407 A > GChange of TAF1 binding ADAP1 chr7 982407 982407 A > GChange of ZNF263 binding ADAP1 chr7 982407 982407 A > GChange of ZNF658B binding ADAP1 chr7 982877 982877 A > TChange of ATF5 binding ADAP1 chr7 982877 982877 A > TChange of HOXC5 binding ADAP1 chr7 982877 982877 A > TChange of MAZ binding ADAP1 chr7 982877 982877 A > TChange of TAF1 binding ADAP1 chr7 982877 982877 A > TChange of ZNF227 binding ADAP1 chr7 982877 982877 A > TChange of ZNF263 binding ADAP1 chr7 982877 982877 A > TChange of ZNF281 binding ADAP1 chr7 982877 982877 A > TChange of ZNF658B binding ADAP1 chr7 982891 982891 G > AChange of ATF5 binding ADAP1 chr7 982891 982891 G > AChange of BCL11A binding ADAP1 chr7 982891 982891 G > AChange of HOXC5 binding ADAP1 chr7 982891 982891 G > AChange of MAZ binding ADAP1 chr7 982891 982891 G > AChange of SPI1 binding ADAP1 chr7 982891 982891 G > AChange of TAF1 binding ADAP1 chr7 982891 982891 G > AChange of ZNF227 binding ADAP1 chr7 982891 982891 G > AChange of ZNF263 binding ADAP1 chr7 982891 982891 G > AChange of ZNF658B binding ADAP1 chr7 983223 983223 G > CChange of ATF5 binding ADAP1 chr7 983223 983223 G > CChange of BCL11A binding ADAP1 chr7 983223 983223 G > CChange of HOXC5 binding ADAP1 chr7 983223 983223 G > CChange of SPI1 binding ADAP1 chr7 983223 983223 G > CChange of ZNF227 binding ADAP1 chr7 983223 983223 G > CChange of ZNF263 binding ADCY5 chr3 123065778 123065778 A > GIncreasing of enhancer activity ADGRL3 chr4 62861941 62861941 G > CGain of HRE motif; Loss of GRHL1 and TCFCP2L1 motif;Decreasing of enhancer activity ADGRL3 chr4 62862251 62862251 G > AGain of LHX3; BRN3; POU6F2; BRN2; OCT1; PIT1 and OC2motif; Loss of PAX2; YYl and CRX motif; Decreasing of enhancer activityADGRL3 chr4 62861964 62861964 A > T Gain of TAXCREB motif;Decreasing of enhancer activity ADH4 chr4 100078751 100078751 T > GLoss of enhancer activity ADH4 chr4 100078890 100078890 G > TLoss of enhancer activity ADO chr10 64445564 64445564 A > GIncreasing of enhancer activity ADO chr10 64445564 64445564 A > GIncreasing of enhancer activity ADO chr10 64445564 64445564 A > GIncreasing of enhancer activity ADO chr10 64445564 64445564 A > GIncreasing of enhancer activity ADO chr10 64445564 64445564 A > GIncreasing of enhancer activity ADO chr10 64445564 64445564 A > GIncreasing of enhancer activity ADSL chr22 40742514 40742514 T > CDecreasing of enhancer activity AFP chr4 74301817 74301817 G > AGain of GMEB1 binding; Increasing of enhancer activity AGAP7P chr1051549496 51549496 AGAP7P chr10 51543344 51543344 C > TLoss of HOXB-like binding; Gain of enhancer activity AKT1 chr14105217554 105217554 G > C Change of CIC binding AKT1 chr14 105217554105217554 G > C Change of NFYA binding AKT1 chr14 105222648 105222648G > A Change of ZAC binding AKT1 chr14 105269669 105269669 C > TChange of ZNF441 binding AKT1 chr14 105444532 105444532 T > GChange of ZNF579 binding AKT1 chr14 105246325 105246325 T > AGain of YY1 binding; Gain of enhancer ALAS2 chrX 55057617 55057617 G > CDecreasing of enhancer activity ALDOB chr9 104198194 104198194 C > TDecreasing of enhancer activity ALPL chr1 21660786 21660786 C > GDecreasing of enhancer activity ALPL chr1 21661555 21661555 T > GDecreasing of enhancer activity ALPL chr1 21661745 21661745 C > GDecreasing of enhancer activity ALPL chr1 21661878 21661878 C > TDecreasing of enhancer activity ANKEF1 chr20 10016207 10016207 C > GLoss of GATA2 motif; Loss of enhancer activity ANKRD26 chr10 2738938327389383 C > T Gain of KLF3;GMEB1; REL; SIX2 binding; Increasing ofenhancer activity ANRIL chr9 22124477 22124477 A > GLoss of STAT1 motif; Decreasing of enhancer activity ANRIL chr9 2211919522119195 Gain of enhancer activity ANRIL chr9 22118102 22118102 T > GIncreasing of TCF7L2 and EP300 binding; Increasing of enhancer activityARFGAP1 chr20 62116270 62116270 A > G Increasing of enhancer activityARFGAP1 chr20 62116557 62116557 C > T Increasing of enhancer activityARFGAP1 chr20 62116577 62116577 C > T Increasing of enhancer activityARFGAP1 chr20 62116662 62116662 A > C Increasing of enhancer activityARFGAP1 chr20 62116771 62116771 C > T Increasing of enhancer activityARFGAP1 chr20 62116885 62116885 G > T Increasing of enhancer activityARFGAP1 chr20 62117295 62117295 T > A Increasing of enhancer activityARFGAP1 chr20 62117683 62117683 G > T Increasing of enhancer activityARFGAP1 chr20 62117868 62117868 C > T Increasing of enhancer activityARFGAP1 chr20 62118212 62118212 C > T Increasing of enhancer activityARFGAP1 chr20 62118213 62118213 C > T Increasing of enhancer activityARFGAP1 chr20 62118250 62118250 C > T Increasing of enhancer activityARFGAP1 chr20 62118282 62118282 A > G Increasing of enhancer activityARFGAP1 chr20 62118486 62118486 C > T Increasing of enhancer activityARFGAP1 chr20 62119030 62119030 G > T Increasing of enhancer activityARFGAP1 chr20 62119047 62119047 C > A Increasing of enhancer activityARID1A chr1 26438008 26438008 G > A Change of EBF1 binding ARID1A chr126438008 26438008 G > A Change of HINFP binding ARID1A chr1 2643800826438008 G > A Change of SP4 binding ARID1A chr1 26438008 26438008 G > AChange of TFAP2E binding ARID1A chr1 26438008 26438008 G > AChange of ZFX binding ARID1A chr1 26798607 26798607 G > AChange of ELF2 binding ARID1A chr1 26798607 26798607 G > AChange of EP300 binding ARID1A chr1 26798607 26798607 G > AChange of TAF1 binding ARID1A chr1 26798607 26798607 G > AChange of ZBTB7B binding ARID1A chr1 26798607 26798607 G > AChange of ZNF181 binding ARID1A chr1 26798607 26798607 G > AChange of ZNF263 binding ARID1A chr1 26798607 26798607 G > AChange of ZNF383 binding ARID1A chr1 26798607 26798607 G > AChange of ZNF436 binding ARID1A chr1 26798607 26798607 G > AChange of ZNF691 binding ARID1A chr1 26798607 26798607 G > AChange of ZSCAN2 binding ARID1A chr1 26798742 26798742 A > CChange of HEYL binding ARID1A chr1 26798742 26798742 A > CChange of ZNF521 binding ARID1A chr1 26798742 26798742 A > CChange of ZNF546 binding ARID1A chr1 27098601 27098601 G > AChange of EZF2 binding ARID1A chr1 27098601 27098601 G > AChange of ZNF729 binding ARID1A chr1 27098601 27098601 G > AChange of ZNF853 binding ARID1A chr1 27492915 27492915 C > TChange of APAK binding ARID1A chr1 27492915 27492915 C > TChange of MZF1 binding ARID1A chr1 27492915 27492915 C > TChange of ZIM2 binding ARID1A chr1 27492915 27492915 C > TChange of ZNF407 binding ARID1A chr1 27492915 27492915 C > TChange of ZNF493 binding ARID1A chr1 27492915 27492915 C > TChange of ZNF530 binding ARID1A chr1 27492915 27492915 C > TChange of ZNF816A binding ARID1A chr1 27720081 27720081 G > AChange of GATA2 binding ARID1A chr1 27720081 27720081 G > AChange of ZNF814 binding ARID1B chr6 156984421 156984421 A > TChange of FUBP1 binding ARID1B chr6 157041328 157041328 G > AChange of SP4 binding ARID1B chr6 157041328 157041328 G > AChange of TFAP2E binding ARID1B chr6 157041328 157041328 G > AChange of ZFX binding ARID1B chr6 157110896 157110896 G > AChange of RXRB binding ARID1B chr6 157110896 157110896 G > AChange of THRA binding ARID1B chr6 157110896 157110896 G > AChange of THRB binding ARID1B chr6 157110896 157110896 G > AChange of ZNF583 binding ARID1B chr6 157154547 157154547 C > TChange of ZNF492 binding ARID1B chr6 157154547 157154547 C > TChange of ZNF570 binding ARID1B chr6 157154547 157154547 C > TChange of ZNF729 binding ARID1B chr6 157389974 157389974 A > GChange of POU1F1 binding ARLTS1 chr13 50945011 50945011 G > ALoss of CDC5 motif; Gain of PLZF motif; Decreasing of enhancer activityASMT chrX 1733783 1733783 A > G Gain of FOXH1 binding;Decreasing of enhancer activity ASMT chrX 1733892 1733892 C > GGain of MAFG; NRL; HEY2 binding; Decreasing of enhancer activity ATAD3Bchr1 928703 928703 C > G Increasing of enhancer activity ATAD3B chr1930053 930053 G > A Increasing of enhancer activity ATAD3B chr1 930797930797 G > C Increasing of enhancer activity ATAD3B chr1 931772 931772G > A Increasing of enhancer activity ATM chr11 107880536 107880536C > G Change of HOXC5 binding ATM chr11 108211845 108211845 C > GChange of ZNF263 binding ATM chr11 108211845 108211845 C > GChange of ZNF519 binding ATM chr11 108211845 108211845 C > GChange of ZNF658B binding ATM chr11 109962688 109962688 G > TChange of ZXDL binding ATP7IP chr12 14410634 14410634 C > TDecreasing of enhancer activity BATF chr14 76005557 76005557 T > CBCAS3, TBX2, chr17 59456589 59456589 C > C Increasing of enhancer TBX4activity BCL11A chr2 60718043 60718043 G > T BCL11A chr2 6071804360718043 G > T Loss of GATAl motif; Decreasing of enhancer activityBCL11A chr2 60725451 60725451 BCL2, PYGO1 chr15 54197663 54203357Deletion Loss of enhancer BCL2, PYGO1 chr15 54197663 54203357 DeletionLoss of enhancer BCL6 NA NA NA NA Gain of enhancer BCL6 NA NA NADuplication Gain of enhancer BCL6 NA NA NA NA Gain of enhancer BCL6 chr3187779884 187823100 Duplication Gain of enhancer BCL6 chr3 187779884187823100 Duplication Gain of enhancer BCL6 chr3 187779884 187823100Duplication Gain of enhancer BCL6 chr3 187779884 187823100 DuplicationGain of enhancer BCL6 chr3 187779884 187823100 DuplicationGain of enhancer BCL6 chr3 187779884 187823100 DuplicationGain of enhancer BCL6 chr3 187779884 187823100 DuplicationGain of enhancer BCL6 chr3 187779884 187823100 DuplicationGain of enhancer BCL6 chr3 187779884 187823100 DuplicationGain of enhancer BCL6 chr3 187779884 187823100 DuplicationGain of enhancer BCL6 chr3 187779884 187823100 DuplicationGain of enhancer BCL6 chr3 187779884 187823100 DuplicationGain of enhancer BCL6 chr3 187779884 187823100 DuplicationGain of enhancer BCL6 chr3 187779884 187823100 DuplicationGain of enhancer BCL6 chr3 187779884 187823100 DuplicationGain of enhancer BCL6 chr3 187779884 187823100 DuplicationGain of enhancer BHLHE41 chr12 26472562 26472562 G > AGain of AP-1 motif; Gain of enhancer activity BMF chr15 4039793640397936 C > A Loss of RELA motif; Decreasing of enhancer activity BMP2chr20 7106289 7106289 T > C Increasing of enhancer activity BMP4 chr1454410919 54410919 T > C Increasing of enhancer activity BRAF chr7139695303 139695303 G > A Change of EGR1 binding BRAF chr7 139695303139695303 G > A Change of ZNF791 binding BRAF chr7 140845142 140845142C > A Change of ZNF236 binding BRAP, chr12 112007756 112007756 C > CIncreasing of enhancer ACAD10, activity ATXN2, C12orf47, ERP29, ALDH2,MAPKAPK5, FAM109A, SH2B3, TRAFD1 BRCA1 chr17 41278377 41278377 G > AGain of GMEB1; CEBPE binding; Increasing of enhancer activity BRCA1chr17 41445837 41445837 C > G Change of HINFP binding BRCA1 chr1741445837 41445837 C > G Change of YYl binding BRCA2 chr13 3289500532895005 T > A Change of ZNF551 binding BRCA2 chr13 33213838 33213838G > T Change of CTCF binding BRCA2 chr13 33213838 33213838 G > TChange of RAD21 binding BRCA2 chr13 33213838 33213838 G > TChange of SMC3 binding BRCA2 chr13 33213838 33213838 G > TChange of TAL2 binding BRCA2 chr13 33213838 33213838 G > TChange of ZNF257 binding BRCA2 chr13 33213838 33213838 G > TChange of ZNF430 binding BRIP1 chr17 59366414 59366414 C > TChange of ZNF513 binding BRIP1 chr17 59366414 59366414 C > TChange of ZNF517 binding BRIP1 chr17 59366943 59366943 A > CChange of ZNF404 binding BRIP1 chr17 59376306 59376306 C > GChange of NKX2-4 binding BRIP1 chr17 59376306 59376306 C > GChange of PBX3 binding BRIP1 chr17 59376306 59376306 C > GChange of POLR3A binding BRIP1 chr17 59377191 59377191 T > CChange of FOXB2 binding BRIP1 chr17 59377191 59377191 T > CChange of NANC > G binding BRIP1 chr17 59377191 59377191 T > CChange of SOX9 binding BRIP1 chr17 59525138 59525138 G > TChange of HES4 binding BRIP1 chr17 59525138 59525138 G > TChange of ZNF627 binding BRIP1 chr17 59715852 59715852 G > CChange of CEBPA binding BRIP1 chr17 59722479 59722479 T > CChange of HDAC2 binding BRIP1 chr17 59722479 59722479 T > CChange of HOXC5 binding BRIP1 chr17 59722479 59722479 T > CChange of ZNF263 binding BRIP1 chr17 59722480 59722480 C > TChange of HDAC2 binding BRIP1 chr17 59722480 59722480 C > TChange of HOXC5 binding BRIP1 chr17 59722480 59722480 C > TChange of ZNF263 binding BRIP1 chr17 59789086 59789086 A > CChange of ZNF425 binding BRIP1 chr20 55684882 55684882 G > CChange of CT53 binding BRIP1 chr20 55684882 55684882 G > CChange of KLF15 binding BRIP1 chr20 55684882 55684882 G > CChange of TFAP2A binding BRIP1 chr20 55684882 55684882 G > CChange of TFAP2E binding BRIP1 chr20 55684882 55684882 G > CChange of ZNF219 binding BRIP1 chr20 55684882 55684882 G > CChange of ZNF263 binding BRIP1 chr20 55684882 55684882 G > CChange of ZNF281 binding BRIP1 chr20 55684882 55684882 G > CChange of ZNF284 binding BRIP1 chr20 55684882 55684882 G > CChange of ZNF716 binding BRIP1 chr20 55701207 55701207 C > TChange of HDAC2 binding BRIP1 chr20 55701207 55701207 C > TChange of IRF4 binding BRIP1 chr20 55702731 55702731 G > TChange of PBX4 binding BRIP1 chr20 55774343 55774343 C > GChange of THAP1 binding BRIP1 chr20 55774343 55774343 C > GChange of YYl binding BRIP1 chr20 55795637 55795637 G > AChange of BCL6 binding BRIP1 chr20 55829393 55829393 C > GChange of HOXB2 binding BRIP1 chr20 55829393 55829393 C > GChange of HOXB3 binding BRIP1 chr20 55829393 55829393 C > GChange of ZNF605 binding BTD NA NA Gain of enhancer BTD NA NAGain of enhancer BTD NA NA Gain of enhancer BTD NA NA Gain of enhancerBTD NA NA Gain of enhancer BTD NA NA Gain of enhancer BTD NA NAGain of enhancer BTD NA NA Gain of enhancer BTD NA NA Gain of enhancerBTD NA NA Gain of enhancer BTD NA NA Gain of enhancer BTD NA NAGain of enhancer BTD NA NA Gain of enhancer BTN3A2 chr6 2823459728234597 C > T Decreasing of enhancer activity BTN3A2 chr6 2823517628235176 A > C Decreasing of enhancer activity C10orf110, chr10 11561651156165 T > T Increasing of enhancer WDR37, IDI2, activity PITRM1,GTPBP4, LARP4B, IDI1, PFKP C13orf34, chr13 72347696 72347696 A > AIncreasing of enhancer DACH1 activity C16orf93 chr16 30669784 30669784G > C Change of SP3 binding C16orf93 chr16 30753142 30753142 C > TChange of SP1 binding C16orf93 chr16 30753142 30753142 C > TChange of SP3 binding C16orf93 chr16 31153547 31153547 A > CChange of SP1 binding C16orf93 chr16 31153547 31153547 A > CChange of SP3 binding C16orf93 chr16 31153547 31153547 A > CChange of SP1 binding C16orf93 chr16 31153547 31153547 A > CChange of SP3 binding C16orf93, chr16 30935409 30935409 C > GChange of SP1 binding PHKG2 C16orf93, chr16 30669784 30669784 G > CChange of SP1 binding SRCAP C16orf93, chr16 30669878 30669878 C > TChange of SP1 binding SRCAP C16orf93, chr16 30669784 30669784 G > CChange of SP1 binding SRCAP, PHKG2 C16orf93, chr16 30753142 30753142C > T Change of SP1 binding SRCAP, PHKG2 C16orf93, chr16 3115354731153547 A > C Change of SP1 binding SRCAP, PHKG2 C19orf40, chr1933356891 33356891 T > C Increasing of enhancer SLC7A10, activity CEBPG,GPATCH1, TDRD12, SLC7A9, ANKRD27, NUDT19, CCDC123, PDCD5 C2orf43 chr220882056 20882056 C5orf35 chr5 56034207 56034207 A > G CACNA1C chr122346830 2346830 T > A Decreasing of enhancer activity CACNA1C chr122346393 2346393 C > T Decreasing of enhancer activity CACNA1C chr122349584 2349584 G > C Decreasing of enhancer activity CACNA1C chr122361460 2361460 C > T Decreasing of enhancer activity CACNA1C chr122349584 2349584 G > C Decreasing of enhancer activity CALR chr1913049218 13049218 C > T CALR chr19 13049375 13049375 G > CGain of GMEB1 binding; Increasing of enhancer activity CAMK1D, chr1012307894 12307894 C > T CDC123 CAMK1D, chr10 12307894 12307894 C > TGain of FOXA1 and FOXA2 CDC123 binding; Gain of enhancer activity CAPGchr2 85769711 85769711 CAPG chr2 85780536 85780536 CAPG chr2 8576220985762209 Change of CTCF binding CARLo-5, chr8 128413305 128413305 T > GIncreasing of enhancer MYC activity CARLo-5, chr8 128413305 128413305G > T Increasing of enhancer MYC activity CARLo-5, chr8 128413305128413305 T > G Increasing of enhancer MYC activity CARLo-5, chr8128413305 128413305 G > T Increasing of enhancer MYC activity CASP3 chr4185569801 185569801 T > G Decreasing of enhancer activity CASP8 chr2202313604 202313604 G > T Change of MEF2A binding CASP8 chr2 202313604202313604 G > T Change of MEF2C binding CASP8 chr2 202900229 202900229C > A Change of SP2 binding CASP8 chr2 202204741 202204741 C > TLoss of MYC binding; Loss of enhancer activity CBX7 chr22 3954229239542292 G > A Decreasing of enhancer activity CBX7 chr22 3954229239542292 G > A Loss of ETS1; ETV4 and PAX6 motif; Decreasing ofenhancer activity CCDC142, chr2 73868328 73868328 A > GIncreasing of enhancer SLC4A5, activity CCT7, STAM BP, FBX041, ACTG2,NAT8B, DUSP11, NAT8, ALMS1, TPRKB, DGUOK, TET3, BOLA3, DCTN1, TTC31,MOBKL1B CCL2 chr17 32579788 32579788 A > G Gain of MSC; MYF6; PKNOX2;TGIF2LX; MEIS3; TCF21; SMAD4; TGIF1; ATOH1; MEIS2; MYOD1; MYC > G;PKNOX1; MEIS1 binding; Increasing of enhancer activity CCL5 chr1734207780 34207780 C > T Gain of GATA2 binding; Increasing of enhanceractivity CCND1 chr11 68859692 68859692 G > C Change of ZNF585B bindingCCND1 chr11 68872778 68872778 C > T Change of HAND2 binding CCND1 chr1168872778 68872778 C > T Change of USF1 binding CCND1 chr11 6887277868872778 C > T Change of USF2 binding CCND1 chr11 68872949 68872949C > T Change of THAP1 binding CCND1 chr11 68872949 68872949 C > TChange of ZNF254 binding CCND1 chr11 68872949 68872949 C > TChange of ZNF306 binding CCND1 chr11 68872949 68872949 C > TChange of ZNF502 binding CCND1 chr11 68881643 68881643 G > TChange of IRX3 binding CCND1 chr11 68886052 68886052 G > TChange of ZNF552 binding CCND1 chr11 69051978 69051978 C > GChange of ZNF585B binding CCND1 chr11 69053154 69053154 G > AChange of ZNF829 binding CCND1 chr11 69088100 69088100 G > CChange of HZF12 binding CCND1 chr11 69088100 69088100 G > CChange of ZNF143 binding CCND1 chr11 69088100 69088100 G > CChange of ZNF521 binding CCND1 chr11 69191851 69191851 A > CChange of CREB1 binding CCND1 chr11 69191851 69191851 A > CChange of KLF14 binding CCND1 chr11 69191851 69191851 A > CChange of KLF16 binding CCND1 chr11 69191851 69191851 A > CChange of SP3 binding CCND1 chr11 69191851 69191851 A > CChange of SP8 binding CCND1 chr11 69243913 69243913 C > TChange of ZNF454 binding CCND1 chr11 69252451 69252451 G > AChange of ZNF281 binding CCND1 chr11 69256005 69256005 A > TChange of HDAC2 binding CCND1 chr11 69256005 69256005 A > TChange of IRF1 binding CCND1 chr11 69256008 69256008 C > TChange of IRF1 binding CCND1 chr11 69256008 69256008 C > TChange of ZNF136 binding CCND1 chr11 69256011 69256011 T > CChange of IRF1 binding CCND1 chr11 69256011 69256011 T > CChange of ZNF136 binding CCND1 chr11 69258373 69258373 A > CChange of CCNT2 binding CCND1 chr11 69258373 69258373 A > CChange of GATA2 binding CCND1 chr11 69258373 69258373 A > CChange of SP1 binding CCND1 chr11 69258373 69258373 A > CChange of SP4 binding CCND1 chr11 69259344 69259344 C > GChange of CTCF binding CCND1 chr11 69259344 69259344 C > GChange of RAD21 binding CCND1 chr11 69259344 69259344 C > GChange of RXRA binding CCND1 chr11 69259344 69259344 C > GChange of SMC3 binding CCND1 chr11 69279835 69279835 G > CChange of ZNF394 binding CCND1 chr11 69279835 69279835 G > CChange of ZNF396 binding CCND1 chr11 69279835 69279835 G > CChange of ZNF492 binding CCND1 chr11 69279835 69279835 G > CChange of ZNF729 binding CCND1 chr11 69279835 69279835 G > CChange of ZNF99 binding CCND1 chr11 69282363 69282363 C > GChange of NFAT5 binding CCND1 chr11 69282363 69282363 C > GChange of NFKB1 binding CCND1 chr11 69282363 69282363 C > GChange of RELA binding CCND1 chr11 69282363 69282363 C > GChange of REL binding CCND1 chr11 69282363 69282363 C > GChange of SALL1 binding CCND1 chr11 69282363 69282363 C > GChange of STAT1 binding CCND1 chr11 69282363 69282363 C > GChange of ZNF227 binding CCND1 chr11 69282363 69282363 C > GChange of ZNF383 binding CCND1 chr11 69282964 69282964 C > GChange of ZNF776 binding CCND1 chr11 69283489 69283489 C > GChange of ZNF543 binding CCND1 chr11 69283489 69283489 C > GChange of ZNF708 binding CCND1 chr11 69287640 69287640 C > TChange of REST binding CCND1 chr11 69287640 69287640 C > TChange of TCF12 binding CCND1 chr11 69305144 69305144 C > GChange of ZNF573 binding CCND1 chr11 69305799 69305799 T > CChange of NANC > G binding CCND1 chr11 69312746 69312746 T > GChange of RREB1 binding CCND1 chr11 69312746 69312746 T > GChange of SP3 binding CCND1 chr11 69312746 69312746 T > GChange of ZNF658B binding CCND1 chr11 69312746 69312746 T > GChange of ZNF658 binding CCND1 chr11 69312746 69312746 T > GChange of ZNF781 binding CCND1 chr11 69315935 69315935 G > TChange of E2F6 binding CCND1 chr11 69315935 69315935 G > TChange of MAZ binding CCND1 chr11 69315935 69315935 G > TChange of ZNF143 binding CCND1 chr11 69315935 69315935 G > TChange of ZNF263 binding CCND1 chr11 69315935 69315935 G > TChange of ZNF391 binding CCND1 chr11 69317977 69317977 G > CChange of RLF binding CCND1 chr11 69317977 69317977 G > CChange of ZNF514 binding CCND1 chr11 69318175 69318175 G > CChange of ZNF394 binding CCND1 chr11 69318175 69318175 G > CChange of ZNF396 binding CCND1 chr11 69324989 69324989 C > TChange of ARNT2 binding CCND1 chr11 69324989 69324989 C > TChange of EGR1 binding CCND1 chr11 69324989 69324989 C > TChange of PLAG1 binding CCND1 chr11 69324989 69324989 C > TChange of SP1 binding CCND1 chr11 69324989 69324989 C > TChange of ZNF780A binding CCND1 chr11 69330742 69330742 T > GChange of BARHL1 binding CCND1 chr11 69330742 69330742 T > GChange of GSX2 binding CCND1 chr11 69330742 69330742 T > GChange of HOXA13 binding CCND1 chr11 69330742 69330742 T > GChange of TLX3 binding CCND1 chr11 69332416 69332416 C > TChange of ZNF69 binding CCND1 chr11 69331642 69331642 C > GLoss of ELK4 motif; Decreasing of enhancer activity CCND1 chr11 6933141869331418 C > T Loss of USF1 motif and USF2 motif; Decreasing ofenhancer activity CCND1 chr11 69345852 69345852 G > TChange of MAZ binding CCND1 chr11 69345852 69345852 G > TChange of ZNF263 binding CCND1 chr11 69345852 69345852 G > TChange of ZNF513 binding CCND1 chr11 69351959 69351959 C > GChange of ZBTB41 binding CCND1 chr11 69355586 69355586 A > CChange of CTCFL binding CCND1 chr11 69355586 69355586 A > CChange of GLI1 binding CCND1 chr11 69355586 69355586 A > CChange of GLI3 binding CCND1 chr11 69390451 69390451 T > AChange of ATF5 binding CCND1 chr11 69390451 69390451 T > AChange of IRF4 binding CCND1 chr11 69390451 69390451 T > AChange of PRDM1 binding CCND1 chr11 69390451 69390451 T > AChange of ZNF227 binding CCND1 chr11 69390451 69390451 T > AChange of ZNF263 binding CCND1 chr11 69390451 69390451 T > AChange of ZNF293 binding CCND1 chr11 69416853 69416853 T > AChange of PLAG1 binding CCND1 chr11 69418111 69418111 G > CChange of ZNF320 binding CCND1 chr11 69418111 69418111 G > CChange of ZNF502 binding CCND1 chr11 69431690 69431690 G > AChange of ZNF799 binding CCND1 chr11 69465198 69465198 A > TChange of ZNF836 binding CCND1 chr11 69239741 69239741 G > ALoss of HIF motif; Decreasing of enhancer activity CCND1 chr11 6925198269251982 C > T Loss of HIF motif; Decreasing of enhancer activity CCND1chr11 69234620 69234620 T > C Loss of HIF motif; Decreasingof enhancer activity CCNE1 chr19 30296853 30296853 T > CGain of KLF5 binding; Gain of enhancer CCN1, chr4 77368847 77368847G > A Increasing of enhancer NUP54, activity STBD1, SDAD1, CXCL10,CCNG2, SCARB2, SHROOM3, CXCL9 CCN1, chr4 77412140 77412140 G > AIncreasing of enhancer SCARB2, activity STBD1, CCNG2, NUP54, SHROOM3,CXCL10, SDAD1, CXCL9 CCR5 chr3 46410171 46410171 C > TLoss of CREB1 motif; Decreasing of enhancer activity CD207 chr2 7107924571079245 C > A Loss of Ik-2 and SIX5 motif CD40 chr20 44740196 44740196T > C Decreasing of enhancer activity CD40 chr20 44740196 44740196 T > CDecreasing of enhancer activity CD40 chr20 44740196 44740196 T > CDecreasing of enhancer activity CD40 chr20 44740196 44740196 T > CDecreasing of enhancer activity CD40 chr20 44740196 44740196 T > CDecreasing of enhancer activity CD40 chr20 44740196 44740196 T > CDecreasing of enhancer activity CD58 chr1 117100957 117100957 A > G CD86chr3 121793187 121793187 C > A CDCA7L chr7 21938240 21938240 T > GIncreasing of IRF4 binding; Increasing of enhancer activity CDCA7L chr721938240 21938240 A > C Loss of GATAl; GATA2 andGATA5 motif; Decreasing of enhancer activity CDH1 chr16 6873847268738472 C > T Change of ZNF80 binding CDH1 chr16 68741288 68741288G > T Change of BATF binding CDH1 chr16 68741288 68741288 G > TChange of FOSL1 binding CDH1 chr16 68741288 68741288 G > TChange of HMGN3 binding CDH1 chr16 68741288 68741288 G > TChange of JUNB binding CDH1 chr16 68741288 68741288 G > TChange of MAFA binding CDH1 chr16 68741288 68741288 G > TChange of MAFK binding CDH1 chr16 68741288 68741288 G > TChange of NFE2 binding CDH1 chr16 68741288 68741288 G > TChange of NR3C1 binding CDH1 chr16 68741288 68741288 G > TChange of SMARCC1 binding CDH1 chr16 68750191 68750191 T > CChange of SOX7 binding CDH1 chr16 68750191 68750191 T > CChange of SOX9 binding CDH1 chr16 68752380 68752380 C > GChange of NR2F1 binding CDH1 chr16 68752380 68752380 C > GChange of RARG binding CDH1 chr16 68823620 68823620 C > TChange of ZNF238 binding CDH1 chr16 68826079 68826079 C > TChange of IKZF1 binding CDH1 chr16 68833932 68833932 T > AChange of ARID3C binding CDH1 chr16 68833932 68833932 T > AChange of MEOX2 binding CDKN1B chr12 12876142 12876142 C > TChange of ZNF253 binding CDKN1B chr12 12876142 12876142 C > TChange of ZNF785 binding CDKN1B chr12 12957277 12957277 G > TChange of NFATC1 binding CDKN2A chr9 21975127 21975127 C > TDecreasing of enhancer activity CDKN2A chr9 22123766 22123766 A > CGain of IRF4 motif; Increasing of enhancer activity CDKN2A chr9 2212447222124472 C > T Loss of TEAD3 and TEAD4 motif; Decreasing ofenhancer activity CDKN2A chr9 22072264 22072264 A > GLoss of GATA motif; Decreasing of enhancer activity CDKN2A chr9 2207679522076795 A > G Loss of TEAD3 and TEAD4 motif; Decreasing ofenhancer activity CDKN2A chr9 22096055 22096055 A > GLoss of PRC1 motif; Decreasing of enhancer activity CDKN2A chr9 2210622522106225 A > G Loss of Smad3 motif; Decreasing of enhancer activityCDKN2A chr9 22106731 22106731 T > A Loss of TEAD3 and TEAD4motif; Decreasing of enhancer activity CDKN2A chr9 22106271 22106271A > G Loss of GATA motif; Decreasing of enhancer activity CDKN2A chr922119195 22119195 T > C Loss of Smad3 motif; Decreasing of enhanceractivity CDKN2A chr9 22116220 22116220 T > C Loss of GATA motif;Decreasing of enhancer activity CDKN2A chr9 22094330 22094330 A > GLoss of TEAD3 and TEAD4 motif; Decreasing of enhancer activity CDKN2Achr1 241012779 241012779 C > T Loss of Meisl motif;Decreasing of enhancer activity CDKN2A chr9 22072638 22072638 A > GGain of GATA motif; Increasing of enhancer activity CDKN2A, chr922124477 22124477 A > G Loss of STAT1 motif; CDKN2BDecreasing of enhancer activity CDKN2B chr6 74592063 74602441 DeletionLoss of enhancer CDKN2B, chr9 22124472 22124472 C > TLoss of STAT1 motif; MTAP, Decreasing of enhancer CDKN2A, activityCDKN2B-AS1 CETP chr16 56995796 56995796 G > A Decreasing of enhanceractivity CFTR chr7 117256712 117256712 G > A CHEK2 chr22 2919638629196386 G > C Change of SP2 binding CHEK2 chr22 29196386 29196386 G > CChange of TFAP4 binding CHEK2 chr22 29196386 29196386 G > CChange of ZNF614 binding CHEK2 chr22 29196404 29196404 G > CChange of EGR4 binding CHEK2 chr22 29205398 29205398 G > TChange of SOX1 binding CHEK2 chr22 29208344 29208344 C > GChange of MAFF binding CHEK2 chr22 29208344 29208344 C > GChange of MAFK binding CHEK2 chr22 29210328 29210328 C > TChange of ELF3 binding CHEK2 chr22 29210328 29210328 C > TChange of ZNF607 binding chrNAl chr2 175629600 175629600 T > CGain of GMEB1; ZNF646; KLF3; RUNX1; HES5 binding; Decreasing of enhanceractivity CLEC16A chr16 11448517 11448517 G > A Increasing of enhanceractivity CLECL1 chr12 9876091 9876091 G > A CLPTM1L chr5 1326501 1326501T > C Increasing of enhancer activity CLPTM1L chr5 1326505 1326505 C > GIncreasing of enhancer activity CLPTM1L chr5 1326904 1326904 G > CIncreasing of enhancer activity CLPTM1L chr5 1326908 1326908 T > AIncreasing of enhancer activity CLPTM1L chr5 1326988 1326988 A > GIncreasing of enhancer activity CLPTM1L chr5 1327062 1327062 G > AIncreasing of enhancer activity CLPTM1L chr5 1327333 1327333 T > GIncreasing of enhancer activity CLPTM1L chr5 1327445 1327445 C > GIncreasing of enhancer activity CLPTM1L chr5 1327544 1327544 T > CIncreasing of enhancer activity CLPTM1L chr5 1327722 1327722 T > CIncreasing of enhancer activity CNKSR3, chr6 154986664 154986664 G > GIncreasing of enhancer RBM16, activity TFB1M CUX1 chr7 101930034101930034 G > C Change of SP3 binding CUX1 chr7 101362186 101362186T > G Change of SP3 binding CUX1 chr7 101362597 101362597 A > TChange of SP3 binding CUX1 chr7 101362186 101362186 T > GChange of SP3 binding CUX1 chr7 101362597 101362597 A > TChange of SP3 binding CUX1 chr7 101589950 101589950 G > CChange of SP3 binding CXorf36 chrx 45298055 45298055 CYBB chrX 3763926237639262 A > C Decreasing of enhancer activity CYBB chrX 3763926437639264 T > C Decreasing of enhancer activity CYBB chrX 3763926737639267 C > T Decreasing of enhancer activity CYP27B1 chr12 5813325658133256 G > A DACH1 chr13 72428647 72428647 G > TDecreasing of enhancer activity DACH1 chr13 72428647 72428647 G > TDecreasing of enhancer activity DAPK1 chr9 89725269 89725269 T > CIncreasing of enhancer activity DCAF7 chr17 61777324 61777324 A > CChange of SP4 binding DCAF7 chr17 61777552 61777552 G > AChange of SP4 binding DCAF7 chr17 61513737 61513737 C > TChange of SP4 binding DCAF7 chr17 61043674 61043674 C > GChange of SP4 binding DCLK3 chr3 37034946 37034946 G > ALoss of TFAP4 binding; Gain of ETS family binding motif;Gain of enhancer DIAPH1 chr5 141014494 141014494 A > G DIS3 chr1373925672 73925672 TCT > ACATCTTTTC Gain of LEF1; TCF7and TTTGAGGCTTAAATTCF7L2 motif; Decreasing of AGTATC (SEQ ID enhancer activity NO: 479)DLX6, DLX5 chr7 95552064 96432064 Deletion Loss of enhancer DRD5, chr49995182 9995182 G > G Increasing of enhancer WDR1, activity SLC2A9 EDN1chr6 12903957 12903957 A > G Increasing of enhancer activity EDN1 chr612903957 12903957 A > G Increasing of enhancer activity EDN1 chr612903957 12903957 A > G Increasing of enhancer activity EDN1 chr612903957 12903957 A > G Increasing of enhancer activity EDN1 chr612903957 12903957 A > G Increasing of enhancer activity EGFR chr755102219 55102219 A > T Change of NPAS3 binding EGFR chr7 5510221955102219 A > T Change of RREB1 binding EGFR chr7 55322571 55322571 C > AChange of ZNF647 binding EGFR chr7 55322596 55322596 G > AChange of SP1 binding EGFR chr7 55322596 55322596 G > AChange of SP4 binding EGFR chr7 55322596 55322596 G > AChange of ZNF189 binding EGFR chr7 55322596 55322596 G > AChange of ZNF254 binding EGFR chr7 55322596 55322596 G > AChange of ZNF263 binding EGFR chr7 55322596 55322596 G > AChange of ZNF647 binding EGLN2 chr19 41365000 41385000 DeletionLoss of enhancer EGR2 chr10 64191785 64202507 Deletion Loss of enhancerEGR2 chr10 64737575 64737575 T > A Gain of EWSR1-FLI1 motif;Increasing of EWSR1-FLI1 binding; Gain of enhancer ELL2 chr5 9526153895261538 G > C Decreasing of enhancer activity ERAP2 chr5 9627329896273298 G > A ERG NA NA NA NA Loss of d ETS; GATA and E-BOX motif; Decreasing of enhancer activity ESR1 chr6 150465639 150465639C > A Change of ZIM2 binding ESR1 chr6 151924498 151924498 T > CDecreasing of enhancer activity ESR1 chr6 151935148 151935148 C > GChange of ZNF21 binding ESR1 chr6 151937492 151937492 G > AChange of PAX6 binding ESR1 chr6 151937492 151937492 G > AChange of RARB binding ESR1 chr6 151937492 151937492 G > AChange of ZNF789 binding ESR1 chr6 151955192 151955192 A > GDecreasing of enhancer activity ESR1 chr6 151955219 151955219 G > TGain of GATA3 motif; Decreasing of enhancer activity ESR1 chr6 151957875151957875 G > C Change of ZNF20 binding ESR1 chr6 151958185 151958185G > A Change of NKX3-1 binding ESR1 chr6 151958185 151958185 G > AChange of POU3F3 binding ESR1 chr6 151961699 151961699 C > TChange of HDAC2 binding ESR1 chr6 151961699 151961699 C > TChange of HOXC5 binding ESR1 chr6 151961699 151961699 C > TChange of ZNF263 binding ESR1 chr6 152024472 152024472 C > GDecreasing of enhancer activity ESR1 chr6 152232725 152232725 G > CChange of FOS binding ESR1 chr6 152232725 152232725 G > CChange of TP63 binding ESR1 chr6 152232725 152232725 G > CChange of TP73 binding ESR1 chr6 152360637 152360637 T > CDecreasing of enhancer activity ESR1 chr6 151953765 151953765 DeletionLoss of enhancer ESR1, chr6 151958815 151958815 T > CDecreasing of enhancer RMND1 activity ESR1, chr6 152432902 152432902T > C Decreasing of enhancer RMND1 activity ESR1, chr6 151949582151949582 A > C Decreasing of enhancer RMND1, activity CCDC170 ESR1,chr6 151949312 151949312 G > A Decreasing of enhancer RMND1, activityCCDC170 ETS2 chr21 40283733 40283733 C > T ETV6 chr12 11883580 11883580T > C Change of LMO2 binding ETV6 chr12 11899976 11899976 A > GChange of ZBTB20 binding ETV6 chr12 12038275 12038275 A > CChange of SRF binding ETV6 chr12 12038275 12038275 A > CChange of YYl binding ETV6 chr12 12879708 12879708 T > GChange of POU2F1 binding ETV6 chr12 12009741 12009741 A > GDecreasing of MAX binding; Decreasing of enhancer activity EVI1 NA NA NAinv(3)(q21q26.2) Gain of enhancer EVI1 NA NA NA t(3; 3)(q21; q26.2)Gain of enhancer EVI1 NA NA NA Inversion Gain of enhancer F7 chr13113760095 113760095 T > G Decreasing of enhancer activity F7 chr13113760101 113760101 C > T Decreasing of enhancer activity F8 chrX154251046 154251046 G > A Decreasing of enhancer activity F9 chrX138612889 138612889 G > A Gain of FOXH1 binding; Decreasing of enhanceractivity FAM122A, chr9 71434707 71434707 A > A Increasing of enhancerFXN activity FAM135B NA NA Gain of enhancer FAM135B NA NAGain of enhancer FAM135B NA NA Gain of enhancer FAM135B NA NAGain of enhancer FAM135B NA NA Gain of enhancer FAM135B NA NAGain of enhancer FAM135B NA NA Gain of enhancer FAM135B NA NAGain of enhancer FAM135B NA NA Gain of enhancer FAM167A chr8 1134397311343973 C > T Increasing of enhancer activity FAM167A chr8 1134397311343973 C > T Increasing of enhancer activity FAM167A chr8 1134397311343973 C > T Increasing of enhancer activity FAM167A chr8 1134397311343973 C > T Increasing of enhancer activity FAM167A chr8 1134397311343973 C > T Increasing of enhancer activity FAM167A chr8 1134397311343973 C > T Increasing of enhancer activity FAM84B chr8 127888731127888731 FGER2 chr10 123333997 123333997 C > T Gain of C/EBPbeta motif;Increasing of enhancer activity FGF10, chr5 44706498 44706498 A > GGain of FOXA1;OCT1 bs; Gain MRPS30 of enhancer activity FGFR2 chr10123340311 123340311 T > C Gain of ER-alpha binding;Gain of FOXA1 binding; Increasing of enhancer activity FGFR2 chr10123340311 123340311 T > C Gain of FOXA1 binding; Gain of enhancer FGFR2chr10 123340311 123340311 C > T Gain of Oct-1/Runx2 motif;Increasing of enhancer activity FGFR2 chr10 123340432 123340432 - > CGain of E2F1 binding; Gain of enhancer FGFR2 chr10 123340432 123340432- > C Gain of E2F1 binding; Increasing of enhancer activity FGFR2 chr10123349324 123349324 T > A Gain of GATA3 binding; Gain of enhancer FGFR3chr4 1770844 1770844 C > G Change of MAZ binding FGFR3 chr4 17708441770844 C > G Change of SP4 binding FGFR3 chr4 1771286 1771286 C > TChange of SP4 binding FGFR3 chr4 1772212 1772212 T > GChange of SP4 binding FGFR3 chr4 1773418 1773418 A > CChange of MAZ binding FGFR3 chr4 1773418 1773418 A > CChange of SP4 binding FGFR3 chr4 1762678 1762678 C > TChange of MAZ binding FGFR3 chr4 1762678 1762678 C > TChange of SP4 binding FGFR3 chr4 1805959 1805959 C > GChange of MAZ binding FN1 chr2 216532560 216532560 G > TIncreasing of enhancer activity FN1 chr2 216532635 216532635 G > AIncreasing of enhancer activity FN1 chr2 216532985 216532985 A > TIncreasing of enhancer activity FN1 chr2 216533394 216533394 G > AIncreasing of enhancer activity FOXA1 chr14 37710185 37710185 A > CChange of ZNF611 binding FOXA1 chr14 37710806 37710806 T > GChange of CTCFL binding FOXA1 chr14 37710806 37710806 T > GChange of EGR1 binding FOXA1 chr14 37710806 37710806 T > GChange of EGR3 binding FOXA1 chr14 37710806 37710806 T > GChange of EGR4 binding FOXA1 chr14 37710806 37710806 T > GChange of GIC > T1 binding FOXA1 chr14 37710806 37710806 T > GChange of KLF15 binding FOXA1 chr14 37710806 37710806 T > GChange of MAZ binding FOXA1 chr14 37710806 37710806 T > GChange of NPAS3 binding FOXA1 chr14 37710806 37710806 T > GChange of RREB1 binding FOXA1 chr14 37710806 37710806 T > GChange of SP1 binding FOXA1 chr14 37710806 37710806 T > GChange of SP3 binding FOXA1 chr14 37710806 37710806 T > GChange of SP4 binding FOXA1 chr14 37710806 37710806 T > GChange of ZBTB7B binding FOXA1 chr14 37710806 37710806 T > GChange of ZNF100 binding FOXA1 chr14 37710806 37710806 T > GChange of ZNF219 binding FOXA1 chr14 37710806 37710806 T > GChange of ZNF436 binding FOXA1 chr14 37710806 37710806 T > GChange of ZNF485 binding FOXA1 chr14 37710806 37710806 T > GChange of ZNF658B binding FOXA1 chr14 37723745 37723745 C > TChange of EGR4 binding FOXA1 chr14 37723745 37723745 C > TChange of ZBTB41 binding FOXA1 chr14 37723745 37723745 C > TChange of ZNF148 binding FOXA1 chr14 37733220 37733220 G > AChange of MEF2A binding FOXA1 chr14 38058268 38058268 C > GChange of MECOM binding FOXA1 chr14 38118241 38118241 C > TChange of ZFPM1 binding FOXA1 chr14 38120099 38120099 G > CChange of ESR1 binding FOXA1 chr14 38120099 38120099 G > CChange of ESRRA binding FOXA1 chr14 38120099 38120099 G > CChange of ESRRB binding FOXA1 chr14 38120099 38120099 G > CChange of NR4A3 binding FOXA1 chr14 38120099 38120099 G > CChange of NR5A1 binding FOXA1 chr14 38120099 38120099 G > CChange of NR5A2 binding FOXA1 chr14 38126241 38126241 C > AChange of ZFP37 binding FOXA1 chr14 38164005 38164005 G > CChange of IKZF1 binding FOXA1 chr14 38167448 38167448 C > AChange of EVX2 binding FOXA1 chr14 38179158 38179158 T > GChange of HNF1A binding FOXA1 chr14 38182676 38182676 C > TChange of THRA binding FOXA1 chr14 38182684 38182684 C > TChange of ZNF226 binding FOXA1 chr14 38182915 38182915 C > GChange of ZNF211 binding FOXA1 chr14 38184293 38184293 G > CChange of NHLH2 binding FOXE1 chr9 100549013 100549013 A > GGain of E-box motif; Gain of enhancer activity FOXE1, chr9 100556972100556972 G > A Increasing of TFAP2A binding; PTCSC2Increasing of enhancer activity FOXE1, chr9 100551768 100551768 A > GIncreasing of TFAP2A binding; PTCSC2 Increasing of enhancer activityFOXE1, chr9 100551908 100551908 A > C Increasing of enhancer PTCSC2activity FOXE1, chr9 100548934 100548934 T > CDecreasing of CEBPb binding; PTCSC2 Diseasing of enhancer activityFOXE1, chr9 100556109 100556109 G > A Increasing of TFAP2A binding;PTCSC2 Increasing of enhancer activity FOXG1 chr14 30000405 30000405G > T Decreasing of enhancer activity FOXL2 chr3 138948982 138956382Deletion Loss of enhancer FOXL2 chr3 138949151 138956509 DeletionLoss of enhancer FOXL2 chr3 138949151 138956509 DeletionLoss of enhancer FOXL2 chr3 138949151 138956509 DeletionLoss of enhancer FOXL2 chr3 138949151 138956509 DeletionLoss of enhancer FOXL2 chr3 138949151 138956509 DeletionLoss of enhancer FOXL2 chr3 138949151 138956509 DeletionLoss of enhancer FOXL2 chr3 138949151 138956509 DeletionLoss of enhancer FOXL2 chr3 138949151 138956509 DeletionLoss of enhancer FOXL2 chr3 140431841 140439199 DeletionLoss of enhancer FOXL2 chr3 140431841 140439199 DeletionLoss of enhancer FOXL2 chr3 140431841 140439199 DeletionLoss of enhancer FOXL2 chr3 140431841 140439199 DeletionLoss of enhancer FOXL2 chr3 140431841 140439199 DeletionLoss of enhancer FOXL2 chr3 140431841 140439199 DeletionLoss of enhancer FOXL2 chr3 140431841 140439199 DeletionLoss of enhancer FOXL2 chr3 140431841 140439199 DeletionLoss of enhancer FRG2 chr4 190959438 190959438 C > TChange of SP8 binding FRG2 chr4 190959439 190959439 G > AChange of SP8 binding FRG2 chr4 190959651 190959651 G > CChange of SP8 binding FTO chr16 53816275 53816275 C > A FTO chr1653816752 53816752 A > G FTO chr16 53816838 53816838 G > A GAD1 chr2171690121 171690121 A > G Decreasing of enhancer activity GAD1 chr2171678379 171678379 A > G Decreasing of enhancer activity GAP43 chr3115377646 115377646 G > T Decreasing of enhancer activity GATA2 NA NA NAt(3; 3)(q21; q26.2) Loss of enhancer GATA2 NA NA NA inv(3)(q21q26.2)Loss of enhancer GATA2 chr3 128202137 128202161Loss of ETS motif; Decreasing of enhancer activity GATA2 chr3 128202154128202154 C > T Decreasing of enhancer activity GATA3 chr10 62442936244293 C > T Change of MAZ binding GATA3 chr10 6244293 6244293 C > TChange of ZNF263 binding GATA3 chr10 7567024 7567024 T > AChange of MSX1 binding GATA3 chr10 7928151 7928151 C > GChange of ZNF117 binding GATA3 chr10 8067866 8067866 G > CChange of HOXC5 binding GATA3 chr10 8102520 8102520 T > AChange of STAT4 binding GATA3 chr10 8102598 8102598 G > TChange of ESR1 binding GATA3 chr10 8102598 8102598 G > TChange of SP3 binding GATA3 chr10 8119116 8119116 T > GChange of FOS binding GATA3 chr10 8374958 8374958 C > TChange of EGR1 binding GATA3 chr10 8374958 8374958 C > TChange of MAZ binding GATA3 chr10 8374958 8374958 C > TChange of PLAG1 binding GATA3 chr10 8374958 8374958 C > TChange of SP1 binding GATA3 chr10 8374958 8374958 C > TChange of SP2 binding GATA3 chr10 8374958 8374958 C > TChange of SP3 binding GATA3 chr10 8374958 8374958 C > TChange of SP4 binding GATA3 chr10 8374958 8374958 C > TChange of WT1 binding GATA3 chr10 8374958 8374958 C > TChange of ZBTB7B binding GATA3 chr10 8374958 8374958 C > TChange of ZNF148 binding GATA3 chr10 8374958 8374958 C > TChange of ZNF189 binding GATA3 chr10 8374958 8374958 C > TChange of ZNF263 binding GATA3 chr10 8374958 8374958 C > TChange of ZNF281 binding GATA3 chr10 8374958 8374958 C > TChange of ZNF658B binding GATA3 chr10 8374958 8374958 C > TChange of ZNF823 binding GATA3 chr10 8393839 8393839 C > AChange of FOXB2 binding GATA3 chr10 8393839 8393839 C > AChange of FOXP4 binding GATA3 chr10 8393839 8393839 C > AChange of KIAA0415 binding GATA3 chr10 8393839 8393839 C > AChange of ZNF227 binding GATA3 chr10 8402402 8402402 G > AChange of E4F1 binding GATA3 chr10 8405624 8405624 G > AChange of ZFP14 binding GATA3 chr10 8405624 8405624 G > AChange of ZIK1 binding GATA3 chr10 8405624 8405624 G > AChange of ZNF816A binding GATA3 chr10 8899177 8899177 G > CChange of TBX3 binding GATA3 chr10 8899177 8899177 G > CChange of ZNF670 binding GATA3 chr10 8899312 8899312 A > TChange of HSF1 binding GATA3 chr10 8899312 8899312 A > TChange of ZNF238 binding GATA3 chr10 8900652 8900652 G > AChange of STAT5A binding GATA3 chr10 8900652 8900652 G > AChange of STAT5B binding GATA3 chr10 8903379 8903379 A > TChange of ZNF331 binding GATA3 chr10 8911062 8911062 C > GChange of SP4 binding GATA3 chr10 9079498 9079498 G > TChange of HNF1A binding GATA3 chr10 9079498 9079498 G > TChange of HNF1B binding GATA3 chr10 9079498 9079498 G > TChange of ONECUT1 binding GATA3 chr10 9079498 9079498 G > TChange of ZNF300 binding GATA3 chr10 9112313 9112313 G > CChange of NPAS3 binding GATA3 chr10 9117103 9117103 G > AChange of ZNF441 binding GATA3 chr10 9201133 9201133 C > AChange of PRDM9 binding GATA3 chr10 9215998 9215998 C > GChange of POU6F2 binding GATA3 chr10 9343954 9343954 C > GChange of FOS binding GATA3 chr10 9343954 9343954 C > GChange of FOXB2 binding GATA3 chr10 9343954 9343954 C > GChange of PBX3 binding GATAD2A chr19 19434350 19434350 C > TDecreasing of enhancer activity GCLM chr1 94375309 94375309 G > ADecreasing of enhancer activity GFI1 NA NA NA NA Gain of enhancer GFI1NA NA NA NA Gain of enhancer GFI1 chr1 93009313 93009313 A > GIncreasing of enhancer activity GIGYF2 NA NA Gain of enhancer GIGYF2 NANA Gain of enhancer GIGYF2 NA NA Gain of enhancer GIGYF2 NA NAGain of enhancer GIGYF2 NA NA Gain of enhancer GIGYF2 NA NAGain of enhancer GIGYF2 NA NA Gain of enhancer GIGYF2 NA NAGain of enhancer GIGYF2 NA NA Gain of enhancer GIGYF2 NA NAGain of enhancer GIGYF2 NA NA Gain of enhancer GIGYF2 NA NAGain of enhancer GIGYF2 NA NA Gain of enhancer GIGYF2 NA NAGain of enhancer GIGYF2 NA NA Gain of enhancer GJB1 chrX 7044303170443031 G > C Gain of GMEB1; KLF3 binding; Decreasing of enhanceractivity GNL3 chr3 52742537 52742537 A > T Decreasing of enhanceractivity GREM1 chr15 32993111 32993111 C > T Increasing of enhanceractivity GSDMC chr8 129978038 129978038 GSK3B chr3 119814957 119814957T > A Increasing of enhancer activity H19 chr11 2020124 2020124 C > AGain of SMAD4; HEY1 binding HAPLN4 chr19 19431963 19431963 G > TDecreasing of enhancer activity HBB chr11 5248393 5248393 G > ADecreasing of enhancer activity HBB chr11 5248402 5248402 G > ADecreasing of enhancer activity HBB chr11 5248491 5248491 C > TDecreasing of enhancer activity HBD chr11 5255749 5255749 G > TDecreasing of enhancer activity HBD chr11 5255778 5255778 C > TGain of GMEB1 binding; Decreasing of enhancer activity HBG1 chr115271262 5271262 A > G Gain of ATOH1 binding; Increasing of enhanceractivity HBG1 chr11 5271289 5271289 G > A Increasing of enhanceractivity HBG2 chr11 5276120 5276120 C > A Increasing of enhanceractivity HBG2 chr11 5276172 5276172 C > T Increasing of enhanceractivity HBG2 chr11 5276186 5276186 A > G Gain of GMEB1; KLF3; ATOH1binding; Increasing of enhancer activity HBG2 chr11 5276213 5276213G > C Increasing of enhancer activity HBM chr16 209709 209709 T > CDecreasing of enhancer activity HERC5, PIGY, chr4 88959922 88959922G > C Increasing of enhancer ABCG2, activity PPM1K, SPARCL1, HERC6, PKD2HHIP chr4 145488334 145488334 T > C Gain of Sp3 motif; Decreasingof enhancer activity HHIP chr4 145487934 145487934 G > ADecreasing of enhancer activity HLA-DRB1, chr6 31888367 31888367 A > GDecreasing of enhancer HLA-C, HLA- activity DRB5, HLA- DQB1 HMBS chr11118955622 118955622 T > A Gain of GMEB1; HEY2 binding; Decreasing ofenhancer activity HMBS chr11 118955641 118955641 C > TGain of ESRRA; NR5A2 binding; Decreasing of enhancer activity HMCN1 chr1185904001 185904001 T > C Decreasing of enhancer activity HMCN1 chr1185904577 185904577 C > T Decreasing of enhancer activity HNF1A chr12121416034 121416034 G > C Decreasing of enhancer activity HNF1A chr12121416448 121416448 G > C Gain of WT1; EGR1 binding;Increasing of enhancer activity HNF4A chr20 42984276 42984276 C > TDecreasing of enhancer activity HOTAIR chr12 54360232 54360232 C > TIncreasing of enhancer activity HRH2 chr5 175109219 175109219 A > GHTR2A chr13 47471478 47471478 C > T HTR3A chr11 113846006 113846006C > T HTRA1 chr10 124217205 124217259 Gain of LYRIC binding; Gain ofenhancer ICOSLG chr21 45615561 45615561 A > G Increasing of enhanceractivity ICOSLG chr21 45615561 45615561 A > G Increasing of enhanceractivity ICOSLG chr21 45615561 45615561 A > G Increasing of enhanceractivity ICOSLG chr21 45615561 45615561 A > G Increasing of enhanceractivity ICOSLG chr21 45615561 45615561 A > G Increasing of enhanceractivity ICOSLG chr21 45615561 45615561 A > G Increasing of enhanceractivity ID2 chr2 8450123 8450123 A > G Increasing of enhancer activityIGF2BP2 chr3 185514393 185514393 T > C IGF2BP2 chr3 185515635 185515635G > A IGF2BP2 chr3 185513296 185513296 T > A IGF2BP2 chr3 185514931185514931 T > C IGF2BP2 chr3 185513392 185513392 A > G IGFBP5 chr2217909463 217909463 G > A Increasing of enhancer activity IHH chr2219925238 219974238 Duplication Gain of enhancer IHH chr2 219925238219974238 Duplication Gain of enhancer IKZF3 chr17 37912377 37912377C > T Decreasing of enhancer activity IL10 chr1 206946407 206946407G > T Decreasing of enhancer activity IL10 chr1 206946634 206946634A > G Gain of NRL binding; Increasing of enhancer activity IL10 chr1206946862 206946862 C > T Decreasing of enhancer activity IL12B chr5158759900 158759900 A > G IL-18 chr11 112026156 112026156 C > GGain of enhancer activity IL-1A chr2 113542960 113542960 T > C IL-1Bchr2 113590390 113590390 C > T IL2RA chr10 6096036 6096036 C > TLoss of GABPA motif; Decreasing of GABPA binding; Decreasing of enhanceractivity IL2RA chr10 6102012 6102012 A > G Increasing of ER binding;Increasing of enhancer activity IL2RA chr10 6093139 6093139 G > ALoss of ELF1 motif; Decreasing of ELF1 binding;Increasing of RUNX3 binding; Decreasing of enhancer activity IL2RA chr106093140 6093140 C > T Loss of ELF1 motif; Decreasing of ELF1 binding;Increasing of RUNX3 binding; Decreasing of enhancer activity IL2RA chr106100790 6100790 G > A Decreasing of EBF1 binding; Decreasing of enhanceractivity IL2RA chr10 6099045 6099045 A > G Decreasing of TFAP4 binding;Loss of enhancer IL2RA chr10 6094697 6094697 C > TDecreasing of MEF2C binding; Loss of enhancer IL2RA chr10 61020126102012 A > G Gain of ER-alpha binding; Gain of enhancer IL2RA chr106101713 6101713 T > C IL2RA chr10 6110829 6110829 C > T IL2RA chr106094697 6094697 C > T Loss of enhancer IL2RA chr10 6094697 6094697 C > TLoss of enhancer IL4 chr5 132009154 132009154 C > TGain of KLF3 binding; Increasing of enhancer activity IL6 chr7 2276654222766542 A > C Increasing of enhancer activity INS chr11 2182419 2182419T > G Decreasing of enhancer activity INSC NA NA Gain of enhancer INSCNA NA Gain of enhancer INSC NA NA Gain of enhancer INSC NA NAGain of enhancer INSC NA NA Gain of enhancer INTS1, chr7 1285195 1285195A > T Increasing of enhancer MICALL2 activity IRAK3 chr12 6658161666581616 A > G Increasing of enhancer activity IRF5 chr7 128573967128573967 G > A Increasing of enhancer activity IRF5 chr7 128573967128573967 G > A Increasing of enhancer activity IRF5 chr7 128573967128573967 G > A Increasing of enhancer activity IRF5 chr7 128573967128573967 G > A Increasing of enhancer activity IRF5 chr7 128573967128573967 G > A Increasing of enhancer activity IRF5 chr7 128573967128573967 G > A Increasing of enhancer activity IRF6 chr1 209989270209989270 G > A Decreasing of enhancer activity IRF6 chr1 209989270209989270 G > A Loss of AP-2alpha motif and TFAP2A motif; Decreasing ofenhancer activity IRF6 chr1 209989270 209989270 G > ALoss of AP-2CE± binding; Loss of enhancer activity IRS4 NA NAGain of enhancer IRS4 NA NA Gain of enhancer IRS4 NA NA Gain of enhancerIRS4 NA NA Gain of enhancer IRX3 chr16 53830465 53830465 G > AIncreasing of enhancer activity IRX3 chr16 53830465 53830465 G > AIncreasing of enhancer activity IRX5, IRX3 chr16 53800954 53800954 T > CLoss of ARID5B motif; Gain of enhancer ITGAM chr16 31276811 31276811G > A Decreasing of enhancer activity ITK chr5 156607793 156607793 C > TIncreasing of enhancer activity JAZF1 chr7 27976563 27976563 A > GGain of NKX3-1 motif; Loss of FOXA1 motif; Decreasing ofenhancer activity JMJD2C, chr16 68820946 68820946 G > ADecreasing of enhancer TMED6 activity JUN chr1 59250452 59250452 A > GIncreasing of enhancer activity JUN chr1 59251097 59251097 T > GIncreasing of enhancer activity KCNQ1 chr11 2847069 2847069 T > G KCNQ1NA NA Gain of enhancer KCNQ1 NA NA Gain of enhancer KCNQ1 NA NAGain of enhancer KCNQ1 NA NA Gain of enhancer KCNQ1 NA NAGain of enhancer KCNQ1 NA NA Gain of enhancer KCNQ1 NA NAGain of enhancer KCNQ1 NA NA Gain of enhancer KCNQ1 NA NAGain of enhancer KCNQ1 NA NA Gain of enhancer KCNQ1 NA NAGain of enhancer KCNQ1 NA NA Gain of enhancer KCNQ1 NA NAGain of enhancer KCNQ1 NA NA Gain of enhancer KCNQ1 NA NAGain of enhancer KCNQ1 NA NA Gain of enhancer KCNQ1 NA NAGain of enhancer KDELR2 chr7 6515150 6515150 A > GDecreasing of enhancer activity KDM5A, chr12 349298 349298 C > TIncreasing of enhancer CCDC77, activity LOC1002 88778 KLF5 chr1373880413 74042621 Amplification Gain of enhancer KLF5 chr13 7388041374042621 Amplification Gain of enhancer KLF5 chr13 73880413 74042621Amplification Gain of enhancer KLF5 chr13 73880413 74042621Amplification Gain of enhancer KLF5 chr13 73880680 73990596Amplification Gain of enhancer KLF5 chr13 73880680 73990596Amplification Gain of enhancer KLK14, SYT3, chr19 51773802 51773802A > G Increasing of enhancer LRRC4B, activity IGLON5 KRT80 chr1252345023 52345023 G > T Change of SP4 binding KRT80 chr12 5234537652345376 G > T Change of SP4 binding KRT80 chr12 53459012 53459012 G > CChange of SP4 binding KRT80 chr12 52417086 52417086 C > TChange of SP4 binding KRT80 chr12 52417086 52417086 C > TChange of SP4 binding KRTCAP3, chr2 27730940 27730940 T > TIncreasing of enhancer ZNF513, activity FTHL3P, SNX17, PPM1G, NRBP1,ZNF512, CCDC121, SLC4A1AP, SUPT7L, AGBL5, SLC30A3, GPN1, MPV17, GCKR,IFT172, FNDC4, GTF3C2, EIF2B4, RBKS, BRE, C2orf16, UCN LAMA5 chr2060909815 60909815 G > C Change of SP3 binding LAMA5 chr20 6090981560909815 G > C Change of SP4 binding LAMA5 chr20 60999979 60999979 T > GChange of SP3 binding LAMA5 chr20 60999979 60999979 T > GChange of SP4 binding LAMA5 chr20 61686432 61686432 G > AChange of SP3 binding LAMA5 chr20 61686432 61686432 G > AChange of SP4 binding LAMA5 chr20 60878221 60878221 T > GChange of SP3 binding LAMA5 chr20 60878221 60878221 T > GChange of SP4 binding LBH chr2 30448344 30448344 T > GDecreasing of enhancer activity LBX1 chr10 102979207 102979207 C > TLIPA NA NA Gain of enhancer LIPA NA NA Gain of enhancer LIPA NA NAGain of enhancer LIPA NA NA Gain of enhancer LIPA NA NA Gain of enhancerLIPA NA NA Gain of enhancer LIPA NA NA Gain of enhancer LIPA NA NAGain of enhancer LIPA NA NA Gain of enhancer LMNB1 chr5 125385805126043053 Deletion Enhancer hijacking; Loss ofintrinsic enhancer; Gain of new enhancer LMNB1 chr5 125385805 126043053Deletion Enhancer hijacking; Loss of intrinsic enhancer; Gain ofnew enhancer LMNB1 chr5 125385805 126043053 DeletionEnhancer hijacking; Loss of intrinsic enhancer; Gain of new enhancerLMO1 chr11 8289480 8289480 C > T Gain of MYB binding; Gain of enhancerLMO1 chr11 8255408 8255408 T > G Gain of GATA motif;Increasing of enhancer activity LPP, BCL6 chr3 187713718 187713718 T > AIncreasing of enhancer activity LRIG1 chr3 66798950 66798950 C > GIncreasing of enhancer activity LRP1 chr12 57534470 57534470 T > CGain of SREBP-1 motif; Increasing of enhancer activity LTA chr6 3152685631526856 T > C Decreasing of enhancer activity MAF chr16 7964598979645989 C > A Increasing of enhancer activity MAP3K1 chr5 5571148955711489 C > T Change of ZNF678 binding MAP3K1 chr5 55724929 55724929C > G Change ofTFCP2 binding MAP3K1 chr5 55786238 55786238 G > AChange of RARB binding MAP3K1 chr5 55786238 55786238 G > AChange of ZNF501 binding MAP3K1 chr5 55786238 55786238 G > AChange of ZNF713 binding MAP3K1 chr5 55832915 55832915 T > GChange of PEG3 binding MAP3K1 chr5 55969689 55969689 G > AChange of SOX15 binding MAP3K1 chr5 55969689 55969689 G > AChange of SOX18 binding MAP3K1 chr5 55969689 55969689 G > AChange of SOX21 binding MAP3K1 chr5 55969689 55969689 G > AChange of SOX2 binding MAP3K1 chr5 55969689 55969689 G > AChange of SOX7 binding MAP3K1 chr5 55969689 55969689 G > AChange of SRY binding MAP3K13 chr3 184919694 184919694 G > CChange of POU1F1 binding MAP3K13 chr3 184919694 184919694 G > CChange of ZNF501 binding MAP3K13 chr3 185216716 185216716 C > GChange of TFCP2 binding MAST2 chr1 46476824 46476824 C > -Increasing of enhancer activity MAST2 chr1 46476865 46476865 C > TIncreasing of enhancer activity MAST2 chr1 46476944 46476944 C > TIncreasing of enhancer activity MAST2 chr1 46477152 46477152 C > TIncreasing of enhancer activity MBL2 chr10 54531685 54531685 C > GDecreasing of enhancer activity MBL2 chr10 54532014 54532014 C > GDecreasing of enhancer activity MECOM, chr3 169150632 169150632 T > CIncreasing of enhancer MYNN, activity ARPM1 MERTK chr2 112753097112753097 C > A Gain of IRF1 motif; Decreasing of enhancer activity METchr7 115956171 115956171 C > A Change of F0XJ2 binding MET chr7115957320 115957320 G > C Change of ZNF136 binding MET chr7 115957320115957320 G > C Change of ZNF670 binding MET chr7 115994876 115994876C > T Change of TEAD1 binding MET chr7 116312444 116312444 G > TChange of BHLHE41 binding MET chr7 116312444 116312444 G > TChange of HEYL binding MET chr7 116312444 116312444 G > TChange of TFAP4 binding MET chr7 116312444 116312444 G > TChange of USF1 binding MET chr7 116312444 116312444 G > TChange of USF2 binding MET chr7 116312573 116312573 G > CChange of E2F1 binding MET chr7 116312573 116312573 G > CChange of NPAS3 binding MET chr7 116312573 116312573 G > CChange of SP1 binding MET chr7 116312573 116312573 G > CChange of SP3 binding MET chr7 116312573 116312573 G > CChange of SP4 binding MET chr7 116312573 116312573 G > CChange of ZBTB7B binding MET chr7 116314193 116314193 T > GChange of ZFX binding MET chr7 116911021 116911021 C > GChange of MEIS2 binding MET chr7 116911021 116911021 C > GChange of MEIS3 binding MET chr7 116911021 116911021 C > GChange of TGIF1 binding MET chr7 116911040 116911040 C > AChange of ZNF282 binding METRNL chr17 81153381 81153381 G > AChange of ZNF735 binding METRNL chr17 81153656 81153656 C > TChange of EGR1 binding METRNL chr17 81153656 81153656 C > TChange of ZNF735 binding METRNL chr17 81153663 81153663 C > TChange of ZNF735 binding METRNL chr17 81153381 81153381 G > AChange of ZNF735 binding METRNL chr17 81153656 81153656 C > TChange of EGR1 binding METRNL chr17 81153656 81153656 C > TChange of ZNF735 binding METRNL chr17 81153663 81153663 C > TChange of ZNF735 binding METRNL chr17 81026079 81026079 C > TChange of EGR1 binding METRNL chr17 81026112 81026112 G > AChange of EGR1 binding miR-122 chr18 56085917 56085917 C > ADecreasing of enhancer activity MIR137, chr1 98515539 98515539 T > AReducing of YYl binding; MIR2682 Decreasing of enhancer activity MIR137,chr1 98515539 98515539 T > A Reducing of YYl binding; MIR2682Decreasing of enhancer activity miR-200b chr1 1099342 1099342 C > AChange of BRCA1; CHD2 motif mir30a chr6 72115621 72115621 G > AChange of AIRE; Sox motif MLH1 chr3 37035012 37035012 C > AGain of HSF1; HSF2 binding; Decreasing of enhancer activity MLLT4 NA NAGain of enhancer MLLT4 NA NA Gain of enhancer MLLT4 NA NAGain of enhancer MLLT4 NA NA Gain of enhancer MLLT4 NA NAGain of enhancer MLLT4 NA NA Gain of enhancer MLLT4 NA NAGain of enhancer MLLT4 NA NA Gain of enhancer MLLT4 NA NAGain of enhancer MLLT4 NA NA Gain of enhancer MLLT4 NA NAGain of enhancer MLLT4 NA NA Gain of enhancer MLLT4 NA NAGain of enhancer MR1 chr1 181020230 181020230 A > G MRPS30, chr544706498 44706498 A > G Gain of enhancer FGF10 MSMB chr10 5154949651549496 C > T Decreasing of enhancer activity MSNP1AS chr5 2596770325967703 C > T Increasing of enhancer activity MTAP, chr9 2212447722124477 A > G Loss of STAT1 motif; CDKN2B- Decreasing of enhancer AS1,activity CDKN2A, CDKN2B MTHFD1L NA NA Gain of enhancer MTHFD1L NA NAGain of enhancer MTHFD1L NA NA Gain of enhancer MTHFD1L NA NAGain of enhancer MTHFD1L NA NA Gain of enhancer MTHFD1L NA NAGain of enhancer MTHFD1L NA NA Gain of enhancer MTHFD1L NA NAGain of enhancer MTHFD1L NA NA Gain of enhancer MTHFD1L NA NAGain of enhancer MTHFD1L NA NA Gain of enhancer MUC1, chr1 150951477150951477 T > C Increasing of enhancer C1orf54, activity THBS3,PSMB4, GBA, GBAP, APH1A, CTSS, ANP32E, ECM1, C1orf51, NBPF10, CA14,LYSMD1, CTSK, ARNT, SETDB1, LASS2, ANXA9, G0LPH3L, PRUNE, C1orf56,CDC42SE1, MLLT11, MRPS21, PRPF3, RPRD2, TARS2, VPS72, ADAMTSL4,MCL1, ENSA, SEMA6C, SCNM1, GABPB2, PIP5K1A, FAM63A, PSMD4 MYB NA NA NARearrangement Gain of enhancer MYC NA NA NA t(3; 8)(q27; q24)Gain of enhancer MYC NA NA NA t(3; 8)(q27; q24) Gain of enhancer MYCchr8 129543949 129554294 Amplification Gain of enhancer MYC chr8129166547 129190290 Amplification Gain of enhancer MYC chr8 128413305128413305 T > G Increasing of enhancer activity MYC chr8 128407443128407443 A > G Increasing of enhancer activity MYC chr8 128413305128413305 T > G Gain of enhancer activity MYC chr8 128413305 128413305T > G Gain of TCF4 motif; Gain of enhancer activity MYC chr8 128413305128413305 T > G Gain of TCF4 motif; Increasing of enhancer activity MYCchr8 128413305 128413305 G > T Gain of TCF7L2 motif;Increasing of enhancer activity MYC chr8 128413305 128413305 T > GGain of TCF7L2 motif; Increasing of enhancer activity MYC chr8 128413305128413305 G > T Gain of TCF7L2 motif; Loss of TCF4 motif; Increasing ofenhancer activity MYC chr8 128413305 128413305 T > GIncreasing of enhancer activity MYC chr8 128413305 128413305 MYC chr8128413305 128413305 T > G MYC chr8 128413305 128413305 T > GGain of enhancer activity MYC chr8 128654265 128654265 MYC chr8128755080 128755080 Loss of TCF binding; Loss of enhancer MYC chr8130161775 130202012 Duplication Gain of enhancer MYC chr8 128011937128011937 T > C Increasing of enhancer activity MYC chr8 128532137128532137 T > C Increasing of enhancer activity MYC chr8 128532137128532137 C > T Increasing of enhancer activity MYC chr8 128093297128093297 C > T Increasing of enhancer activity MYC chr8 128531689128531689 A > T Gain of FoxAl motif; Increasing of enhancer activity MYCchr8 128531873 128531873 G > A Increasing of enhancer activity MYC chr8127924659 127924659 C > A Increasing of enhancer activity MYC chr8128095156 128095156 A > G Increasing of enhancer activity MYC chr8129076573 129076573 C > T MYC chr8 128485038 128485038 A > CIncreasing of enhancer activity MYC chr8 128485038 128485038 C > AIncreasing of enhancer activity MYC chr8 128124126 128124126 T > GIncreasing of enhancer activity MYC chr8 128124916 128124916 C > AIncreasing of enhancer activity MYC chr8 128192981 128192981 A > G MYCchr8 130645692 130645692 A > G Gain of enhancer MYC chr8 128335673128335673 G > A Increasing of enhancer activity MYC chr8 128106880128106880 A > C Increasing of enhancer activity MYC chr8 129186548129186548 A > T MYC chr8 128539360 128539360 T > GIncreasing of enhancer activity MYLK chr3 123415781 123415781 G > ALoss of FOXN1 motif; Decreasing of FOXN1 binding; Decreasing of enhanceractivity NBN chr8 91585087 91585087 G > C Change of HOXC5 binding NBNchr8 91585087 91585087 G > C Change of PRDM1 binding NBN chr8 9158508791585087 G > C Change of ZNF263 binding NCK1 chr3 136801938 136801938A > C Increasing of enhancer activity NCOR1 chr17 16126784 16126784A > G Change of POLR3A binding NCOR1 chr17 16126784 16126784 A > GChange of TOPORS binding NCOR1 chr17 16128122 16128122 C > TChange of TP53 binding NCOR1 chr17 16128122 16128122 C > TChange of TP63 binding NCOR1 chr17 16128122 16128122 C > TChange of ZNF143 binding NCOR1 chr17 16128122 16128122 C > TChange of ZNF302 binding NCOR1 chr17 16128122 16128122 C > TChange of ZNF425 binding NCOR1 chr17 16128122 16128122 C > TChange of ZNF679 binding NCOR1 NA NA Gain of enhancer NCOR1 NA NAGain of enhancer NCOR1 NA NA Gain of enhancer NCOR1 NA NAGain of enhancer NCOR1 NA NA Gain of enhancer NCOR1 NA NAGain of enhancer NCOR1 NA NA Gain of enhancer NCOR1 NA NAGain of enhancer NCOR1 NA NA Gain of enhancer NCOR1 NA NAGain of enhancer NCOR1 NA NA Gain of enhancer NCOR1 NA NAGain of enhancer NCOR1 NA NA Gain of enhancer NEK4 chr3 5281932752819327 T > A Decreasing of enhancer activity NGEF chr2 233743109233743109 A > G Decreasing of enhancer activity NKAIN4 chr20 6208579162085791 G > A Change of EGR1 binding NKAIN4 chr20 62085791 62085791G > A Change of MAZ binding NKAIN4 chr20 62085791 62085791 G > AChange of SP1 binding NKAIN4 chr20 62085791 62085791 G > AChange of SP2 binding NKAIN4 chr20 62085791 62085791 G > AChange of SP3 binding NKAIN4 chr20 62085791 62085791 G > AChange of ZNF263 binding NKAIN4 chr20 62133292 62133292 T > GChange of EGR1 binding NKAIN4 chr20 62133292 62133292 T > GChange of EGR4 binding NKAIN4 chr20 62133292 62133292 T > GChange of MAZ binding NKAIN4 chr20 62133292 62133292 T > GChange of SP1 binding NKAIN4 chr20 62133292 62133292 T > GChange of SP2 binding NKAIN4 chr20 62133292 62133292 T > GChange of SP3 binding NKAIN4 chr20 62133292 62133292 T > GChange of SP4 binding NKAIN4 chr20 62133292 62133292 T > GChange of ZNF263 binding NKAIN4 chr20 62133292 62133292 T > GChange of ZNF281 binding NKAIN4 chr20 61962472 61962472 A > GChange of SP1 binding NKAIN4 chr20 61962472 61962472 A > GChange of SP3 binding NKAIN4 chr20 61962472 61962472 A > GChange of SP4 binding NKAIN4 chr20 61885983 61885983 A > CChange of EGR1 binding NKAIN4 chr20 61885983 61885983 A > CChange of EGR4 binding NKAIN4 chr20 61885983 61885983 A > CChange of MAZ binding NKAIN4 chr20 61885983 61885983 A > CChange of SP1 binding NKAIN4 chr20 61885983 61885983 A > CChange of SP2 binding NKAIN4 chr20 61885983 61885983 A > CChange of SP3 binding NKAIN4 chr20 61885983 61885983 A > CChange of SP4 binding NKAIN4 chr20 61885983 61885983 A > CChange of ZNF263 binding NKAIN4 chr20 61885983 61885983 A > CChange of ZNF281 binding NKAIN4 chr20 61806945 61806945 T > GChange of EGR1 binding NKAIN4 chr20 61806945 61806945 T > GChange of SP1 binding NKAIN4 chr20 61806945 61806945 T > GChange of ZNF281 binding NKAIN4 chr20 61898173 61898173 C > AChange of EGR4 binding NOG chr17 54773238 54773238 A > TLoss ofMEFZCand CDX2 binding ; Loss of enhancer activity NOS1AP chr1162021000 162021000 A > G Increasing of enhancer activity NOS1AP chr1162020969 162020969 A > T Increasing of enhancer activity NOS2 chr1726132301 26139107 Duplication Gain of enhancer NOS2 chr7 2613230126139107 Duplication Gain of enhancer NOTCH1 chr9 139414453 139414453T > G Change of EGR4 binding NOTCH1 chr9 139414453 139414453 T > GChange of GLI2 binding NOTCH1 chr9 139414453 139414453 T > GChange of KLF1 binding NOTCH1 chr9 139414453 139414453 T > GChange of WT1 binding NOTCH1 chr9 139414453 139414453 T > GChange ofZBTB11 binding NOTCH1 chr9 139414453 139414453 T > GChange of ZBTB7B binding NOTCH1 chr9 139414453 139414453 T > GChange of ZNF837 binding NOTCH1 chr9 139460020 139460020 G > TChange of ZEB1 binding NOTCH1 chr9 139460020 139460020 G > TChange of ZNF555 binding NOTCH1 chr9 139460279 139460279 G > CChange of ZAC binding NOTCH1 chr9 139460279 139460279 G > CChange of ZNF208 binding NOTCH1 chr9 139492936 139492936 G > CChange of KLF15 binding NOTCH1 chr9 139492936 139492936 G > CChange of KLF16 binding NOTCH1 chr9 139492936 139492936 G > CChange of ZNF263 binding NOTCH1 chr9 139492936 139492936 G > CChange of ZNF599 binding NOTCH1 chr9 139503959 139503959 C > GChange of ZNF283 binding NOTCH1 chr9 139503959 139503959 C > GChange of ZNF729 binding NOTCH1 chr9 139503959 139503959 C > GChange of ZNF814 binding NOTCH1 chr9 139512789 139512789 A > GChange of TFCP2 binding NOTCH1 chr9 139512789 139512789 A > GChange of TP73 binding NOTCH1 chr9 139512789 139512789 A > GChange of ZNF80 binding NOTCH1 chr9 139513656 139513656 G > AChange of FOXRI binding NOTCH1 chr9 139929812 139929812 G > AChange of NHLH2 binding NOTCH1 chr9 139929812 139929812 G > AChange of TCF12 binding NOTCH1 chr9 139929812 139929812 G > AChange ofTCF3 binding NOTCH1 chr9 139929812 139929812 G > AChange of ZNF524 binding NOTCH2 chr1 121112052 121112052 G > C NR3C1chr5 142782299 142782299 C > T Change of SP4 binding NR3C1 chr5142782658 142782658 A > C Change of SP1 binding NR3C1 chr5 142782658142782658 A > C Change of SP3 binding NR3C1 chr5 142782658 142782658A > C Change of SP4 binding NR3C1 chr5 142782995 142782995 G > AChange of SP1 binding NR3C1 chr5 142782995 142782995 G > AChange of SP3 binding NR3C1 chr5 142782995 142782995 G > AChange of SP4 binding NR3C1 chr5 142783252 142783252 G > TChange of SP1 binding NR3C1 chr5 142783252 142783252 G > TChange of SP3 binding NR3C1 chr5 142783252 142783252 G > TChange of SP4 binding NR3C1 chr5 142783284 142783284 T > CChange of SP1 binding NR3C1 chr5 142783284 142783284 T > CChange of SP3 binding NR3C1 chr5 142783284 142783284 T > CChange of SP4 binding NR3C1 chr5 142783293 142783293 A > CChange of SP1 binding NR3C1 chr5 142783293 142783293 A > CChange of SP3 binding NR3C1 chr5 142783293 142783293 A > CChange of SP4 binding NR3C1 chr5 142783319 142783319 G > AChange of SP4 binding NR3C1 chr5 142783408 142783408 G > CChange of SP1 binding NR3C1 chr5 142783408 142783408 G > CChange of SP3 binding NR3C1 chr5 142783408 142783408 G > CChange of SP4 binding NR3C1 chr5 142783464 142783464 T > GChange of SP3 binding NR3C1 chr5 142783464 142783464 T > GChange of SP4 binding NR3C1 chr5 142783466 142783466 G > AChange of SP1 binding NR3C1 chr5 142783466 142783466 G > AChange of SP3 binding NR3C1 chr5 142783466 142783466 G > AChange of SP4 binding NR3C1 chr5 142783474 142783474 G > CChange of SP1 binding NR3C1 chr5 142783474 142783474 G > CChange of SP3 binding NR3C1 chr5 142783474 142783474 G > CChange of SP4 binding NR3C1 chr5 141228722 141228722 C > GChange of SP1 binding NR3C1 chr5 141228722 141228722 C > GChange of SP3 binding NR3C1 chr5 141228722 141228722 C > GChange of SP4 binding NR3C1 chr5 141229405 141229405 G > AChange of SP1 binding NR3C1 chr5 141229405 141229405 G > AChange of SP3 binding NR3C1 chr5 141229405 141229405 G > AChange of SP4 binding NRAS chr1 115300152 115300152 T > GChange of ELF3 binding NRAS chr1 115300152 115300152 T > GChange of FOXO6 binding NRAS chr1 115300152 115300152 T > GChange of STAT2 binding NRAS chr1 115300152 115300152 T > GChange of ZNF708 binding NRAS chr1 115300224 115300224 C > TChange of EGR4 binding NRAS chr1 115300224 115300224 C > TChange of PRDM9 binding NRAS chr1 115300224 115300224 C > TChange of SP1 binding NRAS chr1 115300224 115300224 C > TChange of SP3 binding NRAS chr1 115300224 115300224 C > TChange of SP4 binding NRAS chr1 115300224 115300224 C > TChange of WT1 binding NRAS chr1 115300224 115300224 C > TChange of ZNF148 binding NRAS chr1 115300224 115300224 C > TChange of ZNF790 binding NRG1 chr8 31495581 31495581 C > TGain of ZNF581; ZNF524; FOXH1 binding; Decreasing of enhancer activityNRGN chr11 124609907 124609907 C > G Gain of NR2C2 binding;Decreasing of enhancer activity NSD1, chr5 176817636 176817636 A > GIncreasing of enhancer MXD3, activity LMAN2, RAB24, PRELID1, GRK6, PRR7,RGS14, F12, DOK3, DDX41, FAM193B, UIMC1, FGFR4, SLC34A1, TMED9, B4GALT7,PDLIM7, DBN1 NT5C2 chr10 104653545 104653545 T > CDecreasing of enhancer activity NUB1, RHEB, chr7 151407801 151407801G > A Increasing of enhancer PRKAG2 activity NUDT11 chrX 5150593151505931 T > C Increasing of enhancer activity NXT1, CST1, chr2023612737 23612737 C > C Increasing of enhancer GZF1, NAPB, activityCST3, CST2, CST5, ENTPD6, PYGB, CST8, CST4, SSTR4, THBD OCIAD2 chr449126582 49126582 T > A Change of ZNF616 binding OCIAD2 chr4 4912689949126899 C > G Change of ZNF616 binding OCIAD2 chr4 49127870 49127870A > T Change of ZNF616 binding OCIAD2 chr4 49141001 49141001 C > AChange of ZNF616 binding OCIAD2 chr4 49142162 49142162 A > CChange of ZNF616 binding OCIAD2 chr4 49142162 49142162 A > CChange of ZNF616 binding ONECUT1 chr15 53942928 53942928 T > CIncreasing of enhancer activity ORMDL3 chr17 38029120 38029120 G > CLoss of CTCF motif; Decreasing of CTCF binding; Increasing of enhanceractivity ORMDL3 chr17 38080865 38080865 A > G Gain of CTCF motif;Increasing of CTCF binding; Increasing of enhancer activity OSGIN1 NA NAGain of enhancer OSGIN1 NA NA Gain of enhancer OSGIN1 NA NAGain of enhancer OSGIN1 NA NA Gain of enhancer OSGIN1 NA NAGain of enhancer OSGIN1 NA NA Gain of enhancer OSGIN1 NA NAGain of enhancer OSGIN1 NA NA Gain of enhancer OSGIN1 NA NAGain of enhancer OSGIN1 NA NA Gain of enhancer OSGIN1 NA NAGain of enhancer OSGIN1 NA NA Gain of enhancer OSGIN1 NA NAGain of enhancer PANK4 chr1 2615274 2615274 C > TChange of RREB1 binding PANK4 chr1 2615274 2615274 C > TChange of SP3 binding PANK4 chr1 2617111 2617111 C > AChange of RREB1 binding PANK4 chr1 2617111 2617111 C > AChange of SP3 binding PANK4 chr1 2617159 2617159 C > AChange of RREB1 binding PANK4 chr1 2617159 2617159 C > AChange of SP3 binding PANK4 chr1 2617877 2617877 C > AChange of RREB1 binding PANK4 chr1 2617877 2617877 C > AChange of SP3 binding PANK4 chr1 2618557 2618557 C > GChange of RREB1 binding PANK4 chr1 2618557 2618557 C > GChange of SP3 binding PANK4 chr1 2246358 2246358 T > GChange of RREB1 binding PANK4 chr1 2246358 2246358 T > GChange of SP3 binding PARD6B chr20 48997377 49019434 AmplificationGain of enhancer PARK2 chr6 163212578 163212578 G > AGain of FOXA motif; Decreasing of enhancer activity PARK2 chr6 163212465163212465 T > C Gain of XBP-1 motif; Loss of SOX motif; Decreasing ofenhancer activity PAX6 NA NA NA Deletion Loss of enhancer PAX6 chr1131642266 31685847 Deletion Loss of enhancer PBRM1 chr3 52211851 52211851G > A Change of ESR1 binding PBRM1 chr3 52211851 52211851 G > AChange of ESR2 binding PBRM1 chr3 52211851 52211851 G > AChange of ZEB1 binding PBRM1 chr3 52274776 52274776 C > GChange ofTCF3 binding PBRM1 chr3 52274776 52274776 C > GChange of ZNF211 binding PBRM1 chr3 52726385 52726385 A > TChange of FOXP4 binding PBRM1 chr3 52732863 52732863 G > CChange of FU20557 binding PBRM1 chr3 52732863 52732863 G > CChange of ZNF836 binding PCAT1 chr8 128104055 128104055 G > TGain of ONECUT2 motif; Increasing of enhancer activity PDE4B chr166746784 66746784 G > A Increasing of enhancer activity PEX10 chr12475021 2475021 C > T Change of SP4 binding PEX10 chr1 2475021 2475021C > T Change of SP4 binding PEX10 chr1 2348267 2348267 G > AChange of SP4 binding PEX10 chr1 2246358 2246358 T > GChange of SP4 binding PEX10 chr1 2246916 2246916 A > CChange of SP4 binding PEX6 chr6 42928461 42928461 C > T Loss of enhancerPFKFB3 chr10 6101713 6101713 C > T Increasing of enhancer activityPFKFB3 chr10 6100725 6100725 A > G Increasing of enhancer activityPFKFB3 chr10 6098949 6098949 C > T Decreasing of enhancer activityPFKFB3 chr10 6101713 6101713 C > T Increasing of enhancer activityPFKFB3 chr10 6100725 6100725 A > G Increasing of enhancer activityPFKFB3 chr10 6098949 6098949 C > T Decreasing of enhancer activityPFKFB3 chr10 6101713 6101713 C > T Increasing of enhancer activityPFKFB3 chr10 6100725 6100725 A > G Increasing of enhancer activityPFKFB3 chr10 6098949 6098949 C > T Decreasing of enhancer activityPFKFB3 chr10 6101713 6101713 C > T Increasing of enhancer activityPFKFB3 chr10 6100725 6100725 A > G Increasing of enhancer activityPFKFB3 chr10 6098949 6098949 C > T Decreasing of enhancer activityPFKFB3 chr10 6101713 6101713 C > T Increasing of enhancer activityPFKFB3 chr10 6100725 6100725 A > G Increasing of enhancer activityPFKFB3 chr10 6098949 6098949 C > T Decreasing of enhancer activityPFKFB3 chr10 6101713 6101713 C > T Increasing of enhancer activityPFKFB3 chr10 6100725 6100725 A > G Increasing of enhancer activityPFKFB3 chr10 6098949 6098949 C > T Decreasing of enhancer activityPFKFB3 chr10 6110875 6110875 A > C Increasing of enhancer activityPFKFB3 chr10 6110875 6110875 A > C Increasing of enhancer activityPFKFB3 chr10 6110875 6110875 A > C Increasing of enhancer activityPFKFB3 chr10 6110875 6110875 A > C Increasing of enhancer activityPFKFB3 chr10 6110875 6110875 A > C Increasing of enhancer activityPFKFB3 chr10 6110875 6110875 A > C Increasing of enhancer activity Pgl3chr11 2186335 2186335 T > C Gain of enhancer PHACTR1 chr6 1290395712903957 A > G Loss of MEF2A motif; Decreasing of enhancer activityPHKG2, chr16 30669784 30669784 G > C Change of SP3 binding C16orf93PHKG2, chr16 30753142 30753142 C > T Change of SP3 binding C16orf93PHKG2, chr16 30935409 30935409 C > G Change of SP3 binding C16orf93PHKG2, chr16 31153547 31153547 A > C Change of SP3 binding C16orf93 PIGMchr1 160001799 160001799 G > C Gain of MIZF binding;Decreasing of enhancer activity PIK3CA chr3 179169002 179169002 C > AChange of EGR3 binding PIK3CA chr3 179169002 179169002 C > AChange of EGR4 binding PIK3CA chr3 179169002 179169002 C > AChange of FKLF binding PIK3CA chr3 179169002 179169002 C > AChange of FOXN4 binding PIK3CA chr3 179169002 179169002 C > AChange of KLF4 binding PIK3CA chr3 179169002 179169002 C > AChange of KLF5 binding PIK3CA chr3 179169002 179169002 C > AChange of KLF7 binding PIK3CA chr3 179169002 179169002 C > AChange of KLF8 binding PIK3CA chr3 179169002 179169002 C > AChange of OSX binding PIK3CA chr3 179169002 179169002 C > AChange of SP1 binding PIK3CA chr3 179169002 179169002 C > AChange of SP2 binding PIK3CA chr3 179169002 179169002 C > AChange of SP3 binding PIK3CA chr3 179169002 179169002 C > AChange of SP4 binding PIK3CA chr3 179169002 179169002 C > AChange of SP5 binding PIK3CA chr3 179169002 179169002 C > AChange of SP8 binding PIK3CA chr3 179169002 179169002 C > AChange of SP9 binding PIK3CA chr3 179169002 179169002 C > AChange of TIEG1 binding PIK3CA chr3 179169002 179169002 C > AChange of ZBTB7B binding PIK3CA chr3 179169002 179169002 C > AChange of ZNF143 binding PIK3CA chr3 179169002 179169002 C > AChange of ZNF460 binding PIK3CA chr3 179169300 179169300 C > GChange of EGR1 binding PIK3CA chr3 179169300 179169300 C > GChange of SP1 binding PIK3CA chr3 179169300 179169300 C > GChange of SP3 binding PIK3CA chr3 179169300 179169300 C > GChange of SP4 binding PIK3CA chr3 179169300 179169300 C > GChange of ZBTB7B binding PIK3CA chr3 179169300 179169300 C > GChange of ZNF148 binding PIK3CA chr3 179169300 179169300 C > GChange of ZNF325 binding PIK3CA chr3 179169404 179169404 A > GChange of E2F1 binding PIK3CA chr3 179169404 179169404 A > GChange of EGR4 binding PIK3CA chr3 179169404 179169404 A > GChange of SP4 binding PIK3CA chr3 179169404 179169404 A > GChange of WT1 binding PIK3CA chr3 179169404 179169404 A > GChange of ZBTB7B binding PIK3CA chr3 179169418 179169418 G > AChange of EGR4 binding PIK3CA chr3 179169418 179169418 G > AChange of MAZ binding PIK3CA chr3 179169418 179169418 G > AChange of PLAG1 binding PIK3CA chr3 179169418 179169418 G > AChange of SP1 binding PIK3CA chr3 179169418 179169418 G > AChange of SP3 binding PIK3CA chr3 179169418 179169418 G > AChange of SP4 binding PIK3CA chr3 179169418 179169418 G > AChange of ZBTB7A binding PIK3CA chr3 179169418 179169418 G > AChange of ZBTB7B binding PIK3CA chr3 179169418 179169418 G > AChange of ZNF350 binding PIK3CA chr3 179169418 179169418 G > AChange of ZNF660 binding PIK3CA chr3 179169418 179169418 G > AChange of ZNF841 binding PIN1 chr19 9945179 9945179 G > CGain of ZDHHC7 binding; Decreasing of enhancer activity PITX1 NA NA NADuplication Gain of enhancer PITX2 chr4 111710169 111710169 C > TDecreasing of enhancer activity PKLR chr1 155271258 155271258 T > CDecreasing of enhancer activity PLEK chr2 68647095 68647095 C > T PLGchr6 161143608 161143608 C > T Increasing of enhancer activity POLH,chr6 43806609 43806609 G > G Increasing of enhancer MRPS18A, activityVEGFA, MAD2L1BP, RSPH9, GTPBP2, CAPN11, ZNF318, MRPL14, TMEM63B, XPO5,HSP90AB1, NFKBIE, TMEM151B, CDC5L, SLC29A1, DLK2, TJAP1 POU3F4 chrX81727184 81731085 Deletion Loss of enhancer POU3F4 chrX 8184052881844429 Deletion Loss of enhancer POU5F1B chr8 128407443 128407443A > G Decreasing of enhancer activity POU5F1B chr8 128413305 128413305G > T Decreasing of enhancer activity POU5F1B chr8 128424792 128424792A > G Decreasing of enhancer activity PPARG chr3 12386337 12386337 PPM1Nchr19 45981772 45981772 C > G Change of CTCF binding PPM1N chr1945981775 45981775 G > T Change of CTCF binding PPM1N chr19 4598177245981772 C > G Change of CTCF binding PPM1N chr19 45981775 45981775G > T Change of CTCF binding PPM1N chr19 45972294 45972294 C > TChange of CTCF binding PPM1N chr19 46319995 46319995 G > TChange of CTCF binding PPM1N chr19 45954137 45954137 G > CChange of SP4 binding PPM1N chr19 45954137 45954137 G > CChange of SP4 binding PPM1N chr19 45394224 45394224 G > TChange of SP4 binding PPM1N chr19 45394538 45394538 G > TChange of SP4 binding PPM1N chr19 45394627 45394627 G > CChange of SP4 binding PPM1N chr19 45942991 45942991 C > TChange of SP4 binding PPM1N chr19 45349271 45349271 G > AChange of SP4 binding PPM1N chr19 45349297 45349297 C > AChange of SP4 binding PPM1N chr19 45811530 45811530 T > GChange of SP4 binding PPP3CA NA NA Gain of enhancer PPP3CA NA NAGain of enhancer PPP3CA NA NA Gain of enhancer PPP3CA NA NAGain of enhancer PPP3CA NA NA Gain of enhancer PPP3CA NA NAGain of enhancer PPP3CA NA NA Gain of enhancer PPP3CA NA NAGain of enhancer PPP3CA NA NA Gain of enhancer PPP3CA NA NAGain of enhancer PPP3CA NA NA Gain of enhancer PPP3CA NA NAGain of enhancer PPP3CA NA NA Gain of enhancer PPP3CA NA NAGain of enhancer PPP4R1L, chr20 57469073 57469073 T > TIncreasing of enhancer ATP5E, activity NPEPL1, STX16, RAB22A,GNAS, VAPB, AURKA, SLMO2, TH1L, CTSZ PREX1 chr20 47375521 47375521 C > TChange of EGR4 binding PREX1 chr20 47375521 47375521 C > TChange of EGR4 binding PREX1 chr20 47120374 47120374 C > AChange of EGR4 binding PRKCA chr17 64306133 64306133 T > CDecreasing of TF binding; Decreasing of enhancer activity PROP1 chr5177421909 177421909 delATG Decreasing of enhancer activity PROP1 chr5177422391 177422391 G > A Decreasing of enhancer activity PRPF40A chr2113978940 113978940 C > G Increasing of enhancer activity PRRX1 chr1170587340 170587340 C > T Increasing of enhancer activity PSEN1 chr1473602899 73602899 C > G Gain of TBX20 binding; Decreasing of enhanceractivity PTCHD1 NA NA Gain of enhancer PTCHD1 NA NA Gain of enhancerPTCHD1 NA NA Gain of enhancer PTCHD1 NA NA Gain of enhancer PTCHD1 NA NAGain of enhancer PTCHD1 NA NA Gain of enhancer PTCHD1 NA NAGain of enhancer PTCHD1 NA NA Gain of enhancer PTCHD1 NA NAGain of enhancer PTCHD1 NA NA Gain of enhancer PTCHD1 NA NAGain of enhancer PTEN chr10 89622988 89622988 A > GDecreasing of enhancer activity PTEN chr10 89623392 89623392 C > TDecreasing of enhancer activity PTEN chr10 89623462 89623462 A > GDecreasing of enhancer activity PTEN chr10 89872831 89872831 G > AChange of PPARG binding PTEN chr10 89913137 89913137 T > CChange of GATA5 binding PTEN chr10 89913137 89913137 T > CChange of HNF1B binding PTEN chr10 89938170 89938170 C > AChange of ZNF274 binding PTEN chr10 90146219 90146219 C > TChange of ZSCAN5C binding PTEN chr17 5519006 5519006 A > G PTF1A chr1023508305 23508305 A > G Loss of FOXA2 motif; Loss of enhancer PTF1Achr10 23508363 23508363 A > G Loss of FOXA2 motif; Loss of enhancerPTF1A chr10 23508363 23508363 A > G Loss of FOXA2 motif; Loss ofenhancer PTF1A chr10 23508365 23508365 A > G Loss of enhancer PTF1Achr10 23508437 23508437 A > G Loss of FOXA2 motif; Loss of enhancerPTF1A chr10 23508446 23508446 A > C Loss of PDX1 motif; Loss of enhancerPTF1A chr10 23508446 23508446 A > C Loss of PDX1 motif; Loss of enhancerPTK2B, CLU, chr8 27456253 27456253 A > G Loss of HSF1 binding; EPHX2Increasing of enhancer activity PVT1 chr8 129106383 129106383 PVT1 chr8128323819 128323819 A > G Decreasing of YYl binding;Increasing of enhancer activity RAB22A chr20 56942557 56942557 A > GIncreasing of enhancer activity RAD21 chr8 117778780 117778780 G > AChange of HES4 binding RAD21 chr8 117778780 117778780 G > AChange of NPAS3 binding RAD21 chr8 117778780 117778780 G > AChange of TFCP2 binding RAD21 chr8 117778780 117778780 G > AChange of ZNF677 binding RAD21 chr8 118742743 118742743 G > AChange of LMO2 binding RAD21 chr8 118742743 118742743 G > AChange of NHLH2 binding RAD21 chr8 118742743 118742743 G > AChange of SZF1 binding RAD21 chr8 118742743 118742743 G > AChange of ZEB1 binding RAD21 chr8 118742743 118742743 G > AChange of ZNF367 binding RAD21 chr8 118743315 118743315 A > GChange of FOXP4 binding RAD21 chr8 118743315 118743315 A > GChange of HDAC2 binding RAD21 chr8 118743315 118743315 A > GChange of IRF4 binding RAD21 chr8 118743315 118743315 A > GChange of ZNF569 binding RAD21 chr8 118744058 118744058 T > GChange of EGR2 binding RAD21 chr8 118744058 118744058 T > GChange of EGR3 binding RAD21 chr8 118744058 118744058 T > GChange of EGR4 binding RAD21 chr8 118744058 118744058 T > GChange of GLI1 binding RAD21 chr8 118744058 118744058 T > GChange of GLI2 binding RAD50 chr5 131826021 131826021 C > GChange of EGR4 binding RAD50 chr5 131838005 131838005 G > TChange of HIVEP3 binding RAD50 chr5 131838005 131838005 G > TChange of RP58 binding RAD50 chr5 131838005 131838005 G > TChange of TP63 binding RAD50 chr5 131838005 131838005 G > TChange of ZFP64 binding RAD50 chr5 131838131 131838131 G > TChange of NR3C1 binding RAD50 chr5 131838131 131838131 G > TChange of YYl binding RAD50 chr5 131892812 131892812 T > GChange of PTF1A binding RAD50 chr5 131892812 131892812 T > GChange of ZNF721 binding RAD50 chr5 131898457 131898457 G > AChange of ZNF280B binding RAD50 chr5 132109775 132109775 G > AChange of ESRRA binding RAD50 chr5 132110041 132110041 G > CChange of TBX20 binding RAD51C chr17 56012996 56012996 G > CChange of PAX5 binding RAD51C chr17 56012996 56012996 G > CChange of SPI1 binding RAD51C chr17 56012996 56012996 G > CChange of STAT1 binding RAD51C chr17 56405056 56405056 C > TChange of ZNF93 binding RAD51C chr17 56491423 56491423 T > GChange of ZNF567 binding RAD51C chr17 56491423 56491423 T > GChange of ZNF605 binding RAD51C chr17 56565448 56565448 G > CChange of EGR1 binding RAD51C chr17 56565448 56565448 G > CChange of EGR4 binding RAD51C chr17 56565448 56565448 G > CChange of PAX5 binding RAD51C chr17 56565448 56565448 G > CChange of SP1 binding RAD51C chr17 56565448 56565448 G > CChange of SP3 binding RAD51C chr17 56565448 56565448 G > CChange of SP4 binding RAD51C chr17 56565448 56565448 G > CChange of ZNF236 binding RAD51C chr17 56565448 56565448 G > CChange of ZNF350 binding RAD51C chr17 56565448 56565448 G > CChange of ZNF647 binding RAD51C chr17 56686893 56686893 C > TChange of TP63 binding RAD51C chr17 56686893 56686893 C > TChange of ZNF302 binding RAD51C chr17 56686893 56686893 C > TChange of ZNF679 binding RAD51C chr17 56687036 56687036 C > GChange of AR binding RAD51C chr17 56687036 56687036 C > GChange of ESR1 binding RAD51C chr17 56687036 56687036 C > GChange of ESR2 binding RAD51C chr17 56687036 56687036 C > GChange of ESRRA binding RAD51C chr17 56727563 56727563 C > TChange of ARNT2 binding RAD51C chr17 56727563 56727563 C > TChange ofZBTB11 binding RAD51C chr17 56819395 56819395 A > TChange of NR3C1 binding RAD51C chr17 56819395 56819395 A > TChange of THAP1 binding RAD51C chr17 56819395 56819395 A > TChange of YYl binding RAD51C chr17 56841079 56841079 T > AChange of ZNF136 binding RAD51C chr17 57030283 57030283 C > GChange of PAX5 binding RAD51C chr17 57030283 57030283 C > GChange of ZNF430 binding RAD51C chr17 57030283 57030283 C > GChange of ZNF658B binding RAD51C chr17 57030283 57030283 C > GChange of ZNF658 binding RAD51C chr17 57030283 57030283 C > GChange of ZNF709 binding RAD51C chr17 57232982 57232982 G > CChange of GFIl binding RAD51C chr17 57232982 57232982 G > CChange of NFYB binding RAD51C chr17 57287378 57287378 A > CChange of ELK1 binding RAD51C chr17 57288400 57288400 C > AChange of ZNF493 binding RAD51C chr17 57923238 57923238 A > CChange of PPARG binding RAD51C chr17 57923238 57923238 A > CChange of RXRA binding RAD51C chr17 57923418 57923418 G > CChange of JUN binding RALY chr20 32605327 32605327 G > C RALY chr2032610401 32610401 C > T RALY chr20 32648738 32648738 G > A RALY chr2032649064 32649064 A > G RALY chr20 32655741 32655741 G > A RALY chr2032656841 32656841 C > G RALY chr20 32654562 32654562 C > A RALY chr2032657378 32657378 C > T RARG chr12 53614168 53614168 G > AChange of ZNF263 binding RARG chr12 53614182 53614182 T > GChange of ZNF263 binding RARG chr12 53615417 53615417 G > AChange of ZNF263 binding RARG chr12 53689776 53689776 C > TChange of ZNF263 binding RARG chr12 53765398 53765398 C > TChange of ZNF263 binding RASA2, chr3 141807137 141807137 C > CIncreasing of enhancer ATP1B3, activity TFDP2, XRN1, RNF7, GK5, ATR RB1chr13 47128005 47128005 G > A Change ofCTCF binding RB1 chr13 4712800547128005 G > A Change of RXRA binding RB1 chr13 47128005 47128005 G > AChange of ZBTB7B binding RB1 chr13 48611842 48611842 C > AChange of ELF2 binding RB1 chr13 48611842 48611842 C > AChange of ETV7 binding RB1 chr13 48611842 48611842 C > AChange of FLU binding RB1 chr13 48668171 48668171 T > CChange of ZNF689 binding RB1 chr13 48669381 48669381 G > TChange of CTCF binding RB1 chr13 48669381 48669381 G > TChange of CTCFL binding RB1 chr13 48669381 48669381 G > TChange of RAD21 binding RB1 chr13 48669381 48669381 G > TChange of RXRA binding RB1 chr13 48669381 48669381 G > TChange of SMC3 binding RB1 chr13 48669381 48669381 G > TChange of YYl binding RB1 chr13 48669381 48669381 G > TChange of ZFP binding RB1 chr13 48669381 48669381 G > TChange of ZNF778 binding RB1 chr13 49067569 49067569 G > TChange of ZAC binding RB1 chr13 50656563 50656563 G > AChange of DMRT1 binding RB1 chr13 50656563 50656563 G > AChange of DMRT3 binding RB1 chr13 50656563 50656563 G > AChange of DMRTA2 binding RBPJ chr4 26085480 26085480 A > GIncreasing of enhancer activity RET NA NA NA Deletion Loss of enhancerRET chr10 43581812 43582711 RET chr10 43582056 43582056 C > TDecreasing of enhancer activity RET chr10 43582056 43582056 C > TDecreasing of enhancer activity RET chr10 43582056 43582056 C > TLoss of SOX10 motif; Decreasing of enhancer activity RET chr10 4344784743447847 A > G Decreasing of enhancer activity RET chr10 4344784743447847 A > G Loss of RARB motif; Decreasing of enhancer activity RETchr10 43552895 43552895 C > T Loss of GATA2 motif;Decreasing of enhancer activity RFX6 chr6 117210052 117210052 C > TGain of HOXB13 motif; Increasing of HOXB13 binding; Increasing ofenhancer activity RFX6 chr6 117210052 117210052 C > TIncreasing of HOXB13 binding; Increasing of enhancer activity RGS1 chr1192535107 192535107 A > C RICTOR, FYB, chr5 39397132 39397132 T > AIncreasing of enhancer TTC33, activity PRKAA1, RPL37, DAB2 RP11 chr198497176 98497176 A > C Decreasing of enhancer 490G2.2 activity RPS6KA4,chr11 64464085 64464085 T > A Increasing of enhancer SF1, activitySLC22A11, SNX15, MAP4K2, PYGM, MEN1, NRXN2, RASGRP2, EHD1, ZFPL1, ATG2A,ARL2, TRMT112 RSBN1L, chr7 77416439 77416439 T > CIncreasing of enhancer TMEM60, activity PTPN12, PION, PHTF2 SARDH chr9136536633 136536633 A > G SCAMP3, chr1 155194980 155194980 T > TIncreasing of enhancer RUSC1, activity FAM189B, ADAR, LENEP, GBA,FLAD1, CLK2, ZBTB7B, FDPS, MUC1, C1orf104, MIR555, ADAM15, HCN3, YY1AP1,PKLR, DAP3, DPM3, EFNA1, RAG1AP1, THBS3, KRTCAP2, TRIM46, CKS1B, EFNA3,LOC645676, ASHIL, MSTO1, GBAP, EFNA4, PBXIP1, PMVK, MTX1, PYGO2, SHC1SCG2 chr2 224466344 224466344 C > T Increasing of enhancer activitySCGB3A2 chr5 147258162 147258162 G > A Decreasing of enhancer activitySDCCAG8 chr1 243639859 243639859 A > G Decreasing of enhancer activitySERCA2B chr12 110718411 110718411 G > T Decreasing of enhancer activitySERPINC1 chr1 173886568 173886568 G > C Decreasing of enhancer activitySHF, chr15 45641225 45641225 C > C Increasing of enhancer SPATA5L1,activity MIR147B, C15orf21, SLC30A4, SQRDL, SLC28A2, GATM, SORD SHH chr7156143386 156732204 Duplication Gain of enhancer SHH chr7 156241020156619399 Duplication Gain of enhancer SHH chr7 156241020 156677759Duplication Gain of enhancer SHH chr7 156241020 156699998 DuplicationGain of enhancer SHH chr7 156354085 156619399 DuplicationGain of enhancer SHH chr7 156354085 156687613 DuplicationGain of enhancer SHH chr7 156368541 156661877 DuplicationGain of enhancer SHH chr7 156539605 156699998 DuplicationGain of enhancer SHH chr7 156547469 156644074 DuplicationGain of enhancer SHH chr7 156572751 156661877 DuplicationGain of enhancer SHH NA NA NA t(5, 7) (q11, q36) SHH NA NA NA inv(7)Enhancer hijacking; Loss of (q22.1; q36.3) intrinsic enhancer; Gain ofnew enhancer SHH chr1 106934 106934 Gain of enhancer SHH chr7 156583831156583831 A > G Gain of ELK4; REL; GMEB1; KLF3; ELF3; ELK1; ETV1binding; Increasing of enhancer activity SHH chr7 156583831 156583831A > G SHH chr7 156583949 156583949 C > G Gain of REL; GMEB1; KLF3binding; Increasing of enhancer activity SHH chr7 156583949 156583949C > G SHH chr7 156583951 156583951 C > T Gain of GMEB1 binding;Increasing of enhancer activity SHH chr7 156584107 156584107 T > GGain of HOXC10; CDX2 binding; Increasing of enhancer activity SHH chr7156584107 156584107 T > G SHH chr7 156584166 156584166 G > AGain of HOXD10 binding; Increasing of enhancer activity SHH chr7156584166 156584166 G > C Gain of HOXD10 binding; Increasing of enhanceractivity SHH chr7 156584166 156584166 G > C SHH chr7 156584166 156584166G > A SHH chr7 156584174 156584174 C > T Increasing of enhancer activitySHH chr7 156584174 156584174 C > T SHH chr7 156584236 156584236 T > GSHH chr7 156584241 156584241 T > C Gain of TCF21; MSC; BNC1binding; Increasing of enhancer activity SHH chr7 156584241 156584241T > C SHH chr7 156584266 156584266 A > T SHH chr7 156584273 156584273G > A SHH chr7 156584275 156584275 T > C SHH chr7 156584465 156584465C > G Gain of TFAP2A; TFAP2E; TFAP2B binding; Increasing ofenhancer activity SHH chr7 156584465 156584465 C > G SHOX NA NA NADeletion Loss of enhancer SHOX NA NA NA Deletion Loss of enhancer SHOXchrX 398357 835529 Amplification Gain of enhancer SIX6 chr14 6097444960974449 A > G Gain of enhancer activity SIX6 chr14 60974427 60974430Loss of enhancer SLC14A2, chr18 43187130 43187130 A > AIncreasing of enhancer SLC14A1 activity SLC1A2 chr11 35440976 35440976T > G Gain of WT1; SMAD4 binding; Decreasing of enhancer activitySLC25A37, chr8 23751151 23751151 C > T Increasing of enhancer NKX3-1,activity ENTPD4, STC1, ADAM7 SLC26A4 chr7 107301201 107301201 T > CGain of GMEB1; SMAD4 binding; Decreasing of enhancer activity SLC37A4chr11 118900338 118900338 G > A Decreasing of enhancer activity SLC4A7chr3 27548900 27548900 C > T Increasing of c-Fos binding;Increasing of enhancer activity SLC6A4 chr17 28564170 28564170 A > GIncreasing of enhancer activity SMAD2 chr18 45446307 45446307 A > GDecreasing of enhancer activity SMAD3 chr15 67442596 67442596 C > TLoss of AP-1 motif; Decreasing of enhancer activity SMAD7 chr18 4644956546449565 C > G Decreasing of enhancer activity SMAD7 chr18 4644880546448805 C > T Decreasing of enhancer activity SMAD7 chr18 4644881946448819 G > C Decreasing of enhancer activity SMAD7 chr18 4644911146449111 T > C Decreasing of enhancer activity SMARCA1 NA NAGain of enhancer SMARCA1 NA NA Gain of enhancer SMARCA1 NA NAGain of enhancer SMARCA1 NA NA Gain of enhancer SMARCA1 NA NAGain of enhancer SMARCA1 NA NA Gain of enhancer SMARCA1 NA NAGain of enhancer SMARCA1 NA NA Gain of enhancer SMARCA1 NA NAGain of enhancer SMARCA1 NA NA Gain of enhancer SMARCA1 NA NAGain of enhancer SMARCA1 NA NA Gain of enhancer SMARCA1 NA NAGain of enhancer SMARCA1 NA NA Gain of enhancer SMARCD1 chr12 5045144550451445 C > G Change of EGR4 binding SMARCD1 chr12 50451445 50451445C > G Change of HDAC2 binding SMARCD1 chr12 50451445 50451445 C > GChange of REST binding SMARCD1 chr12 50451445 50451445 C > GChange of SP4 binding SNCA chr4 90674431 90674431 G > AIncreasing of EMX2; NKX6-1 binding; Increasing of enhancer activitySNHG5 chr6 86246709 86246709 A > C Decreasing of enhancer activity SNHG5chr6 86246709 86246709 A > C Decreasing of enhancer activity SNHG5 chr686223316 86223316 C > T Decreasing of enhancer activity SNHG5 chr686223316 86223316 C > T Decreasing of enhancer activity SNHG5 chr686258614 86258614 A > G Decreasing of enhancer activity SNHG5 chr686258614 86258614 A > G Decreasing of enhancer activity SNHG5 chr686224053 86224053 G > T Decreasing of enhancer activity SNHG5 chr686224053 86224053 G > T Decreasing of enhancer activity SNHG5 chr686205323 86205323 G > T Decreasing of enhancer activity SNHG5 chr686205323 86205323 G > T Decreasing of enhancer activity SNHG5 chr686247799 86247799 C > T Decreasing of enhancer activity SNHG5 chr686247799 86247799 C > T Decreasing of enhancer activity SOD2, chr6160668389 160668389 A > G Increasing of enhancer SLC22A2, activitySLC22A1 SORT1 chr1 109817590 109817590 G > T Gain of C/EBP motif;Increasing of enhancer activity SOX10 chr22 38412215 38412215 G > ALoss of TFAP2A motif; Decreasing of enhancer activity SOX10 chr2238412781 38412781 G > C Decreasing of SOX10 binding;Decreasing of enhancer activity SOX10 chr22 38412423 38412423 C > TSOX10 chr22 38412323 38412323 C > T SOX10 chr22 38412402 38412402 C > TSOX9 chr17 68676303 68676303 T > C Gain of KLF3; HES1; HEY1;HEY2; HES5 binding; Decreasing of enhancer activity SOX9 chr17 6869897768698977 C > T Loss of OCT1 motif; Decreasing of enhancer activity SOX9chr17 68735530 68735530 G > A Decreasing of enhancer activity SOX9 chr1768747322 68747322 T > C Loss of NFAT motif; Decreasing of enhanceractivity SOX9 chr17 68772750 68772750 G > ALoss of CDP motif; Decreasing of enhancer activity SOX9 chr17 6970604469706044 A > C Decreasing of enhancer activity SOX9 chr17 6910865569108655 A > G Gain of AP-1 motif; Loss of FOXA1 motif; Increasing ofenhancer activity SOX9 chr17 69108753 69108753 T > GIncreasing of enhancer activity SOX9 chr17 69107816 69107816 G > AGain of androgen receptor motif; Increasing of enhancer activity SPCS1chr3 52804487 52804487 T > C Decreasing of enhancer activity SPINK1 chr5147211221 147211221 G > A Gain of GMEB1; SMAD4 binding; Increasing ofenhancer activity SPINK1 chr5 147211355 147211355 C > TGain of MYF6 binding; Increasing of enhancer activity SRCAP chr1630669784 30669784 G > C Change of ZNF263 binding SRCAP chr16 3072309730723097 G > A Change of ZNF263 binding SRCAP chr16 30747922 30747922C > T Change of ZNF263 binding SRCAP chr16 30753142 30753142 C > TChange of SP1 binding SRCAP chr16 30753142 30753142 C > TChange of SP1 binding STARD10 chr11 72470916 72470916 DeletionGain of a GTTT repeat; Decreasing of enhancer activity STAT3 chr1740507980 40507980 A > C STUB1 NA NA Gain of enhancer STUB1 NA NAGain of enhancer STUB1 NA NA Gain of enhancer STUB1 NA NAGain of enhancer STUB1 NA NA Gain of enhancer STUB1 NA NAGain of enhancer STUB1 NA NA Gain of enhancer STUB1 NA NAGain of enhancer STUB1 NA NA Gain of enhancer STUB1 NA NAGain of enhancer STUB1 NA NA Gain of enhancer STUB1 NA NAGain of enhancer STUB1 NA NA Gain of enhancer SULF2 chr20 4660238846602388 C > T Change of EGR4 binding SULF2 chr20 46602388 46602388C > T Change of MAZ binding SULF2 chr20 46602388 46602388 C > TChange of SP1 binding SULF2 chr20 46602388 46602388 C > TChange of SP3 binding SULF2 chr20 46602388 46602388 C > TChange of SP4 binding SULF2 chr20 46602388 46602388 C > TChange of ZBTB7B binding SULF2 chr20 46602388 46602388 C > TChange of ZNF263 binding SULF2 chr20 46602388 46602388 C > TChange of ZNF658B binding SULF2 chr20 46603160 46603160 C > TChange of ZNF263 binding SULF2 chr20 46618545 46618545 C > GChange of ZNF263 binding SULF2 chr20 46618545 46618545 C > GChange of ZNF263 binding SULF2 chr20 52748710 52748710 C > TChange of ZNF263 binding SULF2 chr20 46602388 46602388 C > TChange of EGR4 binding SULF2 chr20 46602388 46602388 C > TChange of MAZ binding SULF2 chr20 46602388 46602388 C > TChange of SP1 binding SULF2 chr20 46602388 46602388 C > TChange of SP3 binding SULF2 chr20 46602388 46602388 C > TChange of SP4 binding SULF2 chr20 46602388 46602388 C > TChange of ZBTB7B binding SULF2 chr20 46602388 46602388 C > TChange of ZNF263 binding SULF2 chr20 46602388 46602388 C > TChange of ZNF658B binding SULF2 chr20 46472698 46472698 T > GChange of HOXC5 binding SULF2 chr20 46472698 46472698 T > GChange of MAZ binding SULF2 chr20 46472698 46472698 T > GChange of SP1 binding SULF2 chr20 46472698 46472698 T > GChange of ZBTB7B binding SULF2 chr20 46472698 46472698 T > GChange of ZNF263 binding SULF2 chr20 46472698 46472698 T > GChange of ZNF658B binding SULF2 chr20 46308627 46308627 T > GChange of EGR4 binding SULF2 chr20 46308627 46308627 T > GChange of MAZ binding SULF2 chr20 46308627 46308627 T > GChange of SP1 binding SULF2 chr20 46308627 46308627 T > GChange of SP3 binding SULF2 chr20 46308627 46308627 T > GChange of SP4 binding SULF2 chr20 46308627 46308627 T > GChange of ZBTB7B binding SULF2 chr20 46308627 46308627 T > GChange of ZNF263 binding SULF2 chr20 46308627 46308627 T > GChange of ZNF658B binding SULF2 chr20 46831426 46831426 G > AChange of EGR4 binding SULF2 chr20 46831426 46831426 G > AChange of SP3 binding SULF2 chr20 46831426 46831426 G > AChange of SP4 binding SULF2 chr20 46831426 46831426 G > AChange of ZNF263 binding SULF2 chr20 46779797 46779797 G > CChange of HOXC5 binding SULF2 chr20 46793997 46793997 G > TChange of HOXC5 binding SULF2 chr20 46800093 46800093 G > AChange of SP1 binding SULF2 chr20 46800093 46800093 G > AChange of SP4 binding SULF2 chr20 46800093 46800093 G > AChange of SP1 binding SULF2 chr20 46800093 46800093 G > AChange of SP4 binding SULF2 chr20 47364914 47364914 G > CChange of SP1 binding SULF2 chr20 47366010 47366010 G > CChange of SP1 binding SULF2 chr20 46688376 46688376 C > GChange of SP1 binding SULF2 chr20 45989659 45989659 G > AChange of SP1 binding SULF2 chr20 46182305 46182305 A > CChange of EGR4 binding SULF2 chr20 46182305 46182305 A > CChange of MAZ binding SULF2 chr20 46182305 46182305 A > CChange of SP3 binding SULF2 chr20 46182305 46182305 A > CChange of SP4 binding SULF2 chr20 46182305 46182305 A > CChange of ZBTB7B binding SULF2 chr20 52703188 52703188 G > TChange of ZNF658B binding SULF2 chr20 52703188 52703188 G > TChange of ZNF658B binding SULF2 chr20 46779797 46779797 G > CChange of HOXC5 binding SULF2 chr20 46779797 46779797 G > CChange of HOXC5 binding SULF2 chr20 46710095 46710095 A > TChange of HOXC5 binding TAGAP chr6 159521657 159564248 DuplicationGain of enhancer TAGAP chr6 159521657 159564248 DuplicationGain of enhancer TAGAP chr6 159521657 159564248 DuplicationGain of enhancer TAGAP chr6 159521657 159564248 DuplicationGain of enhancer TAGAP chr6 159521657 159564248 DuplicationGain of enhancer TAGAP chr6 159521657 159564248 DuplicationGain of enhancer TAGAP chr6 159521657 159564248 DuplicationGain of enhancer TAGAP chr6 159521657 159564248 Tandem Gain of enhancerduplication TAL1 chr1 47704954 47704983 Gain of MYB; CBP; RUNX1;GATA3 and TAL1 binding; Gain of enhancer TAL1 chr1 94555832 211935484Deletion Gain of enhancer TBL1X NA NA Gain of enhancer TBL1X NA NAGain of enhancer TBL1X NA NA Gain of enhancer TBL1X NA NAGain of enhancer TBL1X NA NA Gain of enhancer TBL1X NA NAGain of enhancer TBL1X NA NA Gain of enhancer TBL1X NA NAGain of enhancer TBL1X NA NA Gain of enhancer TBL1X NA NAGain of enhancer TBL1X NA NA Gain of enhancer TBL1X NA NAGain of enhancer TBL1X NA NA Gain of enhancer TBL1X NA NAGain of enhancer TBL1X NA NA Gain of enhancer TBX1 chr22 1974357819743578 C > T Increasing of enhancer activity TBX3 chr12 115112467115112467 T > C Change of E2F1 binding TBX3 chr12 115112467 115112467T > C Change of REST binding TBX3 chr12 115112467 115112467 T > CChange of ZBTB7B binding TBX3 chr12 115112467 115112467 T > CChange of ZNF236 binding TBX4, BCAS3, chr17 59239221 59239221 A > AIncreasing of enhancer TBX2, NACA2 activity TBX5 chr12 114704515114704515 G > T Loss of enhancer TBX5 chr12 114704515 114704515 G > TLoss of enhancer TCF21 chr6 134214525 134214525 G > CIncreasing of AP-1 binding; Increasing of enhancer activity TCF7L2 chr10114808902 114808902 G > T Increasing of enhancer activity TCF7L2 chr10114758349 114758349 C > T Increasing of enhancer activity TCF7L2 chr10114758349 114758349 C > T Loss of HMGB1 binding; Gainof enhancer activity TERT chr5 1325104 1345104 Gain of enhancer TERTchr5 1325104 1345104 Gain of enhancer TERT chr5 1325104 1345104Gain of enhancer TERT chr5 1286516 1286516 T > G Increasing of enhanceractivity TERT chr5 1286516 1286516 A > C Increasing of enhancer activityTERT chr5 1287194 1287194 T > C Loss of Snail1 motif;Decreasing Snail1 binding; Increasing of enhancer activity TERT NA NAGain of enhancer TERT NA NA Gain of enhancer TERT NA NA Gain of enhancerTERT NA NA Gain of enhancer TERT NA NA Gain of enhancer TERT NA NAGain of enhancer TERT NA NA Gain of enhancer TERT NA NA Gain of enhancerTERT NA NA Gain of enhancer TERT NA NA Gain of enhancer TERT NA NAGain of enhancer TERT NA NA Gain of enhancer TFF1 chr21 4379691343796913 A > T Loss of Rad21 binding; Loss of enhancer TFF1 chr2143796494 43796494 C > G Loss of ER-alpha binding; Loss of enhancer THchr11 2193085 2193085 A > T Decreasing of enhancer activity TH chr112193086 2193086 C > T Decreasing of enhancer activity TH chr11 21930872193087 G > A Decreasing of enhancer activity THRB chr3 2420498424204984 C > T TNF chr6 31542308 31542308 T > C TNF chr6 3154247631542476 C > A TNFAIP3 chr6 138196066 138196066 TT > A TNFAIP3 chr6138196066 138196066 T > G Loss of NF-CE∫B binding; Lossof enhancer activity TNFRSF10A chr8 23082971 23082971 G > TGain of ZDHHC7; PLAGL1 binding; Decreasing of enhancer activity TNFRSF1Achr12 6440009 6440009 T > C TOX2 chr20 42568164 42568164 C > T TOX3chr16 52586341 52586341 A > G Gain of TOX3 motif and CHD9motif; Decreasing of enhancer activity TOX3 chr16 52599188 52599188C > T Gain of FOXA1 binding; Gain of enhancer activity TP53 chr176938079 6938079 A > G Change of ZNF471 binding TP53 chr17 69392136939213 C > A Change of PAX5 binding TP53 chr17 6939213 6939213 C > AChange of ZNF672 binding TP53 chr17 7465409 7465409 T > GChange of GTF3C2 binding TP53 chr17 7465409 7465409 T > GChange of SP4 binding TP53 chr17 7465409 7465409 T > GChange ofZBTB11 binding TP53 chr17 7465409 7465409 T > GChange of ZBTB7B binding TP53 chr17 7465409 7465409 T > GChange of ZIC3 binding TP53 chr17 7465409 7465409 T > GChange of ZNF345 binding TP53 chr17 7534110 7534110 G > AChange of ZBTB38 binding TP53 chr17 7577498 7577498 C > AChange of RARB binding TP53 chr17 7577498 7577498 C > AChange of THRA binding TP53 chr17 7577580 7577580 T > CChange of SMARCC2 binding TP53 chr17 7577580 7577580 T > CChange of ZNF440 binding TP53 chr17 7578271 7578271 T > CChange of SP1 binding TP53 chr17 7578394 7578394 T > CChange of ZBTB41 binding TP53 chr17 7578394 7578394 T > CChange of ZNF180 binding TP53 chr17 7578394 7578394 T > CChange of ZNF436 binding TP53 chr17 7578394 7578394 T > CChange of ZNF880 binding TP53 chr17 7578478 7578478 G > CChange of EGR1 binding TP53 chr17 7578478 7578478 G > CChange of KLF16 binding TP53 chr17 7578478 7578478 G > CChange of POLR3A binding TP53 chr17 7578478 7578478 G > CChange of SP3 binding TP53 chr17 7578478 7578478 G > CChange of SP4 binding TP53 chr17 7578478 7578478 G > CChange of TBX21 binding TP53 chr17 7578478 7578478 G > CChange of WT1 binding TP53 chr17 7578478 7578478 G > CChange of ZFP2 binding TP53 chr17 7578478 7578478 G > CChange of ZNF729 binding TP53 chr17 7578796 7578796 C > AChange of CTCF binding TP53 chr17 7578796 7578796 C > AChange of RAD21 binding TP53 chr17 7578796 7578796 C > AChange of RXRA binding TP53 chr17 7578796 7578796 C > AChange of ZNF92 binding TP53 chr17 7578947 7578947 C > TChange of NHLH2 binding TP53 chr17 7578947 7578947 C > TChange of SREBF1 binding TP53 chr17 7579313 7579313 G > CChange of POU2F1 binding TP53 chr17 7579529 7579529 C > TChange of SOX9 binding TP53 chr17 7621215 7621215 T > GChange of ZN337 binding TP53 chr17 8023124 8023124 C > TChange of E2F4 binding TP53 chr17 8023124 8023124 C > TChange of HSF1 binding TP53 chr17 8023124 8023124 C > TChange of RBAK binding TP53 chr17 8026793 8026793 C > TChange of MAX binding TP53 chr17 8026793 8026793 C > TChange of ZNF790 binding TPD52L3, chr9 6365683 6365683 A > CDecreasing of enhancer TMED6, activity JMJD2C TPTE chr21 1081601710816017 G > C Change of ZNF616 binding TPTE chr21 10816529 10816529A > G Change of ZNF616 binding TPTE chr21 10813552 10813552 G > AChange of ZNF616 binding TPTE chr21 10814023 10814023 A > GChange of ZNF616 binding TPTE chr21 10814025 10814025 G > TChange of ZNF616 binding TPTE chr21 10814061 10814061 G > TChange of ZNF616 binding TPTE chr21 10814155 10814155 G > TChange of ZNF616 binding TPTE chr21 10814716 10814716 G > TChange of ZNF616 binding TPTE chr21 10832792 10832792 G > TChange of ZNF616 binding TPTE chr21 10833977 10833977 G > AChange of ZNF616 binding TPTE chr21 10833990 10833990 T > CChange of ZNF616 binding TPTE chr21 10834357 10834357 G > AChange of ZNF616 binding TPTE chr21 10851202 10851202 A > GChange of ZNF616 binding TPTE chr21 10853066 10853066 T > GChange of ZNF616 binding TPTE chr21 10820450 10820450 G > CChange of ZNF616 binding TPTE chr21 10796504 10796504 G > TChange of ZNF616 binding TPTE chr21 10849949 10849949 G > AChange of ZNF616 binding TPTE chr21 10850097 10850097 T > AChange of ZNF616 binding TPTE chr21 10851202 10851202 A > GChange of ZNF616 binding TPTE chr21 10845180 10845180 G > TChange of ZNF616 binding TPTE chr21 10845749 10845749 G > CChange of ZNF616 binding TPTE chr21 10780021 10780021 G > TChange of ZNF616 binding TPTE chr21 10830716 10830716 G > AChange of ZNF616 binding TPTE chr21 10831264 10831264 T > CChange of ZNF616 binding TRABD chr22 50627834 50627834 C > TChange of PLAG1 binding TRABD chr22 50714820 50714820 T > AChange of PLAG1 binding TRABD chr22 50639543 50639543 G > AChange of PLAG1 binding TRABD chr22 50608627 50608627 C > GChange of PLAG1 binding TRIM27 chr6 28949254 28949254 A > CDecreasing of enhancer activity TRIM27 chr6 28949312 28949312 C > TIncreasing of enhancer activity TRIM27 chr6 28949469 28949469 C > AIncreasing of enhancer activity TRIM27 chr6 28949509 28949509 G > AIncreasing of enhancer activity TRIM27 chr6 28949511 28949511 G > AIncreasing of enhancer activity TRIM27 chr6 28949524 28949524 C > TIncreasing of enhancer activity TRIM27 chr6 28949535 28949535 C > GIncreasing of enhancer activity TRIM27 chr6 28949821 28949821 C > TIncreasing of enhancer activity TRIM27 chr6 28949841 28949841 G > AIncreasing of enhancer activity TRIM27 chr6 28949944 28949944 C > AIncreasing of enhancer activity TRIM27 chr6 28950014 28950014 C > TIncreasing of enhancer activity TRIM27 chr6 28950037 28950037 CGGTCAGGGAIncreasing of enhancer ATGAGGTTTT activity TCTGTTTTAA CCT (SEQ IDNO: 480)>- TRIM27 chr6 28950039 28950039 G > A Increasing of enhanceractivity TRIM27 chr6 28950050 28950050 G > A Decreasing of enhanceractivity  TRIM27 chr6 28950052 28950052 G > A Increasing of enhanceractivity TRIM27 chr6 28950056 28950056 T > C Increasing of enhanceractivity TRIM27 chr6 28950486 28950486 G > T Increasing of enhanceractivity TRIM27 chr6 28950885 28950885 A > G Increasing of enhanceractivity TRMT11, chr6 127436064 127436064 C > C Increasing of enhancerECHDC1, activity HINT3, C6orf173, RNF146 TSC22D3 NA NA Gain of enhancerTSC22D3 NA NA Gain of enhancer TSC22D3 NA NA Gain of enhancer TSC22D3 NANA Gain of enhancer TSC22D3 NA NA Gain of enhancer TSC22D3 NA NAGain of enhancer TSC22D3 NA NA Gain of enhancer TSC22D3 NA NAGain of enhancer TSC22D3 NA NA Gain of enhancer TSC22D3 NA NAGain of enhancer TSLP chr5 110176128 110176128 G > TIncreasing of NHLH1 binding; Increasing of enhancer activity TSPAN31,chr12 58165085 58165085 G > A Increasing of enhancer CYP27B1, activityTSFM, AVIL, FAM119B TTC24 chr1 156470002 156470002 T > AChange of SP4 binding TTC24 chr1 156470227 156470227 T > GChange of SP4 binding TTC24 chr1 156470331 156470331 C > AChange of SP4 binding TTC24 chr1 156470445 156470445 C > GChange of SP4 binding TTC24 chr1 156470674 156470674 T > CChange of SP4 binding TTC24 chr1 156561525 156561525 T > CChange of SP4 binding TTC24 chr1 156561584 156561584 C > GChange of SP4 binding TTC24 chr1 156645564 156645564 G > AChange of SP4 binding TYK2, ICAM3 chr19 10520064 10520064 G > A TYW5chr2 200780737 200780737 T > C Decreasing of enhancer activity UCP2chr11 73694754 73694754 C > T Gain of PAX5; PAX8 binding;Increasing of enhancer activity UPK3A chr22 45676678 45676678 A > GLoss of GATA2 motif; Loss of enhancer activity UROS chr10 127505277127505277 C > T Gain of ESRRG; NR2F6; NR2F2; NR2C2 binding;Decreasing of enhancer activity USP12 chr13 27523026 27544353Amplification Gain of enhancer VPS13C chr15 62391608 62391608 T > CDecreasing of enhancer activity WFS1 chr4 6299940 6299940 C > TDecreasing of enhancer activity WFS1 chr4 6299387 6299387 G > ADecreasing of enhancer activity XBP1 chr22 29196757 29196757 G > CGain of ZIC3 binding; Decreasing of enhancer activity ZFAND3 chr637775652 37775652 G > A Loss of NEUROD1 binding; Loss of enhancer ZFAS1chr20 47905499 47905499 T > G Gain of JUND motif; Increasing of enhanceractivity ZFP36L1 chr14 69254191 69254191 C > T ZIP11 chr17 7100651271006512 A > C ZIP11 chr17 71012473 71012473 G > C ZMYND11 chr10 375539375539 A > G Change of ZNF274 binding ZMYND11 chr10 127618 127618 A > CChange of ZNF274 binding ZNF48 chr16 30935409 30935409 C > GChange of ZNF263 binding ZNF48 chr16 29911922 29911922 G > CChange of ZNF263 binding ZNF48 chr16 30346156 30346156 A > CChange of ZNF263 binding ZNF48, chr16 30669784 30669784 G > CChange of ZNF263 binding SRCAP ZNF48, chr16 30346156 30346156 A > CChange of ZNF263 binding SRCAP ZNF512B chr20 62594247 62594247 T > CDecreasing of enhancer activity ZNF517, chr8 145913001 145913001 A > CChange of ZNF224 binding RPL8 ZNF517, chr8 145913120 145913120 A > TChange of ZNF224 binding RPL8 ZNF517, chr8 145913262 145913262 A > TChange of ZNF224 binding RPL8 ZNF596 chr8 580156 580156 C > GDecreasing of enhancer activity ZNF596 chr8 580332 580332 C > TDecreasing of enhancer activity ZNF596 chr8 580370 580370 C > TDecreasing of enhancer activity ZNF596 chr8 580698 580698 G > ADecreasing of enhancer activity ZNF596 chr8 581293 581293 G > CDecreasing of enhancer activity

Methods of Reprogramming Cells

The present methods can include using SHAPE to alter expression of cellfate- and differentiation-related target genes, by introducing orremoving a binding site for a cell-reprogramming transcription factor(e.g., adding a site for an activating TF or deleting a site that bindsa repressor, activating by de-repression, or adding a site for arepressive TF to down-regulate expression). Installation of sequencemotifs can be used to drive programmable cellular differentiation fromone cell type to another target cell type.

SHAPE to program cellular differentiation (from iPSCs to specific celltypes, or specific cell types into another) through the modification ofTF gene expression that is involved in cell identity³³. The introductionof sequence motifs to modify (e.g., increase or decrease) the expressionof a target gene product (e.g., RNA, protein) can be performed with agenetic modifier, where the resulting change in transcription of asingle target gene or multiple target genes leads to differentiation ofa cell type to another target cell type. Examples of cell-reprogrammingtranscription factors are listed in Table 7 below.

TABLE 7 Examples of cell-reprogramming transcription factorsTranscription Cell type factor Embryonic SALL4 stem cells OTX2 ZIC3NANOG ZSCAN10 POU5F1 MYCN NR6A1 ZIC2 SOX2 MYC KLF4 Neural OTX2 precursorcells SALL4 SIX3 LHX2 SP8 SOX11 TCF3 PAX6 ZIC2 NR6A1 FOXG1 SOX2 ZIC1REST POU3F2 HES1 RFX4 NEUROG2 ASCL1 PLAGL1 MYC KLF4 CardiomyocytesANKRD1 NKX2-5 E2F8 TBX5 MEF2A ZBF193 MSX2 SOX11 GATA4 LRRFIP1 HAND2Hepatocytes NR1H4 NR1I2 HNF4A NR5A2 HNF4G ATF5 NR1I3 HHEX PROX1 FOXA3CEBPA GATA4 Motor neurons MNX1 ESRRG ISL2 HOXC6 CREM NHLH1 ZNF92 GZF1GLIS3 ISL1 POU3F2 MYT1L ASCL1 NEUROG2 LHX3 Pancreatic islet RFX6 cellsINSM1 PAX6 ISL1 NEUROD1 GLIS3 NR5A2 ZNF165 ARX MNX1 MAFB PDX1 PAX4NEUROG3 Melanocytes PAX3 ALX1 TFAP2A MITF E2F7 SNAI2 LZTS1 ZFY TCFL5PKNOX2 SOX10 Retinal pigment OTX2 epithelial SIX3 LHX2 PAX6 FOXD1 MITFC11orf9 ZNF92 GLIS3 SOX9 NRL CRX RAX MYC KLF4

Methods for Heritable Target Gene Repression

Methlyation of CpG dinucleotides at promoters or enhancers are known fortranscriptional silencing³⁴. This DNA modification is maintained duringreplication by endogenous DNMT1. Previous studies of introducingmethylated DNA at the promoter of reporter plasmids showed therepression of reporter genes³⁵⁻³⁷. SHAPE can be used for theinstallation of methylated CpGs at the regulatory elements (promoters orenhancers) for heritable target gene repression. To achieve CpGmethylation at the promoters or enhancers of target genes, first, wewill identify genes that are highly expressed in target cells. Second,we will methylate CpGs for insertion motifs in vitro using methylasesand SAM. The methylated CpGs can be inserted into the target regions viagenetic modifiers. The in vivo methylation status can be determined viabisulfite genomic sequencing of target regions, and the repressioneffect of target genes can be validated by RT-qPCR.

non-coding RNA is a common strategy to perform target gene repression,where an RNA sequence with complementarity to a target messenger RNA(mRNA) hybridizes to its target and either accelerates degradation ofthe mRNA or prevents translation of the mRNA, ultimately reducing targetgene protein production. Here we describe a strategy within SHAPE toinstall sequence motifs that induce targeting of endogenous non-codingRNAs (e.g., miRNAs, siRNAs, lncRNAs) for heritable target generepression via RNA interference. Following the identification ofendogenously expressed endogenous non-coding RNAs (e.g., miRNAs, siRNAs,lncRNAs) in a cell type or cell types of interest, the specific bindingsites of these non-coding RNAs can be introduced into the target genetranscript at either the 5′ or 3′ UTR or in intronic regions via geneticmodifiers with the ability to introduce insertion edits (e.g.,programmable nucleases+ssODNs/dsODNs, prime editors). This method wouldbe validated by RT-qPCR of the target gene transcript to assess RNAknockdown or protein-based assays (e.g., western blot, ELISA) to assessdownstream protein knockdown to see if target gene repression isachieved.

SHAPE to Increase or Decrease Transcript Stability, and/orTranscription, and/or Protein Output

The activation of target gene protein output can also be performedthrough the introduction of sequence motifs in the untranslated regionto increase transcript stability. Following the identification orgeneration of sequence motifs that have the potential to promote RNAstability, genetic modifiers with the ability to introduce insertionedits (e.g., programmable nucleases+ssODNs/dsODNs, prime editors) can beused to target the 5′ and/or 3′ untranslated regions (UTRs) of targetgenes. The introduction of these RNA-stabilizing sequence motifs can beinserted at all targetable positions of the UTRs to find the optimalpositioning of the editing event. The stabilization RNA can be read outthrough RT-qPCR to quantitate the increase in target RNA abundance thatshould occur through a decreased rate of RNA degradation.

Multiplex SHAPE

Multiplex genome editing with programmable nucleases, base editors, andprime editors can be utilized to induce more robust activation for asingle target gene. The potential to modify more than one genomiclocation within regulatory elements of a single target gene may enableadditive or synergistic effects for target gene activation. Previousstudies showed multiplexed genome engineering of up to 25 humanendogenous targets, suggesting up to 25 sites can be simultaneouslyedited for robust activation of target genes (McCarty, N. S., Graham, A.E., Studená, L. et al. Nat Commun 11, 1281 (2020), Campa, C. C.,Weisbach, N. R., Santinha, A. J. et al. Nat Methods 16, 887-893 (2019)).Multiplex editing can be combinations of different strategies,including: 1) introduction of a de novo transcription factor bindingsite 2) modification of an endogenous transcription factor site toeither increase or decrease its regulatory potential 3) modification ofendogenous spacing of transcription factor binding sites to increase ordecrease regulatory potential. Multiplex editing can be performed withina single regulatory element (e.g., promoter, enhancer), or acrossmultiple regulatory elements.

Multiplex genome editing with programmable nucleases, base editors, andprime editors can also be utilized to induce multi-gene activation.Previous studies showed multiplexed genome engineering of up to 25 humanendogenous targets, suggesting up to 25 sites can be simultaneouslyedited for muti-gene activation (McCarty, N. S., Graham, A. E., Studená,L. et al. Nat Commun 11, 1281 (2020), Campa, C. C., Weisbach, N. R.,Santinha, A. J. et al. Nat Methods 16, 887-893 (2019)). The potential tomodify more than one genomic location may enable the ability to activatemultiple genes in parallel with SHAPE. Multiplex editing can becombinations of different strategies, including: 1) introduction of a denovo transcription factor binding site 2) modification of an endogenoustranscription factor site to either increase or decrease its regulatorypotential 3) modification of endogenous spacing of transcription factorbinding sites to increase or decrease regulatory potential. Multiplexediting can be performed within a single regulatory element (e.g.,promoter, enhancer), or across multiple regulatory elements.

EXAMPLES

The invention is further described in the following examples, which donot limit the scope of the invention described in the claims. Theexamples described herein show gene expression activation by the SHAPEplatform using both dual adenine and cytosine base editors and primeeditors to install de novo transcription factor binding sites in HEK293Tcells. A variety of transcription factor binding motifs were insertedinto endogenous genomic contexts, and gene expression changes weremeasured at the RNA level. Our findings broaden the capabilities fordurable and heritable gene activation by precision genome engineering.

Methods and Materials

The Methods and Materials described herein were used in the Examplesprovided herein.

Molecular Cloning

All base editor (BE) and prime editor (PE) constructs were cloned into amammalian expression plasmid backbone under the control of a pCMVpromoter (AgeI and NotI restriction digest of parental plasmid AddgeneNo. 112101). Gibson fragments with matching overlaps were PCR-amplifiedusing Phusion High-fidelity polymerase (NEB). Fragments weregel-purified and assembled for 1 hour at 50° C. and transformed intochemically competent E. coli (XL1-Blue, Agilent). All guide RNA (gRNA)constructs were cloned into a BsmBI-digested pUC19-based entry vector(BPK1520, Addgene No. 65777) with a U6 promoter driving gRNA expression.We designed the pegRNAs following the previously described defaultdesign rules for designing pegRNAs and ngRNAs (Anzalone et al, Nature2019, 576, pages 149-157). PegRNAs were cloned into the Bsal-digestedpU6-pegRNA-GG-acceptor entry vector (Addgene No. 132777) and ngRNAs werecloned into the BsmBI-digested entry vector BPK1520 that is mentionedabove. Oligos containing the spacer, the 5′phosphorylated pegRNAscaffold, and the 3′ extension sequences were annealed to form dsDNAfragments with compatible overhangs and ligated using T4 ligase (NEB).All plasmids used for transfection experiments were prepared usingQiagen Midi or Maxi Plus kits.

Guide RNAs Used in Nuclease and Base Editor Experiments

All gRNAs for base editors were of the form5′-NNNNNNNNNNNNNNNNNNNNCGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTTT-3′. (SEQ ID NO: 4)

TABLE A Shown below are the spacer regions (NNNNNNNNNNNNNNNNNNNN inSEQ ID NO: 4) for these gRNAs (all written 5′ to 3′). Target SEQ SEQgene/ Spacer ID Genomic target ID site sequence NO: sequence NO: RCC1AACCACACAACGCTA 6 AACCACACAACGCTAT 6 promoter TGACA GACA SAE1TGCCACATAAGTGAC 7 TGCCACATAAGTGACC 7 promoter CACGT ACGT COMTTACCAGCTCTGGGAG 8 TACCAGCTCTGGGAGA 8 promoter ACCAC CCAC RARATTCCAGCTGGTCCCTA 9 TTCCAGCTGGTCCCTAG 9 promoter GAAG AAG IVDGACCAATTTACTGGG 10 GACCAATTTACTGGGTA 10 promoter TACGT CGT

Prime Editing Guide RNAs (pegRNAs)

All pegRNAs for prime editors were of the form5′-NNNNNNNNNNNNNNNNNNNNGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGC TTTTTTT-3′. (SEQ ID NO: 11)

TABLE B Shown below are the spacer and 3′ extension sequencesfor these pegRNAs (all written 5′ to 3′). SEQ SEQ ID ID Target_ PegSpacer_ NO: Extension_ NO: name RNA sequence (#) sequence (#) MYOD1 AGATAAATAGCCC 441 AGGGCTTCCTCACCCCTAGCTTC 12 AGGGCGCCTCGCCAGGCgggggccaatcagcGCCC TGGGCTATTT MYOD1 A GATAAATAGCCC 442AGGGCTTCCTCACCCCTAGCTTC 13 AGGGCGCC TCGCCAGGCgggggccaatcagcgggccaatcagcGCCCTGGGCTATTT MYOD1 A GATAAATAGCCC 443 AGGGCTTCCTCACCCCTAGCTTC 14AGGGCGCC TCGCCAGGCggggccccgcccccGCCC TGGGCTATTT MYOD1 A GATAAATAGCCC 444AGGGCTTCCTCACCCCTAGCTTC 15 AGGGCGCC TCGCCAGGCggggccccgcccccggccccgcccccGCCCTGGGCTATTT MYOD1 A GATAAATAGCCC 445 AGGGCTTCCTCACCCCTAGCTTC 16AGGGCGCC TCGCCAGGCggcacttccgggttGCCCT GGGCTATTT MYOD1 A GATAAATAGCCC 446AGGGCTTCCTCACCCCTAGCTTC 17 AGGGCGCC TCGCCAGGCggcacttccgggttcacttccgggttGCCCTGGGCTATTT MYOD1 A GATAAATAGCCC 447 AGGGCTTCCTCACCCCTAGCTTC 18AGGGCGCC TCGCCAGGCggccttatctgGCCCTGG GCTATTT MYOD1 A GATAAATAGCCC 448AGGGCTTCCTCACCCCTAGCTTC 19 AGGGCGCC TCGCCAGGCggccttatctgccttatctgGCCCTGGGCTATTT MYOD1 A GATAAATAGCCC 449 AGGGCTTCCTCACCCCTAGCTTC 20AGGGCGCC TCGCCAGGCggccttatctgccttatctgcctt atctgGCCCTGGGCTATTT MYOD1 AGATAAATAGCCC 450 AGGGCTTCCTCACCCCTAGCTTC 21 AGGGCGCCTCGCCAGGCggttccttccttccGCCCT GGGCTATTT MYOD1 A GATAAATAGCCC 451AGGGCTTCCTCACCCCTAGCTTCTCG 22 AGGGCGCC CCAGGCggttccttccttccttccttccttccGCCCTGGGCTATTT MYOD1 B CCTCCCTCCCTGC 452 GCCCCTCCACACTGGCGTGCGC 23CCGGTAG GCTAGGTCCCCTAgggggccaatcagc CCGGGCAGGGAGGG MYOD1 B CCTCCCTCCCTGC453 GCCCCTCCACACTGGCGTGCGC 24 CCGGTAG GCTAGGTCCCCTAgggggccaatcagcgggccaatcagcCCGGGCAGGGAGGG MYOD1 B CCTCCCTCCCTGC 454GCCCCTCCACACTGGCGTGCGC 25 CCGGTAG GCTAGGTCCCCTAggggccccgcccccCCGGGCAGGGAGGG MYOD1 B CCTCCCTCCCTGC 455 GCCCCTCCACACTGGCGTGCGC 26CCGGTAG GCTAGGTCCCCTAggggccccgccccc ggccccgcccccCCGGGCAGGGAGG G MYOD1 BCCTCCCTCCCTGC 456 GCCCCTCCACACTGGCGTGCGC 27 CCGGTAGGCTAGGTCCCCTAggcacttccgggttC CGGGCAGGGAGGG MYOD1 B CCTCCCTCCCTGC 457GCCCCTCCACACTGGCGTGCGC 28 CCGGTAG GCTAGGTCCCCTAggcacttccgggttCacttccgggttCCGGGCAGGGAGGG MYOD1 B CCTCCCTCCCTGC 458GCCCCTCCACACTGGCGTGCGC 29 CCGGTAG GCTAGGTCCCCTAggccttatctgCCGGGCAGGGAGGG MYOD1 B CCTCCCTCCCTGC 459 GCCCCTCCACACTGGCGTGCGC 30 CCGGTAGGCTAGGTCCCCTAggccttatctgccttat ctgCCGGGCAGGGAGGG MYOD1 B CCTCCCTCCCTGC460 GCCCCTCCACACTGGCGTGCGC 31 CCGGTAG GCTAGGTCCCCTAggccttatctgccttatctgccttatctgCCGGGCAGGGAGGG MYOD1 B CCTCCCTCCCTGC 461GCCCCTCCACACTGGCGTGCGC 32 CCGGTAG GCTAGGTCCCCTAggttccttccttccCCGGGCAGGGAGGG MYOD1 B CCTCCCTCCCTGC 462 GCCCCTCCACACTGGCGTGCGC 33CCGGTAG GCTAGGTCCCCTAggttccttccttccttc cttccttccCCGGGCAGGGAGGG MYOD1 CGAGGTTTGGAAA 463 GGCAGCCCTAGGCGGCTGCACT 34 GGGCGTGCTGGCTCTCCGGCAgggggccaatcagc CGCCCTTTCCAAAC MYOD1 C GAGGTTTGGAAA 464GGCAGCCCTAGGCGGCTGCACT 35 GGGCGTGC TGGCTCTCCGGCAgggggccaatcagcgggccaatcagcCGCCCTTTCCAAAC MYOD1 C GAGGTTTGGAAA 465GGCAGCCCTAGGCGGCTGCACT 36 GGGCGTGC TGGCTCTCCGGCAggggccccgcccccCGCCCTTTCCAAAC MYOD1 C GAGGTTTGGAAA 466 GGCAGCCCTAGGCGGCTGCACT 37GGGCGTGC TGGCTCTCCGGCAggggccccgccccc ggccccgcccccCGCCCTTTCCAAAC MYOD1 CGAGGTTTGGAAA 467 GGCAGCCCTAGGCGGCTGCACT 38 GGGCGTGCTGGCTCTCCGGCAggcacttccgggttC GCCCTTTCCAAAC MYOD1 C GAGGTTTGGAAA 468GGCAGCCCTAGGCGGCTGCACT 39 GGGCGTGC TGGCTCTCCGGCAggcacttccgggttCacttccgggttCGCCCTTTCCAAAC MYOD1 C GAGGTTTGGAAA 469GGCAGCCCTAGGCGGCTGCACT 40 GGGCGTGC TGGCTCTCCGGCAggccttatctgCGCCCTTTCCAAAC MYOD1 C GAGGTTTGGAAA 470 GGCAGCCCTAGGCGGCTGCACT 41 GGGCGTGCTGGCTCTCCGGCAggccttatctgccttat ctgCGCCCTTTCCAAAC MYOD1 C GAGGTTTGGAAA471 GGCAGCCCTAGGCGGCTGCACT 42 GGGCGTGC TGGCTCTCCGGCAggccttatctgccttatctgccttatctgCGCCCTTTCCAAAC MYOD1 C GAGGTTTGGAAA 472GGCAGCCCTAGGCGGCTGCACT 43 GGGCGTGC TGGCTCTCCGGCAggttccttccttccCGCCCTTTCCAAAC MYOD1 C GAGGTTTGGAAA 473 GGCAGCCCTAGGCGGCTGCACT 44GGGCGTGC TGGCTCTCCGGCAggttccttccttccttc cttccttccCGCCCTTTCCAAAC HBB DGGCTCTTCTGGCA 474 GAGGGAGGGCTGAGGGTTTGAA 45 CTGGCTTGTCCAACTCCTAAGcacttccgggttca cttccgggttCCAGTGCCAGAAGA IL2RA EGGATGAGAGAAG 475 ATTGGGCTGGCGTGTTCAGCCA 46 AGAGTGCTGGAAACTGCCTAGCcacttccgggttca cttccgggttACTCTCTTCTCTCA HER2 FGCCCTCTCTTCGC 476 AGGCGTCCCGGCGCTAGGAGGG 47 GCAGGCCTACGCACCCAGGcacttccgggttcacttcc gggttCCTGCGCGAAGA EpCAM G GAGCGCACACCT477 TCCCGGGAAGGGGCCGAGAGG 48 GCCCGACC CGGGGCCGCCAGGTcacttccgggttcacttccgggttCGGGCAGGTGTG # SEQ ID NO:

PE3 nicking guide RNAs (ngRNAs)

All nicking gRNAs for PE3 system were of the form5′-NNNNNNNNNNNNNNNNNNNNCGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTTT-3′. (SEQ ID NO: 49)

TABLE C Shown below are the protospacer regions for these nicking gRNAs(NNNNNNNNNNNNNNNNNNNN in SEQ ID NO: 49, all written 5′ to 3′). TargetSEQ ID gene pegRNA Protospacer sequence NO: MYOD1 A GAGGCCAATAGGAACACTGC50 MYOD1 A CTCCTGTCCGGCCTGATTTG 51 MYOD1 A CCACCCCTCCCTCTCCTGTC 52 MYOD1B CACCCGACTGCTGTATCCGC 53 MYOD1 B GGCCGCAGGGGCCCGCAGAC 54 MYOD1 BCCAATAGGAACACTGCGGGG 55 MYOD1 C CTCCTCTGTCCCCTGATTTG 56 MYOD1 CGCTAGGTCCCCTACCGGGCA 57 MYOD1 C TCCACACTGGCGTGCGCGCT 58 HBB DGTGGAGCCACACCCTAGGGT 59 IL2RA E GTTGATGACAATATAGTTTG 60 HER2 FGCTGCATTTAGGGATTCTCCG 61 EpCAM G GACTCATCAACGAGCACCAG 62

Cell Culture and Transfections

STR-authenticated HEK293T (CRL-3216), K562 (CCL-243), HeLa (CCL-2), andU2OS cells (similar match to HTB-96; gain of #8 allele at the D5S818locus) were used in this study. HEK293T and HeLa cells were grown inDulbecco's Modified Eagle Medium (DMEM, Gibco) with 10% heat-inactivatedfetal bovine serum (FBS, Gibco) supplemented with 1%penicillin-streptomycin (Gibco) antibiotic mix. K562 cells were grown inRoswell Park Memorial Institute (RPMI) 1640 Medium (Gibco) with 10% FBSsupplemented with 1% Pen-Strep and 1% GlutaMAX (Gibco). U2OS cells weregrown in DMEM with 10% FBS supplemented with 1% Pen-Strep and 1%GlutaMAX. Cells were grown at 37° C. in 5% CO2 incubators andperiodically passaged upon reaching around 80% confluency. Cell culturemedia supernatant was tested for mycoplasma contamination using theMycoAlert mycoplasma detection kit (Lonza) and all tests were negativethroughout the experiments.

Transfections

HEK293T cells were seeded at 1.25×10⁴ cells per well into 96-well flatbottom cell culture plates (Corning) for DNA on-target experiments or at6.25×10⁴ cells per well into 24-well cell culture plates (Corning). 24hours post-seeding, cells were transfected with 30 ng of control orbase/prime editor plasmid and 10 ng of gRNA plasmid (and 3.3 ng nickinggRNA plasmid for PE3) using 0.3 μL of TransIT-X2 (Minis) lipofectionreagent for experiments in 96-well plates, 150 ng control or base editorplasmid and 50 ng gRNA, or 375 ng dCas9-VPR and 125 ng gRNA, and 3 μLTransIT-X2 for experiments in 24-well plates. K562 cells wereelectroporated using the SF Cell Line Nucleofector X Kit (Lonza) or KitV (Lonza), according to the manufacturer's protocol with 2×10⁵ cells pernucleofection and 800 ng control or base/prime editor plasmid, 200 nggRNA or pegRNA plasmid, and 83 ng nicking gRNA plasmid (for PE3) or with1×10⁶ cells per nucleofection and 3840 ng control or prime editorplasmid, 960 ng pegRNA plasmid, and 398.4 ng of nicking gRNA plasmid(for PE3), and 3750 ng dCas9-VPR plasmid and 1250 ng of gRNA. When GFPplasmid was co-transfected, half amount of gRNAs or nicking gRNAs wasused. U2OS cells were electroporated using the SE Cell Line NucleofectorX Kit (Lonza) with 2×10⁵ cells and 800 ng control or base/prime editorplasmid, 200 ng gRNA or pegRNA, and 83 ng nicking gRNA (for PE3). HeLacells were electroporated using the SE Cell Line 4D-Nucleofector X Kit(Lonza) with 5×10⁵ cells and 800 ng control or base/prime editor, 200 nggRNA or pegRNA, and 83 ng nicking gRNA (for PE3). 72 hourspost-transfection, cells were lysed for extraction of genomic DNA(gDNA).

DNA and RNA Extraction

For DNA on-target experiments in 96-well plates, 72 h post-transfection,cells were washed with PBS, lysed with freshly prepared 43.54, DNA lysisbuffer (50 mM Tris HCl pH 8.0, 100 mM NaCl, 5 mM EDTA, 0.05% SDS), 5.25μL Proteinase K (NEB), and 1.25 μL 1M DTT (Sigma). For DNA off-targetexperiments in 24-well plates, cells were lysed in 174 DNA lysis buffer,21 μL Proteinase K, and 5 μL 1M DTT. For RNA off-target experiments, GFPsorted cells were split 20% for DNA and 80% for RNA extraction. Cellswere centrifuged (200 g, 8 min) and lysed as above for DNA or with 350μL RNA lysis buffer LBP (Macherey-Nagel) for RNA. DNA lysates wereincubated at 55° C. on a plate shaker overnight, then gDNA was extractedwith 2× paramagnetic beads (as previously described), washed 3 timeswith 70% EtOH, and eluted in 30-80 μL 0.1×EB buffer (Qiagen). RNAlysates were extracted with the NucleoSpin RNA Plus kit (Macherey-Nagel)following the manufacturer's instructions.

Targeted Amplicon Sequencing

DNA targeted amplicon sequencing was performed as previously described(Grunewald et al, Nature 2019, 569, pages 433-437). Briefly, extractedgDNA was quantified using the Qubit dsDNA HS Assay Kit (Thermo Fisher).Amplicons were constructed in 2 PCR steps. In the first PCR, regions ofinterest (170-250 bp) were amplified from 5-20 ng of gDNA with primerscontaining Illumina forward and reverse adapters on both ends. PCRproducts were quantified on a Synergy HT microplate reader (BioTek) at485/528 nm using a Quantifluor dsDNA quantification system (Promega),pooled and cleaned with 0.7× paramagnetic beads, as previouslydescribed. In a second PCR step (barcoding), unique pairs ofIllumina-compatible indexes (equivalent to TruSeq CD indexes, formerlyknown as TruSeq HT) were added to the amplicons. The amplified productswere cleaned up with 0.7× paramagnetic beads, quantified with theQuantifluor or Qubit systems, and pooled before sequencing. The finallibrary was sequenced on an Illumina MiSeq machine using the MiseqReagent Kit v2 (300 cycles, 2×150 bp, paired-end). Demultiplexed FASTQfiles were downloaded from BaseSpace (Illumina).

Targeted Amplicon Sequencing Analysis

Amplicon sequencing data were analyzed with CRISPResso2 2.0.3016 thatwas run in base editor output mode. Allele frequency tables (CRISPRessooutput) display an editing window that includes the edited As or Cs (CCAmotif in positions 3-4-5 with 1 being the most PAM-distal base).

Flow Cytometry

Cells were washed with cell staining buffer (Biolegends) after 72 hourspost-transfection and incubated with PE conjugated IL2RA (Biolegends),HER2 (Biolegends) or EpCAM antibody (Biolegends) for 15 minutes,followed by twice wash with cell staining buffer. All PE positive cellswere sorted and sorted cells were measured by a LSR Fortessa X-20 flowcytometer (BD) to test durability of target protein expression. Cellstransfected with GFP plasmid were resuspended in cell staining bufferafter 72 hours post-transfection and top 50% GFP positive cells weresorted.

Analysis of Potential SPACE-Encodable Transcription Factor Binding Sites

Annotated transcription start sites from hg38 refseq genes were obtainedand filtered to exclude micro-RNAs, small NF90 associated RNAs (SNARs),long non-coding RNAs, small nucleolar RNAs, and anti-sense transcripts.These RNAs were filtered in part due to redundant annotations at thesame transcription start sites (TSS) and to focus on protein-codinggenes. Next, the remaining TSSes were padded to include the region −500bp to 0 bp relative to the start site. From this 500 bp per-gene window,we found all matches of the “NNCCA GG” (SEQ ID NO:5) motif on eitherstrand that contain a preferential dual-editing window for SPACE and acanonical SpCas9-PAM (NGG). In total, this defined 53,750 protospacers(45,383 unique). To assess the potential for TF motif creation, we usedthe reference sequence to create “SPACE-edited” sequences for each ofthe protospacers by modifying the CCA to TTG. Using a set of 386transcription motifs from the JASPAR2016 motif list20 we determinedwhich motifs could be created with the SPACE modification for eachtranscription factor. Motif matching was performed using the motifmatchrpackage using default parameters as part of the chromVAR suite oftools21. Created motifs were those that did not occur in the referencesequence but were matches in the SPACE-edited sequence.

Measurement of Target Gene Expression for Inserting TF Motis by PE3

HEK293T were transfected with PE3 (60 ng), pegRNA(20 ng) and nickinggRNA (6.64 ng). HEK293T was transfected using lipofection. 24 hoursprior to transfection, HEK293T cells (625000) were seeded in 24-wellplates and then transfected with the plasmids using 3 μl of TransitX2(Mirus Bio, cat #MIR6003) for HEK293T cells. For target geneexpression analysis, total RNA was extracted from the cells 72 hourspost-transfection using the NucleoSpin RNA Plus Kit (Clontech, cat#740984.250) and 250 ng of purified RNA was used for cDNA synthesisusing a High Capacity RNA-to-cDNA kit (ThermoFisher, cat #4387406). 3 μlof 1:20 diluted cDNA was amplified by quantitative PCR (qPCR) using FastSYBR Green Master Mix (ThermoFisher, cat #4385612) with the primerslisted elsewhere in this application. qPCR reactions were performed on aLightCycler 480 (Roche) with the following program: initial denaturationat 95° C. for 20 seconds (s) followed by 45 cycles of 95° C. for 3 s and60° C. for 30 s. Ct values greater than 35 were considered as 35,because Ct values fluctuate for transcripts expressed at very lowlevels. Gene expression levels were normalized to HPRT1 and calculatedrelative to that of the negative controls (PE3 with pegRNA cassette).

Example 1: Introducing De Novo Transcription Factor Binding Sites forGene Activation with Dual Adenine and Cytosine Base Editors

First, a bioinformatic analysis was performed to generate candidategenes with endogenous promoter sequences that can get converted into TFbinding sites using SPACE. Potential target sites had to lie within −500to 0 bp upstream of the TSS, have a C3C4A5 motif, with respect to theprotospacer (1 being the most PAM-distal position). Only sites with acanonical NGG-PAM were considered. The number of genes with one or morecreatable TF binding sites are shown in FIG. 8 . Subsequently, fivegenes were selected for a BE-SHAPE proof-of-concept pilot experiment.HEK293T cells were transfected in duplicate with plasmids co-expressingeither a nCas9 negative control or the dual-deaminase base editor SPACEas well as a gRNA targeting a genomic site in the promoter region of oneof these 5 genes of interest (Table A). 48 hours after transfection,cells were trypsinized and split into a 96-well plate for DNA extractionand maintained in a 24-well plate for RNA extraction. Genomic DNA andRNA was harvested 72 hours post-transfection. DNA was used to createNGS-compatible libraries that were run on an Illumina MiSeq and analyzedusing CRISPResso2 software. Two examples shown in FIGS. 9 a and bindicate efficient dual base editing with SPACE at the target sites. RNAof cells from the same experiment was harvested, reverse transcribedusing the High Capacity Kit from Applied Biosystems and used in RT-qPCRexperiments (triplicate qPCR per condition) to determine the Ct valuesof nCas9 and SPACE experiments. The fold-change expression changes werecalculated and showed an upregulation of expression following SPACEtreatment (base editing) in all 5 genes tested (FIG. 9 c ). These dataindicate that BE-SHAPE enabled the successful upregulation of targetedgenes of interest.

Example 2: Activation of MYOD1 Expression Through the Insertion ofTranscription Factor Binding Sites Via Prime Editing

We tested the SHAPE system at the MYOD1 locus in HEK293T cells. First,we identified candidate transcription factor motif sequences to insertinto varying positions of the MYOD1 locus, ranging from 250 bp upstreamand 50 bp downstream of the MYOD1 transcription start site (TSS). Weidentified ELF, NFY, and SP transcription factors as being activelyexpressed in HEK293T cells, and additionally included GATA1 and EWS-FLI1motifs as positive controls where exogenous GATA1 and EWS-FLI1 would besupplied exogenously (Table D).

TABLE D Transcription factor motifs for transcriptionfactors that are expressed in target celllines HEK293T, U20S, and K562 (ELF, NFY, SP1)and factors that are not expressed in targetcell lines (EWS-FLU, GATA1). Motif name Motif sequence SEQ ID NO: ELFAACCCGGAAGTG 63 NFY GCTGATTGGCCC 64 GATA1 CAGATAAGG 65 SP1 GGGGGCGGGGCC66 EWS-FLI1 GGAA 67

Next, we designed prime editing guide RNAs (pegRNAs) and nicking sgRNAs(ngRNAs) targeting nearby the MYOD1 TSS (Table B and C. We tested primeediting using the PE3 strategy and achieved meaningful insertion editingefficiencies across three different pegRNAs and 10 different motifinsertions (FIG. 2 ). Following the successful insertion oftranscription factor motifs at the MYOD1 locus by PE3, we assessed thechanges in MYOD1 gene expression by RT-qPCR (see methods and materials).The ELF motif exhibited copy-dependent increases in MYOD1 expression,where ELF 2× yielded greater gene activation compared to ELF 1× acrossall pegRNA and ngRNA combinations (FIG. 3 ). The ELF motif insertion wasable to promote gene activation that was up to 30-fold over the negativecontrol. The SP, NFY, and GATA1 motif insertions yielded very modestincreases in gene expression, with no clear advantages of introducingtwo copies (2×) of the motif compared to one copy (1×) (FIGS. 4, 5, 6 ).The EWS-FLI1 experiment was performed by providing an exogenous EWS-FLI1activator by plasmid, and demonstrated meaningful activation levels forpegRNA A, giving gene activation levels of 30-50 fold greater than thenegative control (FIG. 7 ). Only the EWS-FLI1 6× insertion worked, whilethe 3× insertion was much weaker in its ability to activate MYOD1 geneexpression. These results are consistent with the understanding thatEWS-FLI1 typically binds to a minimum repeat sequence of 4×.

Example 3: Stable and Durable Gene Activation or Protein Expression ViaInserting ELF(2×) Motif at Different Endogenous Human Gene Promoters byEnriching Edited Population with Sorting Cells Based on GFP PlasmidCo-Transfected or Sorting Based on Expression of Cell Surface MarkerTarget Genes

We tested the durability of the SHAPE system at various loci ofendogenous promoters of MYOD1, HBB, IL2RA, HER2, and EpCAM in HEK293Tand K562. To do so, we first enriched edited cells via sorting cells forGFP signal or target protein expression. To sort cells for GFP signal,cells were co-transfected with a separate GFP plasmid with prime editorcomplex that was designed to install ELF(2×) motif at the MYOD1, HBB,IL2RA, HER2, or EpCAM. To compare the durability of SHAPE with CRISPRa,cells co-transfected with dCas9-VPR targeting the same target regionsand GFP plasmid were also sorted for GFP. We confirmed stable ELF(2×)insertion at the target promoters and stable target mRNA expression over30 days post-transfection for GFP sorted HEK293T and K562 cells (FIGS.13-18 ). However, dCas9-VPR transfected cells showed rapid decrease oftarget gene expression between 3 and 10 post-transfection (FIGS. 13-15). Next, instead of enriching cells based on GFP protein expression, weused a different enrichment method that sorts cells for target proteinexpression. With the assumption that inserting ELF2× at the promoters ofcell surface marker genes (IL2RA, HER2 and EpCAM) would lead to anincrease in their mRNAs followed by protein expression, we sorted cellsfor cell surface marker proteins. Since this method differentiatingcells that have a functional outcome of ELF2× insertion, the insertionefficiency was higher than sorting methods based on GFP signal. We usedthe same sorting strategy for dCas9-VPR transfected cells that expressthe same cell surface marker proteins. We observed significantly higherlevels of mRNA and protein expression of HER2, IL2RA, and EpCAM forsorted cells compared to the ones from the unsorted populations for bothSHAPE and dCas9-VPR approaches. While dCas9-VPR approach showed that theelevated expression of target mRNA and protein expression after sortingdropped drastically between three and 10 days post-transfection, SHAPEvia prime editing maintained stable ELF(2×) insertion, mRNA expression,and protein expression over 30 days post-transfection (FIGS. 19-21 ).

Example 4: Pooled Screening of Diverse Transcription Factor ClusterMotifs for SHAPE-Mediated Target Protein Expression

We explored the insertion of diverse transcription factor cluster motifsvia prime editing to achieve target protein expression. To do so, weused the IL2RA promoter due to our previous success in activating IL2RAprotein expression and the ability to sort for its expression as a cellsurface marker (FIG. 20 ). For the exploration of diverse transcriptionfactor cluster motifs, we used a database of clustered transcriptionfactor motifs³⁸, and chose 94 of these clustered motifs based ontranscription factor expression in a variety of cell types (K562,HEK293T, U2OS) (Table E). The chosen cluster motifs were all normalizedto 24 bases by extending the motifs through the addition of repeatingcopies of the motif until the 24 bp length was reached. Additionally, weincluded a positive control ELF(2×) motif which we had previously shownto activate IL2RA protein expression, along with 5 negative controlsequences (24 bp) created with a random DNA generator. All clustermotifs and control sequences were inserted at the same position withinthe IL2RA promoter using the pegRNA spacer sequence and ngRNA describedpreviously (Table B, C). The pegRNA constructs encoding all clustermotifs and control sequences, in addition to the ngRNA, were pooled anddouble-electroporated into K562 with the electroporation eventsseparated by 72 hours. Seven days after the second electroporationevent, the K562 cells were sorted based on IL2RA protein expression intonegative and positive populations. Genomic DNA was harvested from boththe IL2RA negative and positive populations and targeted ampliconsequencing was performed at the prime editing insertion location. Eachcluster motif insertion was counted within the sequencing reads in boththe negative and positive samples, normalized based on total read countin each sample, and an enrichment score was calculated (FIG. 22 ). Wefound that the positive control ELF(2×) motif exhibited positiveenrichment (FIG. 22 , black) and that the 5 negative controls showedvery little enrichment (FIG. 22 , dark grey). Several of the clustermotifs within the library showed potential to repress and activatetarget protein expression, shown in the left and right tails of theplot, respectively.

TABLE E Archetype sequences derived from hierarchal-clustered transcription factor motifs andrelevant controls for pooled screening ofactivating or repressing regulatory elements. SEQ ID Cluster NameMotif sequence NO: 1 HD/1 TGATTGCAATCA 68 2 HD/2 CTAATTAA 69 3 HD/3TAATCGGAAAACGATTA 70 4 HD/4 TTAAGTGC 71 5 HD/5 AATTAAAAACCAATTA 72 6HD/6 AATTGGTGCTAAATG 73 7 HD/7 TAATTAGCCAATTA 74 8 HD/8 TAATTAAATTA 75 9HD/9 AATTAATTAAT 76 10 HD/10 GTTAATGATTAAC 77 11 HD/11 TAATCATCATTA 7812 HD/12 TGATTGACAG 79 13 NFY AGCCAATCAG 80 14 CUX/1 AAATCGATA 81 15CUX/3 ATCGATAACTGATCGAT 82 16 CUX/2 ATCGATAACCCTATCGAT 83 17 CUX/4AATCAATGA 84 18 HD/13 TTTATG 85 19 HD/14 TGATTTATG 86 20 HD/15 TGATGGATG87 21 HD/16 TTGATTAAT 88 22 HD/17 GTCGTAAAA 89 23 CPEB1 CAATAAAA 90 24HD/18 GCAATAAAA 91 25 HD/19 TAATCCGATTA 92 26 HD/20 GGATTA 93 27 HD/21TCAAGGA 94 28 HD/22 CCACTTGA 95 29 TCF/LEF AAGATCAAAG 96 30 NR/1GGGTCAAAGGTCA 97 31 NR/2 AAGTCAAAAGTCA 98 32 NR/3 TGGGGCAAAGGTCA 99 33NR/4 GGGTCATGACCC 100 34 NR/5 TGACCTTATAAGGTCA 101 35 NR/6TGACCTTTAAAGGTC 102 36 NR/7 GGTCATTCAAGGTCA 103 37 NR/8TGACCTTACATAAGGTCA 104 38 NR/9 AGGTCAAACTGTGACCT 105 39 NR/10TGACCTTATTAAGGTCA 106 40 NR/11 AAGTTCAAGGTCA 107 41 NR/12AGGTCATCCAAAGGTCA 108 42 NR/13 AGGTCAAAAGGTCA 109 43 NR/14 GTCAAAAAGTCA110 44 NR/15 GGGTCATTGAGTTCA ill 45 NR/16 AGGTCACGAAAGGTCA 112 46 NR/17AGGTCACCCTGACCT 113 47 NR/18 CTCGAGGTCATTGACCC 114 48 NR/19 GAAGTGGGTCA115 49 CREB/ATF/1 ATGACGTCA 116 50 CREB/ATF/2 ATGACGTCAT 117 51CREB/ATF/3 ATGATGCAAT 118 52 CCAAT/CEBP TTGCGCAAT 119 53 AP1/2TGCTGAGTCAT 120 54 AP1/1 TGAGTCAT 121 55 MAF ATTGCTGACTCAGCA 122 56ZNF317 GAATGACAGCTGACTTCTC 123 57 ZNF547 GCTAATGCAGCAGGCATAC 124 58Ebox/CACGTG/1 GTCACGTGA 125 59 Ebox/CACGTG/2 GCCACGTGC 126 60 HIFTACGTGC 127 61 CREB3/XBP1 GATGACGTGGC 128 62 Ebox/CATATG ACCATATGT 12963 Ebox/CAGATGG AAGGAAACAGATGG 130 64 HEN1 GGGAGCAGCTGCGTCC 131 65Ebox/CAGCTG ACAGCTGCT 132 66 SCRT1 GCAACAGGTG 133 67 SNAI2 CAGGTG 134 68Ebox/CACCTG ACACCTG 135 69 MIES TGACAGCTGTCA 136 70 TBX/1TCACACCTAGGTGTGA 137 71 TBX/2 GTGTGAAATTTCACACC 138 72 TBX/3TCACACCTCCAAAGGTGT 139 73 TBX/4 ACCTAAAAGGTGTG 140 AAATTCACA 74 SREBF1GTGGGGTGA 141 75 ZNF257 CTCTTGCCTC 142 76 FOX/1 TGTGGATT 143 77 FOX/2GTAAACATGTTTAC 144 78 FOX/3 GTAAACAATAAACA 145 79 FOX/4 TGTTTACTTA 14680 FOX/5 GTAAACAAACAA 147 81 ZNF435 TGTTAACAGAACACC 148 82 POU/2TGCATAATTAAT 149 83 POU/3 CATGAATATTCA 150 84 OCT4 + SOX2 CTTTGTTATGCAAA151 85 POU/1 TATGCAAAT 152 86 ARI5B TTAGTATTGT 153 87 FOX/6 GTAAATATTTAC154 88 ARISA AATATTGC 155 89 SOX/1 AGGAGCCTTTGTT 156 90 DMRT1GATACAATGTAGC 157 91 SOX/2 ATTGTT 158 92 SOX/3 TGAATTGCATTCA 159 93SOX/4 AACAATTGCAGTGTT 160 94 SOX/5 ATCAATTGCATTGA 161 95 SPIAAAGAGGAAGTA 162 96 ETS/2 AGCAGGAAGTG 163 97 MECP2 CCCGGAG 164 98 ETS/1ACCGGAAGTG 165 99 NFAT/2 GAAAATAATTTTCCA 166 100 NFAT/1 GGAAAATTT 167101 NFAC/2 AAAGAAAAAAAG 168 102 NFAT/3 TTTCCATAATGGAAA 169 103 IRF/3CCGAAACCGAAA 170 104 IRF/1 CGAAACCGAAAC 171 105 PRDM1 AAAGTGAAAGT 172106 IRF/2 AAAGTGAAAGTGAAAG 173 107 ZNF28 TCTATTTCTTCTTGTGTCA 174 108ZIM3 GGGTTTCTGTTGCT 175 109 KLF/SP/2 GGGGGGGGGCGGGGCCG 176 110 ZIC/2GGGGGGGG 177 111 EGR ACGCCCACGCA 178 112 KLF/SP/1 GCCACGCCCCC 179 113GC-tract GGGGAGGAGGGGGGGGGGGA 180 114 MZF1 AAAGGGGACAGGCAGG 181 115ZNF324 TCAAACCATCCTTTGCTGC 182 116 PRDM5 TGGAGAGCAGGG 183 117 EWSR1/FLI1GGAAGGAAGGAAGGAAG 184 118 ZNF436 CAGGGAAGGCTTCCTGGAGGA 185 GG 119 ZNF528AGGGAAGCCATTTCT 186 120 LEF1 TCCTTTGATTTGC 187 121 ZNF354CCAATTCAATTATTTT 188 CCATTTAAT 122 FEZF1 TGCTCTTTT 189 123 ZNF274CATACTGGAGAGAAACCCTA 190 124 ZNF41 ACAAGGGAGTAAGGCACCATG 191 A 125SMARCA5 AATGGAATCGAATGGAATC 192 126 ZNF418 TGCTTTTAGCCTCT 193 127 ZNF85AGAAAACTGAAGTAATC 194 128 NFI/3 TGGCACGGTGCCA 195 129 SMAD CTGTCACCTG196 130 OSR2 GCTGCTTCTGC 197 131 PRDM9 AGATGGCAGCAGCATC 198 132 THAP1TGCCCGCA 199 133 ZSCAN3 GCAGCAGGGCAGTTA 200 134 ZNF549 TCATGAATTGGGCAGC201 135 ZNF134 CCTCACCTAATCAGTTGAAG 202 136 ZNF708 TAATAAGCAGGTACAGC 203137 ZNF768 GGCTCAGAGAGGTTAAG 204 138 BATF GTTTCAATATGACT 205 139 AIRETGGTTTTATTGGTTA 206 140 ZNF563 GGATCCTCACTGGCAGCTG 207 141 ZNF667TGGCCTTAAAAGCTCAGC 208 142 ZNF554 CTGAGCCATGTGGGGTGC 209 143 ZNF140ACCCAGCAATTCCGCTCC 210 144 ZFX CCAGGCCTCGG 211 145 YY1 AAAATGGCGGC 212146 ZBTB6 GGTGCTGGAGCC 213 147 SMAD TGTCTGGCACC 214 148 HAND1GTCTGGCATTTGTC 215 149 PRDM14 GGTTAGAGACC 216 150 SPZ1 AGGGTAACAGC 217151 REST/NRSF CAGCACCATGGACAGCGC 218 152 ZNF332 AGCCTGGTACAGAGCCT 219153 ZNF335 GCTGTCCTCGGCGCTGCCTG 220 154 ZNF382 TAGGGTCTGTAGTGATGTCTC 221155 KAISO AATCTCGCGAGA 222 156 E2F/2 GGCGGGAA 223 157 E2F/3 TTTCCCGCCAAA224 158 E2F/4 GCGCCAAA 225 159 NFKB/3 AAGGGAAATTCC 226 160 NFKB/1GGAAATCCCC 227 161 NFKB/2 GGGGAATCCCC 228 162 REL-halfsite GGGGAAT 229163 ZNF282 TTTCCCACAACACG 230 164 FOX/7 TTCCCCACAC 231 165 RBPJGTGGGAAAA 232 166 TEAD ACATTCCAGGCAT 233 167 STAT/1 TTCTCAGGAA 234 168NFAT/4 TTTCCATGGAAA 235 169 BCL6/1 TGCTTTCTAGGAATTC 236 170 BCL6/2CTTTCTAGGAA 237 171 STAT/2 TTCCAGGAA 238 172 ZNF143 ACCCACAATGCATT 239173 ZNF143 GCATGCTGGGAGTTGTAGT 240 174 EBF1 TCCCAAGGGA 241 175 ZBTB48TAGGGACCG 242 176 PRDM16 CCCAGGGG 243 177 ZNF423 GCACCCAGGGGTGC 244 178RUNX/2 ACCGCAAAAACCGC 245 179 RUNX/1 GTCTGTGGTT 246 180 SIX/1GAAACCTGATA 247 181 GFI CTGTGATT 248 182 TATA TATAAAAGG 249 183 MEF2CTATTTTTAG 250 184 SRF ACCATATATGGTC 251 185 HLTF CCTTAT 252 186 E2F/1AAATGGCGCCAAAA 253 187 HIC/1 TGCCAACCTATGCC 254 188 NFI/2 TGCCAA 255 189NFI/1 TTGGCACGGTGCCA 256 190 SOX/6 AACAATGTGCAGTGTT 257 191 SOX/7ATCAATGTGCAGTGAT 258 192 NRF1 TGCGCATGCGC 259 193 ZNF384/1 GAAAAAA 260194 ZNF384/2 AAAAAAA 261 195 HOMEZ AAACGATTAT 262 196 IRF/4AAACGAAAATCGATT 263 197 ZNF586 AGGCCTAGGAGGAAAAAATG 264 198 ZNF24ATTCATTCATT 265 199 MFZ1 TAGGGGGA 266 200 CENBP CCCGCATACAACGAA 267 201GCM ATGCGGGTACC 268 202 SOX/8 TGAATGTGCAGTCA 269 203 FOX/8 CGGACACAAT270 204 HD/23 TACATGACAT 271 205 HD/24 CGCTGTAAA 272 206 MTF1TTTGCACACGGCAC 273 207 SMAD GTCTAGAC 274 208 ZNF146 TTTCATGGCTGCATA 275GTATTCC 209 HSFY2 TCGAAACGTTCGAA 276 210 HD/25 CTAGTTAA 277 211 SPDEF/1TGGTCCCGGATCA 278 212 SPDEF/2 CAGAAAGAAGTAAA 279 213 ZNF524 CCCTCGAACCC280 214 DMRT3 TGTATCA 281 215 DDIT3 + CEBPA TGCAATCCC 282 216 NR2E3AAGCTT 283 217 ZBTB14 GAGCGCGC 284 218 ZNF57 TGCGGCA 285 219 ZNF250ACCATGCTGTTTTGATTA 286 220 ZNF490 GGGTCTCTTGAAGGCAGCATA 287 221 ZNF53ATCCAC 288 222 ZNF784 GTACCTACCT 289 223 GMEB2/1 ACGTAACCACGTA 290 224LIN54 TTTGAAT 291 225 PRDM4 TTTCAAGGCCCCC 292 226 ZBTB49TTTCGCCTGGCACGTC 293 227 ZNF136 GCTGGATATAGTATTC 294 TTGGTT 228 ZNF431ACCAACCTAAGACAGG 295 229 ZNF306 GGTCTAGCCTCG 296 230 ZNF713AGAAAAATGCCACGAA 297 231 ZNF85 GTGGTATATCCATACAATGGA 298 232 ZNF652AAAGGGTTAA 299 233 P53-like/2 ACATGTCTATGACATGT 300 234 P53-like/3ACATGTCCATGGACATGT 301 235 ZNF232 GTTAAATGTAGATTAA 302 236 ZNF410CATCCCATAATA 303 237 ZBED1 TATCGCGACAT 304 238 PROX1 AAGACGCCTT 305 239MBD2 GGGCCGGAG 306 240 OVOL1 TGTAACTGT 307 241 EVI1/MECOM AGATAAGATAAGA308 242 GATA CTTATCTGTC 309 243 HIC/2 GGTTGCC 310 244 ZFN121CTGGGCAACATAGCAAGAC 311 245 RFX/2 GTTGCTAGGCAAC 312 246 RFX/3GCTGTTGCCAGGC 313 247 RFX/1 GTTGCCATGGCAAC 314 248 NR/20 GAACATTGTGTTCC315 249 HSF TTCTAGAACGTTC 316 250 SMARCA1 CAAGAAGAAT 317 251 ZNF680ATGTCCAAGAAGAATGAGG 318 252 MYB/5 GGCAGTTG 319 253 MYB/1 ACCGTTAACGG 320254 MYB/2 CCGTTAAAACCGTT 321 255 MYB/3 ACCGTTAAACGG 322 256 MYB/4AACCGTTA 323 257 P53-like/l ACATGCCCAGACATGC 324 258 GRHL GAAAAACCGGTT325 259 TFCP2 CCGGTTCAAACCGGT 326 260 ZNF329 CTGGATCCAGCCATGCCTGA 327261 GLIS GACCCCCCACGAAG 328 262 GL1 TCGGTGGTCG 329 263 TFAP2/2GCCCTGAGGGC 330 264 TFAP2/1 GCCTGAGGC 331 265 CTCF CCACCAGGGGGCGC 332266 INSM1 TGTCAGGGGGCA 333 267 ZBTB7A GGGGTCT 334 268 PLAG1GGGGCCCAAGGGGG 335 269 ZNF320 GTGGGACCAGGGGGCCAGT 336 270 ZNF331GGCTGGGCTCAGCTGGGTG 337 271 ZNF449 GGTTGGGCT 338 272 ZKSCAN1GGACCTACTGTGTG 339 273 ZIC ACCCCCCGCTGTG 340 274 HINFP1/1 AACGTCCGCG 341275 HINFP1/2 GCGGACGTTGCAACGTCCGC 342 276 HINFP1/3 GCGGACGTTCAACGTCCGC343 277 GMEB2/2 TACGTAA 344 278 GMEB2/3 ACGTAACTGACGTA 345 279 FOX/9AATGACACAGCG 346 280 SIX/2 ATAGGGTATCACT 347 281 PAX/1 GTCACGCATGACTG348 282 PAX/2 GGGCAGCAGAGCGTGAC 349 283 PAX-halfsite GTCACG 350 284 AHRTGCGTG 351 285 KLF/SP/3 CAGGGGGTG 352 286 ZSCAN4 GCACACACTGAAA 353 287SHAPE_ AACCCGGAAGTGAACC 354 positive_ CGGAAGTG controL_ELF2X 288 SHAPE_GCACTTTGTACAGGGT 355 negative_ GCCATCGG control_1 289 SHAPE_GTTTCTGAACTCTCAG 356 negative_ control_2 ATAGTGGG 290 SHAPE_GCGGTCCAACTTAGGC 357 negative_ GTAAACCT control_3 291 SHAPE_CGATGCTACCTACTCA 358 negative_ GACCCACC control_4 292 SHAPE_ATCCCAGCTGGTTCT 359 negative_ TGGCGTTCT control_5

Example 5: Pooled Screening of Mutagenized ELF(2×) Insertion Motifs forSHAPE-Mediated Tunable Protein Expression

We explored the insertion of mutagenized ELF(2×) insertion motifs viaprime editing to achieve tunable target protein expression. To do so, weused the IL2RA promoter due to our previous success in activating IL2RAprotein expression and the ability to sort for its expression as a cellsurface marker (FIG. 20 ). We mutagenized positions across the ELF motifby introducing single base substitutions at the same positions of eachcopy within the ELF(2×) insertion sequence. We mutated the referencebases to all other possible bases at all positions across the 12 bp ELFmotif for a total of 36 unique mutagenized ELF motifs. Additionally, weincluded a positive control wild type ELF(2×) motif which we hadpreviously shown to activate IL2RA protein expression, along with 5negative control sequences (24 bp) created with a random DNA generator.All mutagenized ELF(2×) motifs and control sequences were inserted atthe same position within the IL2RA promoter using the pegRNA spacersequence and ngRNA described previously (Table B, C). The pegRNAconstructs encoding all mutagenized ELF(2×) motifs and controlsequences, in addition to the ngRNA, were pooled anddouble-electroporated into K562 with the electroporation eventsseparated by 72 hours. Seven days after the second electroporationevent, the K562 cells were sorted based on IL2RA protein expression intonegative and positive populations. Genomic DNA was harvested from boththe IL2RA negative and positive populations and targeted ampliconsequencing was performed at the prime editing insertion location. Eachmutagenized ELF(2×) motif was counted within the sequencing reads inboth the negative and positive samples, normalized based on total readcount in each sample, and an enrichment score was calculated (FIG. 23 ).We found that our positive control wild-type ELF(2×) motif exhibited thehighest positive enrichment (FIG. 23 , black), whereas the 5 negativecontrols showed the most negative enrichment (FIG. 23 , dark grey). Thedifferent ELF motif single-base variants ((FIG. 23 , light grey)exhibited varying degrees of enrichment, suggesting the ability of SHAPEto tune target protein expression by mutagenizing transcription factormotifs.

TABLE F Single-base mutagenized ELF motifs fortuning of target gene activation Motif name Motif sequence SEQ ID NO:ELF 1 mutagenesis BACCCGGAAGTG 360 ELF 2 mutagenesis ABCCCGGAAGTG 361ELF 3 mutagenesis AADCCGGAAGTG 362 ELF 4 mutagenesis AACDCGGAAGTG 363ELF 5 mutagenesis AACCDGGAAGTG 364 ELF 6 mutagenesis AACCCHGAAGTG 365ELF 7 mutagenesis AACCCGHAAGTG 366 ELF 8 mutagenesis AACCCGGBAGTG 367ELF 9 mutagenesis AACCCGGABGTG 368 ELF 10 mutagenesis AACCCGGAAHTG 369ELF 11 mutagenesis AACCCGGAAGVG 370 ELF 12 mutagenesis AACCCGGAAGTH 371

Taken together, these results show that it is possible to use precisiongenome engineering via prime editing to install functional transcriptionfactor binding sites, to ultimately promote heritable gene activation.

TABLE G SNPs that affect microRNA binding sites which are associatedwith autoimmune diseases. Table 2 taken from De Almeida et al, Frontiersin Genetics 2018, 9:139. doi: 10.3389/fgene.2018.00139. eCollection2018. Effect eQTL Ref. Minor P- Target on (effect miRSNP chrpos_bp(hg38) allele allele MAF Disease value OR gene miRNA miRNA NBSdirection) rs7559479 2 102452327 A G 0.22 Crohn's 2.2e−10 1.15 IL18RAPhsa- C 0.79 Yes (up) disease miR- 3156-3p Celiac 1.4e−16 1.19 hsa- C0.86 disease miR- 4301 Inflammatory NA NA hsa- C 0.92 bowel miR- disease136 rs7603250 2 102452374 A T 0.22 Crohn's 1.6e−10 0.8 IL18RAP hsa- C0.94 Yes (up) disease miR- 455- 3p Inflammatory 1.8e−09 0.8 boweldisease Celiac NA NA disease rs3732421 3 119431242 A G 0.16 Multiple3.5e−12 0.85 TMEM39A hsa- D 0.72 No sclerosis miR- 449b- 3p Primary1.7e−11 0.72 hsa- D 0.82 biliary miR- cirrhosis 4691- 3p hssa- D 0.92miR- 449b rs57271503 3 119525746 G A 0.16 Multiple 4.1e−15 0.84 CD80hsa- C 0.71 No sclerosis miR- 769- 5p Primary 9.4e−13 0.71 hsa- C 0.80biliary miR- cirrhosis 4802- 5p hsa- C 0.71 miR- 769- 5p rs1054037 4102631552 T C 0.49 Primary 8.3e−10 0.82 MANBA hsa- D 0.90 Yes biliarymiR- (down/ cirrhosis 660 up) Multiple NA NA hsa- D 0.95 sclerosis miR-5591- 3p hsa- D 0.82 miR- 660- 5p hsa- C 0.71 miR- 7151- 5p hsa- C 0.94miR- 3686 rs4013 4 102631656 T C 0.51 Primary NA NA MANBA hsa- C 0.76Yes biliary miR- (down/ cirrhosis 4742- up) 3p Multiple NA NA hsa- C0.91 sclerosis miR- 4778- 5p hsa- C 0.82 miR- 630 rs1054029 4 102631896A G 0.51 Primary NA NA MANBA hsa- D 0.80 Yes biliary miR- (down/cirrhosis 124- up) 5p Multiple NA NA hsa- D 0.99 sclerosis miR- 4255-hsa- D 0.74 miR- 4766- 5p hsa- D 0.90 miR- 124 hsa- D 0.77 miR- 33ars39602 5 97028750 G C 0.41 Ankylosing NA NA LNPEP hsa- D 0.99 Yesspondylitis miR- (down) 6800- 5p Crohn's 6.9e−11 1.1 disease Juvenile NANA idiopathic arthritis rs2070197 7 128948946 T C 0.1 Systemic 3.0e−401.7 IRF5 hsa- D 0.91 Yes lupus miR- (up) erythematosus 3136- 3p Primaryhsa- D 0.89 biliary miR- cirrhosis 7155- 3p rs10114470 9 114785492 C T0.33 Crohn's 1.5e−15 1.1 TNFSF15 hsa- D 0.84 Yes disease miR- (up) 376a-3p Inflammatory 1.5e−15 0.8 hsa- D 0.74 bowel miR- disease 4753- 5prs3088081 9 136375697 A G 0.42 Inflammatory 1.9e−22 0.8 SNAPC4 hsa- C0.80 Yes bowel miR- (down) disease 3661 Crohn's 2.1e−17 0.8 diseaseUlcerative 1.0e−11 0.8 colitis rs9943 13 39752145 A G 0.34 Juvenile NANA COG6 hsa- C 0.98 Yes idiopathic miR- (down) arthritis 628- RheumatoidNA NA 5p arthritis rs3839999 13 99385548 AT A 0.22 Crohn's NA NA UBAC2hsa- C 0.93 No disease miR- Inflammatory NA NA 365a- bowel 3p diseasers907091 17 39765489 C T 0.51 Primary 1.0e−10 0.7 IKZF3 hsa- D 0.97 Yesbiliary miR- (down) cirrhosis 4497 Type 1 NA NA hsa- C 0.85 diabetesmiR- mellitus 3649 Ulcerative 8.1e−09 0.8 hsa- C 0.92 colitis miR- 4518Inflammatory 3.3e−13 0.8 hsa- C 0.99 bowel miR- disease 330- 5p hsa- C0.86 miR- 518c hsa- C 0.84 miR- 4314 hsa- C 0.99 miR- 326 hsa- C 0.73miR- 3192 rs16940681 17 45834793 G C 0.24 Primary NA NA CRHR1 hsa- D0.84 Yes (up) biltary miR- cirrhosis 6740-5p Type 1 NA NA diabetesmellitus rs2316765 17 45835088 T C 0.24 Primary NA NA CRHR1 hsa- D 0.73Yes (up) biltary miR- cirrhosis 3192 Type 1 NA NA hsa- D 0.97 diabetesmiR- mellitus 30c-2- 3p hsa- D 0.90 miR- 30c-1- 3p rs878886 17 45835124C G 0.24 Primary NA NA CRHR1 hsa- D 0.96 Yes (up) biltary miR- cirrhosis4685- Type 1 NA NA 5p diabetes hsa- D 0.71 mellitus miR- 1915- 3p hsa- D0.86 miR- 3918 hsa- D 0.76 miR- 7160- 3p rs878887 17 45835216 C T 0.24Primary NA NA CRHR1 hsa- C 0.85 Yes (up) biltary miR- cirrhosis 198 Type1 NA NA hsa- D 0.88 diabetes miR- mellitus 3186- 5p hsa- C 0.92 miR- 136rs878888 17 45835269 A G 0.24 Primary NA NA CRHR1 hsa- C 0.70 Yes (up)biltary miR- cirrhosis 5708 Type 1 NA NA hsa- D 0.72 diabetes miR-mellitus 1226- 5p rs4640231 17 45835420 G C 0.24 Primary NA NA CRHR1hsa-miR- D 0.81 Yes (up) biltary 6841-5p cirrhosis Type 1 NA NA hsa-miR-D 0.77 diabetes 6755-5p mellitus rs54482334 17 45835464 T C 0.24 PrimaryNA NA CRHR1 hsa-miR- D 0.93 Yes (up) biltary 6890-5p cirrhosis Type 1 NANA hsa-miR- D 0.94 diabetes 6742-5p mellitus hsa-miR- D 0.77 4722-5phsa-miR- D 0.75 6796-5p hsa-miR- D 0.80 4459 rs12373168 17 45846971 A C0.24 Primary NA NA SPPL2C hsa-miR- D 0.87 No biltary 33b-3p cirrhosisType 1 NA NA hsa-miR- D 0.87 diabetes 519e-3p mellitus rs60474474 1812792737 C T 0.14 Inflammatory 1.4e−10 1.1 PTPN2 hsa-miR- D 0.99 Nobowel 4290 disease Crohn's 2.2e−12 1.2 disease Type 1 NA NA diabetesmellitus Celiac NA NA disease Juvenile NA NA idiopathic arthritisrs45450798 18 12792941 C G 0.14 Inflammatory 2.0e−10 0.8 PTPN2 hsa-miR-D 0.73 No bowel 4531 disease Crohn's 2.9e−12 0.8 disease Type 1 NA NAdiabetes mellitus Celiac NA NA disease Juvenile NA NA idiopathicarthritis rs9950174 18 69846569 T C 0.53 Psoriasis NA NA CD226 hsa-miR-D 0.85 Yes 5189-3p (up) rs727088 18 69863203 G A 0.53 Inflammatory4.6e−9 1.08 CD226 hsa-miR- D 0.75 Yes bowel 513a-3p (up) diseaseUlcerative 1.9e−8 1.1 hsa-miR- D 0.75 colitis 181c Psoriasis NA NArs571689 19 48704297 C T 0.47 Crohn's 7.3e−09 1.1 FUT2 hsa-miR- D 0.89Yes disease 648 (down) Type 1 NA NA hsa-miR- C 0.92 diabetes 552-3pmellitus rs570794 19 48704394 T C 0.47 Crohn's 1.0e−08 0.8 FUT2 hsa-miR-D 0.71 Yes disease 4430 (down) Type 1 NA NA hsa-miR- C 0.79 diabetes1295b- mellitus 5p hsa-miR- C 0.95 4463 hsa-miR- C 0.94 1912 rs507766 1948705286 T C 0.47 Crohn's 1.4e−08 0.8 FUT2 hsa-miR- C 0.83 Yes disease136-5p (down) Type 1 NA NA hsa- C 0.80 diabetes miR- mellitus 675hsa-miR- C 0.92 887 hsa-miR- C 0.73 410 hsa-miR- C 0.75 191 rs506897 1948705372 G C 0.47 Crohn's 7.3e−09 1.1 FUT2 hsa-miR- C 0.81 Yes disease4530 (down) Type 1 NA NA diabetes mellitus rs503279 19 48705753 T C 0.47Crohn's 6.7e−09 0.8 FUT2 hsa-miR- C 0.86 Yes disease 675-3p (down) Type1 NA NA diabetes mellitus rs1056441 20 63738996 C T 0.28 Crohn's 5.4e−110.8 LIME1 hsa-miR- C 0.97 Yes disease 4745-3p (down) Inflammatory1.5e−15 0.8 hsa-miR- C 0.97 bowel disease 1538 hsa-miR- C 0.87 4467hsa-miR- C 0.78 6770-3p hsa-miR- D 0.82 3940-3p hsa-miR- D 0.94 762rs7444 22 21622645 T C 0.2 Systemic 1.8e−22 1.27 UBE2L3 hsa-miR- D 0.90Yes lupus 4741 (up) erythematosus Crohn's 1.3e−12 1.1 hsa-miR- D 0.89disease 4763-3p Inflammatory 6.9e−10 0.8 hsa-miR- D 0.86 bowel disease3918 hsa-miR- D 0.92 1207-5p rs7445 22 21622758 C T 0.19 Crohn's 6.3e−091.1 UBE2L3 hsa-miR- C 0.93 Yes disease 3064-5p (up) Inflammatory 3.5e−101.1 bowel disease Systemic 1.0e−12 1.27 lupus erythematosus NA, P-valuewas not available in the source study but this miRSNP (SNPs that canaffect miRNA binding) is in linkage disequilibrium (r² ≥ 0.8) with themost associated SNP reported; P-value obtained from each study. Bold:reported as associated in the original study. C, creates a binding site;D, disrupts a binding site; chr, chromosome; MAF, global minor allelefrequency from the 1000 Genomes project; up, upregulated effect; down,downregulated effect; pos bp, position in base pair; OR, odds ratio. ORwas calculated based on the minor allele of the respective variant;eQTL, expression quantitative trait locus; NBC, naïve Bayes combinedscore. Table 2 and legend adapted from De Almeida et al, Frontiers inGenetics 9:139 2018 (PMID 29755505)

TABLE H Organ, tissue or cell-specific miRNAs from the miRWalk 2.0database Organ/Tissue/Cell type miRNA MIMATid PMID Adherens Junctionshsa-miR-1 MIMAT0000416 23142026 Adipocytes bta-miR-29a MIMAT000351817652184 Adipocytes bta-miR-29c MIMAT0003829 17652184 Adipocytescfa-miR-29a MIMAT0006626 17652184 Adipocytes cfa-miR-29c MIMAT000670517652184 Adipocytes dre-miR-29a MIMAT0001802 17652184 Adipocyteshsa-miR-125a-5p MIMAT0000443 19011087 Adipocytes hsa-miR-125b-5pMIMAT0000423 19011087 Adipocytes hsa-miR-132-3p MIMAT0000426 19819989Adipocytes hsa-miR-138-5p MIMAT0000430 20486779 Adipocyteshsa-miR-141-3p MIMAT0000432 20005803 Adipocytes hsa-miR-143-3pMIMAT0000435 15504739 Adipocytes hsa-miR-199a-5p MIMAT0000231 19011087Adipocytes hsa-miR-199a-5p MIMAT0000231 22441842 Adipocyteshsa-miR-200a-3p MIMAT0000682 20005803 Adipocytes hsa-miR-200b-3pMIMAT0000318 20005803 Adipocytes hsa-miR-200c-3p MIMAT0000617 20005803Adipocytes hsa-miR-21-5p MIMAT0000076 21381024 Adipocytes hsa-miR-26a-5pMIMAT0000082 19011087 Adipocytes hsa-miR-27b-3p MIMAT0000419 19800867Adipocytes hsa-miR-346 MIMAT0000773 19011087 Adipocytes hsa-miR-429MIMAT0001536 20005803 Adipocytes hsa-miR-519d-3p MIMAT0002853 20057369Adipocytes hsa-miR-637 MIMAT0003307 21880893 Adipocytes mmu-miR-17-5pMIMAT0000649 18287052 Adipocytes mmu-miR-204-5p MIMAT0000237 20039258Adipocytes mmu-miR-211-5p MIMAT0000668 20039258 Adipocytesmmu-miR-29a-3p MIMAT0000535 17652184 Adipocytes mmu-miR-29b-3pMIMAT0000127 17652184 Adipocytes mmu-miR-29c-3p MIMAT0000536 17652184Adipocytes mmu-miR-448-3p MIMAT0001533 20719859 Adipocytes ppy-miR-29aMIMAT0002363 17652184 Adipocytes ppy-miR-29c MIMAT0015735 17652184Adipocytes ptr-miR-29a MIMAT0002364 17652184 Adipocytes ptr-miR-29cMIMAT0008082 17652184 Adipocytes rno-miR-29a-3p MIMAT0000802 17652184Adipocytes rno-miR-29b-3p MIMAT0000801 17652184 Adipocytesrno-miR-29c-3p MIMAT0000803 17652184 Adipocytes ssc-miR-29a MIMAT001387017652184 Adipocytes ssc-miR-29c MIMAT0002166 17652184 Adipocytesxtr-miR-29a MIMAT0003656 17652184 Adipose Tissue hsa-miR-132-3pMIMAT0000426 19819989 Adipose Tissue hsa-miR-141-3p MIMAT000043220005803 Adipose Tissue hsa-miR-196a-5p MIMAT0000226 19063684 AdiposeTissue hsa-miR-200a-3p MIMAT0000682 20005803 Adipose Tissuehsa-miR-200b-3p MIMAT0000318 20005803 Adipose Tissue hsa-miR-200c-3pMIMAT0000617 20005803 Adipose Tissue hsa-miR-21-5p MIMAT0000076 21381024Adipose Tissue hsa-miR-21-5p MIMAT0000076 19816956 Adipose Tissuehsa-miR-26a-5p MIMAT0000082 18197755 Adipose Tissue hsa-miR-429MIMAT0001536 20005803 Adipose Tissue hsa-miR-519d-3p MIMAT000285320057369 Adipose Tissue mmu-miR-200b-3p MIMAT0000233 19787069 AdiposeTissue mmu-miR-200c-3p MIMAT0000657 19787069 Adipose Tissuemmu-miR-346-5p MIMAT0000597 19780716 Adipose Tissue White hsa-miR-21-5pMIMAT0000076 21381024 Adrenal Cortex hsa-miR-200b-3p MIMAT000031819849700 Adrenal Glands mmu-miR-101a-3p MIMAT0000133 22128032 AdrenalGlands mmu-miR-142-3p MIMAT0000155 22128032 Adrenal Glandsmmu-miR-433-3p MIMAT0001420 22128032 Adrenal Glands mmu-miR-96-5pMIMAT0000541 22128032 Adult Stem Cells hsa-miR-34a-5p MIMAT000025517252019 Adult Stem Cells mmu-miR-1a-3p MIMAT0000123 20819939 Adult StemCells mmu-miR-206-3p MIMAT0000239 20819939 Amacrine Cells hsa-miR-182-5pMIMAT0000259 17597072 Amacrine Cells hsa-miR-96-5p MIMAT0000095 17597072Amygdala hsa-miR-183-5p MIMAT0000261 19711202 Amygdala rno-miR-183-5pMIMAT0000860 19711202 Aorta hsa-miR-10a-5p MIMAT0000253 20624982 Aortahsa-miR-21-5p MIMAT0000076 22034194 Aorta mmu-miR-130a-3p MIMAT000014121753805 Aorta mmu-miR-15a-5p MIMAT0000526 21305018 Aorta mmu-miR-497-5pMIMAT0003453 21305018 Aorta Thoracic hsa-miR-10a-5p MIMAT000025320624982 Aorta Thoracic mmu-miR-130a-3p MIMAT0000141 21753805 Arterieshsa-miR-1 MIMAT0000416 21051663 Arteries hsa-miR-155-5p MIMAT000064623108656 Arteries hsa-miR-195-5p MIMAT0000461 22802111 Arterieshsa-miR-204-5p MIMAT0000265 22871591 Arteries hsa-miR-21-5p MIMAT000007622034194 Arteries hsa-miR-21-5p MIMAT0000076 17478730 Arterieshsa-miR-221-3p MIMAT0000278 19150885 Arteries hsa-miR-222-3pMIMAT0000279 19150885 Arteries hsa-miR-31-5p MIMAT0000089 23518389Arteries hsa-miR-616-3p MIMAT0004805 23497787 Arteries mmu-miR-100-3pMIMAT0017051 21339483 Arteries mmu-miR-100-5p MIMAT0000655 21339483Arteries mmu-miR-130a-3p MIMAT0000141 21753805 Arteries rno-miR-145-5pMIMAT0000851 19542014 Arteries rno-miR-21-5p MIMAT0000790 17478730Arteries rno-miR-21-5p MIMAT0000790 22565856 Arteries rno-miR-221-3pMIMAT0000890 19150885 Arteries rno-miR-222-3p MIMAT0000891 19150885Arteries rno-miR-31a-5p MIMAT0000810 19542014 Arteries rno-miR-31a-5pMIMAT0000810 22020941 Astrocytes hsa-miR-125b-5p MIMAT0000423 20347935Astrocytes hsa-miR-326 MIMAT0000756 20667897 Astrocytes hsa-miR-34a-5pMIMAT0000255 19773441 Astrocytes mmu-miR-146a-5p MIMAT0000158 21730286Astrocytes mmu-miR-155-5p MIMAT0000165 21247879 Astrocytesmmu-miR-298-5p MIMAT0000376 21247879 Astrocytes mmu-miR-351-5pMIMAT0000609 21247879 Axons rno-miR-338-3p MIMAT0000581 19020050B-Lymphocytes hsa-let-7a-5p MIMAT0000062 18583325 B-Lymphocyteshsa-miR-107 MIMAT0000104 19692702 B-Lymphocytes hsa-miR-125b-5pMIMAT0000423 20497960 B-Lymphocytes hsa-miR-127-3p MIMAT0000446 19530237B-Lymphocytes hsa-miR-143-3p MIMAT0000435 17892514 B-Lymphocyteshsa-miR-145-5p MIMAT0000437 21360565 B-Lymphocytes hsa-miR-153-3pMIMAT0000439 19676043 B-Lymphocytes hsa-miR-155-5p MIMAT0000646 18262046B-Lymphocytes hsa-miR-155-5p MIMAT0000646 21062812 B-Lymphocyteshsa-miR-155-5p MIMAT0000646 19759154 B-Lymphocytes hsa-miR-155-5pMIMAT0000646 20427544 B-Lymphocytes hsa-miR-155-5p MIMAT0000646 19177201B-Lymphocytes hsa-miR-155-5p MIMAT0000646 17881434 B-Lymphocyteshsa-miR-15a-5p MIMAT0000068 21205967 B-Lymphocytes hsa-miR-16-5pMIMAT0000069 21205967 B-Lymphocytes hsa-miR-17-5p MIMAT0000070 20227518B-Lymphocytes hsa-miR-17-5p MIMAT0000070 18941111 B-Lymphocyteshsa-miR-17-5p MIMAT0000070 19666108 B-Lymphocytes hsa-miR-181a-5pMIMAT0000256 19692702 B-Lymphocytes hsa-miR-181a-5p MIMAT000025620841506 B-Lymphocytes hsa-miR-181b-5p MIMAT0000257 19692702B-Lymphocytes hsa-miR-181b-5p MIMAT0000257 17178851 B-Lymphocyteshsa-miR-196b-5p MIMAT0001080 23293219 B-Lymphocytes hsa-miR-20a-5pMIMAT0000075 19666108 B-Lymphocytes hsa-miR-20a-5p MIMAT0000075 18941111B-Lymphocytes hsa-miR-21-5p MIMAT0000076 21317927 B-Lymphocyteshsa-miR-21-5p MIMAT0000076 21078976 B-Lymphocytes hsa-miR-29a-3pMIMAT0000086 20086245 B-Lymphocytes hsa-miR-29b-3p MIMAT0000100 17178851B-Lymphocytes hsa-miR-29b-3p MIMAT0000100 20086245 B-Lymphocyteshsa-miR-29c-3p MIMAT0000681 20086245 B-Lymphocytes hsa-miR-34a-5pMIMAT0000255 21205967 B-Lymphocytes hsa-miR-34a-5p MIMAT0000255 20598588B-Lymphocytes hsa-miR-34b-3p MIMAT0004676 21205967 B-Lymphocyteshsa-miR-34c-5p MIMAT0000686 21205967 B-Lymphocytes hsa-miR-424-5pMIMAT0001341 21062812 B-Lymphocytes hsa-miR-424-5p MIMAT0001341 19692702B-Lymphocytes hsa-miR-9-5p MIMAT0000441 18583325 B-Lymphocytesmmu-miR-149-5p MIMAT0000159 18762567 B-Lymphocytes mmu-miR-155-5pMIMAT0000165 18450484 B-Lymphocytes mmu-miR-155-5p MIMAT0000165 18455451B-Lymphocytes mmu-miR-155-5p MIMAT0000165 18055230 B-Lymphocytesmmu-miR-181b-5p MIMAT0000673 18762567 B-Lymphocytes mmu-miR-19b-3pMIMAT0000513 18762567 B-Lymphocytes mmu-miR-223-3p MIMAT0000665 20935160B-Lymphocytes mmu-miR-30b-5p MIMAT0000130 18762567 B-Lymphocytesmmu-miR-34a-5p MIMAT0000542 20598588 Back hsa-miR-101-3p MIMAT000009919818710 Back hsa-miR-122-5p MIMAT0000421 17179747 Back hsa-miR-199a-5pMIMAT0000231 19818710 Back hsa-miR-214-3p MIMAT0000271 19818710 Backhsa-miR-98-5p MIMAT0000096 19818710 Back mmu-miR-122-5p MIMAT000024617179747 Back mmu-miR-137-3p MIMAT0000149 20368621 Back mmu-miR-214-3pMIMAT0000661 19818710 Basement Membrane mmu-miR-200b-3p MIMAT000023319787069 Basement Membrane mmu-miR-200c-3p MIMAT0000657 19787069 Bilehsa-miR-122-5p MIMAT0000421 20351063 Bile hsa-miR-15a-5p MIMAT000006818949056 Bile hsa-miR-30a-5p MIMAT0000087 19185580 Bile hsa-miR-34a-5pMIMAT0000255 20185821 Bile hsa-miR-422a MIMAT0001339 20351063 Bilemmu-miR-23b-3p MIMAT0000125 19582816 Bile mmu-miR-24-3p MIMAT000021919582816 Bile mmu-miR-27b-3p MIMAT0000126 19582816 Bile mmu-miR-30a-5pMIMAT0000128 19185580 Bile rno-miR-150-5p MIMAT0000853 19892940 Bilerno-miR-194-5p MIMAT0000869 19892940 Bile Ducts hsa-miR-15a-5pMIMAT0000068 18949056 Bile Ducts mmu-miR-23b-3p MIMAT0000125 19582816Bile Ducts mmu-miR-24-3p MIMAT0000219 19582816 Bile Ducts mmu-miR-27b-3pMIMAT0000126 19582816 Blastocyst hsa-miR-19a-3p MIMAT0000073 19296935Blastocyst hsa-miR-24-3p MIMAT0000080 19296935 Blastocystmmu-miR-101a-3p MIMAT0000133 17848513 Blastocyst mmu-miR-199a-3pMIMAT0000230 17848513 Blastocyst mmu-miR-21a-5p MIMAT0000530 18556655Blood bta-miR-155 MIMAT0009241 20735984 Blood cfa-miR-155 MIMAT000667120735984 Blood dre-miR-155 MIMAT0001851 20735984 Blood gga-miR-155MIMAT0001106 20735984 Blood hsa-let-7a-5p MIMAT0000062 19939273 Bloodhsa-let-7c-3p MIMAT0026472 19939273 Blood hsa-let-7c-5p MIMAT000006419939273 Blood hsa-let-7d-3p MIMAT0004484 19939273 Blood hsa-let-7d-5pMIMAT0000065 19939273 Blood hsa-let-7e-3p MIMAT0004485 19939273 Bloodhsa-let-7e-5p MIMAT0000066 19939273 Blood hsa-let-7g-3p MIMAT000458419939273 Blood hsa-let-7g-5p MIMAT0000414 19939273 Blood hsa-let-7i-3pMIMAT0004585 19939273 Blood hsa-let-7i-5p MIMAT0000415 19939273 Bloodhsa-miR-124-3p MIMAT0000422 19944075 Blood hsa-miR-126-3p MIMAT000044522867989 Blood hsa-miR-129-5p MIMAT0000242 18189265 Bloodhsa-miR-130b-3p MIMAT0000691 18974142 Blood hsa-miR-135a-5p MIMAT000042819944075 Blood hsa-miR-135b-5p MIMAT0000758 19795981 Bloodhsa-miR-146a-5p MIMAT0000449 19333922 Blood hsa-miR-146a-5p MIMAT000044920459811 Blood hsa-miR-146a-5p MIMAT0000449 18759964 Bloodhsa-miR-148a-3p MIMAT0000243 19435428 Blood hsa-miR-155-5p MIMAT000064620735984 Blood hsa-miR-155-5p MIMAT0000646 18950466 Blood hsa-miR-155-5pMIMAT0000646 17668390 Blood hsa-miR-15a-5p MIMAT0000068 21205967 Bloodhsa-miR-16-5p MIMAT0000069 21885851 Blood hsa-miR-16-5p MIMAT000006921205967 Blood hsa-miR-181a-5p MIMAT0000256 20558617 Bloodhsa-miR-181c-5p MIMAT0000258 21112091 Blood hsa-miR-184 MIMAT000045419286996 Blood hsa-miR-195-5p MIMAT0000461 20952681 Blood hsa-miR-19b-3pMIMAT0000074 19435428 Blood hsa-miR-20a-5p MIMAT0000075 19435428 Bloodhsa-miR-214-3p MIMAT0000271 19435428 Blood hsa-miR-221-3p MIMAT000027820505758 Blood hsa-miR-221-3p MIMAT0000278 20516212 Blood hsa-miR-223-3pMIMAT0000280 19278969 Blood hsa-miR-223-3p MIMAT0000280 19017354 Bloodhsa-miR-29a-3p MIMAT0000086 19102781 Blood hsa-miR-29a-3p MIMAT000008619951903 Blood hsa-miR-29b-3p MIMAT0000100 19102781 Blood hsa-miR-31-3pMIMAT0004504 19408243 Blood hsa-miR-31-5p MIMAT0000089 19408243 Bloodhsa-miR-320a MIMAT0000510 18523662 Blood hsa-miR-34a-5p MIMAT000025521205967 Blood hsa-miR-34b-3p MIMAT0004676 21205967 Blood hsa-miR-34c-5pMIMAT0000686 21205967 Blood hsa-miR-381-3p MIMAT0000736 21435336 Bloodhsa-miR-409-3p MIMAT0001639 23360331 Blood hsa-miR-424-5p MIMAT000134120972335 Blood hsa-miR-424-5p MIMAT0001341 21885851 Blood hsa-miR-503-5pMIMAT0002874 21220732 Blood hsa-miR-520h MIMAT0002867 18189265 Bloodhsa-miR-520h MIMAT0002867 19435428 Blood hsa-miR-663a MIMAT000332620622002 Blood hsa-miR-9-5p MIMAT0000441 16831872 Blood hsa-miR-92a-3pMIMAT0000092 19460962 Blood hsa-miR-92a-3p MIMAT0000092 19435428 Bloodhsa-miR-93-5p MIMAT0000093 20956944 Blood hsa-miR-93-5p MIMAT000009318974142 Blood mml-miR-155 MIMAT0006216 20735984 Blood mmu-miR-100-3pMIMAT0017051 21339483 Blood mmu-miR-100-5p MIMAT0000655 21339483 Bloodmmu-miR-125b-5p MIMAT0000136 21118986 Blood mmu-miR-126a-3p MIMAT000013818694565 Blood mmu-miR-223-3p MIMAT0000665 22043014 Blood ppy-miR-155MIMAT0015777 20735984 Blood ptr-miR-155 MIMAT0008048 20735984 Bloodrno-let-7a-5p MIMAT0000774 18258830 Blood rno-let-7b-3p MIMAT000470518258830 Blood rno-let-7b-5p MIMAT0000775 18258830 Blood rno-let-7c-5pMIMAT0000776 18258830 Blood rno-let-7d-3p MIMAT0000563 18258830 Bloodrno-let-7d-5p MIMAT0000562 18258830 Blood rno-let-7e-3p MIMAT000470618258830 Blood rno-let-7e-5p MIMAT0000777 18258830 Blood rno-let-7f-5pMIMAT0000778 18258830 Blood rno-let-7i-3p MIMAT0004707 18258830 Bloodrno-let-7i-5p MIMAT0000779 18258830 Blood rno-miR-100-5p MIMAT000082218258830 Blood rno-miR-101a-3p MIMAT0000823 18258830 Bloodrno-miR-101b-3p MIMAT0000615 18258830 Blood rno-miR-124-3p MIMAT000082818258830 Blood rno-miR-125a-5p MIMAT0000829 18258830 Bloodrno-miR-129-5p MIMAT0000600 18258830 Blood rno-miR-130a-3p MIMAT000083618258830 Blood rno-miR-132-3p MIMAT0000838 18258830 Blood rno-miR-134-5pMIMAT0000840 18258830 Blood rno-miR-138-5p MIMAT0000844 18258830 Bloodrno-miR-139-5p MIMAT0000845 18258830 Blood rno-miR-150-5p MIMAT000085318258830 Blood rno-miR-181b-5p MIMAT0000859 18258830 Bloodrno-miR-185-5p MIMAT0000862 18258830 Blood rno-miR-204-5p MIMAT000087718258830 Blood rno-miR-21-5p MIMAT0000790 18258830 Blood rno-miR-214-3pMIMAT0000885 18258830 Blood rno-miR-215 MIMAT0003118 18258830 Bloodrno-miR-218a-5p MIMAT0000888 18258830 Blood rno-miR-223-3p MIMAT000089218258830 Blood rno-miR-23a-3p MIMAT0000792 18258830 Blood rno-miR-23b-3pMIMAT0000793 18258830 Blood rno-miR-24-3p MIMAT0000794 18258830 Bloodrno-miR-25-3p MIMAT0000795 18258830 Blood rno-miR-26b-5p MIMAT000079718258830 Blood rno-miR-27a-3p MIMAT0000799 18258830 Blood rno-miR-290MIMAT0000893 18258830 Blood rno-miR-292-5p MIMAT0000896 18258830 Bloodrno-miR-293-5p MIMAT0012847 18258830 Blood rno-miR-298-5p MIMAT000090018258830 Blood rno-miR-29a-3p MIMAT0000802 18258830 Blood rno-miR-29b-3pMIMAT0000801 18258830 Blood rno-miR-29c-3p MIMAT0000803 18258830 Bloodrno-miR-301a-3p MIMAT0000552 18258830 Blood rno-miR-30a-3p MIMAT000080918258830 Blood rno-miR-30a-5p MIMAT0000808 18258830 Blood rno-miR-30b-5pMIMAT0000806 18258830 Blood rno-miR-30c-5p MIMAT0000804 18258830 Bloodrno-miR-30e-5p MIMAT0000805 18258830 Blood rno-miR-320-3p MIMAT000090318258830 Blood rno-miR-322-5p MIMAT0001619 18258830 Blood rno-miR-324-5pMIMAT0000553 18258830 Blood rno-miR-327 MIMAT0000561 18258830 Bloodrno-miR-328a-3p MIMAT0000564 18258830 Blood rno-miR-331-3p MIMAT000057018258830 Blood rno-miR-338-3p MIMAT0000581 18258830 Blood rno-miR-342-3pMIMAT0000589 18258830 Blood rno-miR-342-5p MIMAT0004652 18258830 Bloodrno-miR-34a-5p MIMAT0000815 18258830 Blood rno-miR-374-5p MIMAT000320818258830 Blood rno-miR-382-5p MIMAT0003201 18258830 Blood rno-miR-383-5pMIMAT0003114 18258830 Blood rno-miR-409a-3p MIMAT0003205 18258830 Bloodrno-miR-485-5p MIMAT0003203 18258830 Blood rno-miR-494-3p MIMAT000319318258830 Blood rno-miR-497-5p MIMAT0003383 18258830 Blood rno-miR-543-5pMIMAT0004787 18258830 Blood rno-miR-664-3p MIMAT0003382 18258830 Bloodrno-miR-7a-5p MIMAT0000606 18258830 Blood rno-miR-92a-3p MIMAT000081618258830 Blood rno-miR-98-5p MIMAT0000819 18258830 Blood rno-miR-99a-5pMIMAT0000820 18258830 Blood rno-miR-99b-5p MIMAT0000821 18258830 Bloodrno-miR-9a-5p MIMAT0000781 18258830 Blood rno-miR-9a-5p MIMAT000078116831872 Blood xtr-miR-155 MIMAT0003608 20735984 Blood Cellshsa-miR-148a-3p MIMAT0000243 19435428 Blood Cells hsa-miR-19b-3pMIMAT0000074 19435428 Blood Cells hsa-miR-20a-5p MIMAT0000075 19435428Blood Cells hsa-miR-214-3p MIMAT0000271 19435428 Blood Cellshsa-miR-520h MIMAT0002867 19435428 Blood Cells hsa-miR-92a-3pMIMAT0000092 19435428 Blood Cells mmu-miR-125b-5p MIMAT0000136 21118986Blood Platelets hsa-let-7a-5p MIMAT0000062 19939273 Blood Plateletshsa-let-7a-5p MIMAT0000062 20445018 Blood Platelets hsa-let-7c-3pMIMAT0026472 19939273 Blood Platelets hsa-let-7c-5p MIMAT000006420445018 Blood Platelets hsa-let-7c-5p MIMAT0000064 19939273 BloodPlatelets hsa-let-7d-3p MIMAT0004484 19939273 Blood Plateletshsa-let-7d-5p MIMAT0000065 20445018 Blood Platelets hsa-let-7d-5pMIMAT0000065 21266476 Blood Platelets hsa-let-7d-5p MIMAT000006519939273 Blood Platelets hsa-let-7e-3p MIMAT0004485 19939273 BloodPlatelets hsa-let-7e-5p MIMAT0000066 19939273 Blood Plateletshsa-let-7e-5p MIMAT0000066 20445018 Blood Platelets hsa-let-7f-5pMIMAT0000067 20445018 Blood Platelets hsa-let-7g-3p MIMAT000458419939273 Blood Platelets hsa-let-7g-5p MIMAT0000414 19939273 BloodPlatelets hsa-let-7i-3p MIMAT0004585 19939273 Blood Plateletshsa-let-7i-5p MIMAT0000415 19939273 Blood Platelets hsa-miR-10a-5pMIMAT0000253 16549775 Blood Platelets hsa-miR-130a-3p MIMAT000042516549775 Blood Platelets hsa-miR-146b-3p MIMAT0004766 21266476 BloodPlatelets hsa-miR-151a-5p MIMAT0004697 20445018 Blood Plateletshsa-miR-28-5p MIMAT0000085 20445018 Blood Platelets hsa-miR-520a-3pMIMAT0002834 23389994 Blood Platelets hsa-miR-520b MIMAT0002843 23389994Blood Platelets hsa-miR-520e MIMAT0002825 23389994 Blood Plateletshsa-miR-708-3p MIMAT0004927 20445018 Blood Platelets hsa-miR-98-5pMIMAT0000096 20445018 Blood Vessels hsa-miR-126-3p MIMAT0000445 22867989Blood Vessels hsa-miR-16-5p MIMAT0000069 21885851 Blood Vesselshsa-miR-221-3p MIMAT0000278 20516212 Blood Vessels hsa-miR-424-5pMIMAT0001341 21885851 Blood Vessels hsa-miR-92a-3p MIMAT0000092 19460962Blood Vessels hsa-miR-93-5p MIMAT0000093 20956944 Blood Vesselsmmu-miR-100-3p MIMAT0017051 21339483 Blood Vessels mmu-miR-100-5pMIMAT0000655 21339483 Blood Vessels mmu-miR-126a-3p MIMAT000013818694565 Blood-Brain Barrier mmu-miR-15a-5p MIMAT0000526 20445066 BodilySecretions hsa-let-7d-5p MIMAT0000065 21616524 Bodily Secretionshsa-let-7f-5p MIMAT0000067 21616524 Bodily Secretions hsa-let-7g-5pMIMAT0000414 21616524 Bodily Secretions hsa-let-7i-5p MIMAT000041521616524 Bodily Secretions hsa-miR-107 MIMAT0000104 20489155 BodilySecretions hsa-miR-124-3p MIMAT0000422 19404929 Bodily Secretionshsa-miR-125a-5p MIMAT0000443 19011087 Bodily Secretions hsa-miR-125b-5pMIMAT0000423 19011087 Bodily Secretions hsa-miR-126-3p MIMAT000044520083669 Bodily Secretions hsa-miR-146a-5p MIMAT0000449 21236257 BodilySecretions hsa-miR-146a-5p MIMAT0000449 20181935 Bodily Secretionshsa-miR-15a-5p MIMAT0000068 19144710 Bodily Secretions hsa-miR-16-5pMIMAT0000069 19144710 Bodily Secretions hsa-miR-17-5p MIMAT000007020406904 Bodily Secretions hsa-miR-181a-5p MIMAT0000256 22956783 BodilySecretions hsa-miR-184 MIMAT0000454 19286996 Bodily Secretionshsa-miR-199a-5p MIMAT0000231 19011087 Bodily Secretions hsa-miR-19a-3pMIMAT0000073 22105995 Bodily Secretions hsa-miR-19b-3p MIMAT000007422105995 Bodily Secretions hsa-miR-20a-5p MIMAT0000075 20406904 BodilySecretions hsa-miR-21-5p MIMAT0000076 21469086 Bodily Secretionshsa-miR-214-3p MIMAT0000271 22227154 Bodily Secretions hsa-miR-26a-5pMIMAT0000082 19011087 Bodily Secretions hsa-miR-29a-3p MIMAT000008621276447 Bodily Secretions hsa-miR-29a-3p MIMAT0000086 21665270 BodilySecretions hsa-miR-29b-3p MIMAT0000100 21665270 Bodily Secretionshsa-miR-29b-3p MIMAT0000100 20479936 Bodily Secretions hsa-miR-30a-5pMIMAT0000087 23338554 Bodily Secretions hsa-miR-33a-5p MIMAT000009123453925 Bodily Secretions hsa-miR-346 MIMAT0000773 19011087 BodilySecretions hsa-miR-375 MIMAT0000728 15538371 Bodily Secretionshsa-miR-378a-3p MIMAT0000732 19844573 Bodily Secretions hsa-miR-9-5pMIMAT0000441 19008124 Bodily Secretions hsa-miR-9-5p MIMAT000044119572217 Bodily Secretions hsa-miR-9-5p MIMAT0000441 20479936 BodilySecretions hsa-miR-98-5p MIMAT0000096 21616524 Bodily Secretionsmmu-miR-124-3p MIMAT0000134 17462994 Bodily Secretions mmu-miR-133a-3pMIMAT0000145 19043405 Bodily Secretions mmu-miR-206-3p MIMAT000023919043405 Bodily Secretions mmu-miR-21a-5p MIMAT0000530 19043405 BodilySecretions mmu-miR-29a-3p MIMAT0000535 21665270 Bodily Secretionsmmu-miR-29b-3p MIMAT0000127 21665270 Bodily Secretions mmu-miR-375-3pMIMAT0000739 20224724 Bodily Secretions mmu-miR-375-3p MIMAT000073915538371 Bodily Secretions mmu-miR-9-5p MIMAT0000142 21288303 BodilySecretions mmu-miR-93-5p MIMAT0000540 20501654 Bodily Secretionsrno-miR-150-5p MIMAT0000853 19892940 Bodily Secretions rno-miR-194-5pMIMAT0000869 19892940 Bone and Bones bta-miR-130a MIMAT0009223 17855557Bone and Bones bta-miR-335 MIMAT0009291 18185580 Bone and Bonescfa-miR-130a MIMAT0006631 17855557 Bone and Bones cfa-miR-335MIMAT0006624 18185580 Bone and Bones dre-miR-130a MIMAT0001826 17855557Bone and Bones hsa-miR-100-5p MIMAT0000098 22684006 Bone and Boneshsa-miR-106b-5p MIMAT0000680 18728182 Bone and Bones hsa-miR-125a-5pMIMAT0000443 19011087 Bone and Bones hsa-miR-125b-5p MIMAT000042319011087 Bone and Bones hsa-miR-125b-5p MIMAT0000423 19738052 Bone andBones hsa-miR-126-3p MIMAT0000445 18474618 Bone and Bones hsa-miR-126-3pMIMAT0000445 18832181 Bone and Bones hsa-miR-130a-3p MIMAT000042517855557 Bone and Bones hsa-miR-133a-3p MIMAT0000427 23069713 Bone andBones hsa-miR-135b-5p MIMAT0000758 19795981 Bone and Boneshsa-miR-140-5p MIMAT0000431 21576357 Bone and Bones hsa-miR-141-3pMIMAT0000432 19454767 Bone and Bones hsa-miR-142-3p MIMAT000043421394831 Bone and Bones hsa-miR-145-5p MIMAT0000437 23355420 Bone andBones hsa-miR-145-5p MIMAT0000437 18474618 Bone and Boneshsa-miR-146a-5p MIMAT0000449 18174313 Bone and Bones hsa-miR-148a-3pMIMAT0000243 19435428 Bone and Bones hsa-miR-155-5p MIMAT000064618299402 Bone and Bones hsa-miR-155-5p MIMAT0000646 20427544 Bone andBones hsa-miR-155-5p MIMAT0000646 20133617 Bone and Bones hsa-miR-16-5pMIMAT0000069 19738602 Bone and Bones hsa-miR-17-5p MIMAT0000070 19390056Bone and Bones hsa-miR-181a-5p MIMAT0000256 22956783 Bone and Boneshsa-miR-181a-5p MIMAT0000256 18728182 Bone and Bones hsa-miR-181b-5pMIMAT0000257 18728182 Bone and Bones hsa-miR-196a-5p MIMAT000022620480203 Bone and Bones hsa-miR-199a-5p MIMAT0000231 22441842 Bone andBones hsa-miR-199a-5p MIMAT0000231 19011087 Bone and Boneshsa-miR-19a-3p MIMAT0000073 18728182 Bone and Bones hsa-miR-19a-3pMIMAT0000073 19390056 Bone and Bones hsa-miR-19b-3p MIMAT000007419435428 Bone and Bones hsa-miR-19b-3p MIMAT0000074 19390056 Bone andBones hsa-miR-19b-3p MIMAT0000074 18728182 Bone and Boneshsa-miR-200a-3p MIMAT0000682 19454767 Bone and Bones hsa-miR-206MIMAT0000462 17855557 Bone and Bones hsa-miR-20a-5p MIMAT000007519435428 Bone and Bones hsa-miR-20a-5p MIMAT0000075 19390056 Bone andBones hsa-miR-21-5p MIMAT0000076 19578724 Bone and Bones hsa-miR-214-3pMIMAT0000271 19435428 Bone and Bones hsa-miR-24-3p MIMAT0000080 20019669Bone and Bones hsa-miR-25-3p MIMAT0000081 18728182 Bone and Boneshsa-miR-26a-5p MIMAT0000082 18197755 Bone and Bones hsa-miR-26a-5pMIMAT0000082 19011087 Bone and Bones hsa-miR-27a-3p MIMAT000008419440384 Bone and Bones hsa-miR-302a-3p MIMAT0000684 17855557 Bone andBones hsa-miR-30a-5p MIMAT0000087 23287430 Bone and Bones hsa-miR-30c-5pMIMAT0000244 23469762 Bone and Bones hsa-miR-32-5p MIMAT0000090 18728182Bone and Bones hsa-miR-320a MIMAT0000510 17855557 Bone and Boneshsa-miR-335-5p MIMAT0000765 18185580 Bone and Bones hsa-miR-346MIMAT0000773 19011087 Bone and Bones hsa-miR-34a-5p MIMAT000025520598588 Bone and Bones hsa-miR-34b-3p MIMAT0004676 22498974 Bone andBones hsa-miR-34c-5p MIMAT0000686 22498974 Bone and Boneshsa-miR-378a-3p MIMAT0000732 19844573 Bone and Bones hsa-miR-449aMIMAT0001541 21569010 Bone and Bones hsa-miR-489-3p MIMAT000280519440384 Bone and Bones hsa-miR-520h MIMAT0002867 19435428 Bone andBones hsa-miR-637 MIMAT0003307 21880893 Bone and Bones hsa-miR-9-5pMIMAT0000441 19008124 Bone and Bones hsa-miR-92a-3p MIMAT000009219435428 Bone and Bones hsa-miR-92a-3p MIMAT0000092 18728182 Bone andBones hsa-miR-92a-3p MIMAT0000092 19390056 Bone and Bones hsa-miR-93-5pMIMAT0000093 18728182 Bone and Bones mmu-let-7a-5p MIMAT0000521 18474618Bone and Bones mmu-miR-122-5p MIMAT0000246 16258535 Bone and Bonesmmu-miR-122-5p MIMAT0000246 21364282 Bone and Bones mmu-miR-126a-3pMIMAT0000138 18474618 Bone and Bones mmu-miR-133a-3p MIMAT000014518784367 Bone and Bones mmu-miR-135a-5p MIMAT0000147 18784367 Bone andBones mmu-miR-140-5p MIMAT0000151 16828749 Bone and Bones mmu-miR-140-5pMIMAT0000151 21576357 Bone and Bones mmu-miR-141-3p MIMAT000015319454767 Bone and Bones mmu-miR-145a-5p MIMAT0000157 18474618 Bone andBones mmu-miR-199a-3p MIMAT0000230 19251704 Bone and Bonesmmu-miR-200a-3p MIMAT0000519 19454767 Bone and Bones mmu-miR-204-5pMIMAT0000237 20039258 Bone and Bones mmu-miR-206-3p MIMAT000023919933329 Bone and Bones mmu-miR-211-5p MIMAT0000668 20039258 Bone andBones mmu-miR-21a-5p MIMAT0000530 21273303 Bone and Bones mmu-miR-23b-3pMIMAT0000125 19582816 Bone and Bones mmu-miR-24-3p MIMAT0000219 19582816Bone and Bones mmu-miR-27b-3p MIMAT0000126 19342382 Bone and Bonesmmu-miR-27b-3p MIMAT0000126 19582816 Bone and Bones mmu-miR-2861MIMAT0013803 19920351 Bone and Bones mmu-miR-29b-3p MIMAT000012719342382 Bone and Bones mmu-miR-34a-5p MIMAT0000542 20424141 Bone andBones mmu-miR-34a-5p MIMAT0000542 20598588 Bone and Bones mmu-miR-34c-5pMIMAT0000381 18784367 Bone and Bones mmu-miR-370-3p MIMAT000109522587915 Bone and Bones mmu-miR-3960 MIMAT0019336 21324897 Bone andBones mmu-miR-9-5p MIMAT0000142 22465325 Bone and Bones ppy-miR-130aMIMAT0015753 17855557 Bone and Bones ppy-miR-335 MIMAT0015837 18185580Bone and Bones ptr-miR-130a MIMAT0008025 17855557 Bone and Bonesptr-miR-335 MIMAT0008104 18185580 Bone and Bones rno-miR-335MIMAT0000575 18185580 Bone and Bones ssc-miR-130a MIMAT0007758 17855557Bone and Bones ssc-miR-335 MIMAT0013955 18185580 Bone and Bonesxtr-miR-130a MIMAT0003591 17855557 Bone Marrow hsa-miR-125a-5pMIMAT0000443 19011087 Bone Marrow hsa-miR-125b-5p MIMAT0000423 19011087Bone Marrow hsa-miR-126-3p MIMAT0000445 18474618 Bone Marrowhsa-miR-145-5p MIMAT0000437 18474618 Bone Marrow hsa-miR-155-5pMIMAT0000646 18299402 Bone Marrow hsa-miR-199a-5p MIMAT0000231 19011087Bone Marrow hsa-miR-203a MIMAT0000264 21707582 Bone Marrowhsa-miR-26a-5p MIMAT0000082 19011087 Bone Marrow hsa-miR-346MIMAT0000773 19011087 Bone Marrow hsa-miR-637 MIMAT0003307 21880893 BoneMarrow mmu-let-7a-5p MIMAT0000521 18474618 Bone Marrow mmu-miR-126a-3pMIMAT0000138 18474618 Bone Marrow mmu-miR-145a-5p MIMAT0000157 18474618Bone Marrow mmu-miR-9-5p MIMAT0000142 22465325 Bone Marrow Cellshsa-miR-126-3p MIMAT0000445 18474618 Bone Marrow Cells hsa-miR-145-5pMIMAT0000437 18474618 Bone Marrow Cells mmu-let-7a-5p MIMAT000052118474618 Bone Marrow Cells mmu-miR-126a-3p MIMAT0000138 18474618 BoneMarrow Cells mmu-miR-145a-5p MIMAT0000157 18474618 Brain hsa-let-7a-5pMIMAT0000062 20668208 Brain hsa-let-7a-5p MIMAT0000062 19110058 Brainhsa-let-7b-5p MIMAT0000063 20133835 Brain hsa-let-7d-3p MIMAT000448419703567 Brain hsa-let-7d-5p MIMAT0000065 21266476 Brain hsa-let-7d-5pMIMAT0000065 19703567 Brain hsa-let-7d-5p MIMAT0000065 19110058 Brainhsa-miR-1 MIMAT0000416 15685193 Brain hsa-miR-106a-5p MIMAT000010319110058 Brain hsa-miR-106b-5p MIMAT0000680 19110058 Brain hsa-miR-107MIMAT0000104 18234899 Brain hsa-miR-107 MIMAT0000104 20489155 Brainhsa-miR-10a-5p MIMAT0000253 20506192 Brain hsa-miR-124-3p MIMAT000042220362537 Brain hsa-miR-124-3p MIMAT0000422 18434550 Brain hsa-miR-124-3pMIMAT0000422 18577219 Brain hsa-miR-124-3p MIMAT0000422 21196113 Brainhsa-miR-124-3p MIMAT0000422 18607543 Brain hsa-miR-124-3p MIMAT000042219703567 Brain hsa-miR-124-3p MIMAT0000422 15685193 Brain hsa-miR-124-3pMIMAT0000422 19131573 Brain hsa-miR-1258 MIMAT0005909 21266359 Brainhsa-miR-125a-5p MIMAT0000443 18973228 Brain hsa-miR-125b-5p MIMAT000042320347935 Brain hsa-miR-125b-5p MIMAT0000423 19293287 Brainhsa-miR-125b-5p MIMAT0000423 20159450 Brain hsa-miR-128-3p MIMAT000042418810376 Brain hsa-miR-128-3p MIMAT0000424 19010882 Brain hsa-miR-128-3pMIMAT0000424 19941032 Brain hsa-miR-128-3p MIMAT0000424 21143953 Brainhsa-miR-130a-3p MIMAT0000425 19110058 Brain hsa-miR-132-3p MIMAT000042620010955 Brain hsa-miR-132-3p MIMAT0000426 18082412 Brain hsa-miR-137MIMAT0000429 23252729 Brain hsa-miR-137 MIMAT0000429 18577219 Brainhsa-miR-146a-5p MIMAT0000449 20181935 Brain hsa-miR-146a-5p MIMAT000044918801740 Brain hsa-miR-146a-5p MIMAT0000449 19540598 Brainhsa-miR-146b-3p MIMAT0004766 21266476 Brain hsa-miR-151a-3p MIMAT000075721143953 Brain hsa-miR-153-3p MIMAT0000439 19676043 Brain hsa-miR-155-5pMIMAT0000646 19897480 Brain hsa-miR-15a-5p MIMAT0000068 19110058 Brainhsa-miR-15a-5p MIMAT0000068 18434550 Brain hsa-miR-15b-5p MIMAT000041719135980 Brain hsa-miR-16-1-3p MIMAT0004489 23175429 Brain hsa-miR-17-5pMIMAT0000070 19110058 Brain hsa-miR-182-5p MIMAT0000259 17597072 Brainhsa-miR-183-5p MIMAT0000261 19711202 Brain hsa-miR-185-5p MIMAT000045521143953 Brain hsa-miR-18a-5p MIMAT0000072 19131573 Brain hsa-miR-195-5pMIMAT0000461 22217655 Brain hsa-miR-199b-5p MIMAT0000263 19308264 Brainhsa-miR-19b-3p MIMAT0000074 18434550 Brain hsa-miR-200a-3p MIMAT000068219703993 Brain hsa-miR-200b-3p MIMAT0000318 17923093 Brainhsa-miR-205-5p MIMAT0000266 23125283 Brain hsa-miR-20a-5p MIMAT000007519110058 Brain hsa-miR-21-5p MIMAT0000076 18372920 Brain hsa-miR-21-5pMIMAT0000076 21170291 Brain hsa-miR-219a-5p MIMAT0000276 19196972 Brainhsa-miR-221-3p MIMAT0000278 18759060 Brain hsa-miR-221-3p MIMAT000027817721077 Brain hsa-miR-222-3p MIMAT0000279 17721077 Brainhsa-miR-24-1-5p MIMAT0000079 16224024 Brain hsa-miR-26a-5p MIMAT000008219487573 Brain hsa-miR-26a-5p MIMAT0000082 20080666 Brain hsa-miR-296-5pMIMAT0000690 18977327 Brain hsa-miR-29a-3p MIMAT0000086 19584290 Brainhsa-miR-29a-3p MIMAT0000086 20202123 Brain hsa-miR-29a-3p MIMAT000008618434550 Brain hsa-miR-29b-3p MIMAT0000100 18434550 Brain hsa-miR-29c-3pMIMAT0000681 21565331 Brain hsa-miR-320a MIMAT0000510 20628061 Brainhsa-miR-326 MIMAT0000756 19955368 Brain hsa-miR-326 MIMAT000075620667897 Brain hsa-miR-34a-5p MIMAT0000255 20470934 Brain hsa-miR-34a-5pMIMAT0000255 19773441 Brain hsa-miR-373-3p MIMAT0000726 15685193 Brainhsa-miR-383-5p MIMAT0000738 23227829 Brain hsa-miR-383-5p MIMAT000073823564324 Brain hsa-miR-429 MIMAT0001536 17923093 Brain hsa-miR-433-3pMIMAT0001627 18252210 Brain hsa-miR-483-5p MIMAT0004761 22465663 Brainhsa-miR-509-3p MIMAT0002881 21143953 Brain hsa-miR-7-5p MIMAT000025218483236 Brain hsa-miR-7-5p MIMAT0000252 19628698 Brain hsa-miR-758-3pMIMAT0003879 21885853 Brain hsa-miR-802 MIMAT0004185 19897480 Brainhsa-miR-9-3p MIMAT0000442 19118166 Brain hsa-miR-9-5p MIMAT000044119330006 Brain hsa-miR-9-5p MIMAT0000441 18434550 Brain hsa-miR-9-5pMIMAT0000441 19118166 Brain hsa-miR-9-5p MIMAT0000441 18973228 Brainhsa-miR-9-5p MIMAT0000441 20362537 Brain hsa-miR-96-5p MIMAT000009517597072 Brain mmu-let-7b-5p MIMAT0000522 19536157 Brain mmu-let-7b-5pMIMAT0000522 20133835 Brain mmu-let-7d-5p MIMAT0000383 19703567 Brainmmu-miR-124-3p MIMAT0000134 18577219 Brain mmu-miR-124-3p MIMAT000013419287386 Brain mmu-miR-124-3p MIMAT0000134 19703567 Brain mmu-miR-134-5pMIMAT0000146 20622856 Brain mmu-miR-134-5p MIMAT0000146 20126250 Brainmmu-miR-136-5p MIMAT0000148 19536157 Brain mmu-miR-137-3p MIMAT000014918577219 Brain mmu-miR-137-5p MIMAT0016986 18577219 Brainmmu-miR-146a-5p MIMAT0000158 21730286 Brain mmu-miR-149-5p MIMAT000015919536157 Brain mmu-miR-155-5p MIMAT0000165 21247879 Brain mmu-miR-155-5pMIMAT0000165 22043967 Brain mmu-miR-15a-5p MIMAT0000526 19536157 Brainmmu-miR-17-5p MIMAT0000649 19536157 Brain mmu-miR-181a-5p MIMAT000021019536157 Brain mmu-miR-190a-5p MIMAT0000220 19536157 Brainmmu-miR-19b-3p MIMAT0000513 19536157 Brain mmu-miR-1a-3p MIMAT000012317234972 Brain mmu-miR-205-5p MIMAT0000238 23125283 Brainmmu-miR-219a-5p MIMAT0000664 19196972 Brain mmu-miR-21a-5p MIMAT000053018372920 Brain mmu-miR-223-3p MIMAT0000665 19536157 Brain mmu-miR-23a-3pMIMAT0000532 19259393 Brain mmu-miR-23b-3p MIMAT0000125 18716031 Brainmmu-miR-23b-3p MIMAT0000125 19259393 Brain mmu-miR-24-3p MIMAT000021919536157 Brain mmu-miR-26a-5p MIMAT0000533 19536157 Brainmmu-miR-297a-5p MIMAT0000375 19536157 Brain mmu-miR-298-5p MIMAT000037618986979 Brain mmu-miR-298-5p MIMAT0000376 21247879 Brainmmu-miR-301b-3p MIMAT0004186 19536157 Brain mmu-miR-30a-5p MIMAT000012820921386 Brain mmu-miR-30d-5p MIMAT0000515 20921386 Brain mmu-miR-30e-5pMIMAT0000248 19536157 Brain mmu-miR-324-3p MIMAT0000556 19536157 Brainmmu-miR-328-3p MIMAT0000565 18986979 Brain mmu-miR-340-5p MIMAT000465119536157 Brain mmu-miR-346-5p MIMAT0000597 19780716 Brain mmu-miR-34b-5pMIMAT0000382 19536157 Brain mmu-miR-351-5p MIMAT0000609 21247879 Brainmmu-miR-362-5p MIMAT0000706 19536157 Brain mmu-miR-381-3p MIMAT000074620921386 Brain mmu-miR-425-5p MIMAT0004750 19536157 Brainmmu-miR-449a-5p MIMAT0001542 19056356 Brain mmu-miR-451a MIMAT000163219536157 Brain mmu-miR-495-3p MIMAT0003456 20921386 Brain mmu-miR-497-5pMIMAT0003453 20053374 Brain mmu-miR-541-5p MIMAT0003170 19536157 Brainmmu-miR-743a-3p MIMAT0004238 21623795 Brain mmu-miR-758-3p MIMAT000388919536157 Brain mmu-miR-7b-5p MIMAT0000678 19536157 Brain mmu-miR-7b-5pMIMAT0000678 17028171 Brain mmu-miR-9-5p MIMAT0000142 19536157 Brainmmu-miR-9-5p MIMAT0000142 20362537 Brain mmu-miR-9-5p MIMAT000014218842901 Brain rno-let-7a-5p MIMAT0000774 18258830 Brain rno-let-7b-3pMIMAT0004705 18258830 Brain rno-let-7b-5p MIMAT0000775 18258830 Brainrno-let-7c-5p MIMAT0000776 18258830 Brain rno-let-7d-3p MIMAT000056318258830 Brain rno-let-7d-5p MIMAT0000562 19703567 Brain rno-let-7d-5pMIMAT0000562 18258830 Brain rno-let-7d-5p MIMAT0000562 20557304 Brainrno-let-7e-3p MIMAT0004706 18258830 Brain rno-let-7e-5p MIMAT000077718258830 Brain rno-let-7f-5p MIMAT0000778 18258830 Brain rno-let-7i-3pMIMAT0004707 18258830 Brain rno-let-7i-5p MIMAT0000779 18258830 Brainrno-miR-100-5p MIMAT0000822 18258830 Brain rno-miR-101a-3p MIMAT000082318258830 Brain rno-miR-101b-3p MIMAT0000615 18258830 Brainrno-miR-124-3p MIMAT0000828 19703567 Brain rno-miR-124-3p MIMAT000082819131573 Brain rno-miR-124-3p MIMAT0000828 18258830 Brainrno-miR-125a-5p MIMAT0000829 18258830 Brain rno-miR-129-5p MIMAT000060018258830 Brain rno-miR-130a-3p MIMAT0000836 18258830 Brainrno-miR-132-3p MIMAT0000838 18258830 Brain rno-miR-134-5p MIMAT000084016421561 Brain rno-miR-134-5p MIMAT0000840 18258830 Brainrno-miR-135b-5p MIMAT0000611 18667155 Brain rno-miR-138-5p MIMAT000084418258830 Brain rno-miR-139-5p MIMAT0000845 18258830 Brain rno-miR-145-5pMIMAT0000851 19142192 Brain rno-miR-150-5p MIMAT0000853 18258830 Brainrno-miR-181a-5p MIMAT0000858 22144581 Brain rno-miR-181b-5p MIMAT000085918258830 Brain rno-miR-183-5p MIMAT0000860 19711202 Brain rno-miR-185-5pMIMAT0000862 18258830 Brain rno-miR-18a-5p MIMAT0000787 19131573 Brainrno-miR-204-5p MIMAT0000877 18258830 Brain rno-miR-21-5p MIMAT000079021154462 Brain rno-miR-21-5p MIMAT0000790 18258830 Brain rno-miR-214-3pMIMAT0000885 18258830 Brain rno-miR-215 MIMAT0003118 18258830 Brainrno-miR-218a-5p MIMAT0000888 18258830 Brain rno-miR-223-3p MIMAT000089218258830 Brain rno-miR-23a-3p MIMAT0000792 18258830 Brain rno-miR-23b-3pMIMAT0000793 18258830 Brain rno-miR-24-3p MIMAT0000794 18258830 Brainrno-miR-25-3p MIMAT0000795 18258830 Brain rno-miR-26b-5p MIMAT000079718258830 Brain rno-miR-27a-3p MIMAT0000799 18258830 Brain rno-miR-290MIMAT0000893 18258830 Brain rno-miR-292-5p MIMAT0000896 18258830 Brainrno-miR-293-5p MIMAT0012847 18258830 Brain rno-miR-298-5p MIMAT000090018258830 Brain rno-miR-29a-3p MIMAT0000802 18258830 Brain rno-miR-29b-3pMIMAT0000801 18258830 Brain rno-miR-29c-3p MIMAT0000803 18258830 Brainrno-miR-301a-3p MIMAT0000552 18258830 Brain rno-miR-30a-3p MIMAT000080918258830 Brain rno-miR-30a-5p MIMAT0000808 18258830 Brain rno-miR-30b-5pMIMAT0000806 18258830 Brain rno-miR-30c-5p MIMAT0000804 18258830 Brainrno-miR-30e-5p MIMAT0000805 18258830 Brain rno-miR-320-3p MIMAT000090318258830 Brain rno-miR-322-5p MIMAT0001619 18258830 Brain rno-miR-324-5pMIMAT0000553 18258830 Brain rno-miR-327 MIMAT0000561 18258830 Brainrno-miR-328a-3p MIMAT0000564 18258830 Brain rno-miR-331-3p MIMAT000057018258830 Brain rno-miR-338-3p MIMAT0000581 18258830 Brain rno-miR-342-3pMIMAT0000589 18258830 Brain rno-miR-342-5p MIMAT0004652 18258830 Brainrno-miR-34a-5p MIMAT0000815 18258830 Brain rno-miR-374-5p MIMAT000320818258830 Brain rno-miR-382-5p MIMAT0003201 18258830 Brain rno-miR-383-5pMIMAT0003114 18258830 Brain rno-miR-409a-3p MIMAT0003205 18258830 Brainrno-miR-485-5p MIMAT0003203 18258830 Brain rno-miR-494-3p MIMAT000319318258830 Brain rno-miR-497-5p MIMAT0003383 18258830 Brain rno-miR-543-5pMIMAT0004787 18258830 Brain rno-miR-664-3p MIMAT0003382 18258830 Brainrno-miR-7a-5p MIMAT0000606 18258830 Brain rno-miR-92a-3p MIMAT000081618258830 Brain rno-miR-98-5p MIMAT0000819 18258830 Brain rno-miR-99a-5pMIMAT0000820 18258830 Brain rno-miR-99b-5p MIMAT0000821 18258830 Brainrno-miR-9a-5p MIMAT0000781 18667155 Brain rno-miR-9a-5p MIMAT000078118258830 Breast bta-miR-335 MIMAT0009291 18185580 Breast cfa-miR-27aMIMAT0006641 18006846 Breast cfa-miR-335 MIMAT0006624 18185580 Breastdre-miR-27a MIMAT0001796 18006846 Breast hsa-let-7a-5p MIMAT000006218083101 Breast hsa-let-7a-5p MIMAT0000062 18758960 Breast hsa-let-7a-5pMIMAT0000062 19878981 Breast hsa-let-7f-5p MIMAT0000067 22407818 Breasthsa-miR-103a-3p MIMAT0000101 20603000 Breast hsa-miR-106a-5pMIMAT0000103 16461460 Breast hsa-miR-107 MIMAT0000104 20603000 Breasthsa-miR-10b-5p MIMAT0000254 17898713 Breast hsa-miR-10b-5p MIMAT000025422573479 Breast hsa-miR-1226-3p MIMAT0005577 20514397 Breasthsa-miR-1258 MIMAT0005909 21266359 Breast hsa-miR-125a-5p MIMAT000044319875930 Breast hsa-miR-125a-5p MIMAT0000443 21220473 Breasthsa-miR-125b-5p MIMAT0000423 19875930 Breast hsa-miR-125b-5pMIMAT0000423 19570947 Breast hsa-miR-125b-5p MIMAT0000423 20729973Breast hsa-miR-125b-5p MIMAT0000423 19738052 Breast hsa-miR-128-3pMIMAT0000424 20054641 Breast hsa-miR-141-3p MIMAT0000432 18483486 Breasthsa-miR-145-5p MIMAT0000437 21092188 Breast hsa-miR-145-5p MIMAT000043719360360 Breast hsa-miR-145-5p MIMAT0000437 20668064 Breasthsa-miR-145-5p MIMAT0000437 19996288 Breast hsa-miR-146a-5p MIMAT000044918660546 Breast hsa-miR-146a-5p MIMAT0000449 18504431 Breasthsa-miR-146b-5p MIMAT0002809 18504431 Breast hsa-miR-150-5p MIMAT000045118667440 Breast hsa-miR-153-3p MIMAT0000439 20668064 Breasthsa-miR-154-5p MIMAT0000452 20603000 Breast hsa-miR-155-5p MIMAT000064620354188 Breast hsa-miR-155-5p MIMAT0000646 20371610 Breasthsa-miR-155-5p MIMAT0000646 18794355 Breast hsa-miR-155-5p MIMAT000064620427544 Breast hsa-miR-16-5p MIMAT0000069 20668064 Breast hsa-miR-17-5pMIMAT0000070 18695042 Breast hsa-miR-17-5p MIMAT0000070 16940181 Breasthsa-miR-17-5p MIMAT0000070 20406904 Breast hsa-miR-181b-5p MIMAT000025722009755 Breast hsa-miR-182-5p MIMAT0000259 19574223 Breasthsa-miR-182-5p MIMAT0000259 22322863 Breast hsa-miR-182-5p MIMAT000025923430586 Breast hsa-miR-185-5p MIMAT0000455 20603620 Breasthsa-miR-188-5p MIMAT0000457 19223510 Breast hsa-miR-18a-5p MIMAT000007219706389 Breast hsa-miR-193b-3p MIMAT0002819 19701247 Breasthsa-miR-196a-5p MIMAT0000226 20736365 Breast hsa-miR-196a-5pMIMAT0000226 18663355 Breast hsa-miR-196b-5p MIMAT0001080 20736365Breast hsa-miR-198 MIMAT0000228 18667440 Breast hsa-miR-199a-3pMIMAT0000232 21807947 Breast hsa-miR-199b-5p MIMAT0000263 23354452Breast hsa-miR-19b-3p MIMAT0000074 19706389 Breast hsa-miR-200a-3pMIMAT0000682 18376396 Breast hsa-miR-200b-3p MIMAT0000318 18376396Breast hsa-miR-200b-3p MIMAT0000318 19839049 Breast hsa-miR-200b-3pMIMAT0000318 22144583 Breast hsa-miR-200c-3p MIMAT0000617 19665978Breast hsa-miR-200c-3p MIMAT0000617 19223510 Breast hsa-miR-200c-3pMIMAT0000617 19839049 Breast hsa-miR-200c-3p MIMAT0000617 19435871Breast hsa-miR-200c-3p MIMAT0000617 18483486 Breast hsa-miR-203aMIMAT0000264 20668064 Breast hsa-miR-204-5p MIMAT0000265 18922924 Breasthsa-miR-204-5p MIMAT0000265 19074899 Breast hsa-miR-205-5p MIMAT000026618376396 Breast hsa-miR-205-5p MIMAT0000266 19276373 Breasthsa-miR-205-5p MIMAT0000266 22578566 Breast hsa-miR-206 MIMAT000046217312270 Breast hsa-miR-206 MIMAT0000462 18593897 Breast hsa-miR-206MIMAT0000462 20388878 Breast hsa-miR-206 MIMAT0000462 19414598 Breasthsa-miR-20a-5p MIMAT0000075 16461460 Breast hsa-miR-20a-5p MIMAT000007518695042 Breast hsa-miR-20a-5p MIMAT0000075 20406904 Breasthsa-miR-20b-5p MIMAT0001413 20232316 Breast hsa-miR-20b-5p MIMAT000141319706389 Breast hsa-miR-21-5p MIMAT0000076 19264808 Breast hsa-miR-21-5pMIMAT0000076 19473551 Breast hsa-miR-21-5p MIMAT0000076 20346171 Breasthsa-miR-21-5p MIMAT0000076 19302977 Breast hsa-miR-21-5p MIMAT000007621047769 Breast hsa-miR-21-5p MIMAT0000076 17072344 Breast hsa-miR-21-5pMIMAT0000076 17363372 Breast hsa-miR-21-5p MIMAT0000076 20460403 Breasthsa-miR-21-5p MIMAT0000076 19419954 Breast hsa-miR-21-5p MIMAT000007619528081 Breast hsa-miR-21-5p MIMAT0000076 18270520 Breast hsa-miR-21-5pMIMAT0000076 18372920 Breast hsa-miR-21-5p MIMAT0000076 17991735 Breasthsa-miR-21-5p MIMAT0000076 19253296 Breast hsa-miR-210-3p MIMAT000026719652553 Breast hsa-miR-216a-5p MIMAT0000273 21149267 Breast hsa-miR-217MIMAT0000274 20668064 Breast hsa-miR-22-3p MIMAT0000077 19414598 Breasthsa-miR-22-3p MIMAT0000077 20180843 Breast hsa-miR-221-3p MIMAT000027818708351 Breast hsa-miR-221-3p MIMAT0000278 22009755 Breasthsa-miR-221-3p MIMAT0000278 18790736 Breast hsa-miR-221-3p MIMAT000027820388878 Breast hsa-miR-222-3p MIMAT0000279 18708351 Breasthsa-miR-222-3p MIMAT0000279 18790736 Breast hsa-miR-222-3p MIMAT000027920388878 Breast hsa-miR-222-3p MIMAT0000279 22009755 Breasthsa-miR-224-5p MIMAT0000281 20180642 Breast hsa-miR-26a-5p MIMAT000008216461460 Breast hsa-miR-27a-3p MIMAT0000084 20382698 Breasthsa-miR-27a-3p MIMAT0000084 18006846 Breast hsa-miR-27a-3p MIMAT000008419574223 Breast hsa-miR-27b-3p MIMAT0000419 16982751 Breasthsa-miR-299-5p MIMAT0002890 19538464 Breast hsa-miR-29a-3p MIMAT000008622864815 Breast hsa-miR-29b-3p MIMAT0000100 21359530 Breasthsa-miR-29b-3p MIMAT0000100 19706389 Breast hsa-miR-30c-5p MIMAT000024419223510 Breast hsa-miR-30e-5p MIMAT0000692 19223510 Breasthsa-miR-31-3p MIMAT0004504 19524507 Breast hsa-miR-31-5p MIMAT000008919524507 Breast hsa-miR-326 MIMAT0000756 19883630 Breast hsa-miR-328-3pMIMAT0000752 19270061 Breast hsa-miR-328-5p MIMAT0026486 19270061 Breasthsa-miR-330-3p MIMAT0000751 21149267 Breast hsa-miR-335-5p MIMAT000076518185580 Breast hsa-miR-335-5p MIMAT0000765 21618216 Breasthsa-miR-339-5p MIMAT0000764 20932331 Breast hsa-miR-342-3p MIMAT000075321172025 Breast hsa-miR-345-5p MIMAT0000772 20099276 Breasthsa-miR-34a-5p MIMAT0000255 23292869 Breast hsa-miR-34a-5p MIMAT000025521240262 Breast hsa-miR-34a-5p MIMAT0000255 21814748 Breasthsa-miR-373-3p MIMAT0000726 18193036 Breast hsa-miR-373-3p MIMAT000072621271679 Breast hsa-miR-375 MIMAT0000728 20978187 Breast hsa-miR-448MIMAT0001532 20798686 Breast hsa-miR-451a MIMAT0001631 18645025 Breasthsa-miR-483-3p MIMAT0002173 20388800 Breast hsa-miR-494-3p MIMAT000281622544933 Breast hsa-miR-510-5p MIMAT0002882 18922924 Breast hsa-miR-520bMIMAT0002843 20574151 Breast hsa-miR-520c-3p MIMAT0002846 18193036Breast hsa-miR-520e MIMAT0002825 20574151 Breast hsa-miR-559MIMAT0003223 19584269 Breast hsa-miR-608 MIMAT0003276 21149267 Breasthsa-miR-632 MIMAT0003302 17980029 Breast hsa-miR-661 MIMAT000332419584269 Breast hsa-miR-661 MIMAT0003324 20543867 Breast hsa-miR-7-5pMIMAT0000252 19073608 Breast hsa-miR-7-5p MIMAT0000252 20099276 Breasthsa-miR-7-5p MIMAT0000252 18922890 Breast hsa-miR-9-3p MIMAT000044223530058 Breast hsa-miR-9-5p MIMAT0000441 20173740 Breast hsa-miR-92a-3pMIMAT0000092 20484043 Breast hsa-miR-96-5p MIMAT0000095 21203424 Breasthsa-miR-96-5p MIMAT0000095 19574223 Breast hsa-miR-98-5p MIMAT000009619528081 Breast mmu-miR-10b-5p MIMAT0000208 20351690 Breastmmu-miR-155-5p MIMAT0000165 18794355 Breast mmu-miR-200b-3p MIMAT000023319787069 Breast mmu-miR-200c-3p MIMAT0000657 19787069 Breastmmu-miR-21a-5p MIMAT0000530 18372920 Breast mmu-miR-24-2-5p MIMAT000544022911661 Breast mmu-miR-465a-5p MIMAT0002106 18922890 Breast ppy-miR-27aMIMAT0002748 18006846 Breast ppy-miR-335 MIMAT0015837 18185580 Breastptr-miR-27a MIMAT0002750 18006846 Breast ptr-miR-335 MIMAT000810418185580 Breast ptr-miR-520c MIMAT0008199 18193036 Breastrno-miR-200c-3p MIMAT0000873 22144583 Breast rno-miR-335 MIMAT000057518185580 Breast ssc-miR-27a MIMAT0002148 18006846 Breast ssc-miR-335MIMAT0013955 18185580 Breast xtr-miR-27a MIMAT0003570 18006846 CA1Region Hippocampal hsa-miR-183-5p MIMAT0000261 19711202 CA1 RegionHippocampal rno-miR-183-5p MIMAT0000860 19711202 Capillarieshsa-miR-29b-3p MIMAT0000100 21793034 Cardiovascular Systemhsa-miR-195-5p MIMAT0000461 22802111 Cardiovascular Systemmmu-miR-27b-3p MIMAT0000126 20736237 Carotid Arteries hsa-miR-1MIMAT0000416 21051663 Carotid Arteries hsa-miR-195-5p MIMAT000046122802111 Carotid Arteries hsa-miR-21-5p MIMAT0000076 22034194 CarotidArteries hsa-miR-21-5p MIMAT0000076 17478730 Carotid Arterieshsa-miR-221-3p MIMAT0000278 19150885 Carotid Arteries hsa-miR-222-3pMIMAT0000279 19150885 Carotid Arteries hsa-miR-616-3p MIMAT000480523497787 Carotid Arteries rno-miR-145-5p MIMAT0000851 19542014 CarotidArteries rno-miR-21-5p MIMAT0000790 17478730 Carotid Arteriesrno-miR-221-3p MIMAT0000890 19150885 Carotid Arteries rno-miR-222-3pMIMAT0000891 19150885 Carotid Arteries rno-miR-31a-5p MIMAT000081019542014 Carotid Arteries rno-miR-31a-5p MIMAT0000810 22020941 CarotidArtery Internal hsa-miR-616-3p MIMAT0004805 23497787 Cartilagehsa-miR-22-3p MIMAT0000077 19011694 Cartilage hsa-miR-9-5p MIMAT000044119008124 Cartilage mmu-miR-125b-5p MIMAT0000136 21945074 Cartilagemmu-miR-140-5p MIMAT0000151 16828749 Cartilage mmu-miR-140-5pMIMAT0000151 21872590 Cartilage mmu-miR-199a-3p MIMAT0000230 19251704Cartilage mmu-miR-30a-5p MIMAT0000128 21945074 Cartilage mmu-miR-30c-5pMIMAT0000514 21945074 Cell Membrane hsa-miR-1 MIMAT0000416 17401374 CellMembrane hsa-miR-204-5p MIMAT0000265 20056717 Cell Membranehsa-miR-21-5p MIMAT0000076 20056717 Cell Membrane rno-miR-1-3pMIMAT0003125 17401374 Central Nervous System hsa-miR-1 MIMAT000041621169019 Central Nervous System hsa-miR-124-3p MIMAT0000422 18577219Central Nervous System hsa-miR-124-3p MIMAT0000422 23318130 CentralNervous System hsa-miR-125a-5p MIMAT0000443 21220473 Central NervousSystem hsa-miR-133b MIMAT0000770 17761882 Central Nervous Systemhsa-miR-137 MIMAT0000429 18577219 Central Nervous System hsa-miR-19b-3pMIMAT0000074 20435064 Central Nervous System hsa-miR-29a-3p MIMAT000008619584290 Central Nervous System hsa-miR-29a-3p MIMAT0000086 21169019Central Nervous System hsa-miR-302b-5p MIMAT0000714 20435064 CentralNervous System hsa-miR-323a-3p MIMAT0000755 20435064 Central NervousSystem mmu-miR-124-3p MIMAT0000134 18577219 Central Nervous Systemmmu-miR-124-3p MIMAT0000134 21131957 Central Nervous Systemmmu-miR-134-5p MIMAT0000146 20622856 Central Nervous Systemmmu-miR-137-3p MIMAT0000149 18577219 Central Nervous Systemmmu-miR-137-5p MIMAT0016986 18577219 Central Nervous Systemmmu-miR-155-5p MIMAT0000165 21247879 Central Nervous Systemmmu-miR-23a-3p MIMAT0000532 19259393 Central Nervous Systemmmu-miR-23b-3p MIMAT0000125 19259393 Central Nervous Systemmmu-miR-298-5p MIMAT0000376 21247879 Central Nervous Systemmmu-miR-351-5p MIMAT0000609 21247879 Central Nervous System mmu-miR-9-5pMIMAT0000142 21238922 Central Nervous System rno-miR-140-3p MIMAT000057418845019 Central Nervous System rno-miR-34a-5p MIMAT0000815 18704095Cerebellum hsa-miR-124-3p MIMAT0000422 18607543 Cerebellumhsa-miR-199b-5p MIMAT0000263 19308264 Cerebral Cortex hsa-miR-29a-3pMIMAT0000086 20202123 Cerebral Cortex hsa-miR-34a-5p MIMAT000025519683563 Cerebral Cortex mmu-miR-34a-5p MIMAT0000542 19683563 CervixUteri hsa-miR-218-5p MIMAT0000275 17998940 CHO Cells mmu-miR-466h-5pMIMAT0004884 21337326 Chondrocytes hsa-miR-140-5p MIMAT0000431 21576357Chondrocytes hsa-miR-140-5p MIMAT0000431 19948051 Chondrocyteshsa-miR-199a-5p MIMAT0000231 22441842 Chondrocytes hsa-miR-22-3pMIMAT0000077 19011694 Chondrocytes hsa-miR-27a-3p MIMAT0000084 19948051Chondrocytes hsa-miR-27b-3p MIMAT0000419 20131257 Chondrocyteshsa-miR-29a-3p MIMAT0000086 21665270 Chondrocytes hsa-miR-29b-3pMIMAT0000100 21665270 Chondrocytes hsa-miR-9-5p MIMAT0000441 19008124Chondrocytes mmu-miR-125b-5p MIMAT0000136 21945074 Chondrocytesmmu-miR-140-5p MIMAT0000151 21872590 Chondrocytes mmu-miR-140-5pMIMAT0000151 21576357 Chondrocytes mmu-miR-29a-3p MIMAT0000535 21665270Chondrocytes mmu-miR-29b-3p MIMAT0000127 21665270 Chondrocytesmmu-miR-30a-5p MIMAT0000128 21945074 Chondrocytes mmu-miR-30c-5pMIMAT0000514 21945074 Choroid hsa-miR-204-5p MIMAT0000265 20056717Choroid hsa-miR-21-5p MIMAT0000076 20056717 Choroid mmu-miR-449a-5pMIMAT0001542 19056356 Choroid Plexus mmu-miR-449a-5p MIMAT000154219056356 Cilia rno-miR-126a-5p MIMAT0000831 19102782 Ciliarno-miR-128-1-5p MIMAT0017118 19102782 Cilia rno-miR-136-5p MIMAT000084219102782 Cilia rno-miR-147 MIMAT0005297 19102782 Cilia rno-miR-181b-5pMIMAT0000859 19102782 Cilia rno-miR-196a-5p MIMAT0000871 19102782 Ciliarno-miR-203a-5p MIMAT0017153 19102782 Cilia rno-miR-20a-5p MIMAT000060219102782 Cilia rno-miR-21-5p MIMAT0000790 19102782 Cilia rno-miR-216a-5pMIMAT0000886 19102782 Cilia rno-miR-217-5p MIMAT0000887 19102782 Ciliarno-miR-30a-5p MIMAT0000808 19102782 Cilia rno-miR-31a-5p MIMAT000081019102782 Cilia rno-miR-335 MIMAT0000575 19102782 Cilia rno-miR-346MIMAT0000596 19102782 Cilia rno-miR-34b-5p MIMAT0000813 19102782 Ciliarno-miR-377-5p MIMAT0017203 19102782 Cilia rno-miR-379-5p MIMAT000319219102782 Cilia rno-miR-380-5p MIMAT0005308 19102782 Cilia rno-miR-448-5pMIMAT0017177 19102782 Cilia rno-miR-7a-5p MIMAT0000606 19102782 Ciliarno-miR-7b MIMAT0000780 19102782 Cilia rno-miR-96-5p MIMAT000081819102782 Cilia rno-miR-99a-5p MIMAT0000820 19102782 Clone Cellshsa-miR-196a-5p MIMAT0000226 21077158 Clone Cells hsa-miR-199b-5pMIMAT0000263 21557766 Clone Cells mmu-miR-106b-5p MIMAT0000386 21285944Clone Cells mmu-miR-216a-5p MIMAT0000662 20713358 Clone Cellsmmu-miR-93-5p MIMAT0000540 21285944 Cochlea mmu-miR-15a-5p MIMAT000052619416898 Colon bta-miR-143 MIMAT0009233 17504027 Colon cfa-miR-143MIMAT0006682 17504027 Colon dre-miR-143 MIMAT0001840 17504027 Colonhsa-let-7a-5p MIMAT0000062 16651716 Colon hsa-let-7a-5p MIMAT000006217942906 Colon hsa-let-7b-3p MIMAT0004482 18379589 Colon hsa-let-7b-5pMIMAT0000063 18379589 Colon hsa-let-7b-5p MIMAT0000063 17942906 Colonhsa-miR-106a-5p MIMAT0000103 16461460 Colon hsa-miR-106b-5p MIMAT000068021283757 Colon hsa-miR-107 MIMAT0000104 20308559 Colon hsa-miR-126-3pMIMAT0000445 18663744 Colon hsa-miR-128-3p MIMAT0000424 20388705 Colonhsa-miR-137 MIMAT0000429 20682795 Colon hsa-miR-137 MIMAT000042923400681 Colon hsa-miR-140-5p MIMAT0000431 19734943 Colon hsa-miR-141-3pMIMAT0000432 18835392 Colon hsa-miR-143-3p MIMAT0000435 17892514 Colonhsa-miR-143-3p MIMAT0000435 19638978 Colon hsa-miR-143-3p MIMAT000043519843160 Colon hsa-miR-143-3p MIMAT0000435 19439999 Colon hsa-miR-143-3pMIMAT0000435 19464056 Colon hsa-miR-143-3p MIMAT0000435 16969504 Colonhsa-miR-143-3p MIMAT0000435 17504027 Colon hsa-miR-143-3p MIMAT000043521276449 Colon hsa-miR-145-5p MIMAT0000437 21092188 Colon hsa-miR-145-5pMIMAT0000437 20098684 Colon hsa-miR-145-5p MIMAT0000437 20687965 Colonhsa-miR-145-5p MIMAT0000437 20737575 Colon hsa-miR-145-5p MIMAT000043719391107 Colon hsa-miR-155-5p MIMAT0000646 20427544 Colon hsa-miR-15b-5pMIMAT0000417 16609010 Colon hsa-miR-181b-5p MIMAT0000257 20797623 Colonhsa-miR-183-5p MIMAT0000261 21118966 Colon hsa-miR-186-5p MIMAT000045623137536 Colon hsa-miR-18a-3p MIMAT0002891 19372139 Colon hsa-miR-192-5pMIMAT0000222 18835392 Colon hsa-miR-192-5p MIMAT0000222 19088023 Colonhsa-miR-195-5p MIMAT0000461 23526568 Colon hsa-miR-199b-5p MIMAT000026323354452 Colon hsa-miR-200a-3p MIMAT0000682 18835392 Colonhsa-miR-20a-5p MIMAT0000075 16461460 Colon hsa-miR-21-5p MIMAT000007619826040 Colon hsa-miR-21-5p MIMAT0000076 19836969 Colon hsa-miR-21-5pMIMAT0000076 19302977 Colon hsa-miR-21-5p MIMAT0000076 21069438 Colonhsa-miR-21-5p MIMAT0000076 22072622 Colon hsa-miR-21-5p MIMAT000007618372920 Colon hsa-miR-21-5p MIMAT0000076 20797623 Colon hsa-miR-21-5pMIMAT0000076 18508928 Colon hsa-miR-212-3p MIMAT0000269 18162065 Colonhsa-miR-216b-5p MIMAT0004959 23137536 Colon hsa-miR-217 MIMAT000027418835392 Colon hsa-miR-221-3p MIMAT0000278 21278784 Colon hsa-miR-25-3pMIMAT0000081 23435373 Colon hsa-miR-26a-5p MIMAT0000082 16461460 Colonhsa-miR-27b-3p MIMAT0000419 20388705 Colon hsa-miR-27b-3p MIMAT000041918835392 Colon hsa-miR-29a-3p MIMAT0000086 19951903 Colon hsa-miR-320aMIMAT0000510 22134529 Colon hsa-miR-337-3p MIMAT0000754 23137536 Colonhsa-miR-34a-5p MIMAT0000255 17875987 Colon hsa-miR-34a-5p MIMAT000025518755897 Colon hsa-miR-34a-5p MIMAT0000255 21240262 Colon hsa-miR-34a-5pMIMAT0000255 20433755 Colon hsa-miR-362-3p MIMAT0004683 23280316 Colonhsa-miR-365a-3p MIMAT0000710 22072615 Colon hsa-miR-483-3p MIMAT000217320388800 Colon hsa-miR-499a-5p MIMAT0002870 21934092 Colonhsa-miR-499b-5p MIMAT0019897 21934092 Colon hsa-miR-519a-3p MIMAT000286919088191 Colon hsa-miR-519b-3p MIMAT0002837 19088191 Colonhsa-miR-519c-3p MIMAT0002832 19088191 Colon hsa-miR-519c-3p MIMAT000283218573883 Colon hsa-miR-532-5p MIMAT0002888 18835392 Colon hsa-miR-562MIMAT0003226 19789318 Colon hsa-miR-603 MIMAT0003271 18835392 Colonhsa-miR-630 MIMAT0003299 23435373 Colon hsa-miR-633 MIMAT000330320637737 Colon hsa-miR-675-5p MIMAT0004284 19926638 Colon hsa-miR-760MIMAT0004957 23137536 Colon hsa-miR-769-5p MIMAT0003886 18835392 Colonhsa-miR-98-5p MIMAT0000096 17942906 Colon mmu-miR-128-3p MIMAT000014020388705 Colon mmu-miR-140-5p MIMAT0000151 19734943 Colon mmu-miR-21a-5pMIMAT0000530 18508928 Colon mmu-miR-21a-5p MIMAT0000530 18372920 Colonmmu-miR-223-3p MIMAT0000665 22043014 Colon mmu-miR-27b-3p MIMAT000012620388705 Colon ppy-miR-143 MIMAT0002259 17504027 Colon ptr-miR-143MIMAT0002257 17504027 Colon rno-let-7a-5p MIMAT0000774 17942906 Colonxtr-miR-143 MIMAT0003686 17504027 Connective Tissue hsa-miR-146a-5pMIMAT0000449 20375304 Connective Tissue hsa-miR-18a-5p MIMAT000007223249750 Connective Tissue rno-miR-192-5p MIMAT0000867 20393144Connective Tissue rno-miR-215 MIMAT0003118 20393144 Corneahsa-miR-126-3p MIMAT0000445 18987025 Cornea mmu-miR-126a-3p MIMAT000013818987025 Cornea mmu-miR-150-5p MIMAT0000160 18500251 Corneammu-miR-184-3p MIMAT0000213 18500251 Cornea mmu-miR-31-5p MIMAT000053818500251 Coronary Vessels hsa-miR-1 MIMAT0000416 17401374 CoronaryVessels hsa-miR-1 MIMAT0000416 19775284 Coronary Vessels hsa-miR-216a-5pMIMAT0000273 19786632 Coronary Vessels hsa-miR-217 MIMAT0000274 19786632Coronary Vessels hsa-miR-31-5p MIMAT0000089 23518389 Coronary Vesselsrno-miR-1-3p MIMAT0003125 17401374 Coronary Vessels rno-miR-1-3pMIMAT0003125 19775284 Cytoplasm hsa-let-7b-3p MIMAT0004482 17437991Cytoplasm hsa-let-7b-5p MIMAT0000063 17437991 Cytoplasm hsa-let-7b-5pMIMAT0000063 16971064 Cytoplasm hsa-let-7e-3p MIMAT0004485 17437991Cytoplasm hsa-let-7e-5p MIMAT0000066 17437991 Cytoplasm hsa-miR-195-5pMIMAT0000461 22217655 Cytoplasm hsa-miR-200c-3p MIMAT0000617 22015043Cytoplasm hsa-miR-29a-3p MIMAT0000086 20041405 Cytoplasm hsa-miR-29b-3pMIMAT0000100 20041405 Cytoplasm hsa-miR-29c-3p MIMAT0000681 20041405Cytoplasm hsa-miR-320a MIMAT0000510 18852463 Cytoplasm hsa-miR-34a-5pMIMAT0000255 20433755 Cytoplasm hsa-miR-9-3p MIMAT0000442 19118166Cytoplasm hsa-miR-9-5p MIMAT0000441 19118166 Cytoplasm mmu-miR-124-3pMIMAT0000134 19663910 Cytoskeleton hsa-miR-1 MIMAT0000416 20571053Cytoskeleton hsa-miR-126-3p MIMAT0000445 20571053 Cytoskeletonhsa-miR-141-3p MIMAT0000432 20584986 Cytoskeleton hsa-miR-196a-5pMIMAT0000226 21077158 Cytoskeleton hsa-miR-200a-3p MIMAT0000682 19801681Cytoskeleton hsa-miR-200b-3p MIMAT0000318 22144583 Cytoskeletonhsa-miR-200b-3p MIMAT0000318 19801681 Cytoskeleton hsa-miR-21-5pMIMAT0000076 20584986 Cytoskeleton hsa-miR-375 MIMAT0000728 20584986Cytoskeleton hsa-miR-429 MIMAT0001536 19801681 Cytoskeleton hsa-miR-9-5pMIMAT0000441 22131135 Cytoskeleton mmu-miR-124-3p MIMAT0000134 18619591Cytoskeleton mmu-miR-141-3p MIMAT0000153 20584986 Cytoskeletonmmu-miR-375-3p MIMAT0000739 20584986 Cytoskeleton rno-miR-141-3pMIMAT0000846 20584986 Cytoskeleton rno-miR-200c-3p MIMAT0000873 22144583Cytoskeleton rno-miR-21-5p MIMAT0000790 20584986 Cytosol hsa-miR-34a-5pMIMAT0000255 20433755 Dendrites mmu-miR-134-5p MIMAT0000146 20126250Dendrites rno-miR-26a-5p MIMAT0000796 17592044 Dendritic Cellshsa-let-7e-3p MIMAT0004485 19398721 Dendritic Cells hsa-let-7e-5pMIMAT0000066 19398721 Dendritic Cells hsa-let-7i-5p MIMAT000041521742974 Dendritic Cells hsa-miR-146a-5p MIMAT0000449 21236257 DendriticCells hsa-miR-146a-5p MIMAT0000449 20375304 Dendritic Cellshsa-miR-155-3p MIMAT0004658 20852130 Dendritic Cells hsa-miR-155-5pMIMAT0000646 19386588 Dendritic Cells hsa-miR-155-5p MIMAT000064620852130 Dendritic Cells hsa-miR-155-5p MIMAT0000646 19193853 DendriticCells hsa-miR-181a-5p MIMAT0000256 22956783 Dendritic Cellshsa-miR-181a-5p MIMAT0000256 20841506 Dendritic Cells hsa-miR-21-5pMIMAT0000076 19398721 Dendritic Cells hsa-miR-29a-3p MIMAT000008621276447 Dendritic Cells hsa-miR-34a-5p MIMAT0000255 19398721 DendriticCells mmu-miR-148a-3p MIMAT0000516 21068402 Dendritic Cellsmmu-miR-148b-3p MIMAT0000580 21068402 Dendritic Cells mmu-miR-152-3pMIMAT0000162 21068402 Dendritic Cells mmu-miR-155-5p MIMAT000016517463290 Dendritic Cells mmu-miR-155-5p MIMAT0000165 21385848 DendriticCells mmu-miR-155-5p MIMAT0000165 19193853 Dendritic Spineshsa-miR-125b-5p MIMAT0000423 20159450 Dendritic Spines hsa-miR-132-3pMIMAT0000426 19850129 Dendritic Spines rno-miR-134-5p MIMAT000084016421561 Dentate Gyrus rno-miR-21-5p MIMAT0000790 21154462 Dermishsa-miR-424-5p MIMAT0001341 21179471 Duodenum mmu-miR-124-3pMIMAT0000134 17462994 Ear hsa-miR-96-5p MIMAT0000095 19363479 Earmmu-miR-15a-5p MIMAT0000526 19416898 Ear Inner hsa-miR-96-5pMIMAT0000095 19363479 Ear Inner mmu-miR-15a-5p MIMAT0000526 19416898Ectoderm mmu-let-7a-5p MIMAT0000521 19898466 Ectoderm mmu-let-7e-5pMIMAT0000524 19898466 Ectoderm mmu-miR-125a-5p MIMAT0000135 19898466Ectoderm mmu-miR-125b-5p MIMAT0000136 19898466 Ectoderm mmu-miR-128-3pMIMAT0000140 19898466 Embryoid Bodies hsa-miR-302d-3p MIMAT000071819229866 Embryoid Bodies hsa-miR-372-3p MIMAT0000724 19229866 EmbryonalCarcinoma Stem hsa-miR-125a-5p MIMAT0000443 16227573 Cells EmbryonalCarcinoma Stem hsa-miR-125b-5p MIMAT0000423 16227573 Cells EmbryonalCarcinoma Stem hsa-miR-200c-3p MIMAT0000617 19665978 Cells EmbryonalCarcinoma Stem hsa-miR-383-5p MIMAT0000738 21368870 Cells EmbryonalCarcinoma Stem mmu-miR-125b-5p MIMAT0000136 16227573 Cells EmbryonicStem Cells hsa-miR-1 MIMAT0000416 20081117 Embryonic Stem Cellshsa-miR-101-3p MIMAT0000099 19818710 Embryonic Stem Cells hsa-miR-124-3pMIMAT0000422 20362537 Embryonic Stem Cells hsa-miR-126-3p MIMAT000044521304604 Embryonic Stem Cells hsa-miR-128-3p MIMAT0000424 19409607Embryonic Stem Cells hsa-miR-145-5p MIMAT0000437 19409607 Embryonic StemCells hsa-miR-145-5p MIMAT0000437 20382729 Embryonic Stem Cellshsa-miR-195-5p MIMAT0000461 19823043 Embryonic Stem Cellshsa-miR-199a-5p MIMAT0000231 19818710 Embryonic Stem Cells hsa-miR-203aMIMAT0000264 18483491 Embryonic Stem Cells hsa-miR-214-3p MIMAT000027119818710 Embryonic Stem Cells hsa-miR-26b-5p MIMAT0000083 20831567Embryonic Stem Cells hsa-miR-302a-3p MIMAT0000684 21266536 EmbryonicStem Cells hsa-miR-302a-3p MIMAT0000684 21062975 Embryonic Stem Cellshsa-miR-302a-3p MIMAT0000684 19386261 Embryonic Stem Cellshsa-miR-302a-3p MIMAT0000684 21151097 Embryonic Stem Cellshsa-miR-302a-3p MIMAT0000684 23185040 Embryonic Stem Cellshsa-miR-302b-3p MIMAT0000715 23185040 Embryonic Stem Cellshsa-miR-302b-3p MIMAT0000715 21062975 Embryonic Stem Cellshsa-miR-302c-3p MIMAT0000717 23185040 Embryonic Stem Cellshsa-miR-302c-3p MIMAT0000717 21062975 Embryonic Stem Cellshsa-miR-302d-3p MIMAT0000718 19229866 Embryonic Stem Cellshsa-miR-302d-3p MIMAT0000718 23185040 Embryonic Stem Cellshsa-miR-302d-3p MIMAT0000718 21266536 Embryonic Stem Cellshsa-miR-302d-3p MIMAT0000718 21062975 Embryonic Stem Cellshsa-miR-372-3p MIMAT0000724 19823043 Embryonic Stem Cells hsa-miR-372-3pMIMAT0000724 19229866 Embryonic Stem Cells hsa-miR-375 MIMAT000072819807270 Embryonic Stem Cells hsa-miR-380-5p MIMAT0000734 20871609Embryonic Stem Cells hsa-miR-499a-5p MIMAT0002870 20081117 EmbryonicStem Cells hsa-miR-499b-5p MIMAT0019897 20081117 Embryonic Stem Cellshsa-miR-519c-3p MIMAT0002832 19825807 Embryonic Stem Cells hsa-miR-520hMIMAT0002867 19825807 Embryonic Stem Cells hsa-miR-522-3p MIMAT000286821304604 Embryonic Stem Cells hsa-miR-9-5p MIMAT0000441 20362537Embryonic Stem Cells hsa-miR-92b-3p MIMAT0003218 19544458 Embryonic StemCells hsa-miR-98-5p MIMAT0000096 19818710 Embryonic Stem Cellsmmu-let-7c-5p MIMAT0000523 20054295 Embryonic Stem Cells mmu-miR-100-3pMIMAT0017051 20439489 Embryonic Stem Cells mmu-miR-100-5p MIMAT000065520439489 Embryonic Stem Cells mmu-miR-10a-3p MIMAT0004659 20118242Embryonic Stem Cells mmu-miR-10a-5p MIMAT0000648 20118242 Embryonic StemCells mmu-miR-134-5p MIMAT0000146 17916804 Embryonic Stem Cellsmmu-miR-134-5p MIMAT0000146 18806776 Embryonic Stem Cells mmu-miR-137-3pMIMAT0000149 20439489 Embryonic Stem Cells mmu-miR-137-5p MIMAT001698620439489 Embryonic Stem Cells mmu-miR-1a-3p MIMAT0000123 19521018Embryonic Stem Cells mmu-miR-1a-3p MIMAT0000123 20799856 Embryonic StemCells mmu-miR-214-3p MIMAT0000661 19818710 Embryonic Stem Cellsmmu-miR-290a-3p MIMAT0004572 19628328 Embryonic Stem Cellsmmu-miR-291a-3p MIMAT0000368 19628328 Embryonic Stem Cellsmmu-miR-292-3p MIMAT0000370 19628328 Embryonic Stem Cells mmu-miR-293-3pMIMAT0000371 19628328 Embryonic Stem Cells mmu-miR-294-3p MIMAT000037219628328 Embryonic Stem Cells mmu-miR-295-3p MIMAT0000373 19628328Embryonic Stem Cells mmu-miR-296-5p MIMAT0000374 18806776 Embryonic StemCells mmu-miR-466l-3p MIMAT0005830 20410487 Embryonic Stem Cellsmmu-miR-470-5p MIMAT0002111 18806776 Embryonic Stem Cells mmu-miR-9-5pMIMAT0000142 22465325 Embryonic Stem Cells mmu-miR-9-5p MIMAT000014220362537 Embryonic Structures hsa-miR-122-5p MIMAT0000421 20842632Embryonic Structures hsa-miR-125b-5p MIMAT0000423 19293287 EmbryonicStructures hsa-miR-126-3p MIMAT0000445 18694566 Embryonic Structureshsa-miR-155-5p MIMAT0000646 19701459 Embryonic Structures hsa-miR-155-5pMIMAT0000646 19759154 Embryonic Structures hsa-miR-196a-5p MIMAT000022615105502 Embryonic Structures hsa-miR-19a-3p MIMAT0000073 19296935Embryonic Structures hsa-miR-21-5p MIMAT0000076 20813833 EmbryonicStructures hsa-miR-222-3p MIMAT0000279 19589872 Embryonic Structureshsa-miR-24-3p MIMAT0000080 19296935 Embryonic Structures hsa-miR-27a-3pMIMAT0000084 19666532 Embryonic Structures hsa-miR-27a-3p MIMAT000008419114653 Embryonic Structures hsa-miR-27b-3p MIMAT0000419 19666532Embryonic Structures hsa-miR-302a-3p MIMAT0000684 19386261 EmbryonicStructures mmu-miR-101a-3p MIMAT0000133 17848513 Embryonic Structuresmmu-miR-130a-3p MIMAT0000141 19582148 Embryonic Structuresmmu-miR-133a-3p MIMAT0000145 16380711 Embryonic Structuresmmu-miR-135a-5p MIMAT0000147 20619502 Embryonic Structuresmmu-miR-137-3p MIMAT0000149 21256124 Embryonic Structures mmu-miR-140-5pMIMAT0000151 16828749 Embryonic Structures mmu-miR-153-3p MIMAT000016321256124 Embryonic Structures mmu-miR-155-5p MIMAT0000165 19701459Embryonic Structures mmu-miR-16-5p MIMAT0000527 20619502 EmbryonicStructures mmu-miR-18a-5p MIMAT0000528 19114653 Embryonic Structuresmmu-miR-196a-5p MIMAT0000518 15105502 Embryonic Structuresmmu-miR-196a-5p MIMAT0000518 15361871 Embryonic Structuresmmu-miR-199a-3p MIMAT0000230 17848513 Embryonic Structuresmmu-miR-199a-3p MIMAT0000230 19114653 Embryonic Structures mmu-miR-1a-3pMIMAT0000123 16380711 Embryonic Structures mmu-miR-20a-5p MIMAT000052920619502 Embryonic Structures mmu-miR-21a-5p MIMAT0000530 18556655Embryonic Structures mmu-miR-27a-3p MIMAT0000537 19114653 EmbryonicStructures mmu-miR-29b-3p MIMAT0000127 19509302 Embryonic Structuresmmu-miR-30c-5p MIMAT0000514 19114653 Embryonic Structures mmu-miR-363-3pMIMAT0000708 21256124 Embryonic Structures mmu-miR-9-5p MIMAT000014219114653 Endocrine Cells hsa-miR-375 MIMAT0000728 15538371 EndocrineCells mmu-miR-375-3p MIMAT0000739 15538371 Endocrine System hsa-miR-1MIMAT0000416 21169019 Endocrine System hsa-miR-29a-3p MIMAT000008621169019 Endoderm hsa-miR-375 MIMAT0000728 19807270 Endometriumhsa-miR-153-3p MIMAT0000439 20028871 Endometrium hsa-miR-183-5pMIMAT0000261 20028871 Endometrium hsa-miR-186-5p MIMAT0000456 20028871Endometrium hsa-miR-196b-5p MIMAT0001080 23293219 Endometriumhsa-miR-27a-3p MIMAT0000084 20028871 Endometrium hsa-miR-29c-3pMIMAT0000681 21436257 Endometrium hsa-miR-9-5p MIMAT0000441 20028871Endometrium hsa-miR-96-5p MIMAT0000095 20028871 Endoplasmic Reticulumhsa-miR-346 MIMAT0000773 22002058 Endosomes hsa-let-7d-5p MIMAT000006520410187 Endothelial Cells hsa-miR-10a-5p MIMAT0000253 20624982Endothelial Cells hsa-miR-10b-5p MIMAT0000254 21642433 Endothelial Cellshsa-miR-122-5p MIMAT0000421 19726678 Endothelial Cells hsa-miR-126-3pMIMAT0000445 18227515 Endothelial Cells hsa-miR-126-3p MIMAT000044518694566 Endothelial Cells hsa-miR-126-3p MIMAT0000445 22867989Endothelial Cells hsa-miR-130a-3p MIMAT0000425 17957028 EndothelialCells hsa-miR-146a-5p MIMAT0000449 18174313 Endothelial Cellshsa-miR-146a-5p MIMAT0000449 19944095 Endothelial Cells hsa-miR-155-5pMIMAT0000646 23108656 Endothelial Cells hsa-miR-155-5p MIMAT000064619783678 Endothelial Cells hsa-miR-155-5p MIMAT0000646 21310411Endothelial Cells hsa-miR-16-5p MIMAT0000069 21885851 Endothelial Cellshsa-miR-17-5p MIMAT0000070 20299512 Endothelial Cells hsa-miR-181a-5pMIMAT0000256 20558617 Endothelial Cells hsa-miR-18a-5p MIMAT000007220299512 Endothelial Cells hsa-miR-195-5p MIMAT0000461 20952681Endothelial Cells hsa-miR-199a-3p MIMAT0000232 21807947 EndothelialCells hsa-miR-199a-5p MIMAT0000231 23760629 Endothelial Cellshsa-miR-199a-5p MIMAT0000231 19783678 Endothelial Cells hsa-miR-19a-3pMIMAT0000073 20133739 Endothelial Cells hsa-miR-19a-3p MIMAT000007320299512 Endothelial Cells hsa-miR-20a-5p MIMAT0000075 20299512Endothelial Cells hsa-miR-21-5p MIMAT0000076 23313253 Endothelial Cellshsa-miR-21-5p MIMAT0000076 21347332 Endothelial Cells hsa-miR-21-5pMIMAT0000076 23496142 Endothelial Cells hsa-miR-210-3p MIMAT000026719826008 Endothelial Cells hsa-miR-210-3p MIMAT0000267 23322395Endothelial Cells hsa-miR-210-3p MIMAT0000267 18417479 Endothelial Cellshsa-miR-210-3p MIMAT0000267 19808020 Endothelial Cells hsa-miR-214-3pMIMAT0000271 22227154 Endothelial Cells hsa-miR-216a-5p MIMAT000027319786632 Endothelial Cells hsa-miR-216a-5p MIMAT0000273 21149267Endothelial Cells hsa-miR-217 MIMAT0000274 19786632 Endothelial Cellshsa-miR-221-3p MIMAT0000278 20516212 Endothelial Cells hsa-miR-222-3pMIMAT0000279 20489169 Endothelial Cells hsa-miR-23b-3p MIMAT000041820133741 Endothelial Cells hsa-miR-296-5p MIMAT0000690 18977327Endothelial Cells hsa-miR-29b-3p MIMAT0000100 21793034 Endothelial Cellshsa-miR-31-5p MIMAT0000089 23233723 Endothelial Cells hsa-miR-330-3pMIMAT0000751 21149267 Endothelial Cells hsa-miR-34a-5p MIMAT000025520627091 Endothelial Cells hsa-miR-409-3p MIMAT0001639 22531314Endothelial Cells hsa-miR-424-5p MIMAT0001341 20972335 Endothelial Cellshsa-miR-424-5p MIMAT0001341 21885851 Endothelial Cells hsa-miR-503-5pMIMAT0002874 21220732 Endothelial Cells hsa-miR-519c-3p MIMAT000283220233879 Endothelial Cells hsa-miR-608 MIMAT0003276 21149267 EndothelialCells hsa-miR-92a-3p MIMAT0000092 19460962 Endothelial Cellshsa-miR-93-5p MIMAT0000093 20956944 Endothelial Cells mmu-miR-100-3pMIMAT0017051 21339483 Endothelial Cells mmu-miR-100-5p MIMAT000065521339483 Endothelial Cells mmu-miR-126a-3p MIMAT0000138 18694565Endothelial Cells mmu-miR-15a-5p MIMAT0000526 20445066 Endothelial Cellsmmu-miR-29c-3p MIMAT0000536 21310958 Endothelial Cells mmu-miR-34a-5pMIMAT0000542 20424141 Endothelial Cells rno-miR-320-3p MIMAT000090318986336 Endothelium hsa-miR-10a-5p MIMAT0000253 20624982 Endotheliumhsa-miR-424-5p MIMAT0001341 20972335 Enterocytes hsa-miR-510-5pMIMAT0002882 18614545 Enterocytes hsa-miR-626 MIMAT0003295 19892711Enterocytes hsa-miR-7-5p MIMAT0000252 19892711 Enterocytes mmu-miR-706MIMAT0003496 19892711 Epidermis hsa-miR-146a-5p MIMAT0000449 20375304Epidermis hsa-miR-203a MIMAT0000264 18483491 Epidermis hsa-miR-31-5pMIMAT0000089 23233723 Epidermis mmu-let-7a-5p MIMAT0000521 19898466Epidermis mmu-let-7e-5p MIMAT0000524 19898466 Epidermis mmu-miR-125a-5pMIMAT0000135 19898466 Epidermis mmu-miR-125b-5p MIMAT0000136 19898466Epidermis mmu-miR-128-3p MIMAT0000140 19898466 Epididymisrno-miR-200c-3p MIMAT0000873 20705680 Epididymis rno-miR-335MIMAT0000575 20933506 Epithelial Cells hsa-let-7d-5p MIMAT000006520395557 Epithelial Cells hsa-miR-106a-5p MIMAT0000103 20889678Epithelial Cells hsa-miR-106b-5p MIMAT0000680 20101223 Epithelial Cellshsa-miR-1226-3p MIMAT0005577 20514397 Epithelial Cells hsa-miR-1258MIMAT0005909 21266359 Epithelial Cells hsa-miR-126-3p MIMAT000044520083669 Epithelial Cells hsa-miR-128-3p MIMAT0000424 20388705Epithelial Cells hsa-miR-133a-3p MIMAT0000427 18464261 Epithelial Cellshsa-miR-133b MIMAT0000770 18464261 Epithelial Cells hsa-miR-141-3pMIMAT0000432 19854497 Epithelial Cells hsa-miR-141-3p MIMAT000043218835392 Epithelial Cells hsa-miR-141-3p MIMAT0000432 18411277Epithelial Cells hsa-miR-146a-5p MIMAT0000449 20101223 Epithelial Cellshsa-miR-146a-5p MIMAT0000449 20124483 Epithelial Cells hsa-miR-146a-5pMIMAT0000449 20542134 Epithelial Cells hsa-miR-146b-5p MIMAT000280920101223 Epithelial Cells hsa-miR-155-5p MIMAT0000646 18794355Epithelial Cells hsa-miR-15a-5p MIMAT0000068 18949056 Epithelial Cellshsa-miR-184 MIMAT0000454 19033458 Epithelial Cells hsa-miR-192-5pMIMAT0000222 18835392 Epithelial Cells hsa-miR-197-3p MIMAT000022719671678 Epithelial Cells hsa-miR-200a-3p MIMAT0000682 18829540Epithelial Cells hsa-miR-200a-3p MIMAT0000682 18411277 Epithelial Cellshsa-miR-200a-3p MIMAT0000682 18835392 Epithelial Cells hsa-miR-200a-3pMIMAT0000682 19854497 Epithelial Cells hsa-miR-200b-3p MIMAT000031818829540 Epithelial Cells hsa-miR-200b-3p MIMAT0000318 18411277Epithelial Cells hsa-miR-200b-3p MIMAT0000318 19854497 Epithelial Cellshsa-miR-200c-3p MIMAT0000617 18411277 Epithelial Cells hsa-miR-200c-3pMIMAT0000617 19435871 Epithelial Cells hsa-miR-200c-3p MIMAT000061719854497 Epithelial Cells hsa-miR-203a MIMAT0000264 18483491 EpithelialCells hsa-miR-203a MIMAT0000264 22101077 Epithelial Cells hsa-miR-205-5pMIMAT0000266 19033458 Epithelial Cells hsa-miR-21-5p MIMAT000007623292313 Epithelial Cells hsa-miR-21-5p MIMAT0000076 19473551 EpithelialCells hsa-miR-21-5p MIMAT0000076 21047769 Epithelial Cells hsa-miR-21-5pMIMAT0000076 19435867 Epithelial Cells hsa-miR-212-3p MIMAT000026918162065 Epithelial Cells hsa-miR-217 MIMAT0000274 18835392 EpithelialCells hsa-miR-218-5p MIMAT0000275 19168627 Epithelial Cellshsa-miR-221-3p MIMAT0000278 21236259 Epithelial Cells hsa-miR-27b-3pMIMAT0000419 18835392 Epithelial Cells hsa-miR-27b-3p MIMAT000041920388705 Epithelial Cells hsa-miR-302a-3p MIMAT0000684 20101223Epithelial Cells hsa-miR-330-3p MIMAT0000751 19597470 Epithelial Cellshsa-miR-346 MIMAT0000773 22002058 Epithelial Cells hsa-miR-429MIMAT0001536 18411277 Epithelial Cells hsa-miR-429 MIMAT0001536 19854497Epithelial Cells hsa-miR-429 MIMAT0001536 18829540 Epithelial Cellshsa-miR-451a MIMAT0001631 19318487 Epithelial Cells hsa-miR-483-3pMIMAT0002173 22101077 Epithelial Cells hsa-miR-497-5p MIMAT000282023453369 Epithelial Cells hsa-miR-513a-5p MIMAT0002877 19155478Epithelial Cells hsa-miR-532-5p MIMAT0002888 18835392 Epithelial Cellshsa-miR-595 MIMAT0003263 22101077 Epithelial Cells hsa-miR-603MIMAT0003271 18835392 Epithelial Cells hsa-miR-622 MIMAT0003291 22016468Epithelial Cells hsa-miR-7-5p MIMAT0000252 19033458 Epithelial Cellshsa-miR-769-5p MIMAT0003886 18835392 Epithelial Cells hsa-miR-92b-3pMIMAT0003218 21030610 Epithelial Cells hsa-miR-93-5p MIMAT000009319671678 Epithelial Cells hsa-miR-96-5p MIMAT0000095 21203424 EpithelialCells hsa-miR-98-5p MIMAT0000096 19671678 Epithelial Cells hsa-miR-98-5pMIMAT0000096 20486857 Epithelial Cells mmu-miR-128-3p MIMAT000014020388705 Epithelial Cells mmu-miR-141-3p MIMAT0000153 18411277Epithelial Cells mmu-miR-155-5p MIMAT0000165 21807897 Epithelial Cellsmmu-miR-155-5p MIMAT0000165 18794355 Epithelial Cells mmu-miR-17-5pMIMAT0000649 17765889 Epithelial Cells mmu-miR-200a-3p MIMAT000051918411277 Epithelial Cells mmu-miR-200b-3p MIMAT0000233 18411277Epithelial Cells mmu-miR-27b-3p MIMAT0000126 20388705 Epithelial Cellsmmu-miR-429-3p MIMAT0001537 18411277 Epithelium hsa-miR-101-3pMIMAT0000099 19043531 Epithelium hsa-miR-125b-5p MIMAT0000423 19378336Epithelium hsa-miR-133a-3p MIMAT0000427 19378336 Epitheliumhsa-miR-141-3p MIMAT0000432 20053927 Epithelium hsa-miR-143-3pMIMAT0000435 19157460 Epithelium hsa-miR-145-5p MIMAT0000437 19378336Epithelium hsa-miR-146a-5p MIMAT0000449 18174313 Epitheliumhsa-miR-155-5p MIMAT0000646 19701459 Epithelium hsa-miR-182-5pMIMAT0000259 17597072 Epithelium hsa-miR-195-5p MIMAT0000461 19378336Epithelium hsa-miR-199a-3p MIMAT0000232 19378336 Epithelium hsa-miR-203aMIMAT0000264 18483491 Epithelium hsa-miR-204-5p MIMAT0000265 20056717Epithelium hsa-miR-21-5p MIMAT0000076 20346171 Epithelium hsa-miR-21-5pMIMAT0000076 19473551 Epithelium hsa-miR-21-5p MIMAT0000076 20056717Epithelium hsa-miR-218-5p MIMAT0000275 19890957 Epitheliumhsa-miR-218-5p MIMAT0000275 19168627 Epithelium hsa-miR-29a-3pMIMAT0000086 18390668 Epithelium hsa-miR-29c-3p MIMAT0000681 18390668Epithelium hsa-miR-30a-3p MIMAT0000088 19378336 Epitheliumhsa-miR-30a-5p MIMAT0000087 19378336 Epithelium hsa-miR-510-5pMIMAT0002882 18614545 Epithelium hsa-miR-96-5p MIMAT0000095 17597072Epithelium mmu-miR-106b-5p MIMAT0000386 19559694 Epitheliummmu-miR-155-5p MIMAT0000165 19701459 Epithelium mmu-miR-17-5pMIMAT0000649 17765889 Epithelium mmu-miR-17-5p MIMAT0000649 19559694Epithelium mmu-miR-20a-5p MIMAT0000529 19559694 Epitheliummmu-miR-21a-5p MIMAT0000530 21295561 Erythroblasts hsa-miR-223-3pMIMAT0000280 20826802 Erythroblasts hsa-miR-223-3p MIMAT0000280 19278969Erythroblasts hsa-miR-25-3p MIMAT0000081 20826802 Erythroblastsmmu-miR-223-3p MIMAT0000665 20826802 Erythroblasts mmu-miR-25-3pMIMAT0000652 20826802 Erythrocytes hsa-let-7a-5p MIMAT0000062 19939273Erythrocytes hsa-let-7c-3p MIMAT0026472 19939273 Erythrocyteshsa-let-7c-5p MIMAT0000064 19939273 Erythrocytes hsa-let-7d-3pMIMAT0004484 19939273 Erythrocytes hsa-let-7d-5p MIMAT0000065 19939273Erythrocytes hsa-let-7e-3p MIMAT0004485 19939273 Erythrocyteshsa-let-7e-5p MIMAT0000066 19939273 Erythrocytes hsa-let-7g-3pMIMAT0004584 19939273 Erythrocytes hsa-let-7g-5p MIMAT0000414 19939273Erythrocytes hsa-let-7i-3p MIMAT0004585 19939273 Erythrocyteshsa-let-7i-5p MIMAT0000415 19939273 Erythrocytes hsa-miR-320aMIMAT0000510 18523662 Erythroid Cells hsa-let-7a-5p MIMAT000006219939273 Erythroid Cells hsa-let-7c-3p MIMAT0026472 19939273 ErythroidCells hsa-let-7c-5p MIMAT0000064 19939273 Erythroid Cells hsa-let-7d-3pMIMAT0004484 19939273 Erythroid Cells hsa-let-7d-5p MIMAT000006519939273 Erythroid Cells hsa-let-7d-5p MIMAT0000065 20410187 ErythroidCells hsa-let-7e-3p MIMAT0004485 19939273 Erythroid Cells hsa-let-7e-5pMIMAT0000066 19939273 Erythroid Cells hsa-let-7g-3p MIMAT000458419939273 Erythroid Cells hsa-let-7g-5p MIMAT0000414 19939273 ErythroidCells hsa-let-7i-3p MIMAT0004585 19939273 Erythroid Cells hsa-let-7i-5pMIMAT0000415 19939273 Erythroid Cells hsa-miR-150-5p MIMAT000045118539114 Erythroid Cells hsa-miR-223-3p MIMAT0000280 19278969 ErythroidCells hsa-miR-223-3p MIMAT0000280 19017354 Erythroid Precursor Cellshsa-miR-15a-5p MIMAT0000068 21205891 Erythroid Precursor Cellshsa-miR-16-5p MIMAT0000069 21205891 Esophagus hsa-miR-196a-5pMIMAT0000226 19342367 Esophagus hsa-miR-21-5p MIMAT0000076 18372920Esophagus mmu-miR-21a-5p MIMAT0000530 18372920 Eukaryotic Cellshsa-let-7a-5p MIMAT0000062 19939273 Eukaryotic Cells hsa-let-7c-3pMIMAT0026472 19939273 Eukaryotic Cells hsa-let-7c-5p MIMAT000006419939273 Eukaryotic Cells hsa-let-7d-3p MIMAT0004484 19939273 EukaryoticCells hsa-let-7d-5p MIMAT0000065 19939273 Eukaryotic Cells hsa-let-7e-3pMIMAT0004485 19939273 Eukaryotic Cells hsa-let-7e-5p MIMAT000006619939273 Eukaryotic Cells hsa-let-7g-3p MIMAT0004584 19939273 EukaryoticCells hsa-let-7g-5p MIMAT0000414 19939273 Eukaryotic Cells hsa-let-7i-3pMIMAT0004585 19939273 Eukaryotic Cells hsa-let-7i-5p MIMAT000041519939273 Extracellular Matrix bta-miR-335 MIMAT0009291 18185580Extracellular Matrix cfa-miR-335 MIMAT0006624 18185580 ExtracellularMatrix hsa-miR-124-3p MIMAT0000422 21112327 Extracellular Matrixhsa-miR-125b-5p MIMAT0000423 21703189 Extracellular Matrixhsa-miR-155-5p MIMAT0000646 19701459 Extracellular Matrix hsa-miR-17-3pMIMAT0000071 19771525 Extracellular Matrix hsa-miR-17-5p MIMAT000007019771525 Extracellular Matrix hsa-miR-205-5p MIMAT0000266 22578566Extracellular Matrix hsa-miR-25-3p MIMAT0000081 19541842 ExtracellularMatrix hsa-miR-29a-3p MIMAT0000086 18390668 Extracellular Matrixhsa-miR-29a-3p MIMAT0000086 21665270 Extracellular Matrix hsa-miR-29b-3pMIMAT0000100 21665270 Extracellular Matrix hsa-miR-29b-3p MIMAT000010019956414 Extracellular Matrix hsa-miR-29b-3p MIMAT0000100 21793034Extracellular Matrix hsa-miR-29c-3p MIMAT0000681 18390668 ExtracellularMatrix hsa-miR-29c-3p MIMAT0000681 21436257 Extracellular Matrixhsa-miR-335-5p MIMAT0000765 18185580 Extracellular Matrixhsa-miR-378a-3p MIMAT0000732 19844573 Extracellular Matrix hsa-miR-626MIMAT0003295 19892711 Extracellular Matrix hsa-miR-7-5p MIMAT000025219892711 Extracellular Matrix mmu-miR-125b-5p MIMAT0000136 21945074Extracellular Matrix mmu-miR-143-3p MIMAT0000247 20489207 ExtracellularMatrix mmu-miR-155-5p MIMAT0000165 19701459 Extracellular Matrixmmu-miR-15a-5p MIMAT0000526 21305018 Extracellular Matrix mmu-miR-192-5pMIMAT0000517 17360662 Extracellular Matrix mmu-miR-215-5p MIMAT000090417360662 Extracellular Matrix mmu-miR-216a-5p MIMAT0000662 20713358Extracellular Matrix mmu-miR-21a-5p MIMAT0000530 21295561 ExtracellularMatrix mmu-miR-27b-3p MIMAT0000126 19342382 Extracellular Matrixmmu-miR-29a-3p MIMAT0000535 21665270 Extracellular Matrix mmu-miR-29b-3pMIMAT0000127 19342382 Extracellular Matrix mmu-miR-29b-3p MIMAT000012721665270 Extracellular Matrix mmu-miR-29c-3p MIMAT0000536 21310958Extracellular Matrix mmu-miR-30a-5p MIMAT0000128 21945074 ExtracellularMatrix mmu-miR-30c-5p MIMAT0000514 21945074 Extracellular Matrixmmu-miR-497-5p MIMAT0003453 21305018 Extracellular Matrix mmu-miR-706MIMAT0003496 19892711 Extracellular Matrix ppy-miR-335 MIMAT001583718185580 Extracellular Matrix ptr-miR-335 MIMAT0008104 18185580Extracellular Matrix rno-miR-150-5p MIMAT0000853 19892940 ExtracellularMatrix rno-miR-192-5p MIMAT0000867 20393144 Extracellular Matrixrno-miR-194-5p MIMAT0000869 19892940 Extracellular Matrix rno-miR-215MIMAT0003118 20393144 Extracellular Matrix rno-miR-335 MIMAT000057518185580 Extracellular Matrix ssc-miR-335 MIMAT0013955 18185580Extremities hsa-miR-433-3p MIMAT0001627 20181727 Extremitiesmmu-miR-137-3p MIMAT0000149 21256124 Extremities mmu-miR-140-5pMIMAT0000151 21872590 Extremities mmu-miR-140-5p MIMAT0000151 16828749Extremities mmu-miR-153-3p MIMAT0000163 21256124 Extremitiesmmu-miR-363-3p MIMAT0000708 21256124 Extremities rno-miR-138-5pMIMAT0000844 20064393 Eye hsa-miR-1 MIMAT0000416 21169019 Eyehsa-miR-204-5p MIMAT0000265 20713703 Eye hsa-miR-29a-3p MIMAT000008621169019 Eye mmu-miR-184-3p MIMAT0000213 20795863 Fallopian Tubeshsa-miR-182-5p MIMAT0000259 22322863 Femoral Artery mmu-miR-100-3pMIMAT0017051 21339483 Femoral Artery mmu-miR-100-5p MIMAT000065521339483 Fetal Blood hsa-let-7a-5p MIMAT0000062 19939273 Fetal Bloodhsa-let-7c-3p MIMAT0026472 19939273 Fetal Blood hsa-let-7c-5pMIMAT0000064 19939273 Fetal Blood hsa-let-7d-3p MIMAT0004484 19939273Fetal Blood hsa-let-7d-5p MIMAT0000065 19939273 Fetal Bloodhsa-let-7e-3p MIMAT0004485 19939273 Fetal Blood hsa-let-7e-5pMIMAT0000066 19939273 Fetal Blood hsa-let-7g-3p MIMAT0004584 19939273Fetal Blood hsa-let-7g-5p MIMAT0000414 19939273 Fetal Bloodhsa-let-7i-3p MIMAT0004585 19939273 Fetal Blood hsa-let-7i-5pMIMAT0000415 19939273 Fetal Blood hsa-miR-129-5p MIMAT0000242 18189265Fetal Blood hsa-miR-135b-5p MIMAT0000758 19795981 Fetal Bloodhsa-miR-148a-3p MIMAT0000243 19435428 Fetal Blood hsa-miR-155-5pMIMAT0000646 18950466 Fetal Blood hsa-miR-184 MIMAT0000454 19286996Fetal Blood hsa-miR-19b-3p MIMAT0000074 19435428 Fetal Bloodhsa-miR-20a-5p MIMAT0000075 19435428 Fetal Blood hsa-miR-214-3pMIMAT0000271 19435428 Fetal Blood hsa-miR-223-3p MIMAT0000280 19278969Fetal Blood hsa-miR-31-3p MIMAT0004504 19408243 Fetal Bloodhsa-miR-31-5p MIMAT0000089 19408243 Fetal Blood hsa-miR-520hMIMAT0002867 18189265 Fetal Blood hsa-miR-520h MIMAT0002867 19435428Fetal Blood hsa-miR-92a-3p MIMAT0000092 19435428 Fetus hsa-miR-433-3pMIMAT0001627 20181727 Fibroblasts bta-miR-155 MIMAT0009241 20735984Fibroblasts cfa-miR-155 MIMAT0006671 20735984 Fibroblasts dre-miR-155MIMAT0001851 20735984 Fibroblasts gga-miR-155 MIMAT0001106 20735984Fibroblasts hsa-let-7a-5p MIMAT0000062 20005451 Fibroblastshsa-let-7b-3p MIMAT0004482 19126550 Fibroblasts hsa-let-7b-5pMIMAT0000063 19126550 Fibroblasts hsa-miR-125b-5p MIMAT0000423 21412257Fibroblasts hsa-miR-125b-5p MIMAT0000423 19293287 Fibroblastshsa-miR-140-5p MIMAT0000431 23401231 Fibroblasts hsa-miR-141-3pMIMAT0000432 19861690 Fibroblasts hsa-miR-146a-5p MIMAT0000449 20061417Fibroblasts hsa-miR-146a-5p MIMAT0000449 18759964 Fibroblastshsa-miR-146a-5p MIMAT0000449 21968601 Fibroblasts hsa-miR-146b-5pMIMAT0002809 21305051 Fibroblasts hsa-miR-155-5p MIMAT0000646 21093163Fibroblasts hsa-miR-155-5p MIMAT0000646 20735984 Fibroblastshsa-miR-155-5p MIMAT0000646 19701459 Fibroblasts hsa-miR-155-5pMIMAT0000646 16675453 Fibroblasts hsa-miR-155-5p MIMAT0000646 19759154Fibroblasts hsa-miR-155-5p MIMAT0000646 17668390 Fibroblastshsa-miR-15a-5p MIMAT0000068 19823025 Fibroblasts hsa-miR-15b-5pMIMAT0000417 19861690 Fibroblasts hsa-miR-16-5p MIMAT0000069 21885851Fibroblasts hsa-miR-17-5p MIMAT0000070 19823025 Fibroblastshsa-miR-183-5p MIMAT0000261 19940135 Fibroblasts hsa-miR-199a-3pMIMAT0000232 18456660 Fibroblasts hsa-miR-206 MIMAT0000462 17030984Fibroblasts hsa-miR-20a-5p MIMAT0000075 19823025 Fibroblastshsa-miR-21-5p MIMAT0000076 21826097 Fibroblasts hsa-miR-21-5pMIMAT0000076 19509156 Fibroblasts hsa-miR-21-5p MIMAT0000076 19435867Fibroblasts hsa-miR-21-5p MIMAT0000076 20813833 Fibroblastshsa-miR-22-3p MIMAT0000077 22538858 Fibroblasts hsa-miR-223-3pMIMAT0000280 21305051 Fibroblasts hsa-miR-223-3p MIMAT0000280 20826802Fibroblasts hsa-miR-23a-3p MIMAT0000078 21750350 Fibroblastshsa-miR-23b-3p MIMAT0000418 19490101 Fibroblasts hsa-miR-24-3pMIMAT0000080 19861690 Fibroblasts hsa-miR-24-3p MIMAT0000080 18365017Fibroblasts hsa-miR-25-3p MIMAT0000081 19861690 Fibroblastshsa-miR-25-3p MIMAT0000081 20826802 Fibroblasts hsa-miR-29a-3pMIMAT0000086 20201077 Fibroblasts hsa-miR-29b-3p MIMAT0000100 20201077Fibroblasts hsa-miR-29b-3p MIMAT0000100 21305051 Fibroblastshsa-miR-29c-3p MIMAT0000681 21436257 Fibroblasts hsa-miR-29c-3pMIMAT0000681 21305051 Fibroblasts hsa-miR-31-3p MIMAT0004504 20980827Fibroblasts hsa-miR-31-5p MIMAT0000089 20980827 Fibroblastshsa-miR-335-5p MIMAT0000765 21164520 Fibroblasts hsa-miR-378a-3pMIMAT0000732 21471220 Fibroblasts hsa-miR-424-5p MIMAT0001341 21885851Fibroblasts hsa-miR-433-3p MIMAT0001627 20181727 Fibroblastshsa-miR-483-3p MIMAT0002173 21305051 Fibroblasts hsa-miR-505-3pMIMAT0002876 20923760 Fibroblasts hsa-miR-574-5p MIMAT0004795 21305051Fibroblasts mml-miR-155 MIMAT0006216 20735984 Fibroblastsmmu-miR-101b-3p MIMAT0000616 19169275 Fibroblasts mmu-miR-130a-3pMIMAT0000141 19582148 Fibroblasts mmu-miR-133a-3p MIMAT0000145 19043405Fibroblasts mmu-miR-135b-5p MIMAT0000612 23440414 Fibroblastsmmu-miR-143-3p MIMAT0000247 19578358 Fibroblasts mmu-miR-145a-5pMIMAT0000157 19578358 Fibroblasts mmu-miR-155-5p MIMAT0000165 19701459Fibroblasts mmu-miR-196a-5p MIMAT0000518 19169275 Fibroblastsmmu-miR-200a-3p MIMAT0000519 21115742 Fibroblasts mmu-miR-200b-3pMIMAT0000233 21115742 Fibroblasts mmu-miR-200c-3p MIMAT0000657 21115742Fibroblasts mmu-miR-206-3p MIMAT0000239 17030984 Fibroblastsmmu-miR-206-3p MIMAT0000239 19043405 Fibroblasts mmu-miR-21a-5pMIMAT0000530 19043405 Fibroblasts mmu-miR-21a-5p MIMAT0000530 19147652Fibroblasts mmu-miR-223-3p MIMAT0000665 20826802 Fibroblastsmmu-miR-25-3p MIMAT0000652 20826802 Fibroblasts mmu-miR-28a-3pMIMAT0004661 20923760 Fibroblasts mmu-miR-28a-5p MIMAT0000653 20923760Fibroblasts mmu-miR-429-3p MIMAT0001537 21115742 Fibroblastsmmu-miR-505-3p MIMAT0003513 20923760 Fibroblasts mmu-miR-505-5pMIMAT0017259 20923760 Fibroblasts ppy-miR-155 MIMAT0015777 20735984Fibroblasts ptr-miR-155 MIMAT0008048 20735984 Fibroblasts rno-miR-21-5pMIMAT0000790 22565856 Fibroblasts xtr-miR-155 MIMAT0003608 20735984Focal Adhesions hsa-miR-10b-5p MIMAT0000254 22573479 Focal Adhesionshsa-miR-126-3p MIMAT0000445 19767772 Focal Adhesions hsa-miR-151a-5pMIMAT0004697 20305651 Focal Adhesions hsa-miR-21-5p MIMAT000007617681183 Fourth Ventricle mmu-miR-449a-5p MIMAT0001542 19056356 Gangliahsa-miR-18a-5p MIMAT0000072 20080637 Ganglia hsa-miR-19a-3p MIMAT000007320080637 Ganglia Spinal hsa-miR-145-5p MIMAT0000437 21276775 GangliaSpinal hsa-miR-214-3p MIMAT0000271 21276775 Ganglia Sympathetichsa-miR-18a-5p MIMAT0000072 20080637 Ganglia Sympathetic hsa-miR-19a-3pMIMAT0000073 20080637 Gap Junctions hsa-miR-21-5p MIMAT0000076 18508928Gap Junctions mmu-miR-206-3p MIMAT0000239 19933329 Gap Junctionsmmu-miR-21a-5p MIMAT0000530 18508928 Gastric Mucosa hsa-miR-146a-5pMIMAT0000449 20542134 Gastric Mucosa hsa-miR-155-5p MIMAT000064619650740 Gastric Mucosa hsa-miR-218-5p MIMAT0000275 19890957 GastricMucosa hsa-miR-222-3p MIMAT0000279 22321642 Gastric Mucosahsa-miR-223-3p MIMAT0000280 22270966 Gastric Mucosa hsa-miR-34b-3pMIMAT0004676 20924086 Gastric Mucosa hsa-miR-34c-5p MIMAT000068620924086 Gastrointestinal Tract hsa-miR-17-5p MIMAT0000070 20926598Gastrointestinal Tract hsa-miR-20a-5p MIMAT0000075 20926598Gastrointestinal Tract hsa-miR-20b-5p MIMAT0001413 20926598Gastrointestinal Tract hsa-miR-30c-5p MIMAT0000244 20926598Gastrointestinal Tract hsa-miR-30e-5p MIMAT0000692 20926598 Germ Cellshsa-miR-1 MIMAT0000416 18155131 Germ Cells hsa-miR-206 MIMAT000046218155131 Germ Cells hsa-miR-221-3p MIMAT0000278 18155131 Germ Cellshsa-miR-302b-3p MIMAT0000715 19342891 Germ Cells hsa-miR-372-3pMIMAT0000724 16564011 Germ Cells hsa-miR-372-3p MIMAT0000724 18155131Germ Cells hsa-miR-373-3p MIMAT0000726 16564011 Germ Cellshsa-miR-383-5p MIMAT0000738 21368870 Germ Cells mmu-let-7a-5pMIMAT0000521 19898466 Germ Cells mmu-let-7e-5p MIMAT0000524 19898466Germ Cells mmu-miR-125a-5p MIMAT0000135 19898466 Germ Cellsmmu-miR-125b-5p MIMAT0000136 19898466 Germ Cells mmu-miR-128-3pMIMAT0000140 19898466 Germ Cells mmu-miR-290a-3p MIMAT0004572 19628328Germ Cells mmu-miR-291a-3p MIMAT0000368 19628328 Germ Cellsmmu-miR-292-3p MIMAT0000370 19628328 Germ Cells mmu-miR-293-3pMIMAT0000371 19628328 Germ Cells mmu-miR-294-3p MIMAT0000372 19628328Germ Cells mmu-miR-295-3p MIMAT0000373 19628328 Germ Cellsmmu-miR-29b-3p MIMAT0000127 19509302 Germ Layers hsa-miR-135b-5pMIMAT0000758 19795981 Germ Layers hsa-miR-302a-3p MIMAT0000684 21266536Germ Layers hsa-miR-302a-3p MIMAT0000684 19386261 Germ Layershsa-miR-302d-3p MIMAT0000718 21266536 Germinal Center hsa-miR-127-3pMIMAT0000446 19530237 Germinal Center hsa-miR-155-5p MIMAT000064619177201 Germinal Center mmu-miR-155-5p MIMAT0000165 18055230 Gonadsmmu-miR-29b-3p MIMAT0000127 19509302 Granulocyte Precursor Cellshsa-miR-223-3p MIMAT0000280 18278031 Granulocyte Precursor Cellsmmu-miR-223-3p MIMAT0000665 18278031 Granulocyte Precursor Cellsmmu-miR-27a-3p MIMAT0000537 19298589 Granulocyte Precursor Cellsmmu-miR-27b-3p MIMAT0000126 19298589 Granulocytes hsa-miR-146a-5pMIMAT0000449 20375304 Granulocytes hsa-miR-148a-3p MIMAT0000243 19435428Granulocytes hsa-miR-19b-3p MIMAT0000074 19435428 Granulocyteshsa-miR-20a-5p MIMAT0000075 19435428 Granulocytes hsa-miR-214-3pMIMAT0000271 19435428 Granulocytes hsa-miR-223-3p MIMAT0000280 19017354Granulocytes hsa-miR-223-3p MIMAT0000280 18278031 Granulocyteshsa-miR-520h MIMAT0002867 19435428 Granulocytes hsa-miR-92a-3pMIMAT0000092 19435428 Granulocytes mmu-miR-223-3p MIMAT0000665 18278031Granulocytes mmu-miR-27a-3p MIMAT0000537 19298589 Granulocytesmmu-miR-27b-3p MIMAT0000126 19298589 Granulosa Cells hsa-miR-224-5pMIMAT0000281 20118412 Granulosa Cells mmu-miR-503-5p MIMAT000318819799966 Granulosa Cells rno-miR-125a-3p MIMAT0004729 23045399 GranulosaCells rno-miR-125a-5p MIMAT0000829 23045399 Granulosa Cellsrno-miR-455-5p MIMAT0005316 23045399 Growth Plate mmu-miR-125b-5pMIMAT0000136 21945074 Growth Plate mmu-miR-30a-5p MIMAT0000128 21945074Growth Plate mmu-miR-30c-5p MIMAT0000514 21945074 Hair hsa-miR-199a-3pMIMAT0000232 21807947 Hair hsa-miR-96-5p MIMAT0000095 19363479 Hairmmu-miR-15a-5p MIMAT0000526 19416898 Hair mmu-miR-31-5p MIMAT000053820522784 Hair mmu-miR-96-5p MIMAT0000541 19363478 Hair Folliclehsa-miR-199a-3p MIMAT0000232 21807947 Hair Follicle mmu-miR-31-5pMIMAT0000538 20522784 Hand hsa-let-7a-5p MIMAT0000062 18679415 Handhsa-let-7a-5p MIMAT0000062 18758960 Hand hsa-miR-10a-5p MIMAT000025320506192 Hand hsa-miR-125b-5p MIMAT0000423 19570947 Hand hsa-miR-155-5pMIMAT0000646 19538740 Hand hsa-miR-15a-5p MIMAT0000068 17707831 Handhsa-miR-16-5p MIMAT0000069 17707831 Hand hsa-miR-17-5p MIMAT000007018941111 Hand hsa-miR-18a-3p MIMAT0002891 19372139 Hand hsa-miR-20a-5pMIMAT0000075 18941111 Hand hsa-miR-21-5p MIMAT0000076 21317927 Handhsa-miR-29b-3p MIMAT0000100 17707831 Hand hsa-miR-448 MIMAT000153220798686 Hand hsa-miR-503-5p MIMAT0002874 19538740 Hand hsa-miR-519c-3pMIMAT0002832 19825807 Hand hsa-miR-520h MIMAT0002867 19825807 Handmmu-miR-100-3p MIMAT0017051 20439489 Hand mmu-miR-100-5p MIMAT000065520439489 Hand mmu-miR-137-3p MIMAT0000149 20439489 Hand mmu-miR-137-5pMIMAT0016986 20439489 Hand mmu-miR-195a-5p MIMAT0000225 21622680 Handmmu-miR-696 MIMAT0003483 20086200 Head hsa-miR-101-3p MIMAT000009919043531 Head hsa-miR-125a-5p MIMAT0000443 19179615 Head hsa-miR-135b-5pMIMAT0000758 23340180 Head hsa-miR-138-5p MIMAT0000430 21770894 Headhsa-miR-15a-5p MIMAT0000068 19117988 Head hsa-miR-181a-5p MIMAT000025621274007 Head hsa-miR-188-5p MIMAT0000457 19223510 Head hsa-miR-200c-3pMIMAT0000617 21207483 Head hsa-miR-200c-3p MIMAT0000617 19223510 Headhsa-miR-200c-3p MIMAT0000617 21294122 Head hsa-miR-203a MIMAT000026418483491 Head hsa-miR-204-5p MIMAT0000265 20369013 Head hsa-miR-21-5pMIMAT0000076 18372920 Head hsa-miR-30c-5p MIMAT0000244 19223510 Headhsa-miR-30e-5p MIMAT0000692 19223510 Head hsa-miR-31-3p MIMAT000450420145132 Head hsa-miR-31-5p MIMAT0000089 20145132 Head hsa-miR-34a-5pMIMAT0000255 21294122 Head hsa-miR-34a-5p MIMAT0000255 21240262 Headhsa-miR-374a-5p MIMAT0000727 21274007 Head hsa-miR-489-3p MIMAT000280520700123 Head hsa-miR-519a-3p MIMAT0002869 21274007 Head hsa-miR-630MIMAT0003299 21274007 Head hsa-miR-98-5p MIMAT0000096 17222355 Headmmu-miR-127-5p MIMAT0004530 19878148 Head mmu-miR-204-5p MIMAT000023720369013 Head mmu-miR-21a-5p MIMAT0000530 18372920 Head mmu-miR-22-3pMIMAT0000531 19878148 Head mmu-miR-27a-3p MIMAT0000537 19878148 Headmmu-miR-29b-1-5p MIMAT0004523 19878148 Head mmu-miR-382-3p MIMAT000469119878148 Head mmu-miR-411-3p MIMAT0001093 19878148 Head mmu-miR-470-5pMIMAT0002111 19878148 Head mmu-miR-501-3p MIMAT0003509 19878148 Headmmu-miR-669b-5p MIMAT0003476 19878148 Head mmu-miR-676-3p MIMAT000378219878148 Head mmu-miR-96-5p MIMAT0000541 19878148 Heart hsa-miR-1MIMAT0000416 19131648 Heart hsa-miR-1 MIMAT0000416 17401374 Hearthsa-miR-1 MIMAT0000416 19188439 Heart hsa-miR-1 MIMAT0000416 20571053Heart hsa-miR-1 MIMAT0000416 20081117 Heart hsa-miR-1 MIMAT000041615951802 Heart hsa-miR-1 MIMAT0000416 17443681 Heart hsa-miR-1MIMAT0000416 23141496 Heart hsa-miR-1 MIMAT0000416 21169019 Hearthsa-miR-126-3p MIMAT0000445 20571053 Heart hsa-miR-133a-3p MIMAT000042719720047 Heart hsa-miR-133a-3p MIMAT0000427 17443681 Hearthsa-miR-133a-3p MIMAT0000427 23069713 Heart hsa-miR-133b MIMAT000077019720047 Heart hsa-miR-150-5p MIMAT0000451 23211718 Heart hsa-miR-155-5pMIMAT0000646 19897480 Heart hsa-miR-182-5p MIMAT0000259 17597072 Hearthsa-miR-199b-5p MIMAT0000263 21102440 Heart hsa-miR-208a-3p MIMAT000024117379774 Heart hsa-miR-21-5p MIMAT0000076 23313253 Heart hsa-miR-21-5pMIMAT0000076 20219857 Heart hsa-miR-22-3p MIMAT0000077 22538858 Hearthsa-miR-223-3p MIMAT0000280 20080987 Heart hsa-miR-27a-3p MIMAT000008421149577 Heart hsa-miR-29a-3p MIMAT0000086 21169019 Heart hsa-miR-320aMIMAT0000510 19380620 Heart hsa-miR-34a-5p MIMAT0000255 20627091 Hearthsa-miR-499a-5p MIMAT0002870 20081117 Heart hsa-miR-499b-5p MIMAT001989720081117 Heart hsa-miR-802 MIMAT0004185 19897480 Heart hsa-miR-9-5pMIMAT0000441 19188439 Heart hsa-miR-96-5p MIMAT0000095 17597072 Heartmmu-miR-122-5p MIMAT0000246 16258535 Heart mmu-miR-133a-3p MIMAT000014517468766 Heart mmu-miR-133a-3p MIMAT0000145 19043405 Heartmmu-miR-138-5p MIMAT0000150 19004786 Heart mmu-miR-15b-5p MIMAT000012420007690 Heart mmu-miR-16-5p MIMAT0000527 20007690 Heart mmu-miR-195a-5pMIMAT0000225 20007690 Heart mmu-miR-195a-5p MIMAT0000225 21622680 Heartmmu-miR-199b-3p MIMAT0004667 21102440 Heart mmu-miR-1a-3p MIMAT000012317234972 Heart mmu-miR-1a-3p MIMAT0000123 19188439 Heart mmu-miR-1a-3pMIMAT0000123 19521018 Heart mmu-miR-1a-3p MIMAT0000123 19933931 Heartmmu-miR-1a-3p MIMAT0000123 15951802 Heart mmu-miR-1a-3p MIMAT000012317397913 Heart mmu-miR-1a-3p MIMAT0000123 23436819 Heart mmu-miR-206-3pMIMAT0000239 19043405 Heart mmu-miR-208a-3p MIMAT0000520 17379774 Heartmmu-miR-21a-5p MIMAT0000530 19147652 Heart mmu-miR-21a-5p MIMAT000053020404348 Heart mmu-miR-21a-5p MIMAT0000530 19043405 Heart mmu-miR-27b-3pMIMAT0000126 20736237 Heart mmu-miR-320-3p MIMAT0000666 19380620 Heartmmu-miR-322-5p MIMAT0000548 20007690 Heart mmu-miR-494-3p MIMAT000318220837890 Heart rno-miR-1-3p MIMAT0003125 17401374 Heart rno-miR-1-3pMIMAT0003125 19188439 Heart rno-miR-1-3p MIMAT0003125 17516552 Heartrno-miR-1-3p MIMAT0003125 23436819 Heart rno-miR-133a-3p MIMAT000083917516552 Heart rno-miR-133a-3p MIMAT0000839 19720047 Heartrno-miR-133b-3p MIMAT0003126 19720047 Heart rno-miR-15b-5p MIMAT000078420007690 Heart rno-miR-16-5p MIMAT0000785 20007690 Heart rno-miR-195-5pMIMAT0000870 20007690 Heart rno-miR-21-5p MIMAT0000790 19336275 Heartrno-miR-214-3p MIMAT0000885 20007690 Heart rno-miR-23a-3p MIMAT000079219574461 Heart rno-miR-27a-3p MIMAT0000799 19574461 Heart rno-miR-27a-3pMIMAT0000799 21149577 Heart rno-miR-29a-3p MIMAT0000802 20164119 Heartrno-miR-29c-3p MIMAT0000803 20164119 Heart rno-miR-322-5p MIMAT000161920007690 Heart rno-miR-328a-3p MIMAT0000564 21098446 Heart Ventricleshsa-miR-1 MIMAT0000416 20571053 Heart Ventricles hsa-miR-126-3pMIMAT0000445 20571053 Heart Ventricles rno-miR-21-5p MIMAT000079019706597 Hematopoietic Stem Cells hsa-let-7d-5p MIMAT0000065 20410187Hematopoietic Stem Cells hsa-miR-125a-5p MIMAT0000443 20616003Hematopoietic Stem Cells hsa-miR-126-3p MIMAT0000445 18474618Hematopoietic Stem Cells hsa-miR-129-5p MIMAT0000242 18189265Hematopoietic Stem Cells hsa-miR-145-5p MIMAT0000437 18474618Hematopoietic Stem Cells hsa-miR-148a-3p MIMAT0000243 19435428Hematopoietic Stem Cells hsa-miR-155-5p MIMAT0000646 18299402Hematopoietic Stem Cells hsa-miR-19b-3p MIMAT0000074 19435428Hematopoietic Stem Cells hsa-miR-20a-5p MIMAT0000075 19435428Hematopoietic Stem Cells hsa-miR-214-3p MIMAT0000271 19435428Hematopoietic Stem Cells hsa-miR-223-3p MIMAT0000280 19278969Hematopoietic Stem Cells hsa-miR-24-3p MIMAT0000080 17906079Hematopoietic Stem Cells hsa-miR-520h MIMAT0002867 18189265Hematopoietic Stem Cells hsa-miR-520h MIMAT0002867 19435428Hematopoietic Stem Cells hsa-miR-92a-3p MIMAT0000092 19435428Hematopoietic Stem Cells mmu-let-7a-5p MIMAT0000521 18474618Hematopoietic Stem Cells mmu-miR-125b-5p MIMAT0000136 21118986Hematopoietic Stem Cells mmu-miR-126a-3p MIMAT0000138 18474618Hematopoietic Stem Cells mmu-miR-145a-5p MIMAT0000157 18474618Hematopoietic System hsa-miR-124-3p MIMAT0000422 18451139 HematopoieticSystem hsa-miR-155-5p MIMAT0000646 19359473 Hepatic Stellate Cellshsa-miR-143-3p MIMAT0000435 19913496 Hepatic Stellate Cellshsa-miR-218-5p MIMAT0000275 19913496 Hepatic Stellate Cellshsa-miR-29b-3p MIMAT0000100 19913496 Hepatic Stellate Cellsmmu-miR-132-3p MIMAT0000144 19843474 Hepatic Stellate Cellsrno-miR-132-3p MIMAT0000838 19843474 Hepatic Stellate Cellsrno-miR-146a-5p MIMAT0000852 22735812 Hepatic Stellate Cellsrno-miR-150-5p MIMAT0000853 19892940 Hepatic Stellate Cellsrno-miR-15b-5p MIMAT0000784 19232449 Hepatic Stellate Cellsrno-miR-16-5p MIMAT0000785 19232449 Hepatic Stellate Cellsrno-miR-194-5p MIMAT0000869 19892940 Hepatic Stellate Cellsrno-miR-200a-3p MIMAT0000874 19185571 Hepatic Stellate Cellsrno-miR-27a-3p MIMAT0000799 19185571 Hepatic Stellate Cellsrno-miR-27b-3p MIMAT0000798 19185571 Hepatocytes hsa-let-7c-5pMIMAT0000064 20347499 Hepatocytes hsa-let-7g-5p MIMAT0000414 20347499Hepatocytes hsa-miR-103a-3p MIMAT0000101 22723340 Hepatocyteshsa-miR-107 MIMAT0000104 22723340 Hepatocytes hsa-miR-122-5pMIMAT0000421 20351063 Hepatocytes hsa-miR-122-5p MIMAT0000421 23055569Hepatocytes hsa-miR-122-5p MIMAT0000421 23221562 Hepatocyteshsa-miR-122-5p MIMAT0000421 19726678 Hepatocytes hsa-miR-122-5pMIMAT0000421 20842632 Hepatocytes hsa-miR-181a-5p MIMAT0000256 22476949Hepatocytes hsa-miR-181b-5p MIMAT0000257 20023698 Hepatocyteshsa-miR-185-5p MIMAT0000455 23459944 Hepatocytes hsa-miR-193b-3pMIMAT0002819 20103677 Hepatocytes hsa-miR-196a-5p MIMAT0000226 20127796Hepatocytes hsa-miR-21-5p MIMAT0000076 20827319 Hepatocyteshsa-miR-21-5p MIMAT0000076 19072831 Hepatocytes hsa-miR-21-5pMIMAT0000076 17681183 Hepatocytes hsa-miR-223-3p MIMAT0000280 23459944Hepatocytes hsa-miR-296-5p MIMAT0000690 21633093 Hepatocyteshsa-miR-30a-5p MIMAT0000087 19185580 Hepatocytes hsa-miR-33a-5pMIMAT0000091 23547260 Hepatocytes hsa-miR-422a MIMAT0001339 20351063Hepatocytes hsa-miR-96-5p MIMAT0000095 23459944 Hepatocytesmmu-miR-181b-5p MIMAT0000673 20023698 Hepatocytes mmu-miR-194-5pMIMAT0000224 21887698 Hepatocytes mmu-miR-21a-5p MIMAT0000530 20432256Hepatocytes mmu-miR-23b-3p MIMAT0000125 19582816 Hepatocytesmmu-miR-24-3p MIMAT0000219 19582816 Hepatocytes mmu-miR-27b-3pMIMAT0000126 19582816 Hepatocytes mmu-miR-30a-5p MIMAT0000128 19185580Hepatocytes mmu-miR-378a-3p MIMAT0003151 20432256 Hepatocytesmmu-miR-378a-5p MIMAT0000742 20432256 Hippocampus hsa-miR-141-3pMIMAT0000432 20584986 Hippocampus hsa-miR-21-5p MIMAT0000076 20584986Hippocampus hsa-miR-210-3p MIMAT0000267 18539147 Hippocampus hsa-miR-375MIMAT0000728 20584986 Hippocampus mmu-miR-135a-5p MIMAT0000147 20619502Hippocampus mmu-miR-141-3p MIMAT0000153 20584986 Hippocampusmmu-miR-16-5p MIMAT0000527 20619502 Hippocampus mmu-miR-20a-5pMIMAT0000529 20619502 Hippocampus mmu-miR-210-3p MIMAT0000658 18539147Hippocampus mmu-miR-298-5p MIMAT0000376 18986979 Hippocampusmmu-miR-328-3p MIMAT0000565 18986979 Hippocampus mmu-miR-375-3pMIMAT0000739 20584986 Hippocampus rno-miR-141-3p MIMAT0000846 20584986Hippocampus rno-miR-21-5p MIMAT0000790 20584986 Hippocampusrno-miR-21-5p MIMAT0000790 21154462 Hypothalamus mmu-miR-7b-5pMIMAT0000678 17028171 Iliac Artery rno-miR-21-5p MIMAT0000790 22565856Immune System hsa-miR-106a-5p MIMAT0000103 19307576 Immune Systemhsa-miR-146a-5p MIMAT0000449 20375304 Immune System hsa-miR-148a-3pMIMAT0000243 19435428 Immune System hsa-miR-155-3p MIMAT0004658 20852130Immune System hsa-miR-155-5p MIMAT0000646 20219467 Immune Systemhsa-miR-155-5p MIMAT0000646 18299402 Immune System hsa-miR-155-5pMIMAT0000646 21097505 Immune System hsa-miR-155-5p MIMAT0000646 20852130Immune System hsa-miR-155-5p MIMAT0000646 19596814 Immune Systemhsa-miR-155-5p MIMAT0000646 21030878 Immune System hsa-miR-155-5pMIMAT0000646 20209161 Immune System hsa-miR-19b-3p MIMAT0000074 19435428Immune System hsa-miR-20a-5p MIMAT0000075 19435428 Immune Systemhsa-miR-214-3p MIMAT0000271 19435428 Immune System hsa-miR-520hMIMAT0002867 19435428 Immune System hsa-miR-92a-3p MIMAT0000092 19435428Immune System mmu-miR-124-3p MIMAT0000134 21131957 Immune Systemmmu-miR-146a-5p MIMAT0000158 18791161 Immune System mmu-miR-155-5pMIMAT0000165 18055230 Immune System mmu-miR-155-5p MIMAT0000165 21385848Immune System mmu-miR-155-5p MIMAT0000165 17463290 Induced PluripotentStem hsa-miR-302a-3p MIMAT0000684 23185040 Cells Induced PluripotentStem hsa-miR-302a-3p MIMAT0000684 21062975 Cells Induced PluripotentStem hsa-miR-302b-3p MIMAT0000715 23185040 Cells Induced PluripotentStem hsa-miR-302b-3p MIMAT0000715 21062975 Cells Induced PluripotentStem hsa-miR-302c-3p MIMAT0000717 23185040 Cells Induced PluripotentStem hsa-miR-302c-3p MIMAT0000717 21062975 Cells Induced PluripotentStem hsa-miR-302d-3p MIMAT0000718 23185040 Cells Induced PluripotentStem hsa-miR-302d-3p MIMAT0000718 21062975 Cells Induced PluripotentStem mmu-let-7c-5p MIMAT0000523 20054295 Cells Induced Pluripotent Stemmmu-miR-106b-5p MIMAT0000386 21285944 Cells Induced Pluripotent Stemmmu-miR-93-5p MIMAT0000540 21285944 Cells Insulin-Secreting Cellshsa-miR-9-5p MIMAT0000441 16831872 Insulin-Secreting Cellsmmu-miR-375-3p MIMAT0000739 20224724 Insulin-Secreting Cellsmmu-miR-9-5p MIMAT0000142 21288303 Insulin-Secreting Cells rno-miR-9a-5pMIMAT0000781 16831872 Intercellular Junctions hsa-miR-1 MIMAT000041623142026 Intercellular Junctions hsa-miR-203a MIMAT0000264 22101077Intercellular Junctions hsa-miR-483-3p MIMAT0002173 22101077Intercellular Junctions hsa-miR-595 MIMAT0003263 22101077 IntestinalMucosa hsa-miR-221-3p MIMAT0000278 21236259 Intestine Smallhsa-miR-34a-5p MIMAT0000255 21240262 Intestine Small hsa-miR-92b-3pMIMAT0003218 21030610 Intestine Small mmu-miR-194-5p MIMAT000022421887698 Intestines hsa-miR-203a MIMAT0000264 22101077 Intestineshsa-miR-483-3p MIMAT0002173 22101077 Intestines hsa-miR-595 MIMAT000326322101077 Jejunum hsa-miR-626 MIMAT0003295 19892711 Jejunum hsa-miR-7-5pMIMAT0000252 19892711 Jejunum mmu-miR-706 MIMAT0003496 19892711 Jointshsa-miR-19a-3p MIMAT0000073 22105995 Joints hsa-miR-19b-3p MIMAT000007422105995 Jurkat Cells hsa-miR-143-3p MIMAT0000435 19464056 Jurkat Cellshsa-miR-181c-5p MIMAT0000258 21112091 Jurkat Cells hsa-miR-221-3pMIMAT0000278 21236259 Jurkat Cells hsa-miR-27b-3p MIMAT0000419 16982751Jurkat Cells hsa-miR-513a-5p MIMAT0002877 19155478 Keratinocyteshsa-miR-105-5p MIMAT0000102 19509287 Keratinocytes hsa-miR-125b-5pMIMAT0000423 21412257 Keratinocytes hsa-miR-181a-5p MIMAT000025621167132 Keratinocytes hsa-miR-203a MIMAT0000264 18483491 Keratinocyteshsa-miR-203a MIMAT0000264 17622355 Keratinocytes hsa-miR-203aMIMAT0000264 22917968 Keratinocytes hsa-miR-24-3p MIMAT0000080 23553486Keratinocytes hsa-miR-31-5p MIMAT0000089 23553486 Keratinocyteshsa-miR-31-5p MIMAT0000089 23233723 Keratinocytes mmu-miR-31-5pMIMAT0000538 20522784 Kidney hsa-miR-141-3p MIMAT0000432 18925646 Kidneyhsa-miR-15a-5p MIMAT0000068 18949056 Kidney hsa-miR-17-5p MIMAT000007019821056 Kidney hsa-miR-200a-3p MIMAT0000682 19910931 Kidneyhsa-miR-200b-3p MIMAT0000318 19910931 Kidney hsa-miR-21-5p MIMAT000007623292313 Kidney hsa-miR-212-3p MIMAT0000269 22880819 Kidneyhsa-miR-224-5p MIMAT0000281 20180642 Kidney hsa-miR-27a-3p MIMAT000008419513126 Kidney hsa-miR-27b-3p MIMAT0000419 19581388 Kidney hsa-miR-429MIMAT0001536 19910931 Kidney hsa-miR-450a-5p MIMAT0001545 18230805Kidney hsa-miR-562 MIMAT0003226 19789318 Kidney mmu-miR-122-5pMIMAT0000246 16258535 Kidney mmu-miR-192-5p MIMAT0000517 17360662 Kidneymmu-miR-194-5p MIMAT0000224 21887698 Kidney mmu-miR-215-5p MIMAT000090417360662 Kidney mmu-miR-216a-5p MIMAT0000662 20713358 Kidneymmu-miR-216a-5p MIMAT0000662 19543271 Kidney mmu-miR-217-5p MIMAT000067919543271 Kidney mmu-miR-298-5p MIMAT0000376 19581388 Kidneymmu-miR-29c-3p MIMAT0000536 21310958 Kidney mmu-miR-93-5p MIMAT000054020501654 Kidney rno-let-7a-1-3p MIMAT0017085 24885635 Kidneyrno-let-7a-2-3p MIMAT0017086 24885635 Kidney rno-let-7a-5p MIMAT000077424885635 Kidney rno-let-7b-3p MIMAT0004705 24885635 Kidney rno-let-7b-5pMIMAT0000775 24885635 Kidney rno-let-7c-1-3p MIMAT0017087 24885635Kidney rno-let-7c-2-3p MIMAT0017088 24885635 Kidney rno-let-7c-5pMIMAT0000776 24885635 Kidney rno-let-7d-3p MIMAT0000563 24885635 Kidneyrno-let-7d-5p MIMAT0000562 24885635 Kidney rno-let-7e-3p MIMAT000470624885635 Kidney rno-let-7e-5p MIMAT0000777 24885635 Kidneyrno-let-7f-1-3p MIMAT0017089 24885635 Kidney rno-let-7f-2-3pMIMAT0017090 24885635 Kidney rno-let-7f-5p MIMAT0000778 24885635 Kidneyrno-let-7i-3p MIMAT0004707 24885635 Kidney rno-let-7i-5p MIMAT000077924885635 Kidney rno-miR-1-3p MIMAT0003125 24885635 Kidney rno-miR-100-5pMIMAT0000822 24885635 Kidney rno-miR-101a-3p MIMAT0000823 24885635Kidney rno-miR-101a-5p MIMAT0004726 24885635 Kidney rno-miR-101b-3pMIMAT0000615 24885635 Kidney rno-miR-101b-5p MIMAT0017045 24885635Kidney rno-miR-103-1-5p MIMAT0017114 24885635 Kidney rno-miR-103-3pMIMAT0000824 24885635 Kidney rno-miR-106b-3p MIMAT0004727 24885635Kidney rno-miR-106b-5p MIMAT0000825 24885635 Kidney rno-miR-107-3pMIMAT0000826 24885635 Kidney rno-miR-107-5p MIMAT0017115 24885635 Kidneyrno-miR-10a-3p MIMAT0004709 24885635 Kidney rno-miR-10a-5p MIMAT000078224885635 Kidney rno-miR-10b-3p MIMAT0017092 24885635 Kidneyrno-miR-10b-5p MIMAT0000783 24885635 Kidney rno-miR-122-3p MIMAT001711624885635 Kidney rno-miR-122-5p MIMAT0000827 24885635 Kidneyrno-miR-124-3p MIMAT0000828 24885635 Kidney rno-miR-1249 MIMAT001789224885635 Kidney rno-miR-125a-3p MIMAT0004729 24885635 Kidneyrno-miR-125a-5p MIMAT0000829 24885635 Kidney rno-miR-125b-1-3pMIMAT0004730 24885635 Kidney rno-miR-125b-2-3p MIMAT0026467 24885635Kidney rno-miR-125b-5p MIMAT0000830 24885635 Kidney rno-miR-126a-3pMIMAT0000832 24885635 Kidney rno-miR-126a-5p MIMAT0000831 24885635Kidney rno-miR-126a-5p MIMAT0000831 19102782 Kidney rno-miR-126a-5pMIMAT0000831 19102782 Kidney rno-miR-127-5p MIMAT0017117 24885635 Kidneyrno-miR-128-1-5p MIMAT0017118 19102782 Kidney rno-miR-128-1-5pMIMAT0017118 19102782 Kidney rno-miR-128-3p MIMAT0000834 24885635 Kidneyrno-miR-129-1-3p MIMAT0017120 24885635 Kidney rno-miR-129-2-3pMIMAT0000601 24885635 Kidney rno-miR-129-5p MIMAT0000600 24885635 Kidneyrno-miR-1306-3p MIMAT0024852 24885635 Kidney rno-miR-1306-5pMIMAT0024851 24885635 Kidney rno-miR-130a-3p MIMAT0000836 24885635Kidney rno-miR-130b-3p MIMAT0000837 24885635 Kidney rno-miR-130b-5pMIMAT0017122 24885635 Kidney rno-miR-132-3p MIMAT0000838 24885635 Kidneyrno-miR-132-5p MIMAT0017123 23326503 Kidney rno-miR-132-5p MIMAT001712324885635 Kidney rno-miR-133a-3p MIMAT0000839 24885635 Kidneyrno-miR-133b-3p MIMAT0003126 24885635 Kidney rno-miR-134-3p MIMAT001712524885635 Kidney rno-miR-134-5p MIMAT0000840 24885635 Kidneyrno-miR-135a-5p MIMAT0000841 24885635 Kidney rno-miR-135b-3pMIMAT0017043 24885635 Kidney rno-miR-135b-5p MIMAT0000611 24885635Kidney rno-miR-136-3p MIMAT0004733 24885635 Kidney rno-miR-136-5pMIMAT0000842 19102782 Kidney rno-miR-136-5p MIMAT0000842 19102782 Kidneyrno-miR-137-3p MIMAT0000843 24885635 Kidney rno-miR-138-1-3pMIMAT0004734 24885635 Kidney rno-miR-138-2-3p MIMAT0017127 24885635Kidney rno-miR-138-5p MIMAT0000844 24885635 Kidney rno-miR-139-5pMIMAT0000845 24885635 Kidney rno-miR-140-5p MIMAT0000573 24885635 Kidneyrno-miR-141-3p MIMAT0000846 24885635 Kidney rno-miR-142-3p MIMAT000084824885635 Kidney rno-miR-142-5p MIMAT0000847 24885635 Kidneyrno-miR-143-3p MIMAT0000849 24885635 Kidney rno-miR-144-3p MIMAT000085024885635 Kidney rno-miR-144-5p MIMAT0017130 24885635 Kidneyrno-miR-145-5p MIMAT0000851 24885635 Kidney rno-miR-146a-5p MIMAT000085224885635 Kidney rno-miR-146b-5p MIMAT0005595 24885635 Kidneyrno-miR-146b-5p MIMAT0005595 23326503 Kidney rno-miR-147 MIMAT000529719102782 Kidney rno-miR-147 MIMAT0005297 24885635 Kidney rno-miR-147MIMAT0005297 19102782 Kidney rno-miR-148b-3p MIMAT0000579 24885635Kidney rno-miR-148b-5p MIMAT0004645 24885635 Kidney rno-miR-150-3pMIMAT0017133 24885635 Kidney rno-miR-150-5p MIMAT0000853 24885635 Kidneyrno-miR-151-3p MIMAT0000614 24885635 Kidney rno-miR-151-5p MIMAT000061324885635 Kidney rno-miR-152-3p MIMAT0000854 24885635 Kidneyrno-miR-152-5p MIMAT0017134 24885635 Kidney rno-miR-153-3p MIMAT000085524885635 Kidney rno-miR-154-3p MIMAT0017136 24885635 Kidneyrno-miR-154-5p MIMAT0000856 24885635 Kidney rno-miR-15b-3p MIMAT001709324885635 Kidney rno-miR-15b-5p MIMAT0000784 24885635 Kidneyrno-miR-16-3p MIMAT0017094 24885635 Kidney rno-miR-16-5p MIMAT000078524885635 Kidney rno-miR-17-1-3p MIMAT0004710 24885635 Kidneyrno-miR-17-2-3p MIMAT0017295 24885635 Kidney rno-miR-17-5p MIMAT000078624885635 Kidney rno-miR-181a-1-3p MIMAT0000884 24885635 Kidneyrno-miR-181a-2-3p MIMAT0017138 24885635 Kidney rno-miR-181a-5pMIMAT0000858 24885635 Kidney rno-miR-181b-2-3p MIMAT0017140 24885635Kidney rno-miR-181b-5p MIMAT0000859 19102782 Kidney rno-miR-181b-5pMIMAT0000859 19102782 Kidney rno-miR-181b-5p MIMAT0000859 24885635Kidney rno-miR-181d-5p MIMAT0005299 24885635 Kidney rno-miR-182MIMAT0005300 24885635 Kidney rno-miR-183-5p MIMAT0000860 24885635 Kidneyrno-miR-1839-3p MIMAT0024844 24885635 Kidney rno-miR-1839-5pMIMAT0024843 24885635 Kidney rno-miR-1843-3p MIMAT0024848 24885635Kidney rno-miR-1843-5p MIMAT0024847 24885635 Kidney rno-miR-185-5pMIMAT0000862 24885635 Kidney rno-miR-186-3p MIMAT0017143 24885635 Kidneyrno-miR-186-5p MIMAT0000863 24885635 Kidney rno-miR-187-3p MIMAT000086424885635 Kidney rno-miR-188-5p MIMAT0005301 24885635 Kidneyrno-miR-18a-5p MIMAT0000787 24885635 Kidney rno-miR-190a-3p MIMAT001714524885635 Kidney rno-miR-190a-5p MIMAT0000865 24885635 Kidneyrno-miR-190b-5p MIMAT0005302 24885635 Kidney rno-miR-191a-5pMIMAT0000866 24885635 Kidney rno-miR-192-3p MIMAT0017147 24885635 Kidneyrno-miR-192-5p MIMAT0000867 20393144 Kidney rno-miR-192-5p MIMAT000086724885635 Kidney rno-miR-194-3p MIMAT0017148 24885635 Kidneyrno-miR-194-5p MIMAT0000869 24885635 Kidney rno-miR-195-3p MIMAT001714924885635 Kidney rno-miR-195-5p MIMAT0000870 24885635 Kidneyrno-miR-196a-3p MIMAT0004737 24885635 Kidney rno-miR-196a-5pMIMAT0000871 19102782 Kidney rno-miR-196a-5p MIMAT0000871 19102782Kidney rno-miR-196a-5p MIMAT0000871 24885635 Kidney rno-miR-196b-5pMIMAT0001082 24885635 Kidney rno-miR-196c-3p MIMAT0017299 24885635Kidney rno-miR-196c-5p MIMAT0005303 24885635 Kidney rno-miR-199a-3pMIMAT0004738 24885635 Kidney rno-miR-199a-5p MIMAT0000872 24885635Kidney rno-miR-199a-5p MIMAT0000872 23326503 Kidney rno-miR-19a-3pMIMAT0000789 24885635 Kidney rno-miR-19a-5p MIMAT0017098 24885635 Kidneyrno-miR-19b-1-5p MIMAT0017096 24885635 Kidney rno-miR-19b-3pMIMAT0000788 24885635 Kidney rno-miR-200a-3p MIMAT0000874 24885635Kidney rno-miR-200b-3p MIMAT0000875 24885635 Kidney rno-miR-200b-5pMIMAT0017152 24885635 Kidney rno-miR-200c-3p MIMAT0000873 24885635Kidney rno-miR-201-3p MIMAT0017364 24885635 Kidney rno-miR-203a-3pMIMAT0000876 24885635 Kidney rno-miR-203a-5p MIMAT0017153 19102782Kidney rno-miR-203a-5p MIMAT0017153 19102782 Kidney rno-miR-203a-5pMIMAT0017153 24885635 Kidney rno-miR-203b-3p MIMAT0017800 24885635Kidney rno-miR-203b-5p MIMAT0017799 24885635 Kidney rno-miR-204-3pMIMAT0004739 24885635 Kidney rno-miR-204-5p MIMAT0000877 24885635 Kidneyrno-miR-205 MIMAT0000878 24885635 Kidney rno-miR-206-3p MIMAT000087924885635 Kidney rno-miR-20a-3p MIMAT0000603 24885635 Kidneyrno-miR-20a-5p MIMAT0000602 19102782 Kidney rno-miR-20a-5p MIMAT000060219102782 Kidney rno-miR-20a-5p MIMAT0000602 24885635 Kidneyrno-miR-20b-5p MIMAT0003211 24885635 Kidney rno-miR-21-3p MIMAT000471124885635 Kidney rno-miR-21-5p MIMAT0000790 24885635 Kidney rno-miR-21-5pMIMAT0000790 23326503 Kidney rno-miR-21-5p MIMAT0000790 19102782 Kidneyrno-miR-21-5p MIMAT0000790 19102782 Kidney rno-miR-210-3p MIMAT000088124885635 Kidney rno-miR-211-5p MIMAT0000882 24885635 Kidneyrno-miR-212-3p MIMAT0000883 24885635 Kidney rno-miR-212-5p MIMAT001715824885635 Kidney rno-miR-214-3p MIMAT0000885 24885635 Kidneyrno-miR-214-5p MIMAT0017159 23326503 Kidney rno-miR-215 MIMAT000311820393144 Kidney rno-miR-215 MIMAT0003118 24885635 Kidney rno-miR-216a-5pMIMAT0000886 24885635 Kidney rno-miR-216a-5p MIMAT0000886 19102782Kidney rno-miR-216a-5p MIMAT0000886 19102782 Kidney rno-miR-217-5pMIMAT0000887 24885635 Kidney rno-miR-217-5p MIMAT0000887 19102782 Kidneyrno-miR-217-5p MIMAT0000887 19102782 Kidney rno-miR-218a-5p MIMAT000088824885635 Kidney rno-miR-218b MIMAT0017838 24885635 Kidney rno-miR-22-3pMIMAT0000791 24885635 Kidney rno-miR-22-5p MIMAT0003152 24885635 Kidneyrno-miR-221-3p MIMAT0000890 24885635 Kidney rno-miR-221-5p MIMAT001716324885635 Kidney rno-miR-222-3p MIMAT0000891 24885635 Kidneyrno-miR-222-5p MIMAT0017164 24885635 Kidney rno-miR-223-3p MIMAT000089224885635 Kidney rno-miR-223-5p MIMAT0017165 24885635 Kidneyrno-miR-23a-3p MIMAT0000792 24885635 Kidney rno-miR-23a-5p MIMAT000471224885635 Kidney rno-miR-23b-3p MIMAT0000793 24885635 Kidneyrno-miR-23b-5p MIMAT0017099 24885635 Kidney rno-miR-24-1-5p MIMAT000315324885635 Kidney rno-miR-24-2-5p MIMAT0005441 24885635 Kidneyrno-miR-24-3p MIMAT0000794 24885635 Kidney rno-miR-25-3p MIMAT000079524885635 Kidney rno-miR-25-3p MIMAT0000795 21071935 Kidneyrno-miR-26a-5p MIMAT0000796 24885635 Kidney rno-miR-26b-3p MIMAT000471424885635 Kidney rno-miR-26b-5p MIMAT0000797 24885635 Kidneyrno-miR-27a-3p MIMAT0000799 24885635 Kidney rno-miR-27a-5p MIMAT000471524885635 Kidney rno-miR-27b-3p MIMAT0000798 24885635 Kidneyrno-miR-27b-5p MIMAT0017101 24885635 Kidney rno-miR-28-3p MIMAT000471624885635 Kidney rno-miR-28-5p MIMAT0000800 24885635 Kidneyrno-miR-299a-3p MIMAT0017167 24885635 Kidney rno-miR-299a-5pMIMAT0000901 24885635 Kidney rno-miR-299b-5p MIMAT0017833 24885635Kidney rno-miR-29a-3p MIMAT0000802 24885635 Kidney rno-miR-29a-5pMIMAT0004718 24885635 Kidney rno-miR-29b-1-5p MIMAT0005445 24885635Kidney rno-miR-29b-2-5p MIMAT0004717 24885635 Kidney rno-miR-29b-3pMIMAT0000801 24885635 Kidney rno-miR-29c-3p MIMAT0000803 24885635 Kidneyrno-miR-29c-5p MIMAT0003154 24885635 Kidney rno-miR-300-3p MIMAT000090224885635 Kidney rno-miR-300-5p MIMAT0004743 24885635 Kidneyrno-miR-301a-3p MIMAT0000552 24885635 Kidney rno-miR-301a-5pMIMAT0017026 24885635 Kidney rno-miR-301b-3p MIMAT0005304 24885635Kidney rno-miR-3065-3p MIMAT0017840 24885635 Kidney rno-miR-3065-5pMIMAT0017839 24885635 Kidney rno-miR-3072 MIMAT0025071 24885635 Kidneyrno-miR-3075 MIMAT0025057 24885635 Kidney rno-miR-30a-3p MIMAT000080924885635 Kidney rno-miR-30a-5p MIMAT0000808 24885635 Kidneyrno-miR-30a-5p MIMAT0000808 19102782 Kidney rno-miR-30a-5p MIMAT000080819102782 Kidney rno-miR-30b-3p MIMAT0004721 24885635 Kidneyrno-miR-30b-5p MIMAT0000806 24885635 Kidney rno-miR-30c-1-3pMIMAT0004719 24885635 Kidney rno-miR-30c-2-3p MIMAT0005442 24885635Kidney rno-miR-30c-5p MIMAT0000804 24885635 Kidney rno-miR-30d-3pMIMAT0004722 24885635 Kidney rno-miR-30d-5p MIMAT0000807 24885635 Kidneyrno-miR-30e-3p MIMAT0004720 24885635 Kidney rno-miR-30e-5p MIMAT000080524885635 Kidney rno-miR-31a-3p MIMAT0017102 24885635 Kidneyrno-miR-31a-5p MIMAT0000810 24885635 Kidney rno-miR-31a-5p MIMAT000081019102782 Kidney rno-miR-31a-5p MIMAT0000810 19102782 Kidneyrno-miR-31a-5p MIMAT0000810 23326503 Kidney rno-miR-32-5p MIMAT000081124885635 Kidney rno-miR-320-3p MIMAT0000903 24885635 Kidneyrno-miR-322-3p MIMAT0000547 24885635 Kidney rno-miR-322-5p MIMAT000161924885635 Kidney rno-miR-323-3p MIMAT0000550 24885635 Kidneyrno-miR-324-3p MIMAT0000554 24885635 Kidney rno-miR-324-5p MIMAT000055324885635 Kidney rno-miR-326-3p MIMAT0000560 24885635 Kidneyrno-miR-328a-3p MIMAT0000564 24885635 Kidney rno-miR-328b-3pMIMAT0017904 24885635 Kidney rno-miR-329-3p MIMAT0000566 24885635 Kidneyrno-miR-329-5p MIMAT0017031 24885635 Kidney rno-miR-33-3p MIMAT001710424885635 Kidney rno-miR-33-5p MIMAT0000812 24885635 Kidneyrno-miR-330-3p MIMAT0000568 24885635 Kidney rno-miR-330-5p MIMAT000464124885635 Kidney rno-miR-331-3p MIMAT0000570 24885635 Kidney rno-miR-335MIMAT0000575 24885635 Kidney rno-miR-335 MIMAT0000575 19102782 Kidneyrno-miR-335 MIMAT0000575 19102782 Kidney rno-miR-336-5p MIMAT000057624885635 Kidney rno-miR-338-3p MIMAT0000581 24885635 Kidneyrno-miR-339-3p MIMAT0004648 24885635 Kidney rno-miR-339-5p MIMAT000058324885635 Kidney rno-miR-340-3p MIMAT0000585 24885635 Kidneyrno-miR-340-5p MIMAT0004650 24885635 Kidney rno-miR-341 MIMAT000058724885635 Kidney rno-miR-342-3p MIMAT0000589 24885635 Kidneyrno-miR-342-5p MIMAT0004652 24885635 Kidney rno-miR-345-3p MIMAT000465524885635 Kidney rno-miR-345-5p MIMAT0000594 24885635 Kidney rno-miR-346MIMAT0000596 19102782 Kidney rno-miR-346 MIMAT0000596 19102782 Kidneyrno-miR-3473 MIMAT0024853 24885635 Kidney rno-miR-34a-3p MIMAT001710624885635 Kidney rno-miR-34a-5p MIMAT0000815 23326503 Kidneyrno-miR-34a-5p MIMAT0000815 24885635 Kidney rno-miR-34b-5p MIMAT000081319102782 Kidney rno-miR-34b-5p MIMAT0000813 19102782 Kidney rno-miR-350MIMAT0000604 24885635 Kidney rno-miR-351-3p MIMAT0017041 24885635 Kidneyrno-miR-351-5p MIMAT0000608 24885635 Kidney rno-miR-352 MIMAT000061024885635 Kidney rno-miR-3548 MIMAT0017806 24885635 Kidney rno-miR-3553MIMAT0017814 24885635 Kidney rno-miR-3556a MIMAT0017821 24885635 Kidneyrno-miR-3556b MIMAT0017818 24885635 Kidney rno-miR-3557-3p MIMAT001782024885635 Kidney rno-miR-3557-5p MIMAT0017819 24885635 Kidneyrno-miR-3570 MIMAT0017850 24885635 Kidney rno-miR-3571 MIMAT001785124885635 Kidney rno-miR-3574 MIMAT0017860 24885635 Kidneyrno-miR-3583-5p MIMAT0017873 24885635 Kidney rno-miR-3585-5pMIMAT0017878 24885635 Kidney rno-miR-3586-3p MIMAT0017881 24885635Kidney rno-miR-3587 MIMAT0017883 24885635 Kidney rno-miR-3588MIMAT0017887 24885635 Kidney rno-miR-3589 MIMAT0017888 24885635 Kidneyrno-miR-3590-3p MIMAT0017890 24885635 Kidney rno-miR-3590-5pMIMAT0017889 24885635 Kidney rno-miR-3591 MIMAT0017893 24885635 Kidneyrno-miR-3596a MIMAT0017886 24885635 Kidney rno-miR-3596b MIMAT001787124885635 Kidney rno-miR-3596c MIMAT0017877 24885635 Kidney rno-miR-3596dMIMAT0017823 24885635 Kidney rno-miR-361-5p MIMAT0003117 24885635 Kidneyrno-miR-362-3p MIMAT0017357 24885635 Kidney rno-miR-362-5p MIMAT001282824885635 Kidney rno-miR-369-3p MIMAT0003207 24885635 Kidneyrno-miR-374-3p MIMAT0017223 24885635 Kidney rno-miR-374-5p MIMAT000320824885635 Kidney rno-miR-375-3p MIMAT0005307 24885635 Kidneyrno-miR-376a-3p MIMAT0003198 24885635 Kidney rno-miR-376b-3pMIMAT0003196 24885635 Kidney rno-miR-376b-5p MIMAT0003195 24885635Kidney rno-miR-376c-3p MIMAT0003194 24885635 Kidney rno-miR-376c-5pMIMAT0017219 24885635 Kidney rno-miR-377-3p MIMAT0003123 24885635 Kidneyrno-miR-377-5p MIMAT0017203 19102782 Kidney rno-miR-377-5p MIMAT001720319102782 Kidney rno-miR-378a-3p MIMAT0003379 24885635 Kidneyrno-miR-378a-5p MIMAT0003378 24885635 Kidney rno-miR-378b MIMAT002485524885635 Kidney rno-miR-379-3p MIMAT0004791 24885635 Kidneyrno-miR-379-5p MIMAT0003192 19102782 Kidney rno-miR-379-5p MIMAT000319219102782 Kidney rno-miR-379-5p MIMAT0003192 24885635 Kidneyrno-miR-380-3p MIMAT0017302 24885635 Kidney rno-miR-380-5p MIMAT000530824885635 Kidney rno-miR-380-5p MIMAT0005308 19102782 Kidneyrno-miR-380-5p MIMAT0005308 19102782 Kidney rno-miR-381-3p MIMAT000319924885635 Kidney rno-miR-382-5p MIMAT0003201 24885635 Kidneyrno-miR-409a-5p MIMAT0003204 24885635 Kidney rno-miR-410-3p MIMAT000531124885635 Kidney rno-miR-411-3p MIMAT0017304 24885635 Kidneyrno-miR-411-5p MIMAT0005312 24885635 Kidney rno-miR-412-5p MIMAT001720424885635 Kidney rno-miR-423-3p MIMAT0005313 24885635 Kidneyrno-miR-423-5p MIMAT0017305 24885635 Kidney rno-miR-425-3p MIMAT001730624885635 Kidney rno-miR-425-5p MIMAT0005314 24885635 Kidney rno-miR-429MIMAT0001538 24885635 Kidney rno-miR-433-3p MIMAT0001628 24885635 Kidneyrno-miR-434-3p MIMAT0005315 24885635 Kidney rno-miR-434-5p MIMAT001730724885635 Kidney rno-miR-448-5p MIMAT0017177 19102782 Kidneyrno-miR-448-5p MIMAT0017177 19102782 Kidney rno-miR-449a-5p MIMAT000154324885635 Kidney rno-miR-450a-3p MIMAT0017183 24885635 Kidneyrno-miR-450a-5p MIMAT0001547 24885635 Kidney rno-miR-450a-5pMIMAT0001547 18230805 Kidney rno-miR-451-5p MIMAT0001633 24885635 Kidneyrno-miR-455-3p MIMAT0017308 24885635 Kidney rno-miR-455-5p MIMAT000531624885635 Kidney rno-miR-466b-1-3p MIMAT0017285 24885635 Kidneyrno-miR-466b-2-3p MIMAT0017286 24885635 Kidney rno-miR-484 MIMAT000531924885635 Kidney rno-miR-485-3p MIMAT0017222 24885635 Kidneyrno-miR-485-5p MIMAT0003203 24885635 Kidney rno-miR-487b-3p MIMAT000320024885635 Kidney rno-miR-488-3p MIMAT0005341 24885635 Kidneyrno-miR-490-3p MIMAT0012823 24885635 Kidney rno-miR-490-5p MIMAT001735624885635 Kidney rno-miR-494-3p MIMAT0003193 24885635 Kidneyrno-miR-494-5p MIMAT0017218 24885635 Kidney rno-miR-496-3p MIMAT001286024885635 Kidney rno-miR-497-3p MIMAT0017230 24885635 Kidneyrno-miR-497-5p MIMAT0003383 24885635 Kidney rno-miR-499-3p MIMAT001722724885635 Kidney rno-miR-499-5p MIMAT0003381 24885635 Kidneyrno-miR-500-3p MIMAT0005321 24885635 Kidney rno-miR-501-3p MIMAT001719824885635 Kidney rno-miR-503-3p MIMAT0017224 24885635 Kidneyrno-miR-503-5p MIMAT0003213 23326503 Kidney rno-miR-503-5p MIMAT000321324885635 Kidney rno-miR-504 MIMAT0012830 24885635 Kidney rno-miR-509-3pMIMAT0024850 24885635 Kidney rno-miR-509-5p MIMAT0024849 24885635 Kidneyrno-miR-511-3p MIMAT0017358 24885635 Kidney rno-miR-532-3p MIMAT000532324885635 Kidney rno-miR-532-5p MIMAT0005322 24885635 Kidneyrno-miR-539-3p MIMAT0017212 24885635 Kidney rno-miR-541-3p MIMAT001721324885635 Kidney rno-miR-541-5p MIMAT0003177 24885635 Kidneyrno-miR-542-3p MIMAT0003179 24885635 Kidney rno-miR-542-5p MIMAT000317824885635 Kidney rno-miR-543-3p MIMAT0003175 24885635 Kidneyrno-miR-544-3p MIMAT0012831 24885635 Kidney rno-miR-547-3p MIMAT001285124885635 Kidney rno-miR-582-3p MIMAT0017360 24885635 Kidneyrno-miR-582-5p MIMAT0012833 24885635 Kidney rno-miR-598-3p MIMAT000532524885635 Kidney rno-miR-615 MIMAT0012835 24885635 Kidney rno-miR-6215MIMAT0024854 24885635 Kidney rno-miR-6329 MIMAT0025068 24885635 Kidneyrno-miR-6333 MIMAT0025074 24885635 Kidney rno-miR-652-3p MIMAT000534224885635 Kidney rno-miR-653-5p MIMAT0012838 24885635 Kidney rno-miR-668MIMAT0012839 24885635 Kidney rno-miR-672-5p MIMAT0005327 24885635 Kidneyrno-miR-674-3p MIMAT0005330 24885635 Kidney rno-miR-674-5p MIMAT000532924885635 Kidney rno-miR-708-3p MIMAT0005332 24885635 Kidneyrno-miR-708-5p MIMAT0005331 24885635 Kidney rno-miR-7a-2-3p MIMAT001709124885635 Kidney rno-miR-7a-5p MIMAT0000606 24885635 Kidney rno-miR-7a-5pMIMAT0000606 19102782 Kidney rno-miR-7a-5p MIMAT0000606 19102782 Kidneyrno-miR-7b MIMAT0000780 24885635 Kidney rno-miR-7b MIMAT0000780 19102782Kidney rno-miR-7b MIMAT0000780 19102782 Kidney rno-miR-802-3pMIMAT0017362 24885635 Kidney rno-miR-802-5p MIMAT0012840 24885635 Kidneyrno-miR-872-3p MIMAT0005283 24885635 Kidney rno-miR-872-5p MIMAT000528224885635 Kidney rno-miR-874-3p MIMAT0005284 24885635 Kidneyrno-miR-874-5p MIMAT0017290 24885635 Kidney rno-miR-877 MIMAT000528524885635 Kidney rno-miR-92a-1-5p MIMAT0017107 24885635 Kidneyrno-miR-92a-3p MIMAT0000816 24885635 Kidney rno-miR-92b-3p MIMAT000534021071935 Kidney rno-miR-92b-3p MIMAT0005340 24885635 Kidneyrno-miR-93-5p MIMAT0000817 24885635 Kidney rno-miR-96-5p MIMAT000081819102782 Kidney rno-miR-96-5p MIMAT0000818 19102782 Kidney rno-miR-96-5pMIMAT0000818 24885635 Kidney rno-miR-98-5p MIMAT0000819 24885635 Kidneyrno-miR-99a-3p MIMAT0004724 24885635 Kidney rno-miR-99a-5p MIMAT000082024885635 Kidney rno-miR-99a-5p MIMAT0000820 19102782 Kidneyrno-miR-99a-5p MIMAT0000820 19102782 Kidney rno-miR-99b-3p MIMAT000472524885635 Kidney rno-miR-99b-5p MIMAT0000821 24885635 Kidneyrno-miR-9a-3p MIMAT0004708 24885635 Kidney rno-miR-9a-5p MIMAT000078124885635 Kidney rno-miR-9b-5p MIMAT0017835 24885635 Killer Cells Naturalhsa-miR-15a-5p MIMAT0000068 22379033 Killer Cells Natural hsa-miR-15b-5pMIMAT0000417 22379033 Killer Cells Natural hsa-miR-16-5p MIMAT000006922379033 Killer Cells Natural hsa-miR-29a-3p MIMAT0000086 19584290Killer Cells Natural hsa-miR-30c-1-3p MIMAT0004674 22320217 Killer CellsNatural hsa-miR-520b MIMAT0002843 19109132 Killer Cells Naturalmmu-miR-223-3p MIMAT0000665 20935160 Knee hsa-miR-9-5p MIMAT000044119008124 Kupffer Cells hsa-miR-155-5p MIMAT0000646 19783678 KupfferCells hsa-miR-199a-5p MIMAT0000231 19783678 Langerhans Cellshsa-miR-146a-5p MIMAT0000449 20375304 Leukocytes hsa-miR-126-3pMIMAT0000445 18227515 Leukocytes hsa-miR-146a-5p MIMAT0000449 19333922Leukocytes hsa-miR-155-5p MIMAT0000646 21310411 Leukocytes hsa-miR-21-5pMIMAT0000076 21069438 Leukocytes hsa-miR-31-5p MIMAT0000089 23233723Leukocytes hsa-miR-320a MIMAT0000510 18523662 Leukocytes mmu-miR-223-3pMIMAT0000665 22043014 Limb Buds mmu-miR-137-3p MIMAT0000149 21256124Limb Buds mmu-miR-140-5p MIMAT0000151 21872590 Limb Buds mmu-miR-153-3pMIMAT0000163 21256124 Limb Buds mmu-miR-363-3p MIMAT0000708 21256124Liver bta-miR-122 MIMAT0003849 18073344 Liver bta-miR-29a MIMAT000351817652184 Liver bta-miR-29c MIMAT0003829 17652184 Liver cfa-miR-122MIMAT0006619 18073344 Liver cfa-miR-29a MIMAT0006626 17652184 Livercfa-miR-29c MIMAT0006705 17652184 Liver dre-miR-122 MIMAT000181818073344 Liver dre-miR-29a MIMAT0001802 17652184 Liver hsa-let-7b-5pMIMAT0000063 16971064 Liver hsa-let-7c-3p MIMAT0026472 19841744 Liverhsa-let-7c-5p MIMAT0000064 19841744 Liver hsa-miR-1 MIMAT000041618593903 Liver hsa-miR-1 MIMAT0000416 22963810 Liver hsa-miR-101-3pMIMAT0000099 19133651 Liver hsa-miR-103a-3p MIMAT0000101 22723340 Liverhsa-miR-107 MIMAT0000104 22723340 Liver hsa-miR-107 MIMAT000010421029372 Liver hsa-miR-10b-5p MIMAT0000254 19780876 Liver hsa-miR-122-5pMIMAT0000421 19296470 Liver hsa-miR-122-5p MIMAT0000421 20351063 Liverhsa-miR-122-5p MIMAT0000421 17179747 Liver hsa-miR-122-5p MIMAT000042117616664 Liver hsa-miR-122-5p MIMAT0000421 19617899 Liver hsa-miR-122-5pMIMAT0000421 18073344 Liver hsa-miR-122-5p MIMAT0000421 19726678 Liverhsa-miR-122-5p MIMAT0000421 23348614 Liver hsa-miR-122-5p MIMAT000042122276989 Liver hsa-miR-122-5p MIMAT0000421 16459310 Liver hsa-miR-122-5pMIMAT0000421 20842632 Liver hsa-miR-124-3p MIMAT0000422 19843643 Liverhsa-miR-125a-5p MIMAT0000443 21220473 Liver hsa-miR-125a-5p MIMAT000044316331254 Liver hsa-miR-125b-5p MIMAT0000423 20827722 Liverhsa-miR-125b-5p MIMAT0000423 18649363 Liver hsa-miR-140-5p MIMAT000043123401231 Liver hsa-miR-141-3p MIMAT0000432 20005803 Liver hsa-miR-143-3pMIMAT0000435 19913496 Liver hsa-miR-143-3p MIMAT0000435 16966691 Liverhsa-miR-143-3p MIMAT0000435 19472311 Liver hsa-miR-145-5p MIMAT000043723499894 Liver hsa-miR-145-5p MIMAT0000437 22431718 Liver hsa-miR-152-3pMIMAT0000438 20578129 Liver hsa-miR-155-5p MIMAT0000646 19783678 Liverhsa-miR-15a-5p MIMAT0000068 18949056 Liver hsa-miR-181a-5p MIMAT000025622476949 Liver hsa-miR-181a-5p MIMAT0000256 19585654 Liverhsa-miR-181b-5p MIMAT0000257 19585654 Liver hsa-miR-181b-5p MIMAT000025720023698 Liver hsa-miR-181c-5p MIMAT0000258 19585654 Liverhsa-miR-181d-5p MIMAT0002821 19585654 Liver hsa-miR-182-5p MIMAT000025919167416 Liver hsa-miR-182-5p MIMAT0000259 19569050 Liver hsa-miR-183-5pMIMAT0000261 20979053 Liver hsa-miR-183-5p MIMAT0000261 20602797 Liverhsa-miR-185-5p MIMAT0000455 23459944 Liver hsa-miR-186-5p MIMAT000045620979053 Liver hsa-miR-18a-5p MIMAT0000072 19167416 Liver hsa-miR-18a-5pMIMAT0000072 16331254 Liver hsa-miR-191-5p MIMAT0000440 20924108 Liverhsa-miR-193b-3p MIMAT0002819 20655737 Liver hsa-miR-194-5p MIMAT000046019569050 Liver hsa-miR-195-5p MIMAT0000461 16331254 Liverhsa-miR-196a-5p MIMAT0000226 20127796 Liver hsa-miR-199a-3p MIMAT000023216331254 Liver hsa-miR-199a-3p MIMAT0000232 0 Liver hsa-miR-199a-5pMIMAT0000231 20799954 Liver hsa-miR-199a-5p MIMAT0000231 16331254 Liverhsa-miR-199a-5p MIMAT0000231 19783678 Liver hsa-miR-200a-3p MIMAT000068219167416 Liver hsa-miR-200a-3p MIMAT0000682 20005803 Liverhsa-miR-200a-3p MIMAT0000682 16331254 Liver hsa-miR-200b-3p MIMAT000031819167416 Liver hsa-miR-200b-3p MIMAT0000318 20005803 Liverhsa-miR-200b-3p MIMAT0000318 19569050 Liver hsa-miR-200c-3p MIMAT000061719167416 Liver hsa-miR-200c-3p MIMAT0000617 20005803 Liverhsa-miR-200c-3p MIMAT0000617 19569050 Liver hsa-miR-203a MIMAT000026419843643 Liver hsa-miR-21-5p MIMAT0000076 20827319 Liver hsa-miR-21-5pMIMAT0000076 16966691 Liver hsa-miR-21-5p MIMAT0000076 19072831 Liverhsa-miR-21-5p MIMAT0000076 19133651 Liver hsa-miR-21-5p MIMAT000007619167416 Liver hsa-miR-21-5p MIMAT0000076 20167875 Liver hsa-miR-212-3pMIMAT0000269 18162065 Liver hsa-miR-216a-5p MIMAT0000273 23471579 Liverhsa-miR-217 MIMAT0000274 23471579 Liver hsa-miR-218-5p MIMAT000027519913496 Liver hsa-miR-22-3p MIMAT0000077 0 Liver hsa-miR-221-3pMIMAT0000278 20018759 Liver hsa-miR-222-3p MIMAT0000279 20018759 Liverhsa-miR-222-3p MIMAT0000279 20103675 Liver hsa-miR-223-3p MIMAT000028023459944 Liver hsa-miR-223-3p MIMAT0000280 18555017 Liver hsa-miR-224-5pMIMAT0000281 16331254 Liver hsa-miR-26a-5p MIMAT0000082 19524505 Liverhsa-miR-26b-5p MIMAT0000083 19569050 Liver hsa-miR-296-5p MIMAT000069021633093 Liver hsa-miR-29a-3p MIMAT0000086 20943204 Liver hsa-miR-29a-3pMIMAT0000086 21175813 Liver hsa-miR-29b-3p MIMAT0000100 19913496 Liverhsa-miR-30a-5p MIMAT0000087 19185580 Liver hsa-miR-320a MIMAT000051022134529 Liver hsa-miR-320a MIMAT0000510 19070389 Liver hsa-miR-33a-5pMIMAT0000091 20466885 Liver hsa-miR-34a-5p MIMAT0000255 20185821 Liverhsa-miR-34a-5p MIMAT0000255 21240262 Liver hsa-miR-34a-5p MIMAT000025519167416 Liver hsa-miR-374a-5p MIMAT0000727 19569050 Liver hsa-miR-375MIMAT0000728 20226166 Liver hsa-miR-422a MIMAT0001339 20351063 Liverhsa-miR-429 MIMAT0001536 19569050 Liver hsa-miR-429 MIMAT000153620005803 Liver hsa-miR-483-3p MIMAT0002173 20388800 Liverhsa-miR-499a-5p MIMAT0002870 21934092 Liver hsa-miR-499b-5p MIMAT001989721934092 Liver hsa-miR-513a-5p MIMAT0002877 19155478 Liver hsa-miR-631MIMAT0003300 20881232 Liver hsa-miR-758-3p MIMAT0003879 21885853 Liverhsa-miR-96-5p MIMAT0000095 23459944 Liver hsa-miR-96-5p MIMAT000009519167416 Liver mmu-let-7c-5p MIMAT0000523 17438130 Liver mmu-miR-122-5pMIMAT0000246 16459310 Liver mmu-miR-122-5p MIMAT0000246 20582318 Livermmu-miR-122-5p MIMAT0000246 17179747 Liver mmu-miR-122-5p MIMAT000024618158304 Liver mmu-miR-122-5p MIMAT0000246 19487572 Liver mmu-miR-122-5pMIMAT0000246 16258535 Liver mmu-miR-122-5p MIMAT0000246 21364282 Livermmu-miR-127-5p MIMAT0004530 19878148 Liver mmu-miR-132-3p MIMAT000014419843474 Liver mmu-miR-181b-5p MIMAT0000673 20023698 Livermmu-miR-194-5p MIMAT0000224 21887698 Liver mmu-miR-200b-3p MIMAT000023319787069 Liver mmu-miR-200c-3p MIMAT0000657 19787069 Livermmu-miR-21a-5p MIMAT0000530 20167875 Liver mmu-miR-21a-5p MIMAT000053020432256 Liver mmu-miR-22-3p MIMAT0000531 19878148 Liver mmu-miR-221-3pMIMAT0000669 20018759 Liver mmu-miR-23b-3p MIMAT0000125 19582816 Livermmu-miR-24-3p MIMAT0000219 19582816 Liver mmu-miR-27a-3p MIMAT000053719878148 Liver mmu-miR-27b-3p MIMAT0000126 19582816 Liver mmu-miR-29a-3pMIMAT0000535 20943204 Liver mmu-miR-29a-3p MIMAT0000535 17652184 Livermmu-miR-29a-5p MIMAT0004631 20943204 Liver mmu-miR-29b-1-5p MIMAT000452319878148 Liver mmu-miR-29b-3p MIMAT0000127 17652184 Liver mmu-miR-29c-3pMIMAT0000536 17652184 Liver mmu-miR-30a-5p MIMAT0000128 19185580 Livermmu-miR-33-5p MIMAT0000667 20466885 Liver mmu-miR-34a-5p MIMAT000054221216258 Liver mmu-miR-378a-3p MIMAT0003151 20432256 Livermmu-miR-378a-5p MIMAT0000742 20432256 Liver mmu-miR-382-3p MIMAT000469119878148 Liver mmu-miR-411-3p MIMAT0001093 19878148 Liver mmu-miR-429-3pMIMAT0001537 19167416 Liver mmu-miR-470-5p MIMAT0002111 19878148 Livermmu-miR-501-3p MIMAT0003509 19878148 Liver mmu-miR-669b-5p MIMAT000347619878148 Liver mmu-miR-676-3p MIMAT0003782 19878148 Liver mmu-miR-93-5pMIMAT0000540 21216258 Liver mmu-miR-96-5p MIMAT0000541 19878148 Liverppy-miR-122 MIMAT0015746 18073344 Liver ppy-miR-29a MIMAT000236317652184 Liver ppy-miR-29c MIMAT0015735 17652184 Liver ptr-miR-122MIMAT0007963 18073344 Liver ptr-miR-29a MIMAT0002364 17652184 Liverptr-miR-29c MIMAT0008082 17652184 Liver rno-let-7a-5p MIMAT0000774 0Liver rno-let-7b-5p MIMAT0000775 0 Liver rno-let-7c-5p MIMAT0000776 0Liver rno-let-7d-3p MIMAT0000563 0 Liver rno-let-7d-5p MIMAT0000562 0Liver rno-let-7e-5p MIMAT0000777 0 Liver rno-let-7f-2-3p MIMAT0017090 0Liver rno-let-7f-5p MIMAT0000778 0 Liver rno-let-7i-3p MIMAT0004707 0Liver rno-let-7i-5p MIMAT0000779 0 Liver rno-miR-1-3p MIMAT0003125 0Liver rno-miR-100-5p MIMAT0000822 0 Liver rno-miR-101a-3p MIMAT0000823 0Liver rno-miR-101b-3p MIMAT0000615 0 Liver rno-miR-103-3p MIMAT0000824 0Liver rno-miR-107-3p MIMAT0000826 0 Liver rno-miR-10a-5p MIMAT0000782 0Liver rno-miR-122-3p MIMAT0017116 0 Liver rno-miR-122-5p MIMAT0000827 0Liver rno-miR-122-5p MIMAT0000827 18073344 Liver rno-miR-125a-3pMIMAT0004729 23045399 Liver rno-miR-125a-5p MIMAT0000829 0 Liverrno-miR-125a-5p MIMAT0000829 23045399 Liver rno-miR-125b-1-3pMIMAT0004730 0 Liver rno-miR-125b-2-3p MIMAT0026467 0 Liverrno-miR-125b-5p MIMAT0000830 0 Liver rno-miR-126a-3p MIMAT0000832 0Liver rno-miR-126a-5p MIMAT0000831 0 Liver rno-miR-127-3p MIMAT000083318942116 Liver rno-miR-127-3p MIMAT0000833 0 Liver rno-miR-128-3pMIMAT0000834 0 Liver rno-miR-1306-5p MIMAT0024851 0 Liverrno-miR-130a-3p MIMAT0000836 0 Liver rno-miR-130b-3p MIMAT0000837 0Liver rno-miR-132-3p MIMAT0000838 19843474 Liver rno-miR-133a-3pMIMAT0000839 0 Liver rno-miR-133b-3p MIMAT0003126 0 Liverrno-miR-135a-5p MIMAT0000841 0 Liver rno-miR-135b-5p MIMAT0000611 0Liver rno-miR-136-3p MIMAT0004733 0 Liver rno-miR-136-5p MIMAT0000842 0Liver rno-miR-137-3p MIMAT0000843 0 Liver rno-miR-140-3p MIMAT0000574 0Liver rno-miR-140-5p MIMAT0000573 0 Liver rno-miR-141-3p MIMAT0000846 0Liver rno-miR-142-3p MIMAT0000848 0 Liver rno-miR-142-5p MIMAT0000847 0Liver rno-miR-143-5p MIMAT0017129 0 Liver rno-miR-144-3p MIMAT0000850 0Liver rno-miR-146a-5p MIMAT0000852 22735812 Liver rno-miR-146b-5pMIMAT0005595 0 Liver rno-miR-148b-3p MIMAT0000579 0 Liver rno-miR-150-5pMIMAT0000853 19892940 Liver rno-miR-151-3p MIMAT0000614 0 Liverrno-miR-152-3p MIMAT0000854 0 Liver rno-miR-15b-5p MIMAT0000784 0 Liverrno-miR-16-5p MIMAT0000785 0 Liver rno-miR-17-1-3p MIMAT0004710 0 Liverrno-miR-17-5p MIMAT0000786 0 Liver rno-miR-182 MIMAT0005300 19167416Liver rno-miR-185-5p MIMAT0000862 0 Liver rno-miR-186-3p MIMAT0017143 0Liver rno-miR-186-5p MIMAT0000863 0 Liver rno-miR-188-5p MIMAT0005301 0Liver rno-miR-18a-5p MIMAT0000787 19167416 Liver rno-miR-190a-3pMIMAT0017145 0 Liver rno-miR-190a-5p MIMAT0000865 0 Liverrno-miR-190b-5p MIMAT0005302 0 Liver rno-miR-191a-5p MIMAT0000866 0Liver rno-miR-192-5p MIMAT0000867 0 Liver rno-miR-194-5p MIMAT000086919892940 Liver rno-miR-194-5p MIMAT0000869 0 Liver rno-miR-1949MIMAT0017852 0 Liver rno-miR-195-5p MIMAT0000870 0 Liver rno-miR-199a-3pMIMAT0004738 0 Liver rno-miR-199a-5p MIMAT0000872 0 Liver rno-miR-19a-3pMIMAT0000789 0 Liver rno-miR-19b-3p MIMAT0000788 0 Liver rno-miR-200a-3pMIMAT0000874 19167416 Liver rno-miR-200a-3p MIMAT0000874 19185571 Liverrno-miR-200b-3p MIMAT0000875 19167416 Liver rno-miR-200b-3p MIMAT000087518942116 Liver rno-miR-200c-3p MIMAT0000873 19167416 Liverrno-miR-200c-3p MIMAT0000873 0 Liver rno-miR-203a-3p MIMAT0000876 0Liver rno-miR-203a-5p MIMAT0017153 0 Liver rno-miR-204-5p MIMAT0000877 0Liver rno-miR-206-3p MIMAT0000879 0 Liver rno-miR-20a-3p MIMAT0000603 0Liver rno-miR-20a-5p MIMAT0000602 0 Liver rno-miR-20b-5p MIMAT0003211 0Liver rno-miR-21-3p MIMAT0004711 0 Liver rno-miR-21-5p MIMAT0000790 0Liver rno-miR-21-5p MIMAT0000790 19167416 Liver rno-miR-210-3pMIMAT0000881 0 Liver rno-miR-211-5p MIMAT0000882 0 Liver rno-miR-215MIMAT0003118 0 Liver rno-miR-216a-5p MIMAT0000886 0 Liverrno-miR-216b-5p MIMAT0017846 0 Liver rno-miR-217-5p MIMAT0000887 0 Liverrno-miR-218a-5p MIMAT0000888 0 Liver rno-miR-22-3p MIMAT0000791 0 Liverrno-miR-22-5p MIMAT0003152 0 Liver rno-miR-221-3p MIMAT0000890 0 Liverrno-miR-221-5p MIMAT0017163 0 Liver rno-miR-223-3p MIMAT0000892 0 Liverrno-miR-23a-3p MIMAT0000792 0 Liver rno-miR-23b-3p MIMAT0000793 0 Liverrno-miR-23b-5p MIMAT0017099 0 Liver rno-miR-24-3p MIMAT0000794 0 Liverrno-miR-25-3p MIMAT0000795 0 Liver rno-miR-26a-5p MIMAT0000796 0 Liverrno-miR-26b-5p MIMAT0000797 0 Liver rno-miR-27a-3p MIMAT0000799 0 Liverrno-miR-27a-3p MIMAT0000799 19185571 Liver rno-miR-27b-3p MIMAT0000798 0Liver rno-miR-27b-3p MIMAT0000798 19185571 Liver rno-miR-28-3pMIMAT0004716 0 Liver rno-miR-29a-3p MIMAT0000802 0 Liver rno-miR-29a-3pMIMAT0000802 17652184 Liver rno-miR-29a-5p MIMAT0004718 0 Liverrno-miR-29b-3p MIMAT0000801 0 Liver rno-miR-29b-3p MIMAT0000801 17652184Liver rno-miR-29c-3p MIMAT0000803 0 Liver rno-miR-29c-3p MIMAT000080317652184 Liver rno-miR-30a-3p MIMAT0000809 0 Liver rno-miR-30a-5pMIMAT0000808 0 Liver rno-miR-30b-3p MIMAT0004721 0 Liver rno-miR-30b-5pMIMAT0000806 0 Liver rno-miR-30c-1-3p MIMAT0004719 0 Liverrno-miR-30c-2-3p MIMAT0005442 0 Liver rno-miR-30c-5p MIMAT0000804 0Liver rno-miR-30d-3p MIMAT0004722 0 Liver rno-miR-30d-5p MIMAT0000807 0Liver rno-miR-30e-3p MIMAT0004720 0 Liver rno-miR-30e-5p MIMAT0000805 0Liver rno-miR-31a-3p MIMAT0017102 0 Liver rno-miR-31a-5p MIMAT0000810 0Liver rno-miR-320-3p MIMAT0000903 0 Liver rno-miR-322-5p MIMAT0001619 0Liver rno-miR-329-5p MIMAT0017031 0 Liver rno-miR-33-5p MIMAT0000812 0Liver rno-miR-335 MIMAT0000575 0 Liver rno-miR-340-5p MIMAT0004650 0Liver rno-miR-341 MIMAT0000587 0 Liver rno-miR-342-3p MIMAT0000589 0Liver rno-miR-3473 MIMAT0024853 0 Liver rno-miR-34a-3p MIMAT0017106 0Liver rno-miR-34a-5p MIMAT0000815 18942116 Liver rno-miR-34a-5pMIMAT0000815 0 Liver rno-miR-34a-5p MIMAT0000815 19167416 Liverrno-miR-350 MIMAT0000604 0 Liver rno-miR-3556a MIMAT0017821 0 Liverrno-miR-3556b MIMAT0017818 0 Liver rno-miR-3557-3p MIMAT0017820 0 Liverrno-miR-3557-5p MIMAT0017819 0 Liver rno-miR-3558-5p MIMAT0017825 0Liver rno-miR-3559-3p MIMAT0017828 0 Liver rno-miR-3571 MIMAT0017851 0Liver rno-miR-3574 MIMAT0017860 0 Liver rno-miR-3586-3p MIMAT0017881 0Liver rno-miR-3587 MIMAT0017883 0 Liver rno-miR-3588 MIMAT0017887 0Liver rno-miR-3590-3p MIMAT0017890 0 Liver rno-miR-3591 MIMAT0017893 0Liver rno-miR-3596a MIMAT0017886 0 Liver rno-miR-3596b MIMAT0017871 0Liver rno-miR-3596c MIMAT0017877 0 Liver rno-miR-3596d MIMAT0017823 0Liver rno-miR-362-3p MIMAT0017357 0 Liver rno-miR-362-5p MIMAT0012828 0Liver rno-miR-375-3p MIMAT0005307 0 Liver rno-miR-376a-3p MIMAT0003198 0Liver rno-miR-378a-3p MIMAT0003379 0 Liver rno-miR-378a-5p MIMAT00033780 Liver rno-miR-378b MIMAT0024855 0 Liver rno-miR-379-5p MIMAT0003192 0Liver rno-miR-423-5p MIMAT0017305 0 Liver rno-miR-425-5p MIMAT0005314 0Liver rno-miR-429 MIMAT0001538 0 Liver rno-miR-429 MIMAT0001538 19167416Liver rno-miR-449a-5p MIMAT0001543 0 Liver rno-miR-450a-5p MIMAT00015470 Liver rno-miR-451-5p MIMAT0001633 0 Liver rno-miR-455-3p MIMAT00173080 Liver rno-miR-455-5p MIMAT0005316 0 Liver rno-miR-455-5p MIMAT000531623045399 Liver rno-miR-466b-1-3p MIMAT0017285 0 Liver rno-miR-466b-2-3pMIMAT0017286 0 Liver rno-miR-466b-5p MIMAT0005278 0 Liverrno-miR-466c-5p MIMAT0005279 0 Liver rno-miR-497-5p MIMAT0003383 0 Liverrno-miR-499-3p MIMAT0017227 0 Liver rno-miR-499-5p MIMAT0003381 0 Liverrno-miR-501-3p MIMAT0017198 0 Liver rno-miR-501-5p MIMAT0003116 0 Liverrno-miR-503-5p MIMAT0003213 0 Liver rno-miR-511-3p MIMAT0017358 0 Liverrno-miR-532-3p MIMAT0005323 0 Liver rno-miR-532-5p MIMAT0005322 0 Liverrno-miR-542-5p MIMAT0003178 0 Liver rno-miR-547-3p MIMAT0012851 0 Liverrno-miR-582-5p MIMAT0012833 0 Liver rno-miR-6215 MIMAT0024854 0 Liverrno-miR-664-1-5p MIMAT0017228 0 Liver rno-miR-664-2-5p MIMAT0017229 0Liver rno-miR-664-3p MIMAT0003382 0 Liver rno-miR-674-5p MIMAT0005329 0Liver rno-miR-708-5p MIMAT0005331 0 Liver rno-miR-743b-3p MIMAT0005280 0Liver rno-miR-7a-1-3p MIMAT0000607 0 Liver rno-miR-7a-5p MIMAT0000606 0Liver rno-miR-7b MIMAT0000780 0 Liver rno-miR-802-3p MIMAT0017362 0Liver rno-miR-802-5p MIMAT0012840 0 Liver rno-miR-872-3p MIMAT0005283 0Liver rno-miR-872-5p MIMAT0005282 0 Liver rno-miR-92a-1-5p MIMAT00171070 Liver rno-miR-92a-3p MIMAT0000816 0 Liver rno-miR-92b-3p MIMAT00053400 Liver rno-miR-96-5p MIMAT0000818 0 Liver rno-miR-96-5p MIMAT000081819167416 Liver rno-miR-98-5p MIMAT0000819 0 Liver rno-miR-99a-5pMIMAT0000820 0 Liver rno-miR-99b-5p MIMAT0000821 0 Liver ssc-miR-122MIMAT0002119 18073344 Liver ssc-miR-29a MIMAT0013870 17652184 Liverssc-miR-29c MIMAT0002166 17652184 Liver xtr-miR-122 MIMAT000358518073344 Liver xtr-miR-29a MIMAT0003656 17652184 Locus Coeruleusmmu-miR-16-5p MIMAT0000527 20847275 Lung bta-miR-335 MIMAT000929118185580 Lung cfa-miR-335 MIMAT0006624 18185580 Lung hsa-let-7a-5pMIMAT0000062 20005451 Lung hsa-let-7a-5p MIMAT0000062 20033209 Lunghsa-let-7a-5p MIMAT0000062 15766527 Lung hsa-let-7a-5p MIMAT000006219818775 Lung hsa-let-7a-5p MIMAT0000062 16651716 Lung hsa-let-7a-5pMIMAT0000062 20418948 Lung hsa-let-7a-5p MIMAT0000062 17942906 Lunghsa-let-7b-3p MIMAT0004482 18379589 Lung hsa-let-7b-3p MIMAT000448217437991 Lung hsa-let-7b-3p MIMAT0004482 17699775 Lung hsa-let-7b-5pMIMAT0000063 17942906 Lung hsa-let-7b-5p MIMAT0000063 18379589 Lunghsa-let-7b-5p MIMAT0000063 19966857 Lung hsa-let-7b-5p MIMAT000006317437991 Lung hsa-let-7b-5p MIMAT0000063 17699775 Lung hsa-let-7c-5pMIMAT0000064 15766527 Lung hsa-let-7d-5p MIMAT0000065 20395557 Lunghsa-let-7d-5p MIMAT0000065 21616524 Lung hsa-let-7e-3p MIMAT000448517437991 Lung hsa-let-7e-5p MIMAT0000066 17437991 Lung hsa-let-7f-5pMIMAT0000067 19956384 Lung hsa-let-7f-5p MIMAT0000067 21616524 Lunghsa-let-7g-5p MIMAT0000414 18308936 Lung hsa-let-7g-5p MIMAT000041421616524 Lung hsa-let-7i-5p MIMAT0000415 21616524 Lung hsa-miR-1MIMAT0000416 23142026 Lung hsa-miR-106a-5p MIMAT0000103 16461460 Lunghsa-miR-107 MIMAT0000104 19688090 Lung hsa-miR-125a-5p MIMAT000044321220473 Lung hsa-miR-125b-5p MIMAT0000423 19293287 Lung hsa-miR-126-3pMIMAT0000445 19223090 Lung hsa-miR-126-3p MIMAT0000445 18602365 Lunghsa-miR-126-3p MIMAT0000445 20083669 Lung hsa-miR-128-2-5p MIMAT003109518304967 Lung hsa-miR-133b MIMAT0000770 19654003 Lung hsa-miR-134-5pMIMAT0000447 20371173 Lung hsa-miR-137 MIMAT0000429 23178712 Lunghsa-miR-143-3p MIMAT0000435 19472311 Lung hsa-miR-145-5p MIMAT000043721496429 Lung hsa-miR-145-5p MIMAT0000437 21092188 Lung hsa-miR-145-5pMIMAT0000437 19996288 Lung hsa-miR-146b-5p MIMAT0002809 21305051 Lunghsa-miR-155-5p MIMAT0000646 21093163 Lung hsa-miR-155-5p MIMAT000064619701459 Lung hsa-miR-155-5p MIMAT0000646 16675453 Lung hsa-miR-155-5pMIMAT0000646 20427544 Lung hsa-miR-15a-5p MIMAT0000068 19549910 Lunghsa-miR-16-5p MIMAT0000069 19549910 Lung hsa-miR-183-5p MIMAT000026118840437 Lung hsa-miR-185-5p MIMAT0000455 19688090 Lung hsa-miR-188-5pMIMAT0000457 19223510 Lung hsa-miR-196a-5p MIMAT0000226 19418581 Lunghsa-miR-197-3p MIMAT0000227 19671678 Lung hsa-miR-19a-3p MIMAT000007321751348 Lung hsa-miR-200b-3p MIMAT0000318 21993663 Lung hsa-miR-200b-3pMIMAT0000318 22139708 Lung hsa-miR-200c-3p MIMAT0000617 21207483 Lunghsa-miR-200c-3p MIMAT0000617 19223510 Lung hsa-miR-200c-3p MIMAT000061721993663 Lung hsa-miR-200c-3p MIMAT0000617 21294122 Lung hsa-miR-204-5pMIMAT0000265 20369013 Lung hsa-miR-20a-5p MIMAT0000075 21751348 Lunghsa-miR-20a-5p MIMAT0000075 18632605 Lung hsa-miR-20a-5p MIMAT000007516461460 Lung hsa-miR-21-5p MIMAT0000076 18270520 Lung hsa-miR-21-5pMIMAT0000076 22956424 Lung hsa-miR-21-5p MIMAT0000076 18372920 Lunghsa-miR-21-5p MIMAT0000076 17968323 Lung hsa-miR-21-5p MIMAT000007620223231 Lung hsa-miR-22-3p MIMAT0000077 22484852 Lung hsa-miR-221-3pMIMAT0000278 18246122 Lung hsa-miR-222-3p MIMAT0000279 21656127 Lunghsa-miR-222-3p MIMAT0000279 18246122 Lung hsa-miR-223-3p MIMAT000028018278031 Lung hsa-miR-223-3p MIMAT0000280 21305051 Lung hsa-miR-26a-5pMIMAT0000082 16461460 Lung hsa-miR-29a-3p MIMAT0000086 19818597 Lunghsa-miR-29a-3p MIMAT0000086 17890317 Lung hsa-miR-29b-3p MIMAT000010021305051 Lung hsa-miR-29b-3p MIMAT0000100 17890317 Lung hsa-miR-29c-3pMIMAT0000681 21305051 Lung hsa-miR-29c-3p MIMAT0000681 17890317 Lunghsa-miR-30c-5p MIMAT0000244 19223510 Lung hsa-miR-30e-5p MIMAT000069219223510 Lung hsa-miR-31-3p MIMAT0004504 20237410 Lung hsa-miR-31-5pMIMAT0000089 21048943 Lung hsa-miR-31-5p MIMAT0000089 20237410 Lunghsa-miR-31-5p MIMAT0000089 23539435 Lung hsa-miR-335-5p MIMAT000076518185580 Lung hsa-miR-34a-5p MIMAT0000255 21294122 Lung hsa-miR-409-3pMIMAT0001639 22531314 Lung hsa-miR-429 MIMAT0001536 21993663 Lunghsa-miR-449c-5p MIMAT0010251 23507140 Lung hsa-miR-451a MIMAT000163121358675 Lung hsa-miR-483-3p MIMAT0002173 21305051 Lung hsa-miR-499a-5pMIMAT0002870 21934092 Lung hsa-miR-499b-5p MIMAT0019897 21934092 Lunghsa-miR-574-5p MIMAT0004795 21305051 Lung hsa-miR-622 MIMAT000329122016468 Lung hsa-miR-7-5p MIMAT0000252 19073608 Lung hsa-miR-93-5pMIMAT0000093 19671678 Lung hsa-miR-98-5p MIMAT0000096 19671678 Lunghsa-miR-98-5p MIMAT0000096 21616524 Lung hsa-miR-98-5p MIMAT000009617942906 Lung mmu-let-7a-5p MIMAT0000521 20630862 Lung mmu-miR-106b-5pMIMAT0000386 19559694 Lung mmu-miR-10b-5p MIMAT0000208 20351690 Lungmmu-miR-122-5p MIMAT0000246 16258535 Lung mmu-miR-127-3p MIMAT000013922287715 Lung mmu-miR-135b-5p MIMAT0000612 23440414 Lung mmu-miR-155-5pMIMAT0000165 19701459 Lung mmu-miR-155-5p MIMAT0000165 17463290 Lungmmu-miR-17-5p MIMAT0000649 19559694 Lung mmu-miR-17-5p MIMAT000064917765889 Lung mmu-miR-200a-3p MIMAT0000519 21115742 Lung mmu-miR-200b-3pMIMAT0000233 21115742 Lung mmu-miR-200b-3p MIMAT0000233 19787069 Lungmmu-miR-200c-3p MIMAT0000657 21115742 Lung mmu-miR-200c-3p MIMAT000065719787069 Lung mmu-miR-204-5p MIMAT0000237 20369013 Lung mmu-miR-20a-5pMIMAT0000529 19559694 Lung mmu-miR-21a-5p MIMAT0000530 18372920 Lungmmu-miR-21a-5p MIMAT0000530 19748927 Lung mmu-miR-223-3p MIMAT000066518278031 Lung mmu-miR-31-5p MIMAT0000538 20237410 Lung mmu-miR-429-3pMIMAT0001537 21115742 Lung ppy-miR-335 MIMAT0015837 18185580 Lungptr-miR-335 MIMAT0008104 18185580 Lung rno-let-7a-5p MIMAT000077417942906 Lung rno-miR-126a-3p MIMAT0000832 18780894 Lung rno-miR-126a-5pMIMAT0000831 18780894 Lung rno-miR-335 MIMAT0000575 18185580 Lungssc-miR-335 MIMAT0013955 18185580 Lymph hsa-miR-101-3p MIMAT000009919043531 Lymph hsa-miR-135a-5p MIMAT0000428 19666866 Lymphhsa-miR-138-5p MIMAT0000430 23389731 Lymph hsa-miR-143-3p MIMAT000043523276710 Lymph hsa-miR-148a-3p MIMAT0000243 18768788 Lymphhsa-miR-16-2-3p MIMAT0004518 20309880 Lymph hsa-miR-181a-5p MIMAT000025620841506 Lymph hsa-miR-200c-3p MIMAT0000617 21207483 Lymphhsa-miR-200c-3p MIMAT0000617 21294122 Lymph hsa-miR-21-5p MIMAT000007619276261 Lymph hsa-miR-21-5p MIMAT0000076 20346171 Lymph hsa-miR-21-5pMIMAT0000076 22267008 Lymph hsa-miR-21-5p MIMAT0000076 22956424 Lymphhsa-miR-223-3p MIMAT0000280 22270966 Lymph hsa-miR-26a-5p MIMAT000008223338972 Lymph hsa-miR-339-5p MIMAT0000764 20932331 Lymph hsa-miR-34a-5pMIMAT0000255 21294122 Lymph hsa-miR-34a-5p MIMAT0000255 20309880 Lymphhsa-miR-34b-3p MIMAT0004676 18768788 Lymph hsa-miR-34c-5p MIMAT000068618768788 Lymph hsa-miR-497-5p MIMAT0002820 23453369 Lymphhsa-miR-499a-5p MIMAT0002870 21934092 Lymph hsa-miR-499b-5p MIMAT001989721934092 Lymph Nodes hsa-miR-101-3p MIMAT0000099 19043531 Lymph Nodeshsa-miR-148a-3p MIMAT0000243 18768788 Lymph Nodes hsa-miR-16-2-3pMIMAT0004518 20309880 Lymph Nodes hsa-miR-21-5p MIMAT0000076 22267008Lymph Nodes hsa-miR-34a-5p MIMAT0000255 20309880 Lymph Nodeshsa-miR-34b-3p MIMAT0004676 18768788 Lymph Nodes hsa-miR-34c-5pMIMAT0000686 18768788 Lymphocytes hsa-let-7d-5p MIMAT0000065 21616524Lymphocytes hsa-let-7f-5p MIMAT0000067 21616524 Lymphocyteshsa-let-7g-5p MIMAT0000414 21616524 Lymphocytes hsa-let-7i-5pMIMAT0000415 21616524 Lymphocytes hsa-miR-101-3p MIMAT0000099 19043531Lymphocytes hsa-miR-107 MIMAT0000104 20884628 Lymphocytes hsa-miR-122-5pMIMAT0000421 20884628 Lymphocytes hsa-miR-125b-5p MIMAT0000423 20497960Lymphocytes hsa-miR-146a-5p MIMAT0000449 18057241 Lymphocyteshsa-miR-146a-5p MIMAT0000449 19965651 Lymphocytes hsa-miR-148a-3pMIMAT0000243 19435428 Lymphocytes hsa-miR-150-5p MIMAT0000451 17923094Lymphocytes hsa-miR-150-5p MIMAT0000451 18667440 Lymphocyteshsa-miR-155-5p MIMAT0000646 20209161 Lymphocytes hsa-miR-155-5pMIMAT0000646 20680360 Lymphocytes hsa-miR-155-5p MIMAT0000646 19386588Lymphocytes hsa-miR-155-5p MIMAT0000646 18367535 Lymphocyteshsa-miR-15a-5p MIMAT0000068 22379033 Lymphocytes hsa-miR-15b-5pMIMAT0000417 22379033 Lymphocytes hsa-miR-16-5p MIMAT0000069 22379033Lymphocytes hsa-miR-181c-5p MIMAT0000258 21112091 Lymphocyteshsa-miR-198 MIMAT0000228 18667440 Lymphocytes hsa-miR-19b-3pMIMAT0000074 19435428 Lymphocytes hsa-miR-20a-5p MIMAT0000075 19435428Lymphocytes hsa-miR-214-3p MIMAT0000271 20548023 Lymphocyteshsa-miR-214-3p MIMAT0000271 19435428 Lymphocytes hsa-miR-221-3pMIMAT0000278 21236259 Lymphocytes hsa-miR-221-3p MIMAT0000278 20110463Lymphocytes hsa-miR-26a-5p MIMAT0000082 23338972 Lymphocyteshsa-miR-29a-3p MIMAT0000086 20086245 Lymphocytes hsa-miR-29b-3pMIMAT0000100 20086245 Lymphocytes hsa-miR-29c-3p MIMAT0000681 20086245Lymphocytes hsa-miR-34a-5p MIMAT0000255 20598588 Lymphocyteshsa-miR-520h MIMAT0002867 19435428 Lymphocytes hsa-miR-92a-3pMIMAT0000092 19435428 Lymphocytes hsa-miR-98-5p MIMAT0000096 21616524Lymphocytes mmu-miR-125b-5p MIMAT0000136 21118986 Lymphocytesmmu-miR-146a-5p MIMAT0000158 18791161 Lymphocytes mmu-miR-148a-3pMIMAT0000516 21068402 Lymphocytes mmu-miR-148b-3p MIMAT0000580 21068402Lymphocytes mmu-miR-150-5p MIMAT0000160 17923094 Lymphocytesmmu-miR-152-3p MIMAT0000162 21068402 Lymphocytes mmu-miR-155-5pMIMAT0000165 18450484 Lymphocytes mmu-miR-155-5p MIMAT0000165 18455451Lymphocytes mmu-miR-155-5p MIMAT0000165 17463290 Lymphocytesmmu-miR-214-3p MIMAT0000661 20548023 Lymphocytes mmu-miR-223-3pMIMAT0000665 20935160 Lymphocytes mmu-miR-223-3p MIMAT0000665 22043014Lymphocytes mmu-miR-34a-5p MIMAT0000542 20598588 Lymphocytes Nullhsa-miR-1 MIMAT0000416 18593903 Lymphoid Tissue hsa-miR-101-3pMIMAT0000099 19043531 Lymphoid Tissue hsa-miR-16-5p MIMAT000006917351108 Lymphoid Tissue hsa-miR-200a-3p MIMAT0000682 22183793 LymphoidTissue hsa-miR-200b-3p MIMAT0000318 22183793 Lymphoid Tissuehsa-miR-200c-3p MIMAT0000617 22183793 Lymphoid Tissue hsa-miR-7-5pMIMAT0000252 18823940 Macrophages hsa-let-7b-5p MIMAT0000063 20130213Macrophages hsa-miR-101-3p MIMAT0000099 21068409 Macrophageshsa-miR-141-3p MIMAT0000432 18835392 Macrophages hsa-miR-145-5pMIMAT0000437 20130213 Macrophages hsa-miR-146a-5p MIMAT0000449 20542134Macrophages hsa-miR-155-5p MIMAT0000646 21036908 Macrophageshsa-miR-155-5p MIMAT0000646 19359473 Macrophages hsa-miR-155-5pMIMAT0000646 19386588 Macrophages hsa-miR-155-5p MIMAT0000646 19887047Macrophages hsa-miR-155-5p MIMAT0000646 21097505 Macrophageshsa-miR-155-5p MIMAT0000646 19596814 Macrophages hsa-miR-155-5pMIMAT0000646 21030878 Macrophages hsa-miR-155-5p MIMAT0000646 22473996Macrophages hsa-miR-192-5p MIMAT0000222 18835392 Macrophageshsa-miR-195-5p MIMAT0000461 20952681 Macrophages hsa-miR-198MIMAT0000228 19148268 Macrophages hsa-miR-200a-3p MIMAT0000682 18835392Macrophages hsa-miR-203a MIMAT0000264 23522925 Macrophages hsa-miR-21-5pMIMAT0000076 18384814 Macrophages hsa-miR-217 MIMAT0000274 18835392Macrophages hsa-miR-26a-5p MIMAT0000082 20130213 Macrophageshsa-miR-27b-3p MIMAT0000419 20164187 Macrophages hsa-miR-27b-3pMIMAT0000419 18835392 Macrophages hsa-miR-33a-5p MIMAT0000091 20466885Macrophages hsa-miR-34a-5p MIMAT0000255 20130213 Macrophageshsa-miR-451a MIMAT0001631 19318487 Macrophages hsa-miR-532-5pMIMAT0002888 18835392 Macrophages hsa-miR-603 MIMAT0003271 18835392Macrophages hsa-miR-758-3p MIMAT0003879 21885853 Macrophageshsa-miR-769-5p MIMAT0003886 18835392 Macrophages mmu-let-7e-3pMIMAT0017016 19699171 Macrophages mmu-let-7e-5p MIMAT0000524 19699171Macrophages mmu-miR-101a-3p MIMAT0000133 21068409 Macrophagesmmu-miR-122-5p MIMAT0000246 21364282 Macrophages mmu-miR-124-3pMIMAT0000134 21131957 Macrophages mmu-miR-127-3p MIMAT0000139 22287715Macrophages mmu-miR-146a-5p MIMAT0000158 19596990 Macrophagesmmu-miR-155-5p MIMAT0000165 20937844 Macrophages mmu-miR-155-5pMIMAT0000165 19699171 Macrophages mmu-miR-21a-5p MIMAT0000530 21273303Macrophages mmu-miR-33-5p MIMAT0000667 20466885 Macrophagesmmu-miR-33-5p MIMAT0000667 21285396 Macrophages mmu-miR-466l-3pMIMAT0005830 20410487 Macrophages Peritoneal hsa-miR-758-3p MIMAT000387921885853 Macrophages Peritoneal mmu-miR-33-5p MIMAT0000667 21285396Mammary Arteries hsa-miR-155-5p MIMAT0000646 23108656 Mammary GlandsHuman hsa-miR-1258 MIMAT0005909 21266359 Mammary Glands Humanhsa-miR-155-5p MIMAT0000646 18794355 Mammary Glands Humanmmu-miR-101a-3p MIMAT0000133 19281778 Mammary Glands Humanmmu-miR-132-3p MIMAT0000144 21057503 Mammary Glands Human mmu-miR-132-5pMIMAT0016984 21057503 Mammary Glands Human mmu-miR-155-5p MIMAT000016518794355 Mammary Glands Human mmu-miR-212-3p MIMAT0000659 21057503 MastCells hsa-miR-132-3p MIMAT0000426 21853268 Maxillary Sinus hsa-miR-1MIMAT0000416 21701775 Maxillary Sinus hsa-miR-133a-3p MIMAT000042721701775 Megakaryocyte-Erythroid hsa-miR-150-5p MIMAT0000451 18539114Progenitor Cells Megakaryocytes hsa-let-7a-5p MIMAT0000062 20445018Megakaryocytes hsa-let-7c-5p MIMAT0000064 20445018 Megakaryocyteshsa-let-7d-5p MIMAT0000065 20445018 Megakaryocytes hsa-let-7e-5pMIMAT0000066 20445018 Megakaryocytes hsa-let-7f-5p MIMAT0000067 20445018Megakaryocytes hsa-miR-10a-5p MIMAT0000253 16549775 Megakaryocyteshsa-miR-130a-3p MIMAT0000425 16549775 Megakaryocytes hsa-miR-150-5pMIMAT0000451 18539114 Megakaryocytes hsa-miR-151a-5p MIMAT000469720445018 Megakaryocytes hsa-miR-28-5p MIMAT0000085 20445018Megakaryocytes hsa-miR-708-3p MIMAT0004927 20445018 Megakaryocyteshsa-miR-98-5p MIMAT0000096 20445018 Melanocytes hsa-let-7a-5pMIMAT0000062 18679415 Melanocytes hsa-miR-137 MIMAT0000429 21051724Melanocytes hsa-miR-155-5p MIMAT0000646 21466664 Melanocyteshsa-miR-196a-5p MIMAT0000226 20480203 Melanocytes hsa-miR-196a-5pMIMAT0000226 21077158 Melanocytes hsa-miR-211-5p MIMAT0000268 21072171Melanocytes hsa-miR-211-5p MIMAT0000268 21435193 Melanocyteshsa-miR-221-3p MIMAT0000278 23400877 Melanocytes hsa-miR-222-3pMIMAT0000279 23400877 Melanocytes hsa-miR-34a-5p MIMAT0000255 19029026Melanocytes hsa-miR-532-5p MIMAT0002888 19336521 Melanocyteshsa-miR-7-5p MIMAT0000252 19029026 Membranes hsa-miR-1 MIMAT000041617401374 Membranes hsa-miR-128-3p MIMAT0000424 21143953 Membraneshsa-miR-146a-5p MIMAT0000449 18057241 Membranes hsa-miR-151a-3pMIMAT0000757 21143953 Membranes hsa-miR-155-5p MIMAT0000646 19386588Membranes hsa-miR-155-5p MIMAT0000646 22387553 Membranes hsa-miR-15a-5pMIMAT0000068 20385127 Membranes hsa-miR-182-5p MIMAT0000259 23430586Membranes hsa-miR-185-5p MIMAT0000455 21143953 Membranes hsa-miR-204-5pMIMAT0000265 20056717 Membranes hsa-miR-21-5p MIMAT0000076 22387553Membranes hsa-miR-21-5p MIMAT0000076 20056717 Membranes hsa-miR-210-3pMIMAT0000267 19826008 Membranes hsa-miR-29a-3p MIMAT0000086 19951903Membranes hsa-miR-30b-5p MIMAT0000420 22387553 Membranes hsa-miR-320aMIMAT0000510 20628061 Membranes hsa-miR-338-3p MIMAT0000763 18991333Membranes hsa-miR-509-3p MIMAT0002881 21143953 Membranes hsa-miR-92b-3pMIMAT0003218 21030610 Membranes mmu-miR-143-3p MIMAT0000247 20351064Membranes mmu-miR-145a-5p MIMAT0000157 20351064 Membranesmmu-miR-200b-3p MIMAT0000233 19787069 Membranes mmu-miR-200c-3pMIMAT0000657 19787069 Membranes mmu-miR-23a-3p MIMAT0000532 19259393Membranes mmu-miR-23b-3p MIMAT0000125 19259393 Membranes rno-miR-1-3pMIMAT0003125 17401374 Membranes rno-miR-1-3p MIMAT0003125 18801338Membranes rno-miR-338-3p MIMAT0000581 18991333 Meninges hsa-miR-200a-3pMIMAT0000682 19703993 Mesangial Cells hsa-miR-328-3p MIMAT000075218716028 Mesangial Cells hsa-miR-377-3p MIMAT0000730 18716028 MesangialCells mmu-miR-192-5p MIMAT0000517 17360662 Mesangial Cellsmmu-miR-215-5p MIMAT0000904 17360662 Mesangial Cells mmu-miR-216a-5pMIMAT0000662 20713358 Mesangial Cells mmu-miR-216a-5p MIMAT000066219543271 Mesangial Cells mmu-miR-217-5p MIMAT0000679 19543271 MesangialCells rno-miR-192-5p MIMAT0000867 20393144 Mesangial Cells rno-miR-215MIMAT0003118 20393144 Mesangial Cells rno-miR-25-3p MIMAT000079521071935 Mesangial Cells rno-miR-92b-3p MIMAT0005340 21071935Mesencephalon hsa-miR-133b MIMAT0000770 17761882 Mesenchymal Stem Cellsbta-miR-130a MIMAT0009223 17855557 Mesenchymal Stem Cells cfa-miR-130aMIMAT0006631 17855557 Mesenchymal Stem Cells dre-miR-130a MIMAT000182617855557 Mesenchymal Stem Cells hsa-miR-100-5p MIMAT0000098 22684006Mesenchymal Stem Cells hsa-miR-125b-5p MIMAT0000423 18230348 MesenchymalStem Cells hsa-miR-130a-3p MIMAT0000425 17855557 Mesenchymal Stem Cellshsa-miR-133a-3p MIMAT0000427 23069713 Mesenchymal Stem Cellshsa-miR-138-5p MIMAT0000430 20486779 Mesenchymal Stem Cellshsa-miR-145-5p MIMAT0000437 20382729 Mesenchymal Stem Cellshsa-miR-145-5p MIMAT0000437 21217773 Mesenchymal Stem Cellshsa-miR-196a-5p MIMAT0000226 19063684 Mesenchymal Stem Cellshsa-miR-199a-5p MIMAT0000231 22441842 Mesenchymal Stem Cells hsa-miR-206MIMAT0000462 17855557 Mesenchymal Stem Cells hsa-miR-21-5p MIMAT000007621381024 Mesenchymal Stem Cells hsa-miR-21-5p MIMAT0000076 19816956Mesenchymal Stem Cells hsa-miR-21-5p MIMAT0000076 23239100 MesenchymalStem Cells hsa-miR-27a-3p MIMAT0000084 19440384 Mesenchymal Stem Cellshsa-miR-29a-3p MIMAT0000086 21665270 Mesenchymal Stem Cellshsa-miR-29b-3p MIMAT0000100 21665270 Mesenchymal Stem Cellshsa-miR-302a-3p MIMAT0000684 17855557 Mesenchymal Stem Cellshsa-miR-320a MIMAT0000510 17855557 Mesenchymal Stem Cells hsa-miR-335-5pMIMAT0000765 21164520 Mesenchymal Stem Cells hsa-miR-433-3p MIMAT000162723353875 Mesenchymal Stem Cells hsa-miR-489-3p MIMAT0002805 19440384Mesenchymal Stem Cells hsa-miR-637 MIMAT0003307 21880893 MesenchymalStem Cells mmu-miR-204-5p MIMAT0000237 20039258 Mesenchymal Stem Cellsmmu-miR-211-5p MIMAT0000668 20039258 Mesenchymal Stem Cellsmmu-miR-29a-3p MIMAT0000535 21665270 Mesenchymal Stem Cellsmmu-miR-29b-3p MIMAT0000127 21665270 Mesenchymal Stem Cells mmu-miR-9-5pMIMAT0000142 22465325 Mesenchymal Stem Cells ppy-miR-130a MIMAT001575317855557 Mesenchymal Stem Cells ptr-miR-130a MIMAT0008025 17855557Mesenchymal Stem Cells ssc-miR-130a MIMAT0007758 17855557 MesenchymalStem Cells xtr-miR-130a MIMAT0003591 17855557 Mesenteric Arteriesmmu-miR-130a-3p MIMAT0000141 21753805 Mesenteric Artery Superiormmu-miR-130a-3p MIMAT0000141 21753805 Mesoderm hsa-miR-155-5pMIMAT0000646 19701459 Mesoderm mmu-miR-137-3p MIMAT0000149 21256124Mesoderm mmu-miR-153-3p MIMAT0000163 21256124 Mesoderm mmu-miR-155-5pMIMAT0000165 19701459 Mesoderm mmu-miR-21a-5p MIMAT0000530 21295561Mesoderm mmu-miR-290a-3p MIMAT0004572 19628328 Mesoderm mmu-miR-291a-3pMIMAT0000368 19628328 Mesoderm mmu-miR-292-3p MIMAT0000370 19628328Mesoderm mmu-miR-293-3p MIMAT0000371 19628328 Mesoderm mmu-miR-294-3pMIMAT0000372 19628328 Mesoderm mmu-miR-295-3p MIMAT0000373 19628328Mesoderm mmu-miR-363-3p MIMAT0000708 21256124 Microfilaments hsa-miR-1MIMAT0000416 23142026 Microfilaments mmu-miR-124-3p MIMAT000013418619591 Microglia hsa-miR-146a-5p MIMAT0000449 20181935 Microgliammu-miR-124-3p MIMAT0000134 21131957 Microglia mmu-miR-155-5pMIMAT0000165 22043967 Microtubules mmu-miR-124-3p MIMAT0000134 18619591Microvessels hsa-miR-135b-5p MIMAT0000758 23340180 Microvesselshsa-miR-223-3p MIMAT0000280 23208072 Microvessels hsa-miR-29b-3pMIMAT0000100 21793034 Microvessels mmu-miR-15a-5p MIMAT0000526 20445066Middle Cerebral Artery mmu-miR-497-5p MIMAT0003453 20053374 MiddleCerebral Artery rno-let-7a-5p MIMAT0000774 18258830 Middle CerebralArtery rno-let-7b-3p MIMAT0004705 18258830 Middle Cerebral Arteryrno-let-7b-5p MIMAT0000775 18258830 Middle Cerebral Artery rno-let-7c-5pMIMAT0000776 18258830 Middle Cerebral Artery rno-let-7d-3p MIMAT000056318258830 Middle Cerebral Artery rno-let-7d-5p MIMAT0000562 18258830Middle Cerebral Artery rno-let-7e-3p MIMAT0004706 18258830 MiddleCerebral Artery rno-let-7e-5p MIMAT0000777 18258830 Middle CerebralArtery rno-let-7f-5p MIMAT0000778 18258830 Middle Cerebral Arteryrno-let-7i-3p MIMAT0004707 18258830 Middle Cerebral Artery rno-let-7i-5pMIMAT0000779 18258830 Middle Cerebral Artery rno-miR-100-5p MIMAT000082218258830 Middle Cerebral Artery rno-miR-101a-3p MIMAT0000823 18258830Middle Cerebral Artery rno-miR-101b-3p MIMAT0000615 18258830 MiddleCerebral Artery rno-miR-124-3p MIMAT0000828 18258830 Middle CerebralArtery rno-miR-125a-5p MIMAT0000829 18258830 Middle Cerebral Arteryrno-miR-129-5p MIMAT0000600 18258830 Middle Cerebral Arteryrno-miR-130a-3p MIMAT0000836 18258830 Middle Cerebral Arteryrno-miR-132-3p MIMAT0000838 18258830 Middle Cerebral Arteryrno-miR-134-5p MIMAT0000840 18258830 Middle Cerebral Arteryrno-miR-138-5p MIMAT0000844 18258830 Middle Cerebral Arteryrno-miR-139-5p MIMAT0000845 18258830 Middle Cerebral Arteryrno-miR-145-5p MIMAT0000851 19142192 Middle Cerebral Arteryrno-miR-150-5p MIMAT0000853 18258830 Middle Cerebral Arteryrno-miR-181b-5p MIMAT0000859 18258830 Middle Cerebral Arteryrno-miR-185-5p MIMAT0000862 18258830 Middle Cerebral Arteryrno-miR-204-5p MIMAT0000877 18258830 Middle Cerebral Arteryrno-miR-21-5p MIMAT0000790 18258830 Middle Cerebral Arteryrno-miR-214-3p MIMAT0000885 18258830 Middle Cerebral Artery rno-miR-215MIMAT0003118 18258830 Middle Cerebral Artery rno-miR-218a-5pMIMAT0000888 18258830 Middle Cerebral Artery rno-miR-223-3p MIMAT000089218258830 Middle Cerebral Artery rno-miR-23a-3p MIMAT0000792 18258830Middle Cerebral Artery rno-miR-23b-3p MIMAT0000793 18258830 MiddleCerebral Artery rno-miR-24-3p MIMAT0000794 18258830 Middle CerebralArtery rno-miR-25-3p MIMAT0000795 18258830 Middle Cerebral Arteryrno-miR-26b-5p MIMAT0000797 18258830 Middle Cerebral Arteryrno-miR-27a-3p MIMAT0000799 18258830 Middle Cerebral Artery rno-miR-290MIMAT0000893 18258830 Middle Cerebral Artery rno-miR-292-5p MIMAT000089618258830 Middle Cerebral Artery rno-miR-293-5p MIMAT0012847 18258830Middle Cerebral Artery rno-miR-298-5p MIMAT0000900 18258830 MiddleCerebral Artery rno-miR-29a-3p MIMAT0000802 18258830 Middle CerebralArtery rno-miR-29b-3p MIMAT0000801 18258830 Middle Cerebral Arteryrno-miR-29c-3p MIMAT0000803 18258830 Middle Cerebral Arteryrno-miR-301a-3p MIMAT0000552 18258830 Middle Cerebral Arteryrno-miR-30a-3p MIMAT0000809 18258830 Middle Cerebral Arteryrno-miR-30a-5p MIMAT0000808 18258830 Middle Cerebral Arteryrno-miR-30b-5p MIMAT0000806 18258830 Middle Cerebral Arteryrno-miR-30c-5p MIMAT0000804 18258830 Middle Cerebral Arteryrno-miR-30e-5p MIMAT0000805 18258830 Middle Cerebral Arteryrno-miR-320-3p MIMAT0000903 18258830 Middle Cerebral Arteryrno-miR-322-5p MIMAT0001619 18258830 Middle Cerebral Arteryrno-miR-324-5p MIMAT0000553 18258830 Middle Cerebral Artery rno-miR-327MIMAT0000561 18258830 Middle Cerebral Artery rno-miR-328a-3pMIMAT0000564 18258830 Middle Cerebral Artery rno-miR-331-3p MIMAT000057018258830 Middle Cerebral Artery rno-miR-338-3p MIMAT0000581 18258830Middle Cerebral Artery rno-miR-342-3p MIMAT0000589 18258830 MiddleCerebral Artery rno-miR-342-5p MIMAT0004652 18258830 Middle CerebralArtery rno-miR-34a-5p MIMAT0000815 18258830 Middle Cerebral Arteryrno-miR-374-5p MIMAT0003208 18258830 Middle Cerebral Arteryrno-miR-382-5p MIMAT0003201 18258830 Middle Cerebral Arteryrno-miR-383-5p MIMAT0003114 18258830 Middle Cerebral Arteryrno-miR-409a-3p MIMAT0003205 18258830 Middle Cerebral Arteryrno-miR-485-5p MIMAT0003203 18258830 Middle Cerebral Arteryrno-miR-494-3p MIMAT0003193 18258830 Middle Cerebral Arteryrno-miR-497-5p MIMAT0003383 18258830 Middle Cerebral Arteryrno-miR-543-5p MIMAT0004787 18258830 Middle Cerebral Arteryrno-miR-664-3p MIMAT0003382 18258830 Middle Cerebral Arteryrno-miR-7a-5p MIMAT0000606 18258830 Middle Cerebral Arteryrno-miR-92a-3p MIMAT0000816 18258830 Middle Cerebral Arteryrno-miR-98-5p MIMAT0000819 18258830 Middle Cerebral Arteryrno-miR-99a-5p MIMAT0000820 18258830 Middle Cerebral Arteryrno-miR-99b-5p MIMAT0000821 18258830 Middle Cerebral Arteryrno-miR-9a-5p MIMAT0000781 18258830 Milk mmu-miR-101a-3p MIMAT000013319281778 Mitochondria hsa-miR-27a-3p MIMAT0000084 19513126 Mitochondriammu-miR-15b-5p MIMAT0000124 20007690 Mitochondria mmu-miR-16-5pMIMAT0000527 20007690 Mitochondria mmu-miR-195a-5p MIMAT0000225 20007690Mitochondria mmu-miR-322-5p MIMAT0000548 20007690 Mitochondriammu-miR-696 MIMAT0003483 20086200 Mitochondria rno-miR-15b-5pMIMAT0000784 20007690 Mitochondria rno-miR-16-5p MIMAT0000785 20007690Mitochondria rno-miR-195-5p MIMAT0000870 20007690 Mitochondriarno-miR-214-3p MIMAT0000885 20007690 Mitochondria rno-miR-322-5pMIMAT0001619 20007690 Mitochondria rno-miR-499-5p MIMAT0003381 21186368Mitochondrial Membranes rno-miR-1-3p MIMAT0003125 18801338 Monocyteshsa-miR-146a-5p MIMAT0000449 20375304 Monocytes hsa-miR-146a-5pMIMAT0000449 21178010 Monocytes hsa-miR-146a-5p MIMAT0000449 19918258Monocytes hsa-miR-146a-5p MIMAT0000449 16885212 Monocyteshsa-miR-146b-5p MIMAT0002809 16885212 Monocytes hsa-miR-155-5pMIMAT0000646 21030878 Monocytes hsa-miR-155-5p MIMAT0000646 19887047Monocytes hsa-miR-155-5p MIMAT0000646 19289835 Monocytes hsa-miR-195-5pMIMAT0000461 20952681 Monocytes hsa-miR-198 MIMAT0000228 19148268Monocytes hsa-miR-214-3p MIMAT0000271 21228352 Monocytes hsa-miR-663aMIMAT0003326 20622002 Monocytes hsa-miR-9-5p MIMAT0000441 19289835Monocytes mmu-miR-124-3p MIMAT0000134 21131957 Motor Neuronsmmu-miR-128-3p MIMAT0000140 21248104 Motor Neurons mmu-miR-17-5pMIMAT0000649 21248104 Motor Neurons mmu-miR-206-3p MIMAT0000239 20007902Mouth Mucosa hsa-miR-137 MIMAT0000429 18381414 Mouth Mucosahsa-miR-193a-3p MIMAT0000459 18381414 Mouth Mucosa hsa-miR-221-3pMIMAT0000278 21226887 Mouth Mucosa hsa-miR-222-3p MIMAT0000279 21226887Mucous Membrane hsa-miR-137 MIMAT0000429 20682795 Mucous Membranehsa-miR-146a-5p MIMAT0000449 20542134 Mucous Membrane hsa-miR-155-5pMIMAT0000646 19650740 Mucous Membrane hsa-miR-195-5p MIMAT000046120727858 Mucous Membrane hsa-miR-196a-5p MIMAT0000226 19342367 MucousMembrane hsa-miR-196a-5p MIMAT0000226 19418581 Mucous Membranehsa-miR-21-5p MIMAT0000076 19509156 Mucous Membrane hsa-miR-21-5pMIMAT0000076 21468550 Mucous Membrane hsa-miR-218-5p MIMAT000027519890957 Mucous Membrane hsa-miR-221-3p MIMAT0000278 21236259 MucousMembrane hsa-miR-222-3p MIMAT0000279 22321642 Mucous Membranehsa-miR-223-3p MIMAT0000280 22270966 Mucous Membrane hsa-miR-25-3pMIMAT0000081 23435373 Mucous Membrane hsa-miR-34b-3p MIMAT000467620924086 Mucous Membrane hsa-miR-34c-5p MIMAT0000686 20924086 MucousMembrane hsa-miR-365a-3p MIMAT0000710 22072615 Mucous Membranehsa-miR-630 MIMAT0003299 23435373 Mucus hsa-let-7d-5p MIMAT000006521616524 Mucus hsa-let-7f-5p MIMAT0000067 21616524 Mucus hsa-let-7g-5pMIMAT0000414 21616524 Mucus hsa-let-7i-5p MIMAT0000415 21616524 Mucushsa-miR-98-5p MIMAT0000096 21616524 Multipotent Stem Cellsmmu-miR-143-3p MIMAT0000247 19578358 Multipotent Stem Cellsmmu-miR-145a-5p MIMAT0000157 19578358 Muscle Cells hsa-miR-1MIMAT0000416 19131648 Muscle Cells hsa-miR-1 MIMAT0000416 20458751Muscle Cells hsa-miR-1 MIMAT0000416 21051663 Muscle Cells hsa-miR-1MIMAT0000416 19775284 Muscle Cells hsa-miR-101-3p MIMAT0000099 19818710Muscle Cells hsa-miR-125b-5p MIMAT0000423 21200031 Muscle Cellshsa-miR-133a-3p MIMAT0000427 17344217 Muscle Cells hsa-miR-133a-3pMIMAT0000427 19720047 Muscle Cells hsa-miR-133b MIMAT0000770 17344217Muscle Cells hsa-miR-133b MIMAT0000770 19720047 Muscle Cellshsa-miR-150-5p MIMAT0000451 21200031 Muscle Cells hsa-miR-155-5pMIMAT0000646 17588946 Muscle Cells hsa-miR-155-5p MIMAT0000646 21310411Muscle Cells hsa-miR-195-5p MIMAT0000461 22802111 Muscle Cellshsa-miR-199a-5p MIMAT0000231 19818710 Muscle Cells hsa-miR-204-5pMIMAT0000265 22871591 Muscle Cells hsa-miR-21-5p MIMAT0000076 17478730Muscle Cells hsa-miR-21-5p MIMAT0000076 19906824 Muscle Cellshsa-miR-21-5p MIMAT0000076 20219857 Muscle Cells hsa-miR-21-5pMIMAT0000076 22034194 Muscle Cells hsa-miR-21-5p MIMAT0000076 20693317Muscle Cells hsa-miR-214-3p MIMAT0000271 19818710 Muscle Cellshsa-miR-22-3p MIMAT0000077 22538858 Muscle Cells hsa-miR-221-3pMIMAT0000278 19088079 Muscle Cells hsa-miR-221-3p MIMAT0000278 19150885Muscle Cells hsa-miR-221-3p MIMAT0000278 19859555 Muscle Cellshsa-miR-222-3p MIMAT0000279 19150885 Muscle Cells hsa-miR-222-3pMIMAT0000279 19859555 Muscle Cells hsa-miR-25-3p MIMAT0000081 19541842Muscle Cells hsa-miR-26a-5p MIMAT0000082 18281287 Muscle Cellshsa-miR-26a-5p MIMAT0000082 20857419 Muscle Cells hsa-miR-26a-5pMIMAT0000082 20525681 Muscle Cells hsa-miR-27a-3p MIMAT0000084 19666532Muscle Cells hsa-miR-27a-3p MIMAT0000084 21149577 Muscle Cellshsa-miR-27b-3p MIMAT0000419 19666532 Muscle Cells hsa-miR-31-5pMIMAT0000089 23518389 Muscle Cells hsa-miR-638 MIMAT0003308 23554459Muscle Cells hsa-miR-98-5p MIMAT0000096 19818710 Muscle Cellsmmu-miR-100-3p MIMAT0017051 21339483 Muscle Cells mmu-miR-100-5pMIMAT0000655 21339483 Muscle Cells mmu-miR-10a-3p MIMAT0004659 20118242Muscle Cells mmu-miR-10a-5p MIMAT0000648 20118242 Muscle Cellsmmu-miR-125b-5p MIMAT0000136 21200031 Muscle Cells mmu-miR-125b-5pMIMAT0000136 20699419 Muscle Cells mmu-miR-130a-3p MIMAT0000141 21753805Muscle Cells mmu-miR-143-3p MIMAT0000247 20489207 Muscle Cellsmmu-miR-143-3p MIMAT0000247 19578358 Muscle Cells mmu-miR-143-3pMIMAT0000247 20351064 Muscle Cells mmu-miR-145a-5p MIMAT0000157 19578358Muscle Cells mmu-miR-145a-5p MIMAT0000157 20351064 Muscle Cellsmmu-miR-15b-5p MIMAT0000124 20007690 Muscle Cells mmu-miR-16-5pMIMAT0000527 20007690 Muscle Cells mmu-miR-195a-5p MIMAT0000225 20007690Muscle Cells mmu-miR-1a-3p MIMAT0000123 19933931 Muscle Cellsmmu-miR-1a-3p MIMAT0000123 20799856 Muscle Cells mmu-miR-214-3pMIMAT0000661 19818710 Muscle Cells mmu-miR-21a-5p MIMAT0000530 20404348Muscle Cells mmu-miR-26a-5p MIMAT0000533 18281287 Muscle Cellsmmu-miR-322-5p MIMAT0000548 20007690 Muscle Cells mmu-miR-486-5pMIMAT0003130 20142475 Muscle Cells mmu-miR-494-3p MIMAT0003182 20837890Muscle Cells mmu-miR-696 MIMAT0003483 20086200 Muscle Cells rno-miR-1-3pMIMAT0003125 19775284 Muscle Cells rno-miR-133a-3p MIMAT0000839 19720047Muscle Cells rno-miR-133b-3p MIMAT0003126 19720047 Muscle Cellsrno-miR-145-5p MIMAT0000851 19542014 Muscle Cells rno-miR-15b-5pMIMAT0000784 20007690 Muscle Cells rno-miR-16-5p MIMAT0000785 20007690Muscle Cells rno-miR-195-5p MIMAT0000870 20007690 Muscle Cellsrno-miR-208a-3p MIMAT0000880 21720271 Muscle Cells rno-miR-21-5pMIMAT0000790 17478730 Muscle Cells rno-miR-21-5p MIMAT0000790 19706597Muscle Cells rno-miR-21-5p MIMAT0000790 19336275 Muscle Cellsrno-miR-21-5p MIMAT0000790 19158092 Muscle Cells rno-miR-214-3pMIMAT0000885 20007690 Muscle Cells rno-miR-221-3p MIMAT0000890 19150885Muscle Cells rno-miR-222-3p MIMAT0000891 19150885 Muscle Cellsrno-miR-27a-3p MIMAT0000799 21149577 Muscle Cells rno-miR-31a-5pMIMAT0000810 19542014 Muscle Cells rno-miR-31a-5p MIMAT0000810 22020941Muscle Cells rno-miR-322-5p MIMAT0001619 20007690 Muscle Fibers Skeletalhsa-miR-133b MIMAT0000770 17210790 Muscle Fibers Skeletal hsa-miR-221-3pMIMAT0000278 19859555 Muscle Fibers Skeletal hsa-miR-222-3p MIMAT000027919859555 Muscle Fibers Skeletal hsa-miR-26a-5p MIMAT0000082 18281287Muscle Fibers Skeletal mmu-miR-133b-3p MIMAT0000769 17210790 MuscleFibers Skeletal mmu-miR-206-3p MIMAT0000239 21041476 Muscle FibersSkeletal mmu-miR-206-3p MIMAT0000239 20007902 Muscle Fibers Skeletalmmu-miR-26a-5p MIMAT0000533 18281287 Muscle Fibers Skeletalmmu-miR-486-5p MIMAT0003130 21041476 Muscle Skeletal bta-miR-29aMIMAT0003518 17652184 Muscle Skeletal bta-miR-29c MIMAT0003829 17652184Muscle Skeletal cfa-miR-29a MIMAT0006626 17652184 Muscle Skeletalcfa-miR-29c MIMAT0006705 17652184 Muscle Skeletal dre-miR-29aMIMAT0001802 17652184 Muscle Skeletal hsa-miR-1 MIMAT0000416 15951802Muscle Skeletal hsa-miR-1 MIMAT0000416 21169019 Muscle Skeletalhsa-miR-1 MIMAT0000416 20956382 Muscle Skeletal hsa-miR-1 MIMAT000041619710019 Muscle Skeletal hsa-miR-1 MIMAT0000416 20458751 Muscle Skeletalhsa-miR-101-3p MIMAT0000099 19818710 Muscle Skeletal hsa-miR-199a-5pMIMAT0000231 19818710 Muscle Skeletal hsa-miR-206 MIMAT0000462 20956382Muscle Skeletal hsa-miR-206 MIMAT0000462 19710019 Muscle Skeletalhsa-miR-206 MIMAT0000462 19620785 Muscle Skeletal hsa-miR-206MIMAT0000462 17030984 Muscle Skeletal hsa-miR-214-3p MIMAT000027119818710 Muscle Skeletal hsa-miR-221-3p MIMAT0000278 19859555 MuscleSkeletal hsa-miR-222-3p MIMAT0000279 19859555 Muscle Skeletalhsa-miR-26a-5p MIMAT0000082 18281287 Muscle Skeletal hsa-miR-27a-3pMIMAT0000084 19666532 Muscle Skeletal hsa-miR-27b-3p MIMAT000041919666532 Muscle Skeletal hsa-miR-29a-3p MIMAT0000086 21169019 MuscleSkeletal hsa-miR-98-5p MIMAT0000096 19818710 Muscle Skeletalmmu-miR-133a-3p MIMAT0000145 16380711 Muscle Skeletal mmu-miR-133a-3pMIMAT0000145 19073597 Muscle Skeletal mmu-miR-1a-3p MIMAT000012319933931 Muscle Skeletal mmu-miR-1a-3p MIMAT0000123 20799856 MuscleSkeletal mmu-miR-1a-3p MIMAT0000123 15951802 Muscle Skeletalmmu-miR-1a-3p MIMAT0000123 20819939 Muscle Skeletal mmu-miR-1a-3pMIMAT0000123 16380711 Muscle Skeletal mmu-miR-1a-3p MIMAT000012319073597 Muscle Skeletal mmu-miR-206-3p MIMAT0000239 17030984 MuscleSkeletal mmu-miR-206-3p MIMAT0000239 20007902 Muscle Skeletalmmu-miR-206-3p MIMAT0000239 20819939 Muscle Skeletal mmu-miR-210-3pMIMAT0000658 19073597 Muscle Skeletal mmu-miR-214-3p MIMAT000066119818710 Muscle Skeletal mmu-miR-26a-5p MIMAT0000533 18281287 MuscleSkeletal mmu-miR-29a-3p MIMAT0000535 17652184 Muscle Skeletalmmu-miR-29b-3p MIMAT0000127 17652184 Muscle Skeletal mmu-miR-29c-3pMIMAT0000536 17652184 Muscle Skeletal mmu-miR-696 MIMAT0003483 20086200Muscle Skeletal ppy-miR-29a MIMAT0002363 17652184 Muscle Skeletalppy-miR-29c MIMAT0015735 17652184 Muscle Skeletal ptr-miR-29aMIMAT0002364 17652184 Muscle Skeletal ptr-miR-29c MIMAT0008082 17652184Muscle Skeletal rno-miR-24-3p MIMAT0000794 19499150 Muscle Skeletalrno-miR-29a-3p MIMAT0000802 17652184 Muscle Skeletal rno-miR-29b-3pMIMAT0000801 17652184 Muscle Skeletal rno-miR-29c-3p MIMAT000080317652184 Muscle Skeletal ssc-miR-29a MIMAT0013870 17652184 MuscleSkeletal ssc-miR-29c MIMAT0002166 17652184 Muscle Skeletal xtr-miR-29aMIMAT0003656 17652184 Muscle Smooth hsa-miR-1 MIMAT0000416 20458751Muscle Smooth hsa-miR-1 MIMAT0000416 21051663 Muscle Smoothhsa-miR-155-5p MIMAT0000646 17588946 Muscle Smooth hsa-miR-155-5pMIMAT0000646 21310411 Muscle Smooth hsa-miR-195-5p MIMAT0000461 22802111Muscle Smooth hsa-miR-204-5p MIMAT0000265 22871591 Muscle Smoothhsa-miR-21-5p MIMAT0000076 20693317 Muscle Smooth hsa-miR-21-5pMIMAT0000076 17478730 Muscle Smooth hsa-miR-21-5p MIMAT0000076 19906824Muscle Smooth hsa-miR-21-5p MIMAT0000076 22034194 Muscle Smoothhsa-miR-22-3p MIMAT0000077 22538858 Muscle Smooth hsa-miR-221-3pMIMAT0000278 19088079 Muscle Smooth hsa-miR-221-3p MIMAT0000278 19150885Muscle Smooth hsa-miR-222-3p MIMAT0000279 19150885 Muscle Smoothhsa-miR-25-3p MIMAT0000081 19541842 Muscle Smooth hsa-miR-26a-5pMIMAT0000082 20857419 Muscle Smooth hsa-miR-26a-5p MIMAT0000082 20525681Muscle Smooth hsa-miR-31-5p MIMAT0000089 23518389 Muscle Smoothhsa-miR-638 MIMAT0003308 23554459 Muscle Smooth mmu-miR-100-3pMIMAT0017051 21339483 Muscle Smooth mmu-miR-100-5p MIMAT0000655 21339483Muscle Smooth mmu-miR-10a-3p MIMAT0004659 20118242 Muscle Smoothmmu-miR-10a-5p MIMAT0000648 20118242 Muscle Smooth mmu-miR-125b-5pMIMAT0000136 20699419 Muscle Smooth mmu-miR-130a-3p MIMAT000014121753805 Muscle Smooth mmu-miR-143-3p MIMAT0000247 20351064 MuscleSmooth mmu-miR-143-3p MIMAT0000247 20489207 Muscle Smooth mmu-miR-143-3pMIMAT0000247 19578358 Muscle Smooth mmu-miR-145a-5p MIMAT000015719578358 Muscle Smooth mmu-miR-145a-5p MIMAT0000157 20351064 MuscleSmooth mmu-miR-1a-3p MIMAT0000123 20799856 Muscle Smooth rno-miR-145-5pMIMAT0000851 19542014 Muscle Smooth rno-miR-150-5p MIMAT0000853 19892940Muscle Smooth rno-miR-194-5p MIMAT0000869 19892940 Muscle Smoothrno-miR-208a-3p MIMAT0000880 21720271 Muscle Smooth rno-miR-21-5pMIMAT0000790 17478730 Muscle Smooth rno-miR-21-5p MIMAT0000790 19158092Muscle Smooth rno-miR-221-3p MIMAT0000890 19150885 Muscle Smoothrno-miR-222-3p MIMAT0000891 19150885 Muscle Smooth rno-miR-31a-5pMIMAT0000810 19542014 Muscle Smooth rno-miR-31a-5p MIMAT0000810 22020941Muscle Smooth Vascular hsa-miR-155-5p MIMAT0000646 17588946 MuscleSmooth Vascular hsa-miR-195-5p MIMAT0000461 22802111 Muscle SmoothVascular hsa-miR-204-5p MIMAT0000265 22871591 Muscle Smooth Vascularhsa-miR-21-5p MIMAT0000076 22034194 Muscle Smooth Vascular hsa-miR-21-5pMIMAT0000076 20693317 Muscle Smooth Vascular hsa-miR-221-3p MIMAT000027819088079 Muscle Smooth Vascular hsa-miR-221-3p MIMAT0000278 19150885Muscle Smooth Vascular hsa-miR-222-3p MIMAT0000279 19150885 MuscleSmooth Vascular hsa-miR-31-5p MIMAT0000089 23518389 Muscle SmoothVascular hsa-miR-638 MIMAT0003308 23554459 Muscle Smooth Vascularmmu-miR-100-3p MIMAT0017051 21339483 Muscle Smooth Vascularmmu-miR-100-5p MIMAT0000655 21339483 Muscle Smooth Vascularmmu-miR-125b-5p MIMAT0000136 20699419 Muscle Smooth Vascularmmu-miR-130a-3p MIMAT0000141 21753805 Muscle Smooth Vascularmmu-miR-143-3p MIMAT0000247 19578358 Muscle Smooth Vascularmmu-miR-145a-5p MIMAT0000157 19578358 Muscle Smooth Vascularrno-miR-145-5p MIMAT0000851 19542014 Muscle Smooth Vascularrno-miR-208a-3p MIMAT0000880 21720271 Muscle Smooth Vascularrno-miR-21-5p MIMAT0000790 19158092 Muscle Smooth Vascularrno-miR-221-3p MIMAT0000890 19150885 Muscle Smooth Vascularrno-miR-222-3p MIMAT0000891 19150885 Muscle Smooth Vascularrno-miR-31a-5p MIMAT0000810 19542014 Muscle Smooth Vascularrno-miR-31a-5p MIMAT0000810 22020941 Muscles bta-miR-29a MIMAT000351817652184 Muscles bta-miR-29c MIMAT0003829 17652184 Muscles cfa-miR-29aMIMAT0006626 17652184 Muscles cfa-miR-29c MIMAT0006705 17652184 Musclesdre-miR-29a MIMAT0001802 17652184 Muscles hsa-miR-1 MIMAT000041621169019 Muscles hsa-miR-1 MIMAT0000416 19506341 Muscles hsa-miR-1MIMAT0000416 19710019 Muscles hsa-miR-125b-5p MIMAT0000423 21200031Muscles hsa-miR-146a-5p MIMAT0000449 21968601 Muscles hsa-miR-150-5pMIMAT0000451 21200031 Muscles hsa-miR-195-5p MIMAT0000461 22802111Muscles hsa-miR-204-5p MIMAT0000265 22871591 Muscles hsa-miR-206MIMAT0000462 19710019 Muscles hsa-miR-21-5p MIMAT0000076 22034194Muscles hsa-miR-22-3p MIMAT0000077 22538858 Muscles hsa-miR-222-3pMIMAT0000279 23447020 Muscles hsa-miR-26a-5p MIMAT0000082 20857419Muscles hsa-miR-29a-3p MIMAT0000086 21169019 Muscles hsa-miR-31-5pMIMAT0000089 23518389 Muscles hsa-miR-378a-3p MIMAT0000732 21471220Muscles hsa-miR-503-5p MIMAT0002874 21220732 Muscles hsa-miR-638MIMAT0003308 23554459 Muscles mmu-miR-100-3p MIMAT0017051 21339483Muscles mmu-miR-100-5p MIMAT0000655 21339483 Muscles mmu-miR-125b-5pMIMAT0000136 21200031 Muscles mmu-miR-128-3p MIMAT0000140 21248104Muscles mmu-miR-130a-3p MIMAT0000141 21753805 Muscles mmu-miR-17-5pMIMAT0000649 21248104 Muscles mmu-miR-206-3p MIMAT0000239 20007902Muscles mmu-miR-29a-3p MIMAT0000535 17652184 Muscles mmu-miR-29b-3pMIMAT0000127 17652184 Muscles mmu-miR-29c-3p MIMAT0000536 17652184Muscles ppy-miR-29a MIMAT0002363 17652184 Muscles ppy-miR-29cMIMAT0015735 17652184 Muscles ptr-miR-29a MIMAT0002364 17652184 Musclesptr-miR-29c MIMAT0008082 17652184 Muscles rno-miR-1-3p MIMAT000312519506341 Muscles rno-miR-146a-5p MIMAT0000852 22735812 Musclesrno-miR-208a-3p MIMAT0000880 21720271 Muscles rno-miR-21-5p MIMAT000079020553627 Muscles rno-miR-29a-3p MIMAT0000802 17652184 Musclesrno-miR-29b-3p MIMAT0000801 17652184 Muscles rno-miR-29c-3p MIMAT000080317652184 Muscles rno-miR-31a-5p MIMAT0000810 22020941 Musclesssc-miR-29a MIMAT0013870 17652184 Muscles ssc-miR-29c MIMAT000216617652184 Muscles xtr-miR-29a MIMAT0003656 17652184 Myelin Sheathmmu-miR-219a-5p MIMAT0000664 20223198 Myelin Sheath mmu-miR-23a-3pMIMAT0000532 19259393 Myelin Sheath mmu-miR-23b-3p MIMAT0000125 19259393Myelin Sheath rno-miR-29a-3p MIMAT0000802 19170179 Myelin Sheathrno-miR-9a-5p MIMAT0000781 18987208 Myeloid Cells hsa-miR-155-5pMIMAT0000646 21036908 Myeloid Cells hsa-miR-155-5p MIMAT0000646 18299402Myeloid Cells hsa-miR-223-3p MIMAT0000280 20029046 Myeloid Cellshsa-miR-92a-3p MIMAT0000092 19608627 Myeloid Cells mmu-miR-92a-3pMIMAT0000539 19608627 Myoblasts hsa-miR-1 MIMAT0000416 20956382Myoblasts hsa-miR-125b-5p MIMAT0000423 21200031 Myoblasts hsa-miR-133bMIMAT0000770 17210790 Myoblasts hsa-miR-150-5p MIMAT0000451 21200031Myoblasts hsa-miR-181a-5p MIMAT0000256 16489342 Myoblasts hsa-miR-206MIMAT0000462 20956382 Myoblasts hsa-miR-221-3p MIMAT0000278 19859555Myoblasts hsa-miR-222-3p MIMAT0000279 19859555 Myoblasts hsa-miR-26a-5pMIMAT0000082 18281287 Myoblasts hsa-miR-31-5p MIMAT0000089 21212803Myoblasts hsa-miR-378a-3p MIMAT0000732 21471220 Myoblastsmmu-miR-125b-5p MIMAT0000136 21200031 Myoblasts mmu-miR-133a-3pMIMAT0000145 16380711 Myoblasts mmu-miR-133a-3p MIMAT0000145 16923828Myoblasts mmu-miR-133b-3p MIMAT0000769 17210790 Myoblasts mmu-miR-137-3pMIMAT0000149 20534588 Myoblasts mmu-miR-137-5p MIMAT0016986 20534588Myoblasts mmu-miR-181a-5p MIMAT0000210 16489342 Myoblasts mmu-miR-1a-3pMIMAT0000123 20819939 Myoblasts mmu-miR-1a-3p MIMAT0000123 16380711Myoblasts mmu-miR-1a-3p MIMAT0000123 16923828 Myoblasts mmu-miR-206-3pMIMAT0000239 21041476 Myoblasts mmu-miR-206-3p MIMAT0000239 20819939Myoblasts mmu-miR-206-3p MIMAT0000239 16923828 Myoblasts mmu-miR-26a-5pMIMAT0000533 18281287 Myoblasts mmu-miR-486-5p MIMAT0003130 21041476Myocardium hsa-miR-1 MIMAT0000416 20081117 Myocardium hsa-miR-1MIMAT0000416 19506341 Myocardium hsa-miR-133a-3p MIMAT0000427 19720047Myocardium hsa-miR-133b MIMAT0000770 19720047 Myocardium hsa-miR-155-5pMIMAT0000646 20550618 Myocardium hsa-miR-499a-5p MIMAT0002870 20081117Myocardium hsa-miR-499b-5p MIMAT0019897 20081117 Myocardium rno-miR-1-3pMIMAT0003125 19506341 Myocardium rno-miR-133a-3p MIMAT0000839 19720047Myocardium rno-miR-133b-3p MIMAT0003126 19720047 Myocardiumrno-miR-31a-5p MIMAT0000810 23270756 Myocardium rno-miR-384-5pMIMAT0005309 23315007 Myocytes Cardiac hsa-miR-1 MIMAT0000416 21051663Myocytes Cardiac hsa-miR-1 MIMAT0000416 15951802 Myocytes Cardiachsa-miR-1 MIMAT0000416 19188439 Myocytes Cardiac hsa-miR-1 MIMAT000041623141496 Myocytes Cardiac hsa-miR-1 MIMAT0000416 20571053 MyocytesCardiac hsa-miR-1 MIMAT0000416 20081117 Myocytes Cardiac hsa-miR-1MIMAT0000416 19506341 Myocytes Cardiac hsa-miR-126-3p MIMAT000044520571053 Myocytes Cardiac hsa-miR-133a-3p MIMAT0000427 19720047 MyocytesCardiac hsa-miR-133a-3p MIMAT0000427 23069713 Myocytes Cardiachsa-miR-133b MIMAT0000770 19720047 Myocytes Cardiac hsa-miR-150-5pMIMAT0000451 23211718 Myocytes Cardiac hsa-miR-208a-3p MIMAT000024117379774 Myocytes Cardiac hsa-miR-21-5p MIMAT0000076 20219857 MyocytesCardiac hsa-miR-223-3p MIMAT0000280 20080987 Myocytes Cardiachsa-miR-27a-3p MIMAT0000084 21149577 Myocytes Cardiac hsa-miR-320aMIMAT0000510 19380620 Myocytes Cardiac hsa-miR-499a-5p MIMAT000287020081117 Myocytes Cardiac hsa-miR-499b-5p MIMAT0019897 20081117 MyocytesCardiac hsa-miR-9-5p MIMAT0000441 19188439 Myocytes Cardiacmmu-miR-130a-3p MIMAT0000141 19582148 Myocytes Cardiac mmu-miR-133a-3pMIMAT0000145 17468766 Myocytes Cardiac mmu-miR-133a-3p MIMAT000014520173049 Myocytes Cardiac mmu-miR-133a-3p MIMAT0000145 19043405 MyocytesCardiac mmu-miR-138-5p MIMAT0000150 19004786 Myocytes Cardiacmmu-miR-15b-5p MIMAT0000124 20007690 Myocytes Cardiac mmu-miR-16-5pMIMAT0000527 20007690 Myocytes Cardiac mmu-miR-195a-5p MIMAT000022520007690 Myocytes Cardiac mmu-miR-195a-5p MIMAT0000225 21622680 MyocytesCardiac mmu-miR-1a-3p MIMAT0000123 19188439 Myocytes Cardiacmmu-miR-1a-3p MIMAT0000123 15951802 Myocytes Cardiac mmu-miR-1a-3pMIMAT0000123 23436819 Myocytes Cardiac mmu-miR-206-3p MIMAT000023919043405 Myocytes Cardiac mmu-miR-208a-3p MIMAT0000520 17379774 MyocytesCardiac mmu-miR-21a-5p MIMAT0000530 20404348 Myocytes Cardiacmmu-miR-21a-5p MIMAT0000530 19043405 Myocytes Cardiac mmu-miR-320-3pMIMAT0000666 19380620 Myocytes Cardiac mmu-miR-322-5p MIMAT000054820007690 Myocytes Cardiac mmu-miR-494-3p MIMAT0003182 20837890 MyocytesCardiac rno-miR-1-3p MIMAT0003125 23436819 Myocytes Cardiac rno-miR-1-3pMIMAT0003125 19188439 Myocytes Cardiac rno-miR-1-3p MIMAT000312519506341 Myocytes Cardiac rno-miR-1-3p MIMAT0003125 18801338 MyocytesCardiac rno-miR-133a-3p MIMAT0000839 19720047 Myocytes Cardiacrno-miR-133b-3p MIMAT0003126 19720047 Myocytes Cardiac rno-miR-15b-5pMIMAT0000784 20007690 Myocytes Cardiac rno-miR-16-5p MIMAT000078520007690 Myocytes Cardiac rno-miR-195-5p MIMAT0000870 20007690 MyocytesCardiac rno-miR-21-5p MIMAT0000790 19706597 Myocytes Cardiacrno-miR-21-5p MIMAT0000790 19336275 Myocytes Cardiac rno-miR-214-3pMIMAT0000885 20007690 Myocytes Cardiac rno-miR-27a-3p MIMAT000079921149577 Myocytes Cardiac rno-miR-322-5p MIMAT0001619 20007690 MyocytesCardiac rno-miR-499-5p MIMAT0003381 21186368 Myocytes Smooth Musclehsa-miR-1 MIMAT0000416 21051663 Myocytes Smooth Muscle hsa-miR-1MIMAT0000416 20458751 Myocytes Smooth Muscle hsa-miR-155-5p MIMAT000064621310411 Myocytes Smooth Muscle hsa-miR-155-5p MIMAT0000646 17588946Myocytes Smooth Muscle hsa-miR-195-5p MIMAT0000461 22802111 MyocytesSmooth Muscle hsa-miR-204-5p MIMAT0000265 22871591 Myocytes SmoothMuscle hsa-miR-21-5p MIMAT0000076 22034194 Myocytes Smooth Musclehsa-miR-21-5p MIMAT0000076 17478730 Myocytes Smooth Muscle hsa-miR-21-5pMIMAT0000076 20693317 Myocytes Smooth Muscle hsa-miR-21-5p MIMAT000007619906824 Myocytes Smooth Muscle hsa-miR-22-3p MIMAT0000077 22538858Myocytes Smooth Muscle hsa-miR-221-3p MIMAT0000278 19088079 MyocytesSmooth Muscle hsa-miR-221-3p MIMAT0000278 19150885 Myocytes SmoothMuscle hsa-miR-222-3p MIMAT0000279 19150885 Myocytes Smooth Musclehsa-miR-25-3p MIMAT0000081 19541842 Myocytes Smooth Musclehsa-miR-26a-5p MIMAT0000082 20857419 Myocytes Smooth Musclehsa-miR-26a-5p MIMAT0000082 20525681 Myocytes Smooth Musclehsa-miR-31-5p MIMAT0000089 23518389 Myocytes Smooth Muscle hsa-miR-638MIMAT0003308 23554459 Myocytes Smooth Muscle mmu-miR-100-3p MIMAT001705121339483 Myocytes Smooth Muscle mmu-miR-100-5p MIMAT0000655 21339483Myocytes Smooth Muscle mmu-miR-10a-3p MIMAT0004659 20118242 MyocytesSmooth Muscle mmu-miR-10a-5p MIMAT0000648 20118242 Myocytes SmoothMuscle mmu-miR-125b-5p MIMAT0000136 20699419 Myocytes Smooth Musclemmu-miR-130a-3p MIMAT0000141 21753805 Myocytes Smooth Musclemmu-miR-143-3p MIMAT0000247 20351064 Myocytes Smooth Musclemmu-miR-143-3p MIMAT0000247 19578358 Myocytes Smooth Musclemmu-miR-143-3p MIMAT0000247 20489207 Myocytes Smooth Musclemmu-miR-145a-5p MIMAT0000157 20351064 Myocytes Smooth Musclemmu-miR-145a-5p MIMAT0000157 19578358 Myocytes Smooth Musclemmu-miR-1a-3p MIMAT0000123 20799856 Myocytes Smooth Musclerno-miR-145-5p MIMAT0000851 19542014 Myocytes Smooth Musclerno-miR-208a-3p MIMAT0000880 21720271 Myocytes Smooth Musclerno-miR-21-5p MIMAT0000790 19158092 Myocytes Smooth Muscle rno-miR-21-5pMIMAT0000790 17478730 Myocytes Smooth Muscle rno-miR-221-3p MIMAT000089019150885 Myocytes Smooth Muscle rno-miR-222-3p MIMAT0000891 19150885Myocytes Smooth Muscle rno-miR-31a-5p MIMAT0000810 19542014 MyocytesSmooth Muscle rno-miR-31a-5p MIMAT0000810 22020941 Myofibroblastshsa-miR-146a-5p MIMAT0000449 21968601 Myofibroblasts mmu-miR-132-3pMIMAT0000144 19843474 Myofibroblasts rno-miR-132-3p MIMAT000083819843474 Myofibroblasts rno-miR-21-5p MIMAT0000790 22565856Myofibroblasts rno-miR-31a-5p MIMAT0000810 23270756 Myometriumhsa-let-7c-5p MIMAT0000064 17243163 Nasopharynx hsa-miR-200a-3pMIMAT0000682 19931509 Neck hsa-miR-101-3p MIMAT0000099 19043531 Neckhsa-miR-125a-5p MIMAT0000443 19179615 Neck hsa-miR-135b-5p MIMAT000075823340180 Neck hsa-miR-138-5p MIMAT0000430 21770894 Neck hsa-miR-15a-5pMIMAT0000068 19117988 Neck hsa-miR-181a-5p MIMAT0000256 21274007 Neckhsa-miR-188-5p MIMAT0000457 19223510 Neck hsa-miR-200c-3p MIMAT000061721294122 Neck hsa-miR-200c-3p MIMAT0000617 19223510 Neck hsa-miR-200c-3pMIMAT0000617 21207483 Neck hsa-miR-203a MIMAT0000264 18483491 Neckhsa-miR-204-5p MIMAT0000265 20369013 Neck hsa-miR-21-5p MIMAT000007618372920 Neck hsa-miR-30c-5p MIMAT0000244 19223510 Neck hsa-miR-30e-5pMIMAT0000692 19223510 Neck hsa-miR-31-3p MIMAT0004504 20145132 Neckhsa-miR-31-5p MIMAT0000089 20145132 Neck hsa-miR-34a-5p MIMAT000025521294122 Neck hsa-miR-34a-5p MIMAT0000255 21240262 Neck hsa-miR-374a-5pMIMAT0000727 21274007 Neck hsa-miR-489-3p MIMAT0002805 20700123 Neckhsa-miR-519a-3p MIMAT0002869 21274007 Neck hsa-miR-630 MIMAT000329921274007 Neck hsa-miR-98-5p MIMAT0000096 17222355 Neck mmu-miR-204-5pMIMAT0000237 20369013 Neck mmu-miR-21a-5p MIMAT0000530 18372920Neoplastic Stem Cells hsa-let-7a-5p MIMAT0000062 19878981 NeoplasticStem Cells hsa-miR-124-3p MIMAT0000422 18577219 Neoplastic Stem Cellshsa-miR-128-3p MIMAT0000424 20574517 Neoplastic Stem Cells hsa-miR-137MIMAT0000429 18577219 Neoplastic Stem Cells hsa-miR-145-5p MIMAT000043721496429 Neoplastic Stem Cells hsa-miR-145-5p MIMAT0000437 20382729Neoplastic Stem Cells hsa-miR-145-5p MIMAT0000437 20668064 NeoplasticStem Cells hsa-miR-153-3p MIMAT0000439 20668064 Neoplastic Stem Cellshsa-miR-16-5p MIMAT0000069 20668064 Neoplastic Stem Cellshsa-miR-181a-5p MIMAT0000256 19585654 Neoplastic Stem Cellshsa-miR-181b-5p MIMAT0000257 19585654 Neoplastic Stem Cellshsa-miR-181c-5p MIMAT0000258 19585654 Neoplastic Stem Cellshsa-miR-181d-5p MIMAT0002821 19585654 Neoplastic Stem Cellshsa-miR-199b-5p MIMAT0000263 23354452 Neoplastic Stem Cellshsa-miR-199b-5p MIMAT0000263 19308264 Neoplastic Stem Cellshsa-miR-200a-3p MIMAT0000682 21529905 Neoplastic Stem Cellshsa-miR-200c-3p MIMAT0000617 19665978 Neoplastic Stem Cellshsa-miR-200c-3p MIMAT0000617 21294122 Neoplastic Stem Cellshsa-miR-200c-3p MIMAT0000617 21207483 Neoplastic Stem Cells hsa-miR-203aMIMAT0000264 20668064 Neoplastic Stem Cells hsa-miR-21-5p MIMAT000007622072622 Neoplastic Stem Cells hsa-miR-21-5p MIMAT0000076 22528454Neoplastic Stem Cells hsa-miR-217 MIMAT0000274 20668064 Neoplastic StemCells hsa-miR-302a-3p MIMAT0000684 21062975 Neoplastic Stem Cellshsa-miR-302b-3p MIMAT0000715 21062975 Neoplastic Stem Cellshsa-miR-302c-3p MIMAT0000717 21062975 Neoplastic Stem Cellshsa-miR-302d-3p MIMAT0000718 21062975 Neoplastic Stem Cellshsa-miR-31-5p MIMAT0000089 21048943 Neoplastic Stem Cells hsa-miR-34a-5pMIMAT0000255 21240262 Neoplastic Stem Cells hsa-miR-34a-5p MIMAT000025521294122 Neoplastic Stem Cells hsa-miR-34a-5p MIMAT0000255 18803879Neoplastic Stem Cells hsa-miR-34b-3p MIMAT0004676 18803879 NeoplasticStem Cells hsa-miR-34b-5p MIMAT0000685 18803879 Neoplastic Stem Cellshsa-miR-34c-5p MIMAT0000686 18803879 Neoplastic Stem Cellsmmu-miR-124-3p MIMAT0000134 18577219 Neoplastic Stem Cellsmmu-miR-137-3p MIMAT0000149 18577219 Neoplastic Stem Cellsmmu-miR-137-5p MIMAT0016986 18577219 Nerve Fibers hsa-miR-7-5pMIMAT0000252 21156648 Nerve Tissue hsa-miR-7-5p MIMAT0000252 21156648Nervous System bta-miR-132 MIMAT0003812 17553428 Nervous Systembta-miR-219 MIMAT0030444 17553428 Nervous System cfa-miR-132MIMAT0006732 17553428 Nervous System dre-miR-219 MIMAT0001286 17553428Nervous System hsa-miR-1 MIMAT0000416 21169019 Nervous Systemhsa-miR-124-3p MIMAT0000422 18577219 Nervous System hsa-miR-124-3pMIMAT0000422 23318130 Nervous System hsa-miR-125a-5p MIMAT000044321220473 Nervous System hsa-miR-128-3p MIMAT0000424 21143953 NervousSystem hsa-miR-133b MIMAT0000770 17761882 Nervous System hsa-miR-137MIMAT0000429 18577219 Nervous System hsa-miR-145-5p MIMAT000043721276775 Nervous System hsa-miR-151a-3p MIMAT0000757 21143953 NervousSystem hsa-miR-152-3p MIMAT0000438 20841484 Nervous System hsa-miR-184MIMAT0000454 20409325 Nervous System hsa-miR-185-5p MIMAT000045521143953 Nervous System hsa-miR-18a-5p MIMAT0000072 20080637 NervousSystem hsa-miR-19a-3p MIMAT0000073 20080637 Nervous Systemhsa-miR-19b-3p MIMAT0000074 20435064 Nervous System hsa-miR-214-3pMIMAT0000271 21276775 Nervous System hsa-miR-29a-3p MIMAT000008619584290 Nervous System hsa-miR-29a-3p MIMAT0000086 21169019 NervousSystem hsa-miR-302b-5p MIMAT0000714 20435064 Nervous Systemhsa-miR-323a-3p MIMAT0000755 20435064 Nervous System hsa-miR-326MIMAT0000756 19955368 Nervous System hsa-miR-34a-5p MIMAT000025521266077 Nervous System hsa-miR-509-3p MIMAT0002881 21143953 NervousSystem mml-miR-219 MIMAT0002575 17553428 Nervous System mmu-miR-124-3pMIMAT0000134 18577219 Nervous System mmu-miR-124-3p MIMAT000013417679093 Nervous System mmu-miR-124-3p MIMAT0000134 21131957 NervousSystem mmu-miR-124-3p MIMAT0000134 18619591 Nervous Systemmmu-miR-132-3p MIMAT0000144 17553428 Nervous System mmu-miR-134-5pMIMAT0000146 20622856 Nervous System mmu-miR-137-3p MIMAT000014918577219 Nervous System mmu-miR-137-5p MIMAT0016986 18577219 NervousSystem mmu-miR-155-5p MIMAT0000165 21247879 Nervous Systemmmu-miR-219a-5p MIMAT0000664 17553428 Nervous System mmu-miR-23a-3pMIMAT0000532 19259393 Nervous System mmu-miR-23b-3p MIMAT000012519259393 Nervous System mmu-miR-298-5p MIMAT0000376 21247879 NervousSystem mmu-miR-29b-3p MIMAT0000127 21245165 Nervous Systemmmu-miR-351-5p MIMAT0000609 21247879 Nervous System mmu-miR-9-5pMIMAT0000142 21238922 Nervous System ppy-miR-132 MIMAT0015755 17553428Nervous System ppy-miR-219 MIMAT0002577 17553428 Nervous Systemrno-miR-134-5p MIMAT0000840 16421561 Nervous System rno-miR-140-3pMIMAT0000574 18845019 Nervous System rno-miR-34a-5p MIMAT000081518704095 Nervous System ssc-miR-132 MIMAT0025361 17553428 Nervous Systemssc-miR-219 MIMAT0020590 17553428 Nervous System xtr-miR-132MIMAT0003594 17553428 Nervous System xtr-miR-219 MIMAT0003632 17553428Neural Crest hsa-miR-18a-5p MIMAT0000072 20080637 Neural Cresthsa-miR-19a-3p MIMAT0000073 20080637 Neural Crest mmu-miR-143-3pMIMAT0000247 19578358 Neural Crest mmu-miR-145a-5p MIMAT0000157 19578358Neural Plate hsa-miR-302a-3p MIMAT0000684 19386261 Neural Stem Cellshsa-let-7b-5p MIMAT0000063 20133835 Neural Stem Cells hsa-miR-124-3pMIMAT0000422 18577219 Neural Stem Cells hsa-miR-128-3p MIMAT000042419010882 Neural Stem Cells hsa-miR-137 MIMAT0000429 18577219 Neural StemCells hsa-miR-9-5p MIMAT0000441 19330006 Neural Stem Cells mmu-let-7b-5pMIMAT0000522 20133835 Neural Stem Cells mmu-miR-124-3p MIMAT000013418577219 Neural Stem Cells mmu-miR-137-3p MIMAT0000149 20368621 NeuralStem Cells mmu-miR-137-3p MIMAT0000149 18577219 Neural Stem Cellsmmu-miR-137-5p MIMAT0016986 18577219 Neural Stem Cells mmu-miR-146a-5pMIMAT0000158 21730286 Neurites hsa-miR-141-3p MIMAT0000432 20584986Neurites hsa-miR-145-5p MIMAT0000437 21276775 Neurites hsa-miR-18a-5pMIMAT0000072 20080637 Neurites hsa-miR-19a-3p MIMAT0000073 20080637Neurites hsa-miR-205-5p MIMAT0000266 23125283 Neurites hsa-miR-21-5pMIMAT0000076 20584986 Neurites hsa-miR-214-3p MIMAT0000271 21276775Neurites hsa-miR-375 MIMAT0000728 20584986 Neurites mmu-miR-141-3pMIMAT0000153 20584986 Neurites mmu-miR-205-5p MIMAT0000238 23125283Neurites mmu-miR-375-3p MIMAT0000739 20584986 Neurites rno-miR-141-3pMIMAT0000846 20584986 Neurites rno-miR-21-5p MIMAT0000790 20584986Neuroendocrine Cells mmu-miR-17-5p MIMAT0000649 17765889 NeurofibrillaryTangles mmu-miR-135a-5p MIMAT0000147 20619502 Neurofibrillary Tanglesmmu-miR-16-5p MIMAT0000527 20619502 Neurofibrillary Tanglesmmu-miR-195a-5p MIMAT0000225 22721728 Neurofibrillary Tanglesmmu-miR-20a-5p MIMAT0000529 20619502 Neuroglia hsa-miR-125b-5pMIMAT0000423 20347935 Neuroglia mmu-miR-155-5p MIMAT0000165 21247879Neuroglia mmu-miR-298-5p MIMAT0000376 21247879 Neuroglia mmu-miR-351-5pMIMAT0000609 21247879 Neurons hsa-let-7a-5p MIMAT0000062 19110058Neurons hsa-let-7d-5p MIMAT0000065 19110058 Neurons hsa-miR-101-3pMIMAT0000099 20395292 Neurons hsa-miR-101-3p MIMAT0000099 21172309Neurons hsa-miR-106a-5p MIMAT0000103 19110058 Neurons hsa-miR-106b-5pMIMAT0000680 19110058 Neurons hsa-miR-107 MIMAT0000104 20489155 Neuronshsa-miR-10a-5p MIMAT0000253 20506192 Neurons hsa-miR-124-3p MIMAT000042223318130 Neurons hsa-miR-125a-5p MIMAT0000443 16227573 Neuronshsa-miR-125b-5p MIMAT0000423 20159450 Neurons hsa-miR-125b-5pMIMAT0000423 16227573 Neurons hsa-miR-128-3p MIMAT0000424 21143953Neurons hsa-miR-130a-3p MIMAT0000425 19110058 Neurons hsa-miR-132-3pMIMAT0000426 18577589 Neurons hsa-miR-132-3p MIMAT0000426 18082412Neurons hsa-miR-133b MIMAT0000770 19695767 Neurons hsa-miR-133bMIMAT0000770 17761882 Neurons hsa-miR-137 MIMAT0000429 22003227 Neuronshsa-miR-145-5p MIMAT0000437 21276775 Neurons hsa-miR-151a-3pMIMAT0000757 21143953 Neurons hsa-miR-15a-5p MIMAT0000068 19110058Neurons hsa-miR-17-5p MIMAT0000070 19110058 Neurons hsa-miR-185-5pMIMAT0000455 21143953 Neurons hsa-miR-205-5p MIMAT0000266 23125283Neurons hsa-miR-20a-5p MIMAT0000075 19110058 Neurons hsa-miR-21-5pMIMAT0000076 21170291 Neurons hsa-miR-214-3p MIMAT0000271 21276775Neurons hsa-miR-30a-5p MIMAT0000087 18632683 Neurons hsa-miR-509-3pMIMAT0002881 21143953 Neurons hsa-miR-7-5p MIMAT0000252 19628698 Neuronshsa-miR-9-3p MIMAT0000442 19118166 Neurons hsa-miR-9-5p MIMAT000044119118166 Neurons mmu-miR-124-3p MIMAT0000134 19287386 Neuronsmmu-miR-124-3p MIMAT0000134 17679093 Neurons mmu-miR-124-3p MIMAT000013418619591 Neurons mmu-miR-125b-5p MIMAT0000136 16227573 Neuronsmmu-miR-134-5p MIMAT0000146 20126250 Neurons mmu-miR-16-5p MIMAT000052720847275 Neurons mmu-miR-205-5p MIMAT0000238 23125283 Neuronsmmu-miR-206-3p MIMAT0000239 20007902 Neurons mmu-miR-29b-3p MIMAT000012721245165 Neurons mmu-miR-9-5p MIMAT0000142 21238922 Neurons rno-miR-1-3pMIMAT0003125 16260724 Neurons rno-miR-132-3p MIMAT0000838 17994015Neurons rno-miR-132-3p MIMAT0000838 19958814 Neurons rno-miR-132-3pMIMAT0000838 16260724 Neurons rno-miR-133b-3p MIMAT0003126 19695767Neurons rno-miR-134-5p MIMAT0000840 16421561 Neurons rno-miR-134-5pMIMAT0000840 19197241 Neurons rno-miR-181a-5p MIMAT0000858 22144581Neurons rno-miR-21-5p MIMAT0000790 20840605 Neurons rno-miR-338-3pMIMAT0000581 19020050 Neurons rno-miR-92a-3p MIMAT0000816 20050974Neutrophils hsa-miR-146a-5p MIMAT0000449 20375304 Neutrophilshsa-miR-155-5p MIMAT0000646 19289835 Neutrophils hsa-miR-223-3pMIMAT0000280 18278031 Neutrophils hsa-miR-9-5p MIMAT0000441 19289835Neutrophils mmu-miR-223-3p MIMAT0000665 18278031 NIH 3T3 Cellsmmu-miR-298-5p MIMAT0000376 18986979 NIH 3T3 Cells mmu-miR-328-3pMIMAT0000565 18986979 NIH 3T3 Cells rno-miR-335 MIMAT0000575 20933506Nuclear Envelope mmu-miR-23a-3p MIMAT0000532 19259393 Nuclear Envelopemmu-miR-23b-3p MIMAT0000125 19259393 Nuclear Envelope mmu-miR-31-5pMIMAT0000538 20081371 Nuclear Lamina mmu-miR-31-5p MIMAT0000538 20081371Nuclear Pore mmu-miR-23a-3p MIMAT0000532 19259393 Nuclear Poremmu-miR-23b-3p MIMAT0000125 19259393 Nucleus Accumbens rno-miR-181a-5pMIMAT0000858 22144581 Odontoblasts hsa-miR-338-3p MIMAT0000763 23380982Oligodendroglia hsa-miR-122-5p MIMAT0000421 23348614 Oligodendrogliahsa-miR-206 MIMAT0000462 19606501 Oligodendroglia mmu-miR-206-3pMIMAT0000239 19606501 Oligodendroglia mmu-miR-219a-5p MIMAT000066420223197 Oligodendroglia mmu-miR-219a-5p MIMAT0000664 20223198Oligodendroglia mmu-miR-23a-3p MIMAT0000532 19259393 Oligodendrogliammu-miR-23b-3p MIMAT0000125 19259393 Oligodendroglia rno-miR-206-3pMIMAT0000879 19606501 Oligodendroglia rno-miR-9a-5p MIMAT000078118987208 Oocytes hsa-miR-224-5p MIMAT0000281 20118412 Oocyteshsa-miR-302b-3p MIMAT0000715 19342891 Oocytes mmu-miR-503-5pMIMAT0003188 19799966 Organelles hsa-miR-320a MIMAT0000510 18523662Osteoblasts hsa-miR-125a-5p MIMAT0000443 19011087 Osteoblastshsa-miR-125b-5p MIMAT0000423 19011087 Osteoblasts hsa-miR-199a-5pMIMAT0000231 19011087 Osteoblasts hsa-miR-199a-5p MIMAT0000231 22441842Osteoblasts hsa-miR-26a-5p MIMAT0000082 18197755 Osteoblastshsa-miR-26a-5p MIMAT0000082 19011087 Osteoblasts hsa-miR-29b-3pMIMAT0000100 23478036 Osteoblasts hsa-miR-30c-5p MIMAT0000244 23469762Osteoblasts hsa-miR-346 MIMAT0000773 19011087 Osteoblasts hsa-miR-34b-3pMIMAT0004676 22498974 Osteoblasts hsa-miR-34c-5p MIMAT0000686 22498974Osteoblasts hsa-miR-433-3p MIMAT0001627 23353875 Osteoblasts hsa-miR-637MIMAT0003307 21880893 Osteoblasts mmu-miR-206-3p MIMAT0000239 19933329Osteoblasts mmu-miR-2861 MIMAT0013803 19920351 Osteoblastsmmu-miR-370-3p MIMAT0001095 22587915 Osteoblasts mmu-miR-3960MIMAT0019336 21324897 Osteoclasts hsa-miR-148b-3p MIMAT0000759 23238785Osteoclasts hsa-miR-34b-3p MIMAT0004676 22498974 Osteoclastshsa-miR-34c-5p MIMAT0000686 22498974 Ovary hsa-miR-101-3p MIMAT000009917875710 Ovary hsa-miR-125a-5p MIMAT0000443 21220473 Ovaryhsa-miR-140-5p MIMAT0000431 17875710 Ovary hsa-miR-141-3p MIMAT000043219854497 Ovary hsa-miR-141-3p MIMAT0000432 17875710 Ovary hsa-miR-143-3pMIMAT0000435 17875710 Ovary hsa-miR-199a-5p MIMAT0000231 17875710 Ovaryhsa-miR-200a-3p MIMAT0000682 17875710 Ovary hsa-miR-200a-3p MIMAT000068219854497 Ovary hsa-miR-200b-3p MIMAT0000318 17875710 Ovaryhsa-miR-200b-3p MIMAT0000318 19854497 Ovary hsa-miR-200c-3p MIMAT000061717875710 Ovary hsa-miR-200c-3p MIMAT0000617 19854497 Ovaryhsa-miR-212-3p MIMAT0000269 17875710 Ovary hsa-miR-29c-3p MIMAT000068121436257 Ovary hsa-miR-429 MIMAT0001536 19854497 Ovary hsa-miR-9-5pMIMAT0000441 19702828 Ovary mmu-miR-466h-5p MIMAT0004884 21337326 Ovarymmu-miR-503-5p MIMAT0003188 19799966 Palate hsa-miR-140-5p MIMAT000043122012839 Pancreas hsa-miR-143-3p MIMAT0000435 16966691 Pancreashsa-miR-182-5p MIMAT0000259 19569050 Pancreas hsa-miR-194-5pMIMAT0000460 19569050 Pancreas hsa-miR-197-3p MIMAT0000227 23139153Pancreas hsa-miR-200b-3p MIMAT0000318 19569050 Pancreas hsa-miR-200c-3pMIMAT0000617 19569050 Pancreas hsa-miR-21-5p MIMAT0000076 18372920Pancreas hsa-miR-21-5p MIMAT0000076 16966691 Pancreas hsa-miR-26b-5pMIMAT0000083 19569050 Pancreas hsa-miR-298 MIMAT0004901 18642050Pancreas hsa-miR-30a-5p MIMAT0000087 23338554 Pancreas hsa-miR-34a-5pMIMAT0000255 21240262 Pancreas hsa-miR-374a-5p MIMAT0000727 19569050Pancreas hsa-miR-429 MIMAT0001536 19569050 Pancreas hsa-miR-520hMIMAT0002867 20628378 Pancreas mmu-miR-124-3p MIMAT0000134 17462994Pancreas mmu-miR-19b-3p MIMAT0000513 21781967 Pancreas mmu-miR-21a-5pMIMAT0000530 18372920 Pancreatic Ducts hsa-miR-146a-5p MIMAT000044920124483 PC12 Cells hsa-miR-15a-5p MIMAT0000068 20621999 PC12 Cellshsa-miR-16-5p MIMAT0000069 20621999 PC12 Cells hsa-miR-221-3pMIMAT0000278 19438724 PC12 Cells hsa-miR-222-3p MIMAT0000279 19438724PC12 Cells rno-miR-140-3p MIMAT0000574 18845019 PC12 Cellsrno-miR-221-3p MIMAT0000890 19438724 PC12 Cells rno-miR-222-3pMIMAT0000891 19438724 Pericardium rno-miR-31a-5p MIMAT0000810 23270756Philadelphia Chromosome hsa-miR-203a MIMAT0000264 18538733 PhotoreceptorCells hsa-miR-182-5p MIMAT0000259 17597072 Vertebrate PhotoreceptorCells hsa-miR-96-5p MIMAT0000095 17597072 Vertebrate Placentahsa-miR-106a-5p MIMAT0000103 23438603 Placenta hsa-miR-125b-5pMIMAT0000423 21703189 Placenta hsa-miR-155-5p MIMAT0000646 20452491Placenta hsa-miR-195-5p MIMAT0000461 20952681 Placenta hsa-miR-19b-3pMIMAT0000074 23438603 Plasma hsa-let-7a-5p MIMAT0000062 19939273 Plasmahsa-let-7c-3p MIMAT0026472 19939273 Plasma hsa-let-7c-5p MIMAT000006419939273 Plasma hsa-let-7d-3p MIMAT0004484 19939273 Plasma hsa-let-7d-5pMIMAT0000065 19939273 Plasma hsa-let-7e-3p MIMAT0004485 19939273 Plasmahsa-let-7e-5p MIMAT0000066 19939273 Plasma hsa-let-7g-3p MIMAT000458419939273 Plasma hsa-let-7g-5p MIMAT0000414 19939273 Plasma hsa-let-7i-3pMIMAT0004585 19939273 Plasma hsa-let-7i-5p MIMAT0000415 19939273 Plasmahsa-miR-1 MIMAT0000416 23141496 Plasma hsa-miR-106a-5p MIMAT000010320385818 Plasma hsa-miR-106b-5p MIMAT0000680 20385818 Plasmahsa-miR-106b-5p MIMAT0000680 18728182 Plasma hsa-miR-122-5p MIMAT000042116459310 Plasma hsa-miR-125b-5p MIMAT0000423 20497960 Plasmahsa-miR-145-5p MIMAT0000437 23201159 Plasma hsa-miR-181a-5p MIMAT000025618728182 Plasma hsa-miR-181b-5p MIMAT0000257 18728182 Plasmahsa-miR-19a-3p MIMAT0000073 18728182 Plasma hsa-miR-19b-3p MIMAT000007418728182 Plasma hsa-miR-221-3p MIMAT0000278 21487968 Plasmahsa-miR-25-3p MIMAT0000081 18728182 Plasma hsa-miR-32-5p MIMAT000009018728182 Plasma hsa-miR-33a-5p MIMAT0000091 20466882 Plasmahsa-miR-33a-5p MIMAT0000091 20466885 Plasma hsa-miR-33b-5p MIMAT000330120466882 Plasma hsa-miR-503-5p MIMAT0002874 21220732 Plasmahsa-miR-92a-3p MIMAT0000092 18728182 Plasma hsa-miR-93-5p MIMAT000009318728182 Plasma mmu-miR-122-5p MIMAT0000246 21364282 Plasmammu-miR-122-5p MIMAT0000246 16459310 Plasma mmu-miR-122-5p MIMAT000024618158304 Plasma mmu-miR-122-5p MIMAT0000246 16258535 Plasmammu-miR-155-5p MIMAT0000165 18055230 Plasma mmu-miR-33-5p MIMAT000066720466885 Plasma Cells hsa-miR-106b-5p MIMAT0000680 18728182 Plasma Cellshsa-miR-125b-5p MIMAT0000423 20497960 Plasma Cells hsa-miR-181a-5pMIMAT0000256 18728182 Plasma Cells hsa-miR-181b-5p MIMAT0000257 18728182Plasma Cells hsa-miR-19a-3p MIMAT0000073 18728182 Plasma Cellshsa-miR-19b-3p MIMAT0000074 18728182 Plasma Cells hsa-miR-25-3pMIMAT0000081 18728182 Plasma Cells hsa-miR-32-5p MIMAT0000090 18728182Plasma Cells hsa-miR-92a-3p MIMAT0000092 18728182 Plasma Cellshsa-miR-93-5p MIMAT0000093 18728182 Pluripotent Stem Cellshsa-miR-124-3p MIMAT0000422 20362537 Pluripotent Stem Cellshsa-miR-302a-3p MIMAT0000684 21062975 Pluripotent Stem Cellshsa-miR-302a-3p MIMAT0000684 23185040 Pluripotent Stem Cellshsa-miR-302b-3p MIMAT0000715 21062975 Pluripotent Stem Cellshsa-miR-302b-3p MIMAT0000715 23185040 Pluripotent Stem Cellshsa-miR-302c-3p MIMAT0000717 21062975 Pluripotent Stem Cellshsa-miR-302c-3p MIMAT0000717 23185040 Pluripotent Stem Cellshsa-miR-302d-3p MIMAT0000718 21062975 Pluripotent Stem Cellshsa-miR-302d-3p MIMAT0000718 23185040 Pluripotent Stem Cellshsa-miR-9-5p MIMAT0000441 20362537 Pluripotent Stem Cells mmu-let-7c-5pMIMAT0000523 20054295 Pluripotent Stem Cells mmu-miR-106b-5pMIMAT0000386 21285944 Pluripotent Stem Cells mmu-miR-9-5p MIMAT000014220362537 Pluripotent Stem Cells mmu-miR-93-5p MIMAT0000540 21285944Podocytes mmu-miR-29c-3p MIMAT0000536 21310958 Podocytes rno-miR-192-5pMIMAT0000867 20393144 Podocytes rno-miR-215 MIMAT0003118 20393144Polyribosomes hsa-miR-122-5p MIMAT0000421 16777601 Polyribosomeshsa-miR-30a-3p MIMAT0000088 16239240 Polyribosomes hsa-miR-519a-3pMIMAT0002869 19088191 Polyribosomes hsa-miR-519b-3p MIMAT000283719088191 Polyribosomes hsa-miR-519c-3p MIMAT0002832 19088191Polyribosomes mmu-miR-23b-3p MIMAT0000125 18716031 Portal Veinhsa-miR-328-3p MIMAT0000752 18560585 Portal Vein hsa-miR-328-5pMIMAT0026486 18560585 Precursor Cells T-Lymphoid hsa-miR-222-3pMIMAT0000279 23522449 Prefrontal Cortex hsa-miR-219a-5p MIMAT000027619196972 Prefrontal Cortex hsa-miR-30a-5p MIMAT0000087 18632683Prefrontal Cortex mmu-miR-219a-5p MIMAT0000664 19196972 PrefrontalCortex rno-let-7d-5p MIMAT0000562 20557304 Prosencephalon hsa-miR-132-3pMIMAT0000426 18082412 Prosencephalon mmu-miR-9-5p MIMAT0000142 21238922Prostate hsa-let-7a-5p MIMAT0000062 20418948 Prostate hsa-miR-101-3pMIMAT0000099 20478051 Prostate hsa-miR-101-3p MIMAT0000099 19008416Prostate hsa-miR-106a-5p MIMAT0000103 16461460 Prostate hsa-miR-106b-5pMIMAT0000680 18676839 Prostate hsa-miR-107 MIMAT0000104 20884628Prostate hsa-miR-122-5p MIMAT0000421 20884628 Prostate hsa-miR-125b-5pMIMAT0000423 17891175 Prostate hsa-miR-125b-5p MIMAT0000423 18056640Prostate hsa-miR-126-3p MIMAT0000445 18193184 Prostate hsa-miR-126-5pMIMAT0000444 18193184 Prostate hsa-miR-1296-5p MIMAT0005794 20332239Prostate hsa-miR-138-5p MIMAT0000430 18193184 Prostate hsa-miR-141-3pMIMAT0000432 21224847 Prostate hsa-miR-143-3p MIMAT0000435 20353999Prostate hsa-miR-145-5p MIMAT0000437 23355420 Prostate hsa-miR-145-5pMIMAT0000437 23480797 Prostate hsa-miR-145-5p MIMAT0000437 21360565Prostate hsa-miR-145-5p MIMAT0000437 20353999 Prostate hsa-miR-145-5pMIMAT0000437 19996289 Prostate hsa-miR-146a-5p MIMAT0000449 18174313Prostate hsa-miR-146a-5p MIMAT0000449 22161865 Prostate hsa-miR-16-5pMIMAT0000069 19738602 Prostate hsa-miR-17-3p MIMAT0000071 19771525Prostate hsa-miR-17-3p MIMAT0000071 21203553 Prostate hsa-miR-17-5pMIMAT0000070 19771525 Prostate hsa-miR-182-5p MIMAT0000259 19574223Prostate hsa-miR-185-5p MIMAT0000455 23417242 Prostate hsa-miR-199b-5pMIMAT0000263 23354452 Prostate hsa-miR-200c-3p MIMAT0000617 21224847Prostate hsa-miR-205-5p MIMAT0000266 20737563 Prostate hsa-miR-20a-5pMIMAT0000075 16461460 Prostate hsa-miR-21-5p MIMAT0000076 21317927Prostate hsa-miR-21-5p MIMAT0000076 19302977 Prostate hsa-miR-21-5pMIMAT0000076 20813833 Prostate hsa-miR-21-5p MIMAT0000076 21826097Prostate hsa-miR-21-5p MIMAT0000076 18372920 Prostate hsa-miR-21-5pMIMAT0000076 19578724 Prostate hsa-miR-211-5p MIMAT0000268 21072171Prostate hsa-miR-217 MIMAT0000274 19008416 Prostate hsa-miR-221-3pMIMAT0000278 18834855 Prostate hsa-miR-221-3p MIMAT0000278 21487968Prostate hsa-miR-224-5p MIMAT0000281 20180642 Prostate hsa-miR-26a-5pMIMAT0000082 16461460 Prostate hsa-miR-26a-5p MIMAT0000082 20478051Prostate hsa-miR-27a-3p MIMAT0000084 19574223 Prostate hsa-miR-29b-3pMIMAT0000100 20657750 Prostate hsa-miR-32-5p MIMAT0000090 18676839Prostate hsa-miR-330-3p MIMAT0000751 19597470 Prostate hsa-miR-331-3pMIMAT0000760 19996289 Prostate hsa-miR-34a-5p MIMAT0000255 20433755Prostate hsa-miR-34a-5p MIMAT0000255 21240262 Prostate hsa-miR-34a-5pMIMAT0000255 18834855 Prostate hsa-miR-377-3p MIMAT0000730 21203553Prostate hsa-miR-449a MIMAT0001541 19252524 Prostate hsa-miR-449aMIMAT0001541 20948989 Prostate hsa-miR-521 MIMAT0002854 18668526Prostate hsa-miR-616-3p MIMAT0004805 21224345 Prostate hsa-miR-616-5pMIMAT0003284 21224345 Prostate hsa-miR-96-5p MIMAT0000095 19574223Prostate mmu-miR-21a-5p MIMAT0000530 18372920 Pseudopodia hsa-miR-10b-5pMIMAT0000254 22573479 Pseudopodia hsa-miR-124-3p MIMAT0000422 21672940Pulmonary Artery hsa-miR-21-5p MIMAT0000076 20693317 Raphe Nucleimmu-miR-16-5p MIMAT0000527 20847275 Reed-Sternberg Cells hsa-let-7a-5pMIMAT0000062 18583325 Reed-Sternberg Cells hsa-miR-9-5p MIMAT000044118583325 Reticulocytes hsa-miR-320a MIMAT0000510 18523662 Retinahsa-miR-124-3p MIMAT0000422 17724173 Retina hsa-miR-182-5p MIMAT000025917597072 Retina hsa-miR-204-5p MIMAT0000265 20056717 Retinahsa-miR-204-5p MIMAT0000265 20713703 Retina hsa-miR-21-5p MIMAT000007620056717 Retina hsa-miR-29a-3p MIMAT0000086 17724173 Retinahsa-miR-29b-3p MIMAT0000100 17724173 Retina hsa-miR-96-5p MIMAT000009517597072 Retina mmu-miR-150-5p MIMAT0000160 18500251 Retinammu-miR-184-3p MIMAT0000213 18500251 Retina mmu-miR-31-5p MIMAT000053818500251 Retinal Pigment Epithelium hsa-miR-204-5p MIMAT0000265 20056717Retinal Pigment Epithelium hsa-miR-21-5p MIMAT0000076 20056717Rhombencephalon mmu-miR-9-5p MIMAT0000142 21238922 Saphenous Veinhsa-miR-503-5p MIMAT0002874 21220732 Sarcolemma hsa-miR-206 MIMAT000046217030984 Sarcolemma mmu-miR-206-3p MIMAT0000239 17030984 Sarcomereshsa-miR-21-5p MIMAT0000076 18508928 Sarcomeres mmu-miR-21a-5pMIMAT0000530 18508928 Sarcoplasmic Reticulum hsa-miR-1 MIMAT000041619131648 Satellite Cells Skeletal mmu-miR-1a-3p MIMAT0000123 20819939Muscle Satellite Cells Skeletal mmu-miR-206-3p MIMAT0000239 20819939Muscle Schwann Cells hsa-miR-10b-5p MIMAT0000254 20550523 Schwann Cellshsa-miR-7-5p MIMAT0000252 21156648 Schwann Cells rno-miR-29a-3pMIMAT0000802 19170179 Schwann Cells rno-miR-9a-5p MIMAT0000781 18987208Sciatic Nerve hsa-miR-145-5p MIMAT0000437 21276775 Sciatic Nervehsa-miR-214-3p MIMAT0000271 21276775 Secretory Vesicles hsa-miR-9-5pMIMAT0000441 16831872 Secretory Vesicles rno-miR-9a-5p MIMAT000078116831872 Serum hsa-miR-1 MIMAT0000416 20458751 Serum hsa-miR-1MIMAT0000416 19775284 Serum hsa-miR-1 MIMAT0000416 15951802 Serumhsa-miR-101-3p MIMAT0000099 19155302 Serum hsa-miR-122-5p MIMAT000042120351063 Serum hsa-miR-122-5p MIMAT0000421 19726678 Serumhsa-miR-130a-3p MIMAT0000425 17957028 Serum hsa-miR-132-3p MIMAT000042619819989 Serum hsa-miR-133a-3p MIMAT0000427 17344217 Serum hsa-miR-133bMIMAT0000770 17344217 Serum hsa-miR-181a-5p MIMAT0000256 22476949 Serumhsa-miR-200b-3p MIMAT0000318 22144583 Serum hsa-miR-206 MIMAT000046219620785 Serum hsa-miR-21-5p MIMAT0000076 21347332 Serum hsa-miR-21-5pMIMAT0000076 22956424 Serum hsa-miR-21-5p MIMAT0000076 19826040 Serumhsa-miR-221-3p MIMAT0000278 20516212 Serum hsa-miR-221-3p MIMAT000027818413744 Serum hsa-miR-222-3p MIMAT0000279 18413744 Serum hsa-miR-26a-5pMIMAT0000082 20857419 Serum hsa-miR-29a-3p MIMAT0000086 20041405 Serumhsa-miR-29b-3p MIMAT0000100 20041405 Serum hsa-miR-29c-3p MIMAT000068120041405 Serum hsa-miR-31-5p MIMAT0000089 23518389 Serum hsa-miR-422aMIMAT0001339 20351063 Serum mmu-let-7c-5p MIMAT0000523 17438130 Serummmu-miR-133a-3p MIMAT0000145 16380711 Serum mmu-miR-133a-3p MIMAT000014516923828 Serum mmu-miR-143-3p MIMAT0000247 19578358 Serummmu-miR-145a-5p MIMAT0000157 19578358 Serum mmu-miR-1a-3p MIMAT000012315951802 Serum mmu-miR-1a-3p MIMAT0000123 16380711 Serum mmu-miR-1a-3pMIMAT0000123 16923828 Serum mmu-miR-206-3p MIMAT0000239 16923828 Serummmu-miR-486-5p MIMAT0003130 20142475 Serum rno-miR-1-3p MIMAT000312519775284 Serum rno-miR-200c-3p MIMAT0000873 22144583 Side-PopulationCells hsa-miR-520h MIMAT0002867 20628378 Skin hsa-miR-125b-5pMIMAT0000423 21412257 Skin hsa-miR-155-5p MIMAT0000646 20673989 Skinhsa-miR-193b-3p MIMAT0002819 20304954 Skin hsa-miR-200a-3p MIMAT000068220827281 Skin hsa-miR-203a MIMAT0000264 18483491 Skin hsa-miR-203aMIMAT0000264 17622355 Skin hsa-miR-203a MIMAT0000264 20827281 Skinhsa-miR-203a MIMAT0000264 22917968 Skin hsa-miR-203a MIMAT000026418311128 Skin hsa-miR-21-5p MIMAT0000076 19672202 Skin hsa-miR-224-5pMIMAT0000281 20827281 Skin hsa-miR-26a-5p MIMAT0000082 20827281 Skinhsa-miR-27b-3p MIMAT0000419 20827281 Skin hsa-miR-29a-3p MIMAT000008620201077 Skin hsa-miR-29b-3p MIMAT0000100 20201077 Skin hsa-miR-302b-3pMIMAT0000715 19342891 Skin hsa-miR-31-5p MIMAT0000089 23233723 Skinhsa-miR-335-5p MIMAT0000765 21164520 Skin hsa-miR-424-5p MIMAT000134121179471 Skin hsa-miR-433-3p MIMAT0001627 20181727 Skin hsa-miR-532-5pMIMAT0002888 19336521 Skin mmu-miR-122-5p MIMAT0000246 16258535 Skinmmu-miR-203-3p MIMAT0000236 18311128 Skin mmu-miR-31-5p MIMAT000053820522784 Somites mmu-miR-137-3p MIMAT0000149 21256124 Somitesmmu-miR-153-3p MIMAT0000163 21256124 Somites mmu-miR-363-3p MIMAT000070821256124 Spheroids Cellular hsa-miR-299-5p MIMAT0002890 19538464 SpinalCord hsa-miR-124-3p MIMAT0000422 17403776 Spinal Cord hsa-miR-124-3pMIMAT0000422 23318130 Spinal Cord hsa-miR-128-3p MIMAT0000424 17403776Spinal Cord mmu-miR-124-3p MIMAT0000134 17403776 Spinal Cordmmu-miR-219a-5p MIMAT0000664 20223198 Spinal Nerve Roots hsa-miR-145-5pMIMAT0000437 21276775 Spinal Nerve Roots hsa-miR-214-3p MIMAT000027121276775 Spine hsa-miR-10a-5p MIMAT0000253 20506192 Spinehsa-miR-125b-5p MIMAT0000423 20159450 Spine hsa-miR-132-3p MIMAT000042619850129 Spine mmu-miR-134-5p MIMAT0000146 20126250 Spine mmu-miR-140-5pMIMAT0000151 16828749 Spine rno-miR-134-5p MIMAT0000840 16421561 Spinerno-miR-181a-5p MIMAT0000858 22144581 Spleen hsa-miR-34a-5p MIMAT000025520627091 Spleen hsa-miR-7-5p MIMAT0000252 18823940 Spleen mmu-miR-122-5pMIMAT0000246 21364282 Spleen mmu-miR-125b-5p MIMAT0000136 21118986 StemCell Niche mmu-miR-124-3p MIMAT0000134 19287386 Stem Cells bta-miR-130aMIMAT0009223 17855557 Stem Cells bta-miR-335 MIMAT0009291 18185580 StemCells cfa-miR-130a MIMAT0006631 17855557 Stem Cells cfa-miR-335MIMAT0006624 18185580 Stem Cells dre-miR-130a MIMAT0001826 17855557 StemCells hsa-let-7a-5p MIMAT0000062 19878981 Stem Cells hsa-let-7b-5pMIMAT0000063 20133835 Stem Cells hsa-let-7d-5p MIMAT0000065 20410187Stem Cells hsa-miR-1 MIMAT0000416 20081117 Stem Cells hsa-miR-1MIMAT0000416 20956382 Stem Cells hsa-miR-100-5p MIMAT0000098 22684006Stem Cells hsa-miR-101-3p MIMAT0000099 19818710 Stem Cellshsa-miR-106a-5p MIMAT0000103 17589498 Stem Cells hsa-miR-124-3pMIMAT0000422 20362537 Stem Cells hsa-miR-124-3p MIMAT0000422 18577219Stem Cells hsa-miR-125a-5p MIMAT0000443 20616003 Stem Cellshsa-miR-125b-5p MIMAT0000423 18230348 Stem Cells hsa-miR-125b-5pMIMAT0000423 18756266 Stem Cells hsa-miR-125b-5p MIMAT0000423 20216554Stem Cells hsa-miR-126-3p MIMAT0000445 18474618 Stem Cellshsa-miR-126-3p MIMAT0000445 18832181 Stem Cells hsa-miR-126-3pMIMAT0000445 22525256 Stem Cells hsa-miR-126-3p MIMAT0000445 21304604Stem Cells hsa-miR-128-3p MIMAT0000424 20574517 Stem Cellshsa-miR-128-3p MIMAT0000424 19409607 Stem Cells hsa-miR-128-3pMIMAT0000424 19941032 Stem Cells hsa-miR-128-3p MIMAT0000424 19010882Stem Cells hsa-miR-129-5p MIMAT0000242 18189265 Stem Cellshsa-miR-130a-3p MIMAT0000425 17855557 Stem Cells hsa-miR-132-3pMIMAT0000426 19819989 Stem Cells hsa-miR-133a-3p MIMAT0000427 23069713Stem Cells hsa-miR-133b MIMAT0000770 19695767 Stem Cells hsa-miR-135b-5pMIMAT0000758 19795981 Stem Cells hsa-miR-137 MIMAT0000429 18577219 StemCells hsa-miR-137 MIMAT0000429 22003227 Stem Cells hsa-miR-138-5pMIMAT0000430 20486779 Stem Cells hsa-miR-141-3p MIMAT0000432 19454767Stem Cells hsa-miR-142-3p MIMAT0000434 21394831 Stem Cellshsa-miR-144-3p MIMAT0000436 21285251 Stem Cells hsa-miR-145-5pMIMAT0000437 19409607 Stem Cells hsa-miR-145-5p MIMAT0000437 21496429Stem Cells hsa-miR-145-5p MIMAT0000437 20382729 Stem Cellshsa-miR-145-5p MIMAT0000437 18474618 Stem Cells hsa-miR-145-5pMIMAT0000437 20668064 Stem Cells hsa-miR-145-5p MIMAT0000437 21217773Stem Cells hsa-miR-148a-3p MIMAT0000243 19435428 Stem Cellshsa-miR-153-3p MIMAT0000439 20668064 Stem Cells hsa-miR-155-5pMIMAT0000646 18950466 Stem Cells hsa-miR-155-5p MIMAT0000646 18299402Stem Cells hsa-miR-155-5p MIMAT0000646 20550618 Stem Cellshsa-miR-15a-5p MIMAT0000068 21205891 Stem Cells hsa-miR-16-5pMIMAT0000069 20668064 Stem Cells hsa-miR-16-5p MIMAT0000069 20216554Stem Cells hsa-miR-16-5p MIMAT0000069 21205891 Stem Cells hsa-miR-17-5pMIMAT0000070 17589498 Stem Cells hsa-miR-181a-5p MIMAT0000256 19585654Stem Cells hsa-miR-181b-5p MIMAT0000257 19585654 Stem Cellshsa-miR-181c-5p MIMAT0000258 19585654 Stem Cells hsa-miR-181d-5pMIMAT0002821 19585654 Stem Cells hsa-miR-195-5p MIMAT0000461 19823043Stem Cells hsa-miR-196a-5p MIMAT0000226 19063684 Stem Cellshsa-miR-199a-5p MIMAT0000231 22441842 Stem Cells hsa-miR-199a-5pMIMAT0000231 19818710 Stem Cells hsa-miR-199b-5p MIMAT0000263 19308264Stem Cells hsa-miR-199b-5p MIMAT0000263 23354452 Stem Cellshsa-miR-19b-3p MIMAT0000074 19435428 Stem Cells hsa-miR-200a-3pMIMAT0000682 21529905 Stem Cells hsa-miR-200a-3p MIMAT0000682 19454767Stem Cells hsa-miR-200a-3p MIMAT0000682 20827281 Stem Cellshsa-miR-200c-3p MIMAT0000617 19665978 Stem Cells hsa-miR-200c-3pMIMAT0000617 21294122 Stem Cells hsa-miR-200c-3p MIMAT0000617 21207483Stem Cells hsa-miR-203a MIMAT0000264 20668064 Stem Cells hsa-miR-203aMIMAT0000264 18483491 Stem Cells hsa-miR-203a MIMAT0000264 20827281 StemCells hsa-miR-203a MIMAT0000264 18311128 Stem Cells hsa-miR-206MIMAT0000462 20956382 Stem Cells hsa-miR-206 MIMAT0000462 17855557 StemCells hsa-miR-20a-5p MIMAT0000075 19435428 Stem Cells hsa-miR-20a-5pMIMAT0000075 17589498 Stem Cells hsa-miR-21-5p MIMAT0000076 19578724Stem Cells hsa-miR-21-5p MIMAT0000076 20216554 Stem Cells hsa-miR-21-5pMIMAT0000076 19342589 Stem Cells hsa-miR-21-5p MIMAT0000076 22072622Stem Cells hsa-miR-21-5p MIMAT0000076 21381024 Stem Cells hsa-miR-21-5pMIMAT0000076 22528454 Stem Cells hsa-miR-21-5p MIMAT0000076 19816956Stem Cells hsa-miR-21-5p MIMAT0000076 23239100 Stem Cells hsa-miR-21-5pMIMAT0000076 19242418 Stem Cells hsa-miR-214-3p MIMAT0000271 19435428Stem Cells hsa-miR-214-3p MIMAT0000271 19818710 Stem Cellshsa-miR-216a-5p MIMAT0000273 20216554 Stem Cells hsa-miR-217MIMAT0000274 20216554 Stem Cells hsa-miR-217 MIMAT0000274 20668064 StemCells hsa-miR-221-3p MIMAT0000278 20018759 Stem Cells hsa-miR-222-3pMIMAT0000279 20018759 Stem Cells hsa-miR-223-3p MIMAT0000280 18278031Stem Cells hsa-miR-223-3p MIMAT0000280 19278969 Stem Cellshsa-miR-224-5p MIMAT0000281 20827281 Stem Cells hsa-miR-24-3pMIMAT0000080 17906079 Stem Cells hsa-miR-26a-5p MIMAT0000082 20827281Stem Cells hsa-miR-26a-5p MIMAT0000082 20216554 Stem Cellshsa-miR-26a-5p MIMAT0000082 18197755 Stem Cells hsa-miR-26b-5pMIMAT0000083 20831567 Stem Cells hsa-miR-27a-3p MIMAT0000084 19440384Stem Cells hsa-miR-27a-3p MIMAT0000084 19666532 Stem Cellshsa-miR-27b-3p MIMAT0000419 19666532 Stem Cells hsa-miR-27b-3pMIMAT0000419 20827281 Stem Cells hsa-miR-29a-3p MIMAT0000086 21665270Stem Cells hsa-miR-29b-3p MIMAT0000100 23478036 Stem Cellshsa-miR-29b-3p MIMAT0000100 21665270 Stem Cells hsa-miR-302a-3pMIMAT0000684 21062975 Stem Cells hsa-miR-302a-3p MIMAT0000684 21266536Stem Cells hsa-miR-302a-3p MIMAT0000684 21151097 Stem Cellshsa-miR-302a-3p MIMAT0000684 23185040 Stem Cells hsa-miR-302a-3pMIMAT0000684 19386261 Stem Cells hsa-miR-302a-3p MIMAT0000684 17855557Stem Cells hsa-miR-302b-3p MIMAT0000715 21062975 Stem Cellshsa-miR-302b-3p MIMAT0000715 23185040 Stem Cells hsa-miR-302c-3pMIMAT0000717 21062975 Stem Cells hsa-miR-302c-3p MIMAT0000717 23185040Stem Cells hsa-miR-302d-3p MIMAT0000718 21266536 Stem Cellshsa-miR-302d-3p MIMAT0000718 21062975 Stem Cells hsa-miR-302d-3pMIMAT0000718 23185040 Stem Cells hsa-miR-302d-3p MIMAT0000718 19229866Stem Cells hsa-miR-31-5p MIMAT0000089 21048943 Stem Cells hsa-miR-320aMIMAT0000510 17855557 Stem Cells hsa-miR-324-5p MIMAT0000761 18756266Stem Cells hsa-miR-324-5p MIMAT0000761 20216554 Stem Cells hsa-miR-326MIMAT0000756 23341351 Stem Cells hsa-miR-326 MIMAT0000756 20667897 StemCells hsa-miR-326 MIMAT0000756 18756266 Stem Cells hsa-miR-326MIMAT0000756 20216554 Stem Cells hsa-miR-335-5p MIMAT0000765 21164520Stem Cells hsa-miR-335-5p MIMAT0000765 18185580 Stem Cellshsa-miR-34a-5p MIMAT0000255 18803879 Stem Cells hsa-miR-34a-5pMIMAT0000255 21240262 Stem Cells hsa-miR-34a-5p MIMAT0000255 21294122Stem Cells hsa-miR-34a-5p MIMAT0000255 19773441 Stem Cellshsa-miR-34a-5p MIMAT0000255 17252019 Stem Cells hsa-miR-34b-3pMIMAT0004676 18803879 Stem Cells hsa-miR-34b-5p MIMAT0000685 18803879Stem Cells hsa-miR-34c-5p MIMAT0000686 18803879 Stem Cellshsa-miR-372-3p MIMAT0000724 19229866 Stem Cells hsa-miR-372-3pMIMAT0000724 20216554 Stem Cells hsa-miR-372-3p MIMAT0000724 19823043Stem Cells hsa-miR-373-3p MIMAT0000726 20216554 Stem Cells hsa-miR-375MIMAT0000728 19807270 Stem Cells hsa-miR-380-5p MIMAT0000734 20871609Stem Cells hsa-miR-433-3p MIMAT0001627 23353875 Stem Cellshsa-miR-489-3p MIMAT0002805 19440384 Stem Cells hsa-miR-499a-5pMIMAT0002870 20081117 Stem Cells hsa-miR-499b-5p MIMAT0019897 20081117Stem Cells hsa-miR-519c-3p MIMAT0002832 19825807 Stem Cells hsa-miR-520hMIMAT0002867 18189265 Stem Cells hsa-miR-520h MIMAT0002867 19825807 StemCells hsa-miR-520h MIMAT0002867 19435428 Stem Cells hsa-miR-522-3pMIMAT0002868 21304604 Stem Cells hsa-miR-524-5p MIMAT0002849 22871495Stem Cells hsa-miR-637 MIMAT0003307 21880893 Stem Cells hsa-miR-9-5pMIMAT0000441 19330006 Stem Cells hsa-miR-9-5p MIMAT0000441 20362537 StemCells hsa-miR-92a-3p MIMAT0000092 19435428 Stem Cells hsa-miR-92b-3pMIMAT0003218 19544458 Stem Cells hsa-miR-98-5p MIMAT0000096 19818710Stem Cells mmu-let-7a-5p MIMAT0000521 19898466 Stem Cells mmu-let-7a-5pMIMAT0000521 18474618 Stem Cells mmu-let-7b-5p MIMAT0000522 20133835Stem Cells mmu-let-7c-5p MIMAT0000523 20054295 Stem Cells mmu-let-7e-5pMIMAT0000524 19898466 Stem Cells mmu-miR-100-3p MIMAT0017051 20439489Stem Cells mrnu-miR-100-5p MIMAT0000655 20439489 Stem Cellsmmu-miR-106b-5p MIMAT0000386 21285944 Stem Cells mmu-miR-10a-3pMIMAT0004659 20118242 Stem Cells mmu-miR-10a-5p MIMAT0000648 20118242Stem Cells mmu-miR-124-3p MIMAT0000134 19287386 Stem Cellsmmu-miR-124-3p MIMAT0000134 18577219 Stem Cells mmu-miR-124-3pMIMAT0000134 17679093 Stem Cells mmu-miR-125a-5p MIMAT0000135 19898466Stem Cells mmu-miR-125b-5p MIMAT0000136 19898466 Stem Cellsmmu-miR-125b-5p MIMAT0000136 21118986 Stem Cells mmu-miR-125b-5pMIMAT0000136 20216554 Stem Cells mmu-miR-126a-3p MIMAT0000138 20216554Stem Cells mmu-miR-126a-3p MIMAT0000138 18474618 Stem Cellsmmu-miR-128-3p MIMAT0000140 19898466 Stem Cells mmu-miR-134-5pMIMAT0000146 17916804 Stem Cells mmu-miR-134-5p MIMAT0000146 18806776Stem Cells mmu-miR-137-3p MIMAT0000149 20368621 Stem Cellsmmu-miR-137-3p MIMAT0000149 20439489 Stem Cells mmu-miR-137-3pMIMAT0000149 18577219 Stem Cells mmu-miR-137-5p MIMAT0016986 20439489Stem Cells mmu-miR-137-5p MIMAT0016986 18577219 Stem Cellsmrnu-miR-141-3p MIMAT0000153 19454767 Stem Cells mmu-miR-143-3pMIMAT0000247 19578358 Stem Cells mrnu-miR-145a-5p MIMAT0000157 18474618Stem Cells mrnu-miR-145a-5p MIMAT0000157 19578358 Stem Cellsmmu-miR-146a-5p MIMAT0000158 21730286 Stem Cells mmu-miR-17-5pMIMAT0000649 17765889 Stem Cells mmu-miR-199a-3p MIMAT0000230 19251704Stem Cells mmu-miR-19b-3p MIMAT0000513 21781967 Stem Cells mmu-miR-1a-3pMIMAT0000123 20819939 Stem Cells mmu-miR-1a-3p MIMAT0000123 19521018Stem Cells mmu-miR-1a-3p MIMAT0000123 19933931 Stem Cells mmu-miR-1a-3pMIMAT0000123 20799856 Stem Cells mmu-miR-200a-3p MIMAT0000519 19454767Stem Cells mmu-miR-203-3p MIMAT0000236 18311128 Stem Cellsmmu-miR-203-3p MIMAT0000236 20216554 Stem Cells mmu-miR-204-5pMIMAT0000237 20039258 Stem Cells mmu-miR-205-5p MIMAT0000238 20103531Stem Cells mmu-miR-206-3p MIMAT0000239 20819939 Stem Cellsmmu-miR-211-5p MIMAT0000668 20039258 Stem Cells mmu-miR-214-3pMIMAT0000661 19818710 Stem Cells mmu-miR-21a-5p MIMAT0000530 20216554Stem Cells mmu-miR-221-3p MIMAT0000669 20018759 Stem Cellsmmu-miR-223-3p MIMAT0000665 18278031 Stem Cells mmu-miR-23b-3pMIMAT0000125 19582816 Stem Cells mmu-miR-23b-3p MIMAT0000125 20216554Stem Cells mmu-miR-24-3p MIMAT0000219 19582816 Stem Cells mmu-miR-27b-3pMIMAT0000126 19582816 Stem Cells mmu-miR-290a-3p MIMAT0004572 19628328Stem Cells mmu-miR-291a-3p MIMAT0000368 19628328 Stem Cellsmmu-miR-292-3p MIMAT0000370 19628328 Stem Cells mmu-miR-293-3pMIMAT0000371 19628328 Stem Cells mmu-miR-294-3p MIMAT0000372 19628328Stem Cells mmu-miR-295-3p MIMAT0000373 19628328 Stem Cellsmmu-miR-296-5p MIMAT0000374 18806776 Stem Cells mmu-miR-29a-3pMIMAT0000535 21665270 Stem Cells mmu-miR-29b-3p MIMAT0000127 21665270Stem Cells mmu-miR-324-5p MIMAT0000555 20216554 Stem Cellsmmu-miR-326-3p MIMAT0000559 20216554 Stem Cells mmu-miR-34a-5pMIMAT0000542 20424141 Stem Cells mmu-miR-466l-3p MIMAT0005830 20410487Stem Cells mmu-miR-470-5p MIMAT0002111 18806776 Stem Cells mmu-miR-9-5pMIMAT0000142 22465325 Stem Cells mmu-miR-9-5p MIMAT0000142 21238922 StemCells mmu-miR-9-5p MIMAT0000142 20362537 Stem Cells mmu-miR-93-5pMIMAT0000540 21285944 Stem Cells ppy-miR-130a MIMAT0015753 17855557 StemCells ppy-miR-335 MIMAT0015837 18185580 Stem Cells ptr-miR-130aMIMAT0008025 17855557 Stem Cells ptr-miR-335 MIMAT0008104 18185580 StemCells rno-miR-133b-3p MIMAT0003126 19695767 Stem Cells rno-miR-31a-5pMIMAT0000810 23270756 Stem Cells rno-miR-335 MIMAT0000575 18185580 StemCells rno-miR-9a-5p MIMAT0000781 18987208 Stem Cells ssc-miR-130aMIMAT0007758 17855557 Stem Cells ssc-miR-335 MIMAT0013955 18185580 StemCells xtr-miR-130a MIMAT0003591 17855557 Sternum mmu-miR-140-5pMIMAT0000151 16828749 Stomach hsa-miR-106a-5p MIMAT0000103 16461460Stomach hsa-miR-181c-5p MIMAT0000258 20080834 Stomach hsa-miR-20a-5pMIMAT0000075 16461460 Stomach hsa-miR-21-5p MIMAT0000076 18372920Stomach hsa-miR-26a-5p MIMAT0000082 16461460 Stomach hsa-miR-34a-5pMIMAT0000255 21240262 Stomach mmu-miR-21a-5p MIMAT0000530 18372920Stress Fibers hsa-miR-124-3p MIMAT0000422 21672940 Stress Fibershsa-miR-138-5p MIMAT0000430 20232393 Stress Fibers hsa-miR-200b-3pMIMAT0000318 22144583 Stress Fibers hsa-miR-21-5p MIMAT0000076 21347332Stress Fibers rno-miR-200c-3p MIMAT0000873 22144583 Stromal Cellshsa-let-7f-5p MIMAT0000067 22407818 Stromal Cells hsa-miR-125a-5pMIMAT0000443 19011087 Stromal Cells hsa-miR-125b-5p MIMAT000042319011087 Stromal Cells hsa-miR-196b-5p MIMAT0001080 23293219 StromalCells hsa-miR-199a-5p MIMAT0000231 19011087 Stromal Cellshsa-miR-199a-5p MIMAT0000231 22441842 Stromal Cells hsa-miR-222-3pMIMAT0000279 19589872 Stromal Cells hsa-miR-26a-5p MIMAT0000082 19011087Stromal Cells hsa-miR-346 MIMAT0000773 19011087 Stromal Cellshsa-miR-369-5p MIMAT0001621 21136442 Stromal Cells mmu-miR-21a-5pMIMAT0000530 18556655 Stromal Cells mmu-miR-2861 MIMAT0013803 19920351Stromal Cells mmu-miR-3960 MIMAT0019336 21324897 Subcutaneous Fathsa-miR-519d-3p MIMAT0002853 20057369 Submandibular Gland mmu-miR-21a-5pMIMAT0000530 21295561 Suprachiasmatic Nucleus bta-miR-132 MIMAT000381217553428 Suprachiasmatic Nucleus bta-miR-219 MIMAT0030444 17553428Suprachiasmatic Nucleus cfa-miR-132 MIMAT0006732 17553428Suprachiasmatic Nucleus dre-miR-219 MIMAT0001286 17553428Suprachiasmatic Nucleus mml-miR-219 MIMAT0002575 17553428Suprachiasmatic Nucleus mmu-miR-132-3p MIMAT0000144 17553428Suprachiasmatic Nucleus mmu-miR-132-3p MIMAT0000144 21118894Suprachiasmatic Nucleus mmu-miR-132-5p MIMAT0016984 21118894Suprachiasmatic Nucleus mmu-miR-219a-5p MIMAT0000664 17553428Suprachiasmatic Nucleus mmu-miR-7b-5p MIMAT0000678 17028171Suprachiasmatic Nucleus ppy-miR-132 MIMAT0015755 17553428Suprachiasmatic Nucleus ppy-miR-219 MIMAT0002577 17553428Suprachiasmatic Nucleus ssc-miR-132 MIMAT0025361 17553428Suprachiasmatic Nucleus ssc-miR-219 MIMAT0020590 17553428Suprachiasmatic Nucleus xtr-miR-132 MIMAT0003594 17553428Suprachiasmatic Nucleus xtr-miR-219 MIMAT0003632 17553428 SympatheticNervous hsa-miR-152-3p MIMAT0000438 20841484 System Sympathetic Nervoushsa-miR-184 MIMAT0000454 20409325 System Sympathetic Nervoushsa-miR-18a-5p MIMAT0000072 20080637 System Sympathetic Nervoushsa-miR-19a-3p MIMAT0000073 20080637 System Sympathetic Nervoushsa-miR-34a-5p MIMAT0000255 21266077 System Synapses hsa-miR-137MIMAT0000429 22003227 Synapses mmu-miR-206-3p MIMAT0000239 20007902Synapses mmu-miR-34a-5p MIMAT0000542 18835850 Synapses rno-miR-138-5pMIMAT0000844 20064393 Synapses rno-miR-181a-5p MIMAT0000858 22144581Synovial Fluid hsa-miR-146a-5p MIMAT0000449 20459811 T-Lymphocyteshsa-let-7d-5p MIMAT0000065 21616524 T-Lymphocytes hsa-let-7f-5pMIMAT0000067 21616524 T-Lymphocytes hsa-let-7g-5p MIMAT0000414 21616524T-Lymphocytes hsa-let-7i-5p MIMAT0000415 21616524 T-Lymphocyteshsa-miR-106a-5p MIMAT0000103 17575136 T-Lymphocytes hsa-miR-125a-5pMIMAT0000443 20589685 T-Lymphocytes hsa-miR-126-3p MIMAT0000445 21165896T-Lymphocytes hsa-miR-130b-3p MIMAT0000691 18974142 T-Lymphocyteshsa-miR-143-3p MIMAT0000435 19464056 T-Lymphocytes hsa-miR-146a-5pMIMAT0000449 19965651 T-Lymphocytes hsa-miR-146a-5p MIMAT000044920459811 T-Lymphocytes hsa-miR-148a-3p MIMAT0000243 19435428T-Lymphocytes hsa-miR-148a-3p MIMAT0000243 20483747 T-Lymphocyteshsa-miR-155-5p MIMAT0000646 21310411 T-Lymphocytes hsa-miR-155-5pMIMAT0000646 20673989 T-Lymphocytes hsa-miR-155-5p MIMAT0000646 20209161T-Lymphocytes hsa-miR-155-5p MIMAT0000646 20680360 T-Lymphocyteshsa-miR-155-5p MIMAT0000646 21304824 T-Lymphocytes hsa-miR-155-5pMIMAT0000646 22387553 T-Lymphocytes hsa-miR-181c-5p MIMAT000025821112091 T-Lymphocytes hsa-miR-184 MIMAT0000454 19286996 T-Lymphocyteshsa-miR-19b-3p MIMAT0000074 19435428 T-Lymphocytes hsa-miR-19b-3pMIMAT0000074 17575136 T-Lymphocytes hsa-miR-20a-5p MIMAT0000075 19435428T-Lymphocytes hsa-miR-20b-5p MIMAT0001413 17575136 T-Lymphocyteshsa-miR-21-5p MIMAT0000076 22387553 T-Lymphocytes hsa-miR-21-5pMIMAT0000076 21469086 T-Lymphocytes hsa-miR-21-5p MIMAT0000076 20483747T-Lymphocytes hsa-miR-21-5p MIMAT0000076 23416424 T-Lymphocyteshsa-miR-214-3p MIMAT0000271 19435428 T-Lymphocytes hsa-miR-214-3pMIMAT0000271 20548023 T-Lymphocytes hsa-miR-221-3p MIMAT0000278 20110463T-Lymphocytes hsa-miR-222-3p MIMAT0000279 23522449 T-Lymphocyteshsa-miR-26a-5p MIMAT0000082 23338972 T-Lymphocytes hsa-miR-29a-3pMIMAT0000086 19584290 T-Lymphocytes hsa-miR-30b-5p MIMAT0000420 22387553T-Lymphocytes hsa-miR-31-3p MIMAT0004504 19408243 T-Lymphocyteshsa-miR-31-5p MIMAT0000089 19408243 T-Lymphocytes hsa-miR-520hMIMAT0002867 19435428 T-Lymphocytes hsa-miR-92a-3p MIMAT0000092 17575136T-Lymphocytes hsa-miR-92a-3p MIMAT0000092 19435428 T-Lymphocyteshsa-miR-93-5p MIMAT0000093 18974142 T-Lymphocytes hsa-miR-98-5pMIMAT0000096 20589685 T-Lymphocytes hsa-miR-98-5p MIMAT0000096 21616524T-Lymphocytes mmu-miR-106a-5p MIMAT0000385 17575136 T-Lymphocytesmmu-miR-124-3p MIMAT0000134 21131957 T-Lymphocytes mmu-miR-125b-5pMIMAT0000136 21118986 T-Lymphocytes mmu-miR-133a-3p MIMAT000014520173049 T-Lymphocytes mmu-miR-142-3p MIMAT0000155 19098714T-Lymphocytes mmu-miR-155-5p MIMAT0000165 19144316 T-Lymphocytesmmu-miR-155-5p MIMAT0000165 17463290 T-Lymphocytes mmu-miR-155-5pMIMAT0000165 21149603 T-Lymphocytes mmu-miR-181a-5p MIMAT000021017344418 T-Lymphocytes mmu-miR-19b-3p MIMAT0000513 17575136T-Lymphocytes mmu-miR-20b-5p MIMAT0003187 17575136 T-Lymphocytesmmu-miR-214-3p MIMAT0000661 20548023 T-Lymphocytes mmu-miR-92a-3pMIMAT0000539 17575136 T-Lymphocytes rno-miR-23a-3p MIMAT0000792 19574461T-Lymphocytes rno-miR-27a-3p MIMAT0000799 19574461 T-Lymphocytes Helper-hsa-miR-21-5p MIMAT0000076 23416424 Inducer T-Lymphocytes Helper-mmu-miR-326-3p MIMAT0000559 19838199 Inducer T-Lymphocytes Regulatoryhsa-let-7i-5p MIMAT0000415 21742974 T-Lymphocytes Regulatoryhsa-miR-155-5p MIMAT0000646 20209161 T-Lymphocytes Regulatoryhsa-miR-155-5p MIMAT0000646 21304824 T-Lymphocytes Regulatoryhsa-miR-21-5p MIMAT0000076 23416424 T-Lymphocytes Regulatorymmu-miR-142-3p MIMAT0000155 19098714 T-Lymphocytes Regulatorymmu-miR-146a-5p MIMAT0000158 20850013 T-Lymphocytes Regulatorymmu-miR-155-5p MIMAT0000165 19144316 T-Lymphocytes Regulatorymmu-miR-155-5p MIMAT0000165 21149603 Telencephalon mmu-miR-9-5pMIMAT0000142 18842901 Testis hsa-miR-383-5p MIMAT0000738 21368870 Testismmu-miR-709 MIMAT0003499 19029807 Thymus Gland hsa-miR-433-3pMIMAT0001627 20181727 Thymus Gland hsa-miR-7-5p MIMAT0000252 18823940Thymus Gland mmu-miR-29a-3p MIMAT0000535 19959559 Thymus Glandmmu-miR-29b-3p MIMAT0000127 19959559 Thymus Gland mmu-miR-468-3pMIMAT0002109 19959559 Thyroid Gland hsa-let-7f-5p MIMAT0000067 19956384Thyroid Gland hsa-miR-125b-5p MIMAT0000423 17563749 Thyroid Glandhsa-miR-138-5p MIMAT0000430 18201269 Thyroid Gland hsa-miR-146a-5pMIMAT0000449 20061417 Thyroid Gland hsa-miR-146b-5p MIMAT000280916365291 Thyroid Gland hsa-miR-192-5p MIMAT0000222 16822819 ThyroidGland hsa-miR-197-3p MIMAT0000227 16822819 Thyroid Gland hsa-miR-204-5pMIMAT0000265 20691260 Thyroid Gland hsa-miR-206 MIMAT0000462 20388878Thyroid Gland hsa-miR-221-3p MIMAT0000278 20388878 Thyroid Glandhsa-miR-221-3p MIMAT0000278 16365291 Thyroid Gland hsa-miR-222-3pMIMAT0000279 20388878 Thyroid Gland hsa-miR-222-3p MIMAT0000279 16365291Thyroid Gland hsa-miR-26a-5p MIMAT0000082 17563749 Thyroid Glandhsa-miR-27a-3p MIMAT0000084 21149577 Thyroid Gland hsa-miR-320aMIMAT0000510 19164563 Thyroid Gland hsa-miR-346 MIMAT0000773 16822819Thyroid Gland rno-miR-27a-3p MIMAT0000799 21149577 Thyroid Glandrno-miR-34a-5p MIMAT0000815 18704095 Tight Junctions hsa-miR-1MIMAT0000416 23142026 Tight Junctions hsa-miR-155-5p MIMAT000064618794355 Tight Junctions hsa-miR-203a MIMAT0000264 22101077 TightJunctions hsa-miR-212-3p MIMAT0000269 18162065 Tight Junctionshsa-miR-483-3p MIMAT0002173 22101077 Tight Junctions hsa-miR-595MIMAT0003263 22101077 Tight Junctions mmu-miR-155-5p MIMAT000016518794355 Tongue hsa-miR-133a-3p MIMAT0000427 18464261 Tonguehsa-miR-133b MIMAT0000770 18464261 Tongue hsa-miR-138-5p MIMAT000043020232393 Tongue hsa-miR-138-5p MIMAT0000430 20819078 Tonguehsa-miR-222-3p MIMAT0000279 19487542 Tongue hsa-miR-24-3p MIMAT000008020816961 Tongue hsa-miR-7-5p MIMAT0000252 20819078 Trabecular Meshworkhsa-miR-106a-5p MIMAT0000103 19782699 Trabecular Meshwork hsa-miR-182-5pMIMAT0000259 19782699 Trabecular Meshwork hsa-miR-183-5p MIMAT000026119940135 Trabecular Meshwork hsa-miR-24-3p MIMAT0000080 20945401Trabecular Meshwork hsa-miR-29b-3p MIMAT0000100 19956414 Tracheammu-miR-125b-5p MIMAT0000136 21945074 Trachea mmu-miR-30a-5pMIMAT0000128 21945074 Trachea mmu-miR-30c-5p MIMAT0000514 21945074Trophoblasts hsa-miR-106a-5p MIMAT0000103 23438603 Trophoblastshsa-miR-199b-5p MIMAT0000263 19900756 Trophoblasts hsa-miR-19b-3pMIMAT0000074 23438603 Trophoblasts hsa-miR-205-5p MIMAT0000266 20065103Trophoblasts hsa-miR-224-5p MIMAT0000281 20065103 Trophoblastshsa-miR-335-5p MIMAT0000765 20065103 Trophoblasts hsa-miR-34a-5pMIMAT0000255 20351093 Trophoblasts hsa-miR-424-5p MIMAT0001341 20065103Trophoblasts hsa-miR-491-5p MIMAT0002807 20065103 Trophoblastshsa-miR-93-5p MIMAT0000093 20065103 Umbilical Cord hsa-miR-129-5pMIMAT0000242 18189265 Umbilical Cord hsa-miR-135b-5p MIMAT000075819795981 Umbilical Cord hsa-miR-148a-3p MIMAT0000243 19435428 UmbilicalCord hsa-miR-184 MIMAT0000454 19286996 Umbilical Cord hsa-miR-19b-3pMIMAT0000074 19435428 Umbilical Cord hsa-miR-20a-5p MIMAT000007519435428 Umbilical Cord hsa-miR-214-3p MIMAT0000271 19435428 UmbilicalCord hsa-miR-34a-5p MIMAT0000255 20627091 Umbilical Cord hsa-miR-520hMIMAT0002867 19435428 Umbilical Cord hsa-miR-520h MIMAT0002867 18189265Umbilical Cord hsa-miR-92a-3p MIMAT0000092 19435428 Umbilical Veinshsa-miR-155-5p MIMAT0000646 21310411 Umbilical Veins hsa-miR-155-5pMIMAT0000646 23108656 Umbilical Veins hsa-miR-19a-3p MIMAT000007320133739 Umbilical Veins hsa-miR-216a-5p MIMAT0000273 19786632 UmbilicalVeins hsa-miR-217 MIMAT0000274 19786632 Umbilical Veins hsa-miR-409-3pMIMAT0001639 22531314 Umbilical Veins hsa-miR-519c-3p MIMAT000283220233879 Urinary Bladder hsa-miR-100-5p MIMAT0000098 19843843 UrinaryBladder hsa-miR-101-3p MIMAT0000099 19258506 Urinary Bladderhsa-miR-125b-5p MIMAT0000423 20549700 Urinary Bladder hsa-miR-125b-5pMIMAT0000423 19378336 Urinary Bladder hsa-miR-129-5p MIMAT000024219487295 Urinary Bladder hsa-miR-133a-3p MIMAT0000427 19378336 UrinaryBladder hsa-miR-133a-3p MIMAT0000427 20160723 Urinary Bladderhsa-miR-143-3p MIMAT0000435 23104321 Urinary Bladder hsa-miR-143-3pMIMAT0000435 19157460 Urinary Bladder hsa-miR-145-5p MIMAT000043721360565 Urinary Bladder hsa-miR-145-5p MIMAT0000437 23104321 UrinaryBladder hsa-miR-145-5p MIMAT0000437 19915607 Urinary Bladderhsa-miR-145-5p MIMAT0000437 19378336 Urinary Bladder hsa-miR-145-5pMIMAT0000437 20160723 Urinary Bladder hsa-miR-195-5p MIMAT000046122265971 Urinary Bladder hsa-miR-195-5p MIMAT0000461 19378336 UrinaryBladder hsa-miR-199a-3p MIMAT0000232 21807947 Urinary Bladderhsa-miR-199a-3p MIMAT0000232 19378336 Urinary Bladder hsa-miR-200b-3pMIMAT0000318 19671845 Urinary Bladder hsa-miR-200c-3p MIMAT000061719671845 Urinary Bladder hsa-miR-203a MIMAT0000264 21205209 UrinaryBladder hsa-miR-21-5p MIMAT0000076 21468550 Urinary Bladderhsa-miR-30a-3p MIMAT0000088 19378336 Urinary Bladder hsa-miR-30a-5pMIMAT0000087 19378336 Urinary Bladder hsa-miR-34a-5p MIMAT000025521240262 Urinary Bladder hsa-miR-429 MIMAT0001536 19671845 UrinaryBladder hsa-miR-99a-5p MIMAT0000097 19843843 Urothelium hsa-miR-100-5pMIMAT0000098 19843843 Urothelium hsa-miR-125b-5p MIMAT0000423 20549700Urothelium hsa-miR-129-5p MIMAT0000242 19487295 Urotheliumhsa-miR-145-5p MIMAT0000437 19915607 Urothelium hsa-miR-99a-5pMIMAT0000097 19843843 Uterus mmu-miR-101a-3p MIMAT0000133 17848513Uterus mmu-miR-199a-3p MIMAT0000230 17848513 Uterus mmu-miR-21a-5pMIMAT0000530 18556655 Veins hsa-miR-140-5p MIMAT0000431 23401231 Veinshsa-miR-146a-5p MIMAT0000449 22711166 Veins hsa-miR-155-5p MIMAT000064623108656 Veins hsa-miR-16-5p MIMAT0000069 19738602 Veins hsa-miR-328-3pMIMAT0000752 18560585 Veins hsa-miR-328-5p MIMAT0026486 18560585 Veinshsa-miR-409-3p MIMAT0001639 22531314 X Chromosome hsa-miR-106a-5pMIMAT0000103 17575136 X Chromosome hsa-miR-19b-3p MIMAT0000074 17575136X Chromosome hsa-miR-20b-5p MIMAT0001413 17575136 X Chromosomehsa-miR-221-3p MIMAT0000278 17721077 X Chromosome hsa-miR-222-3pMIMAT0000279 17721077 X Chromosome hsa-miR-92a-3p MIMAT0000092 17575136X Chromosome mmu-miR-106a-5p MIMAT0000385 17575136 X Chromosomemmu-miR-19b-3p MIMAT0000513 17575136 X Chromosome mmu-miR-20b-5pMIMAT0003187 17575136 X Chromosome mmu-miR-92a-3p MIMAT0000539 17575136

TABLE I IncRNA-chromatin interaction data - H. sapiens, taken from Supp.Table 1 of Zhang et al, JBC 2019, doi: 10.1074/jbc.RA119.008732;jbc.RA119.008732. LncRNA-chromatin interaction data in human IncRNAcontrol Detected Cell Type IncRNA IP sample IncRNA Method Cell typeDescription sample ID ID PMID HOTAIR ChlRP- MDAMB2 Breast GSM820433,GSM820435 21963238 Seq 31 Cancer GSM820434 LED ChlRP- MCF7 BreastGSM1294974, GSM1294973 25813522 Seq with Cancer GSM1294975 nutlin-3aMEG3 ChOP- BT-549 Breast PRJEB7307 26205790 seq Cancer MALAT1 CHART-MCF7 Breast GSM1411209, GSM1411212 25155612 seq Cancer GSM1411210 NEAT1CHART- MCF7 Breast GSM1411207, GSM1411211 25155612 seq Cancer GSM14112087SK ChlRP- HeLaS3 Cervical GSM1693801, GSM1693803 26878240 Seq cancerGSM1693802 TERC ChlRP- HeLaS3 Cervical GSM820437, GSM820432 21963238 Seqcancer GSM820438 *DACOR1 ChlRP- V852 Colon GSM1854427 GSM185442626307088 Seq cancer (1 run) SNHG1 ChlRP- HCT116 Colon GSM2285442,GSM2285451, 28825722 Seq cancer GSM2285443, GSM2285452, GSM2285444,GSM2285453 GSM2285445, GSM2285446, GSM2285447 DINO ChlRP- U2OS HumanGSM2011201, GSM2011205 27668660 Seq Bone GSM2011202 OsteosarcomaEpithelial Cells 7SK ChlRP- H1 Embryonic GSM1693798, GSM1693800 26878240Seq stem cell GSM1693799 SRA ChlRP- NTERA2 Pluripotent GSM1415922GSM1415924 26496121 Seq human (3 runs) embryonal carcinoma cell line*Long ChlRP- Erythroblast Blood GSM2449980, GSM2449979 28132025noncoding Seq GSM2449981 RNAs transcribed by ERV-9 LTR retro- transposon

TABLE J De novo lncRNA binding motifs discoveredin human lncRNA-chromatin interactiondata - H. sapiens, taken from Supp. Table2 of Zhang et al, JBC 2019 doi: 10.1074/jbc.RA119.008732; jbc.RA119.008732. # of Matched SEQ denovo motif IDmotif instance NO: lncRNA (Homer) p−value (Fimo) (#) HOTAIR.GGCATTTCTGGT 1.00E−123 3 481 MDAMB231 CAAGACCAGAGA 1.00E−101 5 482ATGGGAGGCGCA 1.00E−93 1 483 GCAGAGAAAAGG 1.00E−90 14 484 GTTTGGGCCTCC1.00E−87 6 485 CCTGTATGGAAC 1.00E−81 1 486 GTGTCTACATGC 1.00E−71 2 487CAGGAGGAAGTT 1.00E−67 1 488 AGAAAAGGCTGA 1.00E−65 10 489 TGGAACAAGCAT1.00E−64 2 490 AGGAGGAAGTTC 1.00E−58 5 491 AGAGCAAGGAAG 1.00E−54 9 492GGAGGGGCGTCT 1.00E−51 4 493 GGCCCCAAAGAG 1.00E−45 8 494 AGGAGGCCCAAA1.00E−42 3 495 TTAGCGCCTCCC 1.00E−42 1 496 GGGCTGGTTTCA 1.00E−40 5 497TAACTGGCAGCA 1.00E−38 2 498 ACATGCATCACT 1.00E−35 1 499 KGACTTWGCACT1.00E−32 1 500 GTGCTGATTCCT 1.00E−27 1 501 CACTGCCAACCC 1.00E−25 7 502GGGACAAAAGTT 1.00E−23 4 503 TTTCTGACACTG 1.00E−23 1 504 CAGAGAAAGGCT1.00E−15 5 505 MEG3. GAGAGAGAGAGA 1.00E−35 76 506 BT549 GTGTGTGTGTGT1.00E−23 97 507 TGTATGTGTGTG 1.00E−19 77 508 CAYWGTGTGTGT 1.00E−12 55509 CGGGGTCGBAGC 1.00E−11 8 510 GTTTTTCTAGAA 1.00E−09 9 511 ATCATATCAAAA1.00E−08 5 512 AGAACAGATGTA 1.00E−08 1 513 TGTGTTTCTTCA 1.00E−07 12 514GGTTTTTCACCT 1.00E−07 7 515 ATAGAAAGAAAT 1.00E−07 21 516 TSTMTCTGTMTG1.00E−07 20 517 GMTCMTATCTAT 1.00E−07 3 518 GGGGGGGGGGGG 1.00E−04 72 519TATATATATATA 1.00E−04 9 520 TCTCTCTCTTTT 1.00E−02 45 521 TCTTTCCTTCCT1.00E−01 54 522 7SK.H1 KGGCTGGCTGGC    1e−625 3 523 ATCTGTCACCCC1.00E−271 1 524 GACTCCAGACAC 1.00E−249 1 525 TCCAGACACATC 1.00E−221 1526 CACATGGAGCNG 1.00E−184 2 527 AGACTCCAGACM 1.00E−170 1 528GCCCTCACATCC 1.00E−159 NA 529 GGGACGCACATG 1.00E−153 1 530 BCCAGATCAGCC1.00E−152 2 531 CCTAGCCAGCCR 1.00E−149 1 532 NCAARACTHCAS 1.00E−147 1533 CCCTACGTTCTC 1.00E−130 1 534 TGTCACCCCATT 1.00E−130 1 535TGGACCTTGAGA 1.00E−98 1 536 TACAATGGACCT 1.00E−89 1 537 AGCTCTCAAGGT1.00E−75 1 538 ARCGTAGGGTAG 1.00E−68 1 539 SATGGAGCGGTG 1.00E−51 1 540AAGAGGACGACC 1.00E−41 2 541 TGACTACCCTAC 1.00E−38 1 542 GGACCTTGGAGC1.00E−37 NA 543 GCACTGGAGCGG 1.00E−33 NA 544 TGGCTGGYGTAG 1.00E−33 NA545 GGGCCACCATCA 1.00E−28 NA 546 TTGTGCAGCCTC 1.00E−24 NA 547 7SK.GCCAGCCAGMYM    1e−402 3 548 HeLaS3 GCCCTCACATCC 1.00E−240 NA 529TGGCTGGCTAGG 1.00E−227 1 549 CCCTACGTTCTC 1.00E−226 1 534 GACTCCAGACAC1.00E−218 1 525 TGTCTGGAGTCT 1.00E−137 1 550 CCAGCCAGCTCM 1.00E−120 1551 CCAAGACTCCAG 1.00E−120 1 552 GGGGTGACAGAT 1.00E−111 1 553TACCCTACGTTC 1.00E−106 1 554 TGTCACCCCATT 1.00E−105 1 535 GCCAGATCAGCC1.00E−98 2 555 GACTACCCTACG 1.00E−78 1 556 CACATGGAGCSS 1.00E−68 2 557GCTCTCAAGGTC 1.00E−67 1 558 GACGCACATGGA 1.00E−66 1 559 CATGTGCGTCCC1.00E−65 1 560 CTACGTTTCTCC 1.00E−64 NA 561 AGGGTAGTCAAG 1.00E−56 1 562GSCGCCATCTTG 1.00E−45 NA 563 CAAGGTCCATTG 1.00E−33 1 564 TCGCCAGGGTTG1.00E−33 1 565 GGTCGTCCTCTT 1.00E−32 2 566 GGAAGGGGACAC 1.00E−18 1 567ACGCAATTACTC 1.00E−18 1 568 SNHG1. GGCCTGGATCAT 1.00E−75 18 569 HCT116GAGAGCTCTGTG 1.00E−50 29 570 CCTGGATCATGT 1.00E−50 8 571 GTGGAGTTATGG1.00E−41 6 572 CGCTGGCTTTGC 1.00E−35 22 573 GCTCTTGTGGSC 1.00E−35 5 574TTCCCATAACTC 1.00E−33 8 575 ATACAGCCACCG 1.00E−30 14 576 GCAGACACAGAT1.00E−30 8 577 AGAGCAGCTTGT 1.00E−26 7 578 AACTCAGGCACT 1.00E−25 13 579AGCCCACAGAGC 1.00E−23 9 580 TTGGGAAGTTCA 1.00E−23 27 581 ACTGCTGTTTCA1.00E−19 12 582 CTACCTACATGG 1.00E−16 12 583 GCTAATGATAGC 1.00E−13 NA584 TGCRARCCAGCC 1.00E−09 11 585 GGGGACAGCCAC 1.00E−09 6 586KACCTYCCCCAA 1.00E−07 NA 587 GVTCCTGGRTCS 1.00E−07 8 588 CTGGTCATTGGT1.00E−06 4 589 GCTGGTCTGAGT 1.00E−05 2 590 TATCAGAGGTCA 1.00E−05 4 591GAGATATGGGCC 1.00E−04 8 592 CCTATCTACGCC 1.00E−04 NA 593 MALAT1.GGTTTGCCGCWG 1.00E−09 NA 594 MCF7 CTCAGCTGCCAC 1.00E−05 22 595GGAGCTCACGGG 1.00E−05 2 596 ATATTCTACCGG 1.00E−02 NA 597 GTCTTTACGACA1.00E−02 4 598 GGAATATTCTAC 1.00E−02 4 599 TTTATGACACCG 1.00E−02 5 600CGGTGGAGGAAT 1.00E−02 3 601 GAGTCTGTCCCG 1.00E−02 3 602 NEAT1-YCYYCYCCCYYY 1.00E−71 74 603 MCF7 SCGATTGGYYGR 1.00E−59 3 604AAGGGGGTGGAG 1.00E−50 29 605 GGRRGAAARRAA 1.00E−45 46 606 TVGCCCCGCCCC1.00E−44 14 607 CASCAGRGGGCA 1.00E−42 12 608 CCCTCCCCCAAC 1.00E−19 28609 VTGCGCATGCGC 1.00E−19 2 610 ATTGGCAGGCGG 1.00E−17 10 611CGGTCACGTGAC 1.00E−11 5 612 CACCACCTAGTG 1.00E−11 8 613 CTACAAATCCCA1.00E−11 8 614 CGGAAGTGACGT 1.00E−10 5 615 TTTGTTTGATCT 1.00E−10 12 616ACAGTACAAACT 1.00E−09 6 617 AATCTCGCGAGA 1.00E−09 NA 222 CCGTGACGTCAC1.00E−09 6 618 CCACCAGGGGTC 1.00E−08 5 619 AGGGTTGTGGCC 1.00E−07 5 620CGCAACCTAACC 1.00E−07 5 621 GCCCGAAGCTCC 1.00E−05 6 622 CAGACGGCCTTA1.00E−05 4 623 CTTATTCTCACT 1.00E−05 4 624 TAAAGAAGAAGG 1.00E−05 5 625TGTGTGTGTGCG 1.00E−04 72 626 TERC. GGGGGCTGGGCA    1e−1348 4 627 HeLaS3GGCCACCACCCC    1e−1177 1 628 GGTGGTGGCCAT    1e−818 2 629 GCCTGCCCAGCC   1e−529 1 630 GRGGGCGAGGGS    1e−439 4 631 AAAATGGCCACC    1e−352 2632 MGGAGGGTGGGC    1e−325 2 633 CCACCACCCCTC 1.00E−275 2 634GCCACCACCCTC 1.00E−126 1 635 GGCCCACCTCCT 1.00E−109 3 636 GGGGGCTGGCAG1.00E−96 4 637 GCCTGCCCCAGC 1.00E−80 3 638 CCGCGGCTTCCA 1.00E−79 3 639GCCTCGTCCTGC 1.00E−77 3 640 STCCCCGCGCGY 1.00E−72 6 641 CCCTCNSCCCTC1.00E−69 4 642 CTGAGCTGTGGG 1.00E−58 1 643 GTCAGCCGCGGG 1.00E−55 2 644AGGCCTCGGCTB 1.00E−53 4 645 ACCCAGGACTCG 1.00E−42 2 646 AGGACCACCTCT1.00E−39 NA 647 CAGCAGCTGACA 1.00E−38 2 648 GGCTTCKCCAGG 1.00E−33 1 649TCTKGGCTTTKT 1.00E−32 NA 650 TCAGTTGTAGAG 1.00E−24 NA 651 LED.MCF7CCAACTGGAGGC 1.00E−249 3 652 AGTGAATCACAC 1.00E−97 3 653 RATMMCAACTGG1.00E−86 1 654 TGAATCACACAC 1.00E−78 5 655 GACACCAGGGTT 1.00E−71 7 656GGCCAAAGAGGN 1.00E−64 5 657 GGTCTGAGTTCC 1.00E−56 5 658 GGGCTCCAGAAA1.00E−55 3 659 TTCAAACCCTGG 1.00E−55 3 660 GAGCCCCAAGAA 1.00E−54 6 661CAAGAACAGCTC 1.00E−48 3 662 HGTGTTTCCTGT 1.00E−38 4 663 AGAAGACGTGAC1.00E−35 4 664 CCAGAAGAAATC 1.00E−33 3 665 GGGTCACGGAAG 1.00E−31 5 666AACAGAGCCCCA 1.00E−31 4 667 CAAAGAGCTTTC 1.00E−31 4 668 GGAAGGTCTGAG1.00E−31 7 669 TTCCCTGTGACC 1.00E−30 6 670 GATCTTCCCTGT 1.00E−29 6 671AGCTTCATTCAG 1.00E−27 1 672 NAGAGAGCTGTH 1.00E−26 3 673 ACTGAGACTCCT1.00E−26 3 674 CGCCTAGAAAAC 1.00E−25 1 675 GGTCAAGTCGGT 1.00E−24 3 676SRA. GCCCCCTAGTGG 1.00E−80 NA 677 NTERA2 TTGTTATGCAAA 1.00E−21 1 678CAAATTACTGCA 1.00E−16 1 679 TTAAAGTGGGCT 1.00E−11 1 680 AGGGAGGGGATG1.00E−11 2 681 GAGCCTAATAAA 1.00E−11 NA 682 AGGTTATCTGGT 1.00E−10 1 683GTTTTCTTTGTG 1.00E−10 4 684 CCAAGATTAATT 1.00E−09 4 685 GAAAAAACCGTT1.00E−09 NA 686 CCACSACTAAGC 1.00E−09 3 687 WACYAAATGCGT 1.00E−09 NA 688AACATGTCCCTG 1.00E−08 NA 689 AAATTATTTTAG 1.00E−07 NA 690 BGCATCTAAGCC1.00E−07 NA 691 CTAATGCAGAGA 1.00E−07 2 692 TTGCCTGGAAGG 1.00E−06 NA 693ACCCATCCGCCC 1.00E−06 4 694 AGAGTAGACGGT 1.00E−05 1 695 AAGGGTCCAGCC1.00E−05 7 696 CCACTTGVGATT 1.00E−05 3 697 CAGCCTGTGTAA 1.00E−05 2 698TTCTAATTATCG 1.00E−04 NA 699 ACCGACACGGGG 1.00E−04 NA 700 CGGCGGGARTCT1.00E−04 5 701 DINO. ATTGCAGAGAGG 1.00E−116 untreated 702 U2OSGCAGAGAGGTGC 1.00E−80 703 CCCTACACTCAC 1.00E−60 704 GAGAATGAGTTG1.00E−56 705 HGGAAATTGCAG 1.00E−54 706 VACMCTCACCTG 1.00E−48 707AGAAATCCCTGT 1.00E−40 708 GGAGTATTCAGG 1.00E−30 709 AACCACAGGGAT1.00E−25 710 TTGGAGAATGAG 1.00E−22 711 CACATTTCCCCA 1.00E−18 712TACACCCTACAC 1.00E−17 713 GAGATGAGTTGG 1.00E−17 714 TCCCTCACTAGG1.00E−16 715 GAAAAACAWAGA 1.00E−11 716 CCTGCACTBWCA 1.00E−11 717TCRCYSGGGCAC 1.00E−11 718 GCCCTCACGTGG 1.00E−09 719 ACCCCTATGAAA1.00E−06 720 ACACCCACACGA 1.00E−05 721 TAGGAGGGTGAG 1.00E−05 722ACCCTACCTCCG 1.00E−04 723 CCTGACGTCCTC 1.00E−04 724 CGTAGTAGGTGA1.00E−04 725 AGACTGTACATT 1.00E−02 726 “NA” means this motif is withoutany motif instance in the lncRNA primary sequence. “Untreated” meansthis lncRNA did not perform motif scanning. #, SEQ ID NO:

REFERENCES

-   1. Gaj, T., Gersbach, C. A. & Barbas, C. F., 3rd. ZFN, TALEN, and    CRISPR/Cas-based methods for genome engineering. Trends Biotechnol.    31, 397-405 (2013).-   2. Anzalone, A. V. et al. Search-and-replace genome editing without    double-strand breaks or donor DNA. Nature 576, 149-157 (2019).-   3. Strecker, J. et al. RNA-guided DNA insertion with    CRISPR-associated transposases. Science 365, 48-53 (2019).-   4. Rees, H. A. & Liu, D. R. Base editing: precision chemistry on the    genome and transcriptome of living cells. Nat. Rev. Genet. 19,    770-788 (2018).-   5. Pickar-Oliver, A. & Gersbach, C. A. The next generation of    CRISPR-Cas technologies and applications. Nat. Rev. Mol. Cell Biol.    20, 490-507 (2019).-   6. Thakore, P. I., Black, J. B., Hilton, I. B. & Gersbach, C. A.    Editing the epigenome: technologies for programmable transcription    and epigenetic modulation. Nat. Methods 13, 127-137 (2016).-   7. Wang, H., La Russa, M. & Qi, L. S. CRISPR/Cas9 in Genome Editing    and Beyond. Annu. Rev. Biochem. 85, 227-264 (2016).-   8. Jolma, A. et al. Multiplexed massively parallel SELEX for    characterization of human transcription factor binding    specificities. Genome Res. 20, 861-873 (2010).-   9. Valouev, A. et al. Genome-wide analysis of transcription factor    binding sites based on ChIP-Seq data. Nat. Methods 5, 829-834    (2008).-   10. Bulyk, M. L. Computational prediction of transcription-factor    binding site locations.

Genome Biol. 5, 201 (2003).

-   11. Blanchette, M. et al. Genome-wide computational prediction of    transcriptional regulatory modules reveals new insights into human    gene expression. Genome Res. 16, 656-668 (2006).-   12. Zhao, W. et al. CRISPR-Cas9-mediated functional dissection of    3′-UTRs. Nucleic Acids Res. 45, 10800-10810 (2017).-   13. Xue, M., Zhuo, Y. & Shan, B. MicroRNAs, Long Noncoding RNAs, and    Their Functions in Human Disease. Methods Mol. Biol. 1617, 1-25    (2017).-   14. Li, J., Liang, Q., Song, W. & Marchisio, M. A. Nucleotides    upstream of the Kozak sequence strongly influence gene expression in    the yeast. J. Biol. Eng. 11, 25 (2017).-   15. Pinello, L., Farouni, R. & Yuan, G.-C. Haystack: systematic    analysis of the variation of epigenetic states and cell-type    specific regulatory elements. Bioinformatics 34, 1930-1933 (2018).-   16. Jolma, A. et al. DNA-dependent formation of transcription factor    pairs alters their binding specificity. Nature 527, 384-388 (2015).-   17. Wang, C., Zhang, M. Q. & Zhang, Z. Computational identification    of active enhancers in model organisms. Genomics Proteomics    Bioinformatics 11, 142-150 (2013).-   18. Yang, J. & Corces, V. G. Chromatin insulators: a role in nuclear    organization and gene expression. Adv. Cancer Res. 110, 43-76    (2011).-   19. Doni Jayavelu, N., Jajodia, A., Mishra, A. & Hawkins, R. D.    Candidate silencer elements for the human and mouse genomes. Nat.    Commun. 11, 1061 (2020).-   20. Smale, S. T. & Kadonaga, J. T. The RNA polymerase II core    promoter. Annu. Rev.

Biochem. 72, 449-479 (2003).

-   21. Shen, M. W. et al. Predictable and precise template-free CRISPR    editing of pathogenic variants. Nature 563, 646-651 (2018).-   22. Chen, W. et al. Massively parallel profiling and predictive    modeling of the outcomes of CRISPR/Cas9-mediated double-strand break    repair. Nucleic Acids Res. 47, 7989-8003 (2019).-   23. Nambiar, T. S. et al. Stimulation of CRISPR-mediated    homology-directed repair by an engineered RAD18 variant. Nat.    Commun. 10, 3395 (2019).-   24. Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. &    Liu, D. R. Programmable editing of a target base in genomic DNA    without double-stranded DNA cleavage. Nature 533, 420-424 (2016).-   25. Gaudelli, N. M. et al. Programmable base editing of AT to GC in    genomic DNA without DNA cleavage. Nature 551, 464-471 (2017).-   26. Maresca, M., Lin, V. G., Guo, N. & Yang, Y. Obligate    ligation-gated recombination (ObLiGaRe): custom-designed    nuclease-mediated targeted integration through nonhomologous end    joining. Genome Res. 23, 539-546 (2013).-   27. Suzuki, K. et al. In vivo genome editing via CRISPR/Cas9    mediated homology-independent targeted integration. Nature 540,    144-149 (2016).-   28. Lisse, T. S., Hewison, M. & Adams, J. S. Hormone response    element binding proteins: novel regulators of vitamin D and estrogen    signaling. Steroids 76, 331-339 (2011).-   29. Kribelbauer, J. F., Rastogi, C., Bussemaker, H. J. & Mann, R. S.    Low-Affinity Binding Sites and the Transcription Factor Specificity    Paradox in Eukaryotes. Annu. Rev. Cell Dev. Biol. 35, 357-379    (2019).-   30. Ibarra, I. L. et al. Mechanistic insights into transcription    factor cooperativity and its impact on protein-phenotype    interactions. Nat. Commun. 11, 124 (2020).-   31. Mohaghegh, N. et al. NextPBM: a platform to study cell-specific    transcription factor binding and cooperativity. Nucleic Acids Res.    47, e31 (2019).-   32. Farley, E. K. et al. Suboptimization of developmental enhancers.    Science 350, 325-328 (2015).-   33. D'Alessio, A. C. et al. A Systematic Approach to Identify    Candidate Transcription Factors that Control Cell Identity. Stem    Cell Reports 5, 763-775 (2015).-   34. Jones, P. A. & Takai, D. The role of DNA methylation in    mammalian epigenetics. Science 293, 1068-1070 (2001).-   35. DiNardo, D. N., Butcher, D. T., Robinson, D. P., Archer, T. K. &    Rodenhiser, D. I. Functional analysis of CpG methylation in the    BRCA1 promoter region. Oncogene 20, 5331-5340 (2001).-   36. Guo, Y. et al. Regulation of DNA methylation in human breast    cancer. Effect on the urokinase-type plasminogen activator gene    production and tumor invasion. J. Biol. Chem. 277, 41571-41579    (2002).-   37. Yu, L. et al. Global assessment of promoter methylation in a    mouse model of cancer identifies ID4 as a putative tumor-suppressor    gene in human leukemia. Nat. Genet. 37, 265-274 (2005).-   38. Vierstra, J., Lazar, J., Sandstrom, R. et al. Global reference    mapping of human transcription factor footprints. Nature 583,    729-736 (2020).

EXEMPLARY SEQUENCES Streptococcus pyogenes Cas9, SEQ ID NO: 372MDKKYSIGLDIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDGSPKKKRKVSSDYKDHDGDYKDHDIDYKDDDDKSpRY Cas9 variant, SEQ ID NO: 373MDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAERTRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESIRPKRNSDKLIARKKDWDPKKYGGFLWPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAKQLQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTRLGAPRAFKYFDTTIDPKQYRSTKEVLDATLIHQSITGLYE TRIDLSQLGGDSpG Cas9 variant, SEQ ID NO: 374MDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFLWPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAKQLQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKQYRSTKEVLDATLIHQSITGLYE TRIDLSQLGGDBE1 for Mammalian expression (rAPOBEC1-XTEN- dCas9-NLS), SEQ ID NO: 375MSSETGPVAVDPTLRRRIEPHEFEVFFDPRELRKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGSETPGTSESATPESDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDAIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSPKKKRKVBE2 (rAPOBEC1-XTEN-dCas9-UGI-NLS) SEQ ID NO: 376MSSETGPVAVDPTLRRRIEPHEFEVFFDPRELRKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGSETPGTSESATPESDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDAIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGGSPKKKRKVBE3 (rAPOBEC1-XTEN-Cas9n-UGI-NLS) SEQ ID NO: 377MSSETGPVAVDPTLRRRIEPHEFEVFFDPRELRKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGSETPGTSESATPESDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGGSPKKKRKVCDA1-BE3: SEQ ID NO: 378MTDAEYVRIHEKLDIYTFKKQFFNNKKSVSHRCYVLFELKRRGERRACFWGYAVNKPQSGTERGIHAEIFSIRKVEEYLRDNPGQFTINWYSSWSPCADCAEKILEWYNQELRGNGHTLKIWACKLYYEKNARNQIGLWNLRDNGVGLNVMVSEHYQCCRKIFIQSSHNQLNENRWLEKTLKRAEKRRSELSIMIQVKILHTTKSPAVSGSETPGTSESATPESDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGGSPKKKRKV AID-BE3: SEQ ID NO: 379MDSLLMNRRKFLYQFKNVRWAKGRRETYLCYVVKRRDSATSFSLDFGYLRNKNGCHVELLFLRYISDWDLDPGRCYRVTWFTSWSPCYDCARHVADFLRGNPNLSLRIFTARLYFCEDRKAEPEGLRRLHRAGVQIAIMTFKDYFYCWNTFVENHERTFKAWEGLHENSVRLSRQLRRILLPLYEVDDLRDAFRTLGLSGSETPGTSESATPESDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGGSPKKKRKV BE3-Gam: SEQ ID NO: 380MAKPAKRIKSAAAAYVPQNRDAVITDIKRIGDLQREASRLETEMNDAIAEITEKFAARIAPIKTDIETLSKGVQGWCEANRDELTNGGKVKTANLVTGDVSWRVRPPSVSIRGMDAVMETLERLGLQRFIRTKQEINKEAILLEPKAVAGVAGITVKSGIEDFSIIPFEQEAGISGSETPGTSESATPESSSETGPVAVDPTLRRRIEPHEFEVFFDPRELRKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGSETPGTSESATPESDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKML SGGSPKKKRKVSaBE3-Gam: SEQ ID NO: 381MAKPAKRIKSAAAAYVPQNRDAVITDIKRIGDLQREASRLETEMNDAIAEITEKFAARIAPIKTDIETLSKGVQGWCEANRDELTNGGKVKTANLVTGDVSWRVRPPSVSIRGMDAVMETLERLGLQRFIRTKQEINKEAILLEPKAVAGVAGITVKSGIEDFSIIPFEQEAGISGSETPGTSESATPESSSETGPVAVDPTLRRRIEPHEFEVFFDPRELRKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGSETPGTSESATPESGKRNYILGLAIGITSVGYGIIDYETRDVIDAGVRLFKEANVENNEGRRSKRGARRLKRRRRHRIQRVKKLLFDYNLLTDHSELSGINPYEARVKGLSQKLSEEEFSAALLHLAKRRGVHNVNEVEEDTGNELSTKEQISRNSKALEEKYVAELQLERLKKDGEVRGSINRFKTSDYVKEAKQLLKVQKAYHQLDQSFIDTYIDLLETRRTYYEGPGEGSPFGWKDIKEWYEMLMGHCTYFPEELRSVKYAYNADLYNALNDLNNLVITRDENEKLEYYEKFQIIENVFKQKKKPTLKQIAKEILVNEEDIKGYRVTSTGKPEFTNLKVYHDIKDITARKEIIENAELLDQIAKILTIYQSSEDIQEELTNLNSELTQEEIEQISNLKGYTGTHNLSLKAINLILDELWHTNDNQIAIFNRLKLVPKKVDLSQQKEIPTTLVDDFILSPVVKRSFIQSIKVINAIIKKYGLPNDIIIELAREKNSKDAQKMINEMQKRNRQTNERIEEIIRTTGKENAKYLIEKIKLHDMQEGKCLYSLEAIPLEDLLNNPFNYEVDHIIPRSVSFDNSFNNKVLVKQEENSKKGNRTPFQYLSSSDSKISYETFKKHILNLAKGKGRISKTKKEYLLEERDINRFSVQKDFINRNLVDTRYATRGLMNLLRSYFRVNNLDVKVKSINGGFTSFLRRKWKFKKERNKGYKHHAEDALIIANADFIFKEWKKLDKAKKVMENQMFEEKQAESMPEIETEQEYKEIFITPHQIKHIKDFKDYKYSHRVDKKPNRELINDTLYSTRKDDKGNTLIVNNLNGLYDKDNDKLKKLINKSPEKLLMYHHDPQTYQKLKLIMEQYGDEKNPLYKYYEETGNYLTKYSKKDNGPVIKKIKYYGNKLNAHLDITDDYPNSRNKVVKLSLKPYRFDVYLDNGVYKFVTVKNLDVIKKENYYEVNSKCYEEAKKLKKISNQAEFIASFYNNDLIKINGELYRVIGVNNDLLNRIEVNMIDITYREYLENMNDKRPPRIIKTIASKTQSIKKYSTDILGNLYEVKSKKHPQIIKKGGSPKKKRKVSSDYKDHDGDYKDHDIDYKDDDDKSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGGSPKKKRKV BE4: SEQ ID NO: 382MSSETGPVAVDPTLRRRIEPHEFEVFFDPRELRKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGGSPKKKRKBE4-Gam: SEQ ID NO: 383MAKPAKRIKSAAAAYVPQNRDAVITDIKRIGDLQREASRLETEMNDAIAEITEKFAARIAPIKTDIETLSKGVQGWCEANRDELTNGGKVKTANLVTGDVSWRVRPPSVSIRGMDAVMETLERLGLQRFIRTKQEINKEAILLEPKAVAGVAGITVKSGIEDFSIIPFEQEAGISGSETPGTSESATPESSSETGPVAVDPTLRRRIEPHEFEVFFDPRELRKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGG SPKKKRKSaBE4: SEQ ID NO: 384MSSETGPVAVDPTLRRRIEPHEFEVFFDPRELRKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGGSSGGSSGSETPGTSESATPESSGGSSGGSGKRNYILGLAIGITSVGYGIIDYETRDVIDAGVRLFKEANVENNEGRRSKRGARRLKRRRRHRIQRVKKLLFDYNLLTDHSELSGINPYEARVKGLSQKLSEEEFSAALLHLAKRRGVHNVNEVEEDTGNELSTKEQISRNSKALEEKYVAELQLERLKKDGEVRGSINRFKTSDYVKEAKQLLKVQKAYHQLDQSFIDTYIDLLETRRTYYEGPGEGSPFGWKDIKEWYEMLMGHCTYFPEELRSVKYAYNADLYNALNDLNNLVITRDENEKLEYYEKFQIIENVFKQKKKPTLKQIAKEILVNEEDIKGYRVTSTGKPEFTNLKVYHDIKDITARKEIIENAELLDQIAKILTIYQSSEDIQEELTNLNSELTQEEIEQISNLKGYTGTHNLSLKAINLILDELWHTNDNQIAIFNRLKLVPKKVDLSQQKEIPTTLVDDFILSPVVKRSFIQSIKVINAIIKKYGLPNDIIIELAREKNSKDAQKMINEMQKRNRQTNERIEEIIRTTGKENAKYLIEKIKLHDMQEGKCLYSLEAIPLEDLLNNPFNYEVDHIIPRSVSFDNSFNNKVLVKQEENSKKGNRTPFQYLSSSDSKISYETFKKHILNLAKGKGRISKTKKEYLLEERDINRFSVQKDFINRNLVDTRYATRGLMNLLRSYFRVNNLDVKVKSINGGFTSFLRRKWKFKKERNKGYKHHAEDALIIANADFIFKEWKKLDKAKKVMENQMFEEKQAESMPEIETEQEYKEIFITPHQIKHIKDFKDYKYSHRVDKKPNRELINDTLYSTRKDDKGNTLIVNNLNGLYDKDNDKLKKLINKSPEKLLMYHHDPQTYQKLKLIMEQYGDEKNPLYKYYEETGNYLTKYSKKDNGPVIKKIKYYGNKLNAHLDITDDYPNSRNKVVKLSLKPYRFDVYLDNGVYKFVTVKNLDVIKKENYYEVNSKCYEEAKKLKKISNQAEFIASFYNNDLIKINGELYRVIGVNNDLLNRIEVNMIDITYREYLENMNDKRPPRIIKTIASKTQSIKKYSTDILGNLYEVKSKKHPQIIKKGGSPKKKRKVSSDYKDHDGDYKDHDIDYKDDDDKSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLS GGSPKKKRKVSaBE4-Gam: SEQ ID NO: 385MAKPAKRIKSAAAAYVPQNRDAVITDIKRIGDLQREASRLETEMNDAIAEITEKFAARIAPIKTDIETLSKGVQGWCEANRDELTNGGKVKTANLVTGDVSWRVRPPSVSIRGMDAVMETLERLGLQRFIRTKQEINKEAILLEPKAVAGVAGITVKSGIEDFSIIPFEQEAGISGSETPGTSESATPESSSETGPVAVDPTLRRRIEPHEFEVFFDPRELRKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGGSSGGSSGSETPGTSESATPESSGGSSGGSGKRNYILGLAIGITSVGYGIIDYETRDVIDAGVRLFKEANVENNEGRRSKRGARRLKRRRRHRIQRVKKLLFDYNLLTDHSELSGINPYEARVKGLSQKLSEEEFSAALLHLAKRRGVHNVNEVEEDTGNELSTKEQISRNSKALEEKYVAELQLERLKKDGEVRGSINRFKTSDYVKEAKQLLKVQKAYHQLDQSFIDTYIDLLETRRTYYEGPGEGSPFGWKDIKEWYEMLMGHCTYFPEELRSVKYAYNADLYNALNDLNNLVITRDENEKLEYYEKFQIIENVFKQKKKPTLKQIAKEILVNEEDIKGYRVTSTGKPEFTNLKVYHDIKDITARKEIIENAELLDQIAKILTIYQSSEDIQEELTNLNSELTQEEIEQISNLKGYTGTHNLSLKAINLILDELWHTNDNQIAIFNRLKLVPKKVDLSQQKEIPTTLVDDFILSPVVKRSFIQSIKVINAIIKKYGLPNDIIIELAREKNSKDAQKMINEMQKRNRQTNERIEEIIRTTGKENAKYLIEKIKLHDMQEGKCLYSLEAIPLEDLLNNPFNYEVDHIIPRSVSFDNSFNNKVLVKQEENSKKGNRTPFQYLSSSDSKISYETFKKHILNLAKGKGRISKTKKEYLLEERDINRFSVQKDFINRNLVDTRYATRGLMNLLRSYFRVNNLDVKVKSINGGFTSFLRRKWKFKKERNKGYKHHAEDALIIANADFIFKEWKKLDKAKKVMENQMFEEKQAESMPEIETEQEYKEIFITPHQIKHIKDFKDYKYSHRVDKKPNRELINDTLYSTRKDDKGNTLIVNNLNGLYDKDNDKLKKLINKSPEKLLMYHHDPQTYQKLKLIMEQYGDEKNPLYKYYEETGNYLTKYSKKDNGPVIKKIKYYGNKLNAHLDITDDYPNSRNKVVKLSLKPYRFDVYLDNGVYKFVTVKNLDVIKKENYYEVNSKCYEEAKKLKKISNQAEFIASFYNNDLIKINGELYRVIGVNNDLLNRIEVNMIDITYREYLENMNDKRPPRIIKTIASKTQSIKKYSTDILGNLYEVKSKKHPQIIKKGGSPKKKRKVSSDYKDHDGDYKDHDIDYKDDDDKSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGGSPKKKRKV BE4max and AncBE4max, SEQ ID NO: 386MKRTADGSEFESPKKKRKV [rat APOBEC1 or evoAPOBEC1, or FERNY,or evoFERNY, or ancestral(anc) APOBEC, sequences see below]SGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKML_SGGSGGSGGS_TNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGGSKRTADGSEFEPKKKRKV Rat APOBEC1, SEQ ID NO: 387SSETGPVAVDPTLRRRIEPHEFEVFFDPRELRKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKAnc689 APOBEC, SEQ ID NO: 388SSETGPVAVDPTLRRRIEPHEFEVFFDPRELRKETCLLYEIKWGTSHKIWRHSSKNTTKHVEVNFIEKFTSERHFCPSTSCSITWFLSWSPCGECSKAITEFLSQHPNVTLVIYVARLYHHMDQQNRQGLRDLVNSGVTIQIMTAPEYDYCWRNFVNYPPGKEAHWPRYPPLWMKLYALELHAGILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKAnc687 APOBEC, SEQ ID NO: 389SSETGPVAVDPTLRRRIEPHEFEVFFDPRELRKEACLLYEIKWGTSHKIWRNSGKNTTKHVEVNFIEKFTSERHFCPSISCSITWFLSWSPCWECSKAIREFLSQHPNVTLVIYVARLFQHMDQQNRQGLRDLVNSGVTIQIMTASEYDHCWRNFVNYPPGKEAHWPRYPPLWMKLYALELHAGILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKAnc686 APOBEC, SEQ ID NO: 390SSETGPVAVDPTLRRRFEPEFFNRNYDPRELRKETYLLYEIKWGKESKIWRHTSNNRTQHAEVNFLENFFNELYFNPSTHCSITWFLSWSPCGECSKAIVEFLKEHPNVNLEIYVARLYLCEDERNRQGLRDLVNSGVTIRIMNLPDYNYCWRTFVSHQGGDEDYWPRHFAPWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKAnc655 APOBEC, SEQ ID NO: 391SSETGPVAVDPTLRRRIEPFYFQFNNDPRACRRKTYLCYELKQDGSTWVWKRTLHNKGRHAEICFLEKISSLEKLDPAQHYRITWYMSWSPCSNCAQKIVDFLKEHPHVNLRIYVARLYYHEEERYQEGLRNLRRSGVSIRVMDLPDFEHCWETFVDNGGGPFQPWPGLEELNSKQLSRRLQAGILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKAnc733 APOBEC, SEQ ID NO: 392SSETGPVAVDPTLRRRIEPFHFQFNNDPRAYRRKTYLCYELKQDGSTWVLDRTLRNKGRHAEICFLDKINSWERLDPAQHYRVTWYMSWSPCSNCAQQVVDFLKEHPHVNLRIFAARLYYHEQRRYQEGLRSLRGSGVPVAVMTLPDFEHCWETFVDHGGRPFQPWDGLEELNSRSLSRRLQAGILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKAPOBEC ancestor #686, SEQ ID NO: 393EFFNRNYDPRELRKETYLLYEIKWGKESKIWRHWCTSNNRTQHAEVNFLENFFNELYFNPSTHCSITWFLSWSPCGECSKAIVEFLKEHPNVNLEIYVARLYLCEDERNRQGLRDLVNSGVTIRIMNLPDYNYCWRTFVSHQGGDEDYWPRHFAPWVRLAPOBEC ancestor #733, SEQ ID NO: 394FHFQFNNDPRAYRRKTYLCYELKQDGSTWVLDRGCTLRNKGRHAEICFLDKINSWERLDPAQHYRVTWYMSWSPCSNCAQQVVDFLKEHPHVNLRIFAARLYYHEQRRYQEGLRSLRGSGVPVAVMTLPDFEHCWETFVDHGGRPFQPWDGLEELNSRSLSRRLQAGAPOBEC ancestor #656_FERNY, SEQ ID NO: 395FERNYDPRELRKETYLLYEIKWGKSGKLWRHWCQNNRTQHAEVYFLENIFNARRFNPSTHCSITWYLSWSPCAECSQKIVDFLKEHPNVNLEIYVARLYYHEDERNRQGLRDLVNSGVTIRIMDLPDYNYCWKTFVSDQGGDEDYWPGHFAPWIKQYSLKLAPOBEC ancestor #655, SEQ ID NO: 396FYFQFNNDPRACRRKTYLCYELKQDGSTWVWKRGCTLHNKGRHAEICFLEKISSLEKLDPAQHYRITWYMSWSPCSNCAQKIVDFLKEHPHVNLRIYVARLYYHEEERYQEGLRNLRRSGVSIRVMDLPDFEHCWETFVDNGGGPFQPWPGLEENSKQLSRRLQAGAPOBEC ancestor #649, SEQ ID NO: 397FYEEFNNTLKSCRHKTLLCFSLKQDENTTLWKWGYAHNNGRHAEILVLREIENYEKLDPAAKYRITLYMSYSPCNDCADKIVDFLKKHPNVNLNIKVSRLYYHEDEKYQEGLRNLKQPGVSLKVMDRSDFEECFDLFVDPGGGEFQPWPGLEEKSKQYSATLQAGevoFERNY-APOBEC1, SEQ ID NO: 398SFERNYDPRELRKETYLLYEIKWGKSGKLWRHWCQNNRTQHAEVYFLENIFNARRFNPSTHCSITWYLSWSPCAECSQKIVDFLKEHPNVNLEIYVARLYYPENERNRQGLRDLVNSGVTIRIMDLPDYNYCWKTFVSDQGGDEDYWPGHFAPWIKQYSLKL evoAPOBEC1, SEQ ID NO: 399SSKTGPVAVDPTLRRRIEPHEFEVFFDPRELRKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPNVTLFIYIARLYHLANPRNRQGLRDLISSGVTIQIMTEQESGYCWHNFVNYSPSNESHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQSQLTSFTIALQSCHYQRLPPHILWATGLKABE6.3, SEQ ID NO: 400MSEVEFSHEYWMRHALTLAKRAWDEREVPVGAVLVHNNRVIGEGWNRPIGRHDPTAHAEIMALRQGGLVMQNYRLIDATYVTLEPCVMCAGAMIHSRIGRVVFGARDAKTGAAGSLMDVLHHPGMNHRVEITEGILADECAALLSDFFRMRRQEIKAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSSEVEFSHEYWMRHALTLAKRAWDEREVPVGAVLVLNNRVIGEGWNRSIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYVTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHYPGMNHRVEITEGILADECAALLCYFFRMRRQVFNAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSPKK KRKVABE7.8, SEQ ID NO: 401MSEVEFSHEYWMRHALTLAKRAWDEREVPVGAVLVHNNRVIGEGWNRPIGRHDPTAHAEIMALRQGGLVMQNYRLIDATLYVTLEPCVMCAGAMIHSRIGRVVFGARDAKTGAAGSLMDVLHHPGMNHRVEITEGILADECAALLSDFFRMRRQEIKAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSSEVEFSHEYWMRHALTLAKRALDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYVTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHYPGMNHRVEITEGILADECNALLCYFFRMRRQVFNAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSPK KKRKVABE7.9, SEQ ID NO: 402MSEVEFSHEYWMRHALTLAKRAWDEREVPVGAVLVHNNRVIGEGWNRPIGRHDPTAHAEIMALRQGGLVMQNYRLIDATLYVTLEPCVMCAGAMIHSRIGRVVFGARDAKTGAAGSLMDVLHHPGMNHRVEITEGILADECAALLSDFFRMRRQEIKAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSSEVEFSHEYWMRHALTLAKRALDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYVTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHYPGMNHRVEITEGILADECNALLCYFFRMPRQVFNAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSPK KKRKVABE7.10, SEQ ID NO: 403MSEVEFSHEYWMRHALTLAKRAWDEREVPVGAVLVHNNRVIGEGWNRPIGRHDPTAHAEIMALRQGGLVMQNYRLIDATLYVTLEPCVMCAGAMIHSRIGRVVFGARDAKTGAAGSLMDVLHHPGMNHRVEITEGILADECAALLSDFFRMRRQEIKAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSSEVEFSHEYWMRHALTLAKRARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYVTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHYPGMNHRVEITEGILADECAALLCYFFRMPRQVFNAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSPK KKRKVABEmax, SEQ ID NO: 404MKRTADGSEFESPKKKRKVSEVEFSHEYWMRHALTLAKRAWDEREVPVGAVLVHNNRVIGEGWNRPIGRHDPTAHAEIMALRQGGLVMQNYRLIDATLYVTLEPCVMCAGAMIHSRIGRVVFGARDAKTGAAGSLMDVLHHPGMNHRVEITEGILADECAALLSDFFRMRRQEIKAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSSEVEFSHEYWMRHALTLAKRARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYVTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHYPGMNHRVEITEGILADECAALLCYFFRMPRQVFNAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKV miniABEmax, SEQ ID NO: 405NLS-tadA(7.10)-32AA linker*-hSpCas9n(D10A)-NLS-P2A-EGFP-NLSMKRTADGSEFESPKKKRKVSEVEFSHEYWMRHALTLAKRARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYVTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHYPGMNHRVEITEGILADECAALLCYFFRMPRQVFNAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKVGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKSGGSPKKKRKVminiABEmax-V82G, SEQ ID NO: 406:MKRTADGSEFESPKKKRKVSEVEFSHEYWMRHALTLAKRARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYGTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHYPGMNHRVEITEGILADECAALLCYFFRMPRQVFNAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKVGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKSGGSPKKKRKVminiABEmax-K20A/R21A, SEQ ID NO: 407:MKRTADGSEFESPKKKRKVSEVEFSHEYWMRHALTLAAAARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYVTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHYPGMNHRVEITEGILADECAALLCYFFRMPRQVFNAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKVGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKSGGSPKKKRKVminiABEmax-V106W, SEQ ID NO: 408:MKRTADGSEFESPKKKRKVSEVEFSHEYWMRHALTLAKRARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYVTFEPCVMCAGAMIHSRIGRVVFGWRNAKTGAAGSLMDVLHYPGMNHRVEITEGILADECAALLCYFFRMPRQVFNAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKVGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKSGGSPKKKRKVABEmax containing newer ABE8 TadA* variants (see below), SEQ ID NO: 409MKRTADGSEFESPKKKRKVSEVEFSHEYWMRHALTLAKRAWDEREVPVGAVLVHNNRVIGEGWNRPIGRHDPTAHAEIMALRQGGLVMQNYRLIDATLYVTLEPCVMCAGAMIHSRIGRVVFGARDAKTGAAGSLMDVLHHPGMNHRVEITEGILADECAALLSDFFRMRRQEIKAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGS[TadA* ABE8e orother ABE8 sequences as indicated below]SGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKVminiABEmax containing newer ABE8 TadA* variants(see below), SEQ ID NO: 410MKRTADGSEFESPKKKRKV[TadA* ABE8e or other ABE8 sequences asindicated below]SGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKV TadA* (ABE8e), SEQ ID NO: 411SEVEFSHEYWMRHALTLAKRARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYVTFEPCVMCAGAMIHSRIGRVVFGVRNSKRGAAGSLMNVLNYPGMNHRVEITEGILADECAALLCDFYRMPRQVFNAQKKAQSSINTadA* (ABE8e_V82G), SEQ ID NO: 412SEVEFSHEYWMRHALTLAKRARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYGTFEPCVMCAGAMIHSRIGRVVFGVRNSKRGAAGSLMNVLNYPGMNHRVEITEGILADECAALLCDFYRMPRQVFNAQKKAQSSINTadA* (ABE8e_K20A/R21A), SEQ ID NO: 413SEVEFSHEYWMRHALTLAAAARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYVTFEPCVMCAGAMIHSRIGRVVFGVRNSKRGAAGSLMNVLNYPGMNHRVEITEGILADECAALLCDFYRMPRQVFNAQKKAQSSINTadA* (ABE8.8), SEQ ID NO: 414SEVEFSHEYWMRHALTLAKRARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYVTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHHPGMNHRVEITEGILADECAALLCRFFRMPRRVFNAQKKAQSSTDTadA* (ABE8.13), SEQ ID NO: 415SEVEFSHEYWMRHALTLAKRARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLYDATLYVTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHHPGMNHRVEITEGILADECAALLCRFFRMPRRVFNAQKKAQSSTDTadA* (ABE8.17), SEQ ID NO: 416SEVEFSHEYWMRHALTLAKRARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYSTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHYPGMNHRVEITEGILADECAALLCYFFRMPRRVFNAQKKAQSSTDTadA* (ABE8.20), SEQ ID NO: 417SEVEFSHEYWMRHALTLAKRARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLYDATLYSTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHHPGMNHRVEITEGILADECAALLCRFFRMPRRVFNAQKKAQSSTDSPACE (dual-deaminase base editor), SEQ ID NO: 418MKRTADGSEFESPKKKRKVSEVEFSHEYWMRHALTLAKRARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYGTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHYPGMNHRVEITEGILADECAALLCYFFRMPRQVFNAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKVSGGSSGGSSGSETPGTSESATPESSGGSSGGSTDAEYVRIHEKLDIYTFKKQFFNNKKSVSHRCYVLFELKRRGERRACFWGYAVNKPQSGTERGIHAEIFSIRKVEEYLRDNPGQFTINWYSSWSPCADCAEKILEWYNQELRGNGHTLKIWACKLYYEKNARNQIGLWNLRDNGVGLNVMVSEHYQCCRKIFIQSSHNQLNENRWLEKTLKRAEKWRSELSIMIQVKILHTTKSPAVSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKSGGSPKKKRKSPACE-ΔUGI (SPACE without UGI fusion), SEQ ID NO: 419MKRTADGSEFESPKKKRKVSEVEFSHEYWMRHALTLAKRARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYGTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHYPGMNHRVEITEGILADECAALLCYFFRMPRQVFNAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKVSGGSSGGSSGSETPGTSESATPESSGGSSGGSTDAEYVRIHEKLDIYTFKKQFFNNKKSVSHRCYVLFELKRRGERRACFWGYAVNKPQSGTERGIHAEIFSIRKVEEYLRDNPGQFTINWYSSWSPCADCAEKILEWYNQELRGNGHTLKIWACKLYYEKNARNQIGLWNLRDNGVGLNVMVSEHYQCCRKIFIQSSHNQLNENRWLEKTLKRAEKWRSELSIMIQVKILHTTKSPAVGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKSGGSPKKKRKVSPACE-NG, SEQ ID NO: 420MKRTADGSEFESPKKKRKVSEVEFSHEYWMRHALTLAKRARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYGTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHYPGMNHRVEITEGILADECAALLCYFFRMPRQVFNAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESIRPKRNSDKLIARKKDWDPKKYGGFVSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASARFLQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPRAFKYFDTTIDRKVYRSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKVSGGSSGGSSGSETPGTSESATPESSGGSSGGSTDAEYVRIHEKLDIYTFKKQFFNNKKSVSHRCYVLFELKRRGERRACFWGYAVNKPQSGTERGIHAEIFSIRKVEEYLRDNPGQFTINWYSSWSPCADCAEKILEWYNQELRGNGHTLKIWACKLYYEKNARNQIGLWNLRDNGVGLNVMVSEHYQCCRKIFIQSSHNQLNENRWLEKTLKRAEKWRSELSIMIQVKILHTTKSPAVSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFsVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKSGGSPKKKRK VSPACE-VRQR, SEQ ID NO: 421MKRTADGSEFESPKKKRKVSEVEFSHEYWMRHALTLAKRARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYGTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHYPGMNHRVEITEGILADECAALLCYFFRMPRQVFNAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFVSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASARELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKQYRSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKVSGGSSGGSSGSETPGTSESATPESSGGSSGGSTDAEYVRIHEKLDIYTFKKQFFNNKKSVSHRCYVLFELKRRGERRACFWGYAVNKPQSGTERGIHAEIFSIRKVEEYLRDNPGQFTINWYSSWSPCADCAEKILEWYNQELRGNGHTLKIWACKLYYEKNARNQIGLWNLRDNGVGLNVMVSEHYQCCRKIFIQSSHNQLNENRWLEKTLKRAEKWRSELSIMIQVKILHTTKSPAVSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFsVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKSGGSPKKKRK VSPACE-NAA, SEQ ID NO: 422MKRTADGSEFESPKKKRKVSEVEFSHEYWMRHALTLAKRARDEREVPVGAVLVLNNRVIGEGWNRAIGLHDPTAHAEIMALRQGGLVMQNYRLIDATLYGTFEPCVMCAGAMIHSRIGRVVFGVRNAKTGAAGSLMDVLHYPGMNHRVEITEGILADECAALLCYFFRMPRQVFNAQKKAQSSTDSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEIQTVGQNGGLFDDNPKSPLEVTPSKLVPLKKELNPKKYGGYQKPTTAYPVLLITDTKQLIPISVMNKKQFEQNPVKFLRDRGYQQVGKNDFIKLPKYTLVDIGDGIKRLWASSKEIHKGNQLVVSKKSQILLYHAHHLDSDLSNDYLQNHNQQFDVLFNEIISFSKKCKLGKEHIQKIENVYSNKKNSASIEELAESFIKLLGFTQLGATSPFNFLGVKLNQKQYKGKKDYILPCTEGTLIRQSITGLYETRVDLSKIGEDSGGSKRTADGSEFEPKKKRKVSGGSSGGSSGSETPGTSESATPESSGGSSGGSTDAEYVRIHEKLDIYTFKKQFFNNKKSVSHRCYVLFELKRRGERRACFWGYAVNKPQSGTERGIHAEIFSIRKVEEYLRDNPGQFTINWYSSWSPCADCAEKILEWYNQELRGNGHTLKIWACKLYYEKNARNQIGLWNLRDNGVGLNVMVSEHYQCCRKIFIQSSHNQLNENRWLEKTLKRAEKWRSELSIMIQVKILHTTKSPAVSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLSGGSGGSGGSTNLSDIIEKETGKQLVIQESILMLPEEVEEVIGNKPESDILVHTAYDESTDENVMLLTSDAPEYKPWALVIQDSNGENKIKMLGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKSGGSPKKKRKVBE4max(R33A)-ΔUGI-eUNG, SEQ ID NO: 423MKRTADGSEFESPKKKRKVSSETGPVAVDPTLRRRIEPHEFEVFFDPRELAKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSGGSGGSANELTWHDVLAEEKQQPYFLNTLQTVASERQSGVTIYPPQKDVFNAFRFTELGDVKVVILGQDPYHGPGQAHGLAFSVRPGIAIPPSLLNMYKELENTIPGFTRPNHGYLESWARQGVLLLNTVLTVRAGQAHSHASLGWETFTDKVISLINQHREGVVFLLWGSHAQKKGAIIDKQRHHVLKAPHPSPLSAHRGFFGCNHFVLANQWLEQRGETPIDWMPVLPAESESGGSKRTADGSEFEPKKKRKVGGGGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKeUNG-BE4max(R33A)-ΔUGI = CGBE1, SEQ ID NO: 424MKRTADGSEFESPKKKRKVANELTWHDVLAEEKQQPYFLNTLQTVASERQSGVTIYPPQKDVFNAFRFTELGDVKVVILGQDPYHGPGQAHGLAFSVRPGIAIPPSLLNMYKELENTIPGFTRPNHGYLESWARQGVLLLNTVLTVRAGQAHSHASLGWETFTDKVISLINQHREGVVFLLWGSHAQKKGAIIDKQRHHVLKAPHPSPLSAHRGFFGCNHFVLANQWLEQRGETPIDWMPVLPAESESGGSGGSGGSSSETGPVAVDPTLRRRIEPHEFEVFFDPRELAKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKVGGGGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKBE4max-ΔUGI, SEQ ID NO: 425MKRTADGSEFESPKKKRKVSSETGPVAVDPTLRRRIEPHEFEVFFDPRELRKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKVGGGGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKeA3A-BE3-ΔUGI-eUNG, SEQ ID NO: 426MEASPASGPRHLMDPHIFTSNFNNGIGRHKTYLCYEVERLDNGTSVKMDQHRGFLHGQAKNLLCGFYGRHAELRFLDLVPSLQLDPAQIYRVTWFISWSPCFSWGCAGEVRAFLQENTHVRLRIFAARIYDYDPLYKEALQMLRDAGAQVSIMTYDEFKHCWDTFVDHQGCPFQPWDGLDEHSQALSGRLRAILQNQGNSGSETPGTSESATPESDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSANELTWHDVLAEEKQQPYFLNTLQTVASERQSGVTIYPPQKDVFNAFRFTELGDVKVVILGQDPYHGPGQAHGLAFSVRPGIAIPPSLLNMYKELENTIPGFTRPNHGYLESWARQGVLLLNTVLTVRAGQAHSHASLGWETFTDKVISLINQHREGVVFLLWGSHAQKKGAIIDKQRHHVLKAPHPSPLSAHRGFFGCNHFVLANQWLEQRGETPIDWMPVLPAESESGGSPKKKRKVGGGGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKBE4max(R33A) w/o UGI = miniCGBEl, SEQ ID NO: 427MKRTADGSEFESPKKKRKVSSETGPVAVDPTLRRRIEPHEFEVFFDPRELAKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKVGGGGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK CGBE1_NG, SEQ ID NO: 428MKRTADGSEFESPKKKRKVANELTWHDVLAEEKQQPYFLNTLQTVASERQSGVTIYPPQKDVFNAFRFTELGDVKVVILGQDPYHGPGQAHGLAFSVRPGIAIPPSLLNMYKELENTIPGFTRPNHGYLESWARQGVLLLNTVLTVRAGQAHSHASLGWETFTDKVISLINQHREGVVFLLWGSHAQKKGAIIDKQRHHVLKAPHPSPLSAHRGFFGCNHFVLANQWLEQRGETPIDWMPVLPAESESGGSGGSGGSSSETGPVAVDPTLRRRIEPHEFEVFFDPRELAKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESIRPKRNSDKLIARKKDWDPKKYGGFVSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASARFLQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPRAFKYFDTTIDRKVYRSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKVGGGGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKminiCGBE1_NG, SEQ ID NO: 429MKRTADGSEFESPKKKRKVSSETGPVAVDPTLRRRIEPHEFEVFFDPRELAKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESIRPKRNSDKLIARKKDWDPKKYGGFVSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASARFLQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPRAFKYFDTTIDRKVYRSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKVGGGGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK CGBE1_VRQR, SEQ ID NO: 430MKRTADGSEFESPKKKRKVANELTWHDVLAEEKQQPYFLNTLQTVASERQSGVTIYPPQKDVFNAFRFTELGDVKVVILGQDPYHGPGQAHGLAFSVRPGIAIPPSLLNMYKELENTIPGFTRPNHGYLESWARQGVLLLNTVLTVRAGQAHSHASLGWETFTDKVISLINQHREGVVFLLWGSHAQKKGAIIDKQRHHVLKAPHPSPLSAHRGFFGCNHFVLANQWLEQRGETPIDWMPVLPAESESGGSGGSGGSSSETGPVAVDPTLRRRIEPHEFEVFFDPRELAKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFVSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASARELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKQYRSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKVGGGGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKminiCGBE1_VRQR, SEQ ID NO: 431MKRTADGSEFESPKKKRKVSSETGPVAVDPTLRRRIEPHEFEVFFDPRELAKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLKSGGSSGGSSGSETPGTSESATPESSGGSSGGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFVSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASARELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKQYRSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSKRTADGSEFEPKKKRKVGGGGSGATNFSLLKQAGDVEENPGPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKPrime Editor 1 (PE1), SEQ ID NO: 432MKRTADGSEFESPKKKRKVDKKYSIGLDIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDAIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSSGGSSGSETPGTSESATPESSGGSSGGSSTLNIEDEYRLHETSKEPDVSLGSTWLSDFPQAWAETGGMGLAVRQAPLIIPLKATSTPVSIKQYPMSQEARLGIKPHIQRLLDQGILVPCQSPWNTPLLPVKKPGTNDYRPVQDLREVNKRVEDIHPTVPNPYNLLSGLPPSHQWYTVLDLKDAFFCLRLHPTSQPLFAFEWRDPEMGISGQLTWTRLPQGFKNSPTLFDEALHRDLADFRIQHPDLILLQYVDDLLLAATSELDCQQGTRALLQTLGNLGYRASAKKAQICQKQVKYLGYLLKEGQRWLTEARKETVMGQPTPKTPRQLREFLGTAGFCRLWIPGFAEMAAPLYPLTKTGTLFNWGPDQQKAYQEIKQALLTAPALGLPDLTKPFELFVDEKQGYAKGVLTQKLGPWRRPVAYLSKKLDPVAAGWPPCLRMVAAIAVLTKDAGKLTMGQPLVILAPHAVEALVKQPPDRWLSNARMTHYQALLLDTDRVQFGPVVALNPATLLPLPEEGLQHNCLDILAEAHGTRPDLTDQPLPDADHTWYTDGSSLLQEGQRKAGAAVTTETEVIWAKALPAGTSAQRAELIALTQALKMAEGKKLNVYTDSRYAFATAHIHGEIYRRRGLLTSEGKEIKNKDEILALLKALFLPKRLSIIHCPGHQKGHSAEARGNRMADQAARKAAITETPDTSTLLIENSSPSGGSKRTADGSEFEPKKKRKVPrime Editor 2 (PE2), SEQ ID NO: 433MKRTADGSEFESPKKKRKVDKKYSIGLDIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDAIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGSSGGSSGSETPGTSESATPESSGGSSGGSSTLNIEDEYRLHETSKEPDVSLGSTWLSDFPQAWAETGGMGLAVRQAPLIIPLKATSTPVSIKQYPMSQEARLGIKPHIQRLLDQGILVPCQSPWNTPLLPVKKPGTNDYRPVQDLREVNKRVEDIHPTVPNPYNLLSGLPPSHQWYTVLDLKDAFFCLRLHPTSQPLFAFEWRDPEMGISGQLTWTRLPQGFKNSPTLFNEALHRDLADFRIQHPDLILLQYVDDLLLAATSELDCQQGTRALLQTLGNLGYRASAKKAQICQKQVKYLGYLLKEGQRWLTEARKETVMGQPTPKTPRQLREFLGKAGFCRLFIPGFAEMAAPLYPLTKPGTLFNWGPDQQKAYQEIKQALLTAPALGLPDLTKPFELFVDEKQGYAKGVLTQKLGPWRRPVAYLSKKLDPVAAGWPPCLRMVAAIAVLTKDAGKLTMGQPLVILAPHAVEALVKQPPDRWLSNARMTHYQALLLDTDRVQFGPVVALNPATLLPLPEEGLQHNCLDILAEAHGTRPDLTDQPLPDADHTWYTDGSSLLQEGQRKAGAAVTTETEVIWAKALPAGTSAQRAELIALTQALKMAEGKKLNVYTDSRYAFATAHIHGEIYRRRGWLTSEGKEIKNKDEILALLKALFLPKRLSIIHCPGHQKGHSAEARGNRMADQAARKAAITETPDTSTLLIENSSPSGGSKRTADGSEFEPKKKRKVCAST system, CRISPR-associated transposasefrom cyanobacteria Scytonema hofmanni-ShCas12k (WP_029636312.1) SEQ ID NO: 434MSQITIQARLISFESNRQQLWKLMADLNTPLINELLCQLGQHPDFEKWQQKGKLPSTVVSQLCQPLKTDPRFAGQPSRLYMSAIHIVDYIYKSWLAIQKRLQQQLDGKTRWLEMLNSDAELVELSGDTLEAIRVKAAEILAIAMPASESDSASPKGKKGKKEKKPSSSSPKRSLSKTLFDAYQETEDIKSRSAISYLLKNGCKLTDKEEDSEKFAKRRRQVEIQIQRLTEKLISRMPKGRDLTNAKWLETLLTATTTVAEDNAQAKRWQDILLTRSSSLPFPLVFETNEDMVWSKNQKGRLCVHFNGLSDLIFEVYCGNRQLHWFQRFLEDQQTKRKSKNQHSSGLFTLRNGHLVWLEGEGKGEPWNLHHLTLYCCVDNRLWTEEGTEIVRQEKADEITKFITNMKKKSDLSDTQQALIQRKQSTLTRINNSFERPSQPLYQGQSHILVGVSLGLEKPATVAVVDAIANKVLAYRSIKQLLGDNYELLNRQRRQQQYLSHERHKAQKNFSPNQFGASELGQHIDRLLAKAIVALARTYKAGSIVLPKLGDMREVVQSEIQAIAEQKFPGYIEGQQKYAKQYRVNVHRWSYGRLIQSIQSKAAQTGIVIEEGKQPIRGSPHDKAKELALSAYNLRLTRRSCAST system, CRISPR-associated transposasefrom cyanobacteria Scytonema hofmanni-ShTniQ -- WP_029636334.1 SEQ ID NO: 435MIEAPDVKPWLFLIKPYEGESLSHFLGRFRRANHLSASGLGTLAGIGAIVARWERFHFNPRPSQQELEAIASVVEVDAQRLAQMLPPAGVGMQHEPIRLCGACYAESPCHRIEWQYKSVWKCDRHQLKILAKCPNCQAPFKMPALWEDGCCHRCRMPFAEMAKLQKVCAST system, CRISPR-associated transposasefrom cyanobacteria Scytonema hofmanni-ShTnsB -- WP_084763316.1 SEQ ID NO: 436MNSQQNPDLAVHPLAIPMEGLLGESATTLEKNVIATQLSEEAQVKLEVIQSLLEPCDRTTYGQKLREAAEKLNVSLRTVQRLVKNWEQDGLVGLTQTSRADKGKHRIGEFWENFITKTYKEGNKGSKRMTPKQVALRVEAKARELKDSKPPNYKTVLRVLAPILEKQQKAKSIRSPGWRGTTLSVKTREGKDLSVDYSNHVWQCDHTRVDVLLVDQHGEILSRPWLTTVIDTYSRCIMGINLGFDAPSSGVVALALRHAILPKRYGSEYKLHCEWGTYGKPEHFYTDGGKDFRSNHLSQIGAQLGFVCHLRDRPSEGGVVERPFKTLNDQLFSTLPGYTGSNVQERPEDAEKDARLTLRELEQLLVRYIVDRYNQSIDARMGDQTRFERWEAGLPTVPVPIPERDLDICLMKQSRRTVQRGGCLQFQNLMYRGEYLAGYAGETVNLRFDPRDITTILVYRQENNQEVFLTRAHAQGLETEQLALDEAEAASRRLRTAGKTISNQSLLQEVVDRDALVATKKSRKERQKLEQTVLRSAAVDESNRESLPSQIVEPDEVESTETVHSQYEDIEVWDYEQLREEYGFCAST system, CRISPR-associated transposasefrom cyanobacteria Scytonema hofmanni-ShTnsC - WP_029636336.1 SEQ ID NO: 437MTEAQAIAKQLGGVKPDDEWLQAEIARLKGKSIVPLQQVKTLHDWLDGKRKARKSCRVVGESRTGKTVACDAYRYRHKPQQEAGRPPTVPVVYIRPHQKCGPKDLFKKITEYLKYRVTKGTVSDFRDRTIEVLKGCGVEMLIIDEADRLKPETFADVRDIAEDLGIAVVLVGTDRLDAVIKRDEQVLERFRAHLRFGKLSGEDFKNTVEMWEQMVLKLPVSSNLKSKEMLRILTSATEGYIGRLDEILREAAIRSLSRGLKKIDKAVLQEVAKEYKINTEGRATE system - Vibrio cholerae TniQ, Cas8,Cas7 ,and Cas6 (CASCADE) SEQ ID NO: 438MFLQRPKPYSDESLESFFIRVANKNGYGDVHRFLEATKRFLQDIDHNGYQTFPTDITRINPYSAKNSSSARTASFLKLAQLTFNEPPELLGLAINRTNMKYSPSTSAVVRGAEVFPRSLLRTHSIPCCPLCLRENGYASYLWHFQGYEYCHSHNVPLITTCSCGKEFDYRVSGLKGICCKCKEPITLTSRENGHEAACTVSNWLAGHESKPLPNLPKSYRWGLVHWWMGIKDSEFDHFSFVQFFSNWPRSFHSIIEDEVEFNLEHAVVSTSELRLKDLLGRLFFGSIRLPERNLQHNIILGELLCYLENRLWQDKGLIANLKMNALEATVMLNCSLDQIASMVEQRILKPNRKSKPNSPLDVTDYLFHFGDIFCLWLAEFQSDEFNRSFYVSRWMQTLKELIASNPDDLTTELKRAFRPLTPHIAIDGNELDALTILVNLTDKTDDQKDLLDRAKCKQKLRDEKWWASCINCVNYRQSHNPKFPDIRSEGVIRTQALGELPSFLLSSSKIPPYHWSYSHDSKYVNKSAFLTNEFCWDGEISCLGELLKDADHPLWNTLKKLGCSQKTCKAMAKQLADITLTTINVTLAPNYLTQISLPDSDTSYISLSPVASLSMQSHFHQRLQDENRHSAITRFSRTTNMGVTAMTCGGAFRMLKSGAKFSSPPHHRLNSKRSWLTSEHVQSLKQYQRLNKSLIPENSRIALRRKYKIELQNMVRSWFAMQDHTLDSNILIQHLNHDLSYLGATKRFAYDPAMTKLFTELLKRELSNSINNGEQHTNGSFLVLPNIRVCGATALSSPVTVGIPSLTAFFGFVHAFERNINRTTSSFRVESFAICVHQLHVEKRGLTAEFVEKGDGTISAPATRDDWQCDVVFSLILNTNFAQHIDQDTLVTSLPKRLARGSAKIAIDDFKHINSFSTLETAIESLPIEAGRWLSLYAQSNNNLSDLLAAMTEDHQLMASCVGYHLLEEPKDKPNSLRGYKHAIAECIIGLINSITFSSETDPNTIFWSLKNYQNYLVVQPRSINDETTDKSSLMEAASLAYDVSGQPIKSATAEALAQGNPHQVDFCHVPYGASHIECSFSVSFSSELRQPYKCNSSKVKQTLVQLVELYETKIGWTELATRYLMNICNGKWLWKNTRKAYCWNIVLTPWPWNGEKVGFEDIRTNYTSRQDFKNNKNWSAIVEMIKTAFSSTDGLAIFEVRATLHLPTNAMVRPSQVFTEKESGSKSKSKTQNSRVFQSTTIDGERSPILGAFKTGAAIATIDDWYPEATEPLRVGRFGVHREDVTCYRHPSTGKDFFSILQQAEHYIEVLSANKTPAQETINDMHFLMANLIKGGMFQHKGDINTEGRATE system - Vibrio cholerae TnsA, TnsB, and TnsC SEQ ID NO: 439MATSLPTPSAITTSALEYAFHTPARNLTKSRGKNIHRYVSVKMSKRITVESTLECDACYHFDFEPSIVRFCAQPIRFLYYLNGQSHSYVPDFLVQFDTNEFVLYEVKSAYAKNKPDFDVEWEAKVKAATELGLELELVEESDIRDTVVLNNLKRMHRYASKDELNNVHNSLLKIIKYNGAQSARCLGEQLGLKGRTVLPILCDLLSRCLLDTRLDKPLSLESRFELASYGMSETREARISRAKRAFVSTPSVRKILSYMDRCRDLSDLESEPTCMMVYGASGVGKTTVIKKYLNQNRRESEAGGDIIPVLHIELPDNAKPVDAARELLVEMGDPLALYETDLARLTKRLTELIPAVGVKLIIIDEFQHLVEERSNRVLTQVGNWLKMILNKTKCPIVIFGMPYSKVVLQANSQLHGRFSIQVELRPFSYQGGRGVFKTFLEYLDKALPFEKQAGLANESLQKKLYAFSQGNMRSLRNLIYQASIEAIDNQHETITEEDFVFASKLTSGDKPNSWKNPFEEGVEVTEDMLRPPPKDIGWEDYLRHSTPRVSKPGRNKNFFEMAKKGFSSFHRKAVSSQDTLESIELVSSANCLESVTYQDISAFPETIAVEINFRLSILRFLARKCETIVAKSIEPHRVELQQNYSRKIPSAITIYRWWLAFRKSDYNPISLAPNIKDRGNRETKVSTVVDSIMEQAVERVISGRKVNVSSAYKRVRRKVRQYNLTHGTKYTYPKYESVRKRVKKKTPFELLAAGKGERVAKREFRRMGKKILTSSVLERVEIDHTVVDLFAVHEEYRIPLGRPWLTQLVDCYSKAVIGFYLGFEPPSYVSVSLALKNAIQRKDDLISSYESIENEWLCYGIPDLLVTDNGKEFLSKAFDQACESLLINVHQNKVETPDNKPHVERNYGTINTSLLDDLPGKSFSQYLQREGYDSVGEATLTLNEIREIYLIWLVDIYHKKPNQRGTNCPNVAWKKGCQEWEPEEFSGSKDELDFKFAIVDYKQLTKVGITVYKELSYSNDRLAEYRGKKGNHKVQFKYNPECMAVIWVLDEDMNEYFTVNAIDYEYASRVSLWQHKYNMKYQAELNSAEYDEDKEIDAEIKIEEIADRSIVKTNKIRARRRGARHQENSARAKSISNANPASIQKHEDEIVSADNDDWDIDYVEscherichia phage P1 (Bacteriophage P1) CreRecombinase (Uniprot P06956), SEQ ID NO: 440MSNLLTVHQNLPALPVDATSDEVRKNLMDMFRDRQAFSEHTWKMLLSVCRSWAAWCKLNNRKWFPAEPEDVRDYLLYLQARGLAVKTIQQHLGQLNMLHRRSGLPRPSDSNAVSLVMRRIRKENVDAGERAKQALAFERTDFDQVRSLMENSDRCQDIRNLAFLGIAYNTLLRIAEIARIRVKDISRTDGGRMLIHIGRTKTLVSTAGVEKALSLGVTKLVERWISVSGVADDPNNYLFCRVRKNGVAAPSATSQLSTRALEGIFEATHRLIYGAKDDSGQRYLAWSGHSARVGAARDMARAGVSIPEIMQAGGWTNVNIVMNYIRNLDSETGAMVRLLEDGD

What is claimed is:
 1. A method for identifying a genetic modifier toalter expression of a target gene in a selected cell type, the methodcomprising: providing, optionally from a database, one or more candidateregulatory motif sequences with regulatory potential in the selectedcell type; selecting a sequence of a putative regulatory region of thetarget gene, preferably wherein the putative regulatory region is in apromoter, enhancer, insulator, untranslated region (UTR), or intron,optionally in a non-coding region of the target gene; comparing thesequence of the putative regulatory region to the candidate regulatorymotif sequences, identifying a candidate regulatory motif sequence thathas either no identity at all as a potential insertion site or that hasat least 500% identity and at least one mismatch to a portion of thesequence of the regulatory sequence as a potential substitution site;determining sequence alterations needed to make the putative regulatoryregion match the candidate regulatory motif sequence; and identifyingone or more genetic modifiers capable of making the sequence alterationsneeded to make the putative regulatory region match the candidateregulatory motif sequence, or; optionally wherein identifying a geneticmodifier comprises using an algorithm that compares the putativeregulatory region and candidate regulatory motif sequences from adatabase and identifies candidate regulatory motif sequences that differfrom the putative regulatory region by at least one nucleotide and up to100% as a potential insertion site, or that differ from the putativeregulatory region by at least one nucleotide and up to a selectedamount, optionally at least 50% identity, as a potential substitutionsite, determines sequence alterations needed to make the putativeregulatory region match the candidate regulatory motif sequence,compares the sequence alterations to a database of modifications thatcould be made by a set of genetic modifiers, and identifying one or moregenetic modifiers that can alter the putative regulatory region to matchthe candidate regulatory motif sequence, to thereby introduce afunctional regulatory motif.
 2. The method of claim 1, wherein thecandidate regulatory sequence motif has regulatory potential to affecttarget gene expression at the pre-transcriptional orpost-transcriptional level.
 3. The method of claim 2, wherein thecandidate regulatory sequence motif is a transcription factor bindingsequence that can recruit endogenous transcription factors within a celltype or cell types of interest, where the sequence motif may or may notexist in the genome of the selected cell type.
 4. The method of claim 2,wherein the candidate regulatory sequence motif alters spacing ofendogenous transcription factor binding sites in the putative regulatoryregion.
 5. The method of claim 2, wherein the candidate regulatorysequence motif is a response element that is activated by areceptor-ligand complex through binding of an exogenously deliveredsmall molecule, hormone, or drug for inducible target gene activation.6. The method of claim 2, wherein the candidate regulatory sequencemotif either stabilizes or de-stabilizes target gene transcripts, wherethe candidate regulatory sequence motif may or may not exist in thegenome of the selected cell type.
 7. The method of claim 2, wherein thecandidate regulatory sequence motif is a hybridization target forendogenous non-coding RNAs, where the sequence motif that may or may notexist in the genome of interest.
 8. The method of claim 2, wherein thecandidate regulatory sequence motif modifies the translation initiationand/or elongation efficiency for target gene transcripts, and whereinthe candidate regulatory sequence motif may or may not exist in thegenome of the selected cell type.
 9. The method of claims 1-8, whereinthe putative regulatory region has the potential to modify expression ofthe target gene at the pre-transcriptional or post-transcriptionallevel.
 10. The method of claim 9, wherein the putative regulatory regionis a non-coding DNA sequence within 1 Mb or more of a target gene ofinterest, or spatially-proximal as determined by chromosome conformationcapture assays.
 11. The method of claim 9, wherein the putativeregulatory region is a promoter of a target gene of interest.
 12. Themethod of claim 9, wherein the putative regulatory region comprisesputative enhancer elements of a target gene of interest as defined byhistone marks associated and/or chromatin accessibility featuresassociated with functional enhancer elements; putative insulatorelements of the target gene of interest as defined by histone marksassociated and/or chromatin accessibility features associated withfunctional insulator elements; and/or putative silencer elements of thetarget genes of interest as defined by histone marks associated and/orchromatin accessibility features associated with functional silencerelements.
 13. The method of claim 9, wherein the putative regulatoryregion comprises untranslated regions (UTRs) of the target genetranscripts.
 14. The method of claim 9, wherein the putative regulatoryregions comprise an intronic region of the target gene transcripts. 15.The method of claim 9, wherein the putative regulatory regions comprisesa coding sequence of target gene transcripts.
 16. The method of claims1-15, wherein the identified genetic modifier can introduce a specificsequence motif or modification at the target genomic region.
 17. Themethod of claim 16, wherein the genetic modifier comprises a CRISPR-Casdomain, a zinc-finger DNA binding domain, or a transcriptionactivator-like (TAL) effector domain.
 18. The method of claim 17,wherein the CRISPR-Cas domain is used with a gRNA, wherein the gRNAcomprises a sequence complementary to a sequence of the targetcis-regulatory element of interest.
 19. The method of claim 16, whereinthe genetic modifier is a programmable nuclease, a base editor, or aprime editor.
 20. The method of claim 17, wherein the CRISPR-Cas primeeditor further comprises a prime editing gRNA (pegRNA) and nicking sgRNA(ngRNA) wherein the pegRNA and ngRNA comprise a sequence complementaryto a sequence of the target cis-regulatory element of interest.
 21. Amethod for altering expression of a target gene in a selected cell type,the method comprising: providing, optionally from a database, one ormore candidate regulatory motif sequences with regulatory potential inthe selected cell type; selecting a sequence of a putative regulatoryregion of the target gene, preferably wherein the putative regulatoryregion is in a promoter, enhancer, insulator, untranslated region (UTR),or intron, optionally in a non-coding region of the target gene;comparing the sequence of the putative regulatory region to thecandidate regulatory motif sequences, identifying a candidate regulatorymotif sequence that has either no identity at all as a potentialinsertion site or that has at least 50% identity and at least onemismatch to a portion of the sequence of the regulatory sequence as apotential substitution site; determining sequence alterations needed tomake the putative regulatory region match the candidate regulatory motifsequence; and identifying one or more genetic modifiers capable ofmaking the sequence alterations needed to make the putative regulatoryregion match the candidate regulatory motif sequence, and contacting thecell with the one or more genetic modifiers under conditions and for atime sufficient for the one or more genetic modifiers to make theputative regulatory region match the candidate regulatory motifsequence.
 22. The method of claim 21, wherein identifying a geneticmodifier comprises using an algorithm that compares the putativeregulatory region and candidate regulatory motif sequences from adatabase and identifies candidate regulatory motif sequences that differfrom the putative regulatory region by at least one nucleotide and up to100% as a potential insertion site, or that differ from the putativeregulatory region by at least one nucleotide and up to a selectedamount, optionally at least 50% identity, as a potential substitutionsite, determines sequence alterations needed to make the putativeregulatory region match the candidate regulatory motif sequence,compares the sequence alterations to a database of modifications thatcould be made by a set of genetic modifiers, and identifying one or moregenetic modifiers that can alter the putative regulatory region to matchthe candidate regulatory motif sequence, to thereby introduce afunctional regulatory motif.
 23. A method for altering expression of atarget gene in a selected cell, the method comprising contacting theselected cell with a genetic modifier identified using the method ofclaims 1-20, under conditions sufficient to increase the target geneexpression in the cell.
 24. A method for heterotopic activation of atarget gene expression in a selected cell, the method comprisingcontacting the cell with a genetic modifier identified using the methodof claims 1-20, under conditions sufficient to increase the target geneexpression in the cell.
 25. The method of claims 21-24, wherein thecandidate regulatory sequence motif is introduced into the putativeregulatory region as a single motif or a repetitive sequence withmultiple copies of the single motif, optionally with linker sequencestherebetween.
 26. The method of claims 21-24, wherein the geneticmodifier introduces multiplex edits to alter expression of a singletarget gene.
 27. The method of claims 21-24, wherein the geneticmodifier introduces multiplex edits in to alter expression of multipletarget genes.
 28. The method of any one of claims 1-27, wherein the cellis a eukaryotic cell.
 29. The method of claim 28, wherein the cell is amammalian cell.
 30. The method of claim 29, wherein the cell is a humancell.
 31. A method for treating or reducing risk of a condition or adisease in a subject, wherein the condition or the disease is caused, atleast in part, by insufficient expression of the target gene, the methodcomprising administering to the subject an effective amount of a geneticmodifier identified using the method of any one of claims 1-20, underconditions sufficient to increase the target gene expression in thecell, thereby treating or reducing risk of the condition or the diseasein the subject.
 32. The method of claim 31, wherein the condition or thedisease is caused, at least in part, by insufficient expression of thetarget gene on an allele.
 33. The method of claim 31, wherein thecondition or the disease is related to haploinsufficiency.
 34. Themethod of claim 31 or 32, wherein the condition or the disease iscaused, at least in part, by a dominant-negative gene.
 35. The method ofclaim 31 or 32, wherein the condition or the disease is caused, at leastin part, by insufficient expression of a target gene that is under thecontrol of an enhancer, wherein the enhancer controls the expression ofa plurality of genes.
 36. The method of any one of claims 31-35, whereinthe method causes an increase in the expression of the target gene inthe cell or in the cell of the subject by at least 1.1 fold as measuredby mRNA expression.
 37. A method for treating or reducing risk of acondition or a disease in a subject, wherein the condition or thedisease is caused, at least in part, by overexpression of the targetgene, the method comprising administering to the subject an effectiveamount of a genetic modifier identified using the method of any one ofclaims 1-20, under conditions sufficient to increase the target geneexpression in the cell, thereby treating or reducing risk of thecondition or the disease in the subject.
 38. The method of any one ofclaims 31-37, wherein the method causes a decrease in the expression ofthe target gene in the cell or in the cell of the subject by at least1.1 fold.